data_6iyn_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6iyn _Structure_validation_residue.Date_analyzed 2019-01-18 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.77 118.06 30.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 0.0 109.946 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.83 122.89 48.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.95 0.9 . . . . 0.0 108.627 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 92.5 t -117.52 103.31 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.149 0.98 . . . . 0.0 109.123 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.63 147.47 27.69 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.165 0.586 . . . . 0.0 109.77 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 p -162.47 178.57 8.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.362 1.065 . . . . 0.0 109.493 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.42 5.3 89.89 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 116.537 -0.301 . . . . 0.0 113.433 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.86 135.64 19.37 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.84 178.39 40.59 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -98.66 139.26 34.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.594 0.758 . . . . 0.0 111.006 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 11.3 p -151.12 151.35 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.328 1.051 . . . . 0.0 108.534 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 18.1 mp0 -70.12 159.54 33.72 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.258 0.623 . . . . 0.0 112.272 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 121.92 15.03 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.913 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.51 58.82 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.734 0.646 . . . . 0.0 112.172 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.39 -164.4 37.67 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.068 0.366 . . . . 0.0 112.984 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -148.72 155.67 41.32 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.214 0.606 . . . . 0.0 110.774 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -153.45 136.14 15.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.056 0.942 . . . . 0.0 109.339 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -99.24 132.99 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.277 0.561 . . . . 0.0 110.09 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 4.2 mm? -106.72 159.95 15.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.216 . . . . 0.0 109.79 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -137.75 156.04 48.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.956 0.902 . . . . 0.0 110.007 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 54.0 t -150.66 113.51 4.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 109.6 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -84.4 117.53 23.68 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.85 0.86 . . . . 0.0 109.051 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.3 124.58 49.79 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.263 0.625 . . . . 0.0 109.724 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.1 m -141.77 -178.08 5.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.935 1.294 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.19 -117.17 4.36 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.54 153.82 42.92 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.896 0.848 . . . . 0.0 110.746 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.3 p -68.9 107.29 3.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.909 0.483 . . . . 0.0 109.724 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ASN . 5.2 p90 -64.75 -14.62 59.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.255 0.622 . . . . 0.0 110.924 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.5 p -70.37 -3.55 18.02 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.162 0.985 . . . . 0.0 112.32 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -109.52 7.66 24.82 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.462 1.105 . . . . 0.0 110.08 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.07 156.19 49.08 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.123 0.969 . . . . 0.0 111.091 -173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.8 133.16 50.97 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 17.7 ttp -118.23 142.11 47.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.286 0.634 . . . . 0.0 109.589 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -127.45 154.21 19.48 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.391 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -97.03 125.56 41.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.39 160.22 24.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.263 1.425 . . . . 0.0 107.64 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -139.89 162.14 35.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.86 0.755 . . . . 0.0 111.772 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -165.43 152.93 10.78 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.642 1.213 . . . . 0.0 110.52 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 173.27 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 125.245 1.418 . . . . 0.0 110.231 168.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 65.7 Cg_endo -87.58 80.51 1.3 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.938 1.758 . . . . 0.0 112.046 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.45 73.28 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.347 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -115.29 148.86 38.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.105 0.962 . . . . 0.0 112.03 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 178.19 5.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -61.46 102.63 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -99.86 147.32 25.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.038 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.87 114.49 3.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.229 0.612 . . . . 0.0 110.073 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' HE1' ' A' ' 95' ' ' TYR . 98.5 t -104.12 -55.78 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -158.54 152.49 23.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.547 0.739 . . . . 0.0 110.13 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 42.9 t -137.71 141.86 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.32 1.048 . . . . 0.0 108.58 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.72 145.21 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.73 0.812 . . . . 0.0 109.272 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -81.08 156.34 25.85 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 166.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -52.16 -39.3 59.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.052 0.941 . . . . 0.0 112.523 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -68.49 -26.39 65.45 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.934 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.34 12.31 82.25 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.644 -166.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -65.24 -38.57 90.77 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.068 1.347 . . . . 0.0 110.902 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -128.38 128.08 43.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.492 0.717 . . . . 0.0 110.47 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -122.29 129.97 52.7 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 108.271 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -120.96 138.47 54.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.723 1.209 . . . . 0.0 107.973 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.01 138.82 44.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.195 0.598 . . . . 0.0 110.532 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 147.56 31.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.906 0.883 . . . . 0.0 109.635 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -59.02 -27.27 65.3 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.834 0.854 . . . . 0.0 112.745 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.2 m -64.56 -32.79 74.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.521 0.728 . . . . 0.0 112.019 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.78 5.16 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 124.388 1.075 . . . . 0.0 111.839 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.92 142.66 51.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 0.0 110.833 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.75 -22.51 9.05 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.424 0.453 . . . . 0.0 113.867 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -117.03 -17.43 10.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.535 0.734 . . . . 0.0 111.547 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.61 149.23 23.49 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -149.2 137.4 20.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.101 0.96 . . . . 0.0 108.952 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.03 151.39 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.0 m -146.02 159.6 43.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.972 1.309 . . . . 0.0 108.58 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.65 132.48 5.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.202 0.525 . . . . 0.0 111.238 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.68 107.43 19.09 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 30' ' ' PHE . 1.8 m-20 -69.63 -33.02 72.04 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 0.0 110.824 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.29 83.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.761 0.825 . . . . 0.0 111.104 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -97.72 -0.51 45.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.268 0.627 . . . . 0.0 112.105 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.02 27.37 17.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.774 1.23 . . . . 0.0 113.46 171.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 m -119.36 131.81 55.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.56 0.344 . . . . 0.0 110.75 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 36.0 t -103.31 148.77 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.431 1.092 . . . . 0.0 108.923 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.11 152.07 51.43 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -132.19 108.28 9.16 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -83.61 102.76 12.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.062 0.945 . . . . 0.0 109.508 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 58.4 mtt -88.69 123.61 33.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -123.53 141.95 51.49 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.8 m 53.92 61.33 3.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.411 1.084 . . . . 0.0 111.791 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.38 117.18 11.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.365 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -75.05 149.38 85.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.405 1.082 . . . . 0.0 109.05 174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 19.4 Cg_endo -56.54 -17.78 23.29 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.181 2.587 . . . . 0.0 114.681 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.51 -20.45 58.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.25 1.02 . . . . 0.0 113.051 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -77.14 -0.36 24.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 m -62.62 101.67 0.27 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.461 0.704 . . . . 0.0 110.1 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.54 160.99 15.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.036 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.69 116.52 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.349 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' A' ' 49' ' ' VAL . 15.7 m-85 -91.84 117.09 29.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.706 0.803 . . . . 0.0 111.092 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.64 130.07 47.91 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.038 0.935 . . . . 0.0 109.999 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.539 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.8 m -84.67 124.15 31.17 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.63 20.98 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.038 0.935 . . . . 0.0 109.695 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 35' ' ' MET . . . -119.34 167.93 11.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.858 0.863 . . . . 0.0 111.137 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.73 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.791 175.182 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.81 146.88 51.54 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.521 1.129 . . . . 0.0 109.121 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.02 156.92 42.96 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.034 0.934 . . . . 0.0 109.242 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.62 -163.34 26.14 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.219 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 6' ' ' VAL . 41.7 mt-30 -81.59 -50.1 9.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.097 1.359 . . . . 0.0 110.689 -174.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.5 137.45 6.47 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.789 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -114.59 115.82 27.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 109.564 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -73.49 111.83 8.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.745 0.818 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.5 145.12 16.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 52.2 m -127.88 139.2 52.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.2 p -119.78 113.14 39.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 31.1 t -58.38 113.19 1.85 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.595 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 37.8 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 124.534 1.134 . . . . 0.0 111.13 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -85.57 116.38 23.83 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -110.14 129.84 55.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.424 1.09 . . . . 0.0 108.296 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 34.6 t -121.9 98.25 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.85 139.64 30.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 122.89 0.476 . . . . 0.0 110.166 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -153.46 165.01 37.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.949 0.899 . . . . 0.0 109.957 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.34 -11.45 54.67 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.988 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.29 120.54 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.028 -0.318 . . . . 0.0 112.448 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.6 -169.42 22.9 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -79.63 135.49 36.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.498 0.319 . . . . 0.0 111.275 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.64 139.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.29 1.036 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.83 149.55 35.62 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.687 0.795 . . . . 0.0 112.025 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.27 7.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.218 0.607 . . . . 0.0 110.704 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.71 -10.37 25.65 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.033 0.825 . . . . 0.0 111.541 -175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.46 -170.82 44.5 Favored Glycine 0 C--N 1.346 1.124 0 C-N-CA 123.038 0.351 . . . . 0.0 113.862 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.4 p -121.52 162.1 21.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.252 1.021 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.96 126.9 8.29 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -98.4 118.33 34.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.163 0.585 . . . . 0.0 110.248 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -102.02 154.18 19.21 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.194 0.998 . . . . 0.0 109.018 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -145.67 146.84 31.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.582 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 53.6 t -138.37 123.43 19.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -85.22 114.77 22.57 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.26 24.51 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.408 0.683 . . . . 0.0 109.239 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 t -71.78 164.33 26.2 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.19 -11.25 51.36 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.384 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.9 127.45 26.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.326 1.051 . . . . 0.0 109.28 169.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 p -60.77 89.04 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.12 -18.54 60.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.077 160.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 29.9 p -66.7 -14.43 62.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.069 1.347 . . . . 0.0 112.794 176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m -83.98 -4.24 58.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 0.0 111.225 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.32 168.91 17.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.591 0.757 . . . . 0.0 110.988 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 121.8 33.49 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttp -101.22 130.44 47.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 109.493 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.554 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -134.0 154.25 21.28 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.51 138.89 32.56 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.462 1.105 . . . . 0.0 109.187 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.77 170.25 14.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.159 1.384 . . . . 0.0 108.113 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -153.73 162.05 41.58 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.901 0.319 . . . . 0.0 111.802 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.438 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -168.02 151.86 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.529 1.143 . . . . 0.0 110.835 167.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 169.74 -59.11 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 125.283 1.433 . . . . 0.0 110.885 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.42 70.24 5.13 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.511 2.141 . . . . 0.0 112.609 -169.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.92 17.22 76.8 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.787 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -109.24 140.95 42.22 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 110.745 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.31 170.3 12.91 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.75 105.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.91 154.89 20.95 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 110.647 -171.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -66.6 110.38 3.17 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.674 171.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG11 ' HE1' ' A' ' 95' ' ' TYR . 95.2 t -88.81 -62.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -163.53 134.54 4.65 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.554 HG21 ' HA3' ' A' ' 36' ' ' GLY . 71.3 t -115.41 153.46 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.158 0.983 . . . . 0.0 108.595 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.9 151.39 31.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.6 152.99 44.61 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 52.9 p-90 -61.42 -36.05 79.25 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -82.72 -5.34 58.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.477 0.711 . . . . 0.0 111.659 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.55 79.87 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -58.51 -47.71 83.24 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.742 0.817 . . . . 0.0 111.234 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.1 mtt85 -130.71 141.23 50.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 p -110.99 130.2 55.66 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -114.93 116.33 28.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -114.27 142.21 46.58 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.83 47.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.35 -26.36 60.87 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.689 0.795 . . . . 0.0 111.978 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -69.6 -26.05 64.26 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.595 1.158 . . . . 0.0 112.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 49' ' ' VAL . 33.5 m -127.96 7.64 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.03 0.932 . . . . 0.0 111.652 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.24 124.34 23.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 111.31 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -3.01 85.92 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.11 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -121.15 -10.9 8.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.487 0.643 . . . . 0.0 111.421 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -109.57 162.39 14.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.202 0.601 . . . . 0.0 109.873 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 86.4 m -151.59 130.57 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.267 1.027 . . . . 0.0 109.45 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 50' ' ' ALA . 1.7 mp -103.29 141.12 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 49.5 m -139.27 158.76 43.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.729 1.212 . . . . 0.0 108.248 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.18 131.12 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.029 0.443 . . . . 0.0 110.881 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.01 92.17 5.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.483 1.113 . . . . 0.0 108.27 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.46 -25.58 68.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.146 0.578 . . . . 0.0 111.413 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.8 98.1 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.87 0.868 . . . . 0.0 111.504 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.82 -10.25 37.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.637 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 58.21 45.27 17.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.117 0.967 . . . . 0.0 109.574 -170.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 m -115.34 148.39 39.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.283 1.033 . . . . 0.0 109.408 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 57.6 t -126.68 150.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 108.903 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 86.7 m-85 -133.53 146.23 50.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 0.0 108.975 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.3 tm? -133.87 107.19 7.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 35.4 tt0 -86.75 126.83 34.85 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.434 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.7 mtt -105.48 141.49 36.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.482 1.113 . . . . 0.0 108.824 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -141.61 147.33 37.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t 58.27 52.14 7.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.756 0.823 . . . . 0.0 111.28 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 84' ' ' MET . 77.8 mt -71.51 120.8 17.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.828 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.412 ' O ' HG11 ' A' ' 121' ' ' VAL . 39.2 mtmt -82.99 149.37 59.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.167 0.987 . . . . 0.0 108.985 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -55.98 -18.93 24.12 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 123.387 2.724 . . . . 0.0 114.791 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.49 -20.11 54.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.143 0.977 . . . . 0.0 112.609 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -71.18 -7.76 48.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.223 0.609 . . . . 0.0 112.544 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.5 m -56.58 101.82 0.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.961 0.904 . . . . 0.0 110.302 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.02 159.07 9.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.573 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.1 p -78.89 113.48 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.521 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.0 m-85 -87.98 112.51 22.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.237 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -104.57 122.73 46.21 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.493 1.117 . . . . 0.0 109.098 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.88 132.04 35.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.56 160.29 40.33 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.962 0.905 . . . . 0.0 109.295 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.43 160.65 39.35 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . . . . . . 0 N--CA 1.466 0.659 0 CA-C-O 119.773 -0.459 . . . . 0.0 113.831 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.411 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 20.1 t70 . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 121.207 0.527 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -133.85 153.67 51.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.531 1.132 . . . . 0.0 109.302 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -149.64 148.88 29.83 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.126 0.971 . . . . 0.0 108.882 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.57 -155.7 32.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.935 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.8 mt-30 -97.69 -38.06 9.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.311 1.045 . . . . 0.0 110.587 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.91 136.81 9.2 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.172 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -117.58 114.31 23.23 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.07 0.948 . . . . 0.0 108.805 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 62.3 tp60 -71.9 108.84 5.37 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.32 145.29 7.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 25.2 m -132.6 109.67 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 88' ' ' LYS . 1.7 p -94.7 105.09 16.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.7 t -56.82 118.83 5.31 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.115 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 124.168 0.987 . . . . 0.0 110.928 -176.13 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 112' ' ' TYR . 54.4 tp . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -72.38 104.35 3.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.126 0.57 . . . . 0.0 110.025 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.09 128.95 54.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 108.48 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.8 t -121.9 103.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.78 156.82 18.25 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.231 1.012 . . . . 0.0 110.412 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -159.44 171.81 19.04 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.882 0.873 . . . . 0.0 109.791 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.5 15.42 15.49 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.044 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.79 92.18 0.36 Allowed Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.933 0.301 . . . . 0.0 112.444 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.88 179.96 23.43 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.5 pp -107.36 147.86 29.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.084 0.554 . . . . 0.0 110.571 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.0 p -149.47 145.12 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.553 1.141 . . . . 0.0 108.707 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.2 mp0 -72.61 158.34 35.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.876 0.47 . . . . 0.0 112.026 -172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 114.33 3.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.923 0.889 . . . . 0.0 111.261 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.7 -10.0 25.73 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.486 0.565 . . . . 0.0 112.033 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.02 -163.82 39.33 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.026 0.346 . . . . 0.0 112.713 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.9 p -143.73 158.17 43.87 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.387 0.675 . . . . 0.0 109.981 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -149.59 119.66 7.21 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.9 ttt85 -96.6 116.12 28.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.722 0.809 . . . . 0.0 109.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.586 HD23 ' HE2' ' A' ' 84' ' ' MET . 2.4 mm? -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.173 0.989 . . . . 0.0 110.216 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -132.7 145.22 50.87 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.637 0.775 . . . . 0.0 109.28 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.87 119.37 8.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.325 0.65 . . . . 0.0 110.45 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.73 129.74 34.75 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.029 0.532 . . . . 0.0 110.029 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.93 128.64 54.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.087 0.955 . . . . 0.0 110.156 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -142.76 159.4 42.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.097 0.959 . . . . 0.0 109.816 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.35 -117.96 5.9 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -77.26 163.84 26.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.581 0.752 . . . . 0.0 110.085 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -70.19 97.25 1.18 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.015 0.526 . . . . 0.0 111.1 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -68.43 -23.95 64.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.706 0.802 . . . . 0.0 110.798 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 60.6 p -72.5 -0.05 11.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.949 0.9 . . . . 0.0 112.276 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -99.46 -9.75 23.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.241 0.616 . . . . 0.0 111.116 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -123.48 169.42 11.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.428 0.633 . . . . 0.0 112.323 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.83 125.9 47.38 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.207 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.53 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 9.4 ptm -107.56 170.19 8.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 0.0 110.463 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.41 149.38 18.09 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 113.376 0.11 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -98.1 141.17 31.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.156 0.982 . . . . 0.0 109.995 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -138.28 133.24 32.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.654 1.181 . . . . 0.0 108.724 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -114.79 159.6 20.41 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.058 0.39 . . . . 0.0 111.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.6 pt20 -168.66 151.8 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.505 0.722 . . . . 0.0 110.712 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -179.59 -57.6 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 123.776 0.83 . . . . 0.0 111.114 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.73 64.99 7.39 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.342 2.028 . . . . 0.0 112.348 -171.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.43 22.32 76.37 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.78 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -103.34 149.1 25.08 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.931 0.892 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.38 178.48 5.95 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.472 1.109 . . . . 0.0 108.334 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.04 105.39 0.47 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 150.1 21.01 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.08 112.58 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.757 0.823 . . . . 0.0 110.559 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.18 -66.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.3 135.14 3.02 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.2 t -110.87 132.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.262 1.025 . . . . 0.0 109.208 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.92 151.17 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.688 0.795 . . . . 0.0 110.493 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 25.1 t-20 -75.69 156.65 34.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.982 0.913 . . . . 0.0 109.205 170.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 54.7 p-90 -58.78 -34.52 71.54 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.5 p -95.71 1.55 53.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 0.0 111.678 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.02 9.5 71.46 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 113.363 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -64.01 -35.31 80.3 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.33 1.052 . . . . 0.0 111.181 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 98.5 mtt180 -125.49 138.59 53.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.337 1.055 . . . . 0.0 109.229 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.8 p -140.29 131.92 27.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.621 0.768 . . . . 0.0 109.543 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.37 115.78 24.82 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 147.25 34.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.593 0.357 . . . . 0.0 110.241 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.18 146.59 43.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.22 -34.04 73.1 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.5 m -70.61 -28.16 64.64 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.034 0.534 . . . . 0.0 112.223 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.77 1.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.193 0.597 . . . . 0.0 111.408 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -67.5 120.84 14.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.463 0.705 . . . . 0.0 111.824 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.25 -27.88 4.92 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.748 0.689 . . . . 0.0 113.959 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' NH2' HD21 ' A' ' 87' ' ' LEU . 1.6 ptm180 -89.05 -8.59 53.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.839 0.856 . . . . 0.0 110.901 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.21 151.97 27.64 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.5 m -140.19 119.41 12.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.163 0.985 . . . . 0.0 108.528 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 71' ' ' ILE . 1.1 mp -103.54 127.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 m -133.83 157.78 45.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 108.206 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 150.75 18.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.127 0.489 . . . . 0.0 110.341 174.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 77' ' ' LYS . 17.8 m-20 -119.88 112.14 18.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -71.14 -26.95 63.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.072 0.549 . . . . 0.0 110.788 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.36 59.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.509 0.724 . . . . 0.0 111.02 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 72.5 mmtt -77.5 -25.01 49.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.616 0.366 . . . . 0.0 110.886 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 60.32 44.97 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.388 1.075 . . . . 0.0 110.039 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m -139.08 131.24 28.14 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.847 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.58 141.72 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.65 1.18 . . . . 0.0 109.593 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -125.09 126.33 45.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.186 0.994 . . . . 0.0 109.063 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.37 98.19 6.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -89.16 106.6 18.55 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.298 0.639 . . . . 0.0 110.207 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.586 ' HE2' HD23 ' A' ' 21' ' ' LEU . 56.4 mtm -88.07 139.39 30.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.322 0.649 . . . . 0.0 109.3 174.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 m 59.77 60.29 2.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.187 0.995 . . . . 0.0 111.123 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 84' ' ' MET . 99.3 mt -80.73 127.91 33.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.477 -173.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 2.3 mptp? -92.71 153.91 42.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.3 -25.7 4.97 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.875 3.05 . . . . 0.0 115.142 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.6 pt-20 -71.44 -23.27 61.81 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.743 1.217 . . . . 0.0 113.432 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 1.12 14.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.782 0.833 . . . . 0.0 113.196 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 120' ' ' THR . 54.9 m -62.99 103.13 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.291 0.636 . . . . 0.0 110.337 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.57 155.04 5.85 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.227 0.611 . . . . 0.0 111.452 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.3 p -78.95 112.29 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -87.68 113.47 23.38 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -102.71 128.8 49.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.24 129.38 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -138.53 163.52 31.77 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.264 1.025 . . . . 0.0 109.073 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -138.5 133.7 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.772 0.829 . . . . 0.0 108.774 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.466 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.484 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.508 0.67 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 34.2 m-85 -111.37 151.1 28.85 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.044 0.938 . . . . 0.0 109.14 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 42.4 p90 -166.08 167.42 16.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.869 0.868 . . . . 0.0 109.997 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.99 -147.85 10.13 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.206 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.23 -48.85 9.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.807 0.843 . . . . 0.0 110.383 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.8 151.57 25.33 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.817 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 t -122.64 111.42 16.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.336 1.054 . . . . 0.0 110.077 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 57.2 tp60 -72.47 113.87 9.98 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.474 0.71 . . . . 0.0 110.15 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.499 HG21 ' HE3' ' A' ' 84' ' ' MET . 4.1 m -102.87 146.83 10.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.494 0.718 . . . . 0.0 109.366 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.506 ' HA ' HG23 ' A' ' 92' ' ' THR . 96.4 m -124.63 143.21 50.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.89 0.876 . . . . 0.0 109.001 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.7 p -129.86 125.62 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 109.791 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 7.9 m -80.03 122.48 26.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.468 1.107 . . . . 0.0 111.885 -170.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 123.763 0.825 . . . . 0.0 110.699 174.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -94.94 114.74 26.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.532 0.733 . . . . 0.0 109.328 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.678 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 96.0 mt -106.9 116.96 32.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.4 101.92 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -111.22 125.39 53.76 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.373 -166.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -165.75 -178.74 4.96 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.22 1.008 . . . . 0.0 110.239 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.5 -0.52 26.34 Favored Glycine 0 N--CA 1.476 1.355 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.33 151.51 29.84 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 122.88 0.276 . . . . 0.0 113.064 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.25 -168.94 31.08 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -91.31 145.54 24.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.226 0.536 . . . . 0.0 111.043 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.94 159.89 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.072 1.349 . . . . 0.0 108.13 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -87.26 166.2 15.09 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.957 0.503 . . . . 0.0 111.158 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.45 129.21 38.65 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.319 0.648 . . . . 0.0 109.959 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.46 81.75 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.741 0.651 . . . . 0.0 111.892 -170.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 -165.91 40.55 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 122.804 0.24 . . . . 0.0 112.941 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.8 p -148.18 159.03 44.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.861 0.864 . . . . 0.0 110.2 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -159.52 135.22 8.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.583 0.753 . . . . 0.0 109.496 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -109.38 126.51 53.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.841 0.457 . . . . 0.0 110.136 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -103.96 156.96 17.43 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.352 1.061 . . . . 0.0 109.332 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -144.57 154.64 43.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 111.006 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.6 t -150.68 134.2 16.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.453 0.701 . . . . 0.0 109.923 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 145.94 26.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . . . -105.74 126.66 52.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -133.65 157.72 45.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.603 1.161 . . . . 0.0 109.2 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.96 1.08 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -95.16 164.38 12.89 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.574 0.749 . . . . 0.0 110.055 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.6 m -97.41 121.16 38.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 15.9 p90 -63.5 -16.45 60.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.558 0.743 . . . . 0.0 111.744 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.3 t -68.03 -15.17 63.48 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 0.0 112.613 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 p -93.05 9.68 34.75 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 122.024 -0.422 . . . . 0.0 110.661 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -134.25 167.56 20.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.379 1.071 . . . . 0.0 110.243 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.85 160.45 15.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.441 ' HE1' ' HB3' ' A' ' 35' ' ' MET . 31.1 ttp -140.47 157.71 45.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.64 144.01 9.38 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -96.42 131.63 42.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.92 129.0 37.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.014 0.926 . . . . 0.0 108.557 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -109.05 162.35 14.32 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.727 0.299 . . . . 0.0 110.537 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -167.8 148.53 5.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.091 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . 177.23 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.056 0.942 . . . . 0.0 111.352 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 68.5 Cg_endo -82.2 64.82 8.38 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 122.111 1.874 . . . . 0.0 112.523 -170.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.86 6.43 72.72 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.772 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -105.81 146.25 30.12 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.717 0.807 . . . . 0.0 110.142 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.8 178.04 6.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.861 0.864 . . . . 0.0 109.119 170.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -51.68 104.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.48 151.79 19.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.356 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -64.85 108.34 1.73 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -99.0 -49.08 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB3' HD13 ' A' ' 71' ' ' ILE . . . -167.49 150.3 6.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.23 138.56 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 59' ' ' THR . 8.9 p -131.65 160.45 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.68 158.41 20.81 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -56.53 -38.16 71.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.532 0.733 . . . . 0.0 112.077 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -76.62 -23.48 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.625 0.77 . . . . 0.0 111.642 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.32 8.42 83.51 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.564 -165.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -58.42 -39.01 78.61 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.609 1.164 . . . . 0.0 111.049 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -119.52 130.87 55.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.286 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.443 HG22 HG23 ' A' ' 52' ' ' VAL . 46.5 p -122.36 133.21 54.65 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.906 0.883 . . . . 0.0 109.077 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.76 135.93 50.81 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -134.55 148.64 50.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.326 0.65 . . . . 0.0 109.973 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.99 128.32 33.71 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.66 -20.48 60.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.196 0.598 . . . . 0.0 112.436 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 p -64.94 -44.28 89.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.693 0.797 . . . . 0.0 111.129 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.33 -3.43 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.964 0.906 . . . . 0.0 111.782 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -66.81 134.71 52.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.298 0.639 . . . . 0.0 110.638 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.67 15.52 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.968 0.793 . . . . 0.0 113.387 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 19.0 ptt-85 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.01 0.405 . . . . 0.0 110.424 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.461 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 2.8 m-85 -105.94 151.04 25.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.729 0.812 . . . . 0.0 109.979 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 m -149.14 142.22 24.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.844 1.258 . . . . 0.0 108.211 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 50' ' ' ALA . 1.4 mp -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -140.03 154.57 47.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.237 1.015 . . . . 0.0 108.334 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HG3' ' HE2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -159.72 131.29 6.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.69 98.9 10.26 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.109 0.963 . . . . 0.0 108.537 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.01 -25.5 67.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.98 0.912 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.34 72.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.415 1.086 . . . . 0.0 111.673 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -83.05 -11.23 58.22 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.148 0.579 . . . . 0.0 111.251 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 30.4 m-80 61.18 35.98 18.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 0.0 110.302 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 132.65 53.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.927 0.891 . . . . 0.0 110.257 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.1 t -99.99 153.11 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.112 1.365 . . . . 0.0 110.255 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -136.45 151.79 49.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.439 1.096 . . . . 0.0 109.829 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 1.8 tm? -132.2 115.16 15.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.84 102.31 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 109.725 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.547 ' HB3' HD23 ' A' ' 87' ' ' LEU . 67.1 mtt -95.16 136.8 35.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.422 0.689 . . . . 0.0 109.609 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 20.3 m120 -142.02 161.85 36.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.746 1.219 . . . . 0.0 108.001 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.3 m 54.12 31.41 13.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.297 1.039 . . . . 0.0 112.875 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 84' ' ' MET . 84.5 mt -61.04 130.07 44.55 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.872 0.869 . . . . 0.0 112.653 -169.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.412 ' HD3' ' NH1' ' A' ' 68' ' ' ARG . 2.4 mptp? -98.52 152.3 37.85 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.102 0.961 . . . . 0.0 108.993 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -46.74 -27.38 5.46 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 124.202 3.268 . . . . 0.0 115.936 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -71.21 -16.66 62.52 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.465 ' HB2' HG11 ' A' ' 121' ' ' VAL . 40.3 m-20 -72.68 -11.94 60.83 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.845 0.458 . . . . 0.0 112.103 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 120' ' ' THR . 63.4 m -60.16 105.42 0.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.72 0.808 . . . . 0.0 110.796 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.7 165.88 4.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.883 0.873 . . . . 0.0 110.074 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.3 p -89.26 115.69 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -86.82 155.72 20.18 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.355 1.062 . . . . 0.0 109.439 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -145.81 115.98 7.45 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.75 0.657 . . . . 0.0 109.357 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 26.4 p -83.87 106.09 15.28 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.19 124.66 49.93 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.513 1.125 . . . . 0.0 110.911 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.22 151.24 38.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.716 0.807 . . . . 0.0 110.833 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.581 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -178.037 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.438 0.161 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.73 167.99 20.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.912 0.885 . . . . 0.0 109.911 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -157.4 168.69 26.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.901 0.881 . . . . 0.0 111.256 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -80.7 -172.23 45.28 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.547 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -66.98 -33.88 76.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.161 0.984 . . . . 0.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.52 108.79 2.5 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -100.95 121.84 42.45 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.39 0.676 . . . . 0.0 109.938 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.0 tm0? -90.94 127.71 36.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.9 m -113.43 140.73 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.456 ' HA ' HG23 ' A' ' 92' ' ' THR . 40.2 m -127.33 108.9 11.25 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.0 p -106.62 116.02 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 122.987 0.515 . . . . 0.0 109.63 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -73.57 148.28 43.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 110.614 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 123.916 0.886 . . . . 0.0 110.122 179.656 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -75.88 122.85 24.73 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.355 0.598 . . . . 0.0 110.818 -170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.539 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 70.6 mt -127.36 135.12 50.06 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.363 1.465 . . . . 0.0 108.475 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.38 100.42 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -97.29 135.02 39.81 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.386 0.674 . . . . 0.0 109.612 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -148.54 178.92 8.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.486 1.115 . . . . 0.0 109.49 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.38 -12.35 43.6 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.894 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.89 137.19 21.9 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.85 -169.55 36.91 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.94 137.64 37.72 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.971 0.386 . . . . 0.0 111.168 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.75 155.53 6.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 C-N-CA 124.946 1.298 . . . . 0.0 108.449 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.49 155.16 27.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.362 0.665 . . . . 0.0 109.948 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.46 111.05 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.241 0.616 . . . . 0.0 110.263 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.92 3.93 31.67 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.922 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.88 -165.98 39.53 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 122.97 0.319 . . . . 0.0 113.463 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 m -132.51 158.22 42.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.413 1.085 . . . . 0.0 110.051 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -152.26 151.12 30.54 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -119.96 113.05 19.96 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.151 0.58 . . . . 0.0 110.548 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -101.54 150.08 23.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.363 1.065 . . . . 0.0 108.782 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -153.08 140.48 19.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.363 0.665 . . . . 0.0 109.294 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.7 t -120.6 123.63 43.31 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.525 0.73 . . . . 0.0 110.258 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.47 115.52 22.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -106.8 163.15 13.17 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.377 1.071 . . . . 0.0 110.273 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -66.09 168.6 8.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.16 23.87 8.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.698 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -79.59 179.17 7.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 111.912 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -79.05 70.18 5.35 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.444 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 59.0 m-85 -66.22 -22.08 66.33 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.313 164.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -60.0 -29.81 68.71 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.999 1.32 . . . . 0.0 111.703 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 m -90.28 -15.04 32.03 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 0.0 111.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -108.58 175.5 5.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.853 0.861 . . . . 0.0 110.931 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.48 162.93 17.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 164.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.616 ' HE1' HG13 ' A' ' 80' ' ' VAL . 3.4 ttp -141.93 153.26 44.23 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.0 157.02 27.28 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -96.36 125.13 40.64 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.176 0.99 . . . . 0.0 108.355 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -123.61 170.08 10.81 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.319 1.448 . . . . 0.0 107.873 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -149.67 162.31 40.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.845 0.748 . . . . 0.0 112.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.503 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -170.1 151.5 3.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 124.385 1.053 . . . . 0.0 110.565 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.31 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 124.459 1.104 . . . . 0.0 111.518 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.57 64.87 8.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 C-N-CA 122.131 1.887 . . . . 0.0 112.481 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.16 14.6 66.4 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.894 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -104.92 160.02 15.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.462 0.705 . . . . 0.0 112.055 -172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.12 173.49 7.7 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.878 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -59.3 104.34 0.25 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.126 0.97 . . . . 0.0 109.655 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -106.67 150.49 26.19 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.651 0.78 . . . . 0.0 110.668 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.24 111.03 3.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.352 0.661 . . . . 0.0 110.835 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 HG11 ' HE1' ' A' ' 95' ' ' TYR . 70.1 t -94.15 -62.36 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.74 139.55 5.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG22 ' HA3' ' A' ' 36' ' ' GLY . 76.3 t -123.31 138.32 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.687 0.795 . . . . 0.0 110.436 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.65 157.13 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.283 1.033 . . . . 0.0 109.898 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -84.85 162.96 19.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.421 0.688 . . . . 0.0 112.479 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -81.69 -11.86 58.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.239 0.616 . . . . 0.0 111.537 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.91 83.11 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.509 0.505 . . . . 0.0 112.791 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -72.36 -23.99 61.21 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 110.969 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -122.89 134.85 54.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.117 0.967 . . . . 0.0 109.004 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.6 p -134.81 132.4 38.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.192 0.997 . . . . 0.0 109.156 173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -124.22 134.35 53.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.135 1.374 . . . . 0.0 107.524 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.19 149.2 52.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.226 0.61 . . . . 0.0 110.224 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.63 146.11 42.71 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 166.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.76 -34.76 67.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -71.25 -41.88 69.54 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.327 0.651 . . . . 0.0 111.772 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 HG12 ' A' ' 49' ' ' VAL . 16.1 m -90.17 -5.16 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 122.819 0.448 . . . . 0.0 111.47 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -70.83 120.22 16.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.917 0.887 . . . . 0.0 110.949 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.35 -8.64 77.19 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.449 0.468 . . . . 0.0 113.918 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 20.8 ptp180 -114.37 -26.64 7.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.423 0.689 . . . . 0.0 110.065 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-30 -98.46 150.45 21.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.829 0.851 . . . . 0.0 109.315 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -146.48 134.24 21.18 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.814 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 82' ' ' LEU . 2.8 mp -102.81 136.72 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.6 m -135.42 160.37 38.66 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.757 1.223 . . . . 0.0 108.389 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.2 164.37 32.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.219 0.533 . . . . 0.0 111.437 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -129.76 106.64 8.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.929 1.291 . . . . 0.0 107.557 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.97 -31.1 71.82 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.318 1.047 . . . . 0.0 111.604 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.48 67.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.231 0.612 . . . . 0.0 110.743 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.71 -13.51 58.94 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.254 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.4 m120 59.05 31.86 21.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.26 1.024 . . . . 0.0 110.811 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.7 m -121.03 130.1 53.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 ' HE1' ' A' ' 35' ' ' MET . 22.1 t -105.87 155.14 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.649 1.18 . . . . 0.0 108.519 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -137.66 141.73 41.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.559 1.144 . . . . 0.0 109.376 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.2 tm? -133.44 132.34 40.99 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -113.98 127.98 56.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.436 ' HB3' HD22 ' A' ' 87' ' ' LEU . 43.4 mtt -111.24 133.65 53.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.278 1.031 . . . . 0.0 110.042 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -133.91 149.54 51.3 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 60.05 54.16 4.28 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.036 0.935 . . . . 0.0 111.434 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 84' ' ' MET . 94.7 mt -75.1 115.96 15.3 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.995 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.48 146.11 95.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -61.39 -13.01 26.52 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 123.107 2.538 . . . . 0.0 113.92 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -88.21 -2.49 58.63 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.722 1.209 . . . . 0.0 112.211 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HB3' HG11 ' A' ' 121' ' ' VAL . 14.3 t70 -74.56 -19.82 60.18 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.937 0.895 . . . . 0.0 110.967 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 120' ' ' THR . 88.7 m -48.4 109.17 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.189 1.396 . . . . 0.0 112.32 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.35 153.79 3.06 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.857 0.723 . . . . 0.0 111.011 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 14.9 p -77.65 114.14 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.41 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.8 m-85 -85.6 111.11 19.75 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 121.476 0.655 . . . . 0.0 109.688 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.1 127.88 54.19 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.837 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.3 m -83.87 118.49 24.0 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.4 128.71 54.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.916 0.886 . . . . 0.0 109.007 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.69 169.86 11.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.684 0.794 . . . . 0.0 111.544 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.795 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.121 -176.073 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.027 0.441 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -135.71 160.06 39.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.837 0.855 . . . . 0.0 110.313 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -160.04 143.33 13.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.651 1.18 . . . . 0.0 108.573 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.539 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -90.35 -143.26 10.52 Favored Glycine 0 C--N 1.344 0.99 0 O-C-N 122.977 0.173 . . . . 0.0 112.81 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -84.84 -73.99 0.41 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.027 0.931 . . . . 0.0 110.286 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.48 165.11 11.17 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.201 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.4 t -143.56 108.38 4.91 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.893 0.877 . . . . 0.0 110.269 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 61.4 tp60 -68.97 111.27 4.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.105 0.562 . . . . 0.0 110.877 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -91.74 145.07 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.473 ' HA ' HG21 ' A' ' 92' ' ' THR . 26.8 m -133.72 106.16 7.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.417 0.687 . . . . 0.0 109.492 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 91' ' ' ASP . 2.3 p -99.05 102.15 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.88 0.848 . . . . 0.0 108.774 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -57.18 141.86 44.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.958 1.703 . . . . 0.0 111.674 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.246 0.869 0 C-N-CA 124.022 0.929 . . . . 0.0 111.325 178.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 28' ' ' ARG . 62.1 tp . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.62 106.14 15.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.704 0.801 . . . . 0.0 108.973 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.4 mt -97.57 121.3 39.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.144 0.978 . . . . 0.0 108.846 173.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 60.1 t -114.51 101.19 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.536 0.734 . . . . 0.0 109.176 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -74.92 142.32 44.02 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.526 0.73 . . . . 0.0 109.751 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 p -157.17 166.04 34.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.487 1.115 . . . . 0.0 110.02 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.24 85.51 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.583 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -84.5 139.3 17.95 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.9 -163.95 28.88 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' THR . 3.9 pp -106.7 143.75 34.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.65 0.78 . . . . 0.0 111.623 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 14.5 p -151.57 156.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 108.266 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -73.07 167.38 21.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.719 0.408 . . . . 0.0 111.275 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 121.09 17.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.92 1.03 57.32 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.878 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.52 -172.67 49.27 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 123.058 0.361 . . . . 0.0 112.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -135.26 143.85 46.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.793 0.837 . . . . 0.0 109.664 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -140.97 124.21 16.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.041 0.937 . . . . 0.0 108.611 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -95.13 120.29 35.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.12 0.968 . . . . 0.0 109.737 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.659 HD21 ' HE1' ' A' ' 84' ' ' MET . 3.1 mm? -99.31 157.68 16.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.563 0.745 . . . . 0.0 109.435 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.58 156.26 45.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.44 1.096 . . . . 0.0 108.644 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 52.5 t -150.4 117.61 6.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.768 0.427 . . . . 0.0 110.513 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -85.0 119.27 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.295 0.638 . . . . 0.0 109.662 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 3' ' ' LEU . . . -105.48 124.69 49.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.255 1.022 . . . . 0.0 109.529 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -145.09 163.49 34.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.075 0.55 . . . . 0.0 111.127 -172.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.7 -90.5 1.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 112.362 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 27.8 tpt180 -79.59 154.47 28.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.228 0.611 . . . . 0.0 110.767 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 m -75.12 93.5 2.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.17 0.588 . . . . 0.0 110.091 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -61.36 -29.3 69.82 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.046 0.939 . . . . 0.0 111.43 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.41 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 57.3 p -77.16 0.37 21.96 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.747 0.819 . . . . 0.0 112.519 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -95.21 -14.59 23.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.173 0.589 . . . . 0.0 111.086 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.33 173.01 6.83 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.803 0.841 . . . . 0.0 110.891 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.34 160.81 18.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 163.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.429 ' HE2' ' HB3' ' A' ' 35' ' ' MET . 30.9 ttp -137.87 136.52 37.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -139.38 140.85 11.2 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 122.969 0.319 . . . . 0.0 112.411 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -95.03 135.04 37.05 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.485 1.114 . . . . 0.0 108.96 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -127.81 149.97 50.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.054 1.342 . . . . 0.0 108.189 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -135.59 160.7 37.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.941 0.337 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.93 145.75 6.36 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.725 0.641 . . . . 0.0 110.67 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . -177.03 -63.54 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.387 169.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 90.2 Cg_endo -78.86 75.96 4.77 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.249 1.966 . . . . 0.0 112.393 -171.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 15.58 68.13 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.168 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -105.15 143.25 33.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.281 1.032 . . . . 0.0 111.043 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.56 172.61 8.26 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 162.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -60.05 104.61 0.32 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.098 0.475 . . . . 0.0 110.118 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.57 152.34 18.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.629 1.172 . . . . 0.0 109.564 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -62.17 111.81 2.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.32 -54.08 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 71' ' ' ILE . . . -166.29 136.82 3.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.499 0.499 . . . . 0.0 111.421 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.4 HG22 ' HA3' ' A' ' 36' ' ' GLY . 40.3 t -121.06 129.39 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.257 1.023 . . . . 0.0 109.58 173.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -116.03 158.26 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.284 1.034 . . . . 0.0 108.482 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.31 172.82 10.16 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 36.1 p-90 -62.33 -27.65 69.2 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.906 0.883 . . . . 0.0 113.255 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.3 m -86.06 -22.48 27.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.454 0.702 . . . . 0.0 112.543 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.43 10.98 83.84 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 123.08 0.237 . . . . 0.0 112.55 -172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -83.77 -23.66 31.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.842 1.257 . . . . 0.0 111.336 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -121.32 120.35 34.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.164 0.986 . . . . 0.0 108.574 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -127.93 130.75 48.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.652 0.781 . . . . 0.0 109.02 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.02 132.68 45.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 76.1 m-85 -128.56 150.84 50.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.378 0.671 . . . . 0.0 109.873 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.62 135.31 46.88 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.11 -30.87 38.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 112.0 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -62.88 -43.32 99.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.008 0.923 . . . . 0.0 112.153 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.57 1.71 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 26.3 ttpp -69.55 134.38 48.76 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.745 0.818 . . . . 0.0 110.845 -173.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.01 25.08 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.814 0.696 . . . . 0.0 113.718 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 29.4 ptt-85 -107.35 -20.74 13.18 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.235 0.518 . . . . 0.0 111.24 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-30 -97.61 157.69 15.9 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.161 0.585 . . . . 0.0 110.203 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.8 m -150.2 134.82 17.46 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.613 1.165 . . . . 0.0 109.122 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -102.56 142.04 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 169.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -142.02 160.38 40.33 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.999 1.32 . . . . 0.0 107.632 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 173.85 15.1 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -148.26 118.74 7.41 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.43 -24.67 59.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.814 0.846 . . . . 0.0 111.625 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.26 33.93 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.521 0.728 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.8 mmpt? -87.13 -14.59 40.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 0.0 111.401 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.93 27.72 16.85 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.559 1.162 . . . . 0.0 110.931 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -122.96 133.73 54.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.994 0.518 . . . . 0.0 110.549 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 91.5 t -104.39 154.08 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.591 1.556 . . . . 0.0 109.061 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.55 141.94 41.39 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.416 1.086 . . . . 0.0 109.072 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -131.59 99.56 4.84 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -85.65 117.08 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.372 0.669 . . . . 0.0 109.893 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.659 ' HE1' HD21 ' A' ' 21' ' ' LEU . 44.4 mtm -110.43 99.59 8.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.756 0.822 . . . . 0.0 109.872 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -99.0 154.06 18.38 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.655 0.782 . . . . 0.0 109.817 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t 56.62 42.24 27.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 84' ' ' MET . 18.1 mt -56.03 124.76 18.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.053 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -90.69 142.7 28.07 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -34.55 -40.33 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 125.205 3.936 . . . . 0.0 116.182 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.24 -11.92 60.42 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.507 1.123 . . . . 0.0 113.736 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -80.64 -2.63 47.35 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.589 0.755 . . . . 0.0 112.515 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 120' ' ' THR . 90.0 m -63.47 106.19 0.89 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.319 0.648 . . . . 0.0 110.215 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.01 160.06 4.12 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 0.0 111.014 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 40' ' ' GLN . 7.6 p -83.04 114.54 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -87.5 113.77 23.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.926 0.891 . . . . 0.0 110.408 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.57 126.25 52.31 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.364 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.3 143.89 28.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -140.3 158.71 43.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.995 0.918 . . . . 0.0 109.915 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -134.94 141.83 46.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.988 0.515 . . . . 0.0 110.706 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.02 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 121.378 0.608 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 38.7 m-85 -118.76 155.74 30.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.249 1.019 . . . . 0.0 109.29 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 10.3 p90 -165.68 172.86 11.38 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.226 1.011 . . . . 0.0 109.753 170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.98 -149.69 16.24 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.338 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -84.84 -64.59 1.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.669 1.188 . . . . 0.0 109.109 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.68 142.19 6.28 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.451 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 10.2 t -122.52 117.89 26.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.895 0.878 . . . . 0.0 109.687 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 26.6 tp60 -78.2 106.47 10.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.12 0.568 . . . . 0.0 109.83 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.602 HG23 ' HE2' ' A' ' 84' ' ' MET . 2.9 m -101.2 146.97 8.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.511 0.724 . . . . 0.0 109.276 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.525 ' HA ' HG21 ' A' ' 92' ' ' THR . 47.1 m -131.93 133.99 45.16 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.458 0.703 . . . . 0.0 109.696 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.1 p -114.38 105.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -59.45 112.38 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.733 1.213 . . . . 0.0 110.754 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.242 0.66 0 C-N-CA 123.879 0.871 . . . . 0.0 110.621 -178.312 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 28' ' ' ARG . 43.9 tp . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 26.4 tp60 -80.23 123.38 27.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.438 0.695 . . . . 0.0 109.665 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.493 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.4 mt -111.55 111.28 22.18 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.7 t -98.55 100.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -82.56 131.02 35.22 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.9 m -138.88 128.32 24.41 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.317 1.047 . . . . 0.0 108.763 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.89 -155.13 26.22 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.55 151.01 5.29 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 122.914 0.293 . . . . 0.0 112.899 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.66 -173.61 43.28 Favored Glycine 0 C--O 1.241 0.593 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.08 134.35 41.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.543 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 87' ' ' LEU . 13.5 p -152.56 156.67 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 108.913 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 43.3 mt-30 -81.26 161.23 24.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.368 0.667 . . . . 0.0 110.556 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 131.97 46.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.647 0.379 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.43 -15.08 62.7 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.743 0.652 . . . . 0.0 111.489 -170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.17 -171.08 40.23 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.027 0.346 . . . . 0.0 113.833 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.3 p -137.85 160.34 39.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 0.0 110.885 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.92 164.03 33.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -130.22 140.63 50.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.611 HD21 HD13 ' A' ' 82' ' ' LEU . 1.7 mm? -119.64 157.81 27.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.606 1.563 . . . . 0.0 107.472 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 t -151.56 163.75 38.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.453 0.301 . . . . 0.0 110.256 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 44.6 t -152.86 122.62 6.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.06 0.544 . . . . 0.0 110.61 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 127.63 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.17 136.45 44.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.264 0.626 . . . . 0.0 109.49 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 9.5 t -71.94 -175.44 1.44 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.431 1.092 . . . . 0.0 112.674 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.58 -19.84 54.99 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HB2' HD12 ' A' ' 3' ' ' LEU . 45.7 mmm-85 -60.81 145.88 48.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.602 0.761 . . . . 0.0 111.346 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.3 p -70.63 91.16 0.79 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -60.18 -21.35 61.59 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.141 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 17.6 p -67.17 -0.2 3.19 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.44 1.496 . . . . 0.0 113.462 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 m -106.98 -3.3 20.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.253 0.621 . . . . 0.0 111.019 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.82 155.49 36.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.137 0.575 . . . . 0.0 111.021 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.87 125.84 35.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG2' HG22 ' A' ' 80' ' ' VAL . 3.0 tpt -99.17 116.92 32.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.413 1.085 . . . . 0.0 109.033 -172.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.587 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -132.85 142.19 13.67 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 114.072 0.389 . . . . 0.0 114.072 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -96.72 134.15 40.35 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.959 1.303 . . . . 0.0 109.319 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -124.5 164.73 19.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -143.13 154.12 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.161 0.437 . . . . 0.0 111.548 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.08 151.02 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.623 1.169 . . . . 0.0 109.025 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . 175.36 -64.92 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 C-N-CA 124.017 0.927 . . . . 0.0 111.068 166.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 54.5 Cg_endo -84.43 69.63 6.07 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.008 1.805 . . . . 0.0 111.949 -172.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 5.61 63.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.341 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -92.37 139.97 30.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.142 0.977 . . . . 0.0 109.547 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.44 169.0 12.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.532 0.733 . . . . 0.0 109.495 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -63.11 103.84 0.51 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.91 155.47 22.6 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.904 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.9 109.52 1.28 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.718 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.83 -63.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.47 134.11 1.79 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.724 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.587 HG21 ' HA3' ' A' ' 36' ' ' GLY . 69.9 t -118.31 129.97 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 109.344 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.508 HG23 HG23 ' A' ' 59' ' ' THR . 11.7 p -105.94 146.27 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -77.26 148.91 35.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.4 p-90 -48.26 -33.65 9.04 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -83.57 -32.45 25.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.553 0.741 . . . . 0.0 111.483 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.6 -8.19 61.8 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.35 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.96 -41.46 78.36 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.794 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -107.7 130.87 54.89 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.383 0.673 . . . . 0.0 109.655 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 52' ' ' VAL . 32.9 p -130.94 143.88 51.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.456 1.102 . . . . 0.0 109.002 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -131.45 144.5 51.22 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 109.682 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.89 145.51 42.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.523 0.729 . . . . 0.0 109.075 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.35 -29.61 66.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.536 0.734 . . . . 0.0 112.054 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 m -66.04 -31.27 72.06 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.253 1.021 . . . . 0.0 111.911 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.15 -2.56 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.955 0.902 . . . . 0.0 111.911 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -73.85 137.01 43.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.835 0.454 . . . . 0.0 110.825 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.95 -24.83 22.64 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.678 0.611 . . . . 0.0 113.015 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -113.04 -12.46 13.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.668 0.787 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CD2' HD11 ' A' ' 82' ' ' LEU . 3.1 m-85 -109.78 145.22 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.363 0.665 . . . . 0.0 109.725 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -144.35 129.82 18.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.045 0.938 . . . . 0.0 109.045 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.43 HG12 HD23 ' A' ' 82' ' ' LEU . 5.6 mt -101.65 120.48 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -124.92 138.3 54.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.57 0.748 . . . . 0.0 109.07 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.68 137.61 30.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.626 0.37 . . . . 0.0 110.031 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -105.79 101.6 11.1 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.584 0.754 . . . . 0.0 110.896 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.25 -44.54 79.17 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.282 1.033 . . . . 0.0 110.917 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -86.58 -10.92 52.93 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.401 0.68 . . . . 0.0 111.163 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.452 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 62.97 28.1 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.637 1.175 . . . . 0.0 110.362 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.6 m -121.94 132.15 54.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.666 0.786 . . . . 0.0 110.533 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.512 HG22 ' HG2' ' A' ' 35' ' ' MET . 26.1 t -100.57 157.35 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -139.05 155.46 47.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.54 1.136 . . . . 0.0 109.247 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.611 HD13 HD21 ' A' ' 21' ' ' LEU . 3.2 tm? -130.42 122.14 27.22 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.62 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.347 1.059 . . . . 0.0 108.519 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.475 ' HE2' HG22 ' A' ' 119' ' ' VAL . 48.8 mtt -86.47 125.22 33.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.593 0.757 . . . . 0.0 109.056 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.63 153.59 47.11 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.1 m 54.88 46.48 24.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.825 0.85 . . . . 0.0 111.91 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.426 HD13 HG12 ' A' ' 13' ' ' VAL . 63.9 mt -66.33 128.97 38.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.556 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.08 157.84 53.54 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.521 1.129 . . . . 0.0 108.635 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.49 -16.49 35.97 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.677 2.252 . . . . 0.0 113.722 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.47 -26.3 68.66 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.339 1.056 . . . . 0.0 112.247 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' HG13 ' A' ' 121' ' ' VAL . 13.4 m-20 -76.63 -12.51 60.02 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.514 HG21 ' HA ' ' A' ' 120' ' ' THR . 49.7 m -61.43 99.34 0.1 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.327 0.512 . . . . 0.0 109.683 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.55 157.13 3.14 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.671 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 p -80.11 112.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -87.62 119.55 28.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.177 0.991 . . . . 0.0 109.719 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -101.81 126.18 48.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.185 0.994 . . . . 0.0 109.346 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 20.2 t -85.07 107.66 17.28 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.402 0.681 . . . . 0.0 109.628 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -108.21 158.31 17.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 110.997 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.67 123.51 15.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.162 0.985 . . . . 0.0 108.737 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.406 0 O-C-N 123.414 0.446 . . . . 0.0 112.003 -177.12 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.978 0.418 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -126.8 159.47 33.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 109.303 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 48.8 p90 -155.71 165.92 35.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.483 0.713 . . . . 0.0 110.211 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.7 -170.37 17.97 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.737 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.53 -56.63 11.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.778 0.831 . . . . 0.0 110.967 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.29 151.05 23.76 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.449 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 10.2 t -130.8 136.09 48.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.275 0.63 . . . . 0.0 111.213 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -75.14 108.48 7.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' HE2' ' A' ' 84' ' ' MET . 4.5 m -90.56 139.85 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.514 ' HA ' HG21 ' A' ' 92' ' ' THR . 39.1 m -126.07 105.34 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 91' ' ' ASP . 2.2 p -101.59 109.06 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.192 0.597 . . . . 0.0 109.435 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 46.9 t -55.96 122.36 11.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.87 1.268 . . . . 0.0 111.07 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 123.918 0.887 . . . . 0.0 110.201 176.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 49.7 tp . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 27.5 tt0 -79.56 110.35 14.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.719 0.808 . . . . 0.0 109.578 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.495 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 44.0 mt -104.81 112.99 26.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.66 101.11 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.436 0.694 . . . . 0.0 109.572 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.41 149.3 26.77 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.773 0.32 . . . . 0.0 110.295 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.0 p -159.42 168.22 26.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.318 1.047 . . . . 0.0 109.553 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.46 -7.63 54.1 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 120.034 -0.315 . . . . 0.0 113.177 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 126.59 8.36 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.698 0.249 . . . . 0.0 112.808 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.71 -164.73 20.65 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.77 141.6 30.4 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.119 0.485 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.74 159.41 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.209 1.404 . . . . 0.0 107.968 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -88.11 165.12 15.35 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.889 0.476 . . . . 0.0 111.459 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.91 120.98 13.56 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.453 0.701 . . . . 0.0 109.425 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 5.03 75.8 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.926 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.67 -176.48 49.23 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.572 0.219 . . . . 0.0 113.145 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -134.46 158.04 44.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -158.01 143.13 16.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.295 0.638 . . . . 0.0 109.652 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -111.64 122.23 47.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -96.13 150.36 20.59 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -139.57 125.08 19.22 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.78 135.54 53.41 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.654 0.782 . . . . 0.0 109.107 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 118.93 37.51 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.307 0.643 . . . . 0.0 109.31 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 4' ' ' GLN . . . -104.56 135.94 45.04 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.162 0.585 . . . . 0.0 109.599 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.6 m -149.69 162.7 39.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.991 0.916 . . . . 0.0 110.07 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 -96.24 1.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HB3' ' HE2' ' A' ' 33' ' ' TYR . 16.4 mmt85 -67.27 164.54 18.11 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.07 0.548 . . . . 0.0 111.869 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.3 p -71.63 83.98 0.86 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.874 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' HD1' HD22 ' A' ' 3' ' ' LEU . 78.2 t80 -57.73 -29.99 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.526 0.73 . . . . 0.0 111.37 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -71.18 0.68 7.27 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.392 1.077 . . . . 0.0 112.877 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.1 m -112.5 -9.25 13.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.998 0.919 . . . . 0.0 111.113 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.56 ' HE2' ' HB3' ' A' ' 28' ' ' ARG . 47.0 m-85 -114.79 138.84 50.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.909 0.483 . . . . 0.0 110.75 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 157.62 26.34 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 167.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.507 ' HE3' HG12 ' A' ' 80' ' ' VAL . 13.9 ttp -141.37 147.54 38.2 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -141.82 150.83 22.31 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.23 0.332 . . . . 0.0 112.43 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -97.84 127.51 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.652 0.781 . . . . 0.0 109.155 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.52 132.77 49.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.031 . . . . 0.0 108.271 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 27.6 ptt180 -116.73 158.67 23.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.533 0.333 . . . . 0.0 110.771 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.503 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -170.06 153.81 4.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.686 0.794 . . . . 0.0 109.078 171.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.73 -54.34 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 118.516 -0.755 . . . . 0.0 111.528 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.43 68.22 8.07 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.039 1.826 . . . . 0.0 112.457 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.38 21.14 64.11 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.049 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -115.58 156.62 25.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.336 0.654 . . . . 0.0 111.564 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.57 170.43 16.66 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.546 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -61.64 103.89 0.37 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.55 146.54 24.38 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.671 0.788 . . . . 0.0 109.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -65.25 120.96 13.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.863 0.865 . . . . 0.0 110.23 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.564 HG13 ' HE2' ' A' ' 95' ' ' TYR . 52.0 t -101.94 -54.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -168.31 154.81 7.39 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.112 -173.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG22 ' HA3' ' A' ' 36' ' ' GLY . 70.5 t -140.37 147.5 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.704 1.202 . . . . 0.0 108.328 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG21 HG21 ' A' ' 59' ' ' THR . 10.6 p -141.29 153.1 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.184 0.994 . . . . 0.0 108.985 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -76.66 161.15 28.78 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 167.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -55.17 -39.4 69.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.296 0.638 . . . . 0.0 110.696 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -74.31 -19.99 60.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.474 1.109 . . . . 0.0 111.584 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.03 78.21 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -167.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -58.91 -64.8 0.81 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.286 1.034 . . . . 0.0 110.851 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -112.84 129.56 56.4 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.479 HG21 HG21 ' A' ' 52' ' ' VAL . 65.2 p -114.47 130.31 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -116.23 126.92 54.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -118.7 150.75 39.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.184 0.594 . . . . 0.0 109.923 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 65' ' ' VAL . . . -79.62 130.71 35.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.89 -22.51 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -67.81 -40.98 83.77 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.626 0.77 . . . . 0.0 111.409 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' ALA . 32.2 m -106.86 3.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.934 0.894 . . . . 0.0 111.578 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.6 128.49 36.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.869 0.867 . . . . 0.0 111.288 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 -17.56 50.83 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 113.619 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -103.04 -19.12 14.68 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -102.34 157.88 16.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 110.216 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.2 m -149.27 133.12 17.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.105 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.489 HD13 ' HB2' ' A' ' 50' ' ' ALA . 1.6 mp -103.0 131.13 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -133.15 160.42 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 108.334 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 167.29 30.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.96 111.86 11.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.99 -16.19 60.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.588 0.755 . . . . 0.0 112.083 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.1 -50.64 11.64 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.0 -14.55 57.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 78' ' ' ASN . 0.8 OUTLIER 61.7 28.64 17.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.004 1.321 . . . . 0.0 111.275 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 m -113.51 130.86 56.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.898 0.479 . . . . 0.0 110.516 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.507 HG12 ' HE3' ' A' ' 35' ' ' MET . 25.3 t -100.31 151.55 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 109.787 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -135.5 112.94 10.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.397 1.079 . . . . 0.0 108.931 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.0 tm? -93.6 103.1 15.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 104.06 16.69 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.749 0.82 . . . . 0.0 109.329 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.445 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.7 mtt -90.41 139.4 30.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.85 1.26 . . . . 0.0 110.963 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.61 140.11 45.83 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 54.71 58.84 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 111.713 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 84' ' ' MET . 56.4 mt -64.17 124.78 22.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.819 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.9 mtpt -72.5 144.08 85.99 Favored Pre-proline 0 C--O 1.21 -0.984 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.668 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 51.3 Cg_exo -56.45 -21.52 37.94 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.868 2.379 . . . . 0.0 114.273 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.83 3.46 55.09 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.828 1.251 . . . . 0.0 112.79 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -79.79 -17.05 54.31 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.72 0.808 . . . . 0.0 111.35 -172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 120' ' ' THR . 94.2 m -53.57 108.73 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.701 1.2 . . . . 0.0 112.11 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.95 160.45 4.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.748 0.819 . . . . 0.0 111.295 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 13.8 p -81.04 114.49 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.041 0.448 . . . . 0.0 110.173 173.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.564 ' HE2' HG13 ' A' ' 49' ' ' VAL . 19.8 m-85 -87.23 127.87 35.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.835 1.254 . . . . 0.0 110.374 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.67 142.94 51.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.696 0.798 . . . . 0.0 110.001 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.5 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.5 m -92.22 112.02 23.81 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.004 0.922 . . . . 0.0 109.159 173.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.97 112.71 25.94 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -108.12 169.84 8.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.547 0.739 . . . . 0.0 111.181 -174.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.313 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 51.0 m-85 -127.51 152.6 47.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.639 0.776 . . . . 0.0 110.01 -172.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -132.16 139.06 48.27 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.62 -169.03 44.58 Favored Glycine 0 C--O 1.244 0.741 0 O-C-N 123.117 0.261 . . . . 0.0 113.731 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.82 -54.78 9.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.435 0.694 . . . . 0.0 110.366 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 106.3 2.77 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.198 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -101.69 121.45 42.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.279 1.032 . . . . 0.0 109.848 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.7 tm0? -86.61 124.94 33.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.825 0.45 . . . . 0.0 110.059 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.99 141.31 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.523 0.729 . . . . 0.0 109.04 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.445 ' HA ' HG21 ' A' ' 92' ' ' THR . 57.5 m -129.16 106.84 9.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.281 0.632 . . . . 0.0 109.656 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.8 p -93.36 128.23 44.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.3 t -69.38 111.89 5.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.52 0.728 . . . . 0.0 109.217 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.58 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 34.9 p . . . . . 0 CA--C 1.542 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.655 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.4 tp . . . . . 0 C--O 1.241 0.629 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -72.28 102.69 3.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.572 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 87.9 mt -112.84 103.62 11.62 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 57.3 t -99.74 99.6 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 50.9 mt-10 -85.77 142.67 28.8 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.953 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -158.44 172.28 18.62 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.32 0.648 . . . . 0.0 110.16 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.52 6.77 70.12 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.051 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 119.68 4.97 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.26 -164.86 23.67 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.23 147.1 34.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.13 143.53 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.448 1.099 . . . . 0.0 108.345 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.93 153.37 42.24 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.53 0.732 . . . . 0.0 111.309 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 110.54 2.38 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.126 0.57 . . . . 0.0 110.231 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.05 10.49 59.72 Favored Glycine 0 N--CA 1.464 0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.599 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.29 -169.15 43.08 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.644 0.261 . . . . 0.0 112.998 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.5 p -123.11 148.68 45.42 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.732 0.813 . . . . 0.0 110.759 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 tp -152.66 123.64 7.48 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -99.41 111.16 23.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.64 157.65 20.28 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.043 0.937 . . . . 0.0 110.344 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -147.25 157.92 43.77 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.061 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 43.3 t -142.35 120.97 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.475 0.71 . . . . 0.0 109.799 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -84.79 109.69 18.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.42 38.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.49 0.716 . . . . 0.0 109.368 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -158.58 158.65 34.32 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.669 0.787 . . . . 0.0 109.853 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.72 -93.81 0.93 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -91.64 154.02 19.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.417 0.687 . . . . 0.0 109.453 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.447 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 39.2 p -70.13 84.93 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.43 0.633 . . . . 0.0 110.892 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -63.24 -19.56 64.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.928 0.891 . . . . 0.0 111.212 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -49.22 -40.4 33.62 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.995 1.718 . . . . 0.0 113.141 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 -21.88 50.63 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.138 0.975 . . . . 0.0 112.199 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.93 148.68 22.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.01 156.63 33.88 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 165.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.446 ' HE3' ' HB3' ' A' ' 35' ' ' MET . 24.8 ttp -141.58 141.09 33.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.13 0.572 . . . . 0.0 110.204 -172.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 142.66 14.17 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -97.21 129.32 44.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 108.959 171.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -132.91 143.04 49.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.412 1.085 . . . . 0.0 109.359 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -125.64 155.85 40.14 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.256 0.48 . . . . 0.0 112.25 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.01 144.19 6.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.792 0.837 . . . . 0.0 110.992 171.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 167.87 -50.35 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 125.28 1.432 . . . . 0.0 111.939 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.28 61.96 8.34 Favored 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.558 2.172 . . . . 0.0 113.122 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.52 21.41 70.67 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.553 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -127.67 150.49 49.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.791 0.837 . . . . 0.0 110.728 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 173.47 9.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.82 0.848 . . . . 0.0 109.629 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -69.18 109.06 3.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.333 0.587 . . . . 0.0 111.056 -172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -112.14 157.76 20.44 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.342 -170.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -63.67 121.82 14.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.884 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 65' ' ' VAL . 61.7 t -106.59 -66.85 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 71' ' ' ILE . . . -153.76 134.07 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.56 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -122.29 155.58 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.187 0.995 . . . . 0.0 108.589 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.23 150.27 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.04 170.14 14.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.829 0.452 . . . . 0.0 110.538 171.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -60.37 -43.23 96.77 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -88.63 -2.1 58.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.071 0.548 . . . . 0.0 111.874 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.88 85.12 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.122 0.264 . . . . 0.0 113.076 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.74 -39.44 94.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.2 1.0 . . . . 0.0 111.325 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -115.81 135.08 54.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.671 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 p -125.26 129.33 49.82 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.12 141.44 41.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.447 1.499 . . . . 0.0 108.286 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -141.43 146.09 36.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.292 0.637 . . . . 0.0 109.943 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.97 151.39 40.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 164.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.55 -33.74 47.0 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.12 0.968 . . . . 0.0 112.973 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -75.77 -41.89 51.8 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.098 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG12 ' A' ' 49' ' ' VAL . 9.3 m -92.08 -4.73 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.37 0.668 . . . . 0.0 111.244 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.01 129.14 38.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.587 0.755 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.73 -25.44 6.62 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.787 0.679 . . . . 0.0 113.906 176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 19.6 ptp180 -102.4 -24.58 13.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.531 0.733 . . . . 0.0 111.017 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.403 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.1 m-30 -97.84 161.29 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.5 m -148.41 135.74 20.4 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 108.736 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 50' ' ' ALA . 1.9 mp -100.9 139.16 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -142.37 148.85 38.56 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.191 0.996 . . . . 0.0 109.127 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 136.73 19.95 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -117.29 117.69 30.23 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -85.24 -14.48 46.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.677 0.791 . . . . 0.0 111.928 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.38 -45.91 10.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.257 0.623 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.05 -20.13 56.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.947 0.899 . . . . 0.0 110.448 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.2 39.45 12.66 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.574 1.171 . . . . 0.0 109.74 -175.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 m -129.51 131.43 46.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.917 0.487 . . . . 0.0 111.06 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 75.3 t -98.16 148.3 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 109.878 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -134.28 141.73 47.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 109.085 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.34 105.17 6.81 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -84.27 106.27 15.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.591 0.756 . . . . 0.0 109.068 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.542 ' HB3' HD22 ' A' ' 87' ' ' LEU . 53.3 mtt -102.11 128.7 48.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -128.1 144.39 51.11 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m 57.33 64.51 1.58 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.165 0.986 . . . . 0.0 112.014 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 84' ' ' MET . 91.4 mt -77.77 120.63 22.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.14 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.433 ' O ' HG11 ' A' ' 121' ' ' VAL . 46.4 mtpt -74.23 152.32 88.13 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.073 -0.965 . . . . 0.0 108.643 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.53 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 98.7 Cg_exo -48.78 -26.97 10.39 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.205 2.603 . . . . 0.0 114.773 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.41 -22.72 60.15 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.089 0.956 . . . . 0.0 112.816 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.17 -6.63 14.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.577 0.751 . . . . 0.0 112.346 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 120' ' ' THR . 89.2 m -61.74 98.76 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.78 159.03 7.79 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.523 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -86.35 114.4 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 171.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.459 ' HE2' HG11 ' A' ' 49' ' ' VAL . 49.9 m-85 -86.41 150.06 24.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.931 0.892 . . . . 0.0 108.706 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.65 121.58 12.79 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.7 p -85.09 102.53 13.32 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.39 142.89 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.633 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.64 121.54 44.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.072 0.463 . . . . 0.0 110.256 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.323 -177.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.035 0.445 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.548 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 57.3 m-85 -126.17 155.27 41.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.699 0.8 . . . . 0.0 109.573 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -136.11 147.94 48.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.633 0.773 . . . . 0.0 109.935 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.96 -170.23 45.13 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.521 -0.308 . . . . 0.0 113.46 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 15.5 mm100 -85.66 -38.65 18.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.213 0.605 . . . . 0.0 109.958 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.02 109.32 2.28 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.381 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 8.4 t -99.87 113.67 26.36 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.482 0.658 . . . . 0.0 109.563 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.608 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.1 tm0? -82.15 123.43 28.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -110.09 139.31 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.407 ' HA ' HG21 ' A' ' 92' ' ' THR . 27.6 m -117.66 104.84 11.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.5 p -88.85 101.22 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.0 t -65.71 113.08 4.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.965 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 18.3 p . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.525 0.73 . . . . 0.0 109.622 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 30' ' ' PHE . 46.0 tp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -86.29 104.03 15.44 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.657 0.783 . . . . 0.0 109.282 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.48 104.98 14.82 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.83 114.95 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.67 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -113.49 134.63 54.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.608 0.763 . . . . 0.0 109.422 -168.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -157.22 149.11 22.5 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.454 1.102 . . . . 0.0 109.998 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.13 -6.5 0.82 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.815 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.61 151.81 38.34 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.832 0.316 . . . . 0.0 113.617 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.72 -167.6 34.93 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -93.7 133.48 37.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.304 0.642 . . . . 0.0 110.384 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.57 143.32 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.1 0.96 . . . . 0.0 109.253 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.404 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -62.05 159.02 15.21 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.149 0.979 . . . . 0.0 112.784 -177.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.49 17.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.72 0.808 . . . . 0.0 110.396 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.46 -1.25 69.09 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.252 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.65 -163.41 29.29 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.19 0.424 . . . . 0.0 113.481 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -137.3 146.98 45.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.0 111.03 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.3 tp -154.5 121.41 5.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.45 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -96.23 129.58 43.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.562 1.145 . . . . 0.0 110.574 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -102.92 158.31 16.37 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.31 1.044 . . . . 0.0 108.712 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -151.15 124.17 8.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.656 0.383 . . . . 0.0 110.181 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.67 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 43.3 t -117.34 116.94 28.2 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.578 0.751 . . . . 0.0 110.245 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.03 119.7 25.26 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.05 139.76 40.93 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.39 1.076 . . . . 0.0 109.402 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -153.72 173.26 16.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.895 0.478 . . . . 0.0 110.649 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 -106.26 3.39 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -84.49 168.22 15.66 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.282 0.541 . . . . 0.0 109.743 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -72.43 102.65 3.24 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.901 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HB3' HD12 ' A' ' 3' ' ' LEU . 16.7 p90 -64.85 -25.33 67.85 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.622 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 p -74.93 -0.1 17.52 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.955 1.302 . . . . 0.0 112.596 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -92.31 -7.69 47.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.21 0.604 . . . . 0.0 110.192 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -129.58 154.11 47.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 110.251 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.52 145.14 26.91 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.549 ' SD ' HG23 ' A' ' 80' ' ' VAL . 15.2 ptm -120.24 159.04 25.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.802 0.441 . . . . 0.0 109.898 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.29 142.55 10.36 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.174 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -96.74 132.01 42.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.099 0.96 . . . . 0.0 109.193 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.94 164.82 19.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.374 1.07 . . . . 0.0 108.14 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 38.3 ptt180 -146.92 154.06 40.84 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.746 0.248 . . . . 0.0 111.263 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.414 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.16 145.79 7.25 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.069 0.856 . . . . 0.0 110.169 172.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 93' ' ' ALA . . . 171.55 -52.66 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.23 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.38 50.6 3.06 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.749 2.299 . . . . 0.0 112.657 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.63 -8.92 53.42 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.019 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -94.7 132.35 39.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.77 0.828 . . . . 0.0 109.05 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.02 179.16 5.13 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.946 0.779 . . . . 0.0 110.817 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -54.1 105.4 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.46 0.704 . . . . 0.0 110.247 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -111.73 149.5 31.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.259 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.65 113.82 6.48 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.225 1.01 . . . . 0.0 109.626 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.04 -66.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB1' HD13 ' A' ' 71' ' ' ILE . . . -164.3 162.32 22.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.649 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG22 ' HA3' ' A' ' 36' ' ' GLY . 53.3 t -137.83 152.46 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.714 1.206 . . . . 0.0 107.77 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 59' ' ' THR . 13.3 p -131.46 143.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.047 0.939 . . . . 0.0 108.824 172.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.33 158.18 36.28 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -57.95 -35.63 71.4 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.519 0.728 . . . . 0.0 112.197 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.1 p -76.67 -29.89 56.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.422 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.43 ' HA3' ' NH1' ' A' ' 73' ' ' ARG . . . 83.67 3.42 89.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.524 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -62.69 -34.53 77.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.886 0.874 . . . . 0.0 111.041 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.83 130.9 49.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.734 0.814 . . . . 0.0 110.25 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.456 HG21 HG21 ' A' ' 52' ' ' VAL . 30.5 p -115.44 129.24 56.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.571 1.148 . . . . 0.0 108.896 173.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -93.69 140.94 29.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.203 1.001 . . . . 0.0 108.887 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.39 151.67 50.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.157 0.583 . . . . 0.0 109.866 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.21 144.91 37.93 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 161.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.89 -28.75 64.48 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.855 0.462 . . . . 0.0 112.047 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.4 t -70.99 -44.35 66.14 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.753 0.421 . . . . 0.0 111.124 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -92.83 1.95 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.629 0.372 . . . . 0.0 111.58 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.74 108.82 1.06 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 111.734 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.88 -26.33 13.21 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.662 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 7.1 ptt180 -84.14 -33.47 24.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.294 0.547 . . . . 0.0 109.616 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 5.1 m-30 -97.41 158.74 15.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -145.47 130.69 18.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.206 1.002 . . . . 0.0 108.845 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.478 HD13 ' HB1' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -102.67 126.48 56.84 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 24.8 m -123.81 154.03 40.17 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.149 0.98 . . . . 0.0 108.654 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.43 ' NH1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -140.68 143.85 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -121.78 96.84 5.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.88 -25.38 65.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.514 0.726 . . . . 0.0 111.411 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.52 -52.59 30.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.516 0.727 . . . . 0.0 111.177 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.98 -4.66 59.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.279 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 60.8 30.95 20.0 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.813 1.245 . . . . 0.0 111.616 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -119.96 131.95 55.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.308 0.643 . . . . 0.0 110.827 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.549 HG23 ' SD ' ' A' ' 35' ' ' MET . 57.2 t -96.23 151.08 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 109.077 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 76.6 m-85 -132.62 146.16 51.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.872 0.869 . . . . 0.0 109.077 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -134.74 102.97 5.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.15 102.83 14.83 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.542 ' HB3' HD22 ' A' ' 87' ' ' LEU . 57.5 mtm -89.71 118.31 29.22 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.71 28.94 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.5 m 59.19 47.98 11.0 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.085 0.954 . . . . 0.0 110.827 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 84' ' ' MET . 78.3 mt -63.92 117.69 7.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.968 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 121' ' ' VAL . 48.4 mtpt -77.17 154.79 82.44 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.555 -0.735 . . . . 0.0 109.338 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.98 -25.38 21.94 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.25 2.633 . . . . 0.0 114.421 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.58 -18.72 60.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.867 0.867 . . . . 0.0 112.837 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.73 -8.35 47.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.77 0.828 . . . . 0.0 113.042 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.2 m -62.99 98.52 0.13 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . . . -169.1 159.73 9.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.338 0.655 . . . . 0.0 111.116 -170.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.2 p -83.6 113.51 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -88.45 112.91 23.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.916 0.886 . . . . 0.0 109.238 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -103.6 129.46 50.87 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.439 1.096 . . . . 0.0 110.366 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.17 101.91 13.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.882 0.873 . . . . 0.0 109.578 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.35 28.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.517 0.727 . . . . 0.0 109.446 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.98 136.44 44.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.3 0.64 . . . . 0.0 109.448 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.63 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . . . . . . 0 C--N 1.341 0.852 0 O-C-N 123.641 0.588 . . . . 0.0 113.023 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.63 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 29.5 t70 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.951 0.405 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -139.22 155.23 47.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 0.0 110.074 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -115.06 119.13 35.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.454 1.102 . . . . 0.0 108.416 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.85 151.22 38.86 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.51 -37.1 82.47 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.107 0.454 . . . . 0.0 110.8 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.74 171.79 24.14 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.177 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -127.65 135.18 49.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.971 0.385 . . . . 0.0 110.629 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 11.3 tm0? -80.35 107.79 13.44 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.21 146.38 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.8 m -123.15 114.11 19.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.343 0.657 . . . . 0.0 109.412 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 88' ' ' LYS . 3.7 p -98.56 120.98 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -72.47 111.97 8.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.187 0.995 . . . . 0.0 110.128 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.5 p . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.935 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 61.2 tp . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -85.59 121.91 28.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.879 0.871 . . . . 0.0 109.35 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.578 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 74.7 mt -112.88 107.24 15.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.945 0.898 . . . . 0.0 108.733 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.24 104.42 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.9 156.74 18.73 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.019 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -159.5 172.35 18.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.296 1.038 . . . . 0.0 109.789 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.75 -4.91 69.22 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.285 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -79.43 129.71 9.35 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 117.094 0.447 . . . . 0.0 112.202 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.97 -164.07 29.12 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.3 pp -79.48 147.67 32.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 87' ' ' LEU . 3.9 p -151.64 151.85 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.483 1.113 . . . . 0.0 109.105 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.64 158.16 28.48 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.803 0.841 . . . . 0.0 110.653 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.12 111.16 4.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.543 0.737 . . . . 0.0 110.408 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.75 7.06 57.95 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.2 -163.74 36.34 Favored Glycine 0 C--N 1.352 1.451 0 C-N-CA 122.915 0.293 . . . . 0.0 113.058 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 p -137.13 151.57 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.697 0.799 . . . . 0.0 110.447 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -156.43 120.11 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.396 0.679 . . . . 0.0 109.437 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -92.07 119.59 31.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.419 0.687 . . . . 0.0 109.65 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.28 159.58 20.03 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.118 0.967 . . . . 0.0 109.076 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.9 t -142.41 163.01 34.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.382 0.673 . . . . 0.0 109.44 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.2 t -150.45 143.23 24.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.761 0.824 . . . . 0.0 109.865 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.11 53.72 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.87 122.56 46.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.699 0.8 . . . . 0.0 108.985 -175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.8 m -136.97 147.24 46.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.362 1.065 . . . . 0.0 109.739 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.5 -101.6 2.5 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -74.13 159.14 33.0 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.872 0.844 . . . . 0.0 112.787 -176.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.1 m -72.48 91.21 1.37 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.587 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.925 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 16.0 p -75.07 1.48 13.0 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.211 1.005 . . . . 0.0 112.493 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -98.98 -2.77 36.53 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.621 0.768 . . . . 0.0 110.179 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -131.23 174.38 10.1 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.681 0.792 . . . . 0.0 111.461 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 130.1 56.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.062 0.945 . . . . 0.0 108.459 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -114.64 154.41 28.44 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -156.95 154.25 25.37 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.677 -0.296 . . . . 0.0 113.632 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -97.35 143.08 28.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.791 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -138.2 138.52 38.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.722 1.209 . . . . 0.0 108.684 -175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -112.11 151.79 29.03 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.008 0.822 . . . . 0.0 111.323 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.08 152.05 4.16 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 110.433 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.45 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.155 0.982 . . . . 0.0 111.593 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.35 55.55 4.08 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 122.212 1.941 . . . . 0.0 112.968 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.26 40.95 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.973 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -115.61 162.43 17.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -98.49 166.7 11.23 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 0.0 108.821 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.98 102.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -101.55 153.75 19.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.488 0.715 . . . . 0.0 110.295 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.63 108.57 0.75 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.894 0.878 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.49 -64.31 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -157.81 133.15 8.88 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.435 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG21 ' HA3' ' A' ' 36' ' ' GLY . 79.6 t -126.46 123.85 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.262 1.025 . . . . 0.0 109.481 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.691 HG21 HH11 ' A' ' 73' ' ' ARG . 8.9 p -108.26 160.34 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.449 0.699 . . . . 0.0 109.439 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.97 162.78 13.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 168.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 29.1 p-90 -55.8 -43.84 77.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.293 1.037 . . . . 0.0 113.746 -174.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -83.8 -14.31 51.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.905 0.482 . . . . 0.0 110.913 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.54 10.22 82.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.179 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -67.29 -37.5 83.52 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.417 0.687 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -112.93 121.57 45.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.165 0.586 . . . . 0.0 109.888 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 52' ' ' VAL . 17.5 p -118.04 131.89 56.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.807 1.243 . . . . 0.0 108.133 172.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -124.55 136.35 53.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.274 1.03 . . . . 0.0 108.231 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 70.5 m-85 -141.3 136.94 32.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.376 0.67 . . . . 0.0 109.58 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.91 142.11 53.01 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.47 -29.12 58.16 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.031 0.932 . . . . 0.0 112.721 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -28.78 70.16 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 112.543 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.14 -1.29 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 111.493 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 28.3 ttpp -73.06 126.9 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.497 0.719 . . . . 0.0 110.726 -172.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.67 -25.05 28.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.759 0.662 . . . . 0.0 112.809 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -103.42 -23.79 13.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.092 0.557 . . . . 0.0 110.813 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.45 154.25 19.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.903 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -146.07 135.24 22.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 109.089 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -101.48 128.73 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.8 m -125.17 141.23 52.23 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.691 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.11 149.82 34.75 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.137 0.426 . . . . 0.0 109.961 -177.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -129.44 108.67 10.45 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.721 1.208 . . . . 0.0 108.503 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -68.74 -38.91 80.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 111.061 -173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.18 87.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.98 -13.19 56.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.933 0.493 . . . . 0.0 111.596 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 61.76 28.69 17.66 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.859 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.5 m -124.48 131.9 53.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.157 0.583 . . . . 0.0 110.677 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.68 160.1 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.531 1.132 . . . . 0.0 109.19 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -141.97 148.2 38.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.48 1.512 . . . . 0.0 108.86 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.86 100.83 5.03 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.54 102.29 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.783 0.833 . . . . 0.0 109.635 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.572 ' HB3' HD23 ' A' ' 87' ' ' LEU . 58.5 mtm -88.44 132.43 34.47 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -133.13 153.52 51.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t 58.42 59.77 2.86 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.868 0.842 . . . . 0.0 110.711 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 84' ' ' MET . 76.6 mt -79.83 116.68 20.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.94 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 79.7 mttt -75.37 152.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.89 -25.73 22.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.0 2.467 . . . . 0.0 114.069 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 10.8 pt-20 -70.12 -23.25 63.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.042 0.937 . . . . 0.0 112.95 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.71 -3.69 19.87 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.392 0.677 . . . . 0.0 112.809 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.518 HG21 ' HA ' ' A' ' 120' ' ' THR . 49.3 m -60.99 100.08 0.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.21 0.604 . . . . 0.0 109.719 170.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 161.04 5.55 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.677 0.791 . . . . 0.0 110.269 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.1 p -83.01 117.98 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.46 112.15 23.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -107.99 121.28 44.47 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.127 1.371 . . . . 0.0 109.365 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.7 p -88.52 143.0 27.24 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -142.7 132.94 24.66 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.354 1.062 . . . . 0.0 109.546 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.14 145.83 35.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.847 0.859 . . . . 0.0 110.964 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.686 177.424 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.744 0.307 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -140.61 155.33 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.832 1.253 . . . . 0.0 108.783 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 28.6 p90 -143.96 161.87 37.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.802 0.841 . . . . 0.0 109.667 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.412 ' CA ' ' HB2' ' A' ' 5' ' ' LEU . . . -96.78 -150.08 26.38 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.386 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -90.88 -53.65 4.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.575 0.75 . . . . 0.0 110.21 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.76 120.31 4.49 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.77 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 t -105.86 121.53 44.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.883 0.873 . . . . 0.0 109.61 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 tm0? -87.39 125.28 34.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.928 0.491 . . . . 0.0 110.41 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.42 HG13 ' HA2' ' A' ' 10' ' ' GLY . 5.9 m -111.56 145.4 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.653 0.781 . . . . 0.0 110.025 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.518 ' HA ' HG21 ' A' ' 92' ' ' THR . 91.8 m -133.38 119.65 19.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.048 0.939 . . . . 0.0 108.908 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.3 p -104.89 116.4 48.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.0 m -63.91 113.86 3.72 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.57 1.148 . . . . 0.0 110.004 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.4 p . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 110.981 -176.333 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.686 HD13 ' HB1' ' A' ' 25' ' ' ALA . 40.3 tp . . . . . 0 C--O 1.235 0.309 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -105.14 131.2 52.94 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.525 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 84.6 mt -121.9 118.75 29.67 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.759 1.224 . . . . 0.0 108.455 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.43 103.0 14.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.67 127.74 46.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -155.09 141.27 18.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.341 1.057 . . . . 0.0 110.19 -169.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 117' ' ' THR . . . 145.26 26.03 0.1 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -86.71 132.2 11.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.13 41.76 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.9 144.4 31.96 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.208 0.528 . . . . 0.0 110.56 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.48 153.64 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.531 . . . . 0.0 107.936 -174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.3 157.17 19.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.189 0.596 . . . . 0.0 110.953 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.75 111.79 5.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.463 0.705 . . . . 0.0 110.065 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.99 3.53 48.63 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.889 0.743 . . . . 0.0 111.504 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.76 -163.85 39.22 Favored Glycine 0 C--N 1.35 1.317 0 C-N-CA 122.792 0.234 . . . . 0.0 112.722 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.2 p -138.05 149.01 45.64 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.042 0.937 . . . . 0.0 109.921 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 tp -158.6 145.6 17.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -119.37 131.85 55.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.677 0.391 . . . . 0.0 110.881 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -92.29 159.62 15.52 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.074 0.95 . . . . 0.0 108.899 170.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -149.23 123.81 9.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.65 0.38 . . . . 0.0 110.081 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.611 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 51.7 t -127.38 106.55 9.28 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.145 0.578 . . . . 0.0 110.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.51 141.57 29.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.686 ' HB1' HD13 ' A' ' 3' ' ' LEU . . . -105.4 164.08 12.14 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.291 0.637 . . . . 0.0 109.861 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -66.65 166.92 11.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.384 0.674 . . . . 0.0 111.133 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.41 -13.48 50.28 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.63 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 136.62 57.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.575 1.15 . . . . 0.0 109.427 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 m -77.74 71.41 4.21 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 122.089 0.947 . . . . 0.0 111.966 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -79.84 -8.72 59.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.561 1.144 . . . . 0.0 110.574 164.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 t -57.04 -1.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 125.368 1.467 . . . . 0.0 113.812 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -91.04 -11.5 38.59 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.766 0.826 . . . . 0.0 112.088 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -107.64 167.06 10.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.366 0.666 . . . . 0.0 111.377 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.42 161.61 28.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 168.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.422 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 4.4 ptm -143.0 169.84 16.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.355 0.662 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.4 146.74 11.46 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 121.787 -0.244 . . . . 0.0 113.689 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -97.64 141.1 31.08 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.238 1.415 . . . . 0.0 109.858 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -132.07 164.4 26.32 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.793 1.237 . . . . 0.0 108.884 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.1 156.25 47.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.033 0.379 . . . . 0.0 110.386 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.462 ' O ' HG11 ' A' ' 94' ' ' VAL . 4.5 pt20 -166.38 136.01 3.17 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.976 0.797 . . . . 0.0 110.117 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.31 -62.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 124.469 1.107 . . . . 0.0 111.131 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.6 66.3 6.59 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.041 -168.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.29 62.57 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.96 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -98.91 133.64 42.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.761 0.824 . . . . 0.0 110.152 -173.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.15 174.13 8.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.952 0.901 . . . . 0.0 108.704 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -64.0 104.74 0.75 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.98 152.59 47.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 0.0 111.026 -169.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -58.12 110.61 0.97 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.433 1.493 . . . . 0.0 111.792 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.27 -55.86 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB3' HD13 ' A' ' 71' ' ' ILE . . . -169.07 132.47 1.34 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.745 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.8 141.21 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.571 1.148 . . . . 0.0 108.297 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.31 148.31 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.04 155.86 28.64 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -53.15 -39.07 63.27 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.098 1.359 . . . . 0.0 114.046 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.9 t -75.35 -27.13 59.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.268 0.627 . . . . 0.0 111.32 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.73 72.35 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.2 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -69.12 -55.14 11.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -106.1 124.52 49.71 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.751 . . . . 0.0 110.56 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 p -112.22 149.45 32.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.584 1.153 . . . . 0.0 109.657 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -129.39 123.63 32.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -119.68 159.02 25.26 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -74.87 144.58 43.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 165.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.49 -34.25 64.42 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.042 0.937 . . . . 0.0 112.932 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -65.64 -35.66 81.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.385 0.674 . . . . 0.0 111.575 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 62' ' ' ALA . 17.3 m -111.33 6.16 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 0.0 112.339 -172.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -68.67 111.55 4.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.941 0.496 . . . . 0.0 111.741 -171.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.87 15.01 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.868 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -83.17 -26.42 30.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.459 0.629 . . . . 0.0 109.565 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.16 153.4 18.94 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.6 m -146.98 136.76 23.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.034 0.934 . . . . 0.0 108.902 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -102.85 121.32 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -124.84 138.93 54.24 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -143.18 131.43 22.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.975 0.51 . . . . 0.0 110.068 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.0 95.36 6.12 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.48 -38.22 83.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 111.929 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.04 76.2 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.125 0.57 . . . . 0.0 111.446 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.45 -9.27 50.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.474 0.71 . . . . 0.0 112.042 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 18.4 m-80 58.64 27.33 15.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.683 1.193 . . . . 0.0 111.352 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.5 m -112.81 131.96 55.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.552 0.741 . . . . 0.0 109.283 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 ' HE3' ' A' ' 35' ' ' MET . 5.6 t -117.77 157.22 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.661 -174.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.59 127.85 19.81 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.824 1.25 . . . . 0.0 108.491 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.2 tm? -104.76 100.16 9.8 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.42 103.43 10.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 109.87 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.543 ' HB3' HD23 ' A' ' 87' ' ' LEU . 68.3 mtm -94.31 126.84 39.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.991 0.517 . . . . 0.0 109.775 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.35 148.01 51.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 m 57.55 58.8 3.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.394 1.078 . . . . 0.0 111.08 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 84' ' ' MET . 49.0 mt -73.61 117.5 15.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.502 -1.227 . . . . 0.0 112.221 -174.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -76.88 148.26 78.75 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.48 -24.06 20.9 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.0 2.466 . . . . 0.0 114.521 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -15.61 61.93 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.971 0.908 . . . . 0.0 113.255 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.38 -4.48 48.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.118 0.567 . . . . 0.0 112.261 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 120' ' ' THR . 85.2 m -61.58 103.98 0.38 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.773 0.829 . . . . 0.0 110.442 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.53 163.68 12.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.014 0.525 . . . . 0.0 110.993 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 8.3 p -81.07 121.61 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 168.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -86.01 143.49 28.1 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -135.48 112.3 10.17 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.438 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 41.6 t -83.13 140.6 32.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.61 162.84 34.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 109.366 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.61 26.22 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.191 0.596 . . . . 0.0 110.745 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.454 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.579 -179.335 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -138.77 132.29 30.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.807 0.443 . . . . 0.0 110.513 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 96' ' ' ASN . 4.4 p90 -122.87 161.48 24.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.91 0.884 . . . . 0.0 110.405 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -174.66 47.31 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 114.035 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -66.43 -44.68 82.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.215 1.006 . . . . 0.0 110.526 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 163.33 38.9 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.485 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 9' ' ' GLY . 7.5 t -143.82 138.93 29.03 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.848 0.459 . . . . 0.0 110.109 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.6 tm0? -91.15 121.65 33.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.05 0.54 . . . . 0.0 109.901 -173.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.461 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -107.21 144.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.103 0.961 . . . . 0.0 109.501 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.535 ' HA ' HG22 ' A' ' 92' ' ' THR . 60.1 m -124.06 105.5 9.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.174 0.589 . . . . 0.0 109.891 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.0 101.32 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.266 1.031 . . . . 0.0 109.01 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.6 t -66.46 134.15 51.88 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.121 0.968 . . . . 0.0 111.36 -176.504 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -86.4 125.23 33.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -119.4 120.85 38.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.25 102.8 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.834 0.853 . . . . 0.0 109.316 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.67 138.03 33.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 110.348 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.4 m -149.8 165.79 31.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.892 0.877 . . . . 0.0 110.16 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.77 -1.19 32.03 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 112.867 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 145.64 32.03 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.06 -166.61 33.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.06 144.84 29.64 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.994 0.426 . . . . 0.0 111.227 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.23 161.27 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.662 1.185 . . . . 0.0 108.081 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.8 164.14 13.8 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.75 0.704 . . . . 0.0 110.494 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.48 143.17 50.11 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.471 0.708 . . . . 0.0 110.629 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 3.29 85.7 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -164.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.46 -169.6 46.15 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 114.174 0.43 . . . . 0.0 114.174 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 p -153.28 147.25 25.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.107 0.963 . . . . 0.0 110.03 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 tp -160.79 128.92 4.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.103 0.561 . . . . 0.0 109.803 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -93.77 117.3 29.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.276 0.63 . . . . 0.0 110.138 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.4 mm? -86.02 159.26 19.64 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.328 1.051 . . . . 0.0 109.245 168.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -136.57 165.7 25.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.555 0.742 . . . . 0.0 109.316 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.8 t -146.56 145.73 30.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.056 0.942 . . . . 0.0 109.255 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.66 114.72 20.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . . . -105.44 154.55 20.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.049 0.54 . . . . 0.0 110.615 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 m -62.82 159.69 16.03 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.2 53.24 4.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.52 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -95.62 -167.59 1.63 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.043 1.337 . . . . 0.0 110.414 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 32' ' ' SER . 2.2 m -74.23 22.11 0.09 Allowed 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.4 0.68 . . . . 0.0 111.921 173.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.43 -29.83 69.24 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.306 1.043 . . . . 0.0 111.14 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 m -56.2 -26.29 50.32 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.881 0.872 . . . . 0.0 111.755 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 29' ' ' THR . 23.3 t -113.1 -2.74 14.09 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.04 0.936 . . . . 0.0 112.018 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -83.46 127.19 33.51 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.741 0.7 . . . . 0.0 110.432 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.77 115.98 10.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 4.7 ptm -114.21 170.4 8.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 111.102 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.95 163.32 33.17 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -111.39 138.51 47.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.7 154.0 38.67 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.807 1.243 . . . . 0.0 108.349 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -126.03 158.75 34.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -174.39 160.07 3.16 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.274 0.984 . . . . 0.0 109.887 174.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 171.96 -58.08 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 124.472 1.109 . . . . 0.0 111.052 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.52 63.57 6.62 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 122.368 2.046 . . . . 0.0 112.821 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.61 -5.74 60.12 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.912 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 31.7 mmmt -92.95 148.04 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 109.58 -177.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.77 176.15 5.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.301 0.64 . . . . 0.0 110.359 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -61.13 106.64 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.155 0.582 . . . . 0.0 111.82 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.53 152.51 24.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.917 1.287 . . . . 0.0 110.138 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -57.19 113.98 1.96 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.7 0.8 . . . . 0.0 110.662 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG12 HG13 ' A' ' 65' ' ' VAL . 71.8 t -98.36 -60.81 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.55 155.43 21.98 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.333 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.71 138.3 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.734 1.214 . . . . 0.0 107.957 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.538 HG23 HG21 ' A' ' 59' ' ' THR . 11.1 p -121.3 146.98 25.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.82 142.13 48.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -52.16 -41.4 62.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.291 1.036 . . . . 0.0 112.846 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -81.81 -9.27 59.66 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.46 0.704 . . . . 0.0 111.468 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.35 73.16 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 123.192 0.307 . . . . 0.0 112.561 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 31.2 tpt180 -67.38 -65.31 0.7 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.359 0.664 . . . . 0.0 110.679 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 36.6 mmt180 -113.76 127.41 56.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.279 0.631 . . . . 0.0 110.461 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 52' ' ' VAL . 54.5 p -108.58 150.84 26.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.848 0.859 . . . . 0.0 108.746 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -133.71 130.22 37.85 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' A' ' 70' ' ' THR . 98.3 m-85 -139.19 142.51 37.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.99 0.516 . . . . 0.0 109.982 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.92 142.38 47.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 162.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.51 -24.23 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.558 0.743 . . . . 0.0 111.91 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -61.0 -40.61 94.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.797 1.239 . . . . 0.0 112.199 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.491 HG13 HG12 ' A' ' 49' ' ' VAL . 32.5 m -115.56 1.96 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.809 0.844 . . . . 0.0 111.67 -173.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.21 125.42 25.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.709 0.804 . . . . 0.0 111.676 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.66 -26.16 6.76 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.587 0.554 . . . . 0.0 114.462 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -93.92 -29.58 15.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.203 0.601 . . . . 0.0 110.138 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.33 146.59 25.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.403 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 91.1 m -149.95 130.36 13.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.26 1.024 . . . . 0.0 108.648 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.456 HG13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -102.05 133.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -124.98 152.06 44.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.888 1.275 . . . . 0.0 107.947 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 138.26 16.2 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.546 0.612 . . . . 0.0 111.711 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -93.48 108.43 20.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.3 -37.85 88.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 110.919 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.61 82.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.92 0.763 . . . . 0.0 111.743 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.1 mmpt? -94.68 -16.35 23.19 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.764 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 41.2 m-80 60.81 34.98 19.59 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.544 1.137 . . . . 0.0 110.804 -172.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 m -112.48 131.27 55.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.392 0.677 . . . . 0.0 109.845 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 t -113.22 161.32 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.07 0.948 . . . . 0.0 109.914 -175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -143.5 116.08 8.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.147 0.979 . . . . 0.0 108.874 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 71' ' ' ILE . 2.6 tm? -101.21 96.69 7.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -82.8 129.77 35.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.968 0.907 . . . . 0.0 109.44 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.591 ' HB3' HD23 ' A' ' 87' ' ' LEU . 63.1 mtm -117.26 148.37 41.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.547 0.739 . . . . 0.0 109.992 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -146.25 160.16 42.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.351 1.06 . . . . 0.0 109.189 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m 54.56 48.02 21.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.564 1.145 . . . . 0.0 111.118 171.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.591 HD23 ' HB3' ' A' ' 84' ' ' MET . 97.0 mt -73.28 115.7 12.95 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.195 -171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -65.64 151.81 93.93 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.37 1.068 . . . . 0.0 109.056 166.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 20.0 Cg_endo -57.62 -22.79 53.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.268 2.645 . . . . 0.0 113.355 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 11.6 pt-20 -87.25 7.04 30.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.442 1.097 . . . . 0.0 112.285 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -87.5 2.04 51.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.665 0.386 . . . . 0.0 111.526 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 120' ' ' THR . 92.9 m -62.16 102.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 0.0 109.967 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.19 152.11 4.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.087 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.4 p -81.65 129.57 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.584 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.43 122.29 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.47 0.708 . . . . 0.0 109.854 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -103.76 132.47 49.99 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.773 0.829 . . . . 0.0 109.696 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.4 t -82.91 141.12 32.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' MET . . . -143.49 161.64 37.91 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.257 0.623 . . . . 0.0 109.716 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -141.72 146.42 36.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 0.0 108.991 176.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.687 0 O-C-N 123.18 0.3 . . . . 0.0 112.77 -178.625 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.268 0.556 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -130.99 149.0 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.356 1.062 . . . . 0.0 109.22 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -148.35 158.38 44.06 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.33 1.052 . . . . 0.0 108.492 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.89 -170.22 28.65 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.246 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.42 -39.29 20.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.245 1.018 . . . . 0.0 110.135 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.15 165.58 14.79 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.46 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 t -143.48 108.14 4.87 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 124.521 1.128 . . . . 0.0 109.455 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 58.6 tp60 -77.55 129.58 35.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.561 0.745 . . . . 0.0 111.258 -175.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.37 144.94 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 92' ' ' THR . 60.9 m -127.75 105.97 8.81 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.52 106.64 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.733 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.3 t -61.55 132.21 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.005 1.322 . . . . 0.0 110.717 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 30.8 p . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 123.918 0.887 . . . . 0.0 112.495 -173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.706 HD13 ' HB1' ' A' ' 25' ' ' ALA . 57.6 tp . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -82.44 103.86 12.3 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.31 128.68 44.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.7 t -119.94 102.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.767 0.827 . . . . 0.0 108.931 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -90.92 149.66 21.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.264 0.625 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -154.39 170.07 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.118 0.967 . . . . 0.0 109.921 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.67 43.56 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.094 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.66 88.73 0.54 Allowed Glycine 0 C--N 1.345 1.078 0 C-N-CA 122.916 0.293 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.59 -172.76 13.26 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.184 0.421 . . . . 0.0 112.289 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.98 138.91 31.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.386 0.675 . . . . 0.0 110.684 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 6.4 p -152.2 153.17 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.675 1.19 . . . . 0.0 108.364 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -92.68 160.03 15.17 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.582 -0.699 . . . . 0.0 110.729 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.51 123.81 21.45 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.99 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.49 54.13 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.659 0.599 . . . . 0.0 112.124 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.16 50.33 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.817 0.363 . . . . 0.0 113.182 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.0 p -114.87 162.23 17.19 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.108 0.963 . . . . 0.0 110.398 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -160.55 125.57 3.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 109.927 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -95.2 125.32 39.76 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.09 159.19 16.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.049 1.34 . . . . 0.0 108.644 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -139.69 160.32 40.16 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.771 0.428 . . . . 0.0 110.157 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 52.9 t -150.77 133.04 15.43 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.394 1.078 . . . . 0.0 108.62 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.2 131.71 56.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.706 ' HB1' HD13 ' A' ' 3' ' ' LEU . . . -106.8 137.79 44.18 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.185 0.594 . . . . 0.0 110.681 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -144.44 169.16 18.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.26 -83.9 1.56 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -82.32 154.93 25.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.414 0.686 . . . . 0.0 109.796 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -77.5 96.58 4.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.538 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 54.0 t80 -63.75 -20.94 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.103 0.961 . . . . 0.0 111.311 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -64.53 -7.26 9.57 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.623 0.769 . . . . 0.0 112.779 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -109.44 4.84 22.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.525 0.73 . . . . 0.0 111.305 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.79 140.58 44.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 0.0 111.004 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.24 164.53 21.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.764 0.826 . . . . 0.0 109.693 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.538 ' HB2' ' HE1' ' A' ' 30' ' ' PHE . 1.1 ttp -137.47 155.07 49.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.105 0.562 . . . . 0.0 110.21 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -146.16 147.21 18.02 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.75 129.83 42.85 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -128.1 141.71 51.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.265 1.026 . . . . 0.0 108.234 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -106.58 143.01 35.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.02 146.86 4.6 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.709 0.631 . . . . 0.0 110.255 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.37 -60.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 124.419 1.088 . . . . 0.0 110.789 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 92.5 Cg_endo -87.47 72.67 2.92 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -171.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.95 2.29 61.3 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.282 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.9 139.46 34.52 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.524 0.73 . . . . 0.0 109.526 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.06 175.66 6.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 109.458 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -60.91 105.71 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.736 0.303 . . . . 0.0 110.405 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.5 148.02 30.84 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.349 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.73 110.89 1.88 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.769 0.828 . . . . 0.0 111.323 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.57 -65.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -162.42 135.55 5.98 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.09 0.244 . . . . 0.0 111.402 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG22 ' HA3' ' A' ' 36' ' ' GLY . 82.3 t -121.46 150.37 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.697 1.199 . . . . 0.0 109.17 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 71' ' ' ILE . 8.2 p -144.16 163.91 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.51 1.124 . . . . 0.0 108.755 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -85.22 164.99 17.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 170.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -52.6 -43.25 65.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.088 1.355 . . . . 0.0 113.539 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -95.52 -6.11 41.26 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.42 0.688 . . . . 0.0 111.557 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 52' ' ' VAL . . . 86.14 20.5 55.05 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.404 -0.279 . . . . 0.0 112.404 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -57.75 -40.66 80.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.451 1.1 . . . . 0.0 111.749 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -132.52 138.18 47.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.888 0.875 . . . . 0.0 109.09 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 p -117.22 142.06 47.51 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.241 1.016 . . . . 0.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -136.24 125.89 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -137.74 142.72 40.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.6 131.59 46.74 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 163.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.62 -26.76 62.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 p -67.2 -42.27 84.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.834 0.854 . . . . 0.0 111.408 176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.92 -7.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.97 0.508 . . . . 0.0 111.064 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -76.18 115.87 16.32 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.69 -15.72 41.06 Favored Glycine 0 C--N 1.341 0.849 0 O-C-N 123.72 0.638 . . . . 0.0 112.59 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 18.3 ptp180 -116.41 -22.9 8.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.141 0.576 . . . . 0.0 109.993 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -112.12 143.95 42.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.18 0.992 . . . . 0.0 108.609 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -143.91 130.76 20.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.876 0.87 . . . . 0.0 108.881 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 52' ' ' VAL . 3.7 mt -101.8 126.08 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -137.47 136.8 38.07 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -151.19 153.52 35.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.348 0.594 . . . . 0.0 112.142 -169.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.45 111.25 23.74 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -70.72 -30.22 66.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 112.091 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.59 -31.9 62.2 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.053 0.541 . . . . 0.0 111.813 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -96.55 -6.16 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.655 . . . . 0.0 111.198 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 61.54 31.09 18.94 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.139 0.976 . . . . 0.0 110.514 176.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 m -112.35 132.4 55.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 109.854 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 33.7 t -114.37 154.21 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.384 1.073 . . . . 0.0 110.223 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.81 145.45 48.37 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 125.189 1.396 . . . . 0.0 108.05 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.49 107.58 10.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -82.25 101.67 10.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.949 . . . . 0.0 109.581 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.76 145.18 25.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.25 0.62 . . . . 0.0 109.904 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -145.63 152.84 40.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 m 58.92 46.11 14.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.771 0.828 . . . . 0.0 112.121 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.49 126.56 29.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.593 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 155.87 75.07 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.28 -21.52 60.71 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.418 2.079 . . . . 0.0 113.547 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -77.19 -18.4 57.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.354 0.662 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.554 ' HB2' HG11 ' A' ' 121' ' ' VAL . 2.7 m-20 -67.07 -10.07 46.0 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.302 0.641 . . . . 0.0 111.396 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -56.21 100.98 0.05 OUTLIER 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.048 0.939 . . . . 0.0 109.81 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.06 162.74 4.62 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.22 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -85.81 118.33 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -86.9 115.72 24.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.724 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.82 131.69 48.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.46 ' SG ' ' HG3' ' A' ' 35' ' ' MET . 38.5 t -83.94 106.87 15.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.18 112.29 25.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.87 168.98 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.788 0.835 . . . . 0.0 110.336 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.497 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -176.601 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.001 0.429 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.87 153.52 51.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.076 0.95 . . . . 0.0 109.16 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -153.19 152.14 30.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.11 -159.33 34.06 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 123.233 0.333 . . . . 0.0 113.853 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.01 -26.38 22.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.108 0.963 . . . . 0.0 111.068 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.43 157.92 32.39 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.789 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.3 t -131.04 108.08 9.52 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.401 1.08 . . . . 0.0 108.439 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 10.1 tm0? -81.17 106.16 12.94 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -92.9 142.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.1 m -123.57 111.29 16.09 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.4 p -113.51 106.91 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.679 0.752 . . . . 0.0 109.935 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -78.92 145.63 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.594 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.5 p . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 123.002 0.521 . . . . 0.0 111.071 177.537 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.762 HD11 ' HB1' ' A' ' 25' ' ' ALA . 45.8 tp . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 54.1 tp60 -84.86 104.63 14.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.839 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 23' ' ' CYS . 95.9 mt -95.15 108.76 20.88 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.599 0.759 . . . . 0.0 109.175 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.2 t -97.44 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -112.8 111.85 22.92 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -169.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 117' ' ' THR . 68.3 m -156.19 154.46 30.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.852 1.261 . . . . 0.0 109.256 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.02 -8.23 1.08 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.53 -0.305 . . . . 0.0 112.504 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.23 27.74 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.943 0.306 . . . . 0.0 112.584 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.16 -164.46 29.85 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.08 136.89 37.3 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.257 0.551 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p -151.8 145.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.225 1.41 . . . . 0.0 107.949 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.77 158.94 25.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.089 0.404 . . . . 0.0 110.592 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.53 125.92 27.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.231 0.612 . . . . 0.0 110.183 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 2.12 65.02 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.764 0.665 . . . . 0.0 112.151 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.31 -174.93 35.91 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.935 0.186 . . . . 0.0 113.32 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 p -123.75 147.41 47.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.382 1.073 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 tp -152.51 132.08 13.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.836 0.855 . . . . 0.0 108.762 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.85 127.45 55.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.354 0.662 . . . . 0.0 110.501 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD12 HG11 ' A' ' 119' ' ' VAL . 1.0 OUTLIER -93.03 156.51 16.84 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.788 0.835 . . . . 0.0 108.79 171.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -141.68 125.69 17.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 5' ' ' LEU . 47.9 t -117.17 104.41 11.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.321 0.649 . . . . 0.0 109.814 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.99 121.46 27.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.762 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.5 124.04 48.89 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.882 0.873 . . . . 0.0 109.502 -171.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.523 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 25.5 t -131.19 163.79 26.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.714 0.805 . . . . 0.0 111.012 -171.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 -102.98 1.64 Allowed Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.752 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.42 108.64 18.57 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -56.3 133.17 52.5 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -167.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 6.1 p90 -69.62 -19.52 63.63 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.064 0.945 . . . . 0.0 112.113 -176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 91.0 p -72.35 -5.54 37.0 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -88.13 -1.87 58.27 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.198 0.599 . . . . 0.0 110.436 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -136.79 173.86 11.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.84 0.856 . . . . 0.0 110.872 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.62 162.74 13.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 165.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.605 ' SD ' HG22 ' A' ' 80' ' ' VAL . 11.6 ptm -142.24 157.78 44.46 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 122.15 -0.344 . . . . 0.0 110.44 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -154.31 146.67 15.02 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.683 -0.235 . . . . 0.0 113.227 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -98.98 139.2 34.99 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.073 1.349 . . . . 0.0 109.951 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -129.15 170.22 13.81 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.13 1.372 . . . . 0.0 108.661 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -155.14 158.32 38.8 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.084 0.402 . . . . 0.0 111.833 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.12 153.9 12.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.002 0.921 . . . . 0.0 109.997 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.39 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 124.359 1.064 . . . . 0.0 111.286 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.42 67.35 8.48 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.021 1.814 . . . . 0.0 112.501 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.76 24.8 71.51 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.857 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -115.32 161.13 18.93 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.244 0.617 . . . . 0.0 112.123 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.33 175.35 7.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.637 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -66.1 103.57 0.99 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.72 153.5 17.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.923 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.52 110.64 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.792 0.837 . . . . 0.0 110.097 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.5 t -85.78 -59.41 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -171.47 147.42 2.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.031 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG22 ' HA3' ' A' ' 36' ' ' GLY . 77.3 t -129.22 137.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.177 0.991 . . . . 0.0 108.535 174.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 59' ' ' THR . 7.0 p -124.61 160.65 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.833 0.853 . . . . 0.0 109.571 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.0 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 64.8 p-90 -57.13 -37.25 71.72 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.534 0.733 . . . . 0.0 112.741 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -76.72 -28.96 56.03 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.163 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.93 -8.22 70.34 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.278 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -59.51 -28.47 67.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.742 0.817 . . . . 0.0 112.432 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -108.61 122.55 47.34 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.547 0.739 . . . . 0.0 109.521 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 52' ' ' VAL . 38.6 p -127.15 133.64 50.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.498 1.119 . . . . 0.0 108.886 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -128.58 127.19 41.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -129.52 148.09 51.39 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.366 0.666 . . . . 0.0 110.698 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.69 137.51 42.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.69 -30.48 67.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.68 0.792 . . . . 0.0 112.992 -171.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.7 m -69.6 -41.58 75.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.214 0.606 . . . . 0.0 111.676 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.16 -9.44 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.338 0.655 . . . . 0.0 111.539 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -66.96 144.91 55.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.418 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.71 -24.9 7.96 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.447 0.467 . . . . 0.0 113.701 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 10.7 ptt180 -113.37 -20.72 11.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.223 0.609 . . . . 0.0 111.065 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m-30 -101.09 155.82 17.77 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.231 0.613 . . . . 0.0 110.24 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -149.07 136.6 20.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.112 . . . . 0.0 108.527 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 50' ' ' ALA . 2.1 mp -101.05 121.6 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.6 m -124.3 136.84 54.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.424 HH11 HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.71 131.73 21.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.574 0.702 . . . . 0.0 110.355 -174.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.5 109.15 20.69 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -68.5 -27.65 66.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.856 0.462 . . . . 0.0 110.077 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.59 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.834 0.853 . . . . 0.0 111.637 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -80.42 -16.03 55.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.355 . . . . 0.0 111.078 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.427 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 29.4 m-80 61.87 28.2 17.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.628 1.171 . . . . 0.0 110.872 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -120.83 135.11 55.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.959 0.503 . . . . 0.0 110.622 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.605 HG22 ' SD ' ' A' ' 35' ' ' MET . 19.4 t -108.81 155.59 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.788 1.235 . . . . 0.0 109.378 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -142.52 113.28 7.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.645 1.178 . . . . 0.0 108.961 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 98.86 11.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -84.83 104.92 15.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.803 0.841 . . . . 0.0 110.396 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.551 ' HB3' HD23 ' A' ' 87' ' ' LEU . 57.8 mtm -94.64 142.14 27.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.1 0.56 . . . . 0.0 109.612 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.16 162.44 34.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.563 1.145 . . . . 0.0 108.438 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 m 52.52 45.36 28.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.178 0.991 . . . . 0.0 112.153 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 84' ' ' MET . 81.2 mt -70.86 127.79 33.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.119 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -85.94 144.53 39.31 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.774 0.83 . . . . 0.0 108.94 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -44.15 -35.18 7.53 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 124.428 3.419 . . . . 0.0 115.142 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -73.52 -9.37 58.61 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.78 1.232 . . . . 0.0 113.407 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 -2.2 47.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.022 0.929 . . . . 0.0 112.65 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -58.99 105.81 0.35 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.367 0.667 . . . . 0.0 110.145 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.71 8.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.987 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.4 p -79.75 113.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.9 145.05 27.34 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 108.751 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.23 127.5 26.32 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -84.76 139.79 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.63 157.21 44.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.48 1.112 . . . . 0.0 108.398 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -145.59 164.13 32.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 110.553 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.651 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.033 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 64.8 m-85 -131.13 150.65 52.05 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.841 0.856 . . . . 0.0 109.847 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -124.22 139.24 54.11 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.07 0.948 . . . . 0.0 110.371 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -99.41 167.33 21.22 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.5 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -71.0 -48.39 53.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.803 0.441 . . . . 0.0 111.254 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.502 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.96 129.86 4.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.917 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 8' ' ' SER . 13.8 t -125.34 138.11 54.05 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.497 0.719 . . . . 0.0 110.669 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 54.0 tp60 -81.14 121.16 25.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 110.501 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 21' ' ' LEU . 2.9 m -94.93 137.56 22.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' HG22 ' A' ' 92' ' ' THR . 31.8 m -123.69 103.59 8.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.81 104.75 16.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -59.06 134.5 57.05 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.8 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.241 0.623 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.399 175.092 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 25' ' ' ALA . 40.4 tp . . . . . 0 C--O 1.239 0.51 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.28 107.9 10.02 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.818 0.847 . . . . 0.0 109.349 172.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -102.04 113.54 26.88 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG22 ' NE2' ' A' ' 115' ' ' GLN . 28.2 t -108.34 101.83 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.18 153.11 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.142 0.496 . . . . 0.0 110.678 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.4 p -154.32 170.28 21.68 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.72 18.95 30.82 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.31 86.87 0.32 Allowed Glycine 0 C--N 1.352 1.448 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.31 -168.29 12.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -120.5 147.88 44.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.3 p -151.06 147.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 108.065 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.1 mp0 -78.93 162.8 25.74 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.589 0.631 . . . . 0.0 110.887 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -63.9 138.38 58.45 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.084 0.554 . . . . 0.0 111.538 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -7.55 81.05 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 123.68 0.612 . . . . 0.0 112.507 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.41 -175.83 49.65 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 121.039 0.244 . . . . 0.0 113.332 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.4 p -125.19 159.45 31.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.408 1.083 . . . . 0.0 109.692 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.0 tp -152.45 122.16 6.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -96.6 112.56 24.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.491 0.716 . . . . 0.0 109.997 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -94.21 156.71 16.41 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.477 1.111 . . . . 0.0 109.699 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -133.45 152.92 51.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -149.98 109.83 4.08 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.51 121.0 26.63 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -105.25 129.59 53.58 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.695 0.798 . . . . 0.0 109.518 -175.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.7 t -142.63 154.43 44.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 109.61 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 -114.2 4.57 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.6 mmp_? -61.94 134.36 56.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.063 0.545 . . . . 0.0 111.218 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.359 0.664 . . . . 0.0 110.393 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -64.06 -18.47 64.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.66 0.384 . . . . 0.0 110.265 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 52.0 p -66.79 -9.52 37.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.394 1.077 . . . . 0.0 112.484 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.9 t -98.02 -11.66 22.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 0.0 110.846 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.69 156.55 42.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.006 0.522 . . . . 0.0 111.442 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.96 143.86 26.05 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.446 ' HE2' HG13 ' A' ' 80' ' ' VAL . 10.1 ptm -128.88 170.02 13.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.193 0.597 . . . . 0.0 110.761 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.64 158.33 31.13 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.158 0.286 . . . . 0.0 113.051 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -104.62 136.48 44.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.735 0.814 . . . . 0.0 109.773 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -129.94 153.02 48.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.795 1.238 . . . . 0.0 108.178 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.39 157.98 45.53 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.397 0.544 . . . . 0.0 111.764 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' NE2' ' HG3' ' A' ' 46' ' ' ARG . 3.9 pt20 -164.85 155.39 14.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.217 0.948 . . . . 0.0 110.126 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 175.22 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.806 1.242 . . . . 0.0 110.387 168.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.75 70.85 7.36 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.152 1.901 . . . . 0.0 112.941 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.2 66.62 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.62 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 60.6 mmtt -99.23 144.6 28.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.302 1.041 . . . . 0.0 110.981 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.52 173.21 8.46 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.966 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HG3' ' NE2' ' A' ' 40' ' ' GLN . 1.9 mtm180 -66.61 103.76 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.75 152.65 20.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.287 0.635 . . . . 0.0 109.964 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.11 112.83 2.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.674 0.79 . . . . 0.0 109.653 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.6 -54.87 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.55 ' HB1' HD13 ' A' ' 71' ' ' ILE . . . -163.1 164.07 25.55 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.355 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.31 131.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.88 1.272 . . . . 0.0 108.283 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.86 151.53 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.336 0.655 . . . . 0.0 109.633 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -82.09 147.48 29.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.583 0.753 . . . . 0.0 109.17 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 58.5 p-90 -54.84 -39.3 68.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.525 1.13 . . . . 0.0 113.102 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -80.72 -19.02 45.97 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.913 0.885 . . . . 0.0 110.699 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.97 61.73 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.122 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -74.04 -22.11 59.68 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.992 0.517 . . . . 0.0 110.804 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -133.76 137.79 45.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.194 0.997 . . . . 0.0 110.607 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -136.25 132.21 35.5 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.454 1.102 . . . . 0.0 108.582 168.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -126.32 138.46 53.59 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.98 148.59 52.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.795 0.438 . . . . 0.0 110.237 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 147.63 41.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.33 -43.52 53.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.274 1.03 . . . . 0.0 113.157 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 m -71.44 -29.69 65.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.67 0.788 . . . . 0.0 112.401 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.68 -7.35 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 111.366 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -69.7 132.26 45.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 0.0 110.427 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.67 8.06 74.12 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.705 0.628 . . . . 0.0 113.826 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 15.6 ptt180 -144.08 -26.76 0.53 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.057 0.543 . . . . 0.0 111.265 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-85 -96.27 152.56 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.8 m -150.24 134.3 17.0 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.682 1.193 . . . . 0.0 108.361 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.55 HD13 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -105.19 133.01 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -132.86 163.49 28.98 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.75 146.42 16.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.154 0.502 . . . . 0.0 110.656 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -105.1 121.23 43.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.473 0.709 . . . . 0.0 109.285 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.48 -35.51 75.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.253 0.621 . . . . 0.0 109.968 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.17 -23.82 66.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.637 0.775 . . . . 0.0 112.158 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.23 -20.0 13.64 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.389 0.676 . . . . 0.0 111.078 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 59.41 35.53 23.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.791 1.236 . . . . 0.0 110.757 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -124.27 132.17 53.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.43 0.692 . . . . 0.0 110.349 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG13 ' HE2' ' A' ' 35' ' ' MET . 50.3 t -99.43 130.48 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.524 1.13 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.47 114.56 26.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.676 0.79 . . . . 0.0 109.667 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.8 tm? -97.18 104.07 16.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.412 ' H ' HE21 ' A' ' 83' ' ' GLN . 0.0 OUTLIER -88.24 120.73 29.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.624 0.77 . . . . 0.0 110.493 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.466 ' HB3' HD21 ' A' ' 87' ' ' LEU . 62.9 mtt -105.49 147.74 27.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.291 1.036 . . . . 0.0 109.301 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -141.72 158.12 44.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.038 0.935 . . . . 0.0 108.514 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 m 55.35 41.57 31.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.047 0.939 . . . . 0.0 112.025 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -68.25 118.45 11.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 42.3 mtpt -84.2 154.36 63.33 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.314 172.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 10.8 Cg_endo -52.99 -19.7 11.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.022 2.481 . . . . 0.0 114.415 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 11.9 pt-20 -76.09 -12.33 60.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.14 0.976 . . . . 0.0 112.849 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.54 -5.34 56.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.314 0.646 . . . . 0.0 112.148 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.534 HG21 ' HA ' ' A' ' 120' ' ' THR . 86.8 m -61.51 103.9 0.36 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.403 0.681 . . . . 0.0 110.686 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.02 160.39 12.0 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.982 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.6 p -85.22 111.94 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.264 0.554 . . . . 0.0 109.975 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -88.8 113.41 24.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.35 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.53 126.47 48.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.379 1.072 . . . . 0.0 108.746 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -84.66 136.31 33.8 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -132.16 161.52 33.13 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.936 0.895 . . . . 0.0 109.802 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.77 167.96 23.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.481 0.712 . . . . 0.0 110.032 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.782 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.332 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 121.286 0.565 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -112.66 146.38 38.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.4 p90 -150.33 168.79 23.06 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.298 0.639 . . . . 0.0 109.84 170.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.2 -168.23 18.8 Favored Glycine 0 C--O 1.239 0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.379 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.404 ' NE2' HG22 ' A' ' 6' ' ' VAL . 74.5 mt-30 -83.73 -39.27 20.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.15 0.98 . . . . 0.0 110.575 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.25 132.67 7.84 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.551 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -107.84 111.69 23.96 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.916 0.886 . . . . 0.0 108.744 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 7.8 tm0? -79.24 110.26 14.34 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -96.15 140.35 17.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.534 ' HA ' HG21 ' A' ' 92' ' ' THR . 86.2 m -121.18 112.28 18.45 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.0 p -102.57 119.2 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.475 0.655 . . . . 0.0 109.294 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 5.8 m -65.24 139.0 58.59 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 111.034 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 24.0 t . . . . . 0 C--O 1.238 0.477 0 C-N-CA 123.659 0.784 . . . . 0.0 110.647 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.81 116.9 29.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.984 0.914 . . . . 0.0 109.839 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.503 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.9 mt -118.51 123.05 44.18 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.832 0.853 . . . . 0.0 110.292 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 39.2 t -108.12 104.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.437 1.095 . . . . 0.0 109.421 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -76.29 152.58 36.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.797 0.439 . . . . 0.0 110.916 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -149.13 146.12 27.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.981 0.912 . . . . 0.0 110.276 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.13 20.71 8.15 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.259 0.35 . . . . 0.0 113.079 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.98 85.91 0.67 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.81 -164.29 10.97 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.15 144.25 45.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.084 0.554 . . . . 0.0 111.468 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 19' ' ' LEU . 7.5 p -152.02 152.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.834 1.254 . . . . 0.0 108.51 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 2.8 pt20 -65.53 156.98 30.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.532 0.733 . . . . 0.0 112.412 -176.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 139.77 57.13 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.095 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 -20.05 33.07 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.063 0.227 . . . . 0.0 112.816 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.4 -177.37 51.77 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-O 121.178 0.321 . . . . 0.0 113.467 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 p -115.13 160.7 19.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.073 0.949 . . . . 0.0 110.878 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' A' ' 13' ' ' VAL . 40.8 tp -156.52 125.7 6.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.97 115.86 27.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.855 0.462 . . . . 0.0 109.979 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.5 mm? -94.6 156.38 16.46 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -144.78 144.72 31.31 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 35.5 t -124.98 113.72 18.19 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.924 0.889 . . . . 0.0 108.905 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -83.82 112.9 20.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.7 122.87 45.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.244 0.618 . . . . 0.0 109.401 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 m -62.79 126.08 26.11 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.02 74.44 0.01 OUTLIER Glycine 0 C--N 1.357 1.741 0 O-C-N 125.246 1.591 . . . . 0.0 115.691 -166.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -98.39 -174.79 2.92 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.867 1.267 . . . . 0.0 108.834 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -83.18 86.38 7.04 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.16 -26.35 65.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 35.4 p -66.03 -13.91 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.227 . . . . 0.0 113.055 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -82.19 -14.64 55.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.168 0.587 . . . . 0.0 111.954 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.14 140.94 44.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.064 0.545 . . . . 0.0 111.382 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 137.52 38.63 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 165.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.519 ' SD ' ' SG ' ' A' ' 97' ' ' CYS . 17.4 ttp -126.37 154.79 43.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.6 0.76 . . . . 0.0 109.644 -169.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.54 161.51 32.25 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 117.714 0.234 . . . . 0.0 113.101 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -97.79 139.47 33.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.825 0.85 . . . . 0.0 109.379 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.343 1.057 . . . . 0.0 109.162 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -131.52 161.56 32.3 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.017 0.371 . . . . 0.0 111.775 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -171.91 146.74 2.07 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.357 171.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -178.11 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 123.891 0.876 . . . . 0.0 111.252 171.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 84.3 Cg_endo -80.35 70.27 7.59 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.155 1.903 . . . . 0.0 112.745 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.65 6.16 80.58 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.551 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.25 141.49 28.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.545 0.738 . . . . 0.0 110.633 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.38 176.95 7.61 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 162.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -60.41 104.76 0.36 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.961 0.504 . . . . 0.0 109.833 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.92 148.59 24.31 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.412 0.685 . . . . 0.0 109.634 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.53 121.16 14.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.522 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -104.88 -59.29 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.88 142.9 6.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.605 0.362 . . . . 0.0 110.434 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.0 t -123.99 130.44 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.107 0.963 . . . . 0.0 109.816 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 59' ' ' THR . 10.6 p -106.39 153.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.771 0.828 . . . . 0.0 109.507 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.49 151.71 37.96 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 49.5 p90 -59.69 -36.57 76.76 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.597 0.759 . . . . 0.0 112.165 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -84.46 -15.11 47.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.72 0.808 . . . . 0.0 111.18 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.7 79.99 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 116.416 -0.356 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -63.42 -49.41 73.84 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.679 0.792 . . . . 0.0 111.035 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -114.41 148.05 38.31 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.657 0.783 . . . . 0.0 110.115 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 52' ' ' VAL . 38.0 p -137.82 147.07 44.24 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.126 0.971 . . . . 0.0 109.133 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.98 129.89 38.8 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -122.32 145.96 47.76 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.84 148.59 36.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.46 -26.42 68.51 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 123.394 0.434 . . . . 0.0 111.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -67.17 -41.51 85.83 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.856 0.863 . . . . 0.0 111.186 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 m -112.65 13.46 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 111.65 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.93 105.94 0.75 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.366 1.066 . . . . 0.0 111.74 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.63 -26.04 18.13 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.768 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 16.6 ptp180 -84.54 -28.61 26.53 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 117.634 0.717 . . . . 0.0 110.43 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.402 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.7 m-30 -101.85 150.34 23.27 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.45 0.7 . . . . 0.0 109.44 172.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -147.63 132.74 18.28 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.04 0.936 . . . . 0.0 109.203 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.439 HG12 HD22 ' A' ' 82' ' ' LEU . 19.9 mt -101.88 138.63 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -135.77 156.14 49.27 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 154.55 34.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.323 0.582 . . . . 0.0 110.29 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -127.82 109.11 11.3 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -70.33 -30.92 68.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.704 0.802 . . . . 0.0 110.594 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.8 -38.31 54.2 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.117 0.567 . . . . 0.0 111.45 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.4 mmpt? -79.06 -17.89 54.42 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.31 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 60.74 32.86 20.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.554 1.142 . . . . 0.0 109.832 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 m -133.63 133.09 41.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.435 0.694 . . . . 0.0 110.579 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 45.1 t -104.06 155.43 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.4 1.08 . . . . 0.0 109.425 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.54 137.97 44.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.32 1.048 . . . . 0.0 109.631 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.1 tm? -122.73 105.66 10.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.7 107.96 18.88 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.802 0.841 . . . . 0.0 110.007 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.534 ' SD ' HD21 ' A' ' 87' ' ' LEU . 47.3 mtt -87.9 138.53 31.38 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.68 0.792 . . . . 0.0 109.402 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -139.73 133.2 30.15 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 m 58.36 72.93 0.5 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.717 0.807 . . . . 0.0 111.664 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.534 HD21 ' SD ' ' A' ' 84' ' ' MET . 49.8 mt -71.76 136.74 47.24 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.109 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -74.64 152.2 87.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.266 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.26 -25.16 79.45 Favored 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.297 1.998 . . . . 0.0 113.787 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.94 6.76 48.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.985 0.914 . . . . 0.0 112.931 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.39 -9.48 56.42 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 123.271 0.628 . . . . 0.0 112.315 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.418 ' OG1' HG11 ' A' ' 121' ' ' VAL . 89.1 m -53.77 106.2 0.18 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.841 0.856 . . . . 0.0 111.149 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.84 158.55 20.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 110.017 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 40' ' ' GLN . 15.0 p -89.65 124.54 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -98.25 122.45 41.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.029 0.932 . . . . 0.0 110.297 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.9 128.0 56.35 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' A' ' 35' ' ' MET . 46.8 t -83.78 103.06 12.76 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.52 131.63 52.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.656 0.782 . . . . 0.0 111.134 -175.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.99 167.61 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.574 0.75 . . . . 0.0 110.535 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.831 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.513 -178.738 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 122.028 0.918 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -119.65 153.58 35.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -136.73 154.85 50.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.123 0.487 . . . . 0.0 111.405 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.28 161.45 41.2 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 164.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.87 11.25 6.28 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.37 138.69 1.69 Allowed Glycine 0 C--N 1.347 1.148 0 C-N-CA 123.224 0.44 . . . . 0.0 113.879 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 t -136.45 107.14 6.57 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -75.31 105.77 6.5 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.282 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.64 140.69 15.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 m -125.8 136.84 53.58 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 HG11 ' OG1' ' A' ' 92' ' ' THR . 7.3 p -114.88 125.38 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.054 0.454 . . . . 0.0 110.143 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 28.0 t -83.42 111.71 19.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.1 p . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 123.818 0.847 . . . . 0.0 111.279 -174.68 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 41.0 tp . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.47 128.09 34.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.905 0.882 . . . . 0.0 109.381 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.2 126.46 42.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.277 1.031 . . . . 0.0 108.737 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.27 104.1 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.636 0.775 . . . . 0.0 109.679 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.36 137.36 32.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.891 0.877 . . . . 0.0 109.558 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m -147.64 171.44 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.758 0.823 . . . . 0.0 110.335 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.36 13.13 66.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.037 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.37 145.73 18.61 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.43 -164.46 30.0 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.832 0.316 . . . . 0.0 112.549 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.09 144.11 31.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.129 0.572 . . . . 0.0 110.157 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.5 p -150.83 151.71 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.247 1.019 . . . . 0.0 108.526 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.06 155.61 23.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.676 0.391 . . . . 0.0 110.256 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 129.57 38.4 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.39 66.12 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 123.772 0.701 . . . . 0.0 111.423 -167.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.87 -166.52 31.82 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.198 0.428 . . . . 0.0 113.698 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -147.58 160.83 42.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.272 1.029 . . . . 0.0 110.269 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -155.99 147.64 22.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.012 0.925 . . . . 0.0 108.547 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -128.11 118.68 23.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.281 0.492 . . . . 0.0 109.995 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD22 ' SD ' ' A' ' 84' ' ' MET . 2.5 mm? -90.51 157.43 17.54 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.89 0.876 . . . . 0.0 109.857 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -142.15 123.77 15.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -122.74 118.74 28.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.981 0.512 . . . . 0.0 110.824 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.51 123.97 30.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.329 0.651 . . . . 0.0 110.09 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.81 143.43 38.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.1 0.96 . . . . 0.0 110.121 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -160.07 176.44 11.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.259 0.624 . . . . 0.0 110.419 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.85 -96.48 1.56 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 66.1 mtp180 -79.79 143.53 34.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.1 m -73.47 103.33 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -58.21 -25.9 62.19 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.01 0.924 . . . . 0.0 111.884 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 43.7 p -76.05 0.45 18.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.773 0.829 . . . . 0.0 112.502 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -87.88 -13.69 41.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.15 0.58 . . . . 0.0 110.143 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.53 170.42 10.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.386 0.674 . . . . 0.0 110.571 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 133.62 34.9 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.746 ' HE1' ' SG ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -129.12 131.41 47.22 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.486 0.714 . . . . 0.0 109.35 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.506 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . -152.23 159.98 28.66 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 114.223 0.449 . . . . 0.0 114.223 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -97.52 132.61 43.04 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.295 1.038 . . . . 0.0 110.384 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.59 129.94 45.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 108.387 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -114.53 156.67 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.502 0.321 . . . . 0.0 111.63 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -167.23 149.27 5.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.83 0.706 . . . . 0.0 110.504 173.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . -179.73 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.813 0.845 . . . . 0.0 111.32 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 88.3 Cg_endo -83.21 73.86 5.1 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.155 1.903 . . . . 0.0 112.481 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.03 74.46 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.181 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.6 mmpt? -115.7 145.5 42.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.542 0.737 . . . . 0.0 111.343 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.89 169.85 10.89 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 161.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -64.12 103.8 0.65 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.414 0.626 . . . . 0.0 110.14 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.49 150.38 20.37 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.573 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.01 108.59 1.85 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.946 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -90.11 -68.03 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -163.6 134.28 4.5 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.577 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' HA3' ' A' ' 36' ' ' GLY . 94.5 t -116.17 134.02 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 0.0 109.596 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 59' ' ' THR . 8.1 p -107.27 148.87 11.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 123.448 0.699 . . . . 0.0 110.595 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.1 149.97 35.67 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 168.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 61.8 p-90 -60.02 -34.94 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 0.0 112.925 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -86.86 -10.94 52.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 111.495 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.38 15.52 78.15 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.394 -171.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -59.62 -46.65 88.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.113 0.965 . . . . 0.0 111.11 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -133.57 129.25 36.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 52' ' ' VAL . 36.4 p -117.45 128.7 55.25 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.44 117.13 32.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.39 154.54 27.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 110.309 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.23 146.12 39.28 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.95 -25.91 67.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.905 0.482 . . . . 0.0 112.109 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -70.46 -41.95 72.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.751 0.821 . . . . 0.0 110.878 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HB ' ' CD1' ' A' ' 69' ' ' PHE . 8.1 m -94.63 -4.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.293 0.637 . . . . 0.0 111.992 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -67.36 119.4 12.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 0.0 111.094 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.64 17.88 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 123.525 0.583 . . . . 0.0 113.951 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -96.27 -13.5 23.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.364 0.666 . . . . 0.0 110.79 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CD1' ' HB ' ' A' ' 65' ' ' VAL . 97.3 m-85 -123.76 155.83 37.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.423 0.689 . . . . 0.0 109.261 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.3 m -148.77 138.1 21.76 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 108.289 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -102.81 144.5 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 m -136.48 155.87 49.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.71 157.23 36.26 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.65 119.37 13.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.83 -4.94 58.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.009 0.924 . . . . 0.0 112.269 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.99 -54.1 4.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -78.52 -14.23 59.45 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.873 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.94 34.47 19.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.627 1.171 . . . . 0.0 111.301 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.6 m -119.22 132.46 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.251 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 35' ' ' MET . 51.6 t -104.33 119.39 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.142 0.977 . . . . 0.0 109.965 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.26 121.1 41.61 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.702 0.801 . . . . 0.0 110.281 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -105.64 110.54 22.9 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.84 102.81 13.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.902 0.881 . . . . 0.0 109.899 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.659 ' HE1' HG23 ' A' ' 119' ' ' VAL . 83.8 mtp -87.38 140.28 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 0.0 108.669 171.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.67 154.83 30.72 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 123.071 0.232 . . . . 0.0 110.733 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 m 61.07 38.65 16.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.447 1.099 . . . . 0.0 110.312 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 84' ' ' MET . 90.9 mt -68.11 129.16 39.09 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.188 -169.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -100.69 154.42 37.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.466 1.107 . . . . 0.0 108.077 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.841 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 12.1 Cg_endo -53.77 -24.42 30.52 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 123.446 2.764 . . . . 0.0 114.78 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.86 -13.85 59.57 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 112.68 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.5 -2.1 33.78 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.723 0.809 . . . . 0.0 112.208 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 120' ' ' THR . 65.8 m -62.71 107.91 1.06 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.23 0.612 . . . . 0.0 109.805 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.18 160.01 9.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.572 0.545 . . . . 0.0 110.898 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 40' ' ' GLN . 14.4 p -85.68 115.64 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -94.28 116.25 28.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.106 0.962 . . . . 0.0 108.807 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.06 131.44 48.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.028 0.531 . . . . 0.0 109.72 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.746 ' SG ' ' HE1' ' A' ' 35' ' ' MET . 11.4 t -82.16 102.07 10.85 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.48 162.08 14.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.306 1.042 . . . . 0.0 110.669 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.9 128.52 14.17 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.917 0.887 . . . . 0.0 108.951 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.553 0 O-C-N 123.768 0.668 . . . . 0.0 111.637 -178.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.162 0.506 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.42 150.47 31.1 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.342 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -158.32 151.96 23.47 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.691 1.196 . . . . 0.0 108.316 164.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.63 -163.26 26.43 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.49 -38.03 86.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.859 0.864 . . . . 0.0 110.123 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.34 130.88 7.17 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.909 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -99.93 108.26 20.45 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 109.416 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -79.34 102.86 8.89 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.659 HG23 ' HE1' ' A' ' 84' ' ' MET . 10.9 m -91.62 137.11 22.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.542 ' HA ' HG23 ' A' ' 92' ' ' THR . 24.0 m -121.02 104.68 9.98 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 3.2 p -100.42 117.11 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.5 t -61.95 140.96 58.28 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.841 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 50.0 p . . . . . 0 C--O 1.239 0.524 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.349 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 25' ' ' ALA . 52.9 tp . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 24.9 tt0 -102.83 105.65 16.09 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.599 0.76 . . . . 0.0 109.631 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.486 ' HB3' ' SG ' ' A' ' 97' ' ' CYS . 79.1 mt -91.01 127.23 36.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.594 0.758 . . . . 0.0 109.346 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.11 102.86 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 109.042 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.58 123.19 29.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.1 0.56 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -117.9 130.8 56.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.558 1.143 . . . . 0.0 108.816 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.92 4.99 1.46 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-O 119.861 -0.411 . . . . 0.0 113.345 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.71 102.83 0.8 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.999 0.399 . . . . 0.0 112.17 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.84 -174.56 34.7 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.36 145.2 26.42 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.148 0.499 . . . . 0.0 111.812 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -146.85 154.85 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.47 1.108 . . . . 0.0 108.655 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -87.47 151.31 23.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.864 0.465 . . . . 0.0 111.233 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.91 110.35 5.59 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.431 0.692 . . . . 0.0 110.427 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.25 -4.11 40.8 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.202 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.99 -167.56 42.29 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.667 0.275 . . . . 0.0 112.955 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.7 m -124.92 157.86 34.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.733 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 tp -155.04 123.15 5.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.799 0.84 . . . . 0.0 108.833 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -93.66 119.68 32.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 1.9 mm? -103.84 153.89 20.23 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.83 123.31 8.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 51.9 t -104.99 127.52 52.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.344 0.658 . . . . 0.0 110.087 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.22 127.14 38.68 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.618 0.767 . . . . 0.0 109.601 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -104.83 128.77 53.13 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 4.1 m -120.2 151.08 39.64 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.717 0.807 . . . . 0.0 110.947 -169.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.38 -88.2 0.51 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 124.1 0.875 . . . . 0.0 112.832 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -74.25 146.49 43.21 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 0.0 110.528 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -65.18 110.1 2.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.621 0.768 . . . . 0.0 109.958 170.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 78' ' ' ASN . 2.4 p90 -61.45 -23.92 66.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.325 0.65 . . . . 0.0 110.701 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.3 p -72.03 -8.54 55.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 113.157 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 m -83.27 -2.67 56.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.847 0.459 . . . . 0.0 110.735 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -135.97 163.67 29.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.105 0.962 . . . . 0.0 109.967 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.13 127.18 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.677 ' SD ' ' HB2' ' A' ' 97' ' ' CYS . 8.7 tmm? -119.97 135.91 54.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.693 0.397 . . . . 0.0 109.974 -170.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.647 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -133.07 166.22 23.76 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 123.157 0.408 . . . . 0.0 113.511 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.452 ' NE1' ' HE1' ' A' ' 35' ' ' MET . 55.4 m95 -115.89 145.07 43.2 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 124.034 0.933 . . . . 0.0 108.991 -174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -136.15 146.22 46.67 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.741 1.216 . . . . 0.0 108.907 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -125.38 148.1 48.9 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.238 0.472 . . . . 0.0 110.506 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.84 155.02 4.5 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 123.584 0.754 . . . . 0.0 111.18 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 177.14 -61.07 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.802 1.241 . . . . 0.0 110.263 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.26 75.56 5.0 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 122.377 2.052 . . . . 0.0 112.603 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.16 24.18 70.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.594 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 28.4 mmmt -112.11 144.88 40.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.533 1.133 . . . . 0.0 110.374 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.87 160.93 14.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.906 0.882 . . . . 0.0 109.433 168.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -58.75 105.37 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.143 0.577 . . . . 0.0 111.236 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.78 150.93 19.85 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.549 ' HZ ' ' HB3' ' A' ' 60' ' ' TYR . 54.1 t80 -59.11 111.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.522 1.129 . . . . 0.0 109.112 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -100.06 -65.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.43 130.34 5.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.35 0.119 . . . . 0.0 110.905 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.647 HG21 ' HA3' ' A' ' 36' ' ' GLY . 67.0 t -117.83 138.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.009 0.923 . . . . 0.0 108.762 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.597 HG23 HH11 ' A' ' 73' ' ' ARG . 11.7 p -124.73 140.53 47.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.2 155.98 22.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -55.84 -40.62 73.12 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -167.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -92.42 -0.79 57.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.43 0.692 . . . . 0.0 110.88 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.25 7.57 67.97 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.173 -0.467 . . . . 0.0 114.074 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -66.57 -38.82 87.87 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.678 0.791 . . . . 0.0 110.237 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -115.19 138.05 51.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.545 0.738 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -131.67 144.6 51.14 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.601 1.16 . . . . 0.0 108.987 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.549 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 85.1 m-85 -128.82 137.37 51.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.317 1.047 . . . . 0.0 108.248 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -138.85 150.39 45.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.391 0.676 . . . . 0.0 109.823 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -82.08 138.61 34.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.02 -28.37 67.68 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.204 0.602 . . . . 0.0 111.639 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 t -65.69 -41.8 91.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.283 1.033 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.488 HG23 ' HB1' ' A' ' 62' ' ' ALA . 22.6 m -103.06 -2.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.301 0.64 . . . . 0.0 111.735 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -64.85 117.71 7.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 0.0 111.355 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.29 20.11 Favored Glycine 0 C--N 1.345 1.034 0 O-C-N 123.82 0.7 . . . . 0.0 113.332 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 13.8 ptp180 -95.2 -23.34 17.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.141 0.496 . . . . 0.0 109.872 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 2.9 m-85 -107.03 153.52 22.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 92.4 m -145.31 130.68 18.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.927 0.891 . . . . 0.0 109.468 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 1.2 pp -104.13 128.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.054 0.542 . . . . 0.0 110.273 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -139.16 166.09 25.45 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.616 1.166 . . . . 0.0 108.635 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.597 HH11 HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -159.77 161.46 34.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.111 0.481 . . . . 0.0 110.915 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.6 114.09 17.6 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -67.5 -35.23 78.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.517 0.727 . . . . 0.0 111.983 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.64 67.59 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.602 0.564 . . . . 0.0 111.364 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -83.16 -19.24 36.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.233 0.613 . . . . 0.0 111.779 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 68.08 32.67 4.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.133 . . . . 0.0 110.692 -173.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.7 m -111.35 129.88 55.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.867 0.467 . . . . 0.0 110.073 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.78 144.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.752 0.821 . . . . 0.0 108.959 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 130.0 53.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.852 0.861 . . . . 0.0 109.803 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.9 tm? -115.33 106.68 14.29 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 16.1 mm100 -88.17 103.78 16.08 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.869 0.868 . . . . 0.0 109.682 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.8 mtt -87.28 133.89 33.62 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -141.1 145.3 35.61 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.3 m 56.23 47.03 20.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.164 0.986 . . . . 0.0 111.587 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.56 124.17 20.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.146 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -70.22 155.07 94.03 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 -14.76 29.37 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 122.6 2.2 . . . . 0.0 113.605 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.93 -3.02 56.48 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.335 0.654 . . . . 0.0 112.621 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.66 5.06 8.14 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.488 HG21 ' HA ' ' A' ' 120' ' ' THR . 92.5 m -64.8 100.63 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.87 152.09 11.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.241 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 4.1 p -80.35 123.11 36.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 170.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -94.72 139.11 31.69 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -137.93 121.36 17.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.193 0.997 . . . . 0.0 108.835 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.677 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 30.1 p -86.98 143.71 27.24 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -147.38 134.7 20.65 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.168 0.987 . . . . 0.0 109.729 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -106.98 161.03 15.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.377 0.671 . . . . 0.0 110.834 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 111' ' ' ASP . . . . . . . . 0 C--N 1.343 0.932 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.814 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB3' ' HA2' ' A' ' 100' ' ' GLY . 24.5 t0 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.741 0.781 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 92.5 m-85 -133.13 167.83 19.62 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.628 166.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 38.4 p90 -154.35 169.3 24.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.02 0.928 . . . . 0.0 109.178 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.19 -172.63 21.69 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.648 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.77 -45.12 65.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.333 0.653 . . . . 0.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.13 135.88 1.17 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.451 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.7 t -143.26 140.83 30.83 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.236 0.541 . . . . 0.0 110.314 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 55.8 tp60 -80.42 122.7 27.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.359 1.063 . . . . 0.0 111.408 -171.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.65 145.14 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 92' ' ' THR . 39.4 m -126.91 105.88 8.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.61 0.764 . . . . 0.0 109.339 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.73 117.92 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.402 0.62 . . . . 0.0 109.928 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.1 t -67.34 117.87 9.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.954 0.901 . . . . 0.0 109.802 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.468 0.707 . . . . 0.0 110.382 -178.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 64.5 tp . . . . . 0 C--O 1.236 0.394 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.58 127.66 37.12 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.603 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 73.8 mt -114.23 131.64 56.41 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 59.1 t -114.71 100.37 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.6 130.31 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 109.634 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -138.21 139.99 39.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.311 1.044 . . . . 0.0 109.049 -175.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.62 13.32 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 64.89 3.97 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.95 -164.99 13.35 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 123.569 0.604 . . . . 0.0 111.702 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.4 pp -104.06 142.4 34.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.121 0.569 . . . . 0.0 111.568 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -151.41 144.21 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.883 1.273 . . . . 0.0 108.004 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -69.59 154.57 41.8 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.745 0.418 . . . . 0.0 111.662 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 115.47 5.13 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.461 174.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.32 -14.34 28.02 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 123.885 0.755 . . . . 0.0 111.701 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.33 -163.78 26.75 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 121.307 0.393 . . . . 0.0 113.766 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -144.61 150.93 38.25 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.69 0.796 . . . . 0.0 110.023 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -155.72 124.65 6.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.165 0.586 . . . . 0.0 109.942 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -92.28 129.42 38.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.174 0.59 . . . . 0.0 110.427 175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 82' ' ' LEU . 1.6 mm? -96.18 157.32 15.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.101 0.96 . . . . 0.0 109.084 172.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -144.7 124.1 13.09 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.171 0.589 . . . . 0.0 109.564 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -114.53 115.43 27.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.519 0.728 . . . . 0.0 110.112 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.85 118.66 24.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.59 144.95 31.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.703 0.801 . . . . 0.0 109.759 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t -65.74 159.02 26.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.47 0.708 . . . . 0.0 109.895 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 55.16 4.79 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-O 121.302 0.39 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 3' ' ' LEU . 1.6 mmp_? -98.8 -171.35 2.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.824 1.25 . . . . 0.0 110.781 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.4 p -81.29 41.76 0.63 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.892 0.877 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -69.13 -19.44 64.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.98 0.512 . . . . 0.0 111.817 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -77.39 -16.15 59.0 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 0.0 111.284 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.4 t -81.19 -12.84 59.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.998 0.519 . . . . 0.0 110.2 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.19 159.17 17.61 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 0.0 109.627 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.35 136.91 35.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.481 ' SD ' HG13 ' A' ' 80' ' ' VAL . 2.6 ttp -101.41 155.25 18.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.76 149.93 21.5 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 117.93 0.332 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.428 ' HE1' HG22 ' A' ' 71' ' ' ILE . 85.1 m95 -98.51 131.6 44.61 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.137 0.975 . . . . 0.0 109.564 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -131.37 166.6 20.91 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.686 1.194 . . . . 0.0 108.375 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -157.9 163.46 37.89 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 118.549 0.613 . . . . 0.0 111.408 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.91 162.88 9.46 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.072 0.949 . . . . 0.0 109.314 172.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.54 -58.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 C-N-CA 124.481 1.112 . . . . 0.0 110.891 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.23 69.0 8.13 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 122.692 2.262 . . . . 0.0 112.854 -170.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.81 67.33 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.657 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -107.72 146.64 31.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.535 0.734 . . . . 0.0 110.746 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.24 164.76 20.98 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.637 0.775 . . . . 0.0 108.926 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.13 104.91 0.42 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.214 0.53 . . . . 0.0 110.39 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.96 157.58 15.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.153 1.381 . . . . 0.0 110.727 -170.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.6 121.09 19.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.513 0.725 . . . . 0.0 110.344 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.74 -53.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -167.39 152.56 7.24 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.532 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -133.87 147.28 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.484 1.113 . . . . 0.0 108.782 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.81 148.5 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 125.101 1.36 . . . . 0.0 108.948 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -77.71 161.63 27.59 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -56.92 -36.35 70.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -90.96 -8.37 49.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.075 0.55 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.83 21.16 58.24 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 112.289 -0.324 . . . . 0.0 112.289 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -60.59 -58.47 8.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.682 0.793 . . . . 0.0 111.283 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.09 138.39 53.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.225 0.61 . . . . 0.0 109.989 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -119.74 160.23 22.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 110.64 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -141.97 139.45 32.45 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 107.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.55 152.89 52.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.129 0.571 . . . . 0.0 110.106 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -69.83 133.58 47.55 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 166.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.03 -29.37 69.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -168.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.7 m -67.45 -31.13 71.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.651 0.78 . . . . 0.0 111.64 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG22 ' HB1' ' A' ' 62' ' ' ALA . 20.8 m -113.47 6.96 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.821 0.848 . . . . 0.0 111.661 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -75.1 118.17 17.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.035 0.534 . . . . 0.0 111.845 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.61 -26.12 25.62 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.828 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -94.82 -17.98 21.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.218 0.607 . . . . 0.0 110.117 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -104.7 145.83 29.8 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 m -148.74 138.13 21.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.891 0.876 . . . . 0.0 109.43 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' A' ' 50' ' ' ALA . 2.9 mp -101.11 131.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.8 m -122.43 154.78 37.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 133.38 8.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.046 0.385 . . . . 0.0 110.146 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.39 108.11 18.03 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.66 -29.02 68.21 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.93 0.892 . . . . 0.0 111.059 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.73 68.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.246 0.618 . . . . 0.0 111.162 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -14.96 59.43 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.626 0.37 . . . . 0.0 110.714 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 62.31 28.34 16.88 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 124.667 1.229 . . . . 0.0 110.132 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.3 m -125.99 132.51 52.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.093 0.557 . . . . 0.0 110.259 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.481 HG13 ' SD ' ' A' ' 35' ' ' MET . 21.8 t -105.54 157.63 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.584 1.153 . . . . 0.0 109.137 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -137.84 145.36 42.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.818 1.247 . . . . 0.0 108.774 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.427 HD13 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -134.37 108.61 8.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.07 104.98 16.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.336 0.654 . . . . 0.0 109.73 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.439 ' HE1' HD11 ' A' ' 87' ' ' LEU . 69.7 mtm -88.64 132.41 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -130.69 142.45 50.43 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t 57.73 70.98 0.61 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.67 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD11 ' HE1' ' A' ' 84' ' ' MET . 90.8 mt -84.45 157.17 21.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.417 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -118.31 156.89 50.38 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.28 -21.74 67.98 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.49 2.127 . . . . 0.0 113.059 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.94 -11.43 59.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.274 1.029 . . . . 0.0 112.871 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -83.08 1.48 40.0 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.829 0.452 . . . . 0.0 112.149 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -64.59 108.33 1.65 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.765 0.826 . . . . 0.0 110.397 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.1 164.04 13.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 2.7 p -89.0 112.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -88.23 139.98 29.94 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -125.74 129.34 49.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.543 1.137 . . . . 0.0 108.753 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.44 121.98 28.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -113.71 161.84 17.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.836 0.854 . . . . 0.0 110.006 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.83 143.86 29.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.439 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.631 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.292 0.568 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -128.04 165.26 20.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.967 0.907 . . . . 0.0 109.993 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 44.7 p90 -158.43 167.09 30.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.105 0.962 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.64 -161.26 29.99 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.991 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -85.43 -57.46 3.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.114 0.966 . . . . 0.0 109.209 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.39 144.72 17.7 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.416 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -143.43 149.49 37.7 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.343 0.657 . . . . 0.0 109.291 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 17.5 tm0? -91.36 118.11 30.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.376 0.67 . . . . 0.0 110.383 -169.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.28 126.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.447 0.641 . . . . 0.0 109.54 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 88.4 m -102.32 104.67 15.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.779 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.08 100.56 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.8 m -56.73 116.45 3.16 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.462 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.541 0.6 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 177.695 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.737 0.303 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -108.93 168.72 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.825 0.85 . . . . 0.0 110.201 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 tp -97.72 111.67 23.86 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.77 118.06 30.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 0.0 109.946 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.83 122.89 48.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.95 0.9 . . . . 0.0 108.627 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 92.5 t -117.52 103.31 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.149 0.98 . . . . 0.0 109.123 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.63 147.47 27.69 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.165 0.586 . . . . 0.0 109.77 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 p -162.47 178.57 8.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.362 1.065 . . . . 0.0 109.493 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.42 5.3 89.89 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 116.537 -0.301 . . . . 0.0 113.433 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.86 135.64 19.37 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.84 178.39 40.59 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -98.66 139.26 34.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.594 0.758 . . . . 0.0 111.006 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 11.3 p -151.12 151.35 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.328 1.051 . . . . 0.0 108.534 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 18.1 mp0 -70.12 159.54 33.72 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.258 0.623 . . . . 0.0 112.272 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 121.92 15.03 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.913 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.51 58.82 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.734 0.646 . . . . 0.0 112.172 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.39 -164.4 37.67 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.068 0.366 . . . . 0.0 112.984 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -148.72 155.67 41.32 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.214 0.606 . . . . 0.0 110.774 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -153.45 136.14 15.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.056 0.942 . . . . 0.0 109.339 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -99.24 132.99 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.277 0.561 . . . . 0.0 110.09 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 4.2 mm? -106.72 159.95 15.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.216 . . . . 0.0 109.79 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -137.75 156.04 48.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.956 0.902 . . . . 0.0 110.007 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 54.0 t -150.66 113.51 4.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 109.6 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -84.4 117.53 23.68 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.85 0.86 . . . . 0.0 109.051 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.3 124.58 49.79 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.263 0.625 . . . . 0.0 109.724 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.1 m -141.77 -178.08 5.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.935 1.294 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.19 -117.17 4.36 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.54 153.82 42.92 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.896 0.848 . . . . 0.0 110.746 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.3 p -68.9 107.29 3.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.909 0.483 . . . . 0.0 109.724 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ASN . 5.2 p90 -64.75 -14.62 59.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.255 0.622 . . . . 0.0 110.924 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.5 p -70.37 -3.55 18.02 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.162 0.985 . . . . 0.0 112.32 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -109.52 7.66 24.82 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.462 1.105 . . . . 0.0 110.08 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.07 156.19 49.08 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.123 0.969 . . . . 0.0 111.091 -173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.8 133.16 50.97 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 17.7 ttp -118.23 142.11 47.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.286 0.634 . . . . 0.0 109.589 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -127.45 154.21 19.48 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.391 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -97.03 125.56 41.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.39 160.22 24.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.263 1.425 . . . . 0.0 107.64 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -139.89 162.14 35.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.86 0.755 . . . . 0.0 111.772 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -165.43 152.93 10.78 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.642 1.213 . . . . 0.0 110.52 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 173.27 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 125.245 1.418 . . . . 0.0 110.231 168.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 65.7 Cg_endo -87.58 80.51 1.3 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.938 1.758 . . . . 0.0 112.046 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.45 73.28 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.347 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -115.29 148.86 38.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.105 0.962 . . . . 0.0 112.03 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 178.19 5.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -61.46 102.63 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -99.86 147.32 25.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.038 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.87 114.49 3.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.229 0.612 . . . . 0.0 110.073 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' HE1' ' A' ' 95' ' ' TYR . 98.5 t -104.12 -55.78 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -158.54 152.49 23.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.547 0.739 . . . . 0.0 110.13 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 42.9 t -137.71 141.86 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.32 1.048 . . . . 0.0 108.58 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.72 145.21 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.73 0.812 . . . . 0.0 109.272 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -81.08 156.34 25.85 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 166.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -52.16 -39.3 59.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.052 0.941 . . . . 0.0 112.523 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -68.49 -26.39 65.45 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.934 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.34 12.31 82.25 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.644 -166.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -65.24 -38.57 90.77 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.068 1.347 . . . . 0.0 110.902 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -128.38 128.08 43.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.492 0.717 . . . . 0.0 110.47 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -122.29 129.97 52.7 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 108.271 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -120.96 138.47 54.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.723 1.209 . . . . 0.0 107.973 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.01 138.82 44.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.195 0.598 . . . . 0.0 110.532 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 147.56 31.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.906 0.883 . . . . 0.0 109.635 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -59.02 -27.27 65.3 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.834 0.854 . . . . 0.0 112.745 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.2 m -64.56 -32.79 74.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.521 0.728 . . . . 0.0 112.019 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.78 5.16 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 124.388 1.075 . . . . 0.0 111.839 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.92 142.66 51.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 0.0 110.833 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.75 -22.51 9.05 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.424 0.453 . . . . 0.0 113.867 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -117.03 -17.43 10.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.535 0.734 . . . . 0.0 111.547 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.61 149.23 23.49 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -149.2 137.4 20.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.101 0.96 . . . . 0.0 108.952 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -102.03 151.39 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.0 m -146.02 159.6 43.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.972 1.309 . . . . 0.0 108.58 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.65 132.48 5.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.202 0.525 . . . . 0.0 111.238 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.68 107.43 19.09 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 30' ' ' PHE . 1.8 m-20 -69.63 -33.02 72.04 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 0.0 110.824 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.29 83.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.761 0.825 . . . . 0.0 111.104 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -97.72 -0.51 45.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.268 0.627 . . . . 0.0 112.105 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.02 27.37 17.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.774 1.23 . . . . 0.0 113.46 171.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 m -119.36 131.81 55.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.56 0.344 . . . . 0.0 110.75 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 36.0 t -103.31 148.77 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.431 1.092 . . . . 0.0 108.923 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.11 152.07 51.43 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -132.19 108.28 9.16 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -83.61 102.76 12.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.062 0.945 . . . . 0.0 109.508 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 58.4 mtt -88.69 123.61 33.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -123.53 141.95 51.49 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.8 m 53.92 61.33 3.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.411 1.084 . . . . 0.0 111.791 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.38 117.18 11.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.365 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -75.05 149.38 85.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.405 1.082 . . . . 0.0 109.05 174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.428 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 19.4 Cg_endo -56.54 -17.78 23.29 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.181 2.587 . . . . 0.0 114.681 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.51 -20.45 58.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.25 1.02 . . . . 0.0 113.051 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -77.14 -0.36 24.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.5 m -62.62 101.67 0.27 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.461 0.704 . . . . 0.0 110.1 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.54 160.99 15.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.036 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.69 116.52 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.349 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.468 ' HE1' HG13 ' A' ' 49' ' ' VAL . 15.7 m-85 -91.84 117.09 29.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.706 0.803 . . . . 0.0 111.092 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.64 130.07 47.91 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.038 0.935 . . . . 0.0 109.999 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.539 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.8 m -84.67 124.15 31.17 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.63 20.98 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.038 0.935 . . . . 0.0 109.695 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 35' ' ' MET . . . -119.34 167.93 11.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.858 0.863 . . . . 0.0 111.137 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.94 -146.63 16.73 Favored Glycine 0 C--O 1.244 0.73 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.791 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.52 114.37 20.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.933 0.893 . . . . 0.0 109.81 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -89.65 133.42 34.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 168.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.98 -70.36 0.79 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.451 0.7 . . . . 0.0 110.36 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.92 -36.22 0.42 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.0 t -57.03 126.94 29.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.799 0.84 . . . . 0.0 110.576 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -82.15 2.52 31.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.157 0.583 . . . . 0.0 112.185 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.7 101.04 0.98 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.6 79.71 1.08 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.183 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.15 33.38 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.067 0.947 . . . . 0.0 108.593 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 159.56 28.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.151 2.567 . . . . 0.0 112.571 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.44 -41.96 37.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.601 0.761 . . . . 0.0 109.561 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.81 146.88 51.54 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.521 1.129 . . . . 0.0 109.121 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.02 156.92 42.96 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.034 0.934 . . . . 0.0 109.242 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.62 -163.34 26.14 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.219 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 6' ' ' VAL . 41.7 mt-30 -81.59 -50.1 9.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.097 1.359 . . . . 0.0 110.689 -174.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.5 137.45 6.47 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.789 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -114.59 115.82 27.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 109.564 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -73.49 111.83 8.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.745 0.818 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.5 145.12 16.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 52.2 m -127.88 139.2 52.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.2 p -119.78 113.14 39.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.531 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 31.1 t -58.38 113.19 1.85 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.595 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 37.8 m -74.37 -174.46 2.02 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.534 1.134 . . . . 0.0 111.13 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.3 tp 69.47 97.27 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.575 1.15 . . . . 0.0 109.756 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.43 -27.24 65.87 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.764 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.6 t60 78.04 -32.25 0.17 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.45 1.5 . . . . 0.0 113.644 167.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -68.41 97.11 0.72 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.758 0.79 . . . . 0.0 111.163 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -78.99 -35.41 42.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.8 t60 67.81 -78.33 0.04 OUTLIER 'General case' 0 C--N 1.363 1.157 0 O-C-N 125.02 1.45 . . . . 0.0 109.908 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -151.03 164.52 36.23 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.191 1.397 . . . . 0.0 108.043 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.688 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -153.99 173.55 15.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.001 0.52 . . . . 0.0 110.555 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp -76.36 111.36 11.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -85.57 116.38 23.83 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -110.14 129.84 55.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.424 1.09 . . . . 0.0 108.296 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 34.6 t -121.9 98.25 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.85 139.64 30.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 122.89 0.476 . . . . 0.0 110.166 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -153.46 165.01 37.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.949 0.899 . . . . 0.0 109.957 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.34 -11.45 54.67 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.988 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.29 120.54 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.028 -0.318 . . . . 0.0 112.448 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.6 -169.42 22.9 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -79.63 135.49 36.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.498 0.319 . . . . 0.0 111.275 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.64 139.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.29 1.036 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.83 149.55 35.62 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.687 0.795 . . . . 0.0 112.025 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.27 7.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.218 0.607 . . . . 0.0 110.704 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.71 -10.37 25.65 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.033 0.825 . . . . 0.0 111.541 -175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.46 -170.82 44.5 Favored Glycine 0 C--N 1.346 1.124 0 C-N-CA 123.038 0.351 . . . . 0.0 113.862 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.4 p -121.52 162.1 21.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.252 1.021 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.96 126.9 8.29 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -98.4 118.33 34.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.163 0.585 . . . . 0.0 110.248 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -102.02 154.18 19.21 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.194 0.998 . . . . 0.0 109.018 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -145.67 146.84 31.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.582 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 53.6 t -138.37 123.43 19.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -85.22 114.77 22.57 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.26 24.51 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.408 0.683 . . . . 0.0 109.239 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 t -71.78 164.33 26.2 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.19 -11.25 51.36 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.384 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.9 127.45 26.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.326 1.051 . . . . 0.0 109.28 169.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 p -60.77 89.04 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.12 -18.54 60.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.077 160.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 29.9 p -66.7 -14.43 62.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.069 1.347 . . . . 0.0 112.794 176.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m -83.98 -4.24 58.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 0.0 111.225 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.32 168.91 17.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.591 0.757 . . . . 0.0 110.988 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 121.8 33.49 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttp -101.22 130.44 47.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 109.493 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.554 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -134.0 154.25 21.28 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.51 138.89 32.56 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.462 1.105 . . . . 0.0 109.187 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.77 170.25 14.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.159 1.384 . . . . 0.0 108.113 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -153.73 162.05 41.58 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.901 0.319 . . . . 0.0 111.802 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.438 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -168.02 151.86 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.529 1.143 . . . . 0.0 110.835 167.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 169.74 -59.11 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 125.283 1.433 . . . . 0.0 110.885 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.42 70.24 5.13 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.511 2.141 . . . . 0.0 112.609 -169.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.92 17.22 76.8 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.787 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -109.24 140.95 42.22 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 110.745 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.31 170.3 12.91 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.75 105.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.91 154.89 20.95 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 110.647 -171.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -66.6 110.38 3.17 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.674 171.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG11 ' HE1' ' A' ' 95' ' ' TYR . 95.2 t -88.81 -62.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -163.53 134.54 4.65 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HD3' ' A' ' 101' ' ' LYS . 71.3 t -115.41 153.46 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.158 0.983 . . . . 0.0 108.595 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.9 151.39 31.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.6 152.99 44.61 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 52.9 p-90 -61.42 -36.05 79.25 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -82.72 -5.34 58.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.477 0.711 . . . . 0.0 111.659 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.55 79.87 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -58.51 -47.71 83.24 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.742 0.817 . . . . 0.0 111.234 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.1 mtt85 -130.71 141.23 50.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 p -110.99 130.2 55.66 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -114.93 116.33 28.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -114.27 142.21 46.58 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.83 47.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.35 -26.36 60.87 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.689 0.795 . . . . 0.0 111.978 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -69.6 -26.05 64.26 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.595 1.158 . . . . 0.0 112.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 49' ' ' VAL . 33.5 m -127.96 7.64 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.03 0.932 . . . . 0.0 111.652 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.24 124.34 23.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 111.31 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -3.01 85.92 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.11 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -121.15 -10.9 8.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.487 0.643 . . . . 0.0 111.421 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -109.57 162.39 14.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.202 0.601 . . . . 0.0 109.873 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 86.4 m -151.59 130.57 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.267 1.027 . . . . 0.0 109.45 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 50' ' ' ALA . 1.7 mp -103.29 141.12 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 49.5 m -139.27 158.76 43.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.729 1.212 . . . . 0.0 108.248 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.18 131.12 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.029 0.443 . . . . 0.0 110.881 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.01 92.17 5.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.483 1.113 . . . . 0.0 108.27 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.46 -25.58 68.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.146 0.578 . . . . 0.0 111.413 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.8 98.1 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.87 0.868 . . . . 0.0 111.504 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.82 -10.25 37.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.637 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 58.21 45.27 17.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.117 0.967 . . . . 0.0 109.574 -170.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 m -115.34 148.39 39.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.283 1.033 . . . . 0.0 109.408 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 57.6 t -126.68 150.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 108.903 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 86.7 m-85 -133.53 146.23 50.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 0.0 108.975 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.3 tm? -133.87 107.19 7.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 35.4 tt0 -86.75 126.83 34.85 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.434 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.7 mtt -105.48 141.49 36.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.482 1.113 . . . . 0.0 108.824 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -141.61 147.33 37.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t 58.27 52.14 7.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.756 0.823 . . . . 0.0 111.28 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 84' ' ' MET . 77.8 mt -71.51 120.8 17.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.828 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.412 ' O ' HG11 ' A' ' 121' ' ' VAL . 39.2 mtmt -82.99 149.37 59.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.167 0.987 . . . . 0.0 108.985 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -55.98 -18.93 24.12 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 123.387 2.724 . . . . 0.0 114.791 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.49 -20.11 54.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.143 0.977 . . . . 0.0 112.609 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -71.18 -7.76 48.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.223 0.609 . . . . 0.0 112.544 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.5 m -56.58 101.82 0.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.961 0.904 . . . . 0.0 110.302 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.02 159.07 9.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.573 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.1 p -78.89 113.48 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.521 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.0 m-85 -87.98 112.51 22.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.237 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -104.57 122.73 46.21 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.493 1.117 . . . . 0.0 109.098 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.88 132.04 35.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.56 160.29 40.33 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.962 0.905 . . . . 0.0 109.295 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.43 160.65 39.35 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . 110.57 10.72 21.06 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 119.773 -0.459 . . . . 0.0 113.831 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.561 ' HD3' HG22 ' A' ' 51' ' ' VAL . 87.8 tttt -86.6 149.5 24.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -111.52 169.33 8.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.827 0.851 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.7 101.33 1.65 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.643 0.777 . . . . 0.0 110.241 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.16 -99.06 1.53 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.7 t 60.21 -165.46 0.21 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.465 1.106 . . . . 0.0 111.136 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -114.54 113.53 24.53 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -63.53 134.92 56.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.798 0.439 . . . . 0.0 111.081 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.57 -44.0 0.04 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -172.2 147.68 1.87 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.076 0.95 . . . . 0.0 110.66 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.55 157.35 32.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.307 2.005 . . . . 0.0 111.176 167.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.411 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 20.1 t70 -77.0 -32.75 57.42 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.103 0.561 . . . . 0.0 110.185 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -133.85 153.67 51.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.531 1.132 . . . . 0.0 109.302 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -149.64 148.88 29.83 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.126 0.971 . . . . 0.0 108.882 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.57 -155.7 32.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.935 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.8 mt-30 -97.69 -38.06 9.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.311 1.045 . . . . 0.0 110.587 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.91 136.81 9.2 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.172 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -117.58 114.31 23.23 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.07 0.948 . . . . 0.0 108.805 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 62.3 tp60 -71.9 108.84 5.37 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.32 145.29 7.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 25.2 m -132.6 109.67 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 88' ' ' LYS . 1.7 p -94.7 105.09 16.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.7 t -56.82 118.83 5.31 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.115 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 m -68.47 125.31 26.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.168 0.987 . . . . 0.0 110.928 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 tp -96.15 25.46 4.86 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.859 0.864 . . . . 0.0 109.849 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 63.85 -178.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.553 1.141 . . . . 0.0 111.81 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -103.9 -53.61 2.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 51.31 66.51 1.16 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.473 1.509 . . . . 0.0 112.321 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -177.0 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 65.4 -179.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.829 0.851 . . . . 0.0 110.289 -163.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 63.38 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 109.755 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.634 1.574 . . . . 0.0 108.862 -159.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 pm0 -76.0 152.04 37.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.766 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 112' ' ' TYR . 54.4 tp -85.46 111.6 20.12 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -72.38 104.35 3.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.126 0.57 . . . . 0.0 110.025 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.09 128.95 54.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 108.48 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.8 t -121.9 103.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.78 156.82 18.25 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.231 1.012 . . . . 0.0 110.412 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -159.44 171.81 19.04 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.882 0.873 . . . . 0.0 109.791 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.5 15.42 15.49 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.044 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.79 92.18 0.36 Allowed Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.933 0.301 . . . . 0.0 112.444 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.88 179.96 23.43 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.5 pp -107.36 147.86 29.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.084 0.554 . . . . 0.0 110.571 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.0 p -149.47 145.12 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.553 1.141 . . . . 0.0 108.707 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.2 mp0 -72.61 158.34 35.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.876 0.47 . . . . 0.0 112.026 -172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 114.33 3.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.923 0.889 . . . . 0.0 111.261 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.7 -10.0 25.73 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.486 0.565 . . . . 0.0 112.033 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.02 -163.82 39.33 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.026 0.346 . . . . 0.0 112.713 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.9 p -143.73 158.17 43.87 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.387 0.675 . . . . 0.0 109.981 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -149.59 119.66 7.21 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.9 ttt85 -96.6 116.12 28.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.722 0.809 . . . . 0.0 109.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.586 HD23 ' HE2' ' A' ' 84' ' ' MET . 2.4 mm? -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.173 0.989 . . . . 0.0 110.216 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -132.7 145.22 50.87 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.637 0.775 . . . . 0.0 109.28 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.87 119.37 8.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.325 0.65 . . . . 0.0 110.45 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.73 129.74 34.75 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.029 0.532 . . . . 0.0 110.029 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.93 128.64 54.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.087 0.955 . . . . 0.0 110.156 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.9 m -142.76 159.4 42.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.097 0.959 . . . . 0.0 109.816 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.35 -117.96 5.9 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -77.26 163.84 26.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.581 0.752 . . . . 0.0 110.085 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -70.19 97.25 1.18 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.015 0.526 . . . . 0.0 111.1 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -68.43 -23.95 64.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.706 0.802 . . . . 0.0 110.798 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 60.6 p -72.5 -0.05 11.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.949 0.9 . . . . 0.0 112.276 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -99.46 -9.75 23.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.241 0.616 . . . . 0.0 111.116 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -123.48 169.42 11.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.428 0.633 . . . . 0.0 112.323 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.602 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -100.83 125.9 47.38 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.207 166.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.53 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 9.4 ptm -107.56 170.19 8.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 0.0 110.463 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.41 149.38 18.09 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 113.376 0.11 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -98.1 141.17 31.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.156 0.982 . . . . 0.0 109.995 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -138.28 133.24 32.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.654 1.181 . . . . 0.0 108.724 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -114.79 159.6 20.41 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.058 0.39 . . . . 0.0 111.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.6 pt20 -168.66 151.8 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.505 0.722 . . . . 0.0 110.712 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -179.59 -57.6 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 123.776 0.83 . . . . 0.0 111.114 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.73 64.99 7.39 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.342 2.028 . . . . 0.0 112.348 -171.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.43 22.32 76.37 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.78 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -103.34 149.1 25.08 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.931 0.892 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.38 178.48 5.95 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.472 1.109 . . . . 0.0 108.334 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.04 105.39 0.47 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 150.1 21.01 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -63.08 112.58 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.757 0.823 . . . . 0.0 110.559 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.18 -66.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.3 135.14 3.02 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.2 t -110.87 132.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.262 1.025 . . . . 0.0 109.208 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.92 151.17 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.688 0.795 . . . . 0.0 110.493 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 25.1 t-20 -75.69 156.65 34.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.982 0.913 . . . . 0.0 109.205 170.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 54.7 p-90 -58.78 -34.52 71.54 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.5 p -95.71 1.55 53.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 0.0 111.678 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.02 9.5 71.46 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 113.363 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -64.01 -35.31 80.3 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.33 1.052 . . . . 0.0 111.181 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 98.5 mtt180 -125.49 138.59 53.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.337 1.055 . . . . 0.0 109.229 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.8 p -140.29 131.92 27.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.621 0.768 . . . . 0.0 109.543 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.37 115.78 24.82 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 147.25 34.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.593 0.357 . . . . 0.0 110.241 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.18 146.59 43.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.22 -34.04 73.1 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.5 m -70.61 -28.16 64.64 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.034 0.534 . . . . 0.0 112.223 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -109.77 1.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.193 0.597 . . . . 0.0 111.408 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -67.5 120.84 14.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.463 0.705 . . . . 0.0 111.824 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.25 -27.88 4.92 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.748 0.689 . . . . 0.0 113.959 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' NH2' HD21 ' A' ' 87' ' ' LEU . 1.6 ptm180 -89.05 -8.59 53.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.839 0.856 . . . . 0.0 110.901 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.21 151.97 27.64 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.5 m -140.19 119.41 12.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.163 0.985 . . . . 0.0 108.528 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 71' ' ' ILE . 1.1 mp -103.54 127.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 m -133.83 157.78 45.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 108.206 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 150.75 18.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.127 0.489 . . . . 0.0 110.341 174.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 77' ' ' LYS . 17.8 m-20 -119.88 112.14 18.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -71.14 -26.95 63.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.072 0.549 . . . . 0.0 110.788 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.36 59.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.509 0.724 . . . . 0.0 111.02 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 72.5 mmtt -77.5 -25.01 49.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.616 0.366 . . . . 0.0 110.886 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 60.32 44.97 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.388 1.075 . . . . 0.0 110.039 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m -139.08 131.24 28.14 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.847 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.4 t -101.58 141.72 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.65 1.18 . . . . 0.0 109.593 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -125.09 126.33 45.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.186 0.994 . . . . 0.0 109.063 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.37 98.19 6.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -89.16 106.6 18.55 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.298 0.639 . . . . 0.0 110.207 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.586 ' HE2' HD23 ' A' ' 21' ' ' LEU . 56.4 mtm -88.07 139.39 30.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.322 0.649 . . . . 0.0 109.3 174.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 m 59.77 60.29 2.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.187 0.995 . . . . 0.0 111.123 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 84' ' ' MET . 99.3 mt -80.73 127.91 33.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.477 -173.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 2.3 mptp? -92.71 153.91 42.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.3 -25.7 4.97 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.875 3.05 . . . . 0.0 115.142 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.6 pt-20 -71.44 -23.27 61.81 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.743 1.217 . . . . 0.0 113.432 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 1.12 14.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.782 0.833 . . . . 0.0 113.196 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 120' ' ' THR . 54.9 m -62.99 103.13 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.291 0.636 . . . . 0.0 110.337 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.57 155.04 5.85 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.227 0.611 . . . . 0.0 111.452 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.3 p -78.95 112.29 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -87.68 113.47 23.38 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -102.71 128.8 49.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.24 129.38 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -138.53 163.52 31.77 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.264 1.025 . . . . 0.0 109.073 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -138.5 133.7 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.772 0.829 . . . . 0.0 108.774 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.64 ' HA3' ' HA ' ' A' ' 110' ' ' PRO . . . -176.46 83.44 0.07 OUTLIER Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HB2' ' H ' ' A' ' 34' ' ' ALA . 60.3 tttm -77.61 129.03 35.09 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.362 0.665 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -70.74 82.64 0.62 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 166.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.87 -47.76 8.75 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.109 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.83 175.64 16.0 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.293 172.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 m -76.26 154.87 34.83 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.989 0.516 . . . . 0.0 110.57 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 71.31 16.18 6.18 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.892 1.277 . . . . 0.0 111.981 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -110.45 36.01 3.24 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.888 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.98 63.77 4.39 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.142 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.1 142.24 1.85 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.477 1.111 . . . . 0.0 108.866 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.64 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 71.1 Cg_endo -74.14 108.74 2.73 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.988 1.792 . . . . 0.0 110.839 174.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.81 -32.46 74.0 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.508 0.67 . . . . 0.0 110.831 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 34.2 m-85 -111.37 151.1 28.85 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.044 0.938 . . . . 0.0 109.14 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 42.4 p90 -166.08 167.42 16.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.869 0.868 . . . . 0.0 109.997 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.99 -147.85 10.13 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.206 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.23 -48.85 9.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.807 0.843 . . . . 0.0 110.383 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.8 151.57 25.33 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.817 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 t -122.64 111.42 16.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.336 1.054 . . . . 0.0 110.077 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 57.2 tp60 -72.47 113.87 9.98 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.474 0.71 . . . . 0.0 110.15 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.499 HG21 ' HE3' ' A' ' 84' ' ' MET . 4.1 m -102.87 146.83 10.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.494 0.718 . . . . 0.0 109.366 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.506 ' HA ' HG23 ' A' ' 92' ' ' THR . 96.4 m -124.63 143.21 50.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.89 0.876 . . . . 0.0 109.001 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.7 p -129.86 125.62 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 109.791 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 7.9 m -80.03 122.48 26.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.468 1.107 . . . . 0.0 111.885 -170.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.6 p -78.17 143.73 36.97 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.763 0.825 . . . . 0.0 110.699 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.09 -76.24 0.31 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.793 0.437 . . . . 0.0 111.098 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.74 85.75 7.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.29 0.636 . . . . 0.0 110.405 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -76.98 -29.59 55.59 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.533 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -142.21 143.3 32.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.948 1.299 . . . . 0.0 108.563 169.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -159.16 156.38 28.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.301 0.641 . . . . 0.0 110.329 172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -159.13 128.52 5.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.639 0.775 . . . . 0.0 109.154 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -75.05 104.65 5.72 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 61.2 m80 . . . . . 0 CA--C 1.553 1.092 0 C-N-CA 125.052 1.341 . . . . 0.0 110.307 -177.268 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -99.65 163.7 12.38 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp -86.65 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.264 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -94.94 114.74 26.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.532 0.733 . . . . 0.0 109.328 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.678 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 96.0 mt -106.9 116.96 32.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.4 101.92 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -111.22 125.39 53.76 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.373 -166.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -165.75 -178.74 4.96 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.22 1.008 . . . . 0.0 110.239 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.5 -0.52 26.34 Favored Glycine 0 N--CA 1.476 1.355 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.33 151.51 29.84 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 122.88 0.276 . . . . 0.0 113.064 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.25 -168.94 31.08 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -91.31 145.54 24.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.226 0.536 . . . . 0.0 111.043 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.94 159.89 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.072 1.349 . . . . 0.0 108.13 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -87.26 166.2 15.09 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.957 0.503 . . . . 0.0 111.158 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' H ' HD11 ' A' ' 124' ' ' LEU . . . -70.45 129.21 38.65 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.319 0.648 . . . . 0.0 109.959 173.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.46 81.75 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.741 0.651 . . . . 0.0 111.892 -170.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 -165.91 40.55 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 122.804 0.24 . . . . 0.0 112.941 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.8 p -148.18 159.03 44.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.861 0.864 . . . . 0.0 110.2 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -159.52 135.22 8.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.583 0.753 . . . . 0.0 109.496 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -109.38 126.51 53.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.841 0.457 . . . . 0.0 110.136 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -103.96 156.96 17.43 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.352 1.061 . . . . 0.0 109.332 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -144.57 154.64 43.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 111.006 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.6 t -150.68 134.2 16.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.453 0.701 . . . . 0.0 109.923 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 145.94 26.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . . . -105.74 126.66 52.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -133.65 157.72 45.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.603 1.161 . . . . 0.0 109.2 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.96 1.08 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -95.16 164.38 12.89 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.574 0.749 . . . . 0.0 110.055 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 83.6 m -97.41 121.16 38.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 15.9 p90 -63.5 -16.45 60.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.558 0.743 . . . . 0.0 111.744 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.3 t -68.03 -15.17 63.48 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 0.0 112.613 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 p -93.05 9.68 34.75 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 122.024 -0.422 . . . . 0.0 110.661 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -134.25 167.56 20.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.379 1.071 . . . . 0.0 110.243 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.85 160.45 15.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.441 ' HE1' ' HB3' ' A' ' 35' ' ' MET . 31.1 ttp -140.47 157.71 45.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.64 144.01 9.38 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -96.42 131.63 42.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.92 129.0 37.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.014 0.926 . . . . 0.0 108.557 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -109.05 162.35 14.32 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.727 0.299 . . . . 0.0 110.537 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -167.8 148.53 5.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.091 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . 177.23 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.056 0.942 . . . . 0.0 111.352 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 68.5 Cg_endo -82.2 64.82 8.38 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 122.111 1.874 . . . . 0.0 112.523 -170.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.86 6.43 72.72 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.772 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -105.81 146.25 30.12 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.717 0.807 . . . . 0.0 110.142 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.8 178.04 6.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.861 0.864 . . . . 0.0 109.119 170.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -51.68 104.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.48 151.79 19.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.356 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -64.85 108.34 1.73 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -99.0 -49.08 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB3' HD13 ' A' ' 71' ' ' ILE . . . -167.49 150.3 6.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.23 138.56 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 59' ' ' THR . 8.9 p -131.65 160.45 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.68 158.41 20.81 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -56.53 -38.16 71.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.532 0.733 . . . . 0.0 112.077 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -76.62 -23.48 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.625 0.77 . . . . 0.0 111.642 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.32 8.42 83.51 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.564 -165.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -58.42 -39.01 78.61 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.609 1.164 . . . . 0.0 111.049 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -119.52 130.87 55.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.286 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.443 HG22 HG23 ' A' ' 52' ' ' VAL . 46.5 p -122.36 133.21 54.65 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.906 0.883 . . . . 0.0 109.077 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.76 135.93 50.81 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -134.55 148.64 50.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.326 0.65 . . . . 0.0 109.973 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.99 128.32 33.71 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.66 -20.48 60.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.196 0.598 . . . . 0.0 112.436 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 p -64.94 -44.28 89.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.693 0.797 . . . . 0.0 111.129 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.33 -3.43 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.964 0.906 . . . . 0.0 111.782 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -66.81 134.71 52.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.298 0.639 . . . . 0.0 110.638 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.67 15.52 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.968 0.793 . . . . 0.0 113.387 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.461 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 19.0 ptt-85 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.01 0.405 . . . . 0.0 110.424 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.461 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 2.8 m-85 -105.94 151.04 25.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.729 0.812 . . . . 0.0 109.979 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 m -149.14 142.22 24.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.844 1.258 . . . . 0.0 108.211 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 50' ' ' ALA . 1.4 mp -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -140.03 154.57 47.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.237 1.015 . . . . 0.0 108.334 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.428 ' HG3' ' HE2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -159.72 131.29 6.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.69 98.9 10.26 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.109 0.963 . . . . 0.0 108.537 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.01 -25.5 67.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.98 0.912 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.34 72.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.415 1.086 . . . . 0.0 111.673 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -83.05 -11.23 58.22 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.148 0.579 . . . . 0.0 111.251 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 30.4 m-80 61.18 35.98 18.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 0.0 110.302 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 132.65 53.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.927 0.891 . . . . 0.0 110.257 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.1 t -99.99 153.11 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.112 1.365 . . . . 0.0 110.255 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -136.45 151.79 49.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.439 1.096 . . . . 0.0 109.829 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 1.8 tm? -132.2 115.16 15.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.84 102.31 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 109.725 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.547 ' HB3' HD23 ' A' ' 87' ' ' LEU . 67.1 mtt -95.16 136.8 35.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.422 0.689 . . . . 0.0 109.609 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 20.3 m120 -142.02 161.85 36.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.746 1.219 . . . . 0.0 108.001 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.3 m 54.12 31.41 13.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.297 1.039 . . . . 0.0 112.875 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 84' ' ' MET . 84.5 mt -61.04 130.07 44.55 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.872 0.869 . . . . 0.0 112.653 -169.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.412 ' HD3' ' NH1' ' A' ' 68' ' ' ARG . 2.4 mptp? -98.52 152.3 37.85 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.102 0.961 . . . . 0.0 108.993 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -46.74 -27.38 5.46 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 124.202 3.268 . . . . 0.0 115.936 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -71.21 -16.66 62.52 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.465 ' HB2' HG11 ' A' ' 121' ' ' VAL . 40.3 m-20 -72.68 -11.94 60.83 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.845 0.458 . . . . 0.0 112.103 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 120' ' ' THR . 63.4 m -60.16 105.42 0.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.72 0.808 . . . . 0.0 110.796 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.7 165.88 4.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.883 0.873 . . . . 0.0 110.074 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.3 p -89.26 115.69 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -86.82 155.72 20.18 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.355 1.062 . . . . 0.0 109.439 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -145.81 115.98 7.45 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.75 0.657 . . . . 0.0 109.357 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.481 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 26.4 p -83.87 106.09 15.28 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.19 124.66 49.93 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.513 1.125 . . . . 0.0 110.911 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.22 151.24 38.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.716 0.807 . . . . 0.0 110.833 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.12 -157.57 27.75 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -85.54 123.91 31.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -93.73 51.89 1.62 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.47 1.129 . . . . 0.0 108.748 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -114.37 156.29 24.73 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.674 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.75 107.87 0.23 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.561 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 m -69.03 -39.91 78.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.41 0.684 . . . . 0.0 109.703 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -140.37 92.14 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 62.32 176.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.806 1.242 . . . . 0.0 112.324 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.95 166.52 33.52 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.208 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.4 128.61 5.9 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 141.54 86.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.551 2.167 . . . . 0.0 112.2 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.2 -44.67 94.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.935 0.894 . . . . 0.0 111.265 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.73 167.99 20.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.912 0.885 . . . . 0.0 109.911 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -157.4 168.69 26.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.901 0.881 . . . . 0.0 111.256 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.51 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -80.7 -172.23 45.28 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.547 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -66.98 -33.88 76.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.161 0.984 . . . . 0.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.52 108.79 2.5 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -100.95 121.84 42.45 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.39 0.676 . . . . 0.0 109.938 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.0 tm0? -90.94 127.71 36.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.9 m -113.43 140.73 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.456 ' HA ' HG23 ' A' ' 92' ' ' THR . 40.2 m -127.33 108.9 11.25 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.465 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.0 p -106.62 116.02 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 122.987 0.515 . . . . 0.0 109.63 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -73.57 148.28 43.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 110.614 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.8 p -86.21 109.84 19.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.916 0.886 . . . . 0.0 110.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.474 HD11 ' H ' ' A' ' 15' ' ' ALA . 9.8 mp -114.67 98.91 7.14 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.951 0.901 . . . . 0.0 108.778 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.25 87.58 0.98 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.155 0.979 . . . . 0.0 109.697 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.87 113.95 16.25 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -68.88 142.2 54.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.506 0.322 . . . . 0.0 110.441 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -163.04 153.17 15.99 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.629 0.772 . . . . 0.0 109.695 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -70.95 83.44 0.67 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.384 0.673 . . . . 0.0 110.176 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.1 142.34 28.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.842 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 73.4 m80 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.87 175.58 5.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.63 0.772 . . . . 0.0 109.454 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.67 111.95 17.83 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -75.88 122.85 24.73 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.355 0.598 . . . . 0.0 110.818 -170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.539 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 70.6 mt -127.36 135.12 50.06 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.363 1.465 . . . . 0.0 108.475 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.38 100.42 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -97.29 135.02 39.81 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.386 0.674 . . . . 0.0 109.612 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -148.54 178.92 8.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.486 1.115 . . . . 0.0 109.49 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.38 -12.35 43.6 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.894 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.89 137.19 21.9 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.85 -169.55 36.91 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.94 137.64 37.72 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.971 0.386 . . . . 0.0 111.168 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.75 155.53 6.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 C-N-CA 124.946 1.298 . . . . 0.0 108.449 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.49 155.16 27.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.362 0.665 . . . . 0.0 109.948 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . . . -69.46 111.05 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.241 0.616 . . . . 0.0 110.263 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.92 3.93 31.67 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.922 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.88 -165.98 39.53 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 122.97 0.319 . . . . 0.0 113.463 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 m -132.51 158.22 42.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.413 1.085 . . . . 0.0 110.051 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -152.26 151.12 30.54 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -119.96 113.05 19.96 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.151 0.58 . . . . 0.0 110.548 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -101.54 150.08 23.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.363 1.065 . . . . 0.0 108.782 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -153.08 140.48 19.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.363 0.665 . . . . 0.0 109.294 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.7 t -120.6 123.63 43.31 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.525 0.73 . . . . 0.0 110.258 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.47 115.52 22.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -106.8 163.15 13.17 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.377 1.071 . . . . 0.0 110.273 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -66.09 168.6 8.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.16 23.87 8.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.698 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -79.59 179.17 7.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 111.912 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -79.05 70.18 5.35 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.444 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 59.0 m-85 -66.22 -22.08 66.33 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.313 164.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -60.0 -29.81 68.71 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.999 1.32 . . . . 0.0 111.703 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 m -90.28 -15.04 32.03 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 0.0 111.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -108.58 175.5 5.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.853 0.861 . . . . 0.0 110.931 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.48 162.93 17.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 164.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.616 ' HE1' HG13 ' A' ' 80' ' ' VAL . 3.4 ttp -141.93 153.26 44.23 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.0 157.02 27.28 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -96.36 125.13 40.64 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.176 0.99 . . . . 0.0 108.355 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -123.61 170.08 10.81 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.319 1.448 . . . . 0.0 107.873 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -149.67 162.31 40.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.845 0.748 . . . . 0.0 112.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.503 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -170.1 151.5 3.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 124.385 1.053 . . . . 0.0 110.565 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.31 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 124.459 1.104 . . . . 0.0 111.518 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.57 64.87 8.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 C-N-CA 122.131 1.887 . . . . 0.0 112.481 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.16 14.6 66.4 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.894 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -104.92 160.02 15.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.462 0.705 . . . . 0.0 112.055 -172.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.12 173.49 7.7 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.878 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -59.3 104.34 0.25 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.126 0.97 . . . . 0.0 109.655 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -106.67 150.49 26.19 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.651 0.78 . . . . 0.0 110.668 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.24 111.03 3.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.352 0.661 . . . . 0.0 110.835 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 HG11 ' HE1' ' A' ' 95' ' ' TYR . 70.1 t -94.15 -62.36 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.74 139.55 5.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG22 ' HA3' ' A' ' 36' ' ' GLY . 76.3 t -123.31 138.32 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.687 0.795 . . . . 0.0 110.436 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.65 157.13 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.283 1.033 . . . . 0.0 109.898 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -84.85 162.96 19.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.421 0.688 . . . . 0.0 112.479 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -81.69 -11.86 58.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.239 0.616 . . . . 0.0 111.537 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.91 83.11 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.509 0.505 . . . . 0.0 112.791 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -72.36 -23.99 61.21 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 110.969 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -122.89 134.85 54.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.117 0.967 . . . . 0.0 109.004 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.6 p -134.81 132.4 38.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.192 0.997 . . . . 0.0 109.156 173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -124.22 134.35 53.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.135 1.374 . . . . 0.0 107.524 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.19 149.2 52.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.226 0.61 . . . . 0.0 110.224 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.63 146.11 42.71 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 166.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.76 -34.76 67.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -71.25 -41.88 69.54 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.327 0.651 . . . . 0.0 111.772 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 HG12 ' A' ' 49' ' ' VAL . 16.1 m -90.17 -5.16 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 122.819 0.448 . . . . 0.0 111.47 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -70.83 120.22 16.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.917 0.887 . . . . 0.0 110.949 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.35 -8.64 77.19 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.449 0.468 . . . . 0.0 113.918 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 20.8 ptp180 -114.37 -26.64 7.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.423 0.689 . . . . 0.0 110.065 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-30 -98.46 150.45 21.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.829 0.851 . . . . 0.0 109.315 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -146.48 134.24 21.18 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.814 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 82' ' ' LEU . 2.8 mp -102.81 136.72 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.6 m -135.42 160.37 38.66 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.757 1.223 . . . . 0.0 108.389 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.2 164.37 32.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.219 0.533 . . . . 0.0 111.437 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -129.76 106.64 8.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.929 1.291 . . . . 0.0 107.557 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.97 -31.1 71.82 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.318 1.047 . . . . 0.0 111.604 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.48 67.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.231 0.612 . . . . 0.0 110.743 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.71 -13.51 58.94 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.254 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.4 m120 59.05 31.86 21.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.26 1.024 . . . . 0.0 110.811 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.7 m -121.03 130.1 53.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 ' HE1' ' A' ' 35' ' ' MET . 22.1 t -105.87 155.14 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.649 1.18 . . . . 0.0 108.519 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -137.66 141.73 41.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.559 1.144 . . . . 0.0 109.376 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.2 tm? -133.44 132.34 40.99 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -113.98 127.98 56.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.436 ' HB3' HD22 ' A' ' 87' ' ' LEU . 43.4 mtt -111.24 133.65 53.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.278 1.031 . . . . 0.0 110.042 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -133.91 149.54 51.3 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 60.05 54.16 4.28 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.036 0.935 . . . . 0.0 111.434 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 84' ' ' MET . 94.7 mt -75.1 115.96 15.3 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.995 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.48 146.11 95.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -61.39 -13.01 26.52 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 123.107 2.538 . . . . 0.0 113.92 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -88.21 -2.49 58.63 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.722 1.209 . . . . 0.0 112.211 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HB3' HG11 ' A' ' 121' ' ' VAL . 14.3 t70 -74.56 -19.82 60.18 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.937 0.895 . . . . 0.0 110.967 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.473 HG21 ' HA ' ' A' ' 120' ' ' THR . 88.7 m -48.4 109.17 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.189 1.396 . . . . 0.0 112.32 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.35 153.79 3.06 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.857 0.723 . . . . 0.0 111.011 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 14.9 p -77.65 114.14 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.41 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.8 m-85 -85.6 111.11 19.75 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 121.476 0.655 . . . . 0.0 109.688 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.1 127.88 54.19 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.837 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.3 m -83.87 118.49 24.0 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.476 ' HB2' ' HG3' ' A' ' 110' ' ' PRO . . . -107.4 128.71 54.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.916 0.886 . . . . 0.0 109.007 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.69 169.86 11.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.684 0.794 . . . . 0.0 111.544 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.11 -174.06 15.22 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.121 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.23 110.56 6.76 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 117.19 0.495 . . . . 0.0 109.753 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -81.43 70.07 8.21 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.732 0.777 . . . . 0.0 109.561 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 178.16 150.0 0.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.026 1.33 . . . . 0.0 108.68 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.86 -50.27 3.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 123.233 0.333 . . . . 0.0 112.462 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.1 m -80.61 87.05 5.79 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -79.78 102.15 8.88 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 66.16 -163.12 0.24 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.475 1.11 . . . . 0.0 110.823 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.77 -86.74 1.41 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.82 154.64 7.66 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.898 0.879 . . . . 0.0 109.939 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.476 ' HG3' ' HB2' ' A' ' 98' ' ' ALA . 73.0 Cg_endo -72.93 176.54 8.88 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.607 2.204 . . . . 0.0 111.105 167.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.77 -43.33 75.99 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.027 0.441 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -135.71 160.06 39.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.837 0.855 . . . . 0.0 110.313 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -160.04 143.33 13.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.651 1.18 . . . . 0.0 108.573 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.539 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -90.35 -143.26 10.52 Favored Glycine 0 C--N 1.344 0.99 0 O-C-N 122.977 0.173 . . . . 0.0 112.81 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -84.84 -73.99 0.41 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.027 0.931 . . . . 0.0 110.286 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.48 165.11 11.17 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.201 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.4 t -143.56 108.38 4.91 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.893 0.877 . . . . 0.0 110.269 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 61.4 tp60 -68.97 111.27 4.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.105 0.562 . . . . 0.0 110.877 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -91.74 145.07 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.473 ' HA ' HG21 ' A' ' 92' ' ' THR . 26.8 m -133.72 106.16 7.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.417 0.687 . . . . 0.0 109.492 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 91' ' ' ASP . 2.3 p -99.05 102.15 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.88 0.848 . . . . 0.0 108.774 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -57.18 141.86 44.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.958 1.703 . . . . 0.0 111.674 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t -65.52 149.51 49.93 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.022 0.929 . . . . 0.0 111.325 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 47.9 tp -160.73 -43.5 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.329 0.652 . . . . 0.0 109.754 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.39 83.29 3.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.479 0.712 . . . . 0.0 110.865 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -90.27 -20.84 22.49 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.164 0.586 . . . . 0.0 110.308 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.31 101.28 10.67 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -74.25 93.18 2.32 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -154.26 112.92 3.62 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.253 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -113.79 153.54 28.9 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.365 1.066 . . . . 0.0 109.375 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 69.2 t60 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.275 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.7 tt0 65.57 174.32 0.22 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.804 1.242 . . . . 0.0 111.599 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 28' ' ' ARG . 62.1 tp -87.19 110.27 20.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.62 106.14 15.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.704 0.801 . . . . 0.0 108.973 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.4 mt -97.57 121.3 39.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.144 0.978 . . . . 0.0 108.846 173.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 60.1 t -114.51 101.19 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.536 0.734 . . . . 0.0 109.176 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -74.92 142.32 44.02 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.526 0.73 . . . . 0.0 109.751 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 p -157.17 166.04 34.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.487 1.115 . . . . 0.0 110.02 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.24 85.51 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.583 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -84.5 139.3 17.95 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.9 -163.95 28.88 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' THR . 3.9 pp -106.7 143.75 34.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.65 0.78 . . . . 0.0 111.623 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 14.5 p -151.57 156.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 108.266 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -73.07 167.38 21.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.719 0.408 . . . . 0.0 111.275 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 121.09 17.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.92 1.03 57.32 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.878 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.52 -172.67 49.27 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 123.058 0.361 . . . . 0.0 112.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -135.26 143.85 46.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.793 0.837 . . . . 0.0 109.664 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -140.97 124.21 16.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.041 0.937 . . . . 0.0 108.611 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -95.13 120.29 35.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.12 0.968 . . . . 0.0 109.737 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.659 HD21 ' HE1' ' A' ' 84' ' ' MET . 3.1 mm? -99.31 157.68 16.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.563 0.745 . . . . 0.0 109.435 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.58 156.26 45.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.44 1.096 . . . . 0.0 108.644 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 52.5 t -150.4 117.61 6.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.768 0.427 . . . . 0.0 110.513 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -85.0 119.27 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.295 0.638 . . . . 0.0 109.662 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 3' ' ' LEU . . . -105.48 124.69 49.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.255 1.022 . . . . 0.0 109.529 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -145.09 163.49 34.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.075 0.55 . . . . 0.0 111.127 -172.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.7 -90.5 1.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 112.362 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 27.8 tpt180 -79.59 154.47 28.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.228 0.611 . . . . 0.0 110.767 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 m -75.12 93.5 2.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.17 0.588 . . . . 0.0 110.091 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -61.36 -29.3 69.82 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.046 0.939 . . . . 0.0 111.43 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.41 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 57.3 p -77.16 0.37 21.96 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.747 0.819 . . . . 0.0 112.519 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -95.21 -14.59 23.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.173 0.589 . . . . 0.0 111.086 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.33 173.01 6.83 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.803 0.841 . . . . 0.0 110.891 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.34 160.81 18.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 163.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.429 ' HE2' ' HB3' ' A' ' 35' ' ' MET . 30.9 ttp -137.87 136.52 37.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -139.38 140.85 11.2 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 122.969 0.319 . . . . 0.0 112.411 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -95.03 135.04 37.05 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.485 1.114 . . . . 0.0 108.96 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -127.81 149.97 50.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.054 1.342 . . . . 0.0 108.189 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -135.59 160.7 37.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.941 0.337 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.93 145.75 6.36 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.725 0.641 . . . . 0.0 110.67 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . -177.03 -63.54 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.387 169.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 90.2 Cg_endo -78.86 75.96 4.77 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.249 1.966 . . . . 0.0 112.393 -171.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 15.58 68.13 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.168 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -105.15 143.25 33.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.281 1.032 . . . . 0.0 111.043 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.56 172.61 8.26 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 162.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -60.05 104.61 0.32 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.098 0.475 . . . . 0.0 110.118 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.57 152.34 18.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.629 1.172 . . . . 0.0 109.564 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -62.17 111.81 2.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.32 -54.08 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 71' ' ' ILE . . . -166.29 136.82 3.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.499 0.499 . . . . 0.0 111.421 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.4 HG22 ' HA3' ' A' ' 36' ' ' GLY . 40.3 t -121.06 129.39 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.257 1.023 . . . . 0.0 109.58 173.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -116.03 158.26 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.284 1.034 . . . . 0.0 108.482 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.31 172.82 10.16 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 36.1 p-90 -62.33 -27.65 69.2 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.906 0.883 . . . . 0.0 113.255 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.3 m -86.06 -22.48 27.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.454 0.702 . . . . 0.0 112.543 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.43 10.98 83.84 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 123.08 0.237 . . . . 0.0 112.55 -172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -83.77 -23.66 31.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.842 1.257 . . . . 0.0 111.336 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -121.32 120.35 34.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.164 0.986 . . . . 0.0 108.574 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -127.93 130.75 48.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.652 0.781 . . . . 0.0 109.02 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.02 132.68 45.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 76.1 m-85 -128.56 150.84 50.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.378 0.671 . . . . 0.0 109.873 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.62 135.31 46.88 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.11 -30.87 38.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 112.0 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -62.88 -43.32 99.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.008 0.923 . . . . 0.0 112.153 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.57 1.71 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 26.3 ttpp -69.55 134.38 48.76 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.745 0.818 . . . . 0.0 110.845 -173.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.01 25.08 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.814 0.696 . . . . 0.0 113.718 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 29.4 ptt-85 -107.35 -20.74 13.18 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.235 0.518 . . . . 0.0 111.24 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-30 -97.61 157.69 15.9 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.161 0.585 . . . . 0.0 110.203 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.8 m -150.2 134.82 17.46 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.613 1.165 . . . . 0.0 109.122 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -102.56 142.04 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 169.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -142.02 160.38 40.33 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.999 1.32 . . . . 0.0 107.632 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 173.85 15.1 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -148.26 118.74 7.41 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.43 -24.67 59.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.814 0.846 . . . . 0.0 111.625 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.26 33.93 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.521 0.728 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.8 mmpt? -87.13 -14.59 40.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 0.0 111.401 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.93 27.72 16.85 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.559 1.162 . . . . 0.0 110.931 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -122.96 133.73 54.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.994 0.518 . . . . 0.0 110.549 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 91.5 t -104.39 154.08 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.591 1.556 . . . . 0.0 109.061 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.55 141.94 41.39 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.416 1.086 . . . . 0.0 109.072 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -131.59 99.56 4.84 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -85.65 117.08 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.372 0.669 . . . . 0.0 109.893 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.659 ' HE1' HD21 ' A' ' 21' ' ' LEU . 44.4 mtm -110.43 99.59 8.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.756 0.822 . . . . 0.0 109.872 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -99.0 154.06 18.38 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.655 0.782 . . . . 0.0 109.817 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t 56.62 42.24 27.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.52 HD22 ' HB3' ' A' ' 84' ' ' MET . 18.1 mt -56.03 124.76 18.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.053 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -90.69 142.7 28.07 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.724 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -34.55 -40.33 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 125.205 3.936 . . . . 0.0 116.182 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.24 -11.92 60.42 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.507 1.123 . . . . 0.0 113.736 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -80.64 -2.63 47.35 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.589 0.755 . . . . 0.0 112.515 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 120' ' ' THR . 90.0 m -63.47 106.19 0.89 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.319 0.648 . . . . 0.0 110.215 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.01 160.06 4.12 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 0.0 111.014 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 40' ' ' GLN . 7.6 p -83.04 114.54 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -87.5 113.77 23.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.926 0.891 . . . . 0.0 110.408 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.57 126.25 52.31 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.364 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.3 143.89 28.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -140.3 158.71 43.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.995 0.918 . . . . 0.0 109.915 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -134.94 141.83 46.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.988 0.515 . . . . 0.0 110.706 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.67 165.62 22.25 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -94.96 125.99 40.0 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.021 0.911 . . . . 0.0 110.084 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.531 ' HA ' ' HA3' ' A' ' 108' ' ' GLY . 24.3 m-90 -103.2 22.81 13.41 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.246 1.018 . . . . 0.0 109.892 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.05 141.39 32.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.447 1.099 . . . . 0.0 110.332 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 -73.7 2.52 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.3 t -75.69 147.43 39.42 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.525 0.73 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.16 -21.97 58.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 110.308 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.45 79.64 1.41 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.145 0.978 . . . . 0.0 108.577 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 102' ' ' TRP . . . -76.95 142.46 27.59 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.055 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.17 113.78 43.82 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.585 0.754 . . . . 0.0 111.2 -174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.87 86.15 1.65 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.623 2.215 . . . . 0.0 108.688 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.8 -25.02 64.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.008 0.923 . . . . 0.0 111.438 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 38.7 m-85 -118.76 155.74 30.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.249 1.019 . . . . 0.0 109.29 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 10.3 p90 -165.68 172.86 11.38 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.226 1.011 . . . . 0.0 109.753 170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.98 -149.69 16.24 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.338 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -84.84 -64.59 1.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.669 1.188 . . . . 0.0 109.109 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.68 142.19 6.28 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.451 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 10.2 t -122.52 117.89 26.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.895 0.878 . . . . 0.0 109.687 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 26.6 tp60 -78.2 106.47 10.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.12 0.568 . . . . 0.0 109.83 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.602 HG23 ' HE2' ' A' ' 84' ' ' MET . 2.9 m -101.2 146.97 8.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.511 0.724 . . . . 0.0 109.276 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.525 ' HA ' HG21 ' A' ' 92' ' ' THR . 47.1 m -131.93 133.99 45.16 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.458 0.703 . . . . 0.0 109.696 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.1 p -114.38 105.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -59.45 112.38 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.733 1.213 . . . . 0.0 110.754 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 p -80.73 110.32 16.12 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.879 0.871 . . . . 0.0 110.621 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -87.19 47.42 1.5 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.147 0.979 . . . . 0.0 109.907 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -72.6 145.38 47.38 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.397 -173.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -142.79 134.42 26.58 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.242 1.017 . . . . 0.0 108.896 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.56 149.35 48.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.955 0.502 . . . . 0.0 110.706 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -71.54 96.76 1.57 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.889 0.475 . . . . 0.0 109.987 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 82.2 t60 75.29 139.17 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.041 1.336 . . . . 0.0 113.158 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -68.51 104.84 2.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.994 0.918 . . . . 0.0 109.778 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 124.817 1.247 . . . . 0.0 110.371 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' HD3' ' A' ' 28' ' ' ARG . 58.0 tpp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -154.03 139.69 17.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.65 0.78 . . . . 0.0 109.863 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 28' ' ' ARG . 43.9 tp -88.59 112.27 22.86 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 26.4 tp60 -80.23 123.38 27.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.438 0.695 . . . . 0.0 109.665 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.493 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.4 mt -111.55 111.28 22.18 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.7 t -98.55 100.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -82.56 131.02 35.22 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.9 m -138.88 128.32 24.41 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.317 1.047 . . . . 0.0 108.763 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.89 -155.13 26.22 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.55 151.01 5.29 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 122.914 0.293 . . . . 0.0 112.899 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.66 -173.61 43.28 Favored Glycine 0 C--O 1.241 0.593 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.08 134.35 41.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.543 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 HD13 ' A' ' 87' ' ' LEU . 13.5 p -152.56 156.67 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 108.913 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 43.3 mt-30 -81.26 161.23 24.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.368 0.667 . . . . 0.0 110.556 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 131.97 46.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.647 0.379 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.43 -15.08 62.7 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.743 0.652 . . . . 0.0 111.489 -170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.17 -171.08 40.23 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.027 0.346 . . . . 0.0 113.833 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.3 p -137.85 160.34 39.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 0.0 110.885 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.92 164.03 33.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -130.22 140.63 50.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.611 HD21 HD13 ' A' ' 82' ' ' LEU . 1.7 mm? -119.64 157.81 27.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.606 1.563 . . . . 0.0 107.472 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 t -151.56 163.75 38.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.453 0.301 . . . . 0.0 110.256 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 44.6 t -152.86 122.62 6.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.06 0.544 . . . . 0.0 110.61 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 127.63 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.17 136.45 44.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.264 0.626 . . . . 0.0 109.49 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 9.5 t -71.94 -175.44 1.44 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.431 1.092 . . . . 0.0 112.674 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.58 -19.84 54.99 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 45.7 mmm-85 -60.81 145.88 48.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.602 0.761 . . . . 0.0 111.346 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.3 p -70.63 91.16 0.79 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -60.18 -21.35 61.59 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.141 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 17.6 p -67.17 -0.2 3.19 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.44 1.496 . . . . 0.0 113.462 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 m -106.98 -3.3 20.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.253 0.621 . . . . 0.0 111.019 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.82 155.49 36.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.137 0.575 . . . . 0.0 111.021 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.87 125.84 35.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.512 ' HG2' HG22 ' A' ' 80' ' ' VAL . 3.0 tpt -99.17 116.92 32.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.413 1.085 . . . . 0.0 109.033 -172.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.587 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -132.85 142.19 13.67 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 114.072 0.389 . . . . 0.0 114.072 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -96.72 134.15 40.35 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.959 1.303 . . . . 0.0 109.319 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -124.5 164.73 19.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -143.13 154.12 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.161 0.437 . . . . 0.0 111.548 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.08 151.02 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.623 1.169 . . . . 0.0 109.025 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . 175.36 -64.92 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 C-N-CA 124.017 0.927 . . . . 0.0 111.068 166.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 54.5 Cg_endo -84.43 69.63 6.07 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.008 1.805 . . . . 0.0 111.949 -172.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 5.61 63.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.341 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -92.37 139.97 30.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.142 0.977 . . . . 0.0 109.547 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.44 169.0 12.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.532 0.733 . . . . 0.0 109.495 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -63.11 103.84 0.51 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.91 155.47 22.6 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.904 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.9 109.52 1.28 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.718 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.83 -63.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.47 134.11 1.79 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.724 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.587 HG21 ' HA3' ' A' ' 36' ' ' GLY . 69.9 t -118.31 129.97 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 109.344 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.508 HG23 HG23 ' A' ' 59' ' ' THR . 11.7 p -105.94 146.27 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -77.26 148.91 35.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.4 p-90 -48.26 -33.65 9.04 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -83.57 -32.45 25.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.553 0.741 . . . . 0.0 111.483 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.6 -8.19 61.8 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.35 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.96 -41.46 78.36 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.794 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -107.7 130.87 54.89 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.383 0.673 . . . . 0.0 109.655 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 52' ' ' VAL . 32.9 p -130.94 143.88 51.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.456 1.102 . . . . 0.0 109.002 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -131.45 144.5 51.22 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 109.682 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.89 145.51 42.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.523 0.729 . . . . 0.0 109.075 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.35 -29.61 66.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.536 0.734 . . . . 0.0 112.054 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 m -66.04 -31.27 72.06 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.253 1.021 . . . . 0.0 111.911 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.15 -2.56 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.955 0.902 . . . . 0.0 111.911 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -73.85 137.01 43.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.835 0.454 . . . . 0.0 110.825 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.95 -24.83 22.64 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.678 0.611 . . . . 0.0 113.015 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -113.04 -12.46 13.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.668 0.787 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.431 ' CD2' HD11 ' A' ' 82' ' ' LEU . 3.1 m-85 -109.78 145.22 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.363 0.665 . . . . 0.0 109.725 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -144.35 129.82 18.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.045 0.938 . . . . 0.0 109.045 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.43 HG12 HD23 ' A' ' 82' ' ' LEU . 5.6 mt -101.65 120.48 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -124.92 138.3 54.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.57 0.748 . . . . 0.0 109.07 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.68 137.61 30.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.626 0.37 . . . . 0.0 110.031 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -105.79 101.6 11.1 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.584 0.754 . . . . 0.0 110.896 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.25 -44.54 79.17 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.282 1.033 . . . . 0.0 110.917 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -86.58 -10.92 52.93 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.401 0.68 . . . . 0.0 111.163 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.452 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 62.97 28.1 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.637 1.175 . . . . 0.0 110.362 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.6 m -121.94 132.15 54.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.666 0.786 . . . . 0.0 110.533 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.512 HG22 ' HG2' ' A' ' 35' ' ' MET . 26.1 t -100.57 157.35 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -139.05 155.46 47.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.54 1.136 . . . . 0.0 109.247 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.611 HD13 HD21 ' A' ' 21' ' ' LEU . 3.2 tm? -130.42 122.14 27.22 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.62 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.347 1.059 . . . . 0.0 108.519 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.475 ' HE2' HG22 ' A' ' 119' ' ' VAL . 48.8 mtt -86.47 125.22 33.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.593 0.757 . . . . 0.0 109.056 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.63 153.59 47.11 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.1 m 54.88 46.48 24.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.825 0.85 . . . . 0.0 111.91 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.426 HD13 HG12 ' A' ' 13' ' ' VAL . 63.9 mt -66.33 128.97 38.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.556 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.08 157.84 53.54 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.521 1.129 . . . . 0.0 108.635 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.49 -16.49 35.97 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.677 2.252 . . . . 0.0 113.722 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.47 -26.3 68.66 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.339 1.056 . . . . 0.0 112.247 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' HG13 ' A' ' 121' ' ' VAL . 13.4 m-20 -76.63 -12.51 60.02 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.514 HG21 ' HA ' ' A' ' 120' ' ' THR . 49.7 m -61.43 99.34 0.1 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.327 0.512 . . . . 0.0 109.683 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.55 157.13 3.14 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.671 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 p -80.11 112.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -87.62 119.55 28.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.177 0.991 . . . . 0.0 109.719 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -101.81 126.18 48.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.185 0.994 . . . . 0.0 109.346 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 20.2 t -85.07 107.66 17.28 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.402 0.681 . . . . 0.0 109.628 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -108.21 158.31 17.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 110.997 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.67 123.51 15.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.162 0.985 . . . . 0.0 108.737 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.08 178.54 37.87 Favored Glycine 0 C--N 1.333 0.406 0 O-C-N 123.414 0.446 . . . . 0.0 112.003 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -81.78 95.27 7.22 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 67.54 -78.05 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.903 1.281 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -178.53 -52.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.924 1.69 . . . . 0.0 107.754 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.42 -145.08 8.58 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -148.78 -75.26 0.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.156 0.583 . . . . 0.0 110.132 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -89.63 -33.9 16.49 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.438 0.695 . . . . 0.0 109.13 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -122.5 139.91 53.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.43 1.092 . . . . 0.0 108.182 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.85 130.81 10.38 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.42 104.48 1.67 Allowed Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.327 0.651 . . . . 0.0 110.177 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.08 128.0 20.69 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.858 2.372 . . . . 0.0 111.756 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.77 -46.84 88.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.928 0.891 . . . . 0.0 111.254 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -126.8 159.47 33.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 109.303 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 48.8 p90 -155.71 165.92 35.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.483 0.713 . . . . 0.0 110.211 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.7 -170.37 17.97 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.737 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.53 -56.63 11.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.778 0.831 . . . . 0.0 110.967 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.29 151.05 23.76 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.449 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 10.2 t -130.8 136.09 48.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.275 0.63 . . . . 0.0 111.213 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -75.14 108.48 7.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' HE2' ' A' ' 84' ' ' MET . 4.5 m -90.56 139.85 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.514 ' HA ' HG21 ' A' ' 92' ' ' THR . 39.1 m -126.07 105.34 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 91' ' ' ASP . 2.2 p -101.59 109.06 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.192 0.597 . . . . 0.0 109.435 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 46.9 t -55.96 122.36 11.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.87 1.268 . . . . 0.0 111.07 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.0 t -63.5 93.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.918 0.887 . . . . 0.0 110.201 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.14 100.94 8.29 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -168.79 133.61 1.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.256 1.023 . . . . 0.0 108.579 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -62.96 127.3 30.61 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.567 0.542 . . . . 0.0 110.779 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -165.56 146.07 6.9 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.721 0.809 . . . . 0.0 109.732 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -153.11 131.69 12.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.604 0.762 . . . . 0.0 109.105 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -99.38 151.36 21.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -157.35 179.42 9.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.574 0.75 . . . . 0.0 109.523 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 35.9 m170 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.452 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -139.28 174.08 10.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.814 0.846 . . . . 0.0 111.161 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 49.7 tp -96.31 110.62 22.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 27.5 tt0 -79.56 110.35 14.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.719 0.808 . . . . 0.0 109.578 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.495 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 44.0 mt -104.81 112.99 26.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.66 101.11 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.436 0.694 . . . . 0.0 109.572 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.41 149.3 26.77 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.773 0.32 . . . . 0.0 110.295 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.0 p -159.42 168.22 26.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.318 1.047 . . . . 0.0 109.553 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.46 -7.63 54.1 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 120.034 -0.315 . . . . 0.0 113.177 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 126.59 8.36 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.698 0.249 . . . . 0.0 112.808 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.71 -164.73 20.65 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.77 141.6 30.4 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.119 0.485 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.74 159.41 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.209 1.404 . . . . 0.0 107.968 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -88.11 165.12 15.35 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.889 0.476 . . . . 0.0 111.459 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.91 120.98 13.56 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.453 0.701 . . . . 0.0 109.425 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 5.03 75.8 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.926 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.67 -176.48 49.23 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.572 0.219 . . . . 0.0 113.145 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -134.46 158.04 44.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -158.01 143.13 16.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.295 0.638 . . . . 0.0 109.652 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -111.64 122.23 47.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -96.13 150.36 20.59 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -139.57 125.08 19.22 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.78 135.54 53.41 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.654 0.782 . . . . 0.0 109.107 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 118.93 37.51 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.307 0.643 . . . . 0.0 109.31 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 4' ' ' GLN . . . -104.56 135.94 45.04 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.162 0.585 . . . . 0.0 109.599 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.6 m -149.69 162.7 39.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.991 0.916 . . . . 0.0 110.07 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 -96.24 1.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.56 ' HB3' ' HE2' ' A' ' 33' ' ' TYR . 16.4 mmt85 -67.27 164.54 18.11 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.07 0.548 . . . . 0.0 111.869 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.3 p -71.63 83.98 0.86 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.874 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' HD1' HD22 ' A' ' 3' ' ' LEU . 78.2 t80 -57.73 -29.99 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.526 0.73 . . . . 0.0 111.37 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -71.18 0.68 7.27 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.392 1.077 . . . . 0.0 112.877 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.1 m -112.5 -9.25 13.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.998 0.919 . . . . 0.0 111.113 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.56 ' HE2' ' HB3' ' A' ' 28' ' ' ARG . 47.0 m-85 -114.79 138.84 50.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.909 0.483 . . . . 0.0 110.75 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 157.62 26.34 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 167.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.507 ' HE3' HG12 ' A' ' 80' ' ' VAL . 13.9 ttp -141.37 147.54 38.2 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -141.82 150.83 22.31 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.23 0.332 . . . . 0.0 112.43 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -97.84 127.51 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.652 0.781 . . . . 0.0 109.155 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.52 132.77 49.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.031 . . . . 0.0 108.271 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 27.6 ptt180 -116.73 158.67 23.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.533 0.333 . . . . 0.0 110.771 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.503 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -170.06 153.81 4.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.686 0.794 . . . . 0.0 109.078 171.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.73 -54.34 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 118.516 -0.755 . . . . 0.0 111.528 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.43 68.22 8.07 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.039 1.826 . . . . 0.0 112.457 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.38 21.14 64.11 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.049 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -115.58 156.62 25.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.336 0.654 . . . . 0.0 111.564 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.57 170.43 16.66 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.546 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -61.64 103.89 0.37 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.55 146.54 24.38 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.671 0.788 . . . . 0.0 109.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -65.25 120.96 13.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.863 0.865 . . . . 0.0 110.23 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.564 HG13 ' HE2' ' A' ' 95' ' ' TYR . 52.0 t -101.94 -54.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -168.31 154.81 7.39 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.112 -173.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG22 ' HA3' ' A' ' 36' ' ' GLY . 70.5 t -140.37 147.5 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.704 1.202 . . . . 0.0 108.328 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG21 HG21 ' A' ' 59' ' ' THR . 10.6 p -141.29 153.1 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.184 0.994 . . . . 0.0 108.985 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -76.66 161.15 28.78 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 167.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -55.17 -39.4 69.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.296 0.638 . . . . 0.0 110.696 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -74.31 -19.99 60.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.474 1.109 . . . . 0.0 111.584 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.03 78.21 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -167.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -58.91 -64.8 0.81 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.286 1.034 . . . . 0.0 110.851 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -112.84 129.56 56.4 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.479 HG21 HG21 ' A' ' 52' ' ' VAL . 65.2 p -114.47 130.31 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -116.23 126.92 54.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -118.7 150.75 39.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.184 0.594 . . . . 0.0 109.923 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 65' ' ' VAL . . . -79.62 130.71 35.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.89 -22.51 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -67.81 -40.98 83.77 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.626 0.77 . . . . 0.0 111.409 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' ALA . 32.2 m -106.86 3.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.934 0.894 . . . . 0.0 111.578 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.6 128.49 36.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.869 0.867 . . . . 0.0 111.288 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 -17.56 50.83 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 113.619 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -103.04 -19.12 14.68 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -102.34 157.88 16.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 110.216 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.2 m -149.27 133.12 17.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.105 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.489 HD13 ' HB2' ' A' ' 50' ' ' ALA . 1.6 mp -103.0 131.13 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -133.15 160.42 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 108.334 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 167.29 30.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.96 111.86 11.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.99 -16.19 60.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.588 0.755 . . . . 0.0 112.083 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.1 -50.64 11.64 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.0 -14.55 57.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 78' ' ' ASN . 0.8 OUTLIER 61.7 28.64 17.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.004 1.321 . . . . 0.0 111.275 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 m -113.51 130.86 56.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.898 0.479 . . . . 0.0 110.516 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.507 HG12 ' HE3' ' A' ' 35' ' ' MET . 25.3 t -100.31 151.55 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 109.787 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -135.5 112.94 10.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.397 1.079 . . . . 0.0 108.931 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.0 tm? -93.6 103.1 15.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 104.06 16.69 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.749 0.82 . . . . 0.0 109.329 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.445 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.7 mtt -90.41 139.4 30.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.85 1.26 . . . . 0.0 110.963 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.61 140.11 45.83 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 54.71 58.84 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 111.713 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 84' ' ' MET . 56.4 mt -64.17 124.78 22.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.819 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.9 mtpt -72.5 144.08 85.99 Favored Pre-proline 0 C--O 1.21 -0.984 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.668 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 51.3 Cg_exo -56.45 -21.52 37.94 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.868 2.379 . . . . 0.0 114.273 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.83 3.46 55.09 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.828 1.251 . . . . 0.0 112.79 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -79.79 -17.05 54.31 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.72 0.808 . . . . 0.0 111.35 -172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 120' ' ' THR . 94.2 m -53.57 108.73 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.701 1.2 . . . . 0.0 112.11 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.95 160.45 4.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.748 0.819 . . . . 0.0 111.295 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 13.8 p -81.04 114.49 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.041 0.448 . . . . 0.0 110.173 173.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.564 ' HE2' HG13 ' A' ' 49' ' ' VAL . 19.8 m-85 -87.23 127.87 35.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.835 1.254 . . . . 0.0 110.374 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.67 142.94 51.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.696 0.798 . . . . 0.0 110.001 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.5 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.5 m -92.22 112.02 23.81 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.004 0.922 . . . . 0.0 109.159 173.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.97 112.71 25.94 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -108.12 169.84 8.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.547 0.739 . . . . 0.0 111.181 -174.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.91 -149.66 17.77 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -96.1 117.78 31.39 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -98.95 -3.92 33.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.774 0.83 . . . . 0.0 109.703 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -103.87 171.88 7.11 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.878 0.871 . . . . 0.0 110.783 -169.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.49 -80.47 1.82 Allowed Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.586 0.612 . . . . 0.0 112.091 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.3 t -152.53 29.35 0.54 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.292 1.037 . . . . 0.0 108.67 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.29 29.03 7.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 0.0 110.733 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -70.88 101.55 2.17 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.546 0.738 . . . . 0.0 109.543 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.04 -16.69 32.74 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.415 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.05 101.73 23.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.074 0.949 . . . . 0.0 109.951 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -84.87 162.06 11.98 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.3 2.0 . . . . 0.0 111.656 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.65 -34.38 17.28 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 51.0 m-85 -127.51 152.6 47.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.639 0.776 . . . . 0.0 110.01 -172.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -132.16 139.06 48.27 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.62 -169.03 44.58 Favored Glycine 0 C--O 1.244 0.741 0 O-C-N 123.117 0.261 . . . . 0.0 113.731 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.82 -54.78 9.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.435 0.694 . . . . 0.0 110.366 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 106.3 2.77 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.198 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -101.69 121.45 42.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.279 1.032 . . . . 0.0 109.848 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.7 tm0? -86.61 124.94 33.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.825 0.45 . . . . 0.0 110.059 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.99 141.31 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.523 0.729 . . . . 0.0 109.04 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.445 ' HA ' HG21 ' A' ' 92' ' ' THR . 57.5 m -129.16 106.84 9.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.281 0.632 . . . . 0.0 109.656 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.8 p -93.36 128.23 44.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.3 t -69.38 111.89 5.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.52 0.728 . . . . 0.0 109.217 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.58 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 34.9 p -76.78 81.27 3.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.655 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.1 tp -81.74 72.91 8.8 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.415 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -139.37 161.71 36.8 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.246 1.018 . . . . 0.0 109.748 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.57 -23.49 42.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.155 0.582 . . . . 0.0 110.581 171.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.0 m80 61.23 28.55 18.11 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.655 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -89.62 49.63 1.77 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.727 0.811 . . . . 0.0 110.645 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -77.93 -42.96 31.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -156.9 -76.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.477 1.111 . . . . 0.0 108.636 173.051 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 mtm . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -144.38 64.74 1.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.556 1.17 . . . . 0.0 110.199 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.4 tp -128.67 112.91 14.74 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.175 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -72.28 102.69 3.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.572 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 87.9 mt -112.84 103.62 11.62 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 57.3 t -99.74 99.6 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 50.9 mt-10 -85.77 142.67 28.8 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.953 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -158.44 172.28 18.62 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.32 0.648 . . . . 0.0 110.16 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.52 6.77 70.12 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.051 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 119.68 4.97 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.26 -164.86 23.67 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.23 147.1 34.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.13 143.53 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.448 1.099 . . . . 0.0 108.345 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.93 153.37 42.24 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.53 0.732 . . . . 0.0 111.309 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 110.54 2.38 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.126 0.57 . . . . 0.0 110.231 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.05 10.49 59.72 Favored Glycine 0 N--CA 1.464 0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.599 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.29 -169.15 43.08 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.644 0.261 . . . . 0.0 112.998 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.5 p -123.11 148.68 45.42 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.732 0.813 . . . . 0.0 110.759 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 tp -152.66 123.64 7.48 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -99.41 111.16 23.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.64 157.65 20.28 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.043 0.937 . . . . 0.0 110.344 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -147.25 157.92 43.77 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.061 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 43.3 t -142.35 120.97 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.475 0.71 . . . . 0.0 109.799 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -84.79 109.69 18.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.42 38.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.49 0.716 . . . . 0.0 109.368 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -158.58 158.65 34.32 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.669 0.787 . . . . 0.0 109.853 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.72 -93.81 0.93 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -91.64 154.02 19.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.417 0.687 . . . . 0.0 109.453 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.447 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 39.2 p -70.13 84.93 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.43 0.633 . . . . 0.0 110.892 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -63.24 -19.56 64.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.928 0.891 . . . . 0.0 111.212 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -49.22 -40.4 33.62 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.995 1.718 . . . . 0.0 113.141 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 -21.88 50.63 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.138 0.975 . . . . 0.0 112.199 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.93 148.68 22.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 101' ' ' LYS . . . -76.01 156.63 33.88 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.446 ' HE3' ' HB3' ' A' ' 35' ' ' MET . 24.8 ttp -141.58 141.09 33.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.13 0.572 . . . . 0.0 110.204 -172.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 142.66 14.17 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -97.21 129.32 44.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 108.959 171.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -132.91 143.04 49.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.412 1.085 . . . . 0.0 109.359 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -125.64 155.85 40.14 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.256 0.48 . . . . 0.0 112.25 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.01 144.19 6.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.792 0.837 . . . . 0.0 110.992 171.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 167.87 -50.35 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 125.28 1.432 . . . . 0.0 111.939 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.28 61.96 8.34 Favored 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.558 2.172 . . . . 0.0 113.122 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.52 21.41 70.67 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.553 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -127.67 150.49 49.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.791 0.837 . . . . 0.0 110.728 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 173.47 9.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.82 0.848 . . . . 0.0 109.629 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -69.18 109.06 3.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.333 0.587 . . . . 0.0 111.056 -172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -112.14 157.76 20.44 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.342 -170.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -63.67 121.82 14.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.884 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 65' ' ' VAL . 61.7 t -106.59 -66.85 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB3' HD12 ' A' ' 71' ' ' ILE . . . -153.76 134.07 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.56 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -122.29 155.58 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.187 0.995 . . . . 0.0 108.589 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.23 150.27 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.04 170.14 14.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.829 0.452 . . . . 0.0 110.538 171.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -60.37 -43.23 96.77 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -88.63 -2.1 58.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.071 0.548 . . . . 0.0 111.874 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.88 85.12 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.122 0.264 . . . . 0.0 113.076 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.74 -39.44 94.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.2 1.0 . . . . 0.0 111.325 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -115.81 135.08 54.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.671 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 p -125.26 129.33 49.82 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.12 141.44 41.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.447 1.499 . . . . 0.0 108.286 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -141.43 146.09 36.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.292 0.637 . . . . 0.0 109.943 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.97 151.39 40.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 164.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.55 -33.74 47.0 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.12 0.968 . . . . 0.0 112.973 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -75.77 -41.89 51.8 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.098 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG12 ' A' ' 49' ' ' VAL . 9.3 m -92.08 -4.73 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.37 0.668 . . . . 0.0 111.244 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.01 129.14 38.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.587 0.755 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.73 -25.44 6.62 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.787 0.679 . . . . 0.0 113.906 176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 19.6 ptp180 -102.4 -24.58 13.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.531 0.733 . . . . 0.0 111.017 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.403 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.1 m-30 -97.84 161.29 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.5 m -148.41 135.74 20.4 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 108.736 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 50' ' ' ALA . 1.9 mp -100.9 139.16 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -142.37 148.85 38.56 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.191 0.996 . . . . 0.0 109.127 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 136.73 19.95 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -117.29 117.69 30.23 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -85.24 -14.48 46.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.677 0.791 . . . . 0.0 111.928 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.38 -45.91 10.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.257 0.623 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.05 -20.13 56.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.947 0.899 . . . . 0.0 110.448 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.2 39.45 12.66 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.574 1.171 . . . . 0.0 109.74 -175.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 m -129.51 131.43 46.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.917 0.487 . . . . 0.0 111.06 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 75.3 t -98.16 148.3 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 109.878 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -134.28 141.73 47.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 109.085 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.34 105.17 6.81 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -84.27 106.27 15.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.591 0.756 . . . . 0.0 109.068 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.542 ' HB3' HD22 ' A' ' 87' ' ' LEU . 53.3 mtt -102.11 128.7 48.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -128.1 144.39 51.11 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m 57.33 64.51 1.58 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.165 0.986 . . . . 0.0 112.014 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 84' ' ' MET . 91.4 mt -77.77 120.63 22.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.14 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.433 ' O ' HG11 ' A' ' 121' ' ' VAL . 46.4 mtpt -74.23 152.32 88.13 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.073 -0.965 . . . . 0.0 108.643 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.53 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 98.7 Cg_exo -48.78 -26.97 10.39 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.205 2.603 . . . . 0.0 114.773 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.41 -22.72 60.15 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.089 0.956 . . . . 0.0 112.816 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.17 -6.63 14.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.577 0.751 . . . . 0.0 112.346 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 120' ' ' THR . 89.2 m -61.74 98.76 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.78 159.03 7.79 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.523 -170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -86.35 114.4 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 171.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.459 ' HE2' HG11 ' A' ' 49' ' ' VAL . 49.9 m-85 -86.41 150.06 24.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.931 0.892 . . . . 0.0 108.706 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.65 121.58 12.79 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.7 p -85.09 102.53 13.32 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.39 142.89 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.633 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.64 121.54 44.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.072 0.463 . . . . 0.0 110.256 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.94 142.32 5.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.323 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.597 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 2.9 tmmm? -82.21 102.22 10.98 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 36.5 m0 59.68 83.87 0.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.053 1.341 . . . . 0.0 111.052 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.83 143.35 36.09 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.81 -12.36 47.21 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.505 0.574 . . . . 0.0 112.948 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.1 m 66.89 8.26 5.93 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.014 1.326 . . . . 0.0 112.802 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -178.46 -58.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -82.0 84.97 6.8 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.05 152.2 26.59 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -166.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.26 155.06 70.45 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 123.851 0.86 . . . . 0.0 109.365 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.27 141.82 40.04 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.498 2.132 . . . . 0.0 111.072 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.55 -24.93 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.967 0.507 . . . . 0.0 110.735 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.548 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 57.3 m-85 -126.17 155.27 41.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.699 0.8 . . . . 0.0 109.573 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -136.11 147.94 48.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.633 0.773 . . . . 0.0 109.935 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.96 -170.23 45.13 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.521 -0.308 . . . . 0.0 113.46 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 15.5 mm100 -85.66 -38.65 18.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.213 0.605 . . . . 0.0 109.958 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.02 109.32 2.28 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.381 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 8.4 t -99.87 113.67 26.36 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.482 0.658 . . . . 0.0 109.563 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.608 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.1 tm0? -82.15 123.43 28.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -110.09 139.31 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.407 ' HA ' HG21 ' A' ' 92' ' ' THR . 27.6 m -117.66 104.84 11.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.5 p -88.85 101.22 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.0 t -65.71 113.08 4.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.965 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 18.3 p -70.06 94.98 0.92 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.525 0.73 . . . . 0.0 109.622 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.41 67.73 5.23 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.961 0.904 . . . . 0.0 108.816 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -70.82 -73.09 0.18 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -140.28 -69.13 0.4 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.518 0.727 . . . . 0.0 109.17 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.3 m80 59.74 88.07 0.08 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.027 1.331 . . . . 0.0 111.325 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.3 -179.41 6.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.026 0.93 . . . . 0.0 109.973 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 63.71 30.6 14.71 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.867 0.867 . . . . 0.0 109.902 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -59.58 -31.11 69.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.982 0.913 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 123.877 0.871 . . . . 0.0 108.804 167.646 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -86.67 177.73 7.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.073 0.549 . . . . 0.0 110.516 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 30' ' ' PHE . 46.0 tp -112.72 111.76 22.78 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -86.29 104.03 15.44 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.657 0.783 . . . . 0.0 109.282 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.48 104.98 14.82 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.83 114.95 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.67 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -113.49 134.63 54.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.608 0.763 . . . . 0.0 109.422 -168.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -157.22 149.11 22.5 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.454 1.102 . . . . 0.0 109.998 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.13 -6.5 0.82 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.815 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.61 151.81 38.34 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.832 0.316 . . . . 0.0 113.617 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.72 -167.6 34.93 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -93.7 133.48 37.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.304 0.642 . . . . 0.0 110.384 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.57 143.32 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.1 0.96 . . . . 0.0 109.253 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.404 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -62.05 159.02 15.21 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.149 0.979 . . . . 0.0 112.784 -177.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.49 17.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.72 0.808 . . . . 0.0 110.396 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.46 -1.25 69.09 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.252 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.65 -163.41 29.29 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.19 0.424 . . . . 0.0 113.481 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -137.3 146.98 45.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.0 111.03 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.3 tp -154.5 121.41 5.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.45 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -96.23 129.58 43.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.562 1.145 . . . . 0.0 110.574 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -102.92 158.31 16.37 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.31 1.044 . . . . 0.0 108.712 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -151.15 124.17 8.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.656 0.383 . . . . 0.0 110.181 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 43.3 t -117.34 116.94 28.2 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.578 0.751 . . . . 0.0 110.245 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.03 119.7 25.26 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.05 139.76 40.93 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.39 1.076 . . . . 0.0 109.402 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.6 t -153.72 173.26 16.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.895 0.478 . . . . 0.0 110.649 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 -106.26 3.39 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -84.49 168.22 15.66 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.282 0.541 . . . . 0.0 109.743 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -72.43 102.65 3.24 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.901 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HB3' HD12 ' A' ' 3' ' ' LEU . 16.7 p90 -64.85 -25.33 67.85 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.622 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 p -74.93 -0.1 17.52 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.955 1.302 . . . . 0.0 112.596 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -92.31 -7.69 47.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.21 0.604 . . . . 0.0 110.192 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -129.58 154.11 47.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 110.251 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' A' ' 102' ' ' TRP . . . -86.52 145.14 26.91 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.549 ' SD ' HG23 ' A' ' 80' ' ' VAL . 15.2 ptm -120.24 159.04 25.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.802 0.441 . . . . 0.0 109.898 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.29 142.55 10.36 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.174 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -96.74 132.01 42.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.099 0.96 . . . . 0.0 109.193 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.94 164.82 19.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.374 1.07 . . . . 0.0 108.14 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 38.3 ptt180 -146.92 154.06 40.84 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.746 0.248 . . . . 0.0 111.263 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.414 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.16 145.79 7.25 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.069 0.856 . . . . 0.0 110.169 172.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 93' ' ' ALA . . . 171.55 -52.66 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.23 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.38 50.6 3.06 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.749 2.299 . . . . 0.0 112.657 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.63 -8.92 53.42 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.019 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -94.7 132.35 39.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.77 0.828 . . . . 0.0 109.05 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.02 179.16 5.13 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.946 0.779 . . . . 0.0 110.817 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -54.1 105.4 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.46 0.704 . . . . 0.0 110.247 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -111.73 149.5 31.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.259 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -68.65 113.82 6.48 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.225 1.01 . . . . 0.0 109.626 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.04 -66.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB1' HD13 ' A' ' 71' ' ' ILE . . . -164.3 162.32 22.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.649 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG22 ' HA3' ' A' ' 36' ' ' GLY . 53.3 t -137.83 152.46 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.714 1.206 . . . . 0.0 107.77 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.456 HG21 HG21 ' A' ' 59' ' ' THR . 13.3 p -131.46 143.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.047 0.939 . . . . 0.0 108.824 172.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.33 158.18 36.28 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -57.95 -35.63 71.4 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.519 0.728 . . . . 0.0 112.197 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.1 p -76.67 -29.89 56.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.422 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' HA3' ' NH1' ' A' ' 73' ' ' ARG . . . 83.67 3.42 89.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.524 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -62.69 -34.53 77.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.886 0.874 . . . . 0.0 111.041 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.83 130.9 49.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.734 0.814 . . . . 0.0 110.25 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.456 HG21 HG21 ' A' ' 52' ' ' VAL . 30.5 p -115.44 129.24 56.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.571 1.148 . . . . 0.0 108.896 173.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -93.69 140.94 29.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.203 1.001 . . . . 0.0 108.887 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.39 151.67 50.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.157 0.583 . . . . 0.0 109.866 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.21 144.91 37.93 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 161.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.89 -28.75 64.48 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.855 0.462 . . . . 0.0 112.047 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.4 t -70.99 -44.35 66.14 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.753 0.421 . . . . 0.0 111.124 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -92.83 1.95 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.629 0.372 . . . . 0.0 111.58 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.74 108.82 1.06 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 111.734 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.88 -26.33 13.21 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.662 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 7.1 ptt180 -84.14 -33.47 24.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.294 0.547 . . . . 0.0 109.616 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.414 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 5.1 m-30 -97.41 158.74 15.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -145.47 130.69 18.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.206 1.002 . . . . 0.0 108.845 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.478 HD13 ' HB1' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -102.67 126.48 56.84 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 24.8 m -123.81 154.03 40.17 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.149 0.98 . . . . 0.0 108.654 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' NH1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -140.68 143.85 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -121.78 96.84 5.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.88 -25.38 65.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.514 0.726 . . . . 0.0 111.411 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.52 -52.59 30.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.516 0.727 . . . . 0.0 111.177 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.98 -4.66 59.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.279 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 60.8 30.95 20.0 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.813 1.245 . . . . 0.0 111.616 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -119.96 131.95 55.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.308 0.643 . . . . 0.0 110.827 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.549 HG23 ' SD ' ' A' ' 35' ' ' MET . 57.2 t -96.23 151.08 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 109.077 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 76.6 m-85 -132.62 146.16 51.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.872 0.869 . . . . 0.0 109.077 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -134.74 102.97 5.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.15 102.83 14.83 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.542 ' HB3' HD22 ' A' ' 87' ' ' LEU . 57.5 mtm -89.71 118.31 29.22 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.71 28.94 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.5 m 59.19 47.98 11.0 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.085 0.954 . . . . 0.0 110.827 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 84' ' ' MET . 78.3 mt -63.92 117.69 7.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.968 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 121' ' ' VAL . 48.4 mtpt -77.17 154.79 82.44 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.555 -0.735 . . . . 0.0 109.338 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.98 -25.38 21.94 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.25 2.633 . . . . 0.0 114.421 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.58 -18.72 60.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.867 0.867 . . . . 0.0 112.837 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.73 -8.35 47.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.77 0.828 . . . . 0.0 113.042 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.2 m -62.99 98.52 0.13 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . . . -169.1 159.73 9.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.338 0.655 . . . . 0.0 111.116 -170.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.2 p -83.6 113.51 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -88.45 112.91 23.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.916 0.886 . . . . 0.0 109.238 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -103.6 129.46 50.87 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.439 1.096 . . . . 0.0 110.366 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.17 101.91 13.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.882 0.873 . . . . 0.0 109.578 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.35 28.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.517 0.727 . . . . 0.0 109.446 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.98 136.44 44.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.3 0.64 . . . . 0.0 109.448 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.63 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . 132.13 -28.34 3.5 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.641 0.588 . . . . 0.0 113.023 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -74.66 93.49 2.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.203 0.525 . . . . 0.0 109.708 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.635 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . 22.1 t90 -98.91 2.41 46.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.56 139.34 34.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.654 0.782 . . . . 0.0 110.158 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.87 45.72 1.11 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.0 p -143.64 -68.47 0.33 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.349 0.66 . . . . 0.0 110.294 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.38 -57.91 8.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.802 0.841 . . . . 0.0 110.125 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -167.69 -72.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.881 0.872 . . . . 0.0 109.186 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.59 82.5 0.09 OUTLIER Glycine 0 C--N 1.351 1.367 0 O-C-N 123.544 0.528 . . . . 0.0 112.069 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.8 133.08 82.52 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.271 0.628 . . . . 0.0 111.548 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.31 116.37 3.85 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.171 1.914 . . . . 0.0 110.314 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.63 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 29.5 t70 -62.72 -46.21 89.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.702 1.201 . . . . 0.0 110.564 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -139.22 155.23 47.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 0.0 110.074 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -115.06 119.13 35.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.454 1.102 . . . . 0.0 108.416 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.85 151.22 38.86 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.51 -37.1 82.47 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.107 0.454 . . . . 0.0 110.8 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.74 171.79 24.14 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.177 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -127.65 135.18 49.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.971 0.385 . . . . 0.0 110.629 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 11.3 tm0? -80.35 107.79 13.44 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.21 146.38 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.8 m -123.15 114.11 19.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.343 0.657 . . . . 0.0 109.412 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 88' ' ' LYS . 3.7 p -98.56 120.98 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -72.47 111.97 8.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.187 0.995 . . . . 0.0 110.128 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.5 p -73.42 118.37 16.3 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.0 tp -69.76 78.31 0.45 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.117 0.967 . . . . 0.0 109.988 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -179.88 -38.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.012 1.325 . . . . 0.0 109.187 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -115.18 52.25 0.88 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.121 0.968 . . . . 0.0 109.688 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -78.1 79.71 4.54 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.49 116.46 28.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.282 1.033 . . . . 0.0 110.778 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.07 81.67 5.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.581 0.705 . . . . 0.0 109.944 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.77 147.45 50.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.213 1.005 . . . . 0.0 108.81 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 124.13 0.972 . . . . 0.0 109.501 -177.58 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.533 0.206 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -110.11 160.18 16.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.303 0.641 . . . . 0.0 110.458 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 61.2 tp -115.35 110.63 19.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -85.59 121.91 28.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.879 0.871 . . . . 0.0 109.35 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.578 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 74.7 mt -112.88 107.24 15.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.945 0.898 . . . . 0.0 108.733 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.24 104.42 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.9 156.74 18.73 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.019 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -159.5 172.35 18.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.296 1.038 . . . . 0.0 109.789 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.75 -4.91 69.22 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.285 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 119' ' ' VAL . . . -79.43 129.71 9.35 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 117.094 0.447 . . . . 0.0 112.202 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.97 -164.07 29.12 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.3 pp -79.48 147.67 32.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.433 HG23 HD13 ' A' ' 87' ' ' LEU . 3.9 p -151.64 151.85 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.483 1.113 . . . . 0.0 109.105 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.64 158.16 28.48 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.803 0.841 . . . . 0.0 110.653 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.12 111.16 4.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.543 0.737 . . . . 0.0 110.408 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.75 7.06 57.95 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.2 -163.74 36.34 Favored Glycine 0 C--N 1.352 1.451 0 C-N-CA 122.915 0.293 . . . . 0.0 113.058 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 p -137.13 151.57 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.697 0.799 . . . . 0.0 110.447 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -156.43 120.11 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.396 0.679 . . . . 0.0 109.437 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -92.07 119.59 31.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.419 0.687 . . . . 0.0 109.65 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.28 159.58 20.03 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.118 0.967 . . . . 0.0 109.076 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.9 t -142.41 163.01 34.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.382 0.673 . . . . 0.0 109.44 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.2 t -150.45 143.23 24.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.761 0.824 . . . . 0.0 109.865 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.11 53.72 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.87 122.56 46.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.699 0.8 . . . . 0.0 108.985 -175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.8 m -136.97 147.24 46.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.362 1.065 . . . . 0.0 109.739 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.5 -101.6 2.5 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -74.13 159.14 33.0 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.872 0.844 . . . . 0.0 112.787 -176.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.1 m -72.48 91.21 1.37 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.587 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.925 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 16.0 p -75.07 1.48 13.0 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.211 1.005 . . . . 0.0 112.493 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -98.98 -2.77 36.53 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.621 0.768 . . . . 0.0 110.179 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -131.23 174.38 10.1 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.681 0.792 . . . . 0.0 111.461 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 130.1 56.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.062 0.945 . . . . 0.0 108.459 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -114.64 154.41 28.44 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -156.95 154.25 25.37 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.677 -0.296 . . . . 0.0 113.632 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -97.35 143.08 28.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.791 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -138.2 138.52 38.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.722 1.209 . . . . 0.0 108.684 -175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -112.11 151.79 29.03 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.008 0.822 . . . . 0.0 111.323 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.08 152.05 4.16 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 110.433 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.45 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.155 0.982 . . . . 0.0 111.593 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.35 55.55 4.08 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 122.212 1.941 . . . . 0.0 112.968 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.26 40.95 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.973 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -115.61 162.43 17.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -98.49 166.7 11.23 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 0.0 108.821 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.98 102.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -101.55 153.75 19.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.488 0.715 . . . . 0.0 110.295 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.63 108.57 0.75 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.894 0.878 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.49 -64.31 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -157.81 133.15 8.88 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.435 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG21 ' HA3' ' A' ' 36' ' ' GLY . 79.6 t -126.46 123.85 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.262 1.025 . . . . 0.0 109.481 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.691 HG21 HH11 ' A' ' 73' ' ' ARG . 8.9 p -108.26 160.34 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.449 0.699 . . . . 0.0 109.439 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.97 162.78 13.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 168.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 29.1 p-90 -55.8 -43.84 77.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.293 1.037 . . . . 0.0 113.746 -174.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -83.8 -14.31 51.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.905 0.482 . . . . 0.0 110.913 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.54 10.22 82.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.179 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -67.29 -37.5 83.52 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.417 0.687 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -112.93 121.57 45.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.165 0.586 . . . . 0.0 109.888 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 52' ' ' VAL . 17.5 p -118.04 131.89 56.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.807 1.243 . . . . 0.0 108.133 172.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -124.55 136.35 53.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.274 1.03 . . . . 0.0 108.231 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 70.5 m-85 -141.3 136.94 32.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.376 0.67 . . . . 0.0 109.58 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.91 142.11 53.01 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.47 -29.12 58.16 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.031 0.932 . . . . 0.0 112.721 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -28.78 70.16 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 112.543 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.14 -1.29 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 111.493 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 28.3 ttpp -73.06 126.9 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.497 0.719 . . . . 0.0 110.726 -172.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.67 -25.05 28.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.759 0.662 . . . . 0.0 112.809 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -103.42 -23.79 13.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.092 0.557 . . . . 0.0 110.813 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.45 154.25 19.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.903 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -146.07 135.24 22.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 109.089 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -101.48 128.73 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.8 m -125.17 141.23 52.23 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.691 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.11 149.82 34.75 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.137 0.426 . . . . 0.0 109.961 -177.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -129.44 108.67 10.45 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.721 1.208 . . . . 0.0 108.503 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -68.74 -38.91 80.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 111.061 -173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.18 87.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.98 -13.19 56.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.933 0.493 . . . . 0.0 111.596 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 61.76 28.69 17.66 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.859 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.5 m -124.48 131.9 53.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.157 0.583 . . . . 0.0 110.677 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.68 160.1 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.531 1.132 . . . . 0.0 109.19 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -141.97 148.2 38.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.48 1.512 . . . . 0.0 108.86 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.86 100.83 5.03 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.54 102.29 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.783 0.833 . . . . 0.0 109.635 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.572 ' HB3' HD23 ' A' ' 87' ' ' LEU . 58.5 mtm -88.44 132.43 34.47 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -133.13 153.52 51.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t 58.42 59.77 2.86 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.868 0.842 . . . . 0.0 110.711 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 84' ' ' MET . 76.6 mt -79.83 116.68 20.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.94 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 79.7 mttt -75.37 152.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.89 -25.73 22.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.0 2.467 . . . . 0.0 114.069 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 10.8 pt-20 -70.12 -23.25 63.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.042 0.937 . . . . 0.0 112.95 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.71 -3.69 19.87 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.392 0.677 . . . . 0.0 112.809 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.518 HG21 ' HA ' ' A' ' 120' ' ' THR . 49.3 m -60.99 100.08 0.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.21 0.604 . . . . 0.0 109.719 170.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 161.04 5.55 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.677 0.791 . . . . 0.0 110.269 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.1 p -83.01 117.98 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.46 112.15 23.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -107.99 121.28 44.47 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.127 1.371 . . . . 0.0 109.365 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.7 p -88.52 143.0 27.24 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -142.7 132.94 24.66 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.354 1.062 . . . . 0.0 109.546 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.14 145.83 35.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.847 0.859 . . . . 0.0 110.964 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.34 42.06 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.686 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -89.42 95.95 10.5 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.407 0.622 . . . . 0.0 109.681 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -79.12 78.77 5.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -168.56 115.88 0.67 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.484 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.09 32.96 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.3 p -137.76 -72.72 0.42 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.553 0.741 . . . . 0.0 109.514 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -72.63 -28.84 62.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.569 0.699 . . . . 0.0 109.661 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -87.72 145.54 26.09 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.176 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.4 -161.14 16.1 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-O 119.465 -0.63 . . . . 0.0 111.693 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 69.46 146.2 0.11 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 125.347 1.459 . . . . 0.0 111.534 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.27 138.2 38.79 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 121.85 1.7 . . . . 0.0 110.529 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.42 -32.27 73.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.389 0.676 . . . . 0.0 110.521 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -140.61 155.33 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.832 1.253 . . . . 0.0 108.783 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 28.6 p90 -143.96 161.87 37.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.802 0.841 . . . . 0.0 109.667 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.412 ' CA ' ' HB2' ' A' ' 5' ' ' LEU . . . -96.78 -150.08 26.38 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.386 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -90.88 -53.65 4.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.575 0.75 . . . . 0.0 110.21 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.76 120.31 4.49 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.77 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 t -105.86 121.53 44.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.883 0.873 . . . . 0.0 109.61 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 tm0? -87.39 125.28 34.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.928 0.491 . . . . 0.0 110.41 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.42 HG13 ' HA2' ' A' ' 10' ' ' GLY . 5.9 m -111.56 145.4 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.653 0.781 . . . . 0.0 110.025 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.518 ' HA ' HG21 ' A' ' 92' ' ' THR . 91.8 m -133.38 119.65 19.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.048 0.939 . . . . 0.0 108.908 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.3 p -104.89 116.4 48.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.0 m -63.91 113.86 3.72 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.57 1.148 . . . . 0.0 110.004 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.4 p -73.71 88.2 1.73 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 110.981 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 tp -79.1 77.67 5.57 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.36 4.76 9.68 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.863 -171.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -126.54 146.89 49.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -72.91 -66.97 0.6 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.716 0.806 . . . . 0.0 111.635 -171.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -113.22 27.66 9.42 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.555 0.693 . . . . 0.0 110.92 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -82.03 108.8 15.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.67 -0.643 . . . . 0.0 110.109 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -62.92 122.34 15.75 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.625 0.77 . . . . 0.0 109.965 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.87 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' HG3' ' CE1' ' A' ' 112' ' ' TYR . 54.5 tt0 68.48 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.481 1.512 . . . . 0.0 112.066 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.686 HD13 ' HB1' ' A' ' 25' ' ' ALA . 40.3 tp -84.96 128.49 34.65 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 122.737 0.415 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -105.14 131.2 52.94 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.525 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 84.6 mt -121.9 118.75 29.67 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.759 1.224 . . . . 0.0 108.455 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.43 103.0 14.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.611 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.67 127.74 46.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -155.09 141.27 18.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.341 1.057 . . . . 0.0 110.19 -169.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 117' ' ' THR . . . 145.26 26.03 0.1 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -86.71 132.2 11.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.13 41.76 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.9 144.4 31.96 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.208 0.528 . . . . 0.0 110.56 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.48 153.64 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.531 . . . . 0.0 107.936 -174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.4 ' HG3' HD21 ' A' ' 124' ' ' LEU . 1.7 mp0 -87.3 157.17 19.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.189 0.596 . . . . 0.0 110.953 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.75 111.79 5.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.463 0.705 . . . . 0.0 110.065 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.99 3.53 48.63 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.889 0.743 . . . . 0.0 111.504 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.76 -163.85 39.22 Favored Glycine 0 C--N 1.35 1.317 0 C-N-CA 122.792 0.234 . . . . 0.0 112.722 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.2 p -138.05 149.01 45.64 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.042 0.937 . . . . 0.0 109.921 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 tp -158.6 145.6 17.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -119.37 131.85 55.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.677 0.391 . . . . 0.0 110.881 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -92.29 159.62 15.52 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.074 0.95 . . . . 0.0 108.899 170.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -149.23 123.81 9.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.65 0.38 . . . . 0.0 110.081 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.611 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 51.7 t -127.38 106.55 9.28 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.145 0.578 . . . . 0.0 110.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.51 141.57 29.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.686 ' HB1' HD13 ' A' ' 3' ' ' LEU . . . -105.4 164.08 12.14 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.291 0.637 . . . . 0.0 109.861 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -66.65 166.92 11.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.384 0.674 . . . . 0.0 111.133 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.41 -13.48 50.28 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.63 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 136.62 57.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.575 1.15 . . . . 0.0 109.427 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 m -77.74 71.41 4.21 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 122.089 0.947 . . . . 0.0 111.966 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -79.84 -8.72 59.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.561 1.144 . . . . 0.0 110.574 164.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 t -57.04 -1.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 125.368 1.467 . . . . 0.0 113.812 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -91.04 -11.5 38.59 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.766 0.826 . . . . 0.0 112.088 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -107.64 167.06 10.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.366 0.666 . . . . 0.0 111.377 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.42 161.61 28.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 168.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.422 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 4.4 ptm -143.0 169.84 16.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.355 0.662 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.4 146.74 11.46 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 121.787 -0.244 . . . . 0.0 113.689 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -97.64 141.1 31.08 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.238 1.415 . . . . 0.0 109.858 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -132.07 164.4 26.32 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.793 1.237 . . . . 0.0 108.884 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.1 156.25 47.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.033 0.379 . . . . 0.0 110.386 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.462 ' O ' HG11 ' A' ' 94' ' ' VAL . 4.5 pt20 -166.38 136.01 3.17 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.976 0.797 . . . . 0.0 110.117 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.31 -62.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 124.469 1.107 . . . . 0.0 111.131 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.6 66.3 6.59 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.041 -168.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.29 62.57 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.96 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -98.91 133.64 42.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.761 0.824 . . . . 0.0 110.152 -173.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.15 174.13 8.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.952 0.901 . . . . 0.0 108.704 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -64.0 104.74 0.75 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.98 152.59 47.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 0.0 111.026 -169.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -58.12 110.61 0.97 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.433 1.493 . . . . 0.0 111.792 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.27 -55.86 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB3' HD13 ' A' ' 71' ' ' ILE . . . -169.07 132.47 1.34 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.745 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.8 141.21 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.571 1.148 . . . . 0.0 108.297 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.31 148.31 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.04 155.86 28.64 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -53.15 -39.07 63.27 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.098 1.359 . . . . 0.0 114.046 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.9 t -75.35 -27.13 59.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.268 0.627 . . . . 0.0 111.32 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.73 72.35 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.2 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -69.12 -55.14 11.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -106.1 124.52 49.71 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.751 . . . . 0.0 110.56 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 p -112.22 149.45 32.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.584 1.153 . . . . 0.0 109.657 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -129.39 123.63 32.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -119.68 159.02 25.26 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -74.87 144.58 43.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 165.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.49 -34.25 64.42 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.042 0.937 . . . . 0.0 112.932 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -65.64 -35.66 81.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.385 0.674 . . . . 0.0 111.575 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 62' ' ' ALA . 17.3 m -111.33 6.16 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 0.0 112.339 -172.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -68.67 111.55 4.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.941 0.496 . . . . 0.0 111.741 -171.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.87 15.01 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.868 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -83.17 -26.42 30.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.459 0.629 . . . . 0.0 109.565 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.16 153.4 18.94 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.6 m -146.98 136.76 23.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.034 0.934 . . . . 0.0 108.902 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -102.85 121.32 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -124.84 138.93 54.24 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HB3' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -143.18 131.43 22.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.975 0.51 . . . . 0.0 110.068 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.0 95.36 6.12 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.48 -38.22 83.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 111.929 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.04 76.2 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.125 0.57 . . . . 0.0 111.446 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.45 -9.27 50.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.474 0.71 . . . . 0.0 112.042 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 18.4 m-80 58.64 27.33 15.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.683 1.193 . . . . 0.0 111.352 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.5 m -112.81 131.96 55.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.552 0.741 . . . . 0.0 109.283 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 ' HE3' ' A' ' 35' ' ' MET . 5.6 t -117.77 157.22 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.661 -174.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.59 127.85 19.81 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.824 1.25 . . . . 0.0 108.491 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.2 tm? -104.76 100.16 9.8 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.42 103.43 10.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 109.87 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.543 ' HB3' HD23 ' A' ' 87' ' ' LEU . 68.3 mtm -94.31 126.84 39.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.991 0.517 . . . . 0.0 109.775 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.35 148.01 51.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 m 57.55 58.8 3.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.394 1.078 . . . . 0.0 111.08 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 84' ' ' MET . 49.0 mt -73.61 117.5 15.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.502 -1.227 . . . . 0.0 112.221 -174.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -76.88 148.26 78.75 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.48 -24.06 20.9 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.0 2.466 . . . . 0.0 114.521 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -15.61 61.93 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.971 0.908 . . . . 0.0 113.255 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.38 -4.48 48.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.118 0.567 . . . . 0.0 112.261 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 120' ' ' THR . 85.2 m -61.58 103.98 0.38 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.773 0.829 . . . . 0.0 110.442 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.53 163.68 12.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.014 0.525 . . . . 0.0 110.993 -175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 8.3 p -81.07 121.61 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 168.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -86.01 143.49 28.1 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -135.48 112.3 10.17 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.438 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 41.6 t -83.13 140.6 32.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -143.61 162.84 34.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 109.366 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.61 26.22 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.191 0.596 . . . . 0.0 110.745 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.09 164.21 27.26 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.579 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -93.55 110.57 22.15 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 67.28 88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.797 1.239 . . . . 0.0 109.902 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -150.54 -179.45 7.24 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.866 0.866 . . . . 0.0 111.05 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.53 19.58 61.74 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.18 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.3 t -95.42 61.07 2.31 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.808 0.843 . . . . 0.0 109.806 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 63.7 -78.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.702 1.601 . . . . 0.0 111.859 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -88.4 -15.5 35.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.77 0.828 . . . . 0.0 109.918 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.04 82.75 0.23 Allowed Glycine 0 C--N 1.359 1.84 0 O-C-N 123.679 0.612 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.39 81.23 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.076 0.95 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.59 154.8 45.96 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.345 2.696 . . . . 0.0 113.887 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -53.47 -46.79 70.08 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.319 1.012 . . . . 0.0 112.153 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 2' ' ' GLN . 65.2 m-85 -138.77 132.29 30.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.807 0.443 . . . . 0.0 110.513 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.498 ' HB2' ' ND2' ' A' ' 96' ' ' ASN . 4.4 p90 -122.87 161.48 24.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.91 0.884 . . . . 0.0 110.405 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -174.66 47.31 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 114.035 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -66.43 -44.68 82.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.215 1.006 . . . . 0.0 110.526 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 163.33 38.9 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.485 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 9' ' ' GLY . 7.5 t -143.82 138.93 29.03 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.848 0.459 . . . . 0.0 110.109 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.6 tm0? -91.15 121.65 33.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.05 0.54 . . . . 0.0 109.901 -173.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.461 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -107.21 144.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.103 0.961 . . . . 0.0 109.501 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.535 ' HA ' HG22 ' A' ' 92' ' ' THR . 60.1 m -124.06 105.5 9.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.174 0.589 . . . . 0.0 109.891 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.0 101.32 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.266 1.031 . . . . 0.0 109.01 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.6 t -66.46 134.15 51.88 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 m -70.77 86.75 0.68 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.121 0.968 . . . . 0.0 111.36 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 14' ' ' GLN . 10.9 mp -119.04 62.06 0.8 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.294 1.037 . . . . 0.0 110.106 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 132.91 37.76 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -138.69 80.41 1.79 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -152.94 -51.5 0.1 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.465 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 55.31 46.34 23.74 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.871 1.268 . . . . 0.0 112.255 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.12 122.2 9.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -94.35 143.21 26.59 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 CA--C 1.553 1.074 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.449 176.56 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -140.79 132.41 27.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.869 0.868 . . . . 0.0 108.855 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.16 111.34 22.85 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -86.4 125.23 33.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -119.4 120.85 38.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.25 102.8 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.834 0.853 . . . . 0.0 109.316 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.67 138.03 33.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 110.348 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.4 m -149.8 165.79 31.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.892 0.877 . . . . 0.0 110.16 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.77 -1.19 32.03 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 112.867 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 145.64 32.03 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.06 -166.61 33.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.06 144.84 29.64 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.994 0.426 . . . . 0.0 111.227 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.23 161.27 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.662 1.185 . . . . 0.0 108.081 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.8 164.14 13.8 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.75 0.704 . . . . 0.0 110.494 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . . . -71.48 143.17 50.11 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.471 0.708 . . . . 0.0 110.629 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 3.29 85.7 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -164.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.46 -169.6 46.15 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 114.174 0.43 . . . . 0.0 114.174 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 p -153.28 147.25 25.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.107 0.963 . . . . 0.0 110.03 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 tp -160.79 128.92 4.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.103 0.561 . . . . 0.0 109.803 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -93.77 117.3 29.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.276 0.63 . . . . 0.0 110.138 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.4 mm? -86.02 159.26 19.64 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.328 1.051 . . . . 0.0 109.245 168.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -136.57 165.7 25.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.555 0.742 . . . . 0.0 109.316 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.8 t -146.56 145.73 30.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.056 0.942 . . . . 0.0 109.255 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.66 114.72 20.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 78' ' ' ASN . . . -105.44 154.55 20.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.049 0.54 . . . . 0.0 110.615 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 m -62.82 159.69 16.03 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.2 53.24 4.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.52 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -95.62 -167.59 1.63 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.043 1.337 . . . . 0.0 110.414 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 32' ' ' SER . 2.2 m -74.23 22.11 0.09 Allowed 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.4 0.68 . . . . 0.0 111.921 173.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.43 -29.83 69.24 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.306 1.043 . . . . 0.0 111.14 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 m -56.2 -26.29 50.32 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.881 0.872 . . . . 0.0 111.755 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 29' ' ' THR . 23.3 t -113.1 -2.74 14.09 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.04 0.936 . . . . 0.0 112.018 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -83.46 127.19 33.51 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.741 0.7 . . . . 0.0 110.432 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.77 115.98 10.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.407 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 4.7 ptm -114.21 170.4 8.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 111.102 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.95 163.32 33.17 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -111.39 138.51 47.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.7 154.0 38.67 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.807 1.243 . . . . 0.0 108.349 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -126.03 158.75 34.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -174.39 160.07 3.16 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.274 0.984 . . . . 0.0 109.887 174.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 171.96 -58.08 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 124.472 1.109 . . . . 0.0 111.052 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.52 63.57 6.62 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 122.368 2.046 . . . . 0.0 112.821 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.61 -5.74 60.12 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.912 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 31.7 mmmt -92.95 148.04 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 109.58 -177.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.77 176.15 5.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.301 0.64 . . . . 0.0 110.359 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -61.13 106.64 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.155 0.582 . . . . 0.0 111.82 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.53 152.51 24.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.917 1.287 . . . . 0.0 110.138 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -57.19 113.98 1.96 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.7 0.8 . . . . 0.0 110.662 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.491 HG12 HG13 ' A' ' 65' ' ' VAL . 71.8 t -98.36 -60.81 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.55 155.43 21.98 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.333 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.71 138.3 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.734 1.214 . . . . 0.0 107.957 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG23 HG21 ' A' ' 59' ' ' THR . 11.1 p -121.3 146.98 25.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.82 142.13 48.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -52.16 -41.4 62.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.291 1.036 . . . . 0.0 112.846 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -81.81 -9.27 59.66 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.46 0.704 . . . . 0.0 111.468 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.35 73.16 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 123.192 0.307 . . . . 0.0 112.561 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 31.2 tpt180 -67.38 -65.31 0.7 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.359 0.664 . . . . 0.0 110.679 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.475 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 36.6 mmt180 -113.76 127.41 56.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.279 0.631 . . . . 0.0 110.461 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 52' ' ' VAL . 54.5 p -108.58 150.84 26.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.848 0.859 . . . . 0.0 108.746 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -133.71 130.22 37.85 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.403 ' OH ' ' HA ' ' A' ' 70' ' ' THR . 98.3 m-85 -139.19 142.51 37.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.99 0.516 . . . . 0.0 109.982 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.92 142.38 47.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 162.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.51 -24.23 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.558 0.743 . . . . 0.0 111.91 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -61.0 -40.61 94.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.797 1.239 . . . . 0.0 112.199 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.491 HG13 HG12 ' A' ' 49' ' ' VAL . 32.5 m -115.56 1.96 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.809 0.844 . . . . 0.0 111.67 -173.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.21 125.42 25.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.709 0.804 . . . . 0.0 111.676 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.66 -26.16 6.76 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.587 0.554 . . . . 0.0 114.462 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -93.92 -29.58 15.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.203 0.601 . . . . 0.0 110.138 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.33 146.59 25.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.403 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 91.1 m -149.95 130.36 13.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.26 1.024 . . . . 0.0 108.648 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.456 HG13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -102.05 133.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -124.98 152.06 44.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.888 1.275 . . . . 0.0 107.947 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 138.26 16.2 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.546 0.612 . . . . 0.0 111.711 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -93.48 108.43 20.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.3 -37.85 88.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 110.919 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.61 82.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.92 0.763 . . . . 0.0 111.743 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.1 mmpt? -94.68 -16.35 23.19 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.764 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 41.2 m-80 60.81 34.98 19.59 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.544 1.137 . . . . 0.0 110.804 -172.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 m -112.48 131.27 55.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.392 0.677 . . . . 0.0 109.845 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 t -113.22 161.32 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.07 0.948 . . . . 0.0 109.914 -175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -143.5 116.08 8.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.147 0.979 . . . . 0.0 108.874 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 71' ' ' ILE . 2.6 tm? -101.21 96.69 7.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -82.8 129.77 35.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.968 0.907 . . . . 0.0 109.44 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.591 ' HB3' HD23 ' A' ' 87' ' ' LEU . 63.1 mtm -117.26 148.37 41.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.547 0.739 . . . . 0.0 109.992 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -146.25 160.16 42.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.351 1.06 . . . . 0.0 109.189 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m 54.56 48.02 21.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.564 1.145 . . . . 0.0 111.118 171.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.591 HD23 ' HB3' ' A' ' 84' ' ' MET . 97.0 mt -73.28 115.7 12.95 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.195 -171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -65.64 151.81 93.93 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.37 1.068 . . . . 0.0 109.056 166.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 20.0 Cg_endo -57.62 -22.79 53.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.268 2.645 . . . . 0.0 113.355 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 11.6 pt-20 -87.25 7.04 30.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.442 1.097 . . . . 0.0 112.285 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -87.5 2.04 51.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.665 0.386 . . . . 0.0 111.526 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 120' ' ' THR . 92.9 m -62.16 102.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 0.0 109.967 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.19 152.11 4.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.087 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.4 p -81.65 129.57 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.584 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.43 122.29 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.47 0.708 . . . . 0.0 109.854 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -103.76 132.47 49.99 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.773 0.829 . . . . 0.0 109.696 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.4 t -82.91 141.12 32.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' MET . . . -143.49 161.64 37.91 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.257 0.623 . . . . 0.0 109.716 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -141.72 146.42 36.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 0.0 108.991 176.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.78 153.78 24.99 Favored Glycine 0 C--N 1.338 0.687 0 O-C-N 123.18 0.3 . . . . 0.0 112.77 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -91.38 107.29 19.1 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -88.46 51.12 2.1 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.85 -31.0 40.47 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.85 155.75 15.93 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.066 173.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 p -84.49 88.13 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.716 0.806 . . . . 0.0 110.605 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -92.39 103.02 15.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -83.57 1.32 42.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -174.61 161.03 30.62 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 64.53 92.59 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.924 1.29 . . . . 0.0 111.457 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.38 179.77 5.21 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.922 2.415 . . . . 0.0 112.277 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.18 -42.9 59.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.52 0.728 . . . . 0.0 110.239 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -130.99 149.0 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.356 1.062 . . . . 0.0 109.22 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -148.35 158.38 44.06 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.33 1.052 . . . . 0.0 108.492 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.89 -170.22 28.65 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.246 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.42 -39.29 20.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.245 1.018 . . . . 0.0 110.135 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.15 165.58 14.79 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.46 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 t -143.48 108.14 4.87 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 124.521 1.128 . . . . 0.0 109.455 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 58.6 tp60 -77.55 129.58 35.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.561 0.745 . . . . 0.0 111.258 -175.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.37 144.94 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 92' ' ' THR . 60.9 m -127.75 105.97 8.81 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.52 106.64 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.733 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.3 t -61.55 132.21 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.005 1.322 . . . . 0.0 110.717 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 30.8 p -70.76 135.86 48.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.918 0.887 . . . . 0.0 112.495 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 22.7 tp -66.77 -18.23 65.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.948 0.899 . . . . 0.0 109.75 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.28 -44.5 84.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.081 0.952 . . . . 0.0 110.739 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -111.96 99.82 8.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 -172.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -88.49 -22.04 23.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.277 0.631 . . . . 0.0 111.192 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -75.92 94.01 3.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -123.47 96.33 4.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 109.626 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -83.11 137.51 34.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.758 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.254 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 67.6 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.137 1.375 . . . . 0.0 112.055 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.706 HD13 ' HB1' ' A' ' 25' ' ' ALA . 57.6 tp -108.85 112.57 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -82.44 103.86 12.3 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.31 128.68 44.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.7 t -119.94 102.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.767 0.827 . . . . 0.0 108.931 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -90.92 149.66 21.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.264 0.625 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -154.39 170.07 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.118 0.967 . . . . 0.0 109.921 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.67 43.56 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.094 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.66 88.73 0.54 Allowed Glycine 0 C--N 1.345 1.078 0 C-N-CA 122.916 0.293 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.59 -172.76 13.26 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.184 0.421 . . . . 0.0 112.289 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.98 138.91 31.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.386 0.675 . . . . 0.0 110.684 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 6.4 p -152.2 153.17 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.675 1.19 . . . . 0.0 108.364 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -92.68 160.03 15.17 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.582 -0.699 . . . . 0.0 110.729 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.51 123.81 21.45 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.99 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.49 54.13 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.659 0.599 . . . . 0.0 112.124 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.16 50.33 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.817 0.363 . . . . 0.0 113.182 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.0 p -114.87 162.23 17.19 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.108 0.963 . . . . 0.0 110.398 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -160.55 125.57 3.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 109.927 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -95.2 125.32 39.76 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.09 159.19 16.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.049 1.34 . . . . 0.0 108.644 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -139.69 160.32 40.16 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.771 0.428 . . . . 0.0 110.157 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 52.9 t -150.77 133.04 15.43 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.394 1.078 . . . . 0.0 108.62 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.2 131.71 56.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.706 ' HB1' HD13 ' A' ' 3' ' ' LEU . . . -106.8 137.79 44.18 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.185 0.594 . . . . 0.0 110.681 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -144.44 169.16 18.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.26 -83.9 1.56 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -82.32 154.93 25.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.414 0.686 . . . . 0.0 109.796 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -77.5 96.58 4.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.538 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 54.0 t80 -63.75 -20.94 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.103 0.961 . . . . 0.0 111.311 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -64.53 -7.26 9.57 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.623 0.769 . . . . 0.0 112.779 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -109.44 4.84 22.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.525 0.73 . . . . 0.0 111.305 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.79 140.58 44.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 0.0 111.004 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.24 164.53 21.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.764 0.826 . . . . 0.0 109.693 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.538 ' HB2' ' HE1' ' A' ' 30' ' ' PHE . 1.1 ttp -137.47 155.07 49.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.105 0.562 . . . . 0.0 110.21 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -146.16 147.21 18.02 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.75 129.83 42.85 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -128.1 141.71 51.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.265 1.026 . . . . 0.0 108.234 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -106.58 143.01 35.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.02 146.86 4.6 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.709 0.631 . . . . 0.0 110.255 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.37 -60.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 124.419 1.088 . . . . 0.0 110.789 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 92.5 Cg_endo -87.47 72.67 2.92 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -171.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.95 2.29 61.3 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.282 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.9 139.46 34.52 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.524 0.73 . . . . 0.0 109.526 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.06 175.66 6.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 109.458 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -60.91 105.71 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.736 0.303 . . . . 0.0 110.405 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.5 148.02 30.84 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.349 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.73 110.89 1.88 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.769 0.828 . . . . 0.0 111.323 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.57 -65.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -162.42 135.55 5.98 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.09 0.244 . . . . 0.0 111.402 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG22 ' HA3' ' A' ' 36' ' ' GLY . 82.3 t -121.46 150.37 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.697 1.199 . . . . 0.0 109.17 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 71' ' ' ILE . 8.2 p -144.16 163.91 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.51 1.124 . . . . 0.0 108.755 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -85.22 164.99 17.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 170.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.7 p90 -52.6 -43.25 65.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.088 1.355 . . . . 0.0 113.539 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.4 m -95.52 -6.11 41.26 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.42 0.688 . . . . 0.0 111.557 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 52' ' ' VAL . . . 86.14 20.5 55.05 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.404 -0.279 . . . . 0.0 112.404 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -57.75 -40.66 80.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.451 1.1 . . . . 0.0 111.749 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -132.52 138.18 47.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.888 0.875 . . . . 0.0 109.09 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 p -117.22 142.06 47.51 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.241 1.016 . . . . 0.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -136.24 125.89 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -137.74 142.72 40.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.6 131.59 46.74 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 163.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.62 -26.76 62.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 p -67.2 -42.27 84.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.834 0.854 . . . . 0.0 111.408 176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.92 -7.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.97 0.508 . . . . 0.0 111.064 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -76.18 115.87 16.32 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.69 -15.72 41.06 Favored Glycine 0 C--N 1.341 0.849 0 O-C-N 123.72 0.638 . . . . 0.0 112.59 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 18.3 ptp180 -116.41 -22.9 8.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.141 0.576 . . . . 0.0 109.993 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.418 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -112.12 143.95 42.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.18 0.992 . . . . 0.0 108.609 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -143.91 130.76 20.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.876 0.87 . . . . 0.0 108.881 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 52' ' ' VAL . 3.7 mt -101.8 126.08 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -137.47 136.8 38.07 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -151.19 153.52 35.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.348 0.594 . . . . 0.0 112.142 -169.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.45 111.25 23.74 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -70.72 -30.22 66.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 112.091 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.59 -31.9 62.2 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.053 0.541 . . . . 0.0 111.813 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -96.55 -6.16 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.655 . . . . 0.0 111.198 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 61.54 31.09 18.94 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.139 0.976 . . . . 0.0 110.514 176.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 m -112.35 132.4 55.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 109.854 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 33.7 t -114.37 154.21 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.384 1.073 . . . . 0.0 110.223 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.81 145.45 48.37 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 125.189 1.396 . . . . 0.0 108.05 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.49 107.58 10.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -82.25 101.67 10.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.949 . . . . 0.0 109.581 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.76 145.18 25.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.25 0.62 . . . . 0.0 109.904 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -145.63 152.84 40.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 m 58.92 46.11 14.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.771 0.828 . . . . 0.0 112.121 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.49 126.56 29.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.593 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 155.87 75.07 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.28 -21.52 60.71 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.418 2.079 . . . . 0.0 113.547 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -77.19 -18.4 57.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.354 0.662 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.554 ' HB2' HG11 ' A' ' 121' ' ' VAL . 2.7 m-20 -67.07 -10.07 46.0 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.302 0.641 . . . . 0.0 111.396 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -56.21 100.98 0.05 OUTLIER 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.048 0.939 . . . . 0.0 109.81 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.06 162.74 4.62 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.22 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -85.81 118.33 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -86.9 115.72 24.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.724 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.82 131.69 48.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.46 ' SG ' ' HG3' ' A' ' 35' ' ' MET . 38.5 t -83.94 106.87 15.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.18 112.29 25.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.87 168.98 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.788 0.835 . . . . 0.0 110.336 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.45 172.07 12.42 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -80.25 91.75 5.65 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -78.68 94.88 5.15 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.92 98.19 2.42 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.18 0.592 . . . . 0.0 109.846 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.3 178.88 15.93 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 81.9 p -79.16 4.09 15.82 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.484 1.114 . . . . 0.0 113.091 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.41 -57.42 3.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.257 0.623 . . . . 0.0 110.662 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 55.19 24.72 6.53 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.585 1.154 . . . . 0.0 113.112 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.37 162.74 28.69 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 119.446 -0.641 . . . . 0.0 111.533 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.94 80.84 0.27 Allowed Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.952 0.901 . . . . 0.0 110.994 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.97 146.79 78.71 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.835 2.357 . . . . 0.0 111.525 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -62.87 -38.46 90.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.8 0.44 . . . . 0.0 110.027 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.87 153.52 51.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.076 0.95 . . . . 0.0 109.16 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -153.19 152.14 30.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.11 -159.33 34.06 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 123.233 0.333 . . . . 0.0 113.853 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.01 -26.38 22.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.108 0.963 . . . . 0.0 111.068 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.43 157.92 32.39 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.789 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.3 t -131.04 108.08 9.52 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.401 1.08 . . . . 0.0 108.439 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 10.1 tm0? -81.17 106.16 12.94 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -92.9 142.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.1 m -123.57 111.29 16.09 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.4 p -113.51 106.91 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.679 0.752 . . . . 0.0 109.935 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -78.92 145.63 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.594 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.5 p -63.59 151.4 41.69 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.002 0.521 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.83 86.56 0.09 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 59.78 -173.6 0.11 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.245 1.418 . . . . 0.0 111.372 -169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -90.59 59.67 4.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -109.1 0.17 19.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.686 1.194 . . . . 0.0 111.352 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -138.35 141.42 39.71 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.672 0.789 . . . . 0.0 109.334 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -155.58 45.49 0.47 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.933 0.493 . . . . 0.0 111.213 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 70.47 147.22 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.529 1.132 . . . . 0.0 111.176 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 122.943 0.497 . . . . 0.0 110.774 179.479 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -104.73 163.76 12.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.373 0.669 . . . . 0.0 109.627 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.762 HD11 ' HB1' ' A' ' 25' ' ' ALA . 45.8 tp -90.88 111.6 23.09 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 54.1 tp60 -84.86 104.63 14.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.839 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 23' ' ' CYS . 95.9 mt -95.15 108.76 20.88 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.599 0.759 . . . . 0.0 109.175 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.2 t -97.44 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -112.8 111.85 22.92 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -169.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.434 ' HA ' ' HB ' ' A' ' 117' ' ' THR . 68.3 m -156.19 154.46 30.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.852 1.261 . . . . 0.0 109.256 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.02 -8.23 1.08 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.53 -0.305 . . . . 0.0 112.504 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.23 27.74 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.943 0.306 . . . . 0.0 112.584 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.16 -164.46 29.85 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.08 136.89 37.3 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.257 0.551 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p -151.8 145.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.225 1.41 . . . . 0.0 107.949 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.77 158.94 25.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.089 0.404 . . . . 0.0 110.592 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.53 125.92 27.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.231 0.612 . . . . 0.0 110.183 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 2.12 65.02 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.764 0.665 . . . . 0.0 112.151 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.31 -174.93 35.91 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.935 0.186 . . . . 0.0 113.32 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 p -123.75 147.41 47.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.382 1.073 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 tp -152.51 132.08 13.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.836 0.855 . . . . 0.0 108.762 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.85 127.45 55.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.354 0.662 . . . . 0.0 110.501 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD12 HG11 ' A' ' 119' ' ' VAL . 1.0 OUTLIER -93.03 156.51 16.84 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.788 0.835 . . . . 0.0 108.79 171.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -141.68 125.69 17.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' HD21 ' A' ' 5' ' ' LEU . 47.9 t -117.17 104.41 11.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.321 0.649 . . . . 0.0 109.814 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.99 121.46 27.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.762 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.5 124.04 48.89 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.882 0.873 . . . . 0.0 109.502 -171.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.523 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 25.5 t -131.19 163.79 26.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.714 0.805 . . . . 0.0 111.012 -171.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 -102.98 1.64 Allowed Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.752 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.42 108.64 18.57 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -56.3 133.17 52.5 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -167.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 6.1 p90 -69.62 -19.52 63.63 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.064 0.945 . . . . 0.0 112.113 -176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 91.0 p -72.35 -5.54 37.0 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -88.13 -1.87 58.27 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.198 0.599 . . . . 0.0 110.436 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -136.79 173.86 11.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.84 0.856 . . . . 0.0 110.872 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.62 162.74 13.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 165.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.605 ' SD ' HG22 ' A' ' 80' ' ' VAL . 11.6 ptm -142.24 157.78 44.46 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 122.15 -0.344 . . . . 0.0 110.44 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -154.31 146.67 15.02 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.683 -0.235 . . . . 0.0 113.227 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -98.98 139.2 34.99 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.073 1.349 . . . . 0.0 109.951 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -129.15 170.22 13.81 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.13 1.372 . . . . 0.0 108.661 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -155.14 158.32 38.8 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.084 0.402 . . . . 0.0 111.833 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.12 153.9 12.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.002 0.921 . . . . 0.0 109.997 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.39 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 124.359 1.064 . . . . 0.0 111.286 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.42 67.35 8.48 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.021 1.814 . . . . 0.0 112.501 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.76 24.8 71.51 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.857 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -115.32 161.13 18.93 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.244 0.617 . . . . 0.0 112.123 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.33 175.35 7.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.637 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -66.1 103.57 0.99 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.72 153.5 17.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.923 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.52 110.64 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.792 0.837 . . . . 0.0 110.097 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.5 t -85.78 -59.41 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -171.47 147.42 2.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.031 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG22 ' HA3' ' A' ' 36' ' ' GLY . 77.3 t -129.22 137.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.177 0.991 . . . . 0.0 108.535 174.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 59' ' ' THR . 7.0 p -124.61 160.65 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.833 0.853 . . . . 0.0 109.571 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.0 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 64.8 p-90 -57.13 -37.25 71.72 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.534 0.733 . . . . 0.0 112.741 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -76.72 -28.96 56.03 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.163 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.93 -8.22 70.34 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.278 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -59.51 -28.47 67.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.742 0.817 . . . . 0.0 112.432 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -108.61 122.55 47.34 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.547 0.739 . . . . 0.0 109.521 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 52' ' ' VAL . 38.6 p -127.15 133.64 50.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.498 1.119 . . . . 0.0 108.886 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -128.58 127.19 41.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -129.52 148.09 51.39 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.366 0.666 . . . . 0.0 110.698 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.69 137.51 42.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.69 -30.48 67.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.68 0.792 . . . . 0.0 112.992 -171.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.7 m -69.6 -41.58 75.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.214 0.606 . . . . 0.0 111.676 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.16 -9.44 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.338 0.655 . . . . 0.0 111.539 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -66.96 144.91 55.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.418 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.71 -24.9 7.96 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.447 0.467 . . . . 0.0 113.701 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 10.7 ptt180 -113.37 -20.72 11.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.223 0.609 . . . . 0.0 111.065 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m-30 -101.09 155.82 17.77 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.231 0.613 . . . . 0.0 110.24 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -149.07 136.6 20.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.112 . . . . 0.0 108.527 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 50' ' ' ALA . 2.1 mp -101.05 121.6 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.6 m -124.3 136.84 54.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.424 HH11 HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.71 131.73 21.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.574 0.702 . . . . 0.0 110.355 -174.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.5 109.15 20.69 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -68.5 -27.65 66.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.856 0.462 . . . . 0.0 110.077 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.59 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.834 0.853 . . . . 0.0 111.637 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -80.42 -16.03 55.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.355 . . . . 0.0 111.078 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.427 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 29.4 m-80 61.87 28.2 17.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.628 1.171 . . . . 0.0 110.872 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -120.83 135.11 55.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.959 0.503 . . . . 0.0 110.622 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.605 HG22 ' SD ' ' A' ' 35' ' ' MET . 19.4 t -108.81 155.59 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.788 1.235 . . . . 0.0 109.378 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -142.52 113.28 7.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.645 1.178 . . . . 0.0 108.961 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 98.86 11.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -84.83 104.92 15.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.803 0.841 . . . . 0.0 110.396 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.551 ' HB3' HD23 ' A' ' 87' ' ' LEU . 57.8 mtm -94.64 142.14 27.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.1 0.56 . . . . 0.0 109.612 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.16 162.44 34.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.563 1.145 . . . . 0.0 108.438 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 m 52.52 45.36 28.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.178 0.991 . . . . 0.0 112.153 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 84' ' ' MET . 81.2 mt -70.86 127.79 33.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.119 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -85.94 144.53 39.31 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.774 0.83 . . . . 0.0 108.94 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -44.15 -35.18 7.53 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 124.428 3.419 . . . . 0.0 115.142 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -73.52 -9.37 58.61 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.78 1.232 . . . . 0.0 113.407 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 -2.2 47.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.022 0.929 . . . . 0.0 112.65 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -58.99 105.81 0.35 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.367 0.667 . . . . 0.0 110.145 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.71 8.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.987 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.4 p -79.75 113.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.9 145.05 27.34 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 108.751 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.23 127.5 26.32 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -84.76 139.79 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -131.63 157.21 44.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.48 1.112 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -145.59 164.13 32.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 110.553 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.63 -154.73 21.6 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -88.94 117.4 27.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -59.4 -46.27 89.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.275 1.03 . . . . 0.0 112.318 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.92 153.05 20.47 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.89 49.76 0.43 Allowed Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.7 m 61.21 84.29 0.13 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.122 0.969 . . . . 0.0 109.808 -170.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 75.5 -58.54 0.56 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.798 1.639 . . . . 0.0 110.167 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -155.85 139.91 16.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.974 0.909 . . . . 0.0 109.488 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.88 -113.47 3.54 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.69 138.59 10.05 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 123.894 0.878 . . . . 0.0 109.685 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.514 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 32.9 Cg_exo -61.39 108.61 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.72 2.28 . . . . 0.0 110.982 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.56 -30.67 67.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.641 0.777 . . . . 0.0 111.864 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 64.8 m-85 -131.13 150.65 52.05 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.841 0.856 . . . . 0.0 109.847 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -124.22 139.24 54.11 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.07 0.948 . . . . 0.0 110.371 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -99.41 167.33 21.22 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.5 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -71.0 -48.39 53.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.803 0.441 . . . . 0.0 111.254 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.502 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.96 129.86 4.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.917 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 8' ' ' SER . 13.8 t -125.34 138.11 54.05 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.497 0.719 . . . . 0.0 110.669 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 54.0 tp60 -81.14 121.16 25.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 110.501 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 21' ' ' LEU . 2.9 m -94.93 137.56 22.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.424 ' HA ' HG22 ' A' ' 92' ' ' THR . 31.8 m -123.69 103.59 8.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.81 104.75 16.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -59.06 134.5 57.05 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.8 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 m -74.0 95.59 2.53 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.399 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.21 142.45 58.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.358 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.47 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.194 0.998 . . . . 0.0 112.778 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -146.04 92.54 2.21 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -159.91 137.8 10.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.861 0.464 . . . . 0.0 109.942 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -78.33 97.83 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.785 . . . . 0.0 109.329 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -80.37 115.63 20.01 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.625 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -66.03 160.18 24.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.759 . . . . 0.0 110.972 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.9 p80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 123.908 0.883 . . . . 0.0 109.206 -176.148 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -143.3 168.56 19.49 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.51 0.671 . . . . 0.0 111.589 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 25' ' ' ALA . 40.4 tp -89.57 111.69 22.69 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.121 176.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.28 107.9 10.02 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.818 0.847 . . . . 0.0 109.349 172.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -102.04 113.54 26.88 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG22 ' NE2' ' A' ' 115' ' ' GLN . 28.2 t -108.34 101.83 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.18 153.11 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.142 0.496 . . . . 0.0 110.678 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.4 p -154.32 170.28 21.68 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.72 18.95 30.82 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.31 86.87 0.32 Allowed Glycine 0 C--N 1.352 1.448 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.31 -168.29 12.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -120.5 147.88 44.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.3 p -151.06 147.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 108.065 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.1 mp0 -78.93 162.8 25.74 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.589 0.631 . . . . 0.0 110.887 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' A' ' 124' ' ' LEU . . . -63.9 138.38 58.45 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.084 0.554 . . . . 0.0 111.538 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -7.55 81.05 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 123.68 0.612 . . . . 0.0 112.507 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.41 -175.83 49.65 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 121.039 0.244 . . . . 0.0 113.332 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.4 p -125.19 159.45 31.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.408 1.083 . . . . 0.0 109.692 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.0 tp -152.45 122.16 6.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -96.6 112.56 24.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.491 0.716 . . . . 0.0 109.997 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -94.21 156.71 16.41 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.477 1.111 . . . . 0.0 109.699 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -133.45 152.92 51.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -149.98 109.83 4.08 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.51 121.0 26.63 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -105.25 129.59 53.58 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.695 0.798 . . . . 0.0 109.518 -175.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.7 t -142.63 154.43 44.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 109.61 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 -114.2 4.57 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.476 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.6 mmp_? -61.94 134.36 56.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.063 0.545 . . . . 0.0 111.218 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.359 0.664 . . . . 0.0 110.393 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -64.06 -18.47 64.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.66 0.384 . . . . 0.0 110.265 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 52.0 p -66.79 -9.52 37.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.394 1.077 . . . . 0.0 112.484 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.9 t -98.02 -11.66 22.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 0.0 110.846 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.69 156.55 42.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.006 0.522 . . . . 0.0 111.442 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.96 143.86 26.05 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.446 ' HE2' HG13 ' A' ' 80' ' ' VAL . 10.1 ptm -128.88 170.02 13.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.193 0.597 . . . . 0.0 110.761 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.64 158.33 31.13 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.158 0.286 . . . . 0.0 113.051 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -104.62 136.48 44.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.735 0.814 . . . . 0.0 109.773 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -129.94 153.02 48.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.795 1.238 . . . . 0.0 108.178 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.39 157.98 45.53 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.397 0.544 . . . . 0.0 111.764 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' NE2' ' HG3' ' A' ' 46' ' ' ARG . 3.9 pt20 -164.85 155.39 14.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.217 0.948 . . . . 0.0 110.126 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 175.22 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.806 1.242 . . . . 0.0 110.387 168.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.75 70.85 7.36 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.152 1.901 . . . . 0.0 112.941 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.2 66.62 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.62 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 60.6 mmtt -99.23 144.6 28.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.302 1.041 . . . . 0.0 110.981 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.52 173.21 8.46 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.966 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HG3' ' NE2' ' A' ' 40' ' ' GLN . 1.9 mtm180 -66.61 103.76 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.75 152.65 20.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.287 0.635 . . . . 0.0 109.964 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.11 112.83 2.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.674 0.79 . . . . 0.0 109.653 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.6 -54.87 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.55 ' HB1' HD13 ' A' ' 71' ' ' ILE . . . -163.1 164.07 25.55 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.355 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.31 131.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.88 1.272 . . . . 0.0 108.283 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.86 151.53 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.336 0.655 . . . . 0.0 109.633 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -82.09 147.48 29.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.583 0.753 . . . . 0.0 109.17 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 58.5 p-90 -54.84 -39.3 68.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.525 1.13 . . . . 0.0 113.102 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -80.72 -19.02 45.97 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.913 0.885 . . . . 0.0 110.699 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.97 61.73 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.122 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -74.04 -22.11 59.68 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.992 0.517 . . . . 0.0 110.804 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -133.76 137.79 45.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.194 0.997 . . . . 0.0 110.607 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -136.25 132.21 35.5 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.454 1.102 . . . . 0.0 108.582 168.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -126.32 138.46 53.59 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.98 148.59 52.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.795 0.438 . . . . 0.0 110.237 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 147.63 41.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.33 -43.52 53.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.274 1.03 . . . . 0.0 113.157 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 m -71.44 -29.69 65.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.67 0.788 . . . . 0.0 112.401 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.68 -7.35 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 111.366 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -69.7 132.26 45.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 0.0 110.427 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.67 8.06 74.12 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.705 0.628 . . . . 0.0 113.826 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 15.6 ptt180 -144.08 -26.76 0.53 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.057 0.543 . . . . 0.0 111.265 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-85 -96.27 152.56 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.8 m -150.24 134.3 17.0 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.682 1.193 . . . . 0.0 108.361 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.55 HD13 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -105.19 133.01 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -132.86 163.49 28.98 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.75 146.42 16.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.154 0.502 . . . . 0.0 110.656 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -105.1 121.23 43.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.473 0.709 . . . . 0.0 109.285 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.48 -35.51 75.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.253 0.621 . . . . 0.0 109.968 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.17 -23.82 66.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.637 0.775 . . . . 0.0 112.158 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.23 -20.0 13.64 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.389 0.676 . . . . 0.0 111.078 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 59.41 35.53 23.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.791 1.236 . . . . 0.0 110.757 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -124.27 132.17 53.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.43 0.692 . . . . 0.0 110.349 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG13 ' HE2' ' A' ' 35' ' ' MET . 50.3 t -99.43 130.48 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.524 1.13 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.47 114.56 26.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.676 0.79 . . . . 0.0 109.667 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.8 tm? -97.18 104.07 16.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.412 ' H ' HE21 ' A' ' 83' ' ' GLN . 0.0 OUTLIER -88.24 120.73 29.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.624 0.77 . . . . 0.0 110.493 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.466 ' HB3' HD21 ' A' ' 87' ' ' LEU . 62.9 mtt -105.49 147.74 27.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.291 1.036 . . . . 0.0 109.301 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -141.72 158.12 44.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.038 0.935 . . . . 0.0 108.514 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 m 55.35 41.57 31.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.047 0.939 . . . . 0.0 112.025 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -68.25 118.45 11.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 42.3 mtpt -84.2 154.36 63.33 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.314 172.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.413 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 10.8 Cg_endo -52.99 -19.7 11.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.022 2.481 . . . . 0.0 114.415 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 11.9 pt-20 -76.09 -12.33 60.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.14 0.976 . . . . 0.0 112.849 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.54 -5.34 56.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.314 0.646 . . . . 0.0 112.148 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.534 HG21 ' HA ' ' A' ' 120' ' ' THR . 86.8 m -61.51 103.9 0.36 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.403 0.681 . . . . 0.0 110.686 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.02 160.39 12.0 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.982 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.6 p -85.22 111.94 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.264 0.554 . . . . 0.0 109.975 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -88.8 113.41 24.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.35 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.53 126.47 48.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.379 1.072 . . . . 0.0 108.746 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -84.66 136.31 33.8 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -132.16 161.52 33.13 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.936 0.895 . . . . 0.0 109.802 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.77 167.96 23.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.481 0.712 . . . . 0.0 110.032 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.39 13.98 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -67.63 112.25 4.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.009 0.923 . . . . 0.0 110.107 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -74.66 132.29 41.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.86 102.02 12.07 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.43 149.6 5.04 Favored Glycine 0 C--O 1.244 0.743 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.5 p -77.18 79.02 3.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 110.432 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -126.91 -66.1 0.92 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 57.18 -155.33 0.33 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.209 1.004 . . . . 0.0 111.603 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.73 -62.67 0.58 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.8 127.82 3.64 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.114 0.965 . . . . 0.0 108.467 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.71 145.41 95.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.675 2.25 . . . . 0.0 111.894 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -69.88 -47.85 61.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.286 0.565 . . . . 0.0 110.112 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -112.66 146.38 38.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.4 p90 -150.33 168.79 23.06 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.298 0.639 . . . . 0.0 109.84 170.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.2 -168.23 18.8 Favored Glycine 0 C--O 1.239 0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.379 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.404 ' NE2' HG22 ' A' ' 6' ' ' VAL . 74.5 mt-30 -83.73 -39.27 20.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.15 0.98 . . . . 0.0 110.575 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.25 132.67 7.84 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.551 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -107.84 111.69 23.96 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.916 0.886 . . . . 0.0 108.744 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 7.8 tm0? -79.24 110.26 14.34 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -96.15 140.35 17.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.534 ' HA ' HG21 ' A' ' 92' ' ' THR . 86.2 m -121.18 112.28 18.45 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.0 p -102.57 119.2 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.475 0.655 . . . . 0.0 109.294 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 5.8 m -65.24 139.0 58.59 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 111.034 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 24.0 t -76.0 79.89 2.86 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.659 0.784 . . . . 0.0 110.647 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 64.7 tp -79.84 97.98 6.89 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.38 131.48 48.4 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -82.18 101.02 10.19 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -74.43 104.48 5.18 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.043 0.937 . . . . 0.0 109.831 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -71.88 125.23 26.67 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -67.24 99.1 0.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -80.61 102.99 10.15 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.192 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.549 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 70.8 143.01 0.05 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.466 1.506 . . . . 0.0 111.773 -176.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 tp -89.91 112.5 23.88 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.81 116.9 29.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.984 0.914 . . . . 0.0 109.839 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.503 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.9 mt -118.51 123.05 44.18 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.832 0.853 . . . . 0.0 110.292 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 39.2 t -108.12 104.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.437 1.095 . . . . 0.0 109.421 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -76.29 152.58 36.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.797 0.439 . . . . 0.0 110.916 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -149.13 146.12 27.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.981 0.912 . . . . 0.0 110.276 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.13 20.71 8.15 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.259 0.35 . . . . 0.0 113.079 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.98 85.91 0.67 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.81 -164.29 10.97 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.15 144.25 45.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.084 0.554 . . . . 0.0 111.468 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 19' ' ' LEU . 7.5 p -152.02 152.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.834 1.254 . . . . 0.0 108.51 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 2.8 pt20 -65.53 156.98 30.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.532 0.733 . . . . 0.0 112.412 -176.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 139.77 57.13 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.095 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 -20.05 33.07 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.063 0.227 . . . . 0.0 112.816 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.4 -177.37 51.77 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-O 121.178 0.321 . . . . 0.0 113.467 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 p -115.13 160.7 19.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.073 0.949 . . . . 0.0 110.878 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' A' ' 13' ' ' VAL . 40.8 tp -156.52 125.7 6.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.97 115.86 27.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.855 0.462 . . . . 0.0 109.979 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.5 mm? -94.6 156.38 16.46 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -144.78 144.72 31.31 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 35.5 t -124.98 113.72 18.19 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.924 0.889 . . . . 0.0 108.905 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . . . -83.82 112.9 20.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.7 122.87 45.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.244 0.618 . . . . 0.0 109.401 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 m -62.79 126.08 26.11 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.02 74.44 0.01 OUTLIER Glycine 0 C--N 1.357 1.741 0 O-C-N 125.246 1.591 . . . . 0.0 115.691 -166.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -98.39 -174.79 2.92 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.867 1.267 . . . . 0.0 108.834 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -83.18 86.38 7.04 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.16 -26.35 65.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 35.4 p -66.03 -13.91 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.227 . . . . 0.0 113.055 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -82.19 -14.64 55.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.168 0.587 . . . . 0.0 111.954 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.14 140.94 44.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.064 0.545 . . . . 0.0 111.382 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 137.52 38.63 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 165.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.519 ' SD ' ' SG ' ' A' ' 97' ' ' CYS . 17.4 ttp -126.37 154.79 43.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.6 0.76 . . . . 0.0 109.644 -169.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.54 161.51 32.25 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 117.714 0.234 . . . . 0.0 113.101 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -97.79 139.47 33.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.825 0.85 . . . . 0.0 109.379 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.343 1.057 . . . . 0.0 109.162 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -131.52 161.56 32.3 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.017 0.371 . . . . 0.0 111.775 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -171.91 146.74 2.07 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.357 171.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -178.11 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 123.891 0.876 . . . . 0.0 111.252 171.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 84.3 Cg_endo -80.35 70.27 7.59 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.155 1.903 . . . . 0.0 112.745 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.65 6.16 80.58 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.551 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.25 141.49 28.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.545 0.738 . . . . 0.0 110.633 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.38 176.95 7.61 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 162.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -60.41 104.76 0.36 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.961 0.504 . . . . 0.0 109.833 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.92 148.59 24.31 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.412 0.685 . . . . 0.0 109.634 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.53 121.16 14.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.522 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -104.88 -59.29 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.88 142.9 6.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.605 0.362 . . . . 0.0 110.434 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG11 ' HD2' ' A' ' 101' ' ' LYS . 61.0 t -123.99 130.44 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.107 0.963 . . . . 0.0 109.816 173.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 59' ' ' THR . 10.6 p -106.39 153.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.771 0.828 . . . . 0.0 109.507 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.49 151.71 37.96 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 49.5 p90 -59.69 -36.57 76.76 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.597 0.759 . . . . 0.0 112.165 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -84.46 -15.11 47.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.72 0.808 . . . . 0.0 111.18 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.7 79.99 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 116.416 -0.356 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -63.42 -49.41 73.84 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.679 0.792 . . . . 0.0 111.035 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -114.41 148.05 38.31 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.657 0.783 . . . . 0.0 110.115 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 52' ' ' VAL . 38.0 p -137.82 147.07 44.24 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.126 0.971 . . . . 0.0 109.133 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.98 129.89 38.8 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -122.32 145.96 47.76 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.84 148.59 36.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.46 -26.42 68.51 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 123.394 0.434 . . . . 0.0 111.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -67.17 -41.51 85.83 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.856 0.863 . . . . 0.0 111.186 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 m -112.65 13.46 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 111.65 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.93 105.94 0.75 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.366 1.066 . . . . 0.0 111.74 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.63 -26.04 18.13 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.768 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.402 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 16.6 ptp180 -84.54 -28.61 26.53 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 117.634 0.717 . . . . 0.0 110.43 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.402 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.7 m-30 -101.85 150.34 23.27 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.45 0.7 . . . . 0.0 109.44 172.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -147.63 132.74 18.28 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.04 0.936 . . . . 0.0 109.203 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.439 HG12 HD22 ' A' ' 82' ' ' LEU . 19.9 mt -101.88 138.63 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -135.77 156.14 49.27 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 154.55 34.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.323 0.582 . . . . 0.0 110.29 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -127.82 109.11 11.3 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -70.33 -30.92 68.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.704 0.802 . . . . 0.0 110.594 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.8 -38.31 54.2 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.117 0.567 . . . . 0.0 111.45 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.4 mmpt? -79.06 -17.89 54.42 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.31 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 60.74 32.86 20.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.554 1.142 . . . . 0.0 109.832 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 m -133.63 133.09 41.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.435 0.694 . . . . 0.0 110.579 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 45.1 t -104.06 155.43 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.4 1.08 . . . . 0.0 109.425 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.54 137.97 44.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.32 1.048 . . . . 0.0 109.631 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.1 tm? -122.73 105.66 10.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.7 107.96 18.88 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.802 0.841 . . . . 0.0 110.007 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.534 ' SD ' HD21 ' A' ' 87' ' ' LEU . 47.3 mtt -87.9 138.53 31.38 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.68 0.792 . . . . 0.0 109.402 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -139.73 133.2 30.15 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 m 58.36 72.93 0.5 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.717 0.807 . . . . 0.0 111.664 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.534 HD21 ' SD ' ' A' ' 84' ' ' MET . 49.8 mt -71.76 136.74 47.24 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.109 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -74.64 152.2 87.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.266 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.26 -25.16 79.45 Favored 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.297 1.998 . . . . 0.0 113.787 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.94 6.76 48.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.985 0.914 . . . . 0.0 112.931 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.39 -9.48 56.42 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 123.271 0.628 . . . . 0.0 112.315 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.418 ' OG1' HG11 ' A' ' 121' ' ' VAL . 89.1 m -53.77 106.2 0.18 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.841 0.856 . . . . 0.0 111.149 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.84 158.55 20.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 110.017 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 40' ' ' GLN . 15.0 p -89.65 124.54 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -98.25 122.45 41.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.029 0.932 . . . . 0.0 110.297 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.9 128.0 56.35 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' A' ' 35' ' ' MET . 46.8 t -83.78 103.06 12.76 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.52 131.63 52.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.656 0.782 . . . . 0.0 111.134 -175.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.99 167.61 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.574 0.75 . . . . 0.0 110.535 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.06 62.79 1.79 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.513 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.528 ' HD2' HG11 ' A' ' 51' ' ' VAL . 53.6 tttm -61.59 120.84 11.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 87.9 m95 66.66 104.83 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.797 1.31 . . . . 0.0 108.776 -160.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.21 164.31 11.2 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.071 0.549 . . . . 0.0 111.511 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.05 -40.97 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.167 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.3 t -71.65 -45.92 60.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.299 0.639 . . . . 0.0 110.722 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.52 156.7 48.47 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.624 0.769 . . . . 0.0 110.195 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -80.19 133.8 36.07 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.201 0.6 . . . . 0.0 110.274 173.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.56 163.99 13.27 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.18 95.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -92.5 142.96 2.4 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 121.886 1.724 . . . . 0.0 111.634 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.84 -50.53 23.5 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.028 0.918 . . . . 0.0 108.8 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -119.65 153.58 35.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -136.73 154.85 50.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.123 0.487 . . . . 0.0 111.405 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.28 161.45 41.2 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 164.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.87 11.25 6.28 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.37 138.69 1.69 Allowed Glycine 0 C--N 1.347 1.148 0 C-N-CA 123.224 0.44 . . . . 0.0 113.879 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 t -136.45 107.14 6.57 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -75.31 105.77 6.5 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.282 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.64 140.69 15.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 m -125.8 136.84 53.58 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 HG11 ' OG1' ' A' ' 92' ' ' THR . 7.3 p -114.88 125.38 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.054 0.454 . . . . 0.0 110.143 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 28.0 t -83.42 111.71 19.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.1 p -77.82 138.18 38.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.818 0.847 . . . . 0.0 111.279 -174.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 71.65 -10.24 0.85 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.475 1.51 . . . . 0.0 113.493 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -68.8 100.18 1.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.32 0.509 . . . . 0.0 110.906 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -147.45 -48.45 0.17 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.371 1.069 . . . . 0.0 109.206 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 63.22 34.46 13.39 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 124.588 1.155 . . . . 0.0 109.363 -174.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -69.07 109.16 3.87 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.794 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -103.35 144.49 31.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.701 0.8 . . . . 0.0 108.956 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -82.48 116.87 22.12 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.806 0.442 . . . . 0.0 110.695 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 . . . . . 0 CA--C 1.551 1.007 0 C-N-CA 123.653 0.781 . . . . 0.0 109.134 174.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 tpp . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -133.3 154.0 51.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.022 0.929 . . . . 0.0 109.85 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 41.0 tp -86.18 111.05 20.02 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.47 128.09 34.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.905 0.882 . . . . 0.0 109.381 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.2 126.46 42.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.277 1.031 . . . . 0.0 108.737 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.27 104.1 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.636 0.775 . . . . 0.0 109.679 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.36 137.36 32.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.891 0.877 . . . . 0.0 109.558 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m -147.64 171.44 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.758 0.823 . . . . 0.0 110.335 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.36 13.13 66.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.037 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.37 145.73 18.61 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.43 -164.46 30.0 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.832 0.316 . . . . 0.0 112.549 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.09 144.11 31.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.129 0.572 . . . . 0.0 110.157 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.5 p -150.83 151.71 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.247 1.019 . . . . 0.0 108.526 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.06 155.61 23.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.676 0.391 . . . . 0.0 110.256 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . . . -72.98 129.57 38.4 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.39 66.12 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 123.772 0.701 . . . . 0.0 111.423 -167.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.87 -166.52 31.82 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.198 0.428 . . . . 0.0 113.698 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -147.58 160.83 42.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.272 1.029 . . . . 0.0 110.269 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -155.99 147.64 22.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.012 0.925 . . . . 0.0 108.547 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -128.11 118.68 23.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.281 0.492 . . . . 0.0 109.995 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD22 ' SD ' ' A' ' 84' ' ' MET . 2.5 mm? -90.51 157.43 17.54 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.89 0.876 . . . . 0.0 109.857 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -142.15 123.77 15.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -122.74 118.74 28.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.981 0.512 . . . . 0.0 110.824 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.51 123.97 30.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.329 0.651 . . . . 0.0 110.09 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.81 143.43 38.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.1 0.96 . . . . 0.0 110.121 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -160.07 176.44 11.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.259 0.624 . . . . 0.0 110.419 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.85 -96.48 1.56 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 66.1 mtp180 -79.79 143.53 34.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.1 m -73.47 103.33 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -58.21 -25.9 62.19 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.01 0.924 . . . . 0.0 111.884 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 43.7 p -76.05 0.45 18.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.773 0.829 . . . . 0.0 112.502 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -87.88 -13.69 41.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.15 0.58 . . . . 0.0 110.143 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.53 170.42 10.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.386 0.674 . . . . 0.0 110.571 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 133.62 34.9 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.746 ' HE1' ' SG ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -129.12 131.41 47.22 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.486 0.714 . . . . 0.0 109.35 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.506 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . -152.23 159.98 28.66 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 114.223 0.449 . . . . 0.0 114.223 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -97.52 132.61 43.04 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.295 1.038 . . . . 0.0 110.384 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.59 129.94 45.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 108.387 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -114.53 156.67 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.502 0.321 . . . . 0.0 111.63 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.44 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -167.23 149.27 5.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.83 0.706 . . . . 0.0 110.504 173.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . . . -179.73 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.813 0.845 . . . . 0.0 111.32 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 41' ' ' ALA . 88.3 Cg_endo -83.21 73.86 5.1 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.155 1.903 . . . . 0.0 112.481 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.03 74.46 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.181 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.6 mmpt? -115.7 145.5 42.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.542 0.737 . . . . 0.0 111.343 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.89 169.85 10.89 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 161.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -64.12 103.8 0.65 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.414 0.626 . . . . 0.0 110.14 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.49 150.38 20.37 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.573 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.01 108.59 1.85 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.946 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -90.11 -68.03 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . -163.6 134.28 4.5 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.577 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG13 ' HE1' ' A' ' 102' ' ' TRP . 94.5 t -116.17 134.02 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 0.0 109.596 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 59' ' ' THR . 8.1 p -107.27 148.87 11.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 123.448 0.699 . . . . 0.0 110.595 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.1 149.97 35.67 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 168.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 61.8 p-90 -60.02 -34.94 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 0.0 112.925 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -86.86 -10.94 52.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 111.495 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.38 15.52 78.15 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.394 -171.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -59.62 -46.65 88.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.113 0.965 . . . . 0.0 111.11 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -133.57 129.25 36.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 52' ' ' VAL . 36.4 p -117.45 128.7 55.25 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.44 117.13 32.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.39 154.54 27.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 110.309 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.23 146.12 39.28 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.95 -25.91 67.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.905 0.482 . . . . 0.0 112.109 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -70.46 -41.95 72.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.751 0.821 . . . . 0.0 110.878 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HB ' ' CD1' ' A' ' 69' ' ' PHE . 8.1 m -94.63 -4.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.293 0.637 . . . . 0.0 111.992 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -67.36 119.4 12.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 0.0 111.094 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.64 17.88 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 123.525 0.583 . . . . 0.0 113.951 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -96.27 -13.5 23.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.364 0.666 . . . . 0.0 110.79 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CD1' ' HB ' ' A' ' 65' ' ' VAL . 97.3 m-85 -123.76 155.83 37.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.423 0.689 . . . . 0.0 109.261 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.3 m -148.77 138.1 21.76 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 108.289 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -102.81 144.5 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 m -136.48 155.87 49.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.71 157.23 36.26 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.65 119.37 13.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.83 -4.94 58.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.009 0.924 . . . . 0.0 112.269 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.99 -54.1 4.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -78.52 -14.23 59.45 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.873 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.94 34.47 19.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.627 1.171 . . . . 0.0 111.301 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.6 m -119.22 132.46 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.251 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 35' ' ' MET . 51.6 t -104.33 119.39 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.142 0.977 . . . . 0.0 109.965 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.26 121.1 41.61 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.702 0.801 . . . . 0.0 110.281 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -105.64 110.54 22.9 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.84 102.81 13.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.902 0.881 . . . . 0.0 109.899 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.659 ' HE1' HG23 ' A' ' 119' ' ' VAL . 83.8 mtp -87.38 140.28 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 0.0 108.669 171.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.67 154.83 30.72 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 123.071 0.232 . . . . 0.0 110.733 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 m 61.07 38.65 16.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.447 1.099 . . . . 0.0 110.312 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 84' ' ' MET . 90.9 mt -68.11 129.16 39.09 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.188 -169.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -100.69 154.42 37.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.466 1.107 . . . . 0.0 108.077 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.841 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 12.1 Cg_endo -53.77 -24.42 30.52 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 123.446 2.764 . . . . 0.0 114.78 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.86 -13.85 59.57 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 112.68 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.5 -2.1 33.78 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.723 0.809 . . . . 0.0 112.208 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.542 HG23 ' HA ' ' A' ' 120' ' ' THR . 65.8 m -62.71 107.91 1.06 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.23 0.612 . . . . 0.0 109.805 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.18 160.01 9.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.572 0.545 . . . . 0.0 110.898 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 40' ' ' GLN . 14.4 p -85.68 115.64 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -94.28 116.25 28.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.106 0.962 . . . . 0.0 108.807 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.06 131.44 48.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.028 0.531 . . . . 0.0 109.72 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.746 ' SG ' ' HE1' ' A' ' 35' ' ' MET . 11.4 t -82.16 102.07 10.85 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.48 162.08 14.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.306 1.042 . . . . 0.0 110.669 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.9 128.52 14.17 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.917 0.887 . . . . 0.0 108.951 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.12 158.92 31.21 Favored Glycine 0 C--O 1.241 0.553 0 O-C-N 123.768 0.668 . . . . 0.0 111.637 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -82.49 127.85 33.71 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.628 ' HE1' HG13 ' A' ' 51' ' ' VAL . 17.3 p-90 -147.47 137.64 23.1 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -83.38 -42.65 16.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.192 0.597 . . . . 0.0 110.888 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.69 -89.93 0.1 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 m -66.07 -45.34 81.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.443 0.697 . . . . 0.0 109.342 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -82.62 104.98 13.28 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -94.11 155.97 16.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.778 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.75 -114.83 4.01 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 132.41 7.77 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.76 110.66 0.86 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.01 1.807 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.6 -44.15 71.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.162 0.506 . . . . 0.0 109.839 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.42 150.47 31.1 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.342 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -158.32 151.96 23.47 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.691 1.196 . . . . 0.0 108.316 164.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.63 -163.26 26.43 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.49 -38.03 86.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.859 0.864 . . . . 0.0 110.123 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.34 130.88 7.17 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.909 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -99.93 108.26 20.45 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 109.416 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -79.34 102.86 8.89 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.659 HG23 ' HE1' ' A' ' 84' ' ' MET . 10.9 m -91.62 137.11 22.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.542 ' HA ' HG23 ' A' ' 92' ' ' THR . 24.0 m -121.02 104.68 9.98 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 3.2 p -100.42 117.11 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.5 t -61.95 140.96 58.28 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.841 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 50.0 p -75.58 107.24 7.59 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.349 -175.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -67.66 148.89 50.75 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.485 ' H ' HD13 ' A' ' 124' ' ' LEU . 35.9 mt-10 -54.19 122.45 10.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.925 0.89 . . . . 0.0 112.551 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -95.8 89.51 5.31 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.404 0.682 . . . . 0.0 109.901 173.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -92.62 94.5 9.06 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 166.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -57.09 139.75 51.41 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.775 0.672 . . . . 0.0 111.246 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -68.84 91.64 0.46 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.594 0.758 . . . . 0.0 111.68 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -175.08 125.16 0.26 Allowed 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.369 1.068 . . . . 0.0 109.391 168.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.1 p80 . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 123.04 0.536 . . . . 0.0 109.916 175.432 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.717 0.294 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.92 172.73 15.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.397 0.679 . . . . 0.0 110.876 -171.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 25' ' ' ALA . 52.9 tp -85.93 112.43 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.746 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 24.9 tt0 -102.83 105.65 16.09 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.599 0.76 . . . . 0.0 109.631 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.486 ' HB3' ' SG ' ' A' ' 97' ' ' CYS . 79.1 mt -91.01 127.23 36.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.594 0.758 . . . . 0.0 109.346 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.11 102.86 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 109.042 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.58 123.19 29.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.1 0.56 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -117.9 130.8 56.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.558 1.143 . . . . 0.0 108.816 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.92 4.99 1.46 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-O 119.861 -0.411 . . . . 0.0 113.345 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.71 102.83 0.8 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.999 0.399 . . . . 0.0 112.17 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.84 -174.56 34.7 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.36 145.2 26.42 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.148 0.499 . . . . 0.0 111.812 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -146.85 154.85 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.47 1.108 . . . . 0.0 108.655 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -87.47 151.31 23.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.864 0.465 . . . . 0.0 111.233 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.91 110.35 5.59 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.431 0.692 . . . . 0.0 110.427 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.25 -4.11 40.8 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.202 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.99 -167.56 42.29 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.667 0.275 . . . . 0.0 112.955 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.7 m -124.92 157.86 34.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.733 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 tp -155.04 123.15 5.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.799 0.84 . . . . 0.0 108.833 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -93.66 119.68 32.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 1.9 mm? -103.84 153.89 20.23 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.83 123.31 8.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 51.9 t -104.99 127.52 52.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.344 0.658 . . . . 0.0 110.087 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.22 127.14 38.68 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.618 0.767 . . . . 0.0 109.601 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB2' HD11 ' A' ' 3' ' ' LEU . . . -104.83 128.77 53.13 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 4.1 m -120.2 151.08 39.64 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.717 0.807 . . . . 0.0 110.947 -169.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.38 -88.2 0.51 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 124.1 0.875 . . . . 0.0 112.832 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -74.25 146.49 43.21 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 0.0 110.528 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -65.18 110.1 2.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.621 0.768 . . . . 0.0 109.958 170.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 78' ' ' ASN . 2.4 p90 -61.45 -23.92 66.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.325 0.65 . . . . 0.0 110.701 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.3 p -72.03 -8.54 55.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 113.157 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 m -83.27 -2.67 56.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.847 0.459 . . . . 0.0 110.735 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -135.97 163.67 29.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.105 0.962 . . . . 0.0 109.967 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.13 127.18 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.677 ' SD ' ' HB2' ' A' ' 97' ' ' CYS . 8.7 tmm? -119.97 135.91 54.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.693 0.397 . . . . 0.0 109.974 -170.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.647 ' HA3' HG21 ' A' ' 51' ' ' VAL . . . -133.07 166.22 23.76 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 123.157 0.408 . . . . 0.0 113.511 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.452 ' NE1' ' HE1' ' A' ' 35' ' ' MET . 55.4 m95 -115.89 145.07 43.2 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 124.034 0.933 . . . . 0.0 108.991 -174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -136.15 146.22 46.67 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.741 1.216 . . . . 0.0 108.907 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -125.38 148.1 48.9 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.238 0.472 . . . . 0.0 110.506 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.84 155.02 4.5 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 123.584 0.754 . . . . 0.0 111.18 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 177.14 -61.07 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.802 1.241 . . . . 0.0 110.263 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.26 75.56 5.0 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 122.377 2.052 . . . . 0.0 112.603 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.16 24.18 70.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.594 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 28.4 mmmt -112.11 144.88 40.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.533 1.133 . . . . 0.0 110.374 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.87 160.93 14.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.906 0.882 . . . . 0.0 109.433 168.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -58.75 105.37 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.143 0.577 . . . . 0.0 111.236 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.78 150.93 19.85 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.549 ' HZ ' ' HB3' ' A' ' 60' ' ' TYR . 54.1 t80 -59.11 111.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.522 1.129 . . . . 0.0 109.112 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -100.06 -65.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.43 130.34 5.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.35 0.119 . . . . 0.0 110.905 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.647 HG21 ' HA3' ' A' ' 36' ' ' GLY . 67.0 t -117.83 138.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.009 0.923 . . . . 0.0 108.762 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.597 HG23 HH11 ' A' ' 73' ' ' ARG . 11.7 p -124.73 140.53 47.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.2 155.98 22.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -55.84 -40.62 73.12 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -167.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -92.42 -0.79 57.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.43 0.692 . . . . 0.0 110.88 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.25 7.57 67.97 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.173 -0.467 . . . . 0.0 114.074 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -66.57 -38.82 87.87 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.678 0.791 . . . . 0.0 110.237 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -115.19 138.05 51.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.545 0.738 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -131.67 144.6 51.14 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.601 1.16 . . . . 0.0 108.987 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.549 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 85.1 m-85 -128.82 137.37 51.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.317 1.047 . . . . 0.0 108.248 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -138.85 150.39 45.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.391 0.676 . . . . 0.0 109.823 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . -82.08 138.61 34.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.02 -28.37 67.68 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.204 0.602 . . . . 0.0 111.639 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 t -65.69 -41.8 91.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.283 1.033 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.488 HG23 ' HB1' ' A' ' 62' ' ' ALA . 22.6 m -103.06 -2.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.301 0.64 . . . . 0.0 111.735 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -64.85 117.71 7.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 0.0 111.355 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.29 20.11 Favored Glycine 0 C--N 1.345 1.034 0 O-C-N 123.82 0.7 . . . . 0.0 113.332 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.457 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 13.8 ptp180 -95.2 -23.34 17.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.141 0.496 . . . . 0.0 109.872 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 2.9 m-85 -107.03 153.52 22.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 92.4 m -145.31 130.68 18.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.927 0.891 . . . . 0.0 109.468 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 1.2 pp -104.13 128.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.054 0.542 . . . . 0.0 110.273 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -139.16 166.09 25.45 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.616 1.166 . . . . 0.0 108.635 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.597 HH11 HG23 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -159.77 161.46 34.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.111 0.481 . . . . 0.0 110.915 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.6 114.09 17.6 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -67.5 -35.23 78.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.517 0.727 . . . . 0.0 111.983 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.64 67.59 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.602 0.564 . . . . 0.0 111.364 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -83.16 -19.24 36.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.233 0.613 . . . . 0.0 111.779 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 68.08 32.67 4.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.133 . . . . 0.0 110.692 -173.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.7 m -111.35 129.88 55.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.867 0.467 . . . . 0.0 110.073 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.78 144.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.752 0.821 . . . . 0.0 108.959 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 130.0 53.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.852 0.861 . . . . 0.0 109.803 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.9 tm? -115.33 106.68 14.29 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 16.1 mm100 -88.17 103.78 16.08 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.869 0.868 . . . . 0.0 109.682 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.8 mtt -87.28 133.89 33.62 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -141.1 145.3 35.61 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.3 m 56.23 47.03 20.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.164 0.986 . . . . 0.0 111.587 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.56 124.17 20.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.146 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -70.22 155.07 94.03 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 -14.76 29.37 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 122.6 2.2 . . . . 0.0 113.605 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.93 -3.02 56.48 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.335 0.654 . . . . 0.0 112.621 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.66 5.06 8.14 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.488 HG21 ' HA ' ' A' ' 120' ' ' THR . 92.5 m -64.8 100.63 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.87 152.09 11.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.241 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 4.1 p -80.35 123.11 36.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 170.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -94.72 139.11 31.69 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -137.93 121.36 17.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.193 0.997 . . . . 0.0 108.835 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.677 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 30.1 p -86.98 143.71 27.24 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -147.38 134.7 20.65 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.168 0.987 . . . . 0.0 109.729 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 112' ' ' TYR . . . -106.98 161.03 15.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.377 0.671 . . . . 0.0 110.834 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 111' ' ' ASP . . . -160.99 133.08 3.07 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.814 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -71.8 115.67 11.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.708 0.403 . . . . 0.0 110.384 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 96.0 m95 68.12 103.48 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.041 1.736 . . . . 0.0 112.243 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -126.19 143.36 51.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.602 0.761 . . . . 0.0 110.234 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.38 52.79 0.57 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 t 66.66 15.74 10.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.234 1.413 . . . . 0.0 110.963 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -137.95 41.15 2.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.373 1.069 . . . . 0.0 109.334 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -51.78 115.71 1.79 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.904 0.882 . . . . 0.0 110.398 171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.0 -46.46 93.48 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.45 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.25 154.57 20.03 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 124.296 1.039 . . . . 0.0 109.155 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.2 96.07 0.22 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.003 1.802 . . . . 0.0 109.907 167.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB3' ' HA2' ' A' ' 100' ' ' GLY . 24.5 t0 -62.74 -37.34 86.19 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.669 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 99' ' ' ALA . 92.5 m-85 -133.13 167.83 19.62 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.628 166.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 38.4 p90 -154.35 169.3 24.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.02 0.928 . . . . 0.0 109.178 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.19 -172.63 21.69 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.648 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.77 -45.12 65.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.333 0.653 . . . . 0.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.13 135.88 1.17 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.451 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.7 t -143.26 140.83 30.83 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.236 0.541 . . . . 0.0 110.314 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 55.8 tp60 -80.42 122.7 27.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.359 1.063 . . . . 0.0 111.408 -171.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.65 145.14 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 92' ' ' THR . 39.4 m -126.91 105.88 8.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.61 0.764 . . . . 0.0 109.339 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.73 117.92 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.402 0.62 . . . . 0.0 109.928 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.1 t -67.34 117.87 9.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.954 0.901 . . . . 0.0 109.802 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.7 m -71.74 96.14 1.58 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.468 0.707 . . . . 0.0 110.382 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.72 105.87 18.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.73 173.44 15.26 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.752 0.821 . . . . 0.0 110.03 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -157.35 -58.5 0.08 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -163.23 -38.81 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.25 0.62 . . . . 0.0 110.884 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 38.7 m80 64.54 -177.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.534 1.134 . . . . 0.0 111.246 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -142.32 120.93 12.54 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -108.94 115.28 29.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.017 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -55.84 107.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.937 0.895 . . . . 0.0 111.686 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 64.5 tp -81.31 110.91 17.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.58 127.66 37.12 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.603 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 73.8 mt -114.23 131.64 56.41 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 59.1 t -114.71 100.37 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.6 130.31 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 109.634 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -138.21 139.99 39.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.311 1.044 . . . . 0.0 109.049 -175.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.62 13.32 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 64.89 3.97 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.95 -164.99 13.35 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 123.569 0.604 . . . . 0.0 111.702 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.4 pp -104.06 142.4 34.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.121 0.569 . . . . 0.0 111.568 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -151.41 144.21 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.883 1.273 . . . . 0.0 108.004 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.451 ' HB3' HD22 ' A' ' 124' ' ' LEU . 27.1 mp0 -69.59 154.57 41.8 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.745 0.418 . . . . 0.0 111.662 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 115.47 5.13 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.461 174.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.32 -14.34 28.02 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 123.885 0.755 . . . . 0.0 111.701 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.33 -163.78 26.75 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 121.307 0.393 . . . . 0.0 113.766 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -144.61 150.93 38.25 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.69 0.796 . . . . 0.0 110.023 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -155.72 124.65 6.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.165 0.586 . . . . 0.0 109.942 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -92.28 129.42 38.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.174 0.59 . . . . 0.0 110.427 175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 82' ' ' LEU . 1.6 mm? -96.18 157.32 15.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.101 0.96 . . . . 0.0 109.084 172.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -144.7 124.1 13.09 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.171 0.589 . . . . 0.0 109.564 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -114.53 115.43 27.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.519 0.728 . . . . 0.0 110.112 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.85 118.66 24.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.59 144.95 31.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.703 0.801 . . . . 0.0 109.759 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t -65.74 159.02 26.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.47 0.708 . . . . 0.0 109.895 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 55.16 4.79 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-O 121.302 0.39 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 3' ' ' LEU . 1.6 mmp_? -98.8 -171.35 2.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.824 1.25 . . . . 0.0 110.781 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.4 p -81.29 41.76 0.63 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.892 0.877 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -69.13 -19.44 64.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.98 0.512 . . . . 0.0 111.817 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -77.39 -16.15 59.0 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 0.0 111.284 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.4 t -81.19 -12.84 59.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.998 0.519 . . . . 0.0 110.2 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.19 159.17 17.61 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 0.0 109.627 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.35 136.91 35.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.481 ' SD ' HG13 ' A' ' 80' ' ' VAL . 2.6 ttp -101.41 155.25 18.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.76 149.93 21.5 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 117.93 0.332 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.428 ' HE1' HG22 ' A' ' 71' ' ' ILE . 85.1 m95 -98.51 131.6 44.61 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.137 0.975 . . . . 0.0 109.564 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -131.37 166.6 20.91 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.686 1.194 . . . . 0.0 108.375 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -157.9 163.46 37.89 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 118.549 0.613 . . . . 0.0 111.408 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.91 162.88 9.46 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.072 0.949 . . . . 0.0 109.314 172.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.54 -58.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 C-N-CA 124.481 1.112 . . . . 0.0 110.891 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.23 69.0 8.13 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 122.692 2.262 . . . . 0.0 112.854 -170.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.81 67.33 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.657 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -107.72 146.64 31.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.535 0.734 . . . . 0.0 110.746 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.24 164.76 20.98 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.637 0.775 . . . . 0.0 108.926 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.13 104.91 0.42 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.214 0.53 . . . . 0.0 110.39 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.96 157.58 15.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.153 1.381 . . . . 0.0 110.727 -170.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.6 121.09 19.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.513 0.725 . . . . 0.0 110.344 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.74 -53.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 71' ' ' ILE . . . -167.39 152.56 7.24 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.532 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -133.87 147.28 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.484 1.113 . . . . 0.0 108.782 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.81 148.5 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 125.101 1.36 . . . . 0.0 108.948 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -77.71 161.63 27.59 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -56.92 -36.35 70.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -90.96 -8.37 49.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.075 0.55 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.83 21.16 58.24 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 112.289 -0.324 . . . . 0.0 112.289 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -60.59 -58.47 8.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.682 0.793 . . . . 0.0 111.283 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.09 138.39 53.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.225 0.61 . . . . 0.0 109.989 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -119.74 160.23 22.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 110.64 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -141.97 139.45 32.45 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 107.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.55 152.89 52.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.129 0.571 . . . . 0.0 110.106 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 65' ' ' VAL . . . -69.83 133.58 47.55 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 166.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.03 -29.37 69.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -168.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.7 m -67.45 -31.13 71.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.651 0.78 . . . . 0.0 111.64 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG22 ' HB1' ' A' ' 62' ' ' ALA . 20.8 m -113.47 6.96 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.821 0.848 . . . . 0.0 111.661 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -75.1 118.17 17.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.035 0.534 . . . . 0.0 111.845 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.61 -26.12 25.62 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.828 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -94.82 -17.98 21.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.218 0.607 . . . . 0.0 110.117 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -104.7 145.83 29.8 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 m -148.74 138.13 21.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.891 0.876 . . . . 0.0 109.43 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' A' ' 50' ' ' ALA . 2.9 mp -101.11 131.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.8 m -122.43 154.78 37.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 133.38 8.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.046 0.385 . . . . 0.0 110.146 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.39 108.11 18.03 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.66 -29.02 68.21 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.93 0.892 . . . . 0.0 111.059 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.73 68.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.246 0.618 . . . . 0.0 111.162 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -14.96 59.43 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.626 0.37 . . . . 0.0 110.714 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 62.31 28.34 16.88 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 124.667 1.229 . . . . 0.0 110.132 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.3 m -125.99 132.51 52.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.093 0.557 . . . . 0.0 110.259 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.481 HG13 ' SD ' ' A' ' 35' ' ' MET . 21.8 t -105.54 157.63 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.584 1.153 . . . . 0.0 109.137 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -137.84 145.36 42.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.818 1.247 . . . . 0.0 108.774 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.427 HD13 HD21 ' A' ' 21' ' ' LEU . 2.9 tm? -134.37 108.61 8.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.07 104.98 16.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.336 0.654 . . . . 0.0 109.73 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.439 ' HE1' HD11 ' A' ' 87' ' ' LEU . 69.7 mtm -88.64 132.41 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -130.69 142.45 50.43 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t 57.73 70.98 0.61 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.67 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD11 ' HE1' ' A' ' 84' ' ' MET . 90.8 mt -84.45 157.17 21.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.417 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -118.31 156.89 50.38 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.28 -21.74 67.98 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.49 2.127 . . . . 0.0 113.059 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.94 -11.43 59.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.274 1.029 . . . . 0.0 112.871 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -83.08 1.48 40.0 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.829 0.452 . . . . 0.0 112.149 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -64.59 108.33 1.65 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.765 0.826 . . . . 0.0 110.397 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.1 164.04 13.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 2.7 p -89.0 112.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -88.23 139.98 29.94 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -125.74 129.34 49.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.543 1.137 . . . . 0.0 108.753 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.44 121.98 28.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -113.71 161.84 17.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.836 0.854 . . . . 0.0 110.006 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.83 143.86 29.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.49 165.74 30.76 Favored Glycine 0 C--O 1.239 0.439 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.567 ' HZ1' ' HB3' ' A' ' 101' ' ' LYS . 7.2 mtpm? -72.85 111.79 8.3 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.29 1.77 4.53 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.604 1.162 . . . . 0.0 113.301 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.2 85.86 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.456 . . . . 0.0 109.473 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 -116.4 4.77 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -168.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.5 m 60.92 17.38 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.641 1.177 . . . . 0.0 113.666 171.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.63 -34.78 72.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.534 0.734 . . . . 0.0 110.264 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -115.56 98.16 6.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.76 -142.64 7.39 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.569 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.1 143.37 22.34 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.675 0.79 . . . . 0.0 109.981 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.81 147.85 93.93 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.702 2.268 . . . . 0.0 111.469 170.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.72 -47.33 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.287 0.635 . . . . 0.0 110.149 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -128.04 165.26 20.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.967 0.907 . . . . 0.0 109.993 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 44.7 p90 -158.43 167.09 30.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.105 0.962 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.64 -161.26 29.99 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.991 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -85.43 -57.46 3.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.114 0.966 . . . . 0.0 109.209 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.39 144.72 17.7 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.416 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -143.43 149.49 37.7 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.343 0.657 . . . . 0.0 109.291 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 17.5 tm0? -91.36 118.11 30.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.376 0.67 . . . . 0.0 110.383 -169.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.28 126.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.447 0.641 . . . . 0.0 109.54 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 88.4 m -102.32 104.67 15.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.779 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.08 100.56 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.8 m -56.73 116.45 3.16 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.462 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.9 m -58.97 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 14' ' ' GLN . 26.3 tp -79.87 -3.58 48.57 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.19 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.35 81.23 0.21 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.742 1.217 . . . . 0.0 108.743 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -75.72 117.91 17.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.538 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -86.3 -57.89 2.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 111.247 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -86.77 80.98 8.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.268 0.627 . . . . 0.0 110.037 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -78.78 127.99 32.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.195 0.998 . . . . 0.0 111.624 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -81.94 149.8 28.02 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 0.0 109.943 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.9 t60 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 119.005 -0.521 . . . . 0.0 109.729 176.501 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.77 118.06 30.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 0.0 109.946 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.83 122.89 48.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.95 0.9 . . . . 0.0 108.627 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 92.5 t -117.52 103.31 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.149 0.98 . . . . 0.0 109.123 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.63 147.47 27.69 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.165 0.586 . . . . 0.0 109.77 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 p -162.47 178.57 8.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.362 1.065 . . . . 0.0 109.493 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.42 5.3 89.89 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 116.537 -0.301 . . . . 0.0 113.433 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.86 135.64 19.37 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.84 178.39 40.59 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -98.66 139.26 34.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.594 0.758 . . . . 0.0 111.006 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 11.3 p -151.12 151.35 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.328 1.051 . . . . 0.0 108.534 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 18.1 mp0 -70.12 159.54 33.72 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.258 0.623 . . . . 0.0 112.272 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 121.92 15.03 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.913 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.51 58.82 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.734 0.646 . . . . 0.0 112.172 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.39 -164.4 37.67 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.068 0.366 . . . . 0.0 112.984 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -148.72 155.67 41.32 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.214 0.606 . . . . 0.0 110.774 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -153.45 136.14 15.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.056 0.942 . . . . 0.0 109.339 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -99.24 132.99 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.277 0.561 . . . . 0.0 110.09 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 4.2 mm? -106.72 159.95 15.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.216 . . . . 0.0 109.79 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -137.75 156.04 48.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.956 0.902 . . . . 0.0 110.007 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 54.0 t -150.66 113.51 4.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 109.6 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.4 117.53 23.68 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.85 0.86 . . . . 0.0 109.051 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.3 124.58 49.79 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.263 0.625 . . . . 0.0 109.724 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.1 m -141.77 -178.08 5.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.935 1.294 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.19 -117.17 4.36 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.54 153.82 42.92 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.896 0.848 . . . . 0.0 110.746 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.3 p -68.9 107.29 3.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.909 0.483 . . . . 0.0 109.724 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ASN . 5.2 p90 -64.75 -14.62 59.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.255 0.622 . . . . 0.0 110.924 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.5 p -70.37 -3.55 18.02 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.162 0.985 . . . . 0.0 112.32 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -109.52 7.66 24.82 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.462 1.105 . . . . 0.0 110.08 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.07 156.19 49.08 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.123 0.969 . . . . 0.0 111.091 -173.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.8 133.16 50.97 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 17.7 ttp -118.23 142.11 47.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.286 0.634 . . . . 0.0 109.589 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -127.45 154.21 19.48 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.391 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -97.03 125.56 41.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.39 160.22 24.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.263 1.425 . . . . 0.0 107.64 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -139.89 162.14 35.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.86 0.755 . . . . 0.0 111.772 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.43 152.93 10.78 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.642 1.213 . . . . 0.0 110.52 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 173.27 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 125.245 1.418 . . . . 0.0 110.231 168.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 65.7 Cg_endo -87.58 80.51 1.3 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.938 1.758 . . . . 0.0 112.046 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.45 73.28 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.347 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -115.29 148.86 38.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.105 0.962 . . . . 0.0 112.03 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 178.19 5.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -61.46 102.63 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -99.86 147.32 25.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.038 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.87 114.49 3.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.229 0.612 . . . . 0.0 110.073 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG11 ' HE1' ' A' ' 95' ' ' TYR . 98.5 t -104.12 -55.78 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -158.54 152.49 23.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.547 0.739 . . . . 0.0 110.13 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 36' ' ' GLY . 42.9 t -137.71 141.86 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.32 1.048 . . . . 0.0 108.58 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.72 145.21 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.73 0.812 . . . . 0.0 109.272 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -81.08 156.34 25.85 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 166.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -52.16 -39.3 59.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.052 0.941 . . . . 0.0 112.523 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -68.49 -26.39 65.45 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.934 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.34 12.31 82.25 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.644 -166.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -65.24 -38.57 90.77 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.068 1.347 . . . . 0.0 110.902 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -128.38 128.08 43.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.492 0.717 . . . . 0.0 110.47 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -122.29 129.97 52.7 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 108.271 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -120.96 138.47 54.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.723 1.209 . . . . 0.0 107.973 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.01 138.82 44.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.195 0.598 . . . . 0.0 110.532 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 147.56 31.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.906 0.883 . . . . 0.0 109.635 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -59.02 -27.27 65.3 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.834 0.854 . . . . 0.0 112.745 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.2 m -64.56 -32.79 74.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.521 0.728 . . . . 0.0 112.019 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.78 5.16 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 124.388 1.075 . . . . 0.0 111.839 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.92 142.66 51.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 0.0 110.833 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.75 -22.51 9.05 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.424 0.453 . . . . 0.0 113.867 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -117.03 -17.43 10.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.535 0.734 . . . . 0.0 111.547 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.61 149.23 23.49 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -149.2 137.4 20.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.101 0.96 . . . . 0.0 108.952 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.405 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -102.03 151.39 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 175.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.0 m -146.02 159.6 43.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.972 1.309 . . . . 0.0 108.58 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.65 132.48 5.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.202 0.525 . . . . 0.0 111.238 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.68 107.43 19.09 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 30' ' ' PHE . 1.8 m-20 -69.63 -33.02 72.04 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 0.0 110.824 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.29 83.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.761 0.825 . . . . 0.0 111.104 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -97.72 -0.51 45.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.268 0.627 . . . . 0.0 112.105 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.02 27.37 17.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.774 1.23 . . . . 0.0 113.46 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 m -119.36 131.81 55.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.56 0.344 . . . . 0.0 110.75 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 36.0 t -103.31 148.77 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.431 1.092 . . . . 0.0 108.923 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.11 152.07 51.43 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -132.19 108.28 9.16 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -83.61 102.76 12.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.062 0.945 . . . . 0.0 109.508 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 58.4 mtt -88.69 123.61 33.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -123.53 141.95 51.49 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.8 m 53.92 61.33 3.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.411 1.084 . . . . 0.0 111.791 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.38 117.18 11.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.365 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' O ' HG11 ' A' ' 121' ' ' VAL . 45.5 mtpt -75.05 149.38 85.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.405 1.082 . . . . 0.0 109.05 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 19.4 Cg_endo -56.54 -17.78 23.29 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.181 2.587 . . . . 0.0 114.681 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.51 -20.45 58.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.25 1.02 . . . . 0.0 113.051 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -77.14 -0.36 24.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 120' ' ' THR . 72.5 m -62.62 101.67 0.27 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.461 0.704 . . . . 0.0 110.1 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.54 160.99 15.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.036 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.69 116.52 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.349 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.483 ' HE1' HG11 ' A' ' 49' ' ' VAL . 15.7 m-85 -91.84 117.09 29.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.706 0.803 . . . . 0.0 111.092 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.64 130.07 47.91 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.038 0.935 . . . . 0.0 109.999 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.535 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.8 m -84.67 124.15 31.17 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.63 20.98 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.038 0.935 . . . . 0.0 109.695 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -119.34 167.93 11.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.858 0.863 . . . . 0.0 111.137 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.73 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.791 175.182 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.81 146.88 51.54 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.521 1.129 . . . . 0.0 109.121 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.02 156.92 42.96 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.034 0.934 . . . . 0.0 109.242 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.62 -163.34 26.14 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.219 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -81.59 -50.1 9.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.097 1.359 . . . . 0.0 110.689 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.5 137.45 6.47 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.789 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 21' ' ' LEU . 10.0 t -114.59 115.82 27.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 109.564 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -73.49 111.83 8.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.745 0.818 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.5 145.12 16.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 52.2 m -127.88 139.2 52.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.2 p -119.78 113.14 39.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 31.1 t -58.38 113.19 1.85 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.595 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 37.8 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 124.534 1.134 . . . . 0.0 111.13 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -85.57 116.38 23.83 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -110.14 129.84 55.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.424 1.09 . . . . 0.0 108.296 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 34.6 t -121.9 98.25 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.85 139.64 30.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 122.89 0.476 . . . . 0.0 110.166 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -153.46 165.01 37.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.949 0.899 . . . . 0.0 109.957 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.34 -11.45 54.67 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.988 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.29 120.54 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.028 -0.318 . . . . 0.0 112.448 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.6 -169.42 22.9 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -79.63 135.49 36.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.498 0.319 . . . . 0.0 111.275 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.64 139.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.29 1.036 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.83 149.55 35.62 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.687 0.795 . . . . 0.0 112.025 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.27 7.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.218 0.607 . . . . 0.0 110.704 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.71 -10.37 25.65 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.033 0.825 . . . . 0.0 111.541 -175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.46 -170.82 44.5 Favored Glycine 0 C--N 1.346 1.124 0 C-N-CA 123.038 0.351 . . . . 0.0 113.862 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.4 p -121.52 162.1 21.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.252 1.021 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.96 126.9 8.29 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -98.4 118.33 34.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.163 0.585 . . . . 0.0 110.248 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -102.02 154.18 19.21 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.194 0.998 . . . . 0.0 109.018 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -145.67 146.84 31.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.595 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 53.6 t -138.37 123.43 19.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.22 114.77 22.57 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.26 24.51 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.408 0.683 . . . . 0.0 109.239 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 t -71.78 164.33 26.2 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.19 -11.25 51.36 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.384 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HE ' ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.9 127.45 26.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.326 1.051 . . . . 0.0 109.28 169.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.414 ' H ' ' HE ' ' A' ' 28' ' ' ARG . 6.8 p -60.77 89.04 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.12 -18.54 60.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.077 160.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 29.9 p -66.7 -14.43 62.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.069 1.347 . . . . 0.0 112.794 176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m -83.98 -4.24 58.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 0.0 111.225 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.32 168.91 17.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.591 0.757 . . . . 0.0 110.988 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 121.8 33.49 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttp -101.22 130.44 47.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 109.493 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -134.0 154.25 21.28 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.51 138.89 32.56 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.462 1.105 . . . . 0.0 109.187 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.77 170.25 14.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.159 1.384 . . . . 0.0 108.113 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -153.73 162.05 41.58 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.901 0.319 . . . . 0.0 111.802 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.2 pp0? -168.02 151.86 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.529 1.143 . . . . 0.0 110.835 167.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 169.74 -59.11 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 125.283 1.433 . . . . 0.0 110.885 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.42 70.24 5.13 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.511 2.141 . . . . 0.0 112.609 -169.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.92 17.22 76.8 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.787 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -109.24 140.95 42.22 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 110.745 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.31 170.3 12.91 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.75 105.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.91 154.89 20.95 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 110.647 -171.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -66.6 110.38 3.17 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.674 171.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' HE1' ' A' ' 95' ' ' TYR . 95.2 t -88.81 -62.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.53 134.54 4.65 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.608 HG22 ' HA3' ' A' ' 36' ' ' GLY . 71.3 t -115.41 153.46 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.158 0.983 . . . . 0.0 108.595 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.9 151.39 31.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.6 152.99 44.61 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 52.9 p-90 -61.42 -36.05 79.25 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -82.72 -5.34 58.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.477 0.711 . . . . 0.0 111.659 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.55 79.87 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -58.51 -47.71 83.24 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.742 0.817 . . . . 0.0 111.234 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.1 mtt85 -130.71 141.23 50.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 p -110.99 130.2 55.66 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -114.93 116.33 28.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -114.27 142.21 46.58 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.83 47.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.35 -26.36 60.87 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.689 0.795 . . . . 0.0 111.978 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -69.6 -26.05 64.26 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.595 1.158 . . . . 0.0 112.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 33.5 m -127.96 7.64 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.03 0.932 . . . . 0.0 111.652 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.24 124.34 23.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 111.31 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -3.01 85.92 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.11 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -121.15 -10.9 8.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.487 0.643 . . . . 0.0 111.421 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -109.57 162.39 14.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.202 0.601 . . . . 0.0 109.873 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 86.4 m -151.59 130.57 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.267 1.027 . . . . 0.0 109.45 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.614 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -103.29 141.12 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 49.5 m -139.27 158.76 43.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.729 1.212 . . . . 0.0 108.248 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.18 131.12 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.029 0.443 . . . . 0.0 110.881 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.01 92.17 5.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.483 1.113 . . . . 0.0 108.27 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.46 -25.58 68.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.146 0.578 . . . . 0.0 111.413 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.8 98.1 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.87 0.868 . . . . 0.0 111.504 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.82 -10.25 37.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.637 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 58.21 45.27 17.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.117 0.967 . . . . 0.0 109.574 -170.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 m -115.34 148.39 39.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.283 1.033 . . . . 0.0 109.408 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 57.6 t -126.68 150.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 108.903 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 86.7 m-85 -133.53 146.23 50.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 0.0 108.975 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.3 tm? -133.87 107.19 7.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 35.4 tt0 -86.75 126.83 34.85 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.429 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.7 mtt -105.48 141.49 36.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.482 1.113 . . . . 0.0 108.824 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -141.61 147.33 37.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t 58.27 52.14 7.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.756 0.823 . . . . 0.0 111.28 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 84' ' ' MET . 77.8 mt -71.51 120.8 17.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.828 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.446 ' O ' HG11 ' A' ' 121' ' ' VAL . 39.2 mtmt -82.99 149.37 59.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.167 0.987 . . . . 0.0 108.985 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -55.98 -18.93 24.12 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 123.387 2.724 . . . . 0.0 114.791 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.49 -20.11 54.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.143 0.977 . . . . 0.0 112.609 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -71.18 -7.76 48.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.223 0.609 . . . . 0.0 112.544 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.5 m -56.58 101.82 0.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.961 0.904 . . . . 0.0 110.302 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.02 159.07 9.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.573 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.1 p -78.89 113.48 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.524 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.0 m-85 -87.98 112.51 22.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.237 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -104.57 122.73 46.21 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.493 1.117 . . . . 0.0 109.098 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.88 132.04 35.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.56 160.29 40.33 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.962 0.905 . . . . 0.0 109.295 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.43 160.65 39.35 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 CA-C-O 119.773 -0.459 . . . . 0.0 113.831 176.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 121.207 0.527 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -133.85 153.67 51.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.531 1.132 . . . . 0.0 109.302 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -149.64 148.88 29.83 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.126 0.971 . . . . 0.0 108.882 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.57 -155.7 32.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.935 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -97.69 -38.06 9.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.311 1.045 . . . . 0.0 110.587 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.91 136.81 9.2 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.172 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -117.58 114.31 23.23 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.07 0.948 . . . . 0.0 108.805 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 62.3 tp60 -71.9 108.84 5.37 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.32 145.29 7.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 25.2 m -132.6 109.67 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 88' ' ' LYS . 1.7 p -94.7 105.09 16.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.7 t -56.82 118.83 5.31 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.115 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 124.168 0.987 . . . . 0.0 110.928 -176.13 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' TYR . 54.4 tp . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -72.38 104.35 3.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.126 0.57 . . . . 0.0 110.025 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.09 128.95 54.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 108.48 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.8 t -121.9 103.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.78 156.82 18.25 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.231 1.012 . . . . 0.0 110.412 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -159.44 171.81 19.04 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.882 0.873 . . . . 0.0 109.791 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.5 15.42 15.49 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.044 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.79 92.18 0.36 Allowed Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.933 0.301 . . . . 0.0 112.444 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.88 179.96 23.43 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.5 pp -107.36 147.86 29.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.084 0.554 . . . . 0.0 110.571 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.0 p -149.47 145.12 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.553 1.141 . . . . 0.0 108.707 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.2 mp0 -72.61 158.34 35.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.876 0.47 . . . . 0.0 112.026 -172.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 114.33 3.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.923 0.889 . . . . 0.0 111.261 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.7 -10.0 25.73 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.486 0.565 . . . . 0.0 112.033 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.02 -163.82 39.33 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.026 0.346 . . . . 0.0 112.713 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.9 p -143.73 158.17 43.87 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.387 0.675 . . . . 0.0 109.981 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -149.59 119.66 7.21 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.9 ttt85 -96.6 116.12 28.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.722 0.809 . . . . 0.0 109.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.173 0.989 . . . . 0.0 110.216 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -132.7 145.22 50.87 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.637 0.775 . . . . 0.0 109.28 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.87 119.37 8.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.325 0.65 . . . . 0.0 110.45 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.73 129.74 34.75 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.029 0.532 . . . . 0.0 110.029 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.93 128.64 54.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.087 0.955 . . . . 0.0 110.156 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 49.9 m -142.76 159.4 42.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.097 0.959 . . . . 0.0 109.816 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.35 -117.96 5.9 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -77.26 163.84 26.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.581 0.752 . . . . 0.0 110.085 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -70.19 97.25 1.18 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.015 0.526 . . . . 0.0 111.1 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -68.43 -23.95 64.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.706 0.802 . . . . 0.0 110.798 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 60.6 p -72.5 -0.05 11.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.949 0.9 . . . . 0.0 112.276 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -99.46 -9.75 23.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.241 0.616 . . . . 0.0 111.116 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -123.48 169.42 11.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.428 0.633 . . . . 0.0 112.323 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.83 125.9 47.38 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.207 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 9.4 ptm -107.56 170.19 8.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 0.0 110.463 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.41 149.38 18.09 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 113.376 0.11 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -98.1 141.17 31.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.156 0.982 . . . . 0.0 109.995 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -138.28 133.24 32.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.654 1.181 . . . . 0.0 108.724 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -114.79 159.6 20.41 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.058 0.39 . . . . 0.0 111.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.527 ' O ' HG12 ' A' ' 94' ' ' VAL . 28.3 pt20 -168.66 151.8 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.505 0.722 . . . . 0.0 110.712 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -179.59 -57.6 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 123.776 0.83 . . . . 0.0 111.114 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.73 64.99 7.39 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.342 2.028 . . . . 0.0 112.348 -171.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.43 22.32 76.37 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.78 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -103.34 149.1 25.08 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.931 0.892 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.38 178.48 5.95 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.472 1.109 . . . . 0.0 108.334 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.04 105.39 0.47 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 150.1 21.01 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HE2' HG23 ' A' ' 51' ' ' VAL . 58.2 t80 -63.08 112.58 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.757 0.823 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.18 -66.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.3 135.14 3.02 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' HE2' ' A' ' 48' ' ' PHE . 50.2 t -110.87 132.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.262 1.025 . . . . 0.0 109.208 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.92 151.17 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.688 0.795 . . . . 0.0 110.493 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 25.1 t-20 -75.69 156.65 34.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.982 0.913 . . . . 0.0 109.205 170.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 54.7 p-90 -58.78 -34.52 71.54 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.5 p -95.71 1.55 53.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 0.0 111.678 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.02 9.5 71.46 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 113.363 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -64.01 -35.31 80.3 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.33 1.052 . . . . 0.0 111.181 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 98.5 mtt180 -125.49 138.59 53.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.337 1.055 . . . . 0.0 109.229 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.8 p -140.29 131.92 27.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.621 0.768 . . . . 0.0 109.543 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.37 115.78 24.82 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 147.25 34.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.593 0.357 . . . . 0.0 110.241 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.18 146.59 43.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.22 -34.04 73.1 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.5 m -70.61 -28.16 64.64 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.034 0.534 . . . . 0.0 112.223 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 62' ' ' ALA . 12.1 m -109.77 1.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.193 0.597 . . . . 0.0 111.408 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -67.5 120.84 14.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.463 0.705 . . . . 0.0 111.824 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.25 -27.88 4.92 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.748 0.689 . . . . 0.0 113.959 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' NH2' HD23 ' A' ' 87' ' ' LEU . 1.6 ptm180 -89.05 -8.59 53.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.839 0.856 . . . . 0.0 110.901 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.21 151.97 27.64 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.5 m -140.19 119.41 12.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.163 0.985 . . . . 0.0 108.528 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.1 mp -103.54 127.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 m -133.83 157.78 45.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 108.206 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 150.75 18.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.127 0.489 . . . . 0.0 110.341 174.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 77' ' ' LYS . 17.8 m-20 -119.88 112.14 18.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -71.14 -26.95 63.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.072 0.549 . . . . 0.0 110.788 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.36 59.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.509 0.724 . . . . 0.0 111.02 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 72.5 mmtt -77.5 -25.01 49.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.616 0.366 . . . . 0.0 110.886 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 60.32 44.97 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.388 1.075 . . . . 0.0 110.039 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m -139.08 131.24 28.14 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.847 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 35' ' ' MET . 46.4 t -101.58 141.72 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.65 1.18 . . . . 0.0 109.593 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -125.09 126.33 45.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.186 0.994 . . . . 0.0 109.063 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.37 98.19 6.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -89.16 106.6 18.55 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.298 0.639 . . . . 0.0 110.207 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.4 mtm -88.07 139.39 30.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.322 0.649 . . . . 0.0 109.3 174.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 m 59.77 60.29 2.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.187 0.995 . . . . 0.0 111.123 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 84' ' ' MET . 99.3 mt -80.73 127.91 33.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.477 -173.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 2.3 mptp? -92.71 153.91 42.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.3 -25.7 4.97 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.875 3.05 . . . . 0.0 115.142 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.6 pt-20 -71.44 -23.27 61.81 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.743 1.217 . . . . 0.0 113.432 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 1.12 14.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.782 0.833 . . . . 0.0 113.196 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 120' ' ' THR . 54.9 m -62.99 103.13 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.291 0.636 . . . . 0.0 110.337 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.57 155.04 5.85 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.227 0.611 . . . . 0.0 111.452 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.3 p -78.95 112.29 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -87.68 113.47 23.38 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -102.71 128.8 49.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.24 129.38 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -138.53 163.52 31.77 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.264 1.025 . . . . 0.0 109.073 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -138.5 133.7 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.772 0.829 . . . . 0.0 108.774 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.466 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.484 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.508 0.67 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 34.2 m-85 -111.37 151.1 28.85 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.044 0.938 . . . . 0.0 109.14 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 42.4 p90 -166.08 167.42 16.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.869 0.868 . . . . 0.0 109.997 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.99 -147.85 10.13 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.206 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.23 -48.85 9.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.807 0.843 . . . . 0.0 110.383 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.8 151.57 25.33 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.817 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 t -122.64 111.42 16.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.336 1.054 . . . . 0.0 110.077 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 57.2 tp60 -72.47 113.87 9.98 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.474 0.71 . . . . 0.0 110.15 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.557 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.1 m -102.87 146.83 10.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.494 0.718 . . . . 0.0 109.366 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.52 ' HA ' HG23 ' A' ' 92' ' ' THR . 96.4 m -124.63 143.21 50.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.89 0.876 . . . . 0.0 109.001 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.7 p -129.86 125.62 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 109.791 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.458 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 7.9 m -80.03 122.48 26.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.468 1.107 . . . . 0.0 111.885 -170.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 123.763 0.825 . . . . 0.0 110.699 174.688 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -94.94 114.74 26.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.532 0.733 . . . . 0.0 109.328 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 96.0 mt -106.9 116.96 32.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.4 101.92 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -111.22 125.39 53.76 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.373 -166.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -165.75 -178.74 4.96 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.22 1.008 . . . . 0.0 110.239 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.5 -0.52 26.34 Favored Glycine 0 N--CA 1.476 1.355 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.33 151.51 29.84 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 122.88 0.276 . . . . 0.0 113.064 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.25 -168.94 31.08 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -91.31 145.54 24.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.226 0.536 . . . . 0.0 111.043 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.94 159.89 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.072 1.349 . . . . 0.0 108.13 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -87.26 166.2 15.09 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.957 0.503 . . . . 0.0 111.158 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.45 129.21 38.65 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.319 0.648 . . . . 0.0 109.959 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.46 81.75 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.741 0.651 . . . . 0.0 111.892 -170.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 -165.91 40.55 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 122.804 0.24 . . . . 0.0 112.941 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.8 p -148.18 159.03 44.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.861 0.864 . . . . 0.0 110.2 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -159.52 135.22 8.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.583 0.753 . . . . 0.0 109.496 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -109.38 126.51 53.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.841 0.457 . . . . 0.0 110.136 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -103.96 156.96 17.43 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.352 1.061 . . . . 0.0 109.332 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -144.57 154.64 43.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 111.006 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.6 t -150.68 134.2 16.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.453 0.701 . . . . 0.0 109.923 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 145.94 26.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.74 126.66 52.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -133.65 157.72 45.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.603 1.161 . . . . 0.0 109.2 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.96 1.08 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -95.16 164.38 12.89 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.574 0.749 . . . . 0.0 110.055 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 31' ' ' SER . 83.6 m -97.41 121.16 38.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.469 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 15.9 p90 -63.5 -16.45 60.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.558 0.743 . . . . 0.0 111.744 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 29' ' ' THR . 34.3 t -68.03 -15.17 63.48 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 0.0 112.613 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 p -93.05 9.68 34.75 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 122.024 -0.422 . . . . 0.0 110.661 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -134.25 167.56 20.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.379 1.071 . . . . 0.0 110.243 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.85 160.45 15.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 31.1 ttp -140.47 157.71 45.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.64 144.01 9.38 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -96.42 131.63 42.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.92 129.0 37.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.014 0.926 . . . . 0.0 108.557 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -109.05 162.35 14.32 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.727 0.299 . . . . 0.0 110.537 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.8 148.53 5.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.091 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 177.23 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.056 0.942 . . . . 0.0 111.352 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 68.5 Cg_endo -82.2 64.82 8.38 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 122.111 1.874 . . . . 0.0 112.523 -170.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.86 6.43 72.72 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.772 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -105.81 146.25 30.12 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.717 0.807 . . . . 0.0 110.142 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.8 178.04 6.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.861 0.864 . . . . 0.0 109.119 170.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -51.68 104.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.48 151.79 19.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.356 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -64.85 108.34 1.73 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -99.0 -49.08 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.49 150.3 6.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.23 138.56 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG23 HG22 ' A' ' 59' ' ' THR . 8.9 p -131.65 160.45 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.68 158.41 20.81 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -56.53 -38.16 71.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.532 0.733 . . . . 0.0 112.077 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -76.62 -23.48 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.625 0.77 . . . . 0.0 111.642 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.32 8.42 83.51 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.564 -165.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -58.42 -39.01 78.61 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.609 1.164 . . . . 0.0 111.049 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -119.52 130.87 55.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.286 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.472 HG22 HG23 ' A' ' 52' ' ' VAL . 46.5 p -122.36 133.21 54.65 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.906 0.883 . . . . 0.0 109.077 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.76 135.93 50.81 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -134.55 148.64 50.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.326 0.65 . . . . 0.0 109.973 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.99 128.32 33.71 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.66 -20.48 60.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.196 0.598 . . . . 0.0 112.436 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 p -64.94 -44.28 89.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.693 0.797 . . . . 0.0 111.129 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.33 -3.43 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.964 0.906 . . . . 0.0 111.782 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -66.81 134.71 52.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.298 0.639 . . . . 0.0 110.638 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.67 15.52 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.968 0.793 . . . . 0.0 113.387 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 19.0 ptt-85 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.01 0.405 . . . . 0.0 110.424 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 2.8 m-85 -105.94 151.04 25.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.729 0.812 . . . . 0.0 109.979 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 m -149.14 142.22 24.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.844 1.258 . . . . 0.0 108.211 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.4 mp -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -140.03 154.57 47.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.237 1.015 . . . . 0.0 108.334 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HG3' ' HE2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -159.72 131.29 6.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.69 98.9 10.26 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.109 0.963 . . . . 0.0 108.537 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.01 -25.5 67.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.98 0.912 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.34 72.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.415 1.086 . . . . 0.0 111.673 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -83.05 -11.23 58.22 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.148 0.579 . . . . 0.0 111.251 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.469 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 30.4 m-80 61.18 35.98 18.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 0.0 110.302 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 132.65 53.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.927 0.891 . . . . 0.0 110.257 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.1 t -99.99 153.11 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.112 1.365 . . . . 0.0 110.255 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -136.45 151.79 49.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.439 1.096 . . . . 0.0 109.829 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 1.8 tm? -132.2 115.16 15.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.84 102.31 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 109.725 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.56 ' HB3' HD21 ' A' ' 87' ' ' LEU . 67.1 mtt -95.16 136.8 35.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.422 0.689 . . . . 0.0 109.609 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 20.3 m120 -142.02 161.85 36.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.746 1.219 . . . . 0.0 108.001 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.3 m 54.12 31.41 13.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.297 1.039 . . . . 0.0 112.875 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 84' ' ' MET . 84.5 mt -61.04 130.07 44.55 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.872 0.869 . . . . 0.0 112.653 -169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD3' ' NH1' ' A' ' 68' ' ' ARG . 2.4 mptp? -98.52 152.3 37.85 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.102 0.961 . . . . 0.0 108.993 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -46.74 -27.38 5.46 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 124.202 3.268 . . . . 0.0 115.936 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -71.21 -16.66 62.52 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB2' HG11 ' A' ' 121' ' ' VAL . 40.3 m-20 -72.68 -11.94 60.83 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.845 0.458 . . . . 0.0 112.103 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 120' ' ' THR . 63.4 m -60.16 105.42 0.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.72 0.808 . . . . 0.0 110.796 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.7 165.88 4.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.883 0.873 . . . . 0.0 110.074 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.3 p -89.26 115.69 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -86.82 155.72 20.18 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.355 1.062 . . . . 0.0 109.439 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -145.81 115.98 7.45 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.75 0.657 . . . . 0.0 109.357 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 26.4 p -83.87 106.09 15.28 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.19 124.66 49.93 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.513 1.125 . . . . 0.0 110.911 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.22 151.24 38.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.716 0.807 . . . . 0.0 110.833 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.581 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -178.037 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.438 0.161 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.73 167.99 20.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.912 0.885 . . . . 0.0 109.911 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -157.4 168.69 26.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.901 0.881 . . . . 0.0 111.256 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -80.7 -172.23 45.28 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.547 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -66.98 -33.88 76.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.161 0.984 . . . . 0.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.52 108.79 2.5 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -100.95 121.84 42.45 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.39 0.676 . . . . 0.0 109.938 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -90.94 127.71 36.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -175.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.9 m -113.43 140.73 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.47 ' HA ' HG23 ' A' ' 92' ' ' THR . 40.2 m -127.33 108.9 11.25 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.0 p -106.62 116.02 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 122.987 0.515 . . . . 0.0 109.63 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -73.57 148.28 43.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 110.614 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 123.916 0.886 . . . . 0.0 110.122 179.656 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -75.88 122.85 24.73 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.355 0.598 . . . . 0.0 110.818 -170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 70.6 mt -127.36 135.12 50.06 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.363 1.465 . . . . 0.0 108.475 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.38 100.42 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -97.29 135.02 39.81 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.386 0.674 . . . . 0.0 109.612 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -148.54 178.92 8.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.486 1.115 . . . . 0.0 109.49 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.38 -12.35 43.6 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.894 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.89 137.19 21.9 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.85 -169.55 36.91 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.94 137.64 37.72 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.971 0.386 . . . . 0.0 111.168 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.75 155.53 6.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 C-N-CA 124.946 1.298 . . . . 0.0 108.449 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -80.49 155.16 27.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.362 0.665 . . . . 0.0 109.948 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.46 111.05 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.241 0.616 . . . . 0.0 110.263 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.92 3.93 31.67 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.922 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.88 -165.98 39.53 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 122.97 0.319 . . . . 0.0 113.463 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 m -132.51 158.22 42.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.413 1.085 . . . . 0.0 110.051 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -152.26 151.12 30.54 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -119.96 113.05 19.96 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.151 0.58 . . . . 0.0 110.548 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -101.54 150.08 23.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.363 1.065 . . . . 0.0 108.782 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -153.08 140.48 19.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.363 0.665 . . . . 0.0 109.294 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.7 t -120.6 123.63 43.31 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.525 0.73 . . . . 0.0 110.258 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.47 115.52 22.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -106.8 163.15 13.17 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.377 1.071 . . . . 0.0 110.273 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -66.09 168.6 8.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.16 23.87 8.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.698 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -79.59 179.17 7.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 111.912 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -79.05 70.18 5.35 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.444 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 59.0 m-85 -66.22 -22.08 66.33 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.313 164.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -60.0 -29.81 68.71 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.999 1.32 . . . . 0.0 111.703 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 m -90.28 -15.04 32.03 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 0.0 111.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -108.58 175.5 5.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.853 0.861 . . . . 0.0 110.931 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.48 162.93 17.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 164.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.4 ttp -141.93 153.26 44.23 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.0 157.02 27.28 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -96.36 125.13 40.64 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.176 0.99 . . . . 0.0 108.355 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -123.61 170.08 10.81 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.319 1.448 . . . . 0.0 107.873 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -149.67 162.31 40.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.845 0.748 . . . . 0.0 112.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -170.1 151.5 3.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 124.385 1.053 . . . . 0.0 110.565 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.31 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 124.459 1.104 . . . . 0.0 111.518 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.57 64.87 8.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 C-N-CA 122.131 1.887 . . . . 0.0 112.481 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.16 14.6 66.4 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.894 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -104.92 160.02 15.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.462 0.705 . . . . 0.0 112.055 -172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.12 173.49 7.7 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.878 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -59.3 104.34 0.25 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.126 0.97 . . . . 0.0 109.655 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -106.67 150.49 26.19 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.651 0.78 . . . . 0.0 110.668 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.24 111.03 3.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.352 0.661 . . . . 0.0 110.835 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 HG11 ' A' ' 65' ' ' VAL . 70.1 t -94.15 -62.36 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.74 139.55 5.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 76.3 t -123.31 138.32 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.687 0.795 . . . . 0.0 110.436 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.65 157.13 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.283 1.033 . . . . 0.0 109.898 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 55' ' ' SER . 10.4 t30 -84.85 162.96 19.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 169.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.421 0.688 . . . . 0.0 112.479 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 63.6 p -81.69 -11.86 58.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.239 0.616 . . . . 0.0 111.537 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.91 83.11 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.509 0.505 . . . . 0.0 112.791 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -72.36 -23.99 61.21 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 110.969 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -122.89 134.85 54.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.117 0.967 . . . . 0.0 109.004 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.6 p -134.81 132.4 38.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.192 0.997 . . . . 0.0 109.156 173.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -124.22 134.35 53.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.135 1.374 . . . . 0.0 107.524 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.19 149.2 52.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.226 0.61 . . . . 0.0 110.224 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.63 146.11 42.71 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 166.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.76 -34.76 67.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -71.25 -41.88 69.54 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.327 0.651 . . . . 0.0 111.772 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 49' ' ' VAL . 16.1 m -90.17 -5.16 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 122.819 0.448 . . . . 0.0 111.47 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -70.83 120.22 16.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.917 0.887 . . . . 0.0 110.949 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.35 -8.64 77.19 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.449 0.468 . . . . 0.0 113.918 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 20.8 ptp180 -114.37 -26.64 7.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.423 0.689 . . . . 0.0 110.065 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-30 -98.46 150.45 21.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.829 0.851 . . . . 0.0 109.315 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -146.48 134.24 21.18 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.814 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG13 HD23 ' A' ' 82' ' ' LEU . 2.8 mp -102.81 136.72 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.6 m -135.42 160.37 38.66 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.757 1.223 . . . . 0.0 108.389 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.2 164.37 32.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.219 0.533 . . . . 0.0 111.437 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -129.76 106.64 8.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.929 1.291 . . . . 0.0 107.557 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.97 -31.1 71.82 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.318 1.047 . . . . 0.0 111.604 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.48 67.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.231 0.612 . . . . 0.0 110.743 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.71 -13.51 58.94 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.254 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.4 m120 59.05 31.86 21.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.26 1.024 . . . . 0.0 110.811 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.7 m -121.03 130.1 53.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.87 155.14 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.649 1.18 . . . . 0.0 108.519 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -137.66 141.73 41.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.559 1.144 . . . . 0.0 109.376 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.2 tm? -133.44 132.34 40.99 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -113.98 127.98 56.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.433 ' HB3' HD21 ' A' ' 87' ' ' LEU . 43.4 mtt -111.24 133.65 53.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.278 1.031 . . . . 0.0 110.042 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -133.91 149.54 51.3 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 60.05 54.16 4.28 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.036 0.935 . . . . 0.0 111.434 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 84' ' ' MET . 94.7 mt -75.1 115.96 15.3 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.995 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.48 146.11 95.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -61.39 -13.01 26.52 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 123.107 2.538 . . . . 0.0 113.92 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -88.21 -2.49 58.63 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.722 1.209 . . . . 0.0 112.211 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.483 ' HB3' HG11 ' A' ' 121' ' ' VAL . 14.3 t70 -74.56 -19.82 60.18 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.937 0.895 . . . . 0.0 110.967 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.501 HG23 ' HA ' ' A' ' 120' ' ' THR . 88.7 m -48.4 109.17 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.189 1.396 . . . . 0.0 112.32 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.35 153.79 3.06 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.857 0.723 . . . . 0.0 111.011 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 14.9 p -77.65 114.14 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.8 m-85 -85.6 111.11 19.75 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 121.476 0.655 . . . . 0.0 109.688 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.1 127.88 54.19 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.837 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.3 m -83.87 118.49 24.0 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.4 128.71 54.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.916 0.886 . . . . 0.0 109.007 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.69 169.86 11.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.684 0.794 . . . . 0.0 111.544 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.795 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.121 -176.073 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.027 0.441 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -135.71 160.06 39.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.837 0.855 . . . . 0.0 110.313 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -160.04 143.33 13.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.651 1.18 . . . . 0.0 108.573 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -90.35 -143.26 10.52 Favored Glycine 0 C--N 1.344 0.99 0 O-C-N 122.977 0.173 . . . . 0.0 112.81 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.84 -73.99 0.41 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.027 0.931 . . . . 0.0 110.286 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.48 165.11 11.17 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.201 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.407 HG21 HD12 ' A' ' 21' ' ' LEU . 5.4 t -143.56 108.38 4.91 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.893 0.877 . . . . 0.0 110.269 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 61.4 tp60 -68.97 111.27 4.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.105 0.562 . . . . 0.0 110.877 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -91.74 145.07 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 92' ' ' THR . 26.8 m -133.72 106.16 7.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.417 0.687 . . . . 0.0 109.492 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 91' ' ' ASP . 2.3 p -99.05 102.15 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.88 0.848 . . . . 0.0 108.774 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -57.18 141.86 44.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.958 1.703 . . . . 0.0 111.674 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.246 0.869 0 C-N-CA 124.022 0.929 . . . . 0.0 111.325 178.854 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 28' ' ' ARG . 62.1 tp . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.62 106.14 15.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.704 0.801 . . . . 0.0 108.973 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.532 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.4 mt -97.57 121.3 39.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.144 0.978 . . . . 0.0 108.846 173.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 60.1 t -114.51 101.19 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.536 0.734 . . . . 0.0 109.176 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -74.92 142.32 44.02 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.526 0.73 . . . . 0.0 109.751 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 p -157.17 166.04 34.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.487 1.115 . . . . 0.0 110.02 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.24 85.51 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.583 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -84.5 139.3 17.95 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.9 -163.95 28.88 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' THR . 3.9 pp -106.7 143.75 34.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.65 0.78 . . . . 0.0 111.623 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 14.5 p -151.57 156.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 108.266 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -73.07 167.38 21.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.719 0.408 . . . . 0.0 111.275 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 121.09 17.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.92 1.03 57.32 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.878 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.52 -172.67 49.27 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 123.058 0.361 . . . . 0.0 112.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -135.26 143.85 46.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.793 0.837 . . . . 0.0 109.664 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -140.97 124.21 16.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.041 0.937 . . . . 0.0 108.611 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -95.13 120.29 35.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.12 0.968 . . . . 0.0 109.737 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.1 mm? -99.31 157.68 16.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.563 0.745 . . . . 0.0 109.435 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.58 156.26 45.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.44 1.096 . . . . 0.0 108.644 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.558 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 52.5 t -150.4 117.61 6.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.768 0.427 . . . . 0.0 110.513 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.0 119.27 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.295 0.638 . . . . 0.0 109.662 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.48 124.69 49.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.255 1.022 . . . . 0.0 109.529 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -145.09 163.49 34.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.075 0.55 . . . . 0.0 111.127 -172.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.7 -90.5 1.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 112.362 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 27.8 tpt180 -79.59 154.47 28.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.228 0.611 . . . . 0.0 110.767 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 m -75.12 93.5 2.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.17 0.588 . . . . 0.0 110.091 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -61.36 -29.3 69.82 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.046 0.939 . . . . 0.0 111.43 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 57.3 p -77.16 0.37 21.96 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.747 0.819 . . . . 0.0 112.519 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -95.21 -14.59 23.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.173 0.589 . . . . 0.0 111.086 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.33 173.01 6.83 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.803 0.841 . . . . 0.0 110.891 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.34 160.81 18.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 163.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.9 ttp -137.87 136.52 37.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -139.38 140.85 11.2 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 122.969 0.319 . . . . 0.0 112.411 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -95.03 135.04 37.05 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.485 1.114 . . . . 0.0 108.96 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -127.81 149.97 50.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.054 1.342 . . . . 0.0 108.189 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -135.59 160.7 37.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.941 0.337 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.476 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.3 pp0? -165.93 145.75 6.36 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.725 0.641 . . . . 0.0 110.67 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -177.03 -63.54 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.387 169.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 90.2 Cg_endo -78.86 75.96 4.77 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.249 1.966 . . . . 0.0 112.393 -171.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 15.58 68.13 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.168 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -105.15 143.25 33.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.281 1.032 . . . . 0.0 111.043 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.56 172.61 8.26 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 162.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -60.05 104.61 0.32 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.098 0.475 . . . . 0.0 110.118 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.57 152.34 18.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.629 1.172 . . . . 0.0 109.564 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -62.17 111.81 2.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.32 -54.08 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -166.29 136.82 3.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.499 0.499 . . . . 0.0 111.421 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' HA3' ' A' ' 36' ' ' GLY . 40.3 t -121.06 129.39 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.257 1.023 . . . . 0.0 109.58 173.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -116.03 158.26 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.284 1.034 . . . . 0.0 108.482 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.31 172.82 10.16 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 36.1 p-90 -62.33 -27.65 69.2 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.906 0.883 . . . . 0.0 113.255 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.3 m -86.06 -22.48 27.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.454 0.702 . . . . 0.0 112.543 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.43 10.98 83.84 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 123.08 0.237 . . . . 0.0 112.55 -172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -83.77 -23.66 31.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.842 1.257 . . . . 0.0 111.336 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -121.32 120.35 34.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.164 0.986 . . . . 0.0 108.574 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -127.93 130.75 48.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.652 0.781 . . . . 0.0 109.02 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.02 132.68 45.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 76.1 m-85 -128.56 150.84 50.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.378 0.671 . . . . 0.0 109.873 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.62 135.31 46.88 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.11 -30.87 38.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 112.0 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -62.88 -43.32 99.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.008 0.923 . . . . 0.0 112.153 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.57 1.71 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 26.3 ttpp -69.55 134.38 48.76 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.745 0.818 . . . . 0.0 110.845 -173.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.01 25.08 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.814 0.696 . . . . 0.0 113.718 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 29.4 ptt-85 -107.35 -20.74 13.18 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.235 0.518 . . . . 0.0 111.24 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-30 -97.61 157.69 15.9 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.161 0.585 . . . . 0.0 110.203 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.8 m -150.2 134.82 17.46 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.613 1.165 . . . . 0.0 109.122 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -102.56 142.04 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 169.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -142.02 160.38 40.33 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.999 1.32 . . . . 0.0 107.632 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 173.85 15.1 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -148.26 118.74 7.41 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.43 -24.67 59.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.814 0.846 . . . . 0.0 111.625 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.26 33.93 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.521 0.728 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.8 mmpt? -87.13 -14.59 40.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 0.0 111.401 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 61.93 27.72 16.85 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.559 1.162 . . . . 0.0 110.931 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -122.96 133.73 54.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.994 0.518 . . . . 0.0 110.549 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 91.5 t -104.39 154.08 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.591 1.556 . . . . 0.0 109.061 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.55 141.94 41.39 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.416 1.086 . . . . 0.0 109.072 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -131.59 99.56 4.84 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -85.65 117.08 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.372 0.669 . . . . 0.0 109.893 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.562 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.4 mtm -110.43 99.59 8.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.756 0.822 . . . . 0.0 109.872 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -99.0 154.06 18.38 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.655 0.782 . . . . 0.0 109.817 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t 56.62 42.24 27.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' MET . 18.1 mt -56.03 124.76 18.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.053 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' O ' HG11 ' A' ' 121' ' ' VAL . 80.6 tttt -90.69 142.7 28.07 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.724 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -34.55 -40.33 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 125.205 3.936 . . . . 0.0 116.182 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.24 -11.92 60.42 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.507 1.123 . . . . 0.0 113.736 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -80.64 -2.63 47.35 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.589 0.755 . . . . 0.0 112.515 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 90.0 m -63.47 106.19 0.89 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.319 0.648 . . . . 0.0 110.215 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.01 160.06 4.12 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 0.0 111.014 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 40' ' ' GLN . 7.6 p -83.04 114.54 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -87.5 113.77 23.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.926 0.891 . . . . 0.0 110.408 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.57 126.25 52.31 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.364 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.3 143.89 28.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -140.3 158.71 43.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.995 0.918 . . . . 0.0 109.915 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -134.94 141.83 46.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.988 0.515 . . . . 0.0 110.706 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.02 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 121.378 0.608 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 38.7 m-85 -118.76 155.74 30.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.249 1.019 . . . . 0.0 109.29 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 10.3 p90 -165.68 172.86 11.38 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.226 1.011 . . . . 0.0 109.753 170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.98 -149.69 16.24 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.338 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.84 -64.59 1.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.669 1.188 . . . . 0.0 109.109 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.68 142.19 6.28 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.453 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 10.2 t -122.52 117.89 26.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.895 0.878 . . . . 0.0 109.687 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 26.6 tp60 -78.2 106.47 10.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.12 0.568 . . . . 0.0 109.83 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.2 146.97 8.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.511 0.724 . . . . 0.0 109.276 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 47.1 m -131.93 133.99 45.16 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.458 0.703 . . . . 0.0 109.696 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.1 p -114.38 105.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -59.45 112.38 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.733 1.213 . . . . 0.0 110.754 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.242 0.66 0 C-N-CA 123.879 0.871 . . . . 0.0 110.621 -178.312 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 28' ' ' ARG . 43.9 tp . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 6.6 tp-100 -80.23 123.38 27.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.438 0.695 . . . . 0.0 109.665 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.4 mt -111.55 111.28 22.18 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.7 t -98.55 100.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 6.8 tm-20 -82.56 131.02 35.22 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.9 m -138.88 128.32 24.41 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.317 1.047 . . . . 0.0 108.763 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.89 -155.13 26.22 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.55 151.01 5.29 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 122.914 0.293 . . . . 0.0 112.899 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.66 -173.61 43.28 Favored Glycine 0 C--O 1.241 0.593 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.08 134.35 41.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.543 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 HD12 ' A' ' 87' ' ' LEU . 13.5 p -152.56 156.67 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 108.913 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 43.3 mt-30 -81.26 161.23 24.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.368 0.667 . . . . 0.0 110.556 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 131.97 46.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.647 0.379 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.43 -15.08 62.7 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.743 0.652 . . . . 0.0 111.489 -170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.17 -171.08 40.23 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.027 0.346 . . . . 0.0 113.833 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.3 p -137.85 160.34 39.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 0.0 110.885 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.92 164.03 33.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -130.22 140.63 50.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 82' ' ' LEU . 1.7 mm? -119.64 157.81 27.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.606 1.563 . . . . 0.0 107.472 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 t -151.56 163.75 38.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.453 0.301 . . . . 0.0 110.256 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.6 t -152.86 122.62 6.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.06 0.544 . . . . 0.0 110.61 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 127.63 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.17 136.45 44.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.264 0.626 . . . . 0.0 109.49 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 9.5 t -71.94 -175.44 1.44 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.431 1.092 . . . . 0.0 112.674 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.58 -19.84 54.99 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HB2' HD13 ' A' ' 3' ' ' LEU . 45.7 mmm-85 -60.81 145.88 48.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.602 0.761 . . . . 0.0 111.346 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.3 p -70.63 91.16 0.79 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -60.18 -21.35 61.59 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.141 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 17.6 p -67.17 -0.2 3.19 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.44 1.496 . . . . 0.0 113.462 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 m -106.98 -3.3 20.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.253 0.621 . . . . 0.0 111.019 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.82 155.49 36.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.137 0.575 . . . . 0.0 111.021 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.87 125.84 35.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.538 ' HG2' HG21 ' A' ' 80' ' ' VAL . 3.0 tpt -99.17 116.92 32.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.413 1.085 . . . . 0.0 109.033 -172.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -132.85 142.19 13.67 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 114.072 0.389 . . . . 0.0 114.072 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -96.72 134.15 40.35 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.959 1.303 . . . . 0.0 109.319 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -124.5 164.73 19.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -143.13 154.12 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.161 0.437 . . . . 0.0 111.548 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.08 151.02 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.623 1.169 . . . . 0.0 109.025 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.36 -64.92 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 C-N-CA 124.017 0.927 . . . . 0.0 111.068 166.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 54.5 Cg_endo -84.43 69.63 6.07 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.008 1.805 . . . . 0.0 111.949 -172.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 5.61 63.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.341 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -92.37 139.97 30.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.142 0.977 . . . . 0.0 109.547 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.44 169.0 12.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.532 0.733 . . . . 0.0 109.495 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -63.11 103.84 0.51 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.91 155.47 22.6 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.904 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.9 109.52 1.28 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.718 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.83 -63.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.47 134.11 1.79 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.724 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HA3' ' A' ' 36' ' ' GLY . 69.9 t -118.31 129.97 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 109.344 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 59' ' ' THR . 11.7 p -105.94 146.27 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -77.26 148.91 35.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.4 p-90 -48.26 -33.65 9.04 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -83.57 -32.45 25.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.553 0.741 . . . . 0.0 111.483 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.6 -8.19 61.8 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.35 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.96 -41.46 78.36 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.794 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -107.7 130.87 54.89 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.383 0.673 . . . . 0.0 109.655 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.606 HG22 HG23 ' A' ' 52' ' ' VAL . 32.9 p -130.94 143.88 51.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.456 1.102 . . . . 0.0 109.002 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -131.45 144.5 51.22 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 109.682 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.89 145.51 42.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.523 0.729 . . . . 0.0 109.075 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.35 -29.61 66.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.536 0.734 . . . . 0.0 112.054 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 m -66.04 -31.27 72.06 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.253 1.021 . . . . 0.0 111.911 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.15 -2.56 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.955 0.902 . . . . 0.0 111.911 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -73.85 137.01 43.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.835 0.454 . . . . 0.0 110.825 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.95 -24.83 22.64 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.678 0.611 . . . . 0.0 113.015 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -113.04 -12.46 13.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.668 0.787 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 82' ' ' LEU . 3.1 m-85 -109.78 145.22 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.363 0.665 . . . . 0.0 109.725 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -144.35 129.82 18.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.045 0.938 . . . . 0.0 109.045 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.455 HG12 HD23 ' A' ' 82' ' ' LEU . 5.6 mt -101.65 120.48 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -124.92 138.3 54.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.57 0.748 . . . . 0.0 109.07 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.68 137.61 30.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.626 0.37 . . . . 0.0 110.031 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -105.79 101.6 11.1 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.584 0.754 . . . . 0.0 110.896 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.25 -44.54 79.17 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.282 1.033 . . . . 0.0 110.917 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -86.58 -10.92 52.93 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.401 0.68 . . . . 0.0 111.163 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 62.97 28.1 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.637 1.175 . . . . 0.0 110.362 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.6 m -121.94 132.15 54.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.666 0.786 . . . . 0.0 110.533 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 35' ' ' MET . 26.1 t -100.57 157.35 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -139.05 155.46 47.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.54 1.136 . . . . 0.0 109.247 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -130.42 122.14 27.22 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.62 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.347 1.059 . . . . 0.0 108.519 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 48.8 mtt -86.47 125.22 33.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.593 0.757 . . . . 0.0 109.056 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -128.63 153.59 47.11 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.1 m 54.88 46.48 24.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.825 0.85 . . . . 0.0 111.91 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD12 HG11 ' A' ' 13' ' ' VAL . 63.9 mt -66.33 128.97 38.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.556 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.08 157.84 53.54 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.521 1.129 . . . . 0.0 108.635 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.49 -16.49 35.97 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.677 2.252 . . . . 0.0 113.722 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.47 -26.3 68.66 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.339 1.056 . . . . 0.0 112.247 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.63 -12.51 60.02 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.7 m -61.43 99.34 0.1 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.327 0.512 . . . . 0.0 109.683 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.55 157.13 3.14 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.671 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 p -80.11 112.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -87.62 119.55 28.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.177 0.991 . . . . 0.0 109.719 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -101.81 126.18 48.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.185 0.994 . . . . 0.0 109.346 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 20.2 t -85.07 107.66 17.28 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.402 0.681 . . . . 0.0 109.628 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -108.21 158.31 17.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 110.997 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.67 123.51 15.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.162 0.985 . . . . 0.0 108.737 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.406 0 O-C-N 123.414 0.446 . . . . 0.0 112.003 -177.12 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.978 0.418 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -126.8 159.47 33.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 109.303 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 48.8 p90 -155.71 165.92 35.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.483 0.713 . . . . 0.0 110.211 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.7 -170.37 17.97 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.737 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.53 -56.63 11.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.778 0.831 . . . . 0.0 110.967 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.29 151.05 23.76 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.449 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 10.2 t -130.8 136.09 48.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.275 0.63 . . . . 0.0 111.213 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -75.14 108.48 7.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.56 139.85 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.524 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.1 m -126.07 105.34 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.59 109.06 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.192 0.597 . . . . 0.0 109.435 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 46.9 t -55.96 122.36 11.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.87 1.268 . . . . 0.0 111.07 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 123.918 0.887 . . . . 0.0 110.201 176.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 49.7 tp . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 27.5 tt0 -79.56 110.35 14.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.719 0.808 . . . . 0.0 109.578 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.512 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 44.0 mt -104.81 112.99 26.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.66 101.11 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.436 0.694 . . . . 0.0 109.572 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.41 149.3 26.77 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.773 0.32 . . . . 0.0 110.295 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.0 p -159.42 168.22 26.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.318 1.047 . . . . 0.0 109.553 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.46 -7.63 54.1 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 120.034 -0.315 . . . . 0.0 113.177 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 126.59 8.36 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.698 0.249 . . . . 0.0 112.808 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.71 -164.73 20.65 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.77 141.6 30.4 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.119 0.485 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.74 159.41 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.209 1.404 . . . . 0.0 107.968 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -88.11 165.12 15.35 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.889 0.476 . . . . 0.0 111.459 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.91 120.98 13.56 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.453 0.701 . . . . 0.0 109.425 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 5.03 75.8 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.926 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.67 -176.48 49.23 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.572 0.219 . . . . 0.0 113.145 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -134.46 158.04 44.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -158.01 143.13 16.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.295 0.638 . . . . 0.0 109.652 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -111.64 122.23 47.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -96.13 150.36 20.59 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -139.57 125.08 19.22 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.78 135.54 53.41 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.654 0.782 . . . . 0.0 109.107 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 118.93 37.51 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.307 0.643 . . . . 0.0 109.31 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 4' ' ' GLN . . . -104.56 135.94 45.04 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.162 0.585 . . . . 0.0 109.599 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.6 m -149.69 162.7 39.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.991 0.916 . . . . 0.0 110.07 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 -96.24 1.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.564 ' HB3' ' HE2' ' A' ' 33' ' ' TYR . 16.4 mmt85 -67.27 164.54 18.11 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.07 0.548 . . . . 0.0 111.869 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.3 p -71.63 83.98 0.86 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.874 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.487 ' HD1' HD21 ' A' ' 3' ' ' LEU . 78.2 t80 -57.73 -29.99 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.526 0.73 . . . . 0.0 111.37 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -71.18 0.68 7.27 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.392 1.077 . . . . 0.0 112.877 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.1 m -112.5 -9.25 13.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.998 0.919 . . . . 0.0 111.113 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HE2' ' HB3' ' A' ' 28' ' ' ARG . 47.0 m-85 -114.79 138.84 50.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.909 0.483 . . . . 0.0 110.75 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 157.62 26.34 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 167.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 13.9 ttp -141.37 147.54 38.2 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -141.82 150.83 22.31 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.23 0.332 . . . . 0.0 112.43 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -97.84 127.51 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.652 0.781 . . . . 0.0 109.155 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.52 132.77 49.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.031 . . . . 0.0 108.271 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 27.6 ptt180 -116.73 158.67 23.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.533 0.333 . . . . 0.0 110.771 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.539 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.1 pp0? -170.06 153.81 4.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.686 0.794 . . . . 0.0 109.078 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.73 -54.34 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 118.516 -0.755 . . . . 0.0 111.528 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.43 68.22 8.07 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.039 1.826 . . . . 0.0 112.457 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.38 21.14 64.11 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.049 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -115.58 156.62 25.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.336 0.654 . . . . 0.0 111.564 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.57 170.43 16.66 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.546 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -61.64 103.89 0.37 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.55 146.54 24.38 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.671 0.788 . . . . 0.0 109.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -65.25 120.96 13.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.863 0.865 . . . . 0.0 110.23 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 95' ' ' TYR . 52.0 t -101.94 -54.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -168.31 154.81 7.39 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.112 -173.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 36' ' ' GLY . 70.5 t -140.37 147.5 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.704 1.202 . . . . 0.0 108.328 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -141.29 153.1 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.184 0.994 . . . . 0.0 108.985 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -76.66 161.15 28.78 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 167.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -55.17 -39.4 69.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.296 0.638 . . . . 0.0 110.696 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -74.31 -19.99 60.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.474 1.109 . . . . 0.0 111.584 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.03 78.21 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -167.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -58.91 -64.8 0.81 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.286 1.034 . . . . 0.0 110.851 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -112.84 129.56 56.4 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 52' ' ' VAL . 65.2 p -114.47 130.31 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -116.23 126.92 54.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -118.7 150.75 39.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.184 0.594 . . . . 0.0 109.923 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.62 130.71 35.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.89 -22.51 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -67.81 -40.98 83.77 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.626 0.77 . . . . 0.0 111.409 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 62' ' ' ALA . 32.2 m -106.86 3.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.934 0.894 . . . . 0.0 111.578 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.6 128.49 36.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.869 0.867 . . . . 0.0 111.288 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 -17.56 50.83 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 113.619 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -103.04 -19.12 14.68 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -102.34 157.88 16.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 110.216 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.2 m -149.27 133.12 17.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.105 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.507 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.6 mp -103.0 131.13 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -133.15 160.42 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 108.334 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 167.29 30.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.96 111.86 11.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.99 -16.19 60.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.588 0.755 . . . . 0.0 112.083 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.1 -50.64 11.64 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.0 -14.55 57.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.7 28.64 17.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.004 1.321 . . . . 0.0 111.275 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 m -113.51 130.86 56.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.898 0.479 . . . . 0.0 110.516 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.31 151.55 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 109.787 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -135.5 112.94 10.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.397 1.079 . . . . 0.0 108.931 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.0 tm? -93.6 103.1 15.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 104.06 16.69 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.749 0.82 . . . . 0.0 109.329 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.451 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.7 mtt -90.41 139.4 30.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.85 1.26 . . . . 0.0 110.963 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.61 140.11 45.83 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 54.71 58.84 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 111.713 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 84' ' ' MET . 56.4 mt -64.17 124.78 22.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.819 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.9 mtpt -72.5 144.08 85.99 Favored Pre-proline 0 C--O 1.21 -0.984 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.668 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 51.3 Cg_exo -56.45 -21.52 37.94 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.868 2.379 . . . . 0.0 114.273 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.83 3.46 55.09 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.828 1.251 . . . . 0.0 112.79 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -79.79 -17.05 54.31 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.72 0.808 . . . . 0.0 111.35 -172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 120' ' ' THR . 94.2 m -53.57 108.73 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.701 1.2 . . . . 0.0 112.11 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.95 160.45 4.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.748 0.819 . . . . 0.0 111.295 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 13.8 p -81.04 114.49 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.041 0.448 . . . . 0.0 110.173 173.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HE2' HG11 ' A' ' 49' ' ' VAL . 19.8 m-85 -87.23 127.87 35.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.835 1.254 . . . . 0.0 110.374 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.67 142.94 51.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.696 0.798 . . . . 0.0 110.001 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.488 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.5 m -92.22 112.02 23.81 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.004 0.922 . . . . 0.0 109.159 173.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.97 112.71 25.94 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -108.12 169.84 8.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.547 0.739 . . . . 0.0 111.181 -174.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.313 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 51.0 m-85 -127.51 152.6 47.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.639 0.776 . . . . 0.0 110.01 -172.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -132.16 139.06 48.27 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.512 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.62 -169.03 44.58 Favored Glycine 0 C--O 1.244 0.741 0 O-C-N 123.117 0.261 . . . . 0.0 113.731 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.82 -54.78 9.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.435 0.694 . . . . 0.0 110.366 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 106.3 2.77 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.198 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -101.69 121.45 42.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.279 1.032 . . . . 0.0 109.848 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -86.61 124.94 33.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.825 0.45 . . . . 0.0 110.059 -175.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.99 141.31 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.523 0.729 . . . . 0.0 109.04 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.468 ' HA ' HG23 ' A' ' 92' ' ' THR . 57.5 m -129.16 106.84 9.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.281 0.632 . . . . 0.0 109.656 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.8 p -93.36 128.23 44.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.3 t -69.38 111.89 5.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.52 0.728 . . . . 0.0 109.217 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 34.9 p . . . . . 0 CA--C 1.542 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.655 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.4 tp . . . . . 0 C--O 1.241 0.629 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -72.28 102.69 3.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 87.9 mt -112.84 103.62 11.62 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 57.3 t -99.74 99.6 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 50.9 mt-10 -85.77 142.67 28.8 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.953 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -158.44 172.28 18.62 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.32 0.648 . . . . 0.0 110.16 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.52 6.77 70.12 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.051 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 119.68 4.97 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.26 -164.86 23.67 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.23 147.1 34.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.13 143.53 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.448 1.099 . . . . 0.0 108.345 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -65.93 153.37 42.24 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.53 0.732 . . . . 0.0 111.309 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 110.54 2.38 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.126 0.57 . . . . 0.0 110.231 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.05 10.49 59.72 Favored Glycine 0 N--CA 1.464 0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.599 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.29 -169.15 43.08 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.644 0.261 . . . . 0.0 112.998 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.5 p -123.11 148.68 45.42 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.732 0.813 . . . . 0.0 110.759 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 tp -152.66 123.64 7.48 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -99.41 111.16 23.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.64 157.65 20.28 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.043 0.937 . . . . 0.0 110.344 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -147.25 157.92 43.77 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.061 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 43.3 t -142.35 120.97 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.475 0.71 . . . . 0.0 109.799 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.79 109.69 18.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.42 38.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.49 0.716 . . . . 0.0 109.368 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -158.58 158.65 34.32 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.669 0.787 . . . . 0.0 109.853 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.72 -93.81 0.93 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HD3' ' H ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -91.64 154.02 19.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.417 0.687 . . . . 0.0 109.453 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.458 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 39.2 p -70.13 84.93 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.43 0.633 . . . . 0.0 110.892 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -63.24 -19.56 64.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.928 0.891 . . . . 0.0 111.212 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -49.22 -40.4 33.62 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.995 1.718 . . . . 0.0 113.141 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 -21.88 50.63 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.138 0.975 . . . . 0.0 112.199 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.93 148.68 22.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.01 156.63 33.88 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 165.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttp -141.58 141.09 33.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.13 0.572 . . . . 0.0 110.204 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 142.66 14.17 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -97.21 129.32 44.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 108.959 171.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -132.91 143.04 49.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.412 1.085 . . . . 0.0 109.359 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -125.64 155.85 40.14 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.256 0.48 . . . . 0.0 112.25 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.01 144.19 6.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.792 0.837 . . . . 0.0 110.992 171.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 167.87 -50.35 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 125.28 1.432 . . . . 0.0 111.939 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.28 61.96 8.34 Favored 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.558 2.172 . . . . 0.0 113.122 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.52 21.41 70.67 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.553 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -127.67 150.49 49.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.791 0.837 . . . . 0.0 110.728 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 173.47 9.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.82 0.848 . . . . 0.0 109.629 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -69.18 109.06 3.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.333 0.587 . . . . 0.0 111.056 -172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -112.14 157.76 20.44 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.342 -170.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -63.67 121.82 14.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.884 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 65' ' ' VAL . 61.7 t -106.59 -66.85 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -153.76 134.07 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.56 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -122.29 155.58 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.187 0.995 . . . . 0.0 108.589 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.23 150.27 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.04 170.14 14.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.829 0.452 . . . . 0.0 110.538 171.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -60.37 -43.23 96.77 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -88.63 -2.1 58.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.071 0.548 . . . . 0.0 111.874 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.88 85.12 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.122 0.264 . . . . 0.0 113.076 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.74 -39.44 94.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.2 1.0 . . . . 0.0 111.325 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -115.81 135.08 54.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.671 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 p -125.26 129.33 49.82 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.12 141.44 41.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.447 1.499 . . . . 0.0 108.286 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -141.43 146.09 36.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.292 0.637 . . . . 0.0 109.943 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.97 151.39 40.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 164.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.55 -33.74 47.0 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.12 0.968 . . . . 0.0 112.973 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -75.77 -41.89 51.8 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.098 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 9.3 m -92.08 -4.73 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.37 0.668 . . . . 0.0 111.244 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.01 129.14 38.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.587 0.755 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.73 -25.44 6.62 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.787 0.679 . . . . 0.0 113.906 176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 19.6 ptp180 -102.4 -24.58 13.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.531 0.733 . . . . 0.0 111.017 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.1 m-30 -97.84 161.29 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.5 m -148.41 135.74 20.4 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 108.736 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.9 mp -100.9 139.16 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -142.37 148.85 38.56 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.191 0.996 . . . . 0.0 109.127 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 136.73 19.95 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -117.29 117.69 30.23 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -85.24 -14.48 46.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.677 0.791 . . . . 0.0 111.928 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.38 -45.91 10.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.257 0.623 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.05 -20.13 56.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.947 0.899 . . . . 0.0 110.448 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.2 39.45 12.66 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.574 1.171 . . . . 0.0 109.74 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 m -129.51 131.43 46.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.917 0.487 . . . . 0.0 111.06 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 75.3 t -98.16 148.3 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 109.878 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -134.28 141.73 47.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 109.085 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -133.34 105.17 6.81 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -84.27 106.27 15.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.591 0.756 . . . . 0.0 109.068 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 53.3 mtt -102.11 128.7 48.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -128.1 144.39 51.11 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m 57.33 64.51 1.58 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.165 0.986 . . . . 0.0 112.014 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 91.4 mt -77.77 120.63 22.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.14 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG11 ' A' ' 121' ' ' VAL . 46.4 mtpt -74.23 152.32 88.13 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.073 -0.965 . . . . 0.0 108.643 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 98.7 Cg_exo -48.78 -26.97 10.39 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.205 2.603 . . . . 0.0 114.773 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.41 -22.72 60.15 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.089 0.956 . . . . 0.0 112.816 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.17 -6.63 14.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.577 0.751 . . . . 0.0 112.346 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.2 m -61.74 98.76 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.78 159.03 7.79 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.523 -170.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -86.35 114.4 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 171.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.465 ' HE2' HG11 ' A' ' 49' ' ' VAL . 49.9 m-85 -86.41 150.06 24.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.931 0.892 . . . . 0.0 108.706 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.65 121.58 12.79 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.7 p -85.09 102.53 13.32 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.39 142.89 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.633 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.64 121.54 44.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.072 0.463 . . . . 0.0 110.256 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.323 -177.978 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.035 0.445 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 57.3 m-85 -126.17 155.27 41.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.699 0.8 . . . . 0.0 109.573 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -136.11 147.94 48.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.633 0.773 . . . . 0.0 109.935 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.96 -170.23 45.13 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.521 -0.308 . . . . 0.0 113.46 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 15.5 mm100 -85.66 -38.65 18.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.213 0.605 . . . . 0.0 109.958 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.02 109.32 2.28 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.381 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 8.4 t -99.87 113.67 26.36 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.482 0.658 . . . . 0.0 109.563 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.615 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -82.15 123.43 28.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -110.09 139.31 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.425 ' HA ' HG23 ' A' ' 92' ' ' THR . 27.6 m -117.66 104.84 11.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.5 p -88.85 101.22 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.0 t -65.71 113.08 4.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.965 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 18.3 p . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.525 0.73 . . . . 0.0 109.622 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 30' ' ' PHE . 46.0 tp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -86.29 104.03 15.44 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.657 0.783 . . . . 0.0 109.282 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.48 104.98 14.82 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.83 114.95 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -113.49 134.63 54.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.608 0.763 . . . . 0.0 109.422 -168.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -157.22 149.11 22.5 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.454 1.102 . . . . 0.0 109.998 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.13 -6.5 0.82 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.815 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.61 151.81 38.34 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.832 0.316 . . . . 0.0 113.617 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.72 -167.6 34.93 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -93.7 133.48 37.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.304 0.642 . . . . 0.0 110.384 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.57 143.32 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.1 0.96 . . . . 0.0 109.253 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -62.05 159.02 15.21 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.149 0.979 . . . . 0.0 112.784 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.49 17.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.72 0.808 . . . . 0.0 110.396 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.46 -1.25 69.09 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.252 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.65 -163.41 29.29 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.19 0.424 . . . . 0.0 113.481 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -137.3 146.98 45.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.0 111.03 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.3 tp -154.5 121.41 5.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.45 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -96.23 129.58 43.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.562 1.145 . . . . 0.0 110.574 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -102.92 158.31 16.37 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.31 1.044 . . . . 0.0 108.712 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -151.15 124.17 8.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.656 0.383 . . . . 0.0 110.181 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 43.3 t -117.34 116.94 28.2 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.578 0.751 . . . . 0.0 110.245 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.03 119.7 25.26 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.05 139.76 40.93 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.39 1.076 . . . . 0.0 109.402 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.408 ' O ' HD12 ' A' ' 3' ' ' LEU . 12.6 t -153.72 173.26 16.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.895 0.478 . . . . 0.0 110.649 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 -106.26 3.39 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -84.49 168.22 15.66 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.282 0.541 . . . . 0.0 109.743 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -72.43 102.65 3.24 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.901 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 3' ' ' LEU . 16.7 p90 -64.85 -25.33 67.85 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.622 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 p -74.93 -0.1 17.52 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.955 1.302 . . . . 0.0 112.596 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -92.31 -7.69 47.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.21 0.604 . . . . 0.0 110.192 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -129.58 154.11 47.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 110.251 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.52 145.14 26.91 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 80' ' ' VAL . 15.2 ptm -120.24 159.04 25.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.802 0.441 . . . . 0.0 109.898 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.519 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.29 142.55 10.36 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.174 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -96.74 132.01 42.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.099 0.96 . . . . 0.0 109.193 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.94 164.82 19.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.374 1.07 . . . . 0.0 108.14 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 38.3 ptt180 -146.92 154.06 40.84 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.746 0.248 . . . . 0.0 111.263 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pp0? -165.16 145.79 7.25 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.069 0.856 . . . . 0.0 110.169 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 171.55 -52.66 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.23 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.38 50.6 3.06 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.749 2.299 . . . . 0.0 112.657 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.63 -8.92 53.42 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.019 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -94.7 132.35 39.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.77 0.828 . . . . 0.0 109.05 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.02 179.16 5.13 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.946 0.779 . . . . 0.0 110.817 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -54.1 105.4 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.46 0.704 . . . . 0.0 110.247 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -111.73 149.5 31.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.259 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.406 ' HE2' HG23 ' A' ' 51' ' ' VAL . 87.2 t80 -68.65 113.82 6.48 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.225 1.01 . . . . 0.0 109.626 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.04 -66.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -164.3 162.32 22.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.649 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG22 ' HA3' ' A' ' 36' ' ' GLY . 53.3 t -137.83 152.46 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.714 1.206 . . . . 0.0 107.77 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 59' ' ' THR . 13.3 p -131.46 143.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.047 0.939 . . . . 0.0 108.824 172.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.33 158.18 36.28 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -57.95 -35.63 71.4 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.519 0.728 . . . . 0.0 112.197 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.1 p -76.67 -29.89 56.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.422 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' NH1' ' A' ' 73' ' ' ARG . . . 83.67 3.42 89.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.524 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -62.69 -34.53 77.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.886 0.874 . . . . 0.0 111.041 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.83 130.9 49.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.734 0.814 . . . . 0.0 110.25 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 52' ' ' VAL . 30.5 p -115.44 129.24 56.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.571 1.148 . . . . 0.0 108.896 173.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -93.69 140.94 29.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.203 1.001 . . . . 0.0 108.887 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.39 151.67 50.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.157 0.583 . . . . 0.0 109.866 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.21 144.91 37.93 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 161.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.89 -28.75 64.48 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.855 0.462 . . . . 0.0 112.047 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.4 t -70.99 -44.35 66.14 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.753 0.421 . . . . 0.0 111.124 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -92.83 1.95 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.629 0.372 . . . . 0.0 111.58 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.74 108.82 1.06 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 111.734 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.88 -26.33 13.21 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.662 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 7.1 ptt180 -84.14 -33.47 24.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.294 0.547 . . . . 0.0 109.616 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 5.1 m-30 -97.41 158.74 15.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -145.47 130.69 18.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.206 1.002 . . . . 0.0 108.845 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -102.67 126.48 56.84 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 24.8 m -123.81 154.03 40.17 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.149 0.98 . . . . 0.0 108.654 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.435 ' NH1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -140.68 143.85 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -121.78 96.84 5.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.88 -25.38 65.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.514 0.726 . . . . 0.0 111.411 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.52 -52.59 30.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.516 0.727 . . . . 0.0 111.177 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.98 -4.66 59.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.279 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 60.8 30.95 20.0 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.813 1.245 . . . . 0.0 111.616 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -119.96 131.95 55.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.308 0.643 . . . . 0.0 110.827 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG21 ' SD ' ' A' ' 35' ' ' MET . 57.2 t -96.23 151.08 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 109.077 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 76.6 m-85 -132.62 146.16 51.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.872 0.869 . . . . 0.0 109.077 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -134.74 102.97 5.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.15 102.83 14.83 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.5 mtm -89.71 118.31 29.22 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.81 156.71 28.94 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.5 m 59.19 47.98 11.0 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.085 0.954 . . . . 0.0 110.827 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 84' ' ' MET . 78.3 mt -63.92 117.69 7.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.968 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' O ' HG11 ' A' ' 121' ' ' VAL . 48.4 mtpt -77.17 154.79 82.44 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.555 -0.735 . . . . 0.0 109.338 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.98 -25.38 21.94 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.25 2.633 . . . . 0.0 114.421 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.58 -18.72 60.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.867 0.867 . . . . 0.0 112.837 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.73 -8.35 47.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.77 0.828 . . . . 0.0 113.042 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.2 m -62.99 98.52 0.13 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.1 159.73 9.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.338 0.655 . . . . 0.0 111.116 -170.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.2 p -83.6 113.51 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -88.45 112.91 23.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.916 0.886 . . . . 0.0 109.238 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -103.6 129.46 50.87 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.439 1.096 . . . . 0.0 110.366 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.17 101.91 13.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.882 0.873 . . . . 0.0 109.578 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.35 28.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.517 0.727 . . . . 0.0 109.446 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.98 136.44 44.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.3 0.64 . . . . 0.0 109.448 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.852 0 O-C-N 123.641 0.588 . . . . 0.0 113.023 179.738 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.951 0.405 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -139.22 155.23 47.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 0.0 110.074 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -115.06 119.13 35.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.454 1.102 . . . . 0.0 108.416 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.85 151.22 38.86 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -37.1 82.47 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.107 0.454 . . . . 0.0 110.8 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.74 171.79 24.14 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.177 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -127.65 135.18 49.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.971 0.385 . . . . 0.0 110.629 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -80.35 107.79 13.44 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.4 m -91.21 146.38 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.8 m -123.15 114.11 19.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.343 0.657 . . . . 0.0 109.412 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 88' ' ' LYS . 3.7 p -98.56 120.98 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -72.47 111.97 8.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.187 0.995 . . . . 0.0 110.128 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.5 p . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.935 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 61.2 tp . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -85.59 121.91 28.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.879 0.871 . . . . 0.0 109.35 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.584 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 74.7 mt -112.88 107.24 15.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.945 0.898 . . . . 0.0 108.733 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.24 104.42 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.9 156.74 18.73 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.019 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -159.5 172.35 18.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.296 1.038 . . . . 0.0 109.789 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.75 -4.91 69.22 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.285 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -79.43 129.71 9.35 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 117.094 0.447 . . . . 0.0 112.202 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.97 -164.07 29.12 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.3 pp -79.48 147.67 32.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 87' ' ' LEU . 3.9 p -151.64 151.85 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.483 1.113 . . . . 0.0 109.105 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.64 158.16 28.48 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.803 0.841 . . . . 0.0 110.653 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.12 111.16 4.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.543 0.737 . . . . 0.0 110.408 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.75 7.06 57.95 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.2 -163.74 36.34 Favored Glycine 0 C--N 1.352 1.451 0 C-N-CA 122.915 0.293 . . . . 0.0 113.058 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 p -137.13 151.57 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.697 0.799 . . . . 0.0 110.447 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -156.43 120.11 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.396 0.679 . . . . 0.0 109.437 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -92.07 119.59 31.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.419 0.687 . . . . 0.0 109.65 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.28 159.58 20.03 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.118 0.967 . . . . 0.0 109.076 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.9 t -142.41 163.01 34.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.382 0.673 . . . . 0.0 109.44 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.2 t -150.45 143.23 24.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.761 0.824 . . . . 0.0 109.865 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.11 53.72 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.87 122.56 46.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.699 0.8 . . . . 0.0 108.985 -175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.8 m -136.97 147.24 46.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.362 1.065 . . . . 0.0 109.739 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.5 -101.6 2.5 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -74.13 159.14 33.0 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.872 0.844 . . . . 0.0 112.787 -176.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.1 m -72.48 91.21 1.37 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.587 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.925 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 16.0 p -75.07 1.48 13.0 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.211 1.005 . . . . 0.0 112.493 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -98.98 -2.77 36.53 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.621 0.768 . . . . 0.0 110.179 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -131.23 174.38 10.1 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.681 0.792 . . . . 0.0 111.461 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 130.1 56.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.062 0.945 . . . . 0.0 108.459 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -114.64 154.41 28.44 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -156.95 154.25 25.37 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.677 -0.296 . . . . 0.0 113.632 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -97.35 143.08 28.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.791 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 98' ' ' ALA . 63.6 m-85 -138.2 138.52 38.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.722 1.209 . . . . 0.0 108.684 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -112.11 151.79 29.03 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.008 0.822 . . . . 0.0 111.323 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.08 152.05 4.16 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 110.433 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.45 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.155 0.982 . . . . 0.0 111.593 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.35 55.55 4.08 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 122.212 1.941 . . . . 0.0 112.968 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.26 40.95 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.973 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -115.61 162.43 17.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -98.49 166.7 11.23 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 0.0 108.821 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.98 102.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -101.55 153.75 19.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.488 0.715 . . . . 0.0 110.295 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.63 108.57 0.75 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.894 0.878 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.49 -64.31 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -157.81 133.15 8.88 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.435 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.494 HG22 ' HA3' ' A' ' 36' ' ' GLY . 79.6 t -126.46 123.85 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.262 1.025 . . . . 0.0 109.481 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.709 HG21 HH11 ' A' ' 73' ' ' ARG . 8.9 p -108.26 160.34 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.449 0.699 . . . . 0.0 109.439 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.97 162.78 13.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 168.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 29.1 p-90 -55.8 -43.84 77.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.293 1.037 . . . . 0.0 113.746 -174.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -83.8 -14.31 51.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.905 0.482 . . . . 0.0 110.913 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.54 10.22 82.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.179 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -67.29 -37.5 83.52 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.417 0.687 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -112.93 121.57 45.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.165 0.586 . . . . 0.0 109.888 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.484 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 p -118.04 131.89 56.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.807 1.243 . . . . 0.0 108.133 172.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -124.55 136.35 53.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.274 1.03 . . . . 0.0 108.231 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 70.5 m-85 -141.3 136.94 32.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.376 0.67 . . . . 0.0 109.58 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.91 142.11 53.01 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.47 -29.12 58.16 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.031 0.932 . . . . 0.0 112.721 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -28.78 70.16 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 112.543 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.14 -1.29 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 111.493 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 28.3 ttpp -73.06 126.9 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.497 0.719 . . . . 0.0 110.726 -172.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.67 -25.05 28.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.759 0.662 . . . . 0.0 112.809 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -103.42 -23.79 13.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.092 0.557 . . . . 0.0 110.813 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.45 154.25 19.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.903 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -146.07 135.24 22.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 109.089 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.496 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -101.48 128.73 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.8 m -125.17 141.23 52.23 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.709 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.11 149.82 34.75 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.137 0.426 . . . . 0.0 109.961 -177.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -129.44 108.67 10.45 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.721 1.208 . . . . 0.0 108.503 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -68.74 -38.91 80.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 111.061 -173.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.18 87.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.98 -13.19 56.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.933 0.493 . . . . 0.0 111.596 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 61.76 28.69 17.66 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.859 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.5 m -124.48 131.9 53.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.157 0.583 . . . . 0.0 110.677 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.68 160.1 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.531 1.132 . . . . 0.0 109.19 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -141.97 148.2 38.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.48 1.512 . . . . 0.0 108.86 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.86 100.83 5.03 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.54 102.29 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.783 0.833 . . . . 0.0 109.635 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 87' ' ' LEU . 58.5 mtm -88.44 132.43 34.47 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -133.13 153.52 51.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t 58.42 59.77 2.86 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.868 0.842 . . . . 0.0 110.711 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.6 mt -79.83 116.68 20.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.94 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 79.7 mttt -75.37 152.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.89 -25.73 22.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.0 2.467 . . . . 0.0 114.069 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 10.8 pt-20 -70.12 -23.25 63.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.042 0.937 . . . . 0.0 112.95 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.71 -3.69 19.87 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.392 0.677 . . . . 0.0 112.809 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.3 m -60.99 100.08 0.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.21 0.604 . . . . 0.0 109.719 170.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 161.04 5.55 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.677 0.791 . . . . 0.0 110.269 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.1 p -83.01 117.98 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.46 112.15 23.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -107.99 121.28 44.47 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.127 1.371 . . . . 0.0 109.365 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.7 p -88.52 143.0 27.24 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -142.7 132.94 24.66 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.354 1.062 . . . . 0.0 109.546 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.14 145.83 35.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.847 0.859 . . . . 0.0 110.964 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.686 177.424 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.744 0.307 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -140.61 155.33 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.832 1.253 . . . . 0.0 108.783 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 28.6 p90 -143.96 161.87 37.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.802 0.841 . . . . 0.0 109.667 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 5' ' ' LEU . . . -96.78 -150.08 26.38 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.386 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -90.88 -53.65 4.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.575 0.75 . . . . 0.0 110.21 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.76 120.31 4.49 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.77 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 t -105.86 121.53 44.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.883 0.873 . . . . 0.0 109.61 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -87.39 125.28 34.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.928 0.491 . . . . 0.0 110.41 -171.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 ' HE1' ' A' ' 84' ' ' MET . 5.9 m -111.56 145.4 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.653 0.781 . . . . 0.0 110.025 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 91.8 m -133.38 119.65 19.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.048 0.939 . . . . 0.0 108.908 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.3 p -104.89 116.4 48.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.0 m -63.91 113.86 3.72 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.57 1.148 . . . . 0.0 110.004 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.4 p . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 110.981 -176.333 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.3 tp . . . . . 0 C--O 1.235 0.309 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -105.14 131.2 52.94 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 84.6 mt -121.9 118.75 29.67 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.759 1.224 . . . . 0.0 108.455 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.43 103.0 14.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.67 127.74 46.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -155.09 141.27 18.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.341 1.057 . . . . 0.0 110.19 -169.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG21 ' A' ' 117' ' ' THR . . . 145.26 26.03 0.1 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -86.71 132.2 11.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.13 41.76 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.9 144.4 31.96 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.208 0.528 . . . . 0.0 110.56 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.48 153.64 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.531 . . . . 0.0 107.936 -174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.3 157.17 19.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.189 0.596 . . . . 0.0 110.953 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.75 111.79 5.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.463 0.705 . . . . 0.0 110.065 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.99 3.53 48.63 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.889 0.743 . . . . 0.0 111.504 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.76 -163.85 39.22 Favored Glycine 0 C--N 1.35 1.317 0 C-N-CA 122.792 0.234 . . . . 0.0 112.722 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.2 p -138.05 149.01 45.64 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.042 0.937 . . . . 0.0 109.921 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 tp -158.6 145.6 17.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -119.37 131.85 55.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.677 0.391 . . . . 0.0 110.881 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -92.29 159.62 15.52 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.074 0.95 . . . . 0.0 108.899 170.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -149.23 123.81 9.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.65 0.38 . . . . 0.0 110.081 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 51.7 t -127.38 106.55 9.28 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.145 0.578 . . . . 0.0 110.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.51 141.57 29.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.4 164.08 12.14 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.291 0.637 . . . . 0.0 109.861 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -66.65 166.92 11.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.384 0.674 . . . . 0.0 111.133 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.41 -13.48 50.28 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.63 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 136.62 57.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.575 1.15 . . . . 0.0 109.427 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 m -77.74 71.41 4.21 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 122.089 0.947 . . . . 0.0 111.966 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -79.84 -8.72 59.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.561 1.144 . . . . 0.0 110.574 164.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 t -57.04 -1.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 125.368 1.467 . . . . 0.0 113.812 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -91.04 -11.5 38.59 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.766 0.826 . . . . 0.0 112.088 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -107.64 167.06 10.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.366 0.666 . . . . 0.0 111.377 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.42 161.61 28.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 168.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.427 ' HE3' ' HB2' ' A' ' 35' ' ' MET . 4.4 ptm -143.0 169.84 16.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.355 0.662 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.4 146.74 11.46 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 121.787 -0.244 . . . . 0.0 113.689 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -97.64 141.1 31.08 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.238 1.415 . . . . 0.0 109.858 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -132.07 164.4 26.32 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.793 1.237 . . . . 0.0 108.884 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.1 156.25 47.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.033 0.379 . . . . 0.0 110.386 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.5 pt20 -166.38 136.01 3.17 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.976 0.797 . . . . 0.0 110.117 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 174.31 -62.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 124.469 1.107 . . . . 0.0 111.131 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.6 66.3 6.59 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.041 -168.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.29 62.57 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.96 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -98.91 133.64 42.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.761 0.824 . . . . 0.0 110.152 -173.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.15 174.13 8.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.952 0.901 . . . . 0.0 108.704 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -64.0 104.74 0.75 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.98 152.59 47.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 0.0 111.026 -169.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -58.12 110.61 0.97 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.433 1.493 . . . . 0.0 111.792 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.27 -55.86 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -169.07 132.47 1.34 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.745 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.8 141.21 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.571 1.148 . . . . 0.0 108.297 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 59' ' ' THR . 11.6 p -135.31 148.31 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.04 155.86 28.64 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -53.15 -39.07 63.27 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.098 1.359 . . . . 0.0 114.046 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.9 t -75.35 -27.13 59.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.268 0.627 . . . . 0.0 111.32 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.73 72.35 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.2 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -69.12 -55.14 11.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -106.1 124.52 49.71 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.751 . . . . 0.0 110.56 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.47 HG22 HG23 ' A' ' 52' ' ' VAL . 52.7 p -112.22 149.45 32.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.584 1.153 . . . . 0.0 109.657 174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -129.39 123.63 32.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -119.68 159.02 25.26 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.87 144.58 43.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 165.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.49 -34.25 64.42 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.042 0.937 . . . . 0.0 112.932 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -65.64 -35.66 81.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.385 0.674 . . . . 0.0 111.575 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.3 m -111.33 6.16 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 0.0 112.339 -172.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -68.67 111.55 4.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.941 0.496 . . . . 0.0 111.741 -171.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.87 15.01 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.868 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -83.17 -26.42 30.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.459 0.629 . . . . 0.0 109.565 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.16 153.4 18.94 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.6 m -146.98 136.76 23.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.034 0.934 . . . . 0.0 108.902 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.584 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -102.85 121.32 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -124.84 138.93 54.24 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -143.18 131.43 22.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.975 0.51 . . . . 0.0 110.068 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.0 95.36 6.12 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.48 -38.22 83.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 111.929 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.04 76.2 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.125 0.57 . . . . 0.0 111.446 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.45 -9.27 50.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.474 0.71 . . . . 0.0 112.042 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 18.4 m-80 58.64 27.33 15.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.683 1.193 . . . . 0.0 111.352 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.5 m -112.81 131.96 55.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.552 0.741 . . . . 0.0 109.283 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.423 HG21 ' SD ' ' A' ' 35' ' ' MET . 5.6 t -117.77 157.22 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.661 -174.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.59 127.85 19.81 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.824 1.25 . . . . 0.0 108.491 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.2 tm? -104.76 100.16 9.8 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.42 103.43 10.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 109.87 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 68.3 mtm -94.31 126.84 39.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.991 0.517 . . . . 0.0 109.775 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.35 148.01 51.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 m 57.55 58.8 3.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.394 1.078 . . . . 0.0 111.08 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 49.0 mt -73.61 117.5 15.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.502 -1.227 . . . . 0.0 112.221 -174.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -76.88 148.26 78.75 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.48 -24.06 20.9 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.0 2.466 . . . . 0.0 114.521 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -15.61 61.93 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.971 0.908 . . . . 0.0 113.255 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.38 -4.48 48.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.118 0.567 . . . . 0.0 112.261 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 120' ' ' THR . 85.2 m -61.58 103.98 0.38 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.773 0.829 . . . . 0.0 110.442 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -168.53 163.68 12.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.014 0.525 . . . . 0.0 110.993 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 8.3 p -81.07 121.61 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 168.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -86.01 143.49 28.1 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -135.48 112.3 10.17 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 41.6 t -83.13 140.6 32.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -143.61 162.84 34.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 109.366 -171.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.61 26.22 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.191 0.596 . . . . 0.0 110.745 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.454 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.579 -179.335 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -138.77 132.29 30.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.807 0.443 . . . . 0.0 110.513 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p90 -122.87 161.48 24.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.91 0.884 . . . . 0.0 110.405 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -174.66 47.31 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 114.035 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.43 -44.68 82.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.215 1.006 . . . . 0.0 110.526 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 163.33 38.9 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.485 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 9' ' ' GLY . 7.5 t -143.82 138.93 29.03 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.848 0.459 . . . . 0.0 110.109 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -91.15 121.65 33.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.05 0.54 . . . . 0.0 109.901 -173.097 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -107.21 144.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.103 0.961 . . . . 0.0 109.501 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.57 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.1 m -124.06 105.5 9.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.174 0.589 . . . . 0.0 109.891 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.0 101.32 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.266 1.031 . . . . 0.0 109.01 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.6 t -66.46 134.15 51.88 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.121 0.968 . . . . 0.0 111.36 -176.504 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -86.4 125.23 33.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -119.4 120.85 38.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.25 102.8 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.834 0.853 . . . . 0.0 109.316 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.67 138.03 33.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 110.348 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.4 m -149.8 165.79 31.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.892 0.877 . . . . 0.0 110.16 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.77 -1.19 32.03 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 112.867 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 145.64 32.03 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.06 -166.61 33.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.06 144.84 29.64 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.994 0.426 . . . . 0.0 111.227 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.23 161.27 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.662 1.185 . . . . 0.0 108.081 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -91.8 164.14 13.8 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.75 0.704 . . . . 0.0 110.494 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.48 143.17 50.11 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.471 0.708 . . . . 0.0 110.629 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 3.29 85.7 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -164.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.46 -169.6 46.15 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 114.174 0.43 . . . . 0.0 114.174 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 p -153.28 147.25 25.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.107 0.963 . . . . 0.0 110.03 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 tp -160.79 128.92 4.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.103 0.561 . . . . 0.0 109.803 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -93.77 117.3 29.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.276 0.63 . . . . 0.0 110.138 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.4 mm? -86.02 159.26 19.64 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.328 1.051 . . . . 0.0 109.245 168.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -136.57 165.7 25.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.555 0.742 . . . . 0.0 109.316 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.8 t -146.56 145.73 30.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.056 0.942 . . . . 0.0 109.255 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.66 114.72 20.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.44 154.55 20.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.049 0.54 . . . . 0.0 110.615 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 m -62.82 159.69 16.03 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.2 53.24 4.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.52 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -95.62 -167.59 1.63 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.043 1.337 . . . . 0.0 110.414 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 32' ' ' SER . 2.2 m -74.23 22.11 0.09 Allowed 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.4 0.68 . . . . 0.0 111.921 173.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.43 -29.83 69.24 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.306 1.043 . . . . 0.0 111.14 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 m -56.2 -26.29 50.32 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.881 0.872 . . . . 0.0 111.755 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB3' HG22 ' A' ' 29' ' ' THR . 23.3 t -113.1 -2.74 14.09 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.04 0.936 . . . . 0.0 112.018 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -83.46 127.19 33.51 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.741 0.7 . . . . 0.0 110.432 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.77 115.98 10.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.465 ' HE1' HG11 ' A' ' 80' ' ' VAL . 4.7 ptm -114.21 170.4 8.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 111.102 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.95 163.32 33.17 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -111.39 138.51 47.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.7 154.0 38.67 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.807 1.243 . . . . 0.0 108.349 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -126.03 158.75 34.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -174.39 160.07 3.16 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.274 0.984 . . . . 0.0 109.887 174.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 171.96 -58.08 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 124.472 1.109 . . . . 0.0 111.052 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.52 63.57 6.62 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 122.368 2.046 . . . . 0.0 112.821 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.61 -5.74 60.12 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.912 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 31.7 mmmt -92.95 148.04 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 109.58 -177.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.77 176.15 5.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.301 0.64 . . . . 0.0 110.359 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -61.13 106.64 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.155 0.582 . . . . 0.0 111.82 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.53 152.51 24.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.917 1.287 . . . . 0.0 110.138 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -57.19 113.98 1.96 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.7 0.8 . . . . 0.0 110.662 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 65' ' ' VAL . 71.8 t -98.36 -60.81 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.55 155.43 21.98 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.333 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.71 138.3 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.734 1.214 . . . . 0.0 107.957 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.565 HG23 HG22 ' A' ' 59' ' ' THR . 11.1 p -121.3 146.98 25.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.82 142.13 48.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -52.16 -41.4 62.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.291 1.036 . . . . 0.0 112.846 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -81.81 -9.27 59.66 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.46 0.704 . . . . 0.0 111.468 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.35 73.16 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 123.192 0.307 . . . . 0.0 112.561 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 31.2 tpt180 -67.38 -65.31 0.7 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.359 0.664 . . . . 0.0 110.679 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.481 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 36.6 mmt180 -113.76 127.41 56.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.279 0.631 . . . . 0.0 110.461 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.565 HG22 HG23 ' A' ' 52' ' ' VAL . 54.5 p -108.58 150.84 26.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.848 0.859 . . . . 0.0 108.746 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -133.71 130.22 37.85 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 70' ' ' THR . 98.3 m-85 -139.19 142.51 37.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.99 0.516 . . . . 0.0 109.982 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.92 142.38 47.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 162.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.51 -24.23 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.558 0.743 . . . . 0.0 111.91 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -61.0 -40.61 94.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.797 1.239 . . . . 0.0 112.199 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 49' ' ' VAL . 32.5 m -115.56 1.96 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.809 0.844 . . . . 0.0 111.67 -173.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.21 125.42 25.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.709 0.804 . . . . 0.0 111.676 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.66 -26.16 6.76 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.587 0.554 . . . . 0.0 114.462 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -93.92 -29.58 15.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.203 0.601 . . . . 0.0 110.138 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.33 146.59 25.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.401 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 91.1 m -149.95 130.36 13.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.26 1.024 . . . . 0.0 108.648 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.457 HG13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -102.05 133.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -124.98 152.06 44.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.888 1.275 . . . . 0.0 107.947 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 138.26 16.2 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.546 0.612 . . . . 0.0 111.711 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -93.48 108.43 20.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.3 -37.85 88.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 110.919 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.61 82.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.92 0.763 . . . . 0.0 111.743 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.1 mmpt? -94.68 -16.35 23.19 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.764 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 41.2 m-80 60.81 34.98 19.59 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.544 1.137 . . . . 0.0 110.804 -172.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 m -112.48 131.27 55.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.392 0.677 . . . . 0.0 109.845 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 35' ' ' MET . 6.3 t -113.22 161.32 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.07 0.948 . . . . 0.0 109.914 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -143.5 116.08 8.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.147 0.979 . . . . 0.0 108.874 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.457 HD23 HG13 ' A' ' 71' ' ' ILE . 2.6 tm? -101.21 96.69 7.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -82.8 129.77 35.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.968 0.907 . . . . 0.0 109.44 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.633 ' HB3' HD21 ' A' ' 87' ' ' LEU . 63.1 mtm -117.26 148.37 41.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.547 0.739 . . . . 0.0 109.992 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -146.25 160.16 42.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.351 1.06 . . . . 0.0 109.189 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m 54.56 48.02 21.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.564 1.145 . . . . 0.0 111.118 171.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD21 ' HB3' ' A' ' 84' ' ' MET . 97.0 mt -73.28 115.7 12.95 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.195 -171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -65.64 151.81 93.93 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.37 1.068 . . . . 0.0 109.056 166.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 20.0 Cg_endo -57.62 -22.79 53.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.268 2.645 . . . . 0.0 113.355 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 11.6 pt-20 -87.25 7.04 30.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.442 1.097 . . . . 0.0 112.285 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -87.5 2.04 51.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.665 0.386 . . . . 0.0 111.526 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.9 m -62.16 102.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 0.0 109.967 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.19 152.11 4.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.087 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.4 p -81.65 129.57 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.584 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.43 122.29 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.47 0.708 . . . . 0.0 109.854 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -103.76 132.47 49.99 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.773 0.829 . . . . 0.0 109.696 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.4 t -82.91 141.12 32.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' MET . . . -143.49 161.64 37.91 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.257 0.623 . . . . 0.0 109.716 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 146.42 36.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 0.0 108.991 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.687 0 O-C-N 123.18 0.3 . . . . 0.0 112.77 -178.625 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.268 0.556 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -130.99 149.0 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.356 1.062 . . . . 0.0 109.22 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -148.35 158.38 44.06 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.33 1.052 . . . . 0.0 108.492 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.89 -170.22 28.65 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.246 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -83.42 -39.29 20.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.245 1.018 . . . . 0.0 110.135 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.15 165.58 14.79 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.46 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 t -143.48 108.14 4.87 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 124.521 1.128 . . . . 0.0 109.455 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 58.6 tp60 -77.55 129.58 35.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.561 0.745 . . . . 0.0 111.258 -175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.37 144.94 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.571 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.9 m -127.75 105.97 8.81 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.52 106.64 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.733 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.3 t -61.55 132.21 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.005 1.322 . . . . 0.0 110.717 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 30.8 p . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 123.918 0.887 . . . . 0.0 112.495 -173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.742 HD11 ' HB1' ' A' ' 25' ' ' ALA . 57.6 tp . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -82.44 103.86 12.3 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.31 128.68 44.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.7 t -119.94 102.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.767 0.827 . . . . 0.0 108.931 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -90.92 149.66 21.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.264 0.625 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -154.39 170.07 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.118 0.967 . . . . 0.0 109.921 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.67 43.56 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.094 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.66 88.73 0.54 Allowed Glycine 0 C--N 1.345 1.078 0 C-N-CA 122.916 0.293 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.59 -172.76 13.26 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.184 0.421 . . . . 0.0 112.289 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.98 138.91 31.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.386 0.675 . . . . 0.0 110.684 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 6.4 p -152.2 153.17 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.675 1.19 . . . . 0.0 108.364 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -92.68 160.03 15.17 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.582 -0.699 . . . . 0.0 110.729 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.51 123.81 21.45 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.99 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.49 54.13 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.659 0.599 . . . . 0.0 112.124 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.16 50.33 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.817 0.363 . . . . 0.0 113.182 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.0 p -114.87 162.23 17.19 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.108 0.963 . . . . 0.0 110.398 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -160.55 125.57 3.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 109.927 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -95.2 125.32 39.76 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.09 159.19 16.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.049 1.34 . . . . 0.0 108.644 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -139.69 160.32 40.16 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.771 0.428 . . . . 0.0 110.157 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 52.9 t -150.77 133.04 15.43 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.394 1.078 . . . . 0.0 108.62 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.2 131.71 56.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.742 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -106.8 137.79 44.18 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.185 0.594 . . . . 0.0 110.681 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -144.44 169.16 18.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.26 -83.9 1.56 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -82.32 154.93 25.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.414 0.686 . . . . 0.0 109.796 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -77.5 96.58 4.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.548 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 54.0 t80 -63.75 -20.94 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.103 0.961 . . . . 0.0 111.311 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -64.53 -7.26 9.57 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.623 0.769 . . . . 0.0 112.779 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -109.44 4.84 22.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.525 0.73 . . . . 0.0 111.305 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.79 140.58 44.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 0.0 111.004 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.24 164.53 21.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.764 0.826 . . . . 0.0 109.693 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.548 ' HB2' ' HE1' ' A' ' 30' ' ' PHE . 1.1 ttp -137.47 155.07 49.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.105 0.562 . . . . 0.0 110.21 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -146.16 147.21 18.02 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.75 129.83 42.85 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -128.1 141.71 51.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.265 1.026 . . . . 0.0 108.234 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -106.58 143.01 35.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -168.02 146.86 4.6 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.709 0.631 . . . . 0.0 110.255 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.37 -60.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 124.419 1.088 . . . . 0.0 110.789 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 92.5 Cg_endo -87.47 72.67 2.92 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -171.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.95 2.29 61.3 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.282 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.9 139.46 34.52 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.524 0.73 . . . . 0.0 109.526 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.06 175.66 6.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 109.458 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -60.91 105.71 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.736 0.303 . . . . 0.0 110.405 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.5 148.02 30.84 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.349 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.73 110.89 1.88 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.769 0.828 . . . . 0.0 111.323 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.57 -65.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -162.42 135.55 5.98 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.09 0.244 . . . . 0.0 111.402 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 82.3 t -121.46 150.37 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.697 1.199 . . . . 0.0 109.17 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD12 ' A' ' 71' ' ' ILE . 8.2 p -144.16 163.91 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.51 1.124 . . . . 0.0 108.755 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -85.22 164.99 17.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 170.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 36.7 p90 -52.6 -43.25 65.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.088 1.355 . . . . 0.0 113.539 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HG ' ' HD1' ' A' ' 54' ' ' TRP . 50.4 m -95.52 -6.11 41.26 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.42 0.688 . . . . 0.0 111.557 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 52' ' ' VAL . . . 86.14 20.5 55.05 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.404 -0.279 . . . . 0.0 112.404 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -57.75 -40.66 80.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.451 1.1 . . . . 0.0 111.749 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -132.52 138.18 47.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.888 0.875 . . . . 0.0 109.09 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 p -117.22 142.06 47.51 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.241 1.016 . . . . 0.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -136.24 125.89 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -137.74 142.72 40.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.6 131.59 46.74 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 163.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.62 -26.76 62.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 p -67.2 -42.27 84.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.834 0.854 . . . . 0.0 111.408 176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.92 -7.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.97 0.508 . . . . 0.0 111.064 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -76.18 115.87 16.32 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.69 -15.72 41.06 Favored Glycine 0 C--N 1.341 0.849 0 O-C-N 123.72 0.638 . . . . 0.0 112.59 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 18.3 ptp180 -116.41 -22.9 8.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.141 0.576 . . . . 0.0 109.993 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -112.12 143.95 42.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.18 0.992 . . . . 0.0 108.609 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -143.91 130.76 20.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.876 0.87 . . . . 0.0 108.881 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' A' ' 50' ' ' ALA . 3.7 mt -101.8 126.08 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -137.47 136.8 38.07 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -151.19 153.52 35.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.348 0.594 . . . . 0.0 112.142 -169.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.45 111.25 23.74 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -70.72 -30.22 66.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 112.091 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.59 -31.9 62.2 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.053 0.541 . . . . 0.0 111.813 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -96.55 -6.16 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.655 . . . . 0.0 111.198 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 61.54 31.09 18.94 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.139 0.976 . . . . 0.0 110.514 176.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 m -112.35 132.4 55.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 109.854 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 33.7 t -114.37 154.21 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.384 1.073 . . . . 0.0 110.223 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.81 145.45 48.37 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 125.189 1.396 . . . . 0.0 108.05 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.49 107.58 10.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -82.25 101.67 10.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.949 . . . . 0.0 109.581 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.76 145.18 25.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.25 0.62 . . . . 0.0 109.904 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -145.63 152.84 40.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 m 58.92 46.11 14.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.771 0.828 . . . . 0.0 112.121 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.49 126.56 29.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.593 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 155.87 75.07 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.28 -21.52 60.71 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.418 2.079 . . . . 0.0 113.547 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -77.19 -18.4 57.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.354 0.662 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.569 ' HB2' HG11 ' A' ' 121' ' ' VAL . 2.7 m-20 -67.07 -10.07 46.0 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.302 0.641 . . . . 0.0 111.396 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -56.21 100.98 0.05 OUTLIER 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.048 0.939 . . . . 0.0 109.81 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.06 162.74 4.62 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.22 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -85.81 118.33 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -86.9 115.72 24.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.724 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.82 131.69 48.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 35' ' ' MET . 38.5 t -83.94 106.87 15.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.18 112.29 25.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.87 168.98 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.788 0.835 . . . . 0.0 110.336 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.497 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -176.601 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.001 0.429 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.87 153.52 51.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.076 0.95 . . . . 0.0 109.16 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -153.19 152.14 30.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.11 -159.33 34.06 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 123.233 0.333 . . . . 0.0 113.853 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.01 -26.38 22.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.108 0.963 . . . . 0.0 111.068 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.43 157.92 32.39 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.789 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.3 t -131.04 108.08 9.52 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.401 1.08 . . . . 0.0 108.439 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -81.17 106.16 12.94 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -174.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -92.9 142.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.1 m -123.57 111.29 16.09 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.4 p -113.51 106.91 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.679 0.752 . . . . 0.0 109.935 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -78.92 145.63 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.594 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.5 p . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 123.002 0.521 . . . . 0.0 111.071 177.537 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.781 HD11 ' HB1' ' A' ' 25' ' ' ALA . 45.8 tp . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 7.1 tp-100 -84.86 104.63 14.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.839 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.486 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.9 mt -95.15 108.76 20.88 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.599 0.759 . . . . 0.0 109.175 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.2 t -97.44 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -112.8 111.85 22.92 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -169.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -156.19 154.46 30.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.852 1.261 . . . . 0.0 109.256 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.02 -8.23 1.08 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.53 -0.305 . . . . 0.0 112.504 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.23 27.74 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.943 0.306 . . . . 0.0 112.584 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.16 -164.46 29.85 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.08 136.89 37.3 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.257 0.551 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p -151.8 145.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.225 1.41 . . . . 0.0 107.949 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.77 158.94 25.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.089 0.404 . . . . 0.0 110.592 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.53 125.92 27.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.231 0.612 . . . . 0.0 110.183 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 2.12 65.02 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.764 0.665 . . . . 0.0 112.151 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.31 -174.93 35.91 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.935 0.186 . . . . 0.0 113.32 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 p -123.75 147.41 47.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.382 1.073 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 tp -152.51 132.08 13.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.836 0.855 . . . . 0.0 108.762 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.85 127.45 55.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.354 0.662 . . . . 0.0 110.501 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 HG12 ' A' ' 119' ' ' VAL . 1.0 OUTLIER -93.03 156.51 16.84 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.788 0.835 . . . . 0.0 108.79 171.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -141.68 125.69 17.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 5' ' ' LEU . 47.9 t -117.17 104.41 11.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.321 0.649 . . . . 0.0 109.814 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.99 121.46 27.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.5 124.04 48.89 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.882 0.873 . . . . 0.0 109.502 -171.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 25.5 t -131.19 163.79 26.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.714 0.805 . . . . 0.0 111.012 -171.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 -102.98 1.64 Allowed Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.752 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.42 108.64 18.57 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 31' ' ' SER . 10.3 m -56.3 133.17 52.5 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -167.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.428 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 6.1 p90 -69.62 -19.52 63.63 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.064 0.945 . . . . 0.0 112.113 -176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 29' ' ' THR . 91.0 p -72.35 -5.54 37.0 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -88.13 -1.87 58.27 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.198 0.599 . . . . 0.0 110.436 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -136.79 173.86 11.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.84 0.856 . . . . 0.0 110.872 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.62 162.74 13.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 165.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.637 ' SD ' HG21 ' A' ' 80' ' ' VAL . 11.6 ptm -142.24 157.78 44.46 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 122.15 -0.344 . . . . 0.0 110.44 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -154.31 146.67 15.02 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.683 -0.235 . . . . 0.0 113.227 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -98.98 139.2 34.99 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.073 1.349 . . . . 0.0 109.951 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -129.15 170.22 13.81 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.13 1.372 . . . . 0.0 108.661 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -155.14 158.32 38.8 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.084 0.402 . . . . 0.0 111.833 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.12 153.9 12.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.002 0.921 . . . . 0.0 109.997 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.39 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 124.359 1.064 . . . . 0.0 111.286 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.42 67.35 8.48 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.021 1.814 . . . . 0.0 112.501 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.76 24.8 71.51 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.857 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -115.32 161.13 18.93 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.244 0.617 . . . . 0.0 112.123 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.33 175.35 7.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.637 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -66.1 103.57 0.99 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.72 153.5 17.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.923 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.52 110.64 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.792 0.837 . . . . 0.0 110.097 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.5 t -85.78 -59.41 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -171.47 147.42 2.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.031 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 36' ' ' GLY . 77.3 t -129.22 137.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.177 0.991 . . . . 0.0 108.535 174.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 59' ' ' THR . 7.0 p -124.61 160.65 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.833 0.853 . . . . 0.0 109.571 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.0 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 64.8 p-90 -57.13 -37.25 71.72 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.534 0.733 . . . . 0.0 112.741 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -76.72 -28.96 56.03 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.163 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.93 -8.22 70.34 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.278 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -59.51 -28.47 67.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.742 0.817 . . . . 0.0 112.432 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -108.61 122.55 47.34 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.547 0.739 . . . . 0.0 109.521 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 52' ' ' VAL . 38.6 p -127.15 133.64 50.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.498 1.119 . . . . 0.0 108.886 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -128.58 127.19 41.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -129.52 148.09 51.39 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.366 0.666 . . . . 0.0 110.698 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.69 137.51 42.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.69 -30.48 67.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.68 0.792 . . . . 0.0 112.992 -171.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.7 m -69.6 -41.58 75.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.214 0.606 . . . . 0.0 111.676 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.1 m -93.16 -9.44 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.338 0.655 . . . . 0.0 111.539 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -66.96 144.91 55.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.418 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.71 -24.9 7.96 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.447 0.467 . . . . 0.0 113.701 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.435 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 10.7 ptt180 -113.37 -20.72 11.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.223 0.609 . . . . 0.0 111.065 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m-30 -101.09 155.82 17.77 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.231 0.613 . . . . 0.0 110.24 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -149.07 136.6 20.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.112 . . . . 0.0 108.527 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.1 mp -101.05 121.6 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.6 m -124.3 136.84 54.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.71 131.73 21.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.574 0.702 . . . . 0.0 110.355 -174.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.5 109.15 20.69 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -68.5 -27.65 66.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.856 0.462 . . . . 0.0 110.077 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.59 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.834 0.853 . . . . 0.0 111.637 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -80.42 -16.03 55.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.355 . . . . 0.0 111.078 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 29.4 m-80 61.87 28.2 17.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.628 1.171 . . . . 0.0 110.872 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -120.83 135.11 55.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.959 0.503 . . . . 0.0 110.622 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.637 HG21 ' SD ' ' A' ' 35' ' ' MET . 19.4 t -108.81 155.59 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.788 1.235 . . . . 0.0 109.378 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -142.52 113.28 7.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.645 1.178 . . . . 0.0 108.961 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 98.86 11.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -84.83 104.92 15.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.803 0.841 . . . . 0.0 110.396 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.576 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.8 mtm -94.64 142.14 27.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.1 0.56 . . . . 0.0 109.612 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.16 162.44 34.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.563 1.145 . . . . 0.0 108.438 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 m 52.52 45.36 28.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.178 0.991 . . . . 0.0 112.153 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 84' ' ' MET . 81.2 mt -70.86 127.79 33.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.119 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -85.94 144.53 39.31 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.774 0.83 . . . . 0.0 108.94 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -44.15 -35.18 7.53 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 124.428 3.419 . . . . 0.0 115.142 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -73.52 -9.37 58.61 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.78 1.232 . . . . 0.0 113.407 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 -2.2 47.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.022 0.929 . . . . 0.0 112.65 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -58.99 105.81 0.35 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.367 0.667 . . . . 0.0 110.145 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.71 8.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.987 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.4 p -79.75 113.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.9 145.05 27.34 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 108.751 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.23 127.5 26.32 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -84.76 139.79 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.63 157.21 44.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.48 1.112 . . . . 0.0 108.398 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -145.59 164.13 32.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 110.553 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.651 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.033 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.8 m-85 -131.13 150.65 52.05 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.841 0.856 . . . . 0.0 109.847 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -124.22 139.24 54.11 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.07 0.948 . . . . 0.0 110.371 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -99.41 167.33 21.22 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.5 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -71.0 -48.39 53.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.803 0.441 . . . . 0.0 111.254 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.96 129.86 4.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.917 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.34 138.11 54.05 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.497 0.719 . . . . 0.0 110.669 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 54.0 tp60 -81.14 121.16 25.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 110.501 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 21' ' ' LEU . 2.9 m -94.93 137.56 22.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 92' ' ' THR . 31.8 m -123.69 103.59 8.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.81 104.75 16.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -59.06 134.5 57.05 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.8 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.241 0.623 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.399 175.092 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.4 tp . . . . . 0 C--O 1.239 0.51 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.28 107.9 10.02 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.818 0.847 . . . . 0.0 109.349 172.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -102.04 113.54 26.88 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.34 101.83 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.18 153.11 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.142 0.496 . . . . 0.0 110.678 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.4 p -154.32 170.28 21.68 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.72 18.95 30.82 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.31 86.87 0.32 Allowed Glycine 0 C--N 1.352 1.448 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.31 -168.29 12.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -120.5 147.88 44.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.3 p -151.06 147.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 108.065 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.1 mp0 -78.93 162.8 25.74 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.589 0.631 . . . . 0.0 110.887 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -63.9 138.38 58.45 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.084 0.554 . . . . 0.0 111.538 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -7.55 81.05 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 123.68 0.612 . . . . 0.0 112.507 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.41 -175.83 49.65 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 121.039 0.244 . . . . 0.0 113.332 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.4 p -125.19 159.45 31.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.408 1.083 . . . . 0.0 109.692 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.0 tp -152.45 122.16 6.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -96.6 112.56 24.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.491 0.716 . . . . 0.0 109.997 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -94.21 156.71 16.41 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.477 1.111 . . . . 0.0 109.699 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -133.45 152.92 51.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -149.98 109.83 4.08 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.51 121.0 26.63 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.25 129.59 53.58 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.695 0.798 . . . . 0.0 109.518 -175.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.7 t -142.63 154.43 44.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 109.61 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 -114.2 4.57 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 3' ' ' LEU . 1.6 mmp_? -61.94 134.36 56.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.063 0.545 . . . . 0.0 111.218 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.359 0.664 . . . . 0.0 110.393 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -64.06 -18.47 64.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.66 0.384 . . . . 0.0 110.265 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 52.0 p -66.79 -9.52 37.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.394 1.077 . . . . 0.0 112.484 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.9 t -98.02 -11.66 22.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 0.0 110.846 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.69 156.55 42.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.006 0.522 . . . . 0.0 111.442 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.96 143.86 26.05 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.419 ' SD ' HG21 ' A' ' 80' ' ' VAL . 10.1 ptm -128.88 170.02 13.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.193 0.597 . . . . 0.0 110.761 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.64 158.33 31.13 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.158 0.286 . . . . 0.0 113.051 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -104.62 136.48 44.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.735 0.814 . . . . 0.0 109.773 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -129.94 153.02 48.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.795 1.238 . . . . 0.0 108.178 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.39 157.98 45.53 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.397 0.544 . . . . 0.0 111.764 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.85 155.39 14.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.217 0.948 . . . . 0.0 110.126 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 175.22 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.806 1.242 . . . . 0.0 110.387 168.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.75 70.85 7.36 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.152 1.901 . . . . 0.0 112.941 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.2 66.62 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.62 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 60.6 mmtt -99.23 144.6 28.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.302 1.041 . . . . 0.0 110.981 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.52 173.21 8.46 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.966 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -66.61 103.76 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.75 152.65 20.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.287 0.635 . . . . 0.0 109.964 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.11 112.83 2.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.674 0.79 . . . . 0.0 109.653 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.6 -54.87 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.1 164.07 25.55 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.355 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.31 131.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.88 1.272 . . . . 0.0 108.283 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.86 151.53 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.336 0.655 . . . . 0.0 109.633 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 29.4 t-20 -82.09 147.48 29.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.583 0.753 . . . . 0.0 109.17 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 58.5 p-90 -54.84 -39.3 68.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.525 1.13 . . . . 0.0 113.102 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -80.72 -19.02 45.97 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.913 0.885 . . . . 0.0 110.699 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.97 61.73 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.122 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -74.04 -22.11 59.68 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.992 0.517 . . . . 0.0 110.804 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 28.8 mmt180 -133.76 137.79 45.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.194 0.997 . . . . 0.0 110.607 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -136.25 132.21 35.5 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.454 1.102 . . . . 0.0 108.582 168.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -126.32 138.46 53.59 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.98 148.59 52.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.795 0.438 . . . . 0.0 110.237 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 147.63 41.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.33 -43.52 53.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.274 1.03 . . . . 0.0 113.157 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 m -71.44 -29.69 65.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.67 0.788 . . . . 0.0 112.401 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.68 -7.35 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 111.366 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -69.7 132.26 45.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 0.0 110.427 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.67 8.06 74.12 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.705 0.628 . . . . 0.0 113.826 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 15.6 ptt180 -144.08 -26.76 0.53 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.057 0.543 . . . . 0.0 111.265 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-85 -96.27 152.56 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.8 m -150.24 134.3 17.0 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.682 1.193 . . . . 0.0 108.361 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -105.19 133.01 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -132.86 163.49 28.98 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.75 146.42 16.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.154 0.502 . . . . 0.0 110.656 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -105.1 121.23 43.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.473 0.709 . . . . 0.0 109.285 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.48 -35.51 75.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.253 0.621 . . . . 0.0 109.968 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.17 -23.82 66.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.637 0.775 . . . . 0.0 112.158 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.23 -20.0 13.64 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.389 0.676 . . . . 0.0 111.078 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 59.41 35.53 23.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.791 1.236 . . . . 0.0 110.757 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -124.27 132.17 53.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.43 0.692 . . . . 0.0 110.349 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG21 ' SD ' ' A' ' 35' ' ' MET . 50.3 t -99.43 130.48 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.524 1.13 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.47 114.56 26.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.676 0.79 . . . . 0.0 109.667 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.8 tm? -97.18 104.07 16.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -88.24 120.73 29.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.624 0.77 . . . . 0.0 110.493 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.464 ' HB3' HD21 ' A' ' 87' ' ' LEU . 62.9 mtt -105.49 147.74 27.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.291 1.036 . . . . 0.0 109.301 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -141.72 158.12 44.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.038 0.935 . . . . 0.0 108.514 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 m 55.35 41.57 31.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.047 0.939 . . . . 0.0 112.025 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -68.25 118.45 11.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 42.3 mtpt -84.2 154.36 63.33 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.314 172.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 10.8 Cg_endo -52.99 -19.7 11.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.022 2.481 . . . . 0.0 114.415 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 11.9 pt-20 -76.09 -12.33 60.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.14 0.976 . . . . 0.0 112.849 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.54 -5.34 56.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.314 0.646 . . . . 0.0 112.148 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 120' ' ' THR . 86.8 m -61.51 103.9 0.36 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.403 0.681 . . . . 0.0 110.686 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.02 160.39 12.0 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.982 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.6 p -85.22 111.94 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.264 0.554 . . . . 0.0 109.975 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -88.8 113.41 24.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.35 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.53 126.47 48.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.379 1.072 . . . . 0.0 108.746 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -84.66 136.31 33.8 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -132.16 161.52 33.13 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.936 0.895 . . . . 0.0 109.802 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -147.77 167.96 23.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.481 0.712 . . . . 0.0 110.032 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.782 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.332 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 121.286 0.565 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 54.0 m-85 -112.66 146.38 38.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.4 p90 -150.33 168.79 23.06 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.298 0.639 . . . . 0.0 109.84 170.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.2 -168.23 18.8 Favored Glycine 0 C--O 1.239 0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.379 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -83.73 -39.27 20.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.15 0.98 . . . . 0.0 110.575 -174.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.25 132.67 7.84 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.551 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -107.84 111.69 23.96 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.916 0.886 . . . . 0.0 108.744 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 7.8 tm0? -79.24 110.26 14.34 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -96.15 140.35 17.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.555 ' HA ' HG23 ' A' ' 92' ' ' THR . 86.2 m -121.18 112.28 18.45 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.0 p -102.57 119.2 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.475 0.655 . . . . 0.0 109.294 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 5.8 m -65.24 139.0 58.59 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 111.034 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 24.0 t . . . . . 0 C--O 1.238 0.477 0 C-N-CA 123.659 0.784 . . . . 0.0 110.647 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.81 116.9 29.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.984 0.914 . . . . 0.0 109.839 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.501 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.9 mt -118.51 123.05 44.18 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.832 0.853 . . . . 0.0 110.292 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 39.2 t -108.12 104.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.437 1.095 . . . . 0.0 109.421 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -76.29 152.58 36.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.797 0.439 . . . . 0.0 110.916 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -149.13 146.12 27.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.981 0.912 . . . . 0.0 110.276 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.13 20.71 8.15 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.259 0.35 . . . . 0.0 113.079 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.98 85.91 0.67 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.81 -164.29 10.97 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.15 144.25 45.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.084 0.554 . . . . 0.0 111.468 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 19' ' ' LEU . 7.5 p -152.02 152.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.834 1.254 . . . . 0.0 108.51 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -65.53 156.98 30.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.532 0.733 . . . . 0.0 112.412 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 139.77 57.13 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.095 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 -20.05 33.07 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.063 0.227 . . . . 0.0 112.816 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.4 -177.37 51.77 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-O 121.178 0.321 . . . . 0.0 113.467 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 p -115.13 160.7 19.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.073 0.949 . . . . 0.0 110.878 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HB2' HG11 ' A' ' 13' ' ' VAL . 40.8 tp -156.52 125.7 6.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.97 115.86 27.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.855 0.462 . . . . 0.0 109.979 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.5 mm? -94.6 156.38 16.46 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -144.78 144.72 31.31 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 35.5 t -124.98 113.72 18.19 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.924 0.889 . . . . 0.0 108.905 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -83.82 112.9 20.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.7 122.87 45.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.244 0.618 . . . . 0.0 109.401 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 m -62.79 126.08 26.11 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.02 74.44 0.01 OUTLIER Glycine 0 C--N 1.357 1.741 0 O-C-N 125.246 1.591 . . . . 0.0 115.691 -166.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -98.39 -174.79 2.92 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.867 1.267 . . . . 0.0 108.834 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -83.18 86.38 7.04 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.16 -26.35 65.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 35.4 p -66.03 -13.91 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.227 . . . . 0.0 113.055 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -82.19 -14.64 55.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.168 0.587 . . . . 0.0 111.954 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.14 140.94 44.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.064 0.545 . . . . 0.0 111.382 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 137.52 38.63 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 165.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.519 ' SD ' ' SG ' ' A' ' 97' ' ' CYS . 17.4 ttp -126.37 154.79 43.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.6 0.76 . . . . 0.0 109.644 -169.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.54 161.51 32.25 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 117.714 0.234 . . . . 0.0 113.101 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -97.79 139.47 33.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.825 0.85 . . . . 0.0 109.379 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.343 1.057 . . . . 0.0 109.162 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 95' ' ' TYR . 28.3 ptt180 -131.52 161.56 32.3 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.017 0.371 . . . . 0.0 111.775 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 94' ' ' VAL . 26.2 pt20 -171.91 146.74 2.07 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.357 171.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -178.11 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 123.891 0.876 . . . . 0.0 111.252 171.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 84.3 Cg_endo -80.35 70.27 7.59 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.155 1.903 . . . . 0.0 112.745 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.65 6.16 80.58 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.551 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.25 141.49 28.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.545 0.738 . . . . 0.0 110.633 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.38 176.95 7.61 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 162.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -60.41 104.76 0.36 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.961 0.504 . . . . 0.0 109.833 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.92 148.59 24.31 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.412 0.685 . . . . 0.0 109.634 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.53 121.16 14.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.522 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -104.88 -59.29 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.88 142.9 6.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.605 0.362 . . . . 0.0 110.434 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.0 t -123.99 130.44 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.107 0.963 . . . . 0.0 109.816 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -106.39 153.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.771 0.828 . . . . 0.0 109.507 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.49 151.71 37.96 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 49.5 p90 -59.69 -36.57 76.76 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.597 0.759 . . . . 0.0 112.165 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -84.46 -15.11 47.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.72 0.808 . . . . 0.0 111.18 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.7 79.99 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 116.416 -0.356 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -63.42 -49.41 73.84 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.679 0.792 . . . . 0.0 111.035 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -114.41 148.05 38.31 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.657 0.783 . . . . 0.0 110.115 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 52' ' ' VAL . 38.0 p -137.82 147.07 44.24 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.126 0.971 . . . . 0.0 109.133 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.98 129.89 38.8 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -122.32 145.96 47.76 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.84 148.59 36.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.46 -26.42 68.51 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 123.394 0.434 . . . . 0.0 111.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -67.17 -41.51 85.83 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.856 0.863 . . . . 0.0 111.186 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 m -112.65 13.46 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 111.65 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.93 105.94 0.75 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.366 1.066 . . . . 0.0 111.74 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.63 -26.04 18.13 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.768 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 16.6 ptp180 -84.54 -28.61 26.53 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 117.634 0.717 . . . . 0.0 110.43 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.411 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.7 m-30 -101.85 150.34 23.27 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.45 0.7 . . . . 0.0 109.44 172.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -147.63 132.74 18.28 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.04 0.936 . . . . 0.0 109.203 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 HD23 ' A' ' 82' ' ' LEU . 19.9 mt -101.88 138.63 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -135.77 156.14 49.27 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 154.55 34.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.323 0.582 . . . . 0.0 110.29 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -127.82 109.11 11.3 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -70.33 -30.92 68.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.704 0.802 . . . . 0.0 110.594 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.8 -38.31 54.2 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.117 0.567 . . . . 0.0 111.45 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.4 mmpt? -79.06 -17.89 54.42 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.31 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.74 32.86 20.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.554 1.142 . . . . 0.0 109.832 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 m -133.63 133.09 41.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.435 0.694 . . . . 0.0 110.579 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 45.1 t -104.06 155.43 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.4 1.08 . . . . 0.0 109.425 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.54 137.97 44.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.32 1.048 . . . . 0.0 109.631 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.1 tm? -122.73 105.66 10.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.7 107.96 18.88 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.802 0.841 . . . . 0.0 110.007 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 87' ' ' LEU . 47.3 mtt -87.9 138.53 31.38 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.68 0.792 . . . . 0.0 109.402 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -139.73 133.2 30.15 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 m 58.36 72.93 0.5 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.717 0.807 . . . . 0.0 111.664 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' A' ' 84' ' ' MET . 49.8 mt -71.76 136.74 47.24 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.109 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 121' ' ' VAL . 53.7 mtpt -74.64 152.2 87.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.266 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.26 -25.16 79.45 Favored 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.297 1.998 . . . . 0.0 113.787 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.94 6.76 48.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.985 0.914 . . . . 0.0 112.931 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.39 -9.48 56.42 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 123.271 0.628 . . . . 0.0 112.315 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 121' ' ' VAL . 89.1 m -53.77 106.2 0.18 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.841 0.856 . . . . 0.0 111.149 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.84 158.55 20.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 110.017 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 40' ' ' GLN . 15.0 p -89.65 124.54 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' A' ' 39' ' ' ARG . 23.6 m-85 -98.25 122.45 41.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.029 0.932 . . . . 0.0 110.297 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.9 128.0 56.35 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' A' ' 35' ' ' MET . 46.8 t -83.78 103.06 12.76 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.52 131.63 52.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.656 0.782 . . . . 0.0 111.134 -175.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.99 167.61 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.574 0.75 . . . . 0.0 110.535 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.831 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.513 -178.738 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 122.028 0.918 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -119.65 153.58 35.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -136.73 154.85 50.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.123 0.487 . . . . 0.0 111.405 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.28 161.45 41.2 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 164.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -82.87 11.25 6.28 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.37 138.69 1.69 Allowed Glycine 0 C--N 1.347 1.148 0 C-N-CA 123.224 0.44 . . . . 0.0 113.879 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 t -136.45 107.14 6.57 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -75.31 105.77 6.5 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.282 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.64 140.69 15.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 m -125.8 136.84 53.58 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.3 p -114.88 125.38 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.054 0.454 . . . . 0.0 110.143 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.0 t -83.42 111.71 19.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.1 p . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 123.818 0.847 . . . . 0.0 111.279 -174.68 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 41.0 tp . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.47 128.09 34.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.905 0.882 . . . . 0.0 109.381 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.2 126.46 42.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.277 1.031 . . . . 0.0 108.737 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.27 104.1 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.636 0.775 . . . . 0.0 109.679 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.36 137.36 32.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.891 0.877 . . . . 0.0 109.558 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m -147.64 171.44 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.758 0.823 . . . . 0.0 110.335 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.36 13.13 66.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.037 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.37 145.73 18.61 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.43 -164.46 30.0 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.832 0.316 . . . . 0.0 112.549 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.09 144.11 31.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.129 0.572 . . . . 0.0 110.157 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.5 p -150.83 151.71 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.247 1.019 . . . . 0.0 108.526 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.06 155.61 23.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.676 0.391 . . . . 0.0 110.256 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 129.57 38.4 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.39 66.12 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 123.772 0.701 . . . . 0.0 111.423 -167.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.87 -166.52 31.82 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.198 0.428 . . . . 0.0 113.698 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -147.58 160.83 42.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.272 1.029 . . . . 0.0 110.269 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -155.99 147.64 22.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.012 0.925 . . . . 0.0 108.547 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -128.11 118.68 23.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.281 0.492 . . . . 0.0 109.995 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 84' ' ' MET . 2.5 mm? -90.51 157.43 17.54 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.89 0.876 . . . . 0.0 109.857 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -142.15 123.77 15.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -122.74 118.74 28.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.981 0.512 . . . . 0.0 110.824 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.51 123.97 30.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.329 0.651 . . . . 0.0 110.09 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.81 143.43 38.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.1 0.96 . . . . 0.0 110.121 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -160.07 176.44 11.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.259 0.624 . . . . 0.0 110.419 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.85 -96.48 1.56 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 66.1 mtp180 -79.79 143.53 34.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.1 m -73.47 103.33 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -58.21 -25.9 62.19 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.01 0.924 . . . . 0.0 111.884 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 43.7 p -76.05 0.45 18.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.773 0.829 . . . . 0.0 112.502 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -87.88 -13.69 41.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.15 0.58 . . . . 0.0 110.143 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.53 170.42 10.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.386 0.674 . . . . 0.0 110.571 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 133.62 34.9 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.476 ' SD ' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -129.12 131.41 47.22 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.486 0.714 . . . . 0.0 109.35 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -152.23 159.98 28.66 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 114.223 0.449 . . . . 0.0 114.223 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -97.52 132.61 43.04 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.295 1.038 . . . . 0.0 110.384 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.59 129.94 45.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 108.387 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -114.53 156.67 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.502 0.321 . . . . 0.0 111.63 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.9 pp0? -167.23 149.27 5.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.83 0.706 . . . . 0.0 110.504 173.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -179.73 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.813 0.845 . . . . 0.0 111.32 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 88.3 Cg_endo -83.21 73.86 5.1 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.155 1.903 . . . . 0.0 112.481 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.03 74.46 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.181 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.6 mmpt? -115.7 145.5 42.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.542 0.737 . . . . 0.0 111.343 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.89 169.85 10.89 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 161.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -64.12 103.8 0.65 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.414 0.626 . . . . 0.0 110.14 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.49 150.38 20.37 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.573 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.01 108.59 1.85 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.946 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -90.11 -68.03 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.6 134.28 4.5 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.577 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.526 HG22 ' HA3' ' A' ' 36' ' ' GLY . 94.5 t -116.17 134.02 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 0.0 109.596 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 59' ' ' THR . 8.1 p -107.27 148.87 11.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 123.448 0.699 . . . . 0.0 110.595 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.1 149.97 35.67 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 168.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 61.8 p-90 -60.02 -34.94 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 0.0 112.925 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -86.86 -10.94 52.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 111.495 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.38 15.52 78.15 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.394 -171.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -59.62 -46.65 88.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.113 0.965 . . . . 0.0 111.11 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -133.57 129.25 36.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 52' ' ' VAL . 36.4 p -117.45 128.7 55.25 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.44 117.13 32.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.39 154.54 27.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 110.309 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.23 146.12 39.28 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.95 -25.91 67.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.905 0.482 . . . . 0.0 112.109 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -70.46 -41.95 72.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.751 0.821 . . . . 0.0 110.878 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 69' ' ' PHE . 8.1 m -94.63 -4.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.293 0.637 . . . . 0.0 111.992 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -67.36 119.4 12.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 0.0 111.094 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.64 17.88 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 123.525 0.583 . . . . 0.0 113.951 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -96.27 -13.5 23.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.364 0.666 . . . . 0.0 110.79 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 65' ' ' VAL . 97.3 m-85 -123.76 155.83 37.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.423 0.689 . . . . 0.0 109.261 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.3 m -148.77 138.1 21.76 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 108.289 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.617 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -102.81 144.5 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 m -136.48 155.87 49.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.71 157.23 36.26 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.65 119.37 13.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.83 -4.94 58.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.009 0.924 . . . . 0.0 112.269 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.99 -54.1 4.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -78.52 -14.23 59.45 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.873 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 60.94 34.47 19.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.627 1.171 . . . . 0.0 111.301 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.6 m -119.22 132.46 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.251 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.476 HG11 ' SD ' ' A' ' 35' ' ' MET . 51.6 t -104.33 119.39 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.142 0.977 . . . . 0.0 109.965 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.26 121.1 41.61 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.702 0.801 . . . . 0.0 110.281 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -105.64 110.54 22.9 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.84 102.81 13.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.902 0.881 . . . . 0.0 109.899 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.621 ' HB3' HD21 ' A' ' 87' ' ' LEU . 83.8 mtp -87.38 140.28 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 0.0 108.669 171.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.67 154.83 30.72 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 123.071 0.232 . . . . 0.0 110.733 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 m 61.07 38.65 16.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.447 1.099 . . . . 0.0 110.312 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.9 mt -68.11 129.16 39.09 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.188 -169.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -100.69 154.42 37.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.466 1.107 . . . . 0.0 108.077 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.847 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 12.1 Cg_endo -53.77 -24.42 30.52 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 123.446 2.764 . . . . 0.0 114.78 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.86 -13.85 59.57 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 112.68 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.5 -2.1 33.78 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.723 0.809 . . . . 0.0 112.208 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.561 HG23 ' HA ' ' A' ' 120' ' ' THR . 65.8 m -62.71 107.91 1.06 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.23 0.612 . . . . 0.0 109.805 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.18 160.01 9.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.572 0.545 . . . . 0.0 110.898 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 40' ' ' GLN . 14.4 p -85.68 115.64 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -94.28 116.25 28.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.106 0.962 . . . . 0.0 108.807 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.06 131.44 48.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.028 0.531 . . . . 0.0 109.72 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.4 t -82.16 102.07 10.85 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.48 162.08 14.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.306 1.042 . . . . 0.0 110.669 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.9 128.52 14.17 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.917 0.887 . . . . 0.0 108.951 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.553 0 O-C-N 123.768 0.668 . . . . 0.0 111.637 -178.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.162 0.506 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.42 150.47 31.1 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.342 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -158.32 151.96 23.47 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.691 1.196 . . . . 0.0 108.316 164.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.63 -163.26 26.43 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.49 -38.03 86.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.859 0.864 . . . . 0.0 110.123 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.34 130.88 7.17 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.909 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -99.93 108.26 20.45 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 109.416 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -79.34 102.86 8.89 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -91.62 137.11 22.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.561 ' HA ' HG23 ' A' ' 92' ' ' THR . 24.0 m -121.02 104.68 9.98 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 3.2 p -100.42 117.11 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.5 t -61.95 140.96 58.28 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.847 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 50.0 p . . . . . 0 C--O 1.239 0.524 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.349 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB1' ' A' ' 25' ' ' ALA . 52.9 tp . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 24.9 tt0 -102.83 105.65 16.09 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.599 0.76 . . . . 0.0 109.631 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HB3' ' SG ' ' A' ' 97' ' ' CYS . 79.1 mt -91.01 127.23 36.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.594 0.758 . . . . 0.0 109.346 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.11 102.86 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 109.042 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.58 123.19 29.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.1 0.56 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -117.9 130.8 56.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.558 1.143 . . . . 0.0 108.816 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.92 4.99 1.46 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-O 119.861 -0.411 . . . . 0.0 113.345 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.71 102.83 0.8 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.999 0.399 . . . . 0.0 112.17 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.84 -174.56 34.7 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.36 145.2 26.42 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.148 0.499 . . . . 0.0 111.812 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -146.85 154.85 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.47 1.108 . . . . 0.0 108.655 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -87.47 151.31 23.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.864 0.465 . . . . 0.0 111.233 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.91 110.35 5.59 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.431 0.692 . . . . 0.0 110.427 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.25 -4.11 40.8 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.202 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.99 -167.56 42.29 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.667 0.275 . . . . 0.0 112.955 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.7 m -124.92 157.86 34.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.733 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 tp -155.04 123.15 5.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.799 0.84 . . . . 0.0 108.833 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -93.66 119.68 32.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 1.9 mm? -103.84 153.89 20.23 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.83 123.31 8.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 51.9 t -104.99 127.52 52.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.344 0.658 . . . . 0.0 110.087 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.22 127.14 38.68 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.618 0.767 . . . . 0.0 109.601 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -104.83 128.77 53.13 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.591 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 4.1 m -120.2 151.08 39.64 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.717 0.807 . . . . 0.0 110.947 -169.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.38 -88.2 0.51 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 124.1 0.875 . . . . 0.0 112.832 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -74.25 146.49 43.21 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 0.0 110.528 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -65.18 110.1 2.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.621 0.768 . . . . 0.0 109.958 170.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 78' ' ' ASN . 2.4 p90 -61.45 -23.92 66.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.325 0.65 . . . . 0.0 110.701 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.3 p -72.03 -8.54 55.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 113.157 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 m -83.27 -2.67 56.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.847 0.459 . . . . 0.0 110.735 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -135.97 163.67 29.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.105 0.962 . . . . 0.0 109.967 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.13 127.18 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 97' ' ' CYS . 8.7 tmm? -119.97 135.91 54.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.693 0.397 . . . . 0.0 109.974 -170.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -133.07 166.22 23.76 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 123.157 0.408 . . . . 0.0 113.511 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -115.89 145.07 43.2 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 124.034 0.933 . . . . 0.0 108.991 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -136.15 146.22 46.67 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.741 1.216 . . . . 0.0 108.907 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -125.38 148.1 48.9 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.238 0.472 . . . . 0.0 110.506 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.84 155.02 4.5 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 123.584 0.754 . . . . 0.0 111.18 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 177.14 -61.07 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.802 1.241 . . . . 0.0 110.263 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.26 75.56 5.0 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 122.377 2.052 . . . . 0.0 112.603 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.16 24.18 70.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.594 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 28.4 mmmt -112.11 144.88 40.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.533 1.133 . . . . 0.0 110.374 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.87 160.93 14.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.906 0.882 . . . . 0.0 109.433 168.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -58.75 105.37 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.143 0.577 . . . . 0.0 111.236 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.78 150.93 19.85 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' HZ ' ' HB3' ' A' ' 60' ' ' TYR . 54.1 t80 -59.11 111.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.522 1.129 . . . . 0.0 109.112 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -100.06 -65.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.43 130.34 5.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.35 0.119 . . . . 0.0 110.905 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.688 HG22 ' HA3' ' A' ' 36' ' ' GLY . 67.0 t -117.83 138.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.009 0.923 . . . . 0.0 108.762 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.627 HG21 HH11 ' A' ' 73' ' ' ARG . 11.7 p -124.73 140.53 47.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.2 155.98 22.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -55.84 -40.62 73.12 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -167.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -92.42 -0.79 57.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.43 0.692 . . . . 0.0 110.88 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.25 7.57 67.97 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.173 -0.467 . . . . 0.0 114.074 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -66.57 -38.82 87.87 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.678 0.791 . . . . 0.0 110.237 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -115.19 138.05 51.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.545 0.738 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -131.67 144.6 51.14 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.601 1.16 . . . . 0.0 108.987 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.552 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 85.1 m-85 -128.82 137.37 51.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.317 1.047 . . . . 0.0 108.248 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -138.85 150.39 45.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.391 0.676 . . . . 0.0 109.823 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -82.08 138.61 34.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.02 -28.37 67.68 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.204 0.602 . . . . 0.0 111.639 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 t -65.69 -41.8 91.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.283 1.033 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 62' ' ' ALA . 22.6 m -103.06 -2.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.301 0.64 . . . . 0.0 111.735 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -64.85 117.71 7.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 0.0 111.355 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.29 20.11 Favored Glycine 0 C--N 1.345 1.034 0 O-C-N 123.82 0.7 . . . . 0.0 113.332 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 13.8 ptp180 -95.2 -23.34 17.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.141 0.496 . . . . 0.0 109.872 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 2.9 m-85 -107.03 153.52 22.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 92.4 m -145.31 130.68 18.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.927 0.891 . . . . 0.0 109.468 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.494 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 1.2 pp -104.13 128.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.054 0.542 . . . . 0.0 110.273 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -139.16 166.09 25.45 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.616 1.166 . . . . 0.0 108.635 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.627 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -159.77 161.46 34.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.111 0.481 . . . . 0.0 110.915 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.6 114.09 17.6 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -67.5 -35.23 78.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.517 0.727 . . . . 0.0 111.983 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.64 67.59 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.602 0.564 . . . . 0.0 111.364 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -83.16 -19.24 36.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.233 0.613 . . . . 0.0 111.779 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 2.6 m120 68.08 32.67 4.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.133 . . . . 0.0 110.692 -173.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.7 m -111.35 129.88 55.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.867 0.467 . . . . 0.0 110.073 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.78 144.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.752 0.821 . . . . 0.0 108.959 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 130.0 53.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.852 0.861 . . . . 0.0 109.803 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.9 tm? -115.33 106.68 14.29 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 16.1 mm100 -88.17 103.78 16.08 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.869 0.868 . . . . 0.0 109.682 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.8 mtt -87.28 133.89 33.62 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -141.1 145.3 35.61 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.3 m 56.23 47.03 20.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.164 0.986 . . . . 0.0 111.587 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.56 124.17 20.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.146 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.5 mtpt -70.22 155.07 94.03 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 -14.76 29.37 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 122.6 2.2 . . . . 0.0 113.605 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.93 -3.02 56.48 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.335 0.654 . . . . 0.0 112.621 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.66 5.06 8.14 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.5 m -64.8 100.63 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.87 152.09 11.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.241 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 4.1 p -80.35 123.11 36.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 170.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -94.72 139.11 31.69 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -137.93 121.36 17.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.193 0.997 . . . . 0.0 108.835 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.693 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 30.1 p -86.98 143.71 27.24 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -147.38 134.7 20.65 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.168 0.987 . . . . 0.0 109.729 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.98 161.03 15.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.377 0.671 . . . . 0.0 110.834 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 111' ' ' ASP . . . . . . . . 0 C--N 1.343 0.932 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.814 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB3' ' HA2' ' A' ' 100' ' ' GLY . 24.5 t0 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.741 0.781 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 92.5 m-85 -133.13 167.83 19.62 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.628 166.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 38.4 p90 -154.35 169.3 24.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.02 0.928 . . . . 0.0 109.178 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.19 -172.63 21.69 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.648 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -70.77 -45.12 65.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.333 0.653 . . . . 0.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.13 135.88 1.17 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.451 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.7 t -143.26 140.83 30.83 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.236 0.541 . . . . 0.0 110.314 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 55.8 tp60 -80.42 122.7 27.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.359 1.063 . . . . 0.0 111.408 -171.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.65 145.14 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.4 m -126.91 105.88 8.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.61 0.764 . . . . 0.0 109.339 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.7 p -90.73 117.92 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.402 0.62 . . . . 0.0 109.928 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.1 t -67.34 117.87 9.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.954 0.901 . . . . 0.0 109.802 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.468 0.707 . . . . 0.0 110.382 -178.776 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 64.5 tp . . . . . 0 C--O 1.236 0.394 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.58 127.66 37.12 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.604 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 73.8 mt -114.23 131.64 56.41 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 59.1 t -114.71 100.37 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.6 130.31 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 109.634 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -138.21 139.99 39.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.311 1.044 . . . . 0.0 109.049 -175.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.62 13.32 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 64.89 3.97 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.95 -164.99 13.35 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 123.569 0.604 . . . . 0.0 111.702 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.4 pp -104.06 142.4 34.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.121 0.569 . . . . 0.0 111.568 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -151.41 144.21 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.883 1.273 . . . . 0.0 108.004 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -69.59 154.57 41.8 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.745 0.418 . . . . 0.0 111.662 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 115.47 5.13 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.461 174.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.32 -14.34 28.02 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 123.885 0.755 . . . . 0.0 111.701 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.33 -163.78 26.75 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 121.307 0.393 . . . . 0.0 113.766 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -144.61 150.93 38.25 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.69 0.796 . . . . 0.0 110.023 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -155.72 124.65 6.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.165 0.586 . . . . 0.0 109.942 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -92.28 129.42 38.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.174 0.59 . . . . 0.0 110.427 175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mm? -96.18 157.32 15.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.101 0.96 . . . . 0.0 109.084 172.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -144.7 124.1 13.09 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.171 0.589 . . . . 0.0 109.564 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -114.53 115.43 27.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.519 0.728 . . . . 0.0 110.112 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.85 118.66 24.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.59 144.95 31.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.703 0.801 . . . . 0.0 109.759 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t -65.74 159.02 26.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.47 0.708 . . . . 0.0 109.895 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 55.16 4.79 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-O 121.302 0.39 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 1.6 mmp_? -98.8 -171.35 2.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.824 1.25 . . . . 0.0 110.781 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.4 p -81.29 41.76 0.63 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.892 0.877 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -69.13 -19.44 64.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.98 0.512 . . . . 0.0 111.817 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -77.39 -16.15 59.0 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 0.0 111.284 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.4 t -81.19 -12.84 59.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.998 0.519 . . . . 0.0 110.2 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.19 159.17 17.61 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 0.0 109.627 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.35 136.91 35.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 80' ' ' VAL . 2.6 ttp -101.41 155.25 18.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.76 149.93 21.5 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 117.93 0.332 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HE1' HG23 ' A' ' 71' ' ' ILE . 85.1 m95 -98.51 131.6 44.61 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.137 0.975 . . . . 0.0 109.564 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -131.37 166.6 20.91 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.686 1.194 . . . . 0.0 108.375 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -157.9 163.46 37.89 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 118.549 0.613 . . . . 0.0 111.408 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -169.91 162.88 9.46 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.072 0.949 . . . . 0.0 109.314 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.54 -58.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 C-N-CA 124.481 1.112 . . . . 0.0 110.891 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.23 69.0 8.13 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 122.692 2.262 . . . . 0.0 112.854 -170.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.81 67.33 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.657 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -107.72 146.64 31.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.535 0.734 . . . . 0.0 110.746 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.24 164.76 20.98 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.637 0.775 . . . . 0.0 108.926 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.13 104.91 0.42 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.214 0.53 . . . . 0.0 110.39 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.96 157.58 15.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.153 1.381 . . . . 0.0 110.727 -170.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.6 121.09 19.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.513 0.725 . . . . 0.0 110.344 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.74 -53.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.39 152.56 7.24 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.532 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -133.87 147.28 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.484 1.113 . . . . 0.0 108.782 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 71' ' ' ILE . 13.9 p -133.81 148.5 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 125.101 1.36 . . . . 0.0 108.948 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -77.71 161.63 27.59 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -56.92 -36.35 70.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -90.96 -8.37 49.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.075 0.55 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.83 21.16 58.24 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 112.289 -0.324 . . . . 0.0 112.289 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -60.59 -58.47 8.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.682 0.793 . . . . 0.0 111.283 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.09 138.39 53.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.225 0.61 . . . . 0.0 109.989 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -119.74 160.23 22.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 110.64 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -141.97 139.45 32.45 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 107.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.55 152.89 52.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.129 0.571 . . . . 0.0 110.106 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -69.83 133.58 47.55 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 166.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.03 -29.37 69.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -168.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.7 m -67.45 -31.13 71.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.651 0.78 . . . . 0.0 111.64 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.477 HG22 ' HB3' ' A' ' 62' ' ' ALA . 20.8 m -113.47 6.96 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.821 0.848 . . . . 0.0 111.661 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -75.1 118.17 17.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.035 0.534 . . . . 0.0 111.845 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.61 -26.12 25.62 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.828 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -94.82 -17.98 21.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.218 0.607 . . . . 0.0 110.117 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -104.7 145.83 29.8 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 m -148.74 138.13 21.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.891 0.876 . . . . 0.0 109.43 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.555 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.9 mp -101.11 131.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.8 m -122.43 154.78 37.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 133.38 8.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.046 0.385 . . . . 0.0 110.146 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.39 108.11 18.03 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.66 -29.02 68.21 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.93 0.892 . . . . 0.0 111.059 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.73 68.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.246 0.618 . . . . 0.0 111.162 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -14.96 59.43 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.626 0.37 . . . . 0.0 110.714 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 62.31 28.34 16.88 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 124.667 1.229 . . . . 0.0 110.132 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.3 m -125.99 132.51 52.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.093 0.557 . . . . 0.0 110.259 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 35' ' ' MET . 21.8 t -105.54 157.63 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.584 1.153 . . . . 0.0 109.137 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -137.84 145.36 42.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.818 1.247 . . . . 0.0 108.774 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 21' ' ' LEU . 2.9 tm? -134.37 108.61 8.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.07 104.98 16.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.336 0.654 . . . . 0.0 109.73 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.427 ' HB3' HD21 ' A' ' 87' ' ' LEU . 69.7 mtm -88.64 132.41 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -130.69 142.45 50.43 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t 57.73 70.98 0.61 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.67 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.8 mt -84.45 157.17 21.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.417 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -118.31 156.89 50.38 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.28 -21.74 67.98 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.49 2.127 . . . . 0.0 113.059 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.94 -11.43 59.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.274 1.029 . . . . 0.0 112.871 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -83.08 1.48 40.0 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.829 0.452 . . . . 0.0 112.149 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -64.59 108.33 1.65 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.765 0.826 . . . . 0.0 110.397 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.1 164.04 13.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.645 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 2.7 p -89.0 112.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -88.23 139.98 29.94 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -125.74 129.34 49.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.543 1.137 . . . . 0.0 108.753 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.44 121.98 28.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -113.71 161.84 17.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.836 0.854 . . . . 0.0 110.006 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.83 143.86 29.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.439 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.631 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.292 0.568 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -128.04 165.26 20.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.967 0.907 . . . . 0.0 109.993 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 44.7 p90 -158.43 167.09 30.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.105 0.962 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.64 -161.26 29.99 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.991 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -85.43 -57.46 3.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.114 0.966 . . . . 0.0 109.209 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.39 144.72 17.7 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.416 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -143.43 149.49 37.7 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.343 0.657 . . . . 0.0 109.291 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -91.36 118.11 30.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.376 0.67 . . . . 0.0 110.383 -169.097 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.28 126.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.447 0.641 . . . . 0.0 109.54 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 88.4 m -102.32 104.67 15.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.779 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.08 100.56 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.8 m -56.73 116.45 3.16 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.462 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.541 0.6 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 177.695 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.737 0.303 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -108.93 168.72 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.825 0.85 . . . . 0.0 110.201 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 tp -97.72 111.67 23.86 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.77 118.06 30.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 0.0 109.946 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.83 122.89 48.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.95 0.9 . . . . 0.0 108.627 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 92.5 t -117.52 103.31 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.149 0.98 . . . . 0.0 109.123 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.63 147.47 27.69 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.165 0.586 . . . . 0.0 109.77 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 p -162.47 178.57 8.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.362 1.065 . . . . 0.0 109.493 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.42 5.3 89.89 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 116.537 -0.301 . . . . 0.0 113.433 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.86 135.64 19.37 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.84 178.39 40.59 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -98.66 139.26 34.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.594 0.758 . . . . 0.0 111.006 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 11.3 p -151.12 151.35 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.328 1.051 . . . . 0.0 108.534 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 18.1 mp0 -70.12 159.54 33.72 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.258 0.623 . . . . 0.0 112.272 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 121.92 15.03 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.913 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.51 58.82 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.734 0.646 . . . . 0.0 112.172 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.39 -164.4 37.67 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.068 0.366 . . . . 0.0 112.984 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -148.72 155.67 41.32 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.214 0.606 . . . . 0.0 110.774 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -153.45 136.14 15.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.056 0.942 . . . . 0.0 109.339 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -99.24 132.99 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.277 0.561 . . . . 0.0 110.09 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 4.2 mm? -106.72 159.95 15.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.216 . . . . 0.0 109.79 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -137.75 156.04 48.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.956 0.902 . . . . 0.0 110.007 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 54.0 t -150.66 113.51 4.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 109.6 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.4 117.53 23.68 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.85 0.86 . . . . 0.0 109.051 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.3 124.58 49.79 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.263 0.625 . . . . 0.0 109.724 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.1 m -141.77 -178.08 5.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.935 1.294 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.19 -117.17 4.36 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.54 153.82 42.92 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.896 0.848 . . . . 0.0 110.746 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.3 p -68.9 107.29 3.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.909 0.483 . . . . 0.0 109.724 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ASN . 5.2 p90 -64.75 -14.62 59.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.255 0.622 . . . . 0.0 110.924 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.5 p -70.37 -3.55 18.02 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.162 0.985 . . . . 0.0 112.32 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -109.52 7.66 24.82 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.462 1.105 . . . . 0.0 110.08 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.07 156.19 49.08 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.123 0.969 . . . . 0.0 111.091 -173.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.8 133.16 50.97 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 17.7 ttp -118.23 142.11 47.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.286 0.634 . . . . 0.0 109.589 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -127.45 154.21 19.48 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.391 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -97.03 125.56 41.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.39 160.22 24.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.263 1.425 . . . . 0.0 107.64 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -139.89 162.14 35.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.86 0.755 . . . . 0.0 111.772 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -165.43 152.93 10.78 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.642 1.213 . . . . 0.0 110.52 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 173.27 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 125.245 1.418 . . . . 0.0 110.231 168.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 65.7 Cg_endo -87.58 80.51 1.3 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.938 1.758 . . . . 0.0 112.046 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.45 73.28 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.347 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -115.29 148.86 38.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.105 0.962 . . . . 0.0 112.03 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 178.19 5.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -61.46 102.63 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -99.86 147.32 25.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.038 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.87 114.49 3.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.229 0.612 . . . . 0.0 110.073 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG11 ' HE1' ' A' ' 95' ' ' TYR . 98.5 t -104.12 -55.78 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -158.54 152.49 23.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.547 0.739 . . . . 0.0 110.13 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 36' ' ' GLY . 42.9 t -137.71 141.86 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.32 1.048 . . . . 0.0 108.58 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.72 145.21 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.73 0.812 . . . . 0.0 109.272 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -81.08 156.34 25.85 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 166.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -52.16 -39.3 59.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.052 0.941 . . . . 0.0 112.523 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -68.49 -26.39 65.45 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.934 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.34 12.31 82.25 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.644 -166.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -65.24 -38.57 90.77 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.068 1.347 . . . . 0.0 110.902 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -128.38 128.08 43.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.492 0.717 . . . . 0.0 110.47 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -122.29 129.97 52.7 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 108.271 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -120.96 138.47 54.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.723 1.209 . . . . 0.0 107.973 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.01 138.82 44.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.195 0.598 . . . . 0.0 110.532 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 147.56 31.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.906 0.883 . . . . 0.0 109.635 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -59.02 -27.27 65.3 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.834 0.854 . . . . 0.0 112.745 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.2 m -64.56 -32.79 74.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.521 0.728 . . . . 0.0 112.019 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.78 5.16 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 124.388 1.075 . . . . 0.0 111.839 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.92 142.66 51.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 0.0 110.833 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.75 -22.51 9.05 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.424 0.453 . . . . 0.0 113.867 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -117.03 -17.43 10.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.535 0.734 . . . . 0.0 111.547 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.61 149.23 23.49 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -149.2 137.4 20.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.101 0.96 . . . . 0.0 108.952 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.405 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -102.03 151.39 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 175.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.0 m -146.02 159.6 43.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.972 1.309 . . . . 0.0 108.58 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.65 132.48 5.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.202 0.525 . . . . 0.0 111.238 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.68 107.43 19.09 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 30' ' ' PHE . 1.8 m-20 -69.63 -33.02 72.04 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 0.0 110.824 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.29 83.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.761 0.825 . . . . 0.0 111.104 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -97.72 -0.51 45.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.268 0.627 . . . . 0.0 112.105 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.02 27.37 17.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.774 1.23 . . . . 0.0 113.46 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 m -119.36 131.81 55.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.56 0.344 . . . . 0.0 110.75 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 36.0 t -103.31 148.77 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.431 1.092 . . . . 0.0 108.923 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.11 152.07 51.43 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -132.19 108.28 9.16 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -83.61 102.76 12.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.062 0.945 . . . . 0.0 109.508 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 58.4 mtt -88.69 123.61 33.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -123.53 141.95 51.49 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.8 m 53.92 61.33 3.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.411 1.084 . . . . 0.0 111.791 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.38 117.18 11.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.365 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' O ' HG11 ' A' ' 121' ' ' VAL . 45.5 mtpt -75.05 149.38 85.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.405 1.082 . . . . 0.0 109.05 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 19.4 Cg_endo -56.54 -17.78 23.29 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.181 2.587 . . . . 0.0 114.681 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.51 -20.45 58.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.25 1.02 . . . . 0.0 113.051 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -77.14 -0.36 24.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 120' ' ' THR . 72.5 m -62.62 101.67 0.27 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.461 0.704 . . . . 0.0 110.1 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.54 160.99 15.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.036 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.69 116.52 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.349 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.483 ' HE1' HG11 ' A' ' 49' ' ' VAL . 15.7 m-85 -91.84 117.09 29.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.706 0.803 . . . . 0.0 111.092 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.64 130.07 47.91 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.038 0.935 . . . . 0.0 109.999 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.535 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.8 m -84.67 124.15 31.17 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.63 20.98 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.038 0.935 . . . . 0.0 109.695 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -119.34 167.93 11.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.858 0.863 . . . . 0.0 111.137 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.94 -146.63 16.73 Favored Glycine 0 C--O 1.244 0.73 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.791 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.52 114.37 20.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.933 0.893 . . . . 0.0 109.81 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -89.65 133.42 34.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 168.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.98 -70.36 0.79 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.451 0.7 . . . . 0.0 110.36 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.92 -36.22 0.42 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.0 t -57.03 126.94 29.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.799 0.84 . . . . 0.0 110.576 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -82.15 2.52 31.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.157 0.583 . . . . 0.0 112.185 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.7 101.04 0.98 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.6 79.71 1.08 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.183 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.15 33.38 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.067 0.947 . . . . 0.0 108.593 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 159.56 28.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.151 2.567 . . . . 0.0 112.571 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.44 -41.96 37.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.601 0.761 . . . . 0.0 109.561 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.81 146.88 51.54 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.521 1.129 . . . . 0.0 109.121 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.02 156.92 42.96 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.034 0.934 . . . . 0.0 109.242 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.62 -163.34 26.14 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.219 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -81.59 -50.1 9.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.097 1.359 . . . . 0.0 110.689 -174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.5 137.45 6.47 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.789 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 21' ' ' LEU . 10.0 t -114.59 115.82 27.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 109.564 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -73.49 111.83 8.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.745 0.818 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.5 145.12 16.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 52.2 m -127.88 139.2 52.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.2 p -119.78 113.14 39.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 31.1 t -58.38 113.19 1.85 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.595 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 37.8 m -74.37 -174.46 2.02 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.534 1.134 . . . . 0.0 111.13 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.3 tp 69.47 97.27 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.575 1.15 . . . . 0.0 109.756 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.43 -27.24 65.87 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.764 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.6 t60 78.04 -32.25 0.17 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.45 1.5 . . . . 0.0 113.644 167.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -68.41 97.11 0.72 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.758 0.79 . . . . 0.0 111.163 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -78.99 -35.41 42.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.8 t60 67.81 -78.33 0.04 OUTLIER 'General case' 0 C--N 1.363 1.157 0 O-C-N 125.02 1.45 . . . . 0.0 109.908 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -151.03 164.52 36.23 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.191 1.397 . . . . 0.0 108.043 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.688 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -153.99 173.55 15.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.001 0.52 . . . . 0.0 110.555 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp -76.36 111.36 11.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -85.57 116.38 23.83 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -110.14 129.84 55.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.424 1.09 . . . . 0.0 108.296 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 34.6 t -121.9 98.25 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.85 139.64 30.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 122.89 0.476 . . . . 0.0 110.166 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -153.46 165.01 37.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.949 0.899 . . . . 0.0 109.957 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.34 -11.45 54.67 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.988 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.29 120.54 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.028 -0.318 . . . . 0.0 112.448 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.6 -169.42 22.9 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -79.63 135.49 36.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.498 0.319 . . . . 0.0 111.275 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.64 139.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.29 1.036 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.83 149.55 35.62 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.687 0.795 . . . . 0.0 112.025 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.27 7.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.218 0.607 . . . . 0.0 110.704 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.71 -10.37 25.65 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.033 0.825 . . . . 0.0 111.541 -175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.46 -170.82 44.5 Favored Glycine 0 C--N 1.346 1.124 0 C-N-CA 123.038 0.351 . . . . 0.0 113.862 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.4 p -121.52 162.1 21.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.252 1.021 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.96 126.9 8.29 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -98.4 118.33 34.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.163 0.585 . . . . 0.0 110.248 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -102.02 154.18 19.21 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.194 0.998 . . . . 0.0 109.018 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -145.67 146.84 31.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.595 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 53.6 t -138.37 123.43 19.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.22 114.77 22.57 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.26 24.51 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.408 0.683 . . . . 0.0 109.239 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 t -71.78 164.33 26.2 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.19 -11.25 51.36 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.384 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HE ' ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.9 127.45 26.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.326 1.051 . . . . 0.0 109.28 169.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.414 ' H ' ' HE ' ' A' ' 28' ' ' ARG . 6.8 p -60.77 89.04 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.12 -18.54 60.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.077 160.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 29.9 p -66.7 -14.43 62.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.069 1.347 . . . . 0.0 112.794 176.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m -83.98 -4.24 58.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 0.0 111.225 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.32 168.91 17.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.591 0.757 . . . . 0.0 110.988 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 121.8 33.49 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttp -101.22 130.44 47.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 109.493 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -134.0 154.25 21.28 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.51 138.89 32.56 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.462 1.105 . . . . 0.0 109.187 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.77 170.25 14.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.159 1.384 . . . . 0.0 108.113 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -153.73 162.05 41.58 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.901 0.319 . . . . 0.0 111.802 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.2 pp0? -168.02 151.86 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.529 1.143 . . . . 0.0 110.835 167.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 169.74 -59.11 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 125.283 1.433 . . . . 0.0 110.885 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.42 70.24 5.13 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.511 2.141 . . . . 0.0 112.609 -169.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.92 17.22 76.8 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.787 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -109.24 140.95 42.22 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 110.745 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.31 170.3 12.91 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.75 105.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.91 154.89 20.95 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 110.647 -171.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -66.6 110.38 3.17 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.674 171.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' HE1' ' A' ' 95' ' ' TYR . 95.2 t -88.81 -62.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.53 134.54 4.65 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.608 HG22 ' HA3' ' A' ' 36' ' ' GLY . 71.3 t -115.41 153.46 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.158 0.983 . . . . 0.0 108.595 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.9 151.39 31.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.6 152.99 44.61 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 52.9 p-90 -61.42 -36.05 79.25 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -82.72 -5.34 58.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.477 0.711 . . . . 0.0 111.659 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.55 79.87 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -58.51 -47.71 83.24 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.742 0.817 . . . . 0.0 111.234 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.1 mtt85 -130.71 141.23 50.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 p -110.99 130.2 55.66 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -114.93 116.33 28.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -114.27 142.21 46.58 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.83 47.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.35 -26.36 60.87 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.689 0.795 . . . . 0.0 111.978 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -69.6 -26.05 64.26 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.595 1.158 . . . . 0.0 112.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 33.5 m -127.96 7.64 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.03 0.932 . . . . 0.0 111.652 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.24 124.34 23.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 111.31 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -3.01 85.92 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.11 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -121.15 -10.9 8.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.487 0.643 . . . . 0.0 111.421 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -109.57 162.39 14.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.202 0.601 . . . . 0.0 109.873 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 86.4 m -151.59 130.57 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.267 1.027 . . . . 0.0 109.45 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.614 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -103.29 141.12 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 49.5 m -139.27 158.76 43.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.729 1.212 . . . . 0.0 108.248 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.18 131.12 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.029 0.443 . . . . 0.0 110.881 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.01 92.17 5.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.483 1.113 . . . . 0.0 108.27 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.46 -25.58 68.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.146 0.578 . . . . 0.0 111.413 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.8 98.1 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.87 0.868 . . . . 0.0 111.504 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.82 -10.25 37.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.637 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 58.21 45.27 17.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.117 0.967 . . . . 0.0 109.574 -170.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 m -115.34 148.39 39.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.283 1.033 . . . . 0.0 109.408 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 57.6 t -126.68 150.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 108.903 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 86.7 m-85 -133.53 146.23 50.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 0.0 108.975 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.3 tm? -133.87 107.19 7.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 35.4 tt0 -86.75 126.83 34.85 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.429 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.7 mtt -105.48 141.49 36.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.482 1.113 . . . . 0.0 108.824 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -141.61 147.33 37.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t 58.27 52.14 7.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.756 0.823 . . . . 0.0 111.28 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 84' ' ' MET . 77.8 mt -71.51 120.8 17.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.828 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' O ' HG11 ' A' ' 121' ' ' VAL . 39.2 mtmt -82.99 149.37 59.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.167 0.987 . . . . 0.0 108.985 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -55.98 -18.93 24.12 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 123.387 2.724 . . . . 0.0 114.791 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.49 -20.11 54.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.143 0.977 . . . . 0.0 112.609 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -71.18 -7.76 48.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.223 0.609 . . . . 0.0 112.544 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.5 m -56.58 101.82 0.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.961 0.904 . . . . 0.0 110.302 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.02 159.07 9.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.573 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.1 p -78.89 113.48 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.524 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.0 m-85 -87.98 112.51 22.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.237 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -104.57 122.73 46.21 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.493 1.117 . . . . 0.0 109.098 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.88 132.04 35.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.56 160.29 40.33 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.962 0.905 . . . . 0.0 109.295 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.43 160.65 39.35 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.494 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . 110.57 10.72 21.06 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 119.773 -0.459 . . . . 0.0 113.831 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HD3' HG21 ' A' ' 51' ' ' VAL . 87.8 tttt -86.6 149.5 24.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -111.52 169.33 8.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.827 0.851 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.7 101.33 1.65 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.643 0.777 . . . . 0.0 110.241 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.16 -99.06 1.53 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.7 t 60.21 -165.46 0.21 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.465 1.106 . . . . 0.0 111.136 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -114.54 113.53 24.53 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -63.53 134.92 56.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.798 0.439 . . . . 0.0 111.081 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.57 -44.0 0.04 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -172.2 147.68 1.87 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.076 0.95 . . . . 0.0 110.66 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.55 157.35 32.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.307 2.005 . . . . 0.0 111.176 167.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.494 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 20.1 t70 -77.0 -32.75 57.42 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.103 0.561 . . . . 0.0 110.185 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -133.85 153.67 51.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.531 1.132 . . . . 0.0 109.302 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -149.64 148.88 29.83 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.126 0.971 . . . . 0.0 108.882 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.57 -155.7 32.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.935 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -97.69 -38.06 9.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.311 1.045 . . . . 0.0 110.587 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.91 136.81 9.2 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.172 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -117.58 114.31 23.23 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.07 0.948 . . . . 0.0 108.805 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 62.3 tp60 -71.9 108.84 5.37 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.32 145.29 7.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 25.2 m -132.6 109.67 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 88' ' ' LYS . 1.7 p -94.7 105.09 16.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.7 t -56.82 118.83 5.31 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.115 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 m -68.47 125.31 26.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.168 0.987 . . . . 0.0 110.928 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 tp -96.15 25.46 4.86 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.859 0.864 . . . . 0.0 109.849 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 63.85 -178.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.553 1.141 . . . . 0.0 111.81 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -103.9 -53.61 2.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 51.31 66.51 1.16 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.473 1.509 . . . . 0.0 112.321 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -177.0 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 65.4 -179.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.829 0.851 . . . . 0.0 110.289 -163.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 63.38 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 109.755 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.634 1.574 . . . . 0.0 108.862 -159.767 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 pm0 -76.0 152.04 37.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.766 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' TYR . 54.4 tp -85.46 111.6 20.12 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -72.38 104.35 3.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.126 0.57 . . . . 0.0 110.025 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.09 128.95 54.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 108.48 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.8 t -121.9 103.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.78 156.82 18.25 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.231 1.012 . . . . 0.0 110.412 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -159.44 171.81 19.04 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.882 0.873 . . . . 0.0 109.791 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.5 15.42 15.49 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.044 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.79 92.18 0.36 Allowed Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.933 0.301 . . . . 0.0 112.444 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.88 179.96 23.43 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.5 pp -107.36 147.86 29.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.084 0.554 . . . . 0.0 110.571 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.0 p -149.47 145.12 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.553 1.141 . . . . 0.0 108.707 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.2 mp0 -72.61 158.34 35.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.876 0.47 . . . . 0.0 112.026 -172.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 114.33 3.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.923 0.889 . . . . 0.0 111.261 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.7 -10.0 25.73 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.486 0.565 . . . . 0.0 112.033 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.02 -163.82 39.33 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.026 0.346 . . . . 0.0 112.713 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.9 p -143.73 158.17 43.87 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.387 0.675 . . . . 0.0 109.981 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -149.59 119.66 7.21 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.9 ttt85 -96.6 116.12 28.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.722 0.809 . . . . 0.0 109.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.173 0.989 . . . . 0.0 110.216 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -132.7 145.22 50.87 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.637 0.775 . . . . 0.0 109.28 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.87 119.37 8.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.325 0.65 . . . . 0.0 110.45 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.73 129.74 34.75 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.029 0.532 . . . . 0.0 110.029 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.93 128.64 54.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.087 0.955 . . . . 0.0 110.156 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 49.9 m -142.76 159.4 42.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.097 0.959 . . . . 0.0 109.816 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.35 -117.96 5.9 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -77.26 163.84 26.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.581 0.752 . . . . 0.0 110.085 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -70.19 97.25 1.18 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.015 0.526 . . . . 0.0 111.1 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -68.43 -23.95 64.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.706 0.802 . . . . 0.0 110.798 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 60.6 p -72.5 -0.05 11.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.949 0.9 . . . . 0.0 112.276 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -99.46 -9.75 23.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.241 0.616 . . . . 0.0 111.116 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -123.48 169.42 11.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.428 0.633 . . . . 0.0 112.323 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -100.83 125.9 47.38 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.207 166.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 9.4 ptm -107.56 170.19 8.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 0.0 110.463 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.41 149.38 18.09 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 113.376 0.11 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -98.1 141.17 31.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.156 0.982 . . . . 0.0 109.995 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -138.28 133.24 32.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.654 1.181 . . . . 0.0 108.724 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -114.79 159.6 20.41 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.058 0.39 . . . . 0.0 111.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.527 ' O ' HG12 ' A' ' 94' ' ' VAL . 28.3 pt20 -168.66 151.8 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.505 0.722 . . . . 0.0 110.712 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -179.59 -57.6 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 123.776 0.83 . . . . 0.0 111.114 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.73 64.99 7.39 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.342 2.028 . . . . 0.0 112.348 -171.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.43 22.32 76.37 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.78 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -103.34 149.1 25.08 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.931 0.892 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.38 178.48 5.95 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.472 1.109 . . . . 0.0 108.334 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.04 105.39 0.47 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 150.1 21.01 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HE2' HG23 ' A' ' 51' ' ' VAL . 58.2 t80 -63.08 112.58 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.757 0.823 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.18 -66.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.3 135.14 3.02 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' HE2' ' A' ' 48' ' ' PHE . 50.2 t -110.87 132.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.262 1.025 . . . . 0.0 109.208 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.92 151.17 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.688 0.795 . . . . 0.0 110.493 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 25.1 t-20 -75.69 156.65 34.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.982 0.913 . . . . 0.0 109.205 170.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 54.7 p-90 -58.78 -34.52 71.54 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.5 p -95.71 1.55 53.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 0.0 111.678 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.02 9.5 71.46 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 113.363 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -64.01 -35.31 80.3 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.33 1.052 . . . . 0.0 111.181 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 98.5 mtt180 -125.49 138.59 53.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.337 1.055 . . . . 0.0 109.229 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.8 p -140.29 131.92 27.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.621 0.768 . . . . 0.0 109.543 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.37 115.78 24.82 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 147.25 34.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.593 0.357 . . . . 0.0 110.241 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.18 146.59 43.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.22 -34.04 73.1 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.5 m -70.61 -28.16 64.64 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.034 0.534 . . . . 0.0 112.223 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 62' ' ' ALA . 12.1 m -109.77 1.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.193 0.597 . . . . 0.0 111.408 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -67.5 120.84 14.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.463 0.705 . . . . 0.0 111.824 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.25 -27.88 4.92 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.748 0.689 . . . . 0.0 113.959 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' NH2' HD23 ' A' ' 87' ' ' LEU . 1.6 ptm180 -89.05 -8.59 53.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.839 0.856 . . . . 0.0 110.901 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.21 151.97 27.64 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.5 m -140.19 119.41 12.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.163 0.985 . . . . 0.0 108.528 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.1 mp -103.54 127.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 m -133.83 157.78 45.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 108.206 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 150.75 18.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.127 0.489 . . . . 0.0 110.341 174.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 77' ' ' LYS . 17.8 m-20 -119.88 112.14 18.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -71.14 -26.95 63.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.072 0.549 . . . . 0.0 110.788 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.36 59.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.509 0.724 . . . . 0.0 111.02 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 72.5 mmtt -77.5 -25.01 49.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.616 0.366 . . . . 0.0 110.886 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 60.32 44.97 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.388 1.075 . . . . 0.0 110.039 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m -139.08 131.24 28.14 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.847 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 35' ' ' MET . 46.4 t -101.58 141.72 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.65 1.18 . . . . 0.0 109.593 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -125.09 126.33 45.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.186 0.994 . . . . 0.0 109.063 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.37 98.19 6.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -89.16 106.6 18.55 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.298 0.639 . . . . 0.0 110.207 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.4 mtm -88.07 139.39 30.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.322 0.649 . . . . 0.0 109.3 174.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 m 59.77 60.29 2.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.187 0.995 . . . . 0.0 111.123 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 84' ' ' MET . 99.3 mt -80.73 127.91 33.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.477 -173.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 2.3 mptp? -92.71 153.91 42.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.3 -25.7 4.97 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.875 3.05 . . . . 0.0 115.142 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.6 pt-20 -71.44 -23.27 61.81 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.743 1.217 . . . . 0.0 113.432 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 1.12 14.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.782 0.833 . . . . 0.0 113.196 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 120' ' ' THR . 54.9 m -62.99 103.13 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.291 0.636 . . . . 0.0 110.337 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.57 155.04 5.85 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.227 0.611 . . . . 0.0 111.452 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.3 p -78.95 112.29 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -87.68 113.47 23.38 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -102.71 128.8 49.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.24 129.38 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -138.53 163.52 31.77 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.264 1.025 . . . . 0.0 109.073 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -138.5 133.7 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.772 0.829 . . . . 0.0 108.774 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 110' ' ' PRO . . . -176.46 83.44 0.07 OUTLIER Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.645 ' HB2' ' H ' ' A' ' 34' ' ' ALA . 60.3 tttm -77.61 129.03 35.09 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.362 0.665 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -70.74 82.64 0.62 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 166.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.87 -47.76 8.75 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.109 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.83 175.64 16.0 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.293 172.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 m -76.26 154.87 34.83 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.989 0.516 . . . . 0.0 110.57 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 71.31 16.18 6.18 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.892 1.277 . . . . 0.0 111.981 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -110.45 36.01 3.24 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.888 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.98 63.77 4.39 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.142 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.1 142.24 1.85 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.477 1.111 . . . . 0.0 108.866 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.651 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 71.1 Cg_endo -74.14 108.74 2.73 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.988 1.792 . . . . 0.0 110.839 174.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.81 -32.46 74.0 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.508 0.67 . . . . 0.0 110.831 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 34.2 m-85 -111.37 151.1 28.85 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.044 0.938 . . . . 0.0 109.14 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 42.4 p90 -166.08 167.42 16.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.869 0.868 . . . . 0.0 109.997 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.99 -147.85 10.13 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.206 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.23 -48.85 9.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.807 0.843 . . . . 0.0 110.383 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.8 151.57 25.33 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.817 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 t -122.64 111.42 16.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.336 1.054 . . . . 0.0 110.077 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 57.2 tp60 -72.47 113.87 9.98 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.474 0.71 . . . . 0.0 110.15 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.557 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.1 m -102.87 146.83 10.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.494 0.718 . . . . 0.0 109.366 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.52 ' HA ' HG23 ' A' ' 92' ' ' THR . 96.4 m -124.63 143.21 50.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.89 0.876 . . . . 0.0 109.001 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.7 p -129.86 125.62 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 109.791 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.458 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 7.9 m -80.03 122.48 26.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.468 1.107 . . . . 0.0 111.885 -170.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.6 p -78.17 143.73 36.97 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.763 0.825 . . . . 0.0 110.699 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.09 -76.24 0.31 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.793 0.437 . . . . 0.0 111.098 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.74 85.75 7.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.29 0.636 . . . . 0.0 110.405 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -76.98 -29.59 55.59 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.533 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -142.21 143.3 32.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.948 1.299 . . . . 0.0 108.563 169.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -159.16 156.38 28.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.301 0.641 . . . . 0.0 110.329 172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -159.13 128.52 5.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.639 0.775 . . . . 0.0 109.154 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -75.05 104.65 5.72 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 61.2 m80 . . . . . 0 CA--C 1.553 1.092 0 C-N-CA 125.052 1.341 . . . . 0.0 110.307 -177.268 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -99.65 163.7 12.38 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp -86.65 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.264 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -94.94 114.74 26.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.532 0.733 . . . . 0.0 109.328 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 96.0 mt -106.9 116.96 32.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.4 101.92 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -111.22 125.39 53.76 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.373 -166.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -165.75 -178.74 4.96 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.22 1.008 . . . . 0.0 110.239 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.5 -0.52 26.34 Favored Glycine 0 N--CA 1.476 1.355 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.33 151.51 29.84 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 122.88 0.276 . . . . 0.0 113.064 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.25 -168.94 31.08 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -91.31 145.54 24.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.226 0.536 . . . . 0.0 111.043 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.94 159.89 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.072 1.349 . . . . 0.0 108.13 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -87.26 166.2 15.09 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.957 0.503 . . . . 0.0 111.158 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' H ' HD13 ' A' ' 124' ' ' LEU . . . -70.45 129.21 38.65 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.319 0.648 . . . . 0.0 109.959 173.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.46 81.75 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.741 0.651 . . . . 0.0 111.892 -170.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 -165.91 40.55 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 122.804 0.24 . . . . 0.0 112.941 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.8 p -148.18 159.03 44.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.861 0.864 . . . . 0.0 110.2 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -159.52 135.22 8.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.583 0.753 . . . . 0.0 109.496 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -109.38 126.51 53.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.841 0.457 . . . . 0.0 110.136 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -103.96 156.96 17.43 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.352 1.061 . . . . 0.0 109.332 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -144.57 154.64 43.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 111.006 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.6 t -150.68 134.2 16.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.453 0.701 . . . . 0.0 109.923 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 145.94 26.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.74 126.66 52.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -133.65 157.72 45.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.603 1.161 . . . . 0.0 109.2 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.96 1.08 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -95.16 164.38 12.89 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.574 0.749 . . . . 0.0 110.055 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 31' ' ' SER . 83.6 m -97.41 121.16 38.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 15.9 p90 -63.5 -16.45 60.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.558 0.743 . . . . 0.0 111.744 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 29' ' ' THR . 34.3 t -68.03 -15.17 63.48 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 0.0 112.613 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 p -93.05 9.68 34.75 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 122.024 -0.422 . . . . 0.0 110.661 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -134.25 167.56 20.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.379 1.071 . . . . 0.0 110.243 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.85 160.45 15.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 31.1 ttp -140.47 157.71 45.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.64 144.01 9.38 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -96.42 131.63 42.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.92 129.0 37.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.014 0.926 . . . . 0.0 108.557 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -109.05 162.35 14.32 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.727 0.299 . . . . 0.0 110.537 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.8 148.53 5.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.091 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 177.23 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.056 0.942 . . . . 0.0 111.352 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 68.5 Cg_endo -82.2 64.82 8.38 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 122.111 1.874 . . . . 0.0 112.523 -170.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.86 6.43 72.72 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.772 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -105.81 146.25 30.12 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.717 0.807 . . . . 0.0 110.142 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.8 178.04 6.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.861 0.864 . . . . 0.0 109.119 170.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -51.68 104.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.48 151.79 19.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.356 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -64.85 108.34 1.73 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -99.0 -49.08 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.49 150.3 6.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.23 138.56 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG23 HG22 ' A' ' 59' ' ' THR . 8.9 p -131.65 160.45 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.68 158.41 20.81 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -56.53 -38.16 71.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.532 0.733 . . . . 0.0 112.077 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -76.62 -23.48 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.625 0.77 . . . . 0.0 111.642 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.32 8.42 83.51 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.564 -165.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -58.42 -39.01 78.61 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.609 1.164 . . . . 0.0 111.049 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -119.52 130.87 55.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.286 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.472 HG22 HG23 ' A' ' 52' ' ' VAL . 46.5 p -122.36 133.21 54.65 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.906 0.883 . . . . 0.0 109.077 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.76 135.93 50.81 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -134.55 148.64 50.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.326 0.65 . . . . 0.0 109.973 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.99 128.32 33.71 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.66 -20.48 60.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.196 0.598 . . . . 0.0 112.436 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 p -64.94 -44.28 89.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.693 0.797 . . . . 0.0 111.129 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.33 -3.43 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.964 0.906 . . . . 0.0 111.782 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -66.81 134.71 52.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.298 0.639 . . . . 0.0 110.638 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.67 15.52 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.968 0.793 . . . . 0.0 113.387 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 19.0 ptt-85 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.01 0.405 . . . . 0.0 110.424 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 2.8 m-85 -105.94 151.04 25.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.729 0.812 . . . . 0.0 109.979 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 m -149.14 142.22 24.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.844 1.258 . . . . 0.0 108.211 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.4 mp -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -140.03 154.57 47.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.237 1.015 . . . . 0.0 108.334 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HG3' ' HE2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -159.72 131.29 6.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.69 98.9 10.26 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.109 0.963 . . . . 0.0 108.537 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.01 -25.5 67.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.98 0.912 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.34 72.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.415 1.086 . . . . 0.0 111.673 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -83.05 -11.23 58.22 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.148 0.579 . . . . 0.0 111.251 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.469 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 30.4 m-80 61.18 35.98 18.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 0.0 110.302 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 132.65 53.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.927 0.891 . . . . 0.0 110.257 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.1 t -99.99 153.11 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.112 1.365 . . . . 0.0 110.255 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -136.45 151.79 49.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.439 1.096 . . . . 0.0 109.829 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 1.8 tm? -132.2 115.16 15.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.84 102.31 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 109.725 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.56 ' HB3' HD21 ' A' ' 87' ' ' LEU . 67.1 mtt -95.16 136.8 35.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.422 0.689 . . . . 0.0 109.609 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 20.3 m120 -142.02 161.85 36.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.746 1.219 . . . . 0.0 108.001 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.3 m 54.12 31.41 13.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.297 1.039 . . . . 0.0 112.875 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 84' ' ' MET . 84.5 mt -61.04 130.07 44.55 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.872 0.869 . . . . 0.0 112.653 -169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD3' ' NH1' ' A' ' 68' ' ' ARG . 2.4 mptp? -98.52 152.3 37.85 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.102 0.961 . . . . 0.0 108.993 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -46.74 -27.38 5.46 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 124.202 3.268 . . . . 0.0 115.936 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -71.21 -16.66 62.52 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB2' HG11 ' A' ' 121' ' ' VAL . 40.3 m-20 -72.68 -11.94 60.83 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.845 0.458 . . . . 0.0 112.103 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 120' ' ' THR . 63.4 m -60.16 105.42 0.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.72 0.808 . . . . 0.0 110.796 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.7 165.88 4.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.883 0.873 . . . . 0.0 110.074 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.3 p -89.26 115.69 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -86.82 155.72 20.18 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.355 1.062 . . . . 0.0 109.439 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -145.81 115.98 7.45 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.75 0.657 . . . . 0.0 109.357 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 26.4 p -83.87 106.09 15.28 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.19 124.66 49.93 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.513 1.125 . . . . 0.0 110.911 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.22 151.24 38.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.716 0.807 . . . . 0.0 110.833 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.12 -157.57 27.75 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -85.54 123.91 31.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -93.73 51.89 1.62 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.47 1.129 . . . . 0.0 108.748 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -114.37 156.29 24.73 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.674 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.75 107.87 0.23 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.561 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 m -69.03 -39.91 78.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.41 0.684 . . . . 0.0 109.703 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -140.37 92.14 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 62.32 176.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.806 1.242 . . . . 0.0 112.324 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.95 166.52 33.52 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.208 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.4 128.61 5.9 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 141.54 86.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.551 2.167 . . . . 0.0 112.2 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.2 -44.67 94.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.935 0.894 . . . . 0.0 111.265 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.73 167.99 20.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.912 0.885 . . . . 0.0 109.911 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -157.4 168.69 26.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.901 0.881 . . . . 0.0 111.256 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -80.7 -172.23 45.28 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.547 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -66.98 -33.88 76.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.161 0.984 . . . . 0.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.52 108.79 2.5 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -100.95 121.84 42.45 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.39 0.676 . . . . 0.0 109.938 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -90.94 127.71 36.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -175.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.9 m -113.43 140.73 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.47 ' HA ' HG23 ' A' ' 92' ' ' THR . 40.2 m -127.33 108.9 11.25 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.0 p -106.62 116.02 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 122.987 0.515 . . . . 0.0 109.63 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -73.57 148.28 43.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 110.614 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.8 p -86.21 109.84 19.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.916 0.886 . . . . 0.0 110.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 15' ' ' ALA . 9.8 mp -114.67 98.91 7.14 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.951 0.901 . . . . 0.0 108.778 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.25 87.58 0.98 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.155 0.979 . . . . 0.0 109.697 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.87 113.95 16.25 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -68.88 142.2 54.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.506 0.322 . . . . 0.0 110.441 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -163.04 153.17 15.99 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.629 0.772 . . . . 0.0 109.695 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -70.95 83.44 0.67 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.384 0.673 . . . . 0.0 110.176 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.1 142.34 28.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.842 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 73.4 m80 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.713 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -120.87 175.58 5.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.63 0.772 . . . . 0.0 109.454 174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.67 111.95 17.83 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -75.88 122.85 24.73 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.355 0.598 . . . . 0.0 110.818 -170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 70.6 mt -127.36 135.12 50.06 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.363 1.465 . . . . 0.0 108.475 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.38 100.42 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -97.29 135.02 39.81 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.386 0.674 . . . . 0.0 109.612 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -148.54 178.92 8.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.486 1.115 . . . . 0.0 109.49 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.38 -12.35 43.6 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.894 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.89 137.19 21.9 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.85 -169.55 36.91 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.94 137.64 37.72 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.971 0.386 . . . . 0.0 111.168 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.75 155.53 6.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 C-N-CA 124.946 1.298 . . . . 0.0 108.449 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -80.49 155.16 27.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.362 0.665 . . . . 0.0 109.948 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 124' ' ' LEU . . . -69.46 111.05 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.241 0.616 . . . . 0.0 110.263 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.92 3.93 31.67 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.922 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.88 -165.98 39.53 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 122.97 0.319 . . . . 0.0 113.463 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 m -132.51 158.22 42.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.413 1.085 . . . . 0.0 110.051 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -152.26 151.12 30.54 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -119.96 113.05 19.96 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.151 0.58 . . . . 0.0 110.548 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -101.54 150.08 23.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.363 1.065 . . . . 0.0 108.782 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -153.08 140.48 19.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.363 0.665 . . . . 0.0 109.294 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.7 t -120.6 123.63 43.31 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.525 0.73 . . . . 0.0 110.258 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.47 115.52 22.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -106.8 163.15 13.17 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.377 1.071 . . . . 0.0 110.273 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -66.09 168.6 8.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.16 23.87 8.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.698 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -79.59 179.17 7.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 111.912 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -79.05 70.18 5.35 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.444 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 59.0 m-85 -66.22 -22.08 66.33 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.313 164.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -60.0 -29.81 68.71 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.999 1.32 . . . . 0.0 111.703 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 m -90.28 -15.04 32.03 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 0.0 111.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -108.58 175.5 5.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.853 0.861 . . . . 0.0 110.931 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.48 162.93 17.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 164.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.4 ttp -141.93 153.26 44.23 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.0 157.02 27.28 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -96.36 125.13 40.64 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.176 0.99 . . . . 0.0 108.355 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -123.61 170.08 10.81 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.319 1.448 . . . . 0.0 107.873 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -149.67 162.31 40.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.845 0.748 . . . . 0.0 112.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -170.1 151.5 3.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 124.385 1.053 . . . . 0.0 110.565 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.31 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 124.459 1.104 . . . . 0.0 111.518 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.57 64.87 8.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 C-N-CA 122.131 1.887 . . . . 0.0 112.481 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.16 14.6 66.4 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.894 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -104.92 160.02 15.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.462 0.705 . . . . 0.0 112.055 -172.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.12 173.49 7.7 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.878 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -59.3 104.34 0.25 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.126 0.97 . . . . 0.0 109.655 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -106.67 150.49 26.19 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.651 0.78 . . . . 0.0 110.668 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.24 111.03 3.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.352 0.661 . . . . 0.0 110.835 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 HG11 ' A' ' 65' ' ' VAL . 70.1 t -94.15 -62.36 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.74 139.55 5.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 76.3 t -123.31 138.32 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.687 0.795 . . . . 0.0 110.436 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.65 157.13 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.283 1.033 . . . . 0.0 109.898 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 55' ' ' SER . 10.4 t30 -84.85 162.96 19.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 169.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.421 0.688 . . . . 0.0 112.479 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 63.6 p -81.69 -11.86 58.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.239 0.616 . . . . 0.0 111.537 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.91 83.11 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.509 0.505 . . . . 0.0 112.791 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -72.36 -23.99 61.21 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 110.969 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -122.89 134.85 54.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.117 0.967 . . . . 0.0 109.004 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.6 p -134.81 132.4 38.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.192 0.997 . . . . 0.0 109.156 173.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -124.22 134.35 53.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.135 1.374 . . . . 0.0 107.524 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.19 149.2 52.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.226 0.61 . . . . 0.0 110.224 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.63 146.11 42.71 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 166.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.76 -34.76 67.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -71.25 -41.88 69.54 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.327 0.651 . . . . 0.0 111.772 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 49' ' ' VAL . 16.1 m -90.17 -5.16 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 122.819 0.448 . . . . 0.0 111.47 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -70.83 120.22 16.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.917 0.887 . . . . 0.0 110.949 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.35 -8.64 77.19 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.449 0.468 . . . . 0.0 113.918 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 20.8 ptp180 -114.37 -26.64 7.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.423 0.689 . . . . 0.0 110.065 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-30 -98.46 150.45 21.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.829 0.851 . . . . 0.0 109.315 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -146.48 134.24 21.18 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.814 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.581 HG13 HD23 ' A' ' 82' ' ' LEU . 2.8 mp -102.81 136.72 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.6 m -135.42 160.37 38.66 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.757 1.223 . . . . 0.0 108.389 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.2 164.37 32.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.219 0.533 . . . . 0.0 111.437 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -129.76 106.64 8.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.929 1.291 . . . . 0.0 107.557 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.97 -31.1 71.82 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.318 1.047 . . . . 0.0 111.604 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.48 67.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.231 0.612 . . . . 0.0 110.743 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.71 -13.51 58.94 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.254 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.4 m120 59.05 31.86 21.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.26 1.024 . . . . 0.0 110.811 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.7 m -121.03 130.1 53.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.87 155.14 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.649 1.18 . . . . 0.0 108.519 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -137.66 141.73 41.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.559 1.144 . . . . 0.0 109.376 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.2 tm? -133.44 132.34 40.99 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -113.98 127.98 56.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.433 ' HB3' HD21 ' A' ' 87' ' ' LEU . 43.4 mtt -111.24 133.65 53.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.278 1.031 . . . . 0.0 110.042 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -133.91 149.54 51.3 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 60.05 54.16 4.28 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.036 0.935 . . . . 0.0 111.434 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 84' ' ' MET . 94.7 mt -75.1 115.96 15.3 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.995 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.48 146.11 95.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -61.39 -13.01 26.52 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 123.107 2.538 . . . . 0.0 113.92 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -88.21 -2.49 58.63 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.722 1.209 . . . . 0.0 112.211 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.483 ' HB3' HG11 ' A' ' 121' ' ' VAL . 14.3 t70 -74.56 -19.82 60.18 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.937 0.895 . . . . 0.0 110.967 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.501 HG23 ' HA ' ' A' ' 120' ' ' THR . 88.7 m -48.4 109.17 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.189 1.396 . . . . 0.0 112.32 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.35 153.79 3.06 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.857 0.723 . . . . 0.0 111.011 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 14.9 p -77.65 114.14 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.8 m-85 -85.6 111.11 19.75 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 121.476 0.655 . . . . 0.0 109.688 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.1 127.88 54.19 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.837 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.3 m -83.87 118.49 24.0 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' HB1' ' HG3' ' A' ' 110' ' ' PRO . . . -107.4 128.71 54.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.916 0.886 . . . . 0.0 109.007 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.69 169.86 11.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.684 0.794 . . . . 0.0 111.544 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.11 -174.06 15.22 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.121 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.23 110.56 6.76 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 117.19 0.495 . . . . 0.0 109.753 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -81.43 70.07 8.21 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.732 0.777 . . . . 0.0 109.561 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 178.16 150.0 0.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.026 1.33 . . . . 0.0 108.68 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.86 -50.27 3.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 123.233 0.333 . . . . 0.0 112.462 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.1 m -80.61 87.05 5.79 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -79.78 102.15 8.88 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 66.16 -163.12 0.24 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.475 1.11 . . . . 0.0 110.823 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.77 -86.74 1.41 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.82 154.64 7.66 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.898 0.879 . . . . 0.0 109.939 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HG3' ' HB1' ' A' ' 98' ' ' ALA . 73.0 Cg_endo -72.93 176.54 8.88 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.607 2.204 . . . . 0.0 111.105 167.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.77 -43.33 75.99 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.027 0.441 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -135.71 160.06 39.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.837 0.855 . . . . 0.0 110.313 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -160.04 143.33 13.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.651 1.18 . . . . 0.0 108.573 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -90.35 -143.26 10.52 Favored Glycine 0 C--N 1.344 0.99 0 O-C-N 122.977 0.173 . . . . 0.0 112.81 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.84 -73.99 0.41 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.027 0.931 . . . . 0.0 110.286 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.48 165.11 11.17 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.201 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.407 HG21 HD12 ' A' ' 21' ' ' LEU . 5.4 t -143.56 108.38 4.91 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.893 0.877 . . . . 0.0 110.269 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 61.4 tp60 -68.97 111.27 4.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.105 0.562 . . . . 0.0 110.877 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -91.74 145.07 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 92' ' ' THR . 26.8 m -133.72 106.16 7.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.417 0.687 . . . . 0.0 109.492 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 91' ' ' ASP . 2.3 p -99.05 102.15 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.88 0.848 . . . . 0.0 108.774 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -57.18 141.86 44.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.958 1.703 . . . . 0.0 111.674 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t -65.52 149.51 49.93 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.022 0.929 . . . . 0.0 111.325 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 47.9 tp -160.73 -43.5 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.329 0.652 . . . . 0.0 109.754 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.39 83.29 3.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.479 0.712 . . . . 0.0 110.865 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -90.27 -20.84 22.49 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.164 0.586 . . . . 0.0 110.308 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.31 101.28 10.67 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -74.25 93.18 2.32 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -154.26 112.92 3.62 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.253 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -113.79 153.54 28.9 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.365 1.066 . . . . 0.0 109.375 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 69.2 t60 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.275 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.7 tt0 65.57 174.32 0.22 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.804 1.242 . . . . 0.0 111.599 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 28' ' ' ARG . 62.1 tp -87.19 110.27 20.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.62 106.14 15.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.704 0.801 . . . . 0.0 108.973 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.532 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.4 mt -97.57 121.3 39.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.144 0.978 . . . . 0.0 108.846 173.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 60.1 t -114.51 101.19 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.536 0.734 . . . . 0.0 109.176 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -74.92 142.32 44.02 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.526 0.73 . . . . 0.0 109.751 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 p -157.17 166.04 34.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.487 1.115 . . . . 0.0 110.02 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.24 85.51 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.583 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -84.5 139.3 17.95 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.9 -163.95 28.88 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' THR . 3.9 pp -106.7 143.75 34.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.65 0.78 . . . . 0.0 111.623 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 14.5 p -151.57 156.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 108.266 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -73.07 167.38 21.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.719 0.408 . . . . 0.0 111.275 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . . . -70.4 121.09 17.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 0.0 109.935 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.92 1.03 57.32 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.878 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.52 -172.67 49.27 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 123.058 0.361 . . . . 0.0 112.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -135.26 143.85 46.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.793 0.837 . . . . 0.0 109.664 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -140.97 124.21 16.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.041 0.937 . . . . 0.0 108.611 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -95.13 120.29 35.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.12 0.968 . . . . 0.0 109.737 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.1 mm? -99.31 157.68 16.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.563 0.745 . . . . 0.0 109.435 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.58 156.26 45.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.44 1.096 . . . . 0.0 108.644 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.558 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 52.5 t -150.4 117.61 6.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.768 0.427 . . . . 0.0 110.513 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.0 119.27 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.295 0.638 . . . . 0.0 109.662 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.48 124.69 49.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.255 1.022 . . . . 0.0 109.529 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -145.09 163.49 34.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.075 0.55 . . . . 0.0 111.127 -172.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.7 -90.5 1.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 112.362 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 27.8 tpt180 -79.59 154.47 28.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.228 0.611 . . . . 0.0 110.767 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 m -75.12 93.5 2.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.17 0.588 . . . . 0.0 110.091 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -61.36 -29.3 69.82 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.046 0.939 . . . . 0.0 111.43 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 57.3 p -77.16 0.37 21.96 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.747 0.819 . . . . 0.0 112.519 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -95.21 -14.59 23.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.173 0.589 . . . . 0.0 111.086 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.33 173.01 6.83 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.803 0.841 . . . . 0.0 110.891 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.34 160.81 18.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 163.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.9 ttp -137.87 136.52 37.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -139.38 140.85 11.2 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 122.969 0.319 . . . . 0.0 112.411 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -95.03 135.04 37.05 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.485 1.114 . . . . 0.0 108.96 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -127.81 149.97 50.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.054 1.342 . . . . 0.0 108.189 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -135.59 160.7 37.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.941 0.337 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.476 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.3 pp0? -165.93 145.75 6.36 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.725 0.641 . . . . 0.0 110.67 175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -177.03 -63.54 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.387 169.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 90.2 Cg_endo -78.86 75.96 4.77 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.249 1.966 . . . . 0.0 112.393 -171.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 15.58 68.13 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.168 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -105.15 143.25 33.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.281 1.032 . . . . 0.0 111.043 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.56 172.61 8.26 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 162.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -60.05 104.61 0.32 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.098 0.475 . . . . 0.0 110.118 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.57 152.34 18.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.629 1.172 . . . . 0.0 109.564 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -62.17 111.81 2.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.32 -54.08 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -166.29 136.82 3.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.499 0.499 . . . . 0.0 111.421 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' HA3' ' A' ' 36' ' ' GLY . 40.3 t -121.06 129.39 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.257 1.023 . . . . 0.0 109.58 173.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -116.03 158.26 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.284 1.034 . . . . 0.0 108.482 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.31 172.82 10.16 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 36.1 p-90 -62.33 -27.65 69.2 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.906 0.883 . . . . 0.0 113.255 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.3 m -86.06 -22.48 27.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.454 0.702 . . . . 0.0 112.543 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.43 10.98 83.84 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 123.08 0.237 . . . . 0.0 112.55 -172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -83.77 -23.66 31.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.842 1.257 . . . . 0.0 111.336 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -121.32 120.35 34.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.164 0.986 . . . . 0.0 108.574 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -127.93 130.75 48.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.652 0.781 . . . . 0.0 109.02 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.02 132.68 45.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 76.1 m-85 -128.56 150.84 50.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.378 0.671 . . . . 0.0 109.873 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.62 135.31 46.88 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.11 -30.87 38.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 112.0 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -62.88 -43.32 99.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.008 0.923 . . . . 0.0 112.153 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.57 1.71 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 26.3 ttpp -69.55 134.38 48.76 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.745 0.818 . . . . 0.0 110.845 -173.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.01 25.08 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.814 0.696 . . . . 0.0 113.718 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 29.4 ptt-85 -107.35 -20.74 13.18 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.235 0.518 . . . . 0.0 111.24 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-30 -97.61 157.69 15.9 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.161 0.585 . . . . 0.0 110.203 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.8 m -150.2 134.82 17.46 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.613 1.165 . . . . 0.0 109.122 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -102.56 142.04 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 169.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -142.02 160.38 40.33 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.999 1.32 . . . . 0.0 107.632 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 173.85 15.1 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -148.26 118.74 7.41 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.43 -24.67 59.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.814 0.846 . . . . 0.0 111.625 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.26 33.93 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.521 0.728 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.8 mmpt? -87.13 -14.59 40.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 0.0 111.401 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 61.93 27.72 16.85 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.559 1.162 . . . . 0.0 110.931 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -122.96 133.73 54.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.994 0.518 . . . . 0.0 110.549 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 91.5 t -104.39 154.08 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.591 1.556 . . . . 0.0 109.061 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.55 141.94 41.39 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.416 1.086 . . . . 0.0 109.072 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -131.59 99.56 4.84 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -85.65 117.08 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.372 0.669 . . . . 0.0 109.893 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.562 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.4 mtm -110.43 99.59 8.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.756 0.822 . . . . 0.0 109.872 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -99.0 154.06 18.38 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.655 0.782 . . . . 0.0 109.817 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t 56.62 42.24 27.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' MET . 18.1 mt -56.03 124.76 18.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.053 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' O ' HG11 ' A' ' 121' ' ' VAL . 80.6 tttt -90.69 142.7 28.07 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.724 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -34.55 -40.33 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 125.205 3.936 . . . . 0.0 116.182 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.24 -11.92 60.42 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.507 1.123 . . . . 0.0 113.736 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -80.64 -2.63 47.35 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.589 0.755 . . . . 0.0 112.515 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 90.0 m -63.47 106.19 0.89 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.319 0.648 . . . . 0.0 110.215 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.01 160.06 4.12 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 0.0 111.014 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 40' ' ' GLN . 7.6 p -83.04 114.54 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -87.5 113.77 23.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.926 0.891 . . . . 0.0 110.408 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.57 126.25 52.31 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.364 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.3 143.89 28.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -140.3 158.71 43.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.995 0.918 . . . . 0.0 109.915 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -134.94 141.83 46.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.988 0.515 . . . . 0.0 110.706 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.67 165.62 22.25 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -94.96 125.99 40.0 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.021 0.911 . . . . 0.0 110.084 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.544 ' HA ' ' HA3' ' A' ' 108' ' ' GLY . 24.3 m-90 -103.2 22.81 13.41 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.246 1.018 . . . . 0.0 109.892 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.05 141.39 32.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.447 1.099 . . . . 0.0 110.332 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 -73.7 2.52 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.3 t -75.69 147.43 39.42 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.525 0.73 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.16 -21.97 58.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 110.308 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.45 79.64 1.41 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.145 0.978 . . . . 0.0 108.577 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 102' ' ' TRP . . . -76.95 142.46 27.59 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.055 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.17 113.78 43.82 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.585 0.754 . . . . 0.0 111.2 -174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.87 86.15 1.65 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.623 2.215 . . . . 0.0 108.688 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.8 -25.02 64.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.008 0.923 . . . . 0.0 111.438 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 38.7 m-85 -118.76 155.74 30.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.249 1.019 . . . . 0.0 109.29 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 10.3 p90 -165.68 172.86 11.38 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.226 1.011 . . . . 0.0 109.753 170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.98 -149.69 16.24 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.338 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -84.84 -64.59 1.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.669 1.188 . . . . 0.0 109.109 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.68 142.19 6.28 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.453 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 10.2 t -122.52 117.89 26.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.895 0.878 . . . . 0.0 109.687 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 26.6 tp60 -78.2 106.47 10.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.12 0.568 . . . . 0.0 109.83 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.2 146.97 8.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.511 0.724 . . . . 0.0 109.276 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 47.1 m -131.93 133.99 45.16 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.458 0.703 . . . . 0.0 109.696 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.1 p -114.38 105.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -59.45 112.38 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.733 1.213 . . . . 0.0 110.754 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 p -80.73 110.32 16.12 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.879 0.871 . . . . 0.0 110.621 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 15' ' ' ALA . 1.1 pp -87.19 47.42 1.5 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.147 0.979 . . . . 0.0 109.907 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -72.6 145.38 47.38 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.397 -173.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -142.79 134.42 26.58 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.242 1.017 . . . . 0.0 108.896 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.56 149.35 48.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.955 0.502 . . . . 0.0 110.706 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -71.54 96.76 1.57 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.889 0.475 . . . . 0.0 109.987 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 82.2 t60 75.29 139.17 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.041 1.336 . . . . 0.0 113.158 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -68.51 104.84 2.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.994 0.918 . . . . 0.0 109.778 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 124.817 1.247 . . . . 0.0 110.371 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' ' HD3' ' A' ' 28' ' ' ARG . 58.0 tpp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -154.03 139.69 17.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.65 0.78 . . . . 0.0 109.863 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 28' ' ' ARG . 43.9 tp -88.59 112.27 22.86 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 6.6 tp-100 -80.23 123.38 27.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.438 0.695 . . . . 0.0 109.665 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.4 mt -111.55 111.28 22.18 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.7 t -98.55 100.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 6.8 tm-20 -82.56 131.02 35.22 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.9 m -138.88 128.32 24.41 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.317 1.047 . . . . 0.0 108.763 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.89 -155.13 26.22 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.55 151.01 5.29 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 122.914 0.293 . . . . 0.0 112.899 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.66 -173.61 43.28 Favored Glycine 0 C--O 1.241 0.593 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.08 134.35 41.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.543 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 HD12 ' A' ' 87' ' ' LEU . 13.5 p -152.56 156.67 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 108.913 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 43.3 mt-30 -81.26 161.23 24.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.368 0.667 . . . . 0.0 110.556 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 131.97 46.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.647 0.379 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.43 -15.08 62.7 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.743 0.652 . . . . 0.0 111.489 -170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.17 -171.08 40.23 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.027 0.346 . . . . 0.0 113.833 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.3 p -137.85 160.34 39.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 0.0 110.885 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.92 164.03 33.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -130.22 140.63 50.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 82' ' ' LEU . 1.7 mm? -119.64 157.81 27.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.606 1.563 . . . . 0.0 107.472 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 t -151.56 163.75 38.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.453 0.301 . . . . 0.0 110.256 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.6 t -152.86 122.62 6.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.06 0.544 . . . . 0.0 110.61 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 127.63 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.17 136.45 44.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.264 0.626 . . . . 0.0 109.49 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 9.5 t -71.94 -175.44 1.44 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.431 1.092 . . . . 0.0 112.674 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.58 -19.84 54.99 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 45.7 mmm-85 -60.81 145.88 48.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.602 0.761 . . . . 0.0 111.346 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.3 p -70.63 91.16 0.79 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -60.18 -21.35 61.59 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.141 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 17.6 p -67.17 -0.2 3.19 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.44 1.496 . . . . 0.0 113.462 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 m -106.98 -3.3 20.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.253 0.621 . . . . 0.0 111.019 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.82 155.49 36.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.137 0.575 . . . . 0.0 111.021 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.87 125.84 35.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.538 ' HG2' HG21 ' A' ' 80' ' ' VAL . 3.0 tpt -99.17 116.92 32.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.413 1.085 . . . . 0.0 109.033 -172.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -132.85 142.19 13.67 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 114.072 0.389 . . . . 0.0 114.072 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -96.72 134.15 40.35 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.959 1.303 . . . . 0.0 109.319 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -124.5 164.73 19.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -143.13 154.12 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.161 0.437 . . . . 0.0 111.548 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.08 151.02 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.623 1.169 . . . . 0.0 109.025 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.36 -64.92 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 C-N-CA 124.017 0.927 . . . . 0.0 111.068 166.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 54.5 Cg_endo -84.43 69.63 6.07 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.008 1.805 . . . . 0.0 111.949 -172.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 5.61 63.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.341 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -92.37 139.97 30.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.142 0.977 . . . . 0.0 109.547 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.44 169.0 12.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.532 0.733 . . . . 0.0 109.495 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -63.11 103.84 0.51 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.91 155.47 22.6 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.904 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.9 109.52 1.28 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.718 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.83 -63.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.47 134.11 1.79 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.724 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HA3' ' A' ' 36' ' ' GLY . 69.9 t -118.31 129.97 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 109.344 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 59' ' ' THR . 11.7 p -105.94 146.27 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -77.26 148.91 35.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.4 p-90 -48.26 -33.65 9.04 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -83.57 -32.45 25.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.553 0.741 . . . . 0.0 111.483 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.6 -8.19 61.8 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.35 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.96 -41.46 78.36 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.794 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -107.7 130.87 54.89 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.383 0.673 . . . . 0.0 109.655 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.606 HG22 HG23 ' A' ' 52' ' ' VAL . 32.9 p -130.94 143.88 51.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.456 1.102 . . . . 0.0 109.002 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -131.45 144.5 51.22 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 109.682 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.89 145.51 42.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.523 0.729 . . . . 0.0 109.075 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.35 -29.61 66.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.536 0.734 . . . . 0.0 112.054 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 m -66.04 -31.27 72.06 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.253 1.021 . . . . 0.0 111.911 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.15 -2.56 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.955 0.902 . . . . 0.0 111.911 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -73.85 137.01 43.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.835 0.454 . . . . 0.0 110.825 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.95 -24.83 22.64 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.678 0.611 . . . . 0.0 113.015 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -113.04 -12.46 13.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.668 0.787 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 82' ' ' LEU . 3.1 m-85 -109.78 145.22 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.363 0.665 . . . . 0.0 109.725 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -144.35 129.82 18.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.045 0.938 . . . . 0.0 109.045 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.455 HG12 HD23 ' A' ' 82' ' ' LEU . 5.6 mt -101.65 120.48 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -124.92 138.3 54.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.57 0.748 . . . . 0.0 109.07 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.68 137.61 30.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.626 0.37 . . . . 0.0 110.031 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -105.79 101.6 11.1 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.584 0.754 . . . . 0.0 110.896 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.25 -44.54 79.17 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.282 1.033 . . . . 0.0 110.917 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -86.58 -10.92 52.93 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.401 0.68 . . . . 0.0 111.163 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 62.97 28.1 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.637 1.175 . . . . 0.0 110.362 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.6 m -121.94 132.15 54.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.666 0.786 . . . . 0.0 110.533 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 35' ' ' MET . 26.1 t -100.57 157.35 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -139.05 155.46 47.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.54 1.136 . . . . 0.0 109.247 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -130.42 122.14 27.22 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.62 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.347 1.059 . . . . 0.0 108.519 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 48.8 mtt -86.47 125.22 33.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.593 0.757 . . . . 0.0 109.056 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -128.63 153.59 47.11 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.1 m 54.88 46.48 24.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.825 0.85 . . . . 0.0 111.91 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD12 HG11 ' A' ' 13' ' ' VAL . 63.9 mt -66.33 128.97 38.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.556 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.08 157.84 53.54 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.521 1.129 . . . . 0.0 108.635 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.49 -16.49 35.97 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.677 2.252 . . . . 0.0 113.722 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.47 -26.3 68.66 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.339 1.056 . . . . 0.0 112.247 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.63 -12.51 60.02 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.7 m -61.43 99.34 0.1 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.327 0.512 . . . . 0.0 109.683 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.55 157.13 3.14 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.671 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 p -80.11 112.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -87.62 119.55 28.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.177 0.991 . . . . 0.0 109.719 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -101.81 126.18 48.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.185 0.994 . . . . 0.0 109.346 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 20.2 t -85.07 107.66 17.28 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.402 0.681 . . . . 0.0 109.628 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -108.21 158.31 17.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 110.997 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.67 123.51 15.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.162 0.985 . . . . 0.0 108.737 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.08 178.54 37.87 Favored Glycine 0 C--N 1.333 0.406 0 O-C-N 123.414 0.446 . . . . 0.0 112.003 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -81.78 95.27 7.22 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 67.54 -78.05 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.903 1.281 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -178.53 -52.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.924 1.69 . . . . 0.0 107.754 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.42 -145.08 8.58 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -148.78 -75.26 0.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.156 0.583 . . . . 0.0 110.132 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -89.63 -33.9 16.49 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.438 0.695 . . . . 0.0 109.13 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -122.5 139.91 53.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.43 1.092 . . . . 0.0 108.182 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.85 130.81 10.38 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.42 104.48 1.67 Allowed Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.327 0.651 . . . . 0.0 110.177 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.08 128.0 20.69 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.858 2.372 . . . . 0.0 111.756 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.77 -46.84 88.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.928 0.891 . . . . 0.0 111.254 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -126.8 159.47 33.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 109.303 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 48.8 p90 -155.71 165.92 35.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.483 0.713 . . . . 0.0 110.211 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.7 -170.37 17.97 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.737 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.53 -56.63 11.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.778 0.831 . . . . 0.0 110.967 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.29 151.05 23.76 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.449 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 10.2 t -130.8 136.09 48.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.275 0.63 . . . . 0.0 111.213 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -75.14 108.48 7.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.56 139.85 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.524 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.1 m -126.07 105.34 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.59 109.06 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.192 0.597 . . . . 0.0 109.435 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 46.9 t -55.96 122.36 11.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.87 1.268 . . . . 0.0 111.07 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.0 t -63.5 93.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.918 0.887 . . . . 0.0 110.201 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.14 100.94 8.29 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -168.79 133.61 1.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.256 1.023 . . . . 0.0 108.579 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -62.96 127.3 30.61 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.567 0.542 . . . . 0.0 110.779 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -165.56 146.07 6.9 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.721 0.809 . . . . 0.0 109.732 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -153.11 131.69 12.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.604 0.762 . . . . 0.0 109.105 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -99.38 151.36 21.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -157.35 179.42 9.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.574 0.75 . . . . 0.0 109.523 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 35.9 m170 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.452 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -139.28 174.08 10.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.814 0.846 . . . . 0.0 111.161 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 49.7 tp -96.31 110.62 22.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 27.5 tt0 -79.56 110.35 14.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.719 0.808 . . . . 0.0 109.578 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.512 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 44.0 mt -104.81 112.99 26.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.66 101.11 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.436 0.694 . . . . 0.0 109.572 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.41 149.3 26.77 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.773 0.32 . . . . 0.0 110.295 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.0 p -159.42 168.22 26.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.318 1.047 . . . . 0.0 109.553 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.46 -7.63 54.1 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 120.034 -0.315 . . . . 0.0 113.177 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 126.59 8.36 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.698 0.249 . . . . 0.0 112.808 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.71 -164.73 20.65 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.77 141.6 30.4 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.119 0.485 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.74 159.41 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.209 1.404 . . . . 0.0 107.968 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -88.11 165.12 15.35 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.889 0.476 . . . . 0.0 111.459 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.91 120.98 13.56 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.453 0.701 . . . . 0.0 109.425 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 5.03 75.8 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.926 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.67 -176.48 49.23 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.572 0.219 . . . . 0.0 113.145 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -134.46 158.04 44.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -158.01 143.13 16.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.295 0.638 . . . . 0.0 109.652 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -111.64 122.23 47.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -96.13 150.36 20.59 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -139.57 125.08 19.22 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.78 135.54 53.41 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.654 0.782 . . . . 0.0 109.107 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 118.93 37.51 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.307 0.643 . . . . 0.0 109.31 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 4' ' ' GLN . . . -104.56 135.94 45.04 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.162 0.585 . . . . 0.0 109.599 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.6 m -149.69 162.7 39.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.991 0.916 . . . . 0.0 110.07 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 -96.24 1.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.564 ' HB3' ' HE2' ' A' ' 33' ' ' TYR . 16.4 mmt85 -67.27 164.54 18.11 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.07 0.548 . . . . 0.0 111.869 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.3 p -71.63 83.98 0.86 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.874 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.487 ' HD1' HD21 ' A' ' 3' ' ' LEU . 78.2 t80 -57.73 -29.99 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.526 0.73 . . . . 0.0 111.37 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -71.18 0.68 7.27 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.392 1.077 . . . . 0.0 112.877 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.1 m -112.5 -9.25 13.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.998 0.919 . . . . 0.0 111.113 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HE2' ' HB3' ' A' ' 28' ' ' ARG . 47.0 m-85 -114.79 138.84 50.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.909 0.483 . . . . 0.0 110.75 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 157.62 26.34 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 167.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 13.9 ttp -141.37 147.54 38.2 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -141.82 150.83 22.31 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.23 0.332 . . . . 0.0 112.43 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -97.84 127.51 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.652 0.781 . . . . 0.0 109.155 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.52 132.77 49.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.031 . . . . 0.0 108.271 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 27.6 ptt180 -116.73 158.67 23.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.533 0.333 . . . . 0.0 110.771 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.539 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.1 pp0? -170.06 153.81 4.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.686 0.794 . . . . 0.0 109.078 171.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.73 -54.34 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 118.516 -0.755 . . . . 0.0 111.528 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.43 68.22 8.07 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.039 1.826 . . . . 0.0 112.457 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.38 21.14 64.11 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.049 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -115.58 156.62 25.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.336 0.654 . . . . 0.0 111.564 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.57 170.43 16.66 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.546 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -61.64 103.89 0.37 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.55 146.54 24.38 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.671 0.788 . . . . 0.0 109.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -65.25 120.96 13.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.863 0.865 . . . . 0.0 110.23 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 95' ' ' TYR . 52.0 t -101.94 -54.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -168.31 154.81 7.39 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.112 -173.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 36' ' ' GLY . 70.5 t -140.37 147.5 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.704 1.202 . . . . 0.0 108.328 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -141.29 153.1 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.184 0.994 . . . . 0.0 108.985 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -76.66 161.15 28.78 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 167.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -55.17 -39.4 69.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.296 0.638 . . . . 0.0 110.696 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -74.31 -19.99 60.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.474 1.109 . . . . 0.0 111.584 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.03 78.21 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -167.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -58.91 -64.8 0.81 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.286 1.034 . . . . 0.0 110.851 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -112.84 129.56 56.4 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 52' ' ' VAL . 65.2 p -114.47 130.31 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -116.23 126.92 54.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -118.7 150.75 39.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.184 0.594 . . . . 0.0 109.923 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.62 130.71 35.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.89 -22.51 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -67.81 -40.98 83.77 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.626 0.77 . . . . 0.0 111.409 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 62' ' ' ALA . 32.2 m -106.86 3.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.934 0.894 . . . . 0.0 111.578 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.6 128.49 36.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.869 0.867 . . . . 0.0 111.288 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 -17.56 50.83 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 113.619 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -103.04 -19.12 14.68 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -102.34 157.88 16.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 110.216 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.2 m -149.27 133.12 17.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.105 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.507 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.6 mp -103.0 131.13 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -133.15 160.42 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 108.334 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 167.29 30.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.96 111.86 11.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.99 -16.19 60.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.588 0.755 . . . . 0.0 112.083 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.1 -50.64 11.64 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.0 -14.55 57.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.7 28.64 17.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.004 1.321 . . . . 0.0 111.275 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 m -113.51 130.86 56.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.898 0.479 . . . . 0.0 110.516 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.31 151.55 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 109.787 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -135.5 112.94 10.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.397 1.079 . . . . 0.0 108.931 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.0 tm? -93.6 103.1 15.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 104.06 16.69 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.749 0.82 . . . . 0.0 109.329 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.451 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.7 mtt -90.41 139.4 30.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.85 1.26 . . . . 0.0 110.963 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.61 140.11 45.83 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 54.71 58.84 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 111.713 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 84' ' ' MET . 56.4 mt -64.17 124.78 22.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.819 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.9 mtpt -72.5 144.08 85.99 Favored Pre-proline 0 C--O 1.21 -0.984 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.668 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 51.3 Cg_exo -56.45 -21.52 37.94 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.868 2.379 . . . . 0.0 114.273 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.83 3.46 55.09 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.828 1.251 . . . . 0.0 112.79 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -79.79 -17.05 54.31 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.72 0.808 . . . . 0.0 111.35 -172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 120' ' ' THR . 94.2 m -53.57 108.73 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.701 1.2 . . . . 0.0 112.11 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.95 160.45 4.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.748 0.819 . . . . 0.0 111.295 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 13.8 p -81.04 114.49 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.041 0.448 . . . . 0.0 110.173 173.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HE2' HG11 ' A' ' 49' ' ' VAL . 19.8 m-85 -87.23 127.87 35.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.835 1.254 . . . . 0.0 110.374 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.67 142.94 51.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.696 0.798 . . . . 0.0 110.001 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.488 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.5 m -92.22 112.02 23.81 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.004 0.922 . . . . 0.0 109.159 173.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.97 112.71 25.94 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -108.12 169.84 8.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.547 0.739 . . . . 0.0 111.181 -174.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.91 -149.66 17.77 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -96.1 117.78 31.39 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -98.95 -3.92 33.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.774 0.83 . . . . 0.0 109.703 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -103.87 171.88 7.11 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.878 0.871 . . . . 0.0 110.783 -169.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.49 -80.47 1.82 Allowed Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.586 0.612 . . . . 0.0 112.091 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.3 t -152.53 29.35 0.54 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.292 1.037 . . . . 0.0 108.67 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.29 29.03 7.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 0.0 110.733 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -70.88 101.55 2.17 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.546 0.738 . . . . 0.0 109.543 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.04 -16.69 32.74 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.415 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.05 101.73 23.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.074 0.949 . . . . 0.0 109.951 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -84.87 162.06 11.98 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.3 2.0 . . . . 0.0 111.656 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.65 -34.38 17.28 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 51.0 m-85 -127.51 152.6 47.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.639 0.776 . . . . 0.0 110.01 -172.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -132.16 139.06 48.27 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.512 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.62 -169.03 44.58 Favored Glycine 0 C--O 1.244 0.741 0 O-C-N 123.117 0.261 . . . . 0.0 113.731 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.82 -54.78 9.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.435 0.694 . . . . 0.0 110.366 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 106.3 2.77 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.198 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -101.69 121.45 42.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.279 1.032 . . . . 0.0 109.848 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -86.61 124.94 33.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.825 0.45 . . . . 0.0 110.059 -175.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.99 141.31 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.523 0.729 . . . . 0.0 109.04 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.468 ' HA ' HG23 ' A' ' 92' ' ' THR . 57.5 m -129.16 106.84 9.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.281 0.632 . . . . 0.0 109.656 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.8 p -93.36 128.23 44.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.3 t -69.38 111.89 5.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.52 0.728 . . . . 0.0 109.217 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 34.9 p -76.78 81.27 3.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.655 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.1 tp -81.74 72.91 8.8 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.415 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -139.37 161.71 36.8 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.246 1.018 . . . . 0.0 109.748 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.57 -23.49 42.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.155 0.582 . . . . 0.0 110.581 171.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.0 m80 61.23 28.55 18.11 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.655 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -89.62 49.63 1.77 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.727 0.811 . . . . 0.0 110.645 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -77.93 -42.96 31.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -156.9 -76.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.477 1.111 . . . . 0.0 108.636 173.051 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 mtm . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -144.38 64.74 1.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.556 1.17 . . . . 0.0 110.199 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.4 tp -128.67 112.91 14.74 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.175 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -72.28 102.69 3.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 87.9 mt -112.84 103.62 11.62 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 57.3 t -99.74 99.6 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 50.9 mt-10 -85.77 142.67 28.8 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.953 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -158.44 172.28 18.62 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.32 0.648 . . . . 0.0 110.16 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.52 6.77 70.12 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.051 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 119.68 4.97 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.26 -164.86 23.67 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.23 147.1 34.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.13 143.53 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.448 1.099 . . . . 0.0 108.345 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -65.93 153.37 42.24 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.53 0.732 . . . . 0.0 111.309 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 110.54 2.38 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.126 0.57 . . . . 0.0 110.231 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.05 10.49 59.72 Favored Glycine 0 N--CA 1.464 0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.599 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.29 -169.15 43.08 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.644 0.261 . . . . 0.0 112.998 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.5 p -123.11 148.68 45.42 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.732 0.813 . . . . 0.0 110.759 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 tp -152.66 123.64 7.48 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -99.41 111.16 23.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.64 157.65 20.28 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.043 0.937 . . . . 0.0 110.344 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -147.25 157.92 43.77 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.061 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 43.3 t -142.35 120.97 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.475 0.71 . . . . 0.0 109.799 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.79 109.69 18.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.42 38.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.49 0.716 . . . . 0.0 109.368 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -158.58 158.65 34.32 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.669 0.787 . . . . 0.0 109.853 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.72 -93.81 0.93 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HD3' ' H ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -91.64 154.02 19.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.417 0.687 . . . . 0.0 109.453 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.458 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 39.2 p -70.13 84.93 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.43 0.633 . . . . 0.0 110.892 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -63.24 -19.56 64.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.928 0.891 . . . . 0.0 111.212 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -49.22 -40.4 33.62 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.995 1.718 . . . . 0.0 113.141 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 -21.88 50.63 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.138 0.975 . . . . 0.0 112.199 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.93 148.68 22.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . . . -76.01 156.63 33.88 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttp -141.58 141.09 33.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.13 0.572 . . . . 0.0 110.204 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 142.66 14.17 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -97.21 129.32 44.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 108.959 171.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -132.91 143.04 49.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.412 1.085 . . . . 0.0 109.359 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -125.64 155.85 40.14 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.256 0.48 . . . . 0.0 112.25 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.01 144.19 6.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.792 0.837 . . . . 0.0 110.992 171.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 167.87 -50.35 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 125.28 1.432 . . . . 0.0 111.939 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.28 61.96 8.34 Favored 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.558 2.172 . . . . 0.0 113.122 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.52 21.41 70.67 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.553 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -127.67 150.49 49.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.791 0.837 . . . . 0.0 110.728 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 173.47 9.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.82 0.848 . . . . 0.0 109.629 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -69.18 109.06 3.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.333 0.587 . . . . 0.0 111.056 -172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -112.14 157.76 20.44 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.342 -170.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -63.67 121.82 14.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.884 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 65' ' ' VAL . 61.7 t -106.59 -66.85 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -153.76 134.07 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.56 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -122.29 155.58 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.187 0.995 . . . . 0.0 108.589 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.23 150.27 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.04 170.14 14.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.829 0.452 . . . . 0.0 110.538 171.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -60.37 -43.23 96.77 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -88.63 -2.1 58.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.071 0.548 . . . . 0.0 111.874 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.88 85.12 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.122 0.264 . . . . 0.0 113.076 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.74 -39.44 94.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.2 1.0 . . . . 0.0 111.325 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -115.81 135.08 54.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.671 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 p -125.26 129.33 49.82 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.12 141.44 41.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.447 1.499 . . . . 0.0 108.286 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -141.43 146.09 36.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.292 0.637 . . . . 0.0 109.943 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.97 151.39 40.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 164.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.55 -33.74 47.0 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.12 0.968 . . . . 0.0 112.973 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -75.77 -41.89 51.8 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.098 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 9.3 m -92.08 -4.73 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.37 0.668 . . . . 0.0 111.244 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.01 129.14 38.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.587 0.755 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.73 -25.44 6.62 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.787 0.679 . . . . 0.0 113.906 176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 19.6 ptp180 -102.4 -24.58 13.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.531 0.733 . . . . 0.0 111.017 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.1 m-30 -97.84 161.29 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.5 m -148.41 135.74 20.4 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 108.736 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.9 mp -100.9 139.16 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -142.37 148.85 38.56 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.191 0.996 . . . . 0.0 109.127 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 136.73 19.95 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -117.29 117.69 30.23 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -85.24 -14.48 46.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.677 0.791 . . . . 0.0 111.928 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.38 -45.91 10.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.257 0.623 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.05 -20.13 56.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.947 0.899 . . . . 0.0 110.448 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.2 39.45 12.66 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.574 1.171 . . . . 0.0 109.74 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 m -129.51 131.43 46.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.917 0.487 . . . . 0.0 111.06 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 75.3 t -98.16 148.3 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 109.878 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -134.28 141.73 47.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 109.085 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -133.34 105.17 6.81 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -84.27 106.27 15.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.591 0.756 . . . . 0.0 109.068 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 53.3 mtt -102.11 128.7 48.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -128.1 144.39 51.11 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m 57.33 64.51 1.58 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.165 0.986 . . . . 0.0 112.014 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 91.4 mt -77.77 120.63 22.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.14 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG11 ' A' ' 121' ' ' VAL . 46.4 mtpt -74.23 152.32 88.13 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.073 -0.965 . . . . 0.0 108.643 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 98.7 Cg_exo -48.78 -26.97 10.39 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.205 2.603 . . . . 0.0 114.773 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.41 -22.72 60.15 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.089 0.956 . . . . 0.0 112.816 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.17 -6.63 14.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.577 0.751 . . . . 0.0 112.346 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.2 m -61.74 98.76 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.78 159.03 7.79 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.523 -170.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -86.35 114.4 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 171.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.465 ' HE2' HG11 ' A' ' 49' ' ' VAL . 49.9 m-85 -86.41 150.06 24.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.931 0.892 . . . . 0.0 108.706 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.65 121.58 12.79 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.7 p -85.09 102.53 13.32 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.39 142.89 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.633 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.64 121.54 44.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.072 0.463 . . . . 0.0 110.256 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.94 142.32 5.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.323 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . 2.9 tmmm? -82.21 102.22 10.98 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 36.5 m0 59.68 83.87 0.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.053 1.341 . . . . 0.0 111.052 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.83 143.35 36.09 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.81 -12.36 47.21 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.505 0.574 . . . . 0.0 112.948 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.1 m 66.89 8.26 5.93 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.014 1.326 . . . . 0.0 112.802 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -178.46 -58.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -82.0 84.97 6.8 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.05 152.2 26.59 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -166.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.26 155.06 70.45 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 123.851 0.86 . . . . 0.0 109.365 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.27 141.82 40.04 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.498 2.132 . . . . 0.0 111.072 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.55 -24.93 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.967 0.507 . . . . 0.0 110.735 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 57.3 m-85 -126.17 155.27 41.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.699 0.8 . . . . 0.0 109.573 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -136.11 147.94 48.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.633 0.773 . . . . 0.0 109.935 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.96 -170.23 45.13 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.521 -0.308 . . . . 0.0 113.46 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 15.5 mm100 -85.66 -38.65 18.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.213 0.605 . . . . 0.0 109.958 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.02 109.32 2.28 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.381 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 8.4 t -99.87 113.67 26.36 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.482 0.658 . . . . 0.0 109.563 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.615 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -82.15 123.43 28.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -110.09 139.31 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.425 ' HA ' HG23 ' A' ' 92' ' ' THR . 27.6 m -117.66 104.84 11.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.5 p -88.85 101.22 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.0 t -65.71 113.08 4.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.965 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 18.3 p -70.06 94.98 0.92 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.525 0.73 . . . . 0.0 109.622 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.41 67.73 5.23 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.961 0.904 . . . . 0.0 108.816 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -70.82 -73.09 0.18 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -140.28 -69.13 0.4 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.518 0.727 . . . . 0.0 109.17 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 59.74 88.07 0.08 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.027 1.331 . . . . 0.0 111.325 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.3 -179.41 6.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.026 0.93 . . . . 0.0 109.973 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 63.71 30.6 14.71 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.867 0.867 . . . . 0.0 109.902 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -59.58 -31.11 69.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.982 0.913 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 123.877 0.871 . . . . 0.0 108.804 167.646 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -86.67 177.73 7.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.073 0.549 . . . . 0.0 110.516 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 30' ' ' PHE . 46.0 tp -112.72 111.76 22.78 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -86.29 104.03 15.44 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.657 0.783 . . . . 0.0 109.282 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.48 104.98 14.82 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.83 114.95 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -113.49 134.63 54.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.608 0.763 . . . . 0.0 109.422 -168.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -157.22 149.11 22.5 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.454 1.102 . . . . 0.0 109.998 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.13 -6.5 0.82 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.815 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.61 151.81 38.34 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.832 0.316 . . . . 0.0 113.617 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.72 -167.6 34.93 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -93.7 133.48 37.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.304 0.642 . . . . 0.0 110.384 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.57 143.32 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.1 0.96 . . . . 0.0 109.253 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -62.05 159.02 15.21 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.149 0.979 . . . . 0.0 112.784 -177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.49 17.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.72 0.808 . . . . 0.0 110.396 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.46 -1.25 69.09 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.252 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.65 -163.41 29.29 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.19 0.424 . . . . 0.0 113.481 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -137.3 146.98 45.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.0 111.03 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.3 tp -154.5 121.41 5.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.45 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -96.23 129.58 43.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.562 1.145 . . . . 0.0 110.574 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -102.92 158.31 16.37 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.31 1.044 . . . . 0.0 108.712 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -151.15 124.17 8.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.656 0.383 . . . . 0.0 110.181 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 43.3 t -117.34 116.94 28.2 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.578 0.751 . . . . 0.0 110.245 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.03 119.7 25.26 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.05 139.76 40.93 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.39 1.076 . . . . 0.0 109.402 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.408 ' O ' HD12 ' A' ' 3' ' ' LEU . 12.6 t -153.72 173.26 16.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.895 0.478 . . . . 0.0 110.649 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 -106.26 3.39 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -84.49 168.22 15.66 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.282 0.541 . . . . 0.0 109.743 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -72.43 102.65 3.24 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.901 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 3' ' ' LEU . 16.7 p90 -64.85 -25.33 67.85 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.622 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 p -74.93 -0.1 17.52 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.955 1.302 . . . . 0.0 112.596 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -92.31 -7.69 47.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.21 0.604 . . . . 0.0 110.192 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -129.58 154.11 47.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 110.251 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 102' ' ' TRP . . . -86.52 145.14 26.91 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 80' ' ' VAL . 15.2 ptm -120.24 159.04 25.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.802 0.441 . . . . 0.0 109.898 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.519 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.29 142.55 10.36 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.174 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -96.74 132.01 42.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.099 0.96 . . . . 0.0 109.193 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.94 164.82 19.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.374 1.07 . . . . 0.0 108.14 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 38.3 ptt180 -146.92 154.06 40.84 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.746 0.248 . . . . 0.0 111.263 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pp0? -165.16 145.79 7.25 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.069 0.856 . . . . 0.0 110.169 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 171.55 -52.66 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.23 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.38 50.6 3.06 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.749 2.299 . . . . 0.0 112.657 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.63 -8.92 53.42 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.019 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -94.7 132.35 39.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.77 0.828 . . . . 0.0 109.05 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.02 179.16 5.13 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.946 0.779 . . . . 0.0 110.817 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -54.1 105.4 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.46 0.704 . . . . 0.0 110.247 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -111.73 149.5 31.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.259 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.406 ' HE2' HG23 ' A' ' 51' ' ' VAL . 87.2 t80 -68.65 113.82 6.48 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.225 1.01 . . . . 0.0 109.626 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.04 -66.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -164.3 162.32 22.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.649 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG22 ' HA3' ' A' ' 36' ' ' GLY . 53.3 t -137.83 152.46 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.714 1.206 . . . . 0.0 107.77 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 59' ' ' THR . 13.3 p -131.46 143.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.047 0.939 . . . . 0.0 108.824 172.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.33 158.18 36.28 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -57.95 -35.63 71.4 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.519 0.728 . . . . 0.0 112.197 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.1 p -76.67 -29.89 56.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.422 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' NH1' ' A' ' 73' ' ' ARG . . . 83.67 3.42 89.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.524 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -62.69 -34.53 77.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.886 0.874 . . . . 0.0 111.041 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.83 130.9 49.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.734 0.814 . . . . 0.0 110.25 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 52' ' ' VAL . 30.5 p -115.44 129.24 56.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.571 1.148 . . . . 0.0 108.896 173.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -93.69 140.94 29.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.203 1.001 . . . . 0.0 108.887 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.39 151.67 50.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.157 0.583 . . . . 0.0 109.866 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.21 144.91 37.93 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 161.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.89 -28.75 64.48 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.855 0.462 . . . . 0.0 112.047 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.4 t -70.99 -44.35 66.14 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.753 0.421 . . . . 0.0 111.124 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -92.83 1.95 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.629 0.372 . . . . 0.0 111.58 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.74 108.82 1.06 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 111.734 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.88 -26.33 13.21 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.662 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 7.1 ptt180 -84.14 -33.47 24.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.294 0.547 . . . . 0.0 109.616 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 5.1 m-30 -97.41 158.74 15.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -145.47 130.69 18.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.206 1.002 . . . . 0.0 108.845 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -102.67 126.48 56.84 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 24.8 m -123.81 154.03 40.17 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.149 0.98 . . . . 0.0 108.654 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' NH1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -140.68 143.85 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -121.78 96.84 5.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.88 -25.38 65.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.514 0.726 . . . . 0.0 111.411 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.52 -52.59 30.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.516 0.727 . . . . 0.0 111.177 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.98 -4.66 59.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.279 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 60.8 30.95 20.0 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.813 1.245 . . . . 0.0 111.616 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -119.96 131.95 55.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.308 0.643 . . . . 0.0 110.827 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG21 ' SD ' ' A' ' 35' ' ' MET . 57.2 t -96.23 151.08 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 109.077 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 76.6 m-85 -132.62 146.16 51.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.872 0.869 . . . . 0.0 109.077 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -134.74 102.97 5.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.15 102.83 14.83 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.5 mtm -89.71 118.31 29.22 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -118.81 156.71 28.94 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.5 m 59.19 47.98 11.0 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.085 0.954 . . . . 0.0 110.827 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 84' ' ' MET . 78.3 mt -63.92 117.69 7.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.968 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' O ' HG11 ' A' ' 121' ' ' VAL . 48.4 mtpt -77.17 154.79 82.44 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.555 -0.735 . . . . 0.0 109.338 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.98 -25.38 21.94 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.25 2.633 . . . . 0.0 114.421 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.58 -18.72 60.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.867 0.867 . . . . 0.0 112.837 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.73 -8.35 47.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.77 0.828 . . . . 0.0 113.042 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.2 m -62.99 98.52 0.13 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.1 159.73 9.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.338 0.655 . . . . 0.0 111.116 -170.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.2 p -83.6 113.51 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -88.45 112.91 23.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.916 0.886 . . . . 0.0 109.238 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -103.6 129.46 50.87 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.439 1.096 . . . . 0.0 110.366 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.17 101.91 13.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.882 0.873 . . . . 0.0 109.578 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.35 28.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.517 0.727 . . . . 0.0 109.446 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.98 136.44 44.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.3 0.64 . . . . 0.0 109.448 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.695 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . 132.13 -28.34 3.5 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.641 0.588 . . . . 0.0 113.023 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -74.66 93.49 2.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.203 0.525 . . . . 0.0 109.708 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.637 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . 22.1 t90 -98.91 2.41 46.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.56 139.34 34.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.654 0.782 . . . . 0.0 110.158 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.87 45.72 1.11 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.0 p -143.64 -68.47 0.33 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.349 0.66 . . . . 0.0 110.294 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.38 -57.91 8.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.802 0.841 . . . . 0.0 110.125 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -167.69 -72.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.881 0.872 . . . . 0.0 109.186 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.59 82.5 0.09 OUTLIER Glycine 0 C--N 1.351 1.367 0 O-C-N 123.544 0.528 . . . . 0.0 112.069 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.8 133.08 82.52 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.271 0.628 . . . . 0.0 111.548 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.31 116.37 3.85 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.171 1.914 . . . . 0.0 110.314 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.695 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 29.5 t70 -62.72 -46.21 89.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.702 1.201 . . . . 0.0 110.564 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -139.22 155.23 47.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 0.0 110.074 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -115.06 119.13 35.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.454 1.102 . . . . 0.0 108.416 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.85 151.22 38.86 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.51 -37.1 82.47 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.107 0.454 . . . . 0.0 110.8 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.74 171.79 24.14 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.177 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -127.65 135.18 49.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.971 0.385 . . . . 0.0 110.629 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -80.35 107.79 13.44 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.4 m -91.21 146.38 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.8 m -123.15 114.11 19.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.343 0.657 . . . . 0.0 109.412 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 88' ' ' LYS . 3.7 p -98.56 120.98 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -72.47 111.97 8.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.187 0.995 . . . . 0.0 110.128 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.5 p -73.42 118.37 16.3 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.0 tp -69.76 78.31 0.45 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.117 0.967 . . . . 0.0 109.988 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -179.88 -38.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.012 1.325 . . . . 0.0 109.187 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -115.18 52.25 0.88 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.121 0.968 . . . . 0.0 109.688 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -78.1 79.71 4.54 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.49 116.46 28.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.282 1.033 . . . . 0.0 110.778 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.07 81.67 5.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.581 0.705 . . . . 0.0 109.944 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.77 147.45 50.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.213 1.005 . . . . 0.0 108.81 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 124.13 0.972 . . . . 0.0 109.501 -177.58 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.533 0.206 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -110.11 160.18 16.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.303 0.641 . . . . 0.0 110.458 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 61.2 tp -115.35 110.63 19.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -85.59 121.91 28.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.879 0.871 . . . . 0.0 109.35 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.584 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 74.7 mt -112.88 107.24 15.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.945 0.898 . . . . 0.0 108.733 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.24 104.42 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.9 156.74 18.73 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.019 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -159.5 172.35 18.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.296 1.038 . . . . 0.0 109.789 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.75 -4.91 69.22 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.285 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -79.43 129.71 9.35 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 117.094 0.447 . . . . 0.0 112.202 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.97 -164.07 29.12 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.3 pp -79.48 147.67 32.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 87' ' ' LEU . 3.9 p -151.64 151.85 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.483 1.113 . . . . 0.0 109.105 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.64 158.16 28.48 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.803 0.841 . . . . 0.0 110.653 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.12 111.16 4.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.543 0.737 . . . . 0.0 110.408 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.75 7.06 57.95 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.2 -163.74 36.34 Favored Glycine 0 C--N 1.352 1.451 0 C-N-CA 122.915 0.293 . . . . 0.0 113.058 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 p -137.13 151.57 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.697 0.799 . . . . 0.0 110.447 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -156.43 120.11 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.396 0.679 . . . . 0.0 109.437 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -92.07 119.59 31.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.419 0.687 . . . . 0.0 109.65 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.28 159.58 20.03 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.118 0.967 . . . . 0.0 109.076 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.9 t -142.41 163.01 34.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.382 0.673 . . . . 0.0 109.44 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.2 t -150.45 143.23 24.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.761 0.824 . . . . 0.0 109.865 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.11 53.72 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.87 122.56 46.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.699 0.8 . . . . 0.0 108.985 -175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.8 m -136.97 147.24 46.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.362 1.065 . . . . 0.0 109.739 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.5 -101.6 2.5 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -74.13 159.14 33.0 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.872 0.844 . . . . 0.0 112.787 -176.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.1 m -72.48 91.21 1.37 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.587 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.925 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 16.0 p -75.07 1.48 13.0 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.211 1.005 . . . . 0.0 112.493 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -98.98 -2.77 36.53 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.621 0.768 . . . . 0.0 110.179 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -131.23 174.38 10.1 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.681 0.792 . . . . 0.0 111.461 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 130.1 56.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.062 0.945 . . . . 0.0 108.459 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -114.64 154.41 28.44 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -156.95 154.25 25.37 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.677 -0.296 . . . . 0.0 113.632 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -97.35 143.08 28.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.791 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 98' ' ' ALA . 63.6 m-85 -138.2 138.52 38.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.722 1.209 . . . . 0.0 108.684 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -112.11 151.79 29.03 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.008 0.822 . . . . 0.0 111.323 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.08 152.05 4.16 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 110.433 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.45 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.155 0.982 . . . . 0.0 111.593 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.35 55.55 4.08 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 122.212 1.941 . . . . 0.0 112.968 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.26 40.95 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.973 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -115.61 162.43 17.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -98.49 166.7 11.23 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 0.0 108.821 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.98 102.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -101.55 153.75 19.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.488 0.715 . . . . 0.0 110.295 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.63 108.57 0.75 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.894 0.878 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.49 -64.31 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -157.81 133.15 8.88 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.435 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.494 HG22 ' HA3' ' A' ' 36' ' ' GLY . 79.6 t -126.46 123.85 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.262 1.025 . . . . 0.0 109.481 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.709 HG21 HH11 ' A' ' 73' ' ' ARG . 8.9 p -108.26 160.34 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.449 0.699 . . . . 0.0 109.439 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.97 162.78 13.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 168.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 29.1 p-90 -55.8 -43.84 77.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.293 1.037 . . . . 0.0 113.746 -174.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -83.8 -14.31 51.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.905 0.482 . . . . 0.0 110.913 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.54 10.22 82.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.179 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -67.29 -37.5 83.52 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.417 0.687 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -112.93 121.57 45.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.165 0.586 . . . . 0.0 109.888 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.484 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 p -118.04 131.89 56.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.807 1.243 . . . . 0.0 108.133 172.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -124.55 136.35 53.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.274 1.03 . . . . 0.0 108.231 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 70.5 m-85 -141.3 136.94 32.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.376 0.67 . . . . 0.0 109.58 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.91 142.11 53.01 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.47 -29.12 58.16 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.031 0.932 . . . . 0.0 112.721 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -28.78 70.16 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 112.543 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.14 -1.29 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 111.493 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 28.3 ttpp -73.06 126.9 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.497 0.719 . . . . 0.0 110.726 -172.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.67 -25.05 28.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.759 0.662 . . . . 0.0 112.809 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -103.42 -23.79 13.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.092 0.557 . . . . 0.0 110.813 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.45 154.25 19.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.903 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -146.07 135.24 22.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 109.089 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.496 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -101.48 128.73 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.8 m -125.17 141.23 52.23 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.709 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.11 149.82 34.75 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.137 0.426 . . . . 0.0 109.961 -177.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -129.44 108.67 10.45 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.721 1.208 . . . . 0.0 108.503 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -68.74 -38.91 80.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 111.061 -173.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.18 87.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.98 -13.19 56.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.933 0.493 . . . . 0.0 111.596 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 61.76 28.69 17.66 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.859 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.5 m -124.48 131.9 53.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.157 0.583 . . . . 0.0 110.677 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.68 160.1 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.531 1.132 . . . . 0.0 109.19 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -141.97 148.2 38.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.48 1.512 . . . . 0.0 108.86 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.86 100.83 5.03 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.54 102.29 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.783 0.833 . . . . 0.0 109.635 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 87' ' ' LEU . 58.5 mtm -88.44 132.43 34.47 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -133.13 153.52 51.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t 58.42 59.77 2.86 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.868 0.842 . . . . 0.0 110.711 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.6 mt -79.83 116.68 20.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.94 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 79.7 mttt -75.37 152.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.89 -25.73 22.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.0 2.467 . . . . 0.0 114.069 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 10.8 pt-20 -70.12 -23.25 63.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.042 0.937 . . . . 0.0 112.95 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.71 -3.69 19.87 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.392 0.677 . . . . 0.0 112.809 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.3 m -60.99 100.08 0.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.21 0.604 . . . . 0.0 109.719 170.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 161.04 5.55 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.677 0.791 . . . . 0.0 110.269 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.1 p -83.01 117.98 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.46 112.15 23.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -107.99 121.28 44.47 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.127 1.371 . . . . 0.0 109.365 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.7 p -88.52 143.0 27.24 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -142.7 132.94 24.66 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.354 1.062 . . . . 0.0 109.546 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.14 145.83 35.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.847 0.859 . . . . 0.0 110.964 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.34 42.06 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.686 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -89.42 95.95 10.5 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.407 0.622 . . . . 0.0 109.681 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -79.12 78.77 5.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -168.56 115.88 0.67 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.484 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.09 32.96 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.3 p -137.76 -72.72 0.42 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.553 0.741 . . . . 0.0 109.514 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -72.63 -28.84 62.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.569 0.699 . . . . 0.0 109.661 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -87.72 145.54 26.09 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.176 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.4 -161.14 16.1 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-O 119.465 -0.63 . . . . 0.0 111.693 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 69.46 146.2 0.11 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 125.347 1.459 . . . . 0.0 111.534 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.27 138.2 38.79 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 121.85 1.7 . . . . 0.0 110.529 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.42 -32.27 73.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.389 0.676 . . . . 0.0 110.521 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -140.61 155.33 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.832 1.253 . . . . 0.0 108.783 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 28.6 p90 -143.96 161.87 37.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.802 0.841 . . . . 0.0 109.667 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 5' ' ' LEU . . . -96.78 -150.08 26.38 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.386 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -90.88 -53.65 4.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.575 0.75 . . . . 0.0 110.21 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.76 120.31 4.49 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.77 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 t -105.86 121.53 44.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.883 0.873 . . . . 0.0 109.61 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.7 OUTLIER -87.39 125.28 34.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.928 0.491 . . . . 0.0 110.41 -171.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 ' HE1' ' A' ' 84' ' ' MET . 5.9 m -111.56 145.4 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.653 0.781 . . . . 0.0 110.025 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 91.8 m -133.38 119.65 19.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.048 0.939 . . . . 0.0 108.908 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.3 p -104.89 116.4 48.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.0 m -63.91 113.86 3.72 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.57 1.148 . . . . 0.0 110.004 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.4 p -73.71 88.2 1.73 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 110.981 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 tp -79.1 77.67 5.57 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.36 4.76 9.68 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.863 -171.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -126.54 146.89 49.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -72.91 -66.97 0.6 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.716 0.806 . . . . 0.0 111.635 -171.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -113.22 27.66 9.42 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.555 0.693 . . . . 0.0 110.92 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -82.03 108.8 15.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.67 -0.643 . . . . 0.0 110.109 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -62.92 122.34 15.75 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.625 0.77 . . . . 0.0 109.965 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.87 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HG3' ' CE1' ' A' ' 112' ' ' TYR . 54.5 tt0 68.48 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.481 1.512 . . . . 0.0 112.066 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.3 tp -84.96 128.49 34.65 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 122.737 0.415 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -105.14 131.2 52.94 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 84.6 mt -121.9 118.75 29.67 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.759 1.224 . . . . 0.0 108.455 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.43 103.0 14.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.67 127.74 46.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -155.09 141.27 18.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.341 1.057 . . . . 0.0 110.19 -169.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG21 ' A' ' 117' ' ' THR . . . 145.26 26.03 0.1 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -86.71 132.2 11.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.13 41.76 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.9 144.4 31.96 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.208 0.528 . . . . 0.0 110.56 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.48 153.64 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.531 . . . . 0.0 107.936 -174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' HD22 ' A' ' 124' ' ' LEU . 1.7 mp0 -87.3 157.17 19.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.189 0.596 . . . . 0.0 110.953 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.75 111.79 5.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.463 0.705 . . . . 0.0 110.065 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.99 3.53 48.63 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.889 0.743 . . . . 0.0 111.504 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.76 -163.85 39.22 Favored Glycine 0 C--N 1.35 1.317 0 C-N-CA 122.792 0.234 . . . . 0.0 112.722 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.2 p -138.05 149.01 45.64 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.042 0.937 . . . . 0.0 109.921 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 tp -158.6 145.6 17.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -119.37 131.85 55.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.677 0.391 . . . . 0.0 110.881 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -92.29 159.62 15.52 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.074 0.95 . . . . 0.0 108.899 170.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -149.23 123.81 9.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.65 0.38 . . . . 0.0 110.081 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 51.7 t -127.38 106.55 9.28 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.145 0.578 . . . . 0.0 110.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.51 141.57 29.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.4 164.08 12.14 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.291 0.637 . . . . 0.0 109.861 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -66.65 166.92 11.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.384 0.674 . . . . 0.0 111.133 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.41 -13.48 50.28 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.63 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 136.62 57.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.575 1.15 . . . . 0.0 109.427 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 m -77.74 71.41 4.21 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 122.089 0.947 . . . . 0.0 111.966 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -79.84 -8.72 59.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.561 1.144 . . . . 0.0 110.574 164.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 t -57.04 -1.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 125.368 1.467 . . . . 0.0 113.812 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -91.04 -11.5 38.59 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.766 0.826 . . . . 0.0 112.088 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -107.64 167.06 10.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.366 0.666 . . . . 0.0 111.377 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.42 161.61 28.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 168.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HE3' ' HB2' ' A' ' 35' ' ' MET . 4.4 ptm -143.0 169.84 16.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.355 0.662 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.4 146.74 11.46 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 121.787 -0.244 . . . . 0.0 113.689 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -97.64 141.1 31.08 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.238 1.415 . . . . 0.0 109.858 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -132.07 164.4 26.32 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.793 1.237 . . . . 0.0 108.884 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.1 156.25 47.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.033 0.379 . . . . 0.0 110.386 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.5 pt20 -166.38 136.01 3.17 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.976 0.797 . . . . 0.0 110.117 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 174.31 -62.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 124.469 1.107 . . . . 0.0 111.131 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.6 66.3 6.59 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.041 -168.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.29 62.57 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.96 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -98.91 133.64 42.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.761 0.824 . . . . 0.0 110.152 -173.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.15 174.13 8.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.952 0.901 . . . . 0.0 108.704 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -64.0 104.74 0.75 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.98 152.59 47.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 0.0 111.026 -169.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -58.12 110.61 0.97 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.433 1.493 . . . . 0.0 111.792 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.27 -55.86 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -169.07 132.47 1.34 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.745 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.8 141.21 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.571 1.148 . . . . 0.0 108.297 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 59' ' ' THR . 11.6 p -135.31 148.31 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.04 155.86 28.64 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -53.15 -39.07 63.27 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.098 1.359 . . . . 0.0 114.046 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.9 t -75.35 -27.13 59.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.268 0.627 . . . . 0.0 111.32 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.73 72.35 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.2 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -69.12 -55.14 11.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -106.1 124.52 49.71 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.751 . . . . 0.0 110.56 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.47 HG22 HG23 ' A' ' 52' ' ' VAL . 52.7 p -112.22 149.45 32.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.584 1.153 . . . . 0.0 109.657 174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -129.39 123.63 32.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -119.68 159.02 25.26 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.87 144.58 43.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 165.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.49 -34.25 64.42 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.042 0.937 . . . . 0.0 112.932 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -65.64 -35.66 81.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.385 0.674 . . . . 0.0 111.575 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.3 m -111.33 6.16 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 0.0 112.339 -172.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -68.67 111.55 4.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.941 0.496 . . . . 0.0 111.741 -171.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.87 15.01 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.868 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -83.17 -26.42 30.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.459 0.629 . . . . 0.0 109.565 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.16 153.4 18.94 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.6 m -146.98 136.76 23.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.034 0.934 . . . . 0.0 108.902 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.584 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -102.85 121.32 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -124.84 138.93 54.24 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -143.18 131.43 22.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.975 0.51 . . . . 0.0 110.068 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.0 95.36 6.12 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.48 -38.22 83.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 111.929 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.04 76.2 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.125 0.57 . . . . 0.0 111.446 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.45 -9.27 50.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.474 0.71 . . . . 0.0 112.042 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 18.4 m-80 58.64 27.33 15.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.683 1.193 . . . . 0.0 111.352 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.5 m -112.81 131.96 55.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.552 0.741 . . . . 0.0 109.283 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.423 HG21 ' SD ' ' A' ' 35' ' ' MET . 5.6 t -117.77 157.22 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.661 -174.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.59 127.85 19.81 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.824 1.25 . . . . 0.0 108.491 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.2 tm? -104.76 100.16 9.8 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.42 103.43 10.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 109.87 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 68.3 mtm -94.31 126.84 39.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.991 0.517 . . . . 0.0 109.775 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.35 148.01 51.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 m 57.55 58.8 3.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.394 1.078 . . . . 0.0 111.08 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 49.0 mt -73.61 117.5 15.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.502 -1.227 . . . . 0.0 112.221 -174.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -76.88 148.26 78.75 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.48 -24.06 20.9 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.0 2.466 . . . . 0.0 114.521 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -15.61 61.93 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.971 0.908 . . . . 0.0 113.255 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.38 -4.48 48.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.118 0.567 . . . . 0.0 112.261 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 120' ' ' THR . 85.2 m -61.58 103.98 0.38 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.773 0.829 . . . . 0.0 110.442 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -168.53 163.68 12.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.014 0.525 . . . . 0.0 110.993 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 8.3 p -81.07 121.61 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 168.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -86.01 143.49 28.1 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -135.48 112.3 10.17 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 41.6 t -83.13 140.6 32.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -143.61 162.84 34.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 109.366 -171.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.61 26.22 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.191 0.596 . . . . 0.0 110.745 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.09 164.21 27.26 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.579 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -93.55 110.57 22.15 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 67.28 88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.797 1.239 . . . . 0.0 109.902 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -150.54 -179.45 7.24 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.866 0.866 . . . . 0.0 111.05 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.53 19.58 61.74 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.18 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.3 t -95.42 61.07 2.31 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.808 0.843 . . . . 0.0 109.806 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 63.7 -78.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.702 1.601 . . . . 0.0 111.859 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -88.4 -15.5 35.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.77 0.828 . . . . 0.0 109.918 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.04 82.75 0.23 Allowed Glycine 0 C--N 1.359 1.84 0 O-C-N 123.679 0.612 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.39 81.23 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.076 0.95 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.59 154.8 45.96 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.345 2.696 . . . . 0.0 113.887 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -53.47 -46.79 70.08 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.319 1.012 . . . . 0.0 112.153 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.409 ' CE1' ' HG3' ' A' ' 2' ' ' GLN . 65.2 m-85 -138.77 132.29 30.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.807 0.443 . . . . 0.0 110.513 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p90 -122.87 161.48 24.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.91 0.884 . . . . 0.0 110.405 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -174.66 47.31 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 114.035 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.43 -44.68 82.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.215 1.006 . . . . 0.0 110.526 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 163.33 38.9 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.485 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 9' ' ' GLY . 7.5 t -143.82 138.93 29.03 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.848 0.459 . . . . 0.0 110.109 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.6 OUTLIER -91.15 121.65 33.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.05 0.54 . . . . 0.0 109.901 -173.097 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -107.21 144.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.103 0.961 . . . . 0.0 109.501 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.57 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.1 m -124.06 105.5 9.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.174 0.589 . . . . 0.0 109.891 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.0 101.32 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.266 1.031 . . . . 0.0 109.01 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.6 t -66.46 134.15 51.88 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 m -70.77 86.75 0.68 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.121 0.968 . . . . 0.0 111.36 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD22 ' HG3' ' A' ' 14' ' ' GLN . 10.9 mp -119.04 62.06 0.8 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.294 1.037 . . . . 0.0 110.106 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 132.91 37.76 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -138.69 80.41 1.79 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -152.94 -51.5 0.1 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.465 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 55.31 46.34 23.74 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.871 1.268 . . . . 0.0 112.255 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.12 122.2 9.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -94.35 143.21 26.59 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 CA--C 1.553 1.074 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.449 176.56 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -140.79 132.41 27.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.869 0.868 . . . . 0.0 108.855 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.16 111.34 22.85 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -86.4 125.23 33.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -119.4 120.85 38.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.25 102.8 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.834 0.853 . . . . 0.0 109.316 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.67 138.03 33.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 110.348 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.4 m -149.8 165.79 31.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.892 0.877 . . . . 0.0 110.16 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.77 -1.19 32.03 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 112.867 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 145.64 32.03 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.06 -166.61 33.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.06 144.84 29.64 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.994 0.426 . . . . 0.0 111.227 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.23 161.27 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.662 1.185 . . . . 0.0 108.081 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -91.8 164.14 13.8 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.75 0.704 . . . . 0.0 110.494 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . . . -71.48 143.17 50.11 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.471 0.708 . . . . 0.0 110.629 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 3.29 85.7 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -164.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.46 -169.6 46.15 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 114.174 0.43 . . . . 0.0 114.174 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 p -153.28 147.25 25.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.107 0.963 . . . . 0.0 110.03 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 tp -160.79 128.92 4.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.103 0.561 . . . . 0.0 109.803 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -93.77 117.3 29.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.276 0.63 . . . . 0.0 110.138 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.4 mm? -86.02 159.26 19.64 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.328 1.051 . . . . 0.0 109.245 168.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -136.57 165.7 25.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.555 0.742 . . . . 0.0 109.316 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.8 t -146.56 145.73 30.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.056 0.942 . . . . 0.0 109.255 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.66 114.72 20.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.44 154.55 20.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.049 0.54 . . . . 0.0 110.615 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 m -62.82 159.69 16.03 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.2 53.24 4.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.52 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -95.62 -167.59 1.63 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.043 1.337 . . . . 0.0 110.414 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 32' ' ' SER . 2.2 m -74.23 22.11 0.09 Allowed 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.4 0.68 . . . . 0.0 111.921 173.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.43 -29.83 69.24 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.306 1.043 . . . . 0.0 111.14 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 m -56.2 -26.29 50.32 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.881 0.872 . . . . 0.0 111.755 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB3' HG22 ' A' ' 29' ' ' THR . 23.3 t -113.1 -2.74 14.09 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.04 0.936 . . . . 0.0 112.018 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -83.46 127.19 33.51 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.741 0.7 . . . . 0.0 110.432 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.77 115.98 10.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.465 ' HE1' HG11 ' A' ' 80' ' ' VAL . 4.7 ptm -114.21 170.4 8.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 111.102 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.95 163.32 33.17 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -111.39 138.51 47.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.7 154.0 38.67 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.807 1.243 . . . . 0.0 108.349 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -126.03 158.75 34.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -174.39 160.07 3.16 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.274 0.984 . . . . 0.0 109.887 174.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 171.96 -58.08 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 124.472 1.109 . . . . 0.0 111.052 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.52 63.57 6.62 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 122.368 2.046 . . . . 0.0 112.821 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.61 -5.74 60.12 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.912 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 31.7 mmmt -92.95 148.04 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 109.58 -177.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.77 176.15 5.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.301 0.64 . . . . 0.0 110.359 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -61.13 106.64 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.155 0.582 . . . . 0.0 111.82 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.53 152.51 24.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.917 1.287 . . . . 0.0 110.138 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -57.19 113.98 1.96 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.7 0.8 . . . . 0.0 110.662 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 65' ' ' VAL . 71.8 t -98.36 -60.81 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.55 155.43 21.98 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.333 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.71 138.3 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.734 1.214 . . . . 0.0 107.957 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.565 HG23 HG22 ' A' ' 59' ' ' THR . 11.1 p -121.3 146.98 25.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.82 142.13 48.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -52.16 -41.4 62.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.291 1.036 . . . . 0.0 112.846 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -81.81 -9.27 59.66 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.46 0.704 . . . . 0.0 111.468 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.35 73.16 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 123.192 0.307 . . . . 0.0 112.561 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 31.2 tpt180 -67.38 -65.31 0.7 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.359 0.664 . . . . 0.0 110.679 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.481 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 36.6 mmt180 -113.76 127.41 56.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.279 0.631 . . . . 0.0 110.461 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.565 HG22 HG23 ' A' ' 52' ' ' VAL . 54.5 p -108.58 150.84 26.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.848 0.859 . . . . 0.0 108.746 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -133.71 130.22 37.85 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 70' ' ' THR . 98.3 m-85 -139.19 142.51 37.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.99 0.516 . . . . 0.0 109.982 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.92 142.38 47.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 162.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.51 -24.23 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.558 0.743 . . . . 0.0 111.91 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -61.0 -40.61 94.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.797 1.239 . . . . 0.0 112.199 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 49' ' ' VAL . 32.5 m -115.56 1.96 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.809 0.844 . . . . 0.0 111.67 -173.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.21 125.42 25.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.709 0.804 . . . . 0.0 111.676 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.66 -26.16 6.76 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.587 0.554 . . . . 0.0 114.462 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -93.92 -29.58 15.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.203 0.601 . . . . 0.0 110.138 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.33 146.59 25.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.401 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 91.1 m -149.95 130.36 13.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.26 1.024 . . . . 0.0 108.648 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.457 HG13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -102.05 133.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -124.98 152.06 44.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.888 1.275 . . . . 0.0 107.947 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 138.26 16.2 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.546 0.612 . . . . 0.0 111.711 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -93.48 108.43 20.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.3 -37.85 88.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 110.919 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.61 82.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.92 0.763 . . . . 0.0 111.743 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.1 mmpt? -94.68 -16.35 23.19 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.764 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 41.2 m-80 60.81 34.98 19.59 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.544 1.137 . . . . 0.0 110.804 -172.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 m -112.48 131.27 55.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.392 0.677 . . . . 0.0 109.845 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 35' ' ' MET . 6.3 t -113.22 161.32 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.07 0.948 . . . . 0.0 109.914 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -143.5 116.08 8.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.147 0.979 . . . . 0.0 108.874 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.457 HD23 HG13 ' A' ' 71' ' ' ILE . 2.6 tm? -101.21 96.69 7.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -82.8 129.77 35.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.968 0.907 . . . . 0.0 109.44 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.633 ' HB3' HD21 ' A' ' 87' ' ' LEU . 63.1 mtm -117.26 148.37 41.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.547 0.739 . . . . 0.0 109.992 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -146.25 160.16 42.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.351 1.06 . . . . 0.0 109.189 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m 54.56 48.02 21.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.564 1.145 . . . . 0.0 111.118 171.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD21 ' HB3' ' A' ' 84' ' ' MET . 97.0 mt -73.28 115.7 12.95 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.195 -171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -65.64 151.81 93.93 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.37 1.068 . . . . 0.0 109.056 166.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 20.0 Cg_endo -57.62 -22.79 53.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.268 2.645 . . . . 0.0 113.355 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 11.6 pt-20 -87.25 7.04 30.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.442 1.097 . . . . 0.0 112.285 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -87.5 2.04 51.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.665 0.386 . . . . 0.0 111.526 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.9 m -62.16 102.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 0.0 109.967 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.19 152.11 4.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.087 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.4 p -81.65 129.57 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.584 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.43 122.29 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.47 0.708 . . . . 0.0 109.854 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -103.76 132.47 49.99 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.773 0.829 . . . . 0.0 109.696 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.4 t -82.91 141.12 32.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' MET . . . -143.49 161.64 37.91 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.257 0.623 . . . . 0.0 109.716 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 146.42 36.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 0.0 108.991 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.78 153.78 24.99 Favored Glycine 0 C--N 1.338 0.687 0 O-C-N 123.18 0.3 . . . . 0.0 112.77 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -91.38 107.29 19.1 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -88.46 51.12 2.1 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.85 -31.0 40.47 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.85 155.75 15.93 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.066 173.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 p -84.49 88.13 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.716 0.806 . . . . 0.0 110.605 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -92.39 103.02 15.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -83.57 1.32 42.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -174.61 161.03 30.62 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 64.53 92.59 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.924 1.29 . . . . 0.0 111.457 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.38 179.77 5.21 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.922 2.415 . . . . 0.0 112.277 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.18 -42.9 59.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.52 0.728 . . . . 0.0 110.239 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -130.99 149.0 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.356 1.062 . . . . 0.0 109.22 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -148.35 158.38 44.06 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.33 1.052 . . . . 0.0 108.492 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.89 -170.22 28.65 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.246 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -83.42 -39.29 20.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.245 1.018 . . . . 0.0 110.135 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.15 165.58 14.79 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.46 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 t -143.48 108.14 4.87 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 124.521 1.128 . . . . 0.0 109.455 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 58.6 tp60 -77.55 129.58 35.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.561 0.745 . . . . 0.0 111.258 -175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.37 144.94 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.571 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.9 m -127.75 105.97 8.81 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.52 106.64 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.733 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.3 t -61.55 132.21 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.005 1.322 . . . . 0.0 110.717 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 30.8 p -70.76 135.86 48.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.918 0.887 . . . . 0.0 112.495 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 22.7 tp -66.77 -18.23 65.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.948 0.899 . . . . 0.0 109.75 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.28 -44.5 84.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.081 0.952 . . . . 0.0 110.739 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -111.96 99.82 8.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 -172.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -88.49 -22.04 23.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.277 0.631 . . . . 0.0 111.192 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -75.92 94.01 3.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -123.47 96.33 4.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 109.626 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -83.11 137.51 34.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.758 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.254 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 67.6 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.137 1.375 . . . . 0.0 112.055 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.742 HD11 ' HB1' ' A' ' 25' ' ' ALA . 57.6 tp -108.85 112.57 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -82.44 103.86 12.3 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.31 128.68 44.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.7 t -119.94 102.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.767 0.827 . . . . 0.0 108.931 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -90.92 149.66 21.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.264 0.625 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -154.39 170.07 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.118 0.967 . . . . 0.0 109.921 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.67 43.56 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.094 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.66 88.73 0.54 Allowed Glycine 0 C--N 1.345 1.078 0 C-N-CA 122.916 0.293 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.59 -172.76 13.26 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.184 0.421 . . . . 0.0 112.289 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.98 138.91 31.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.386 0.675 . . . . 0.0 110.684 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 6.4 p -152.2 153.17 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.675 1.19 . . . . 0.0 108.364 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -92.68 160.03 15.17 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.582 -0.699 . . . . 0.0 110.729 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.51 123.81 21.45 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.99 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.49 54.13 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.659 0.599 . . . . 0.0 112.124 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.16 50.33 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.817 0.363 . . . . 0.0 113.182 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.0 p -114.87 162.23 17.19 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.108 0.963 . . . . 0.0 110.398 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -160.55 125.57 3.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 109.927 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -95.2 125.32 39.76 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.09 159.19 16.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.049 1.34 . . . . 0.0 108.644 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -139.69 160.32 40.16 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.771 0.428 . . . . 0.0 110.157 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 52.9 t -150.77 133.04 15.43 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.394 1.078 . . . . 0.0 108.62 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.2 131.71 56.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.742 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -106.8 137.79 44.18 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.185 0.594 . . . . 0.0 110.681 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -144.44 169.16 18.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.26 -83.9 1.56 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -82.32 154.93 25.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.414 0.686 . . . . 0.0 109.796 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -77.5 96.58 4.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.548 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 54.0 t80 -63.75 -20.94 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.103 0.961 . . . . 0.0 111.311 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -64.53 -7.26 9.57 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.623 0.769 . . . . 0.0 112.779 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -109.44 4.84 22.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.525 0.73 . . . . 0.0 111.305 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.79 140.58 44.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 0.0 111.004 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.24 164.53 21.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.764 0.826 . . . . 0.0 109.693 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.548 ' HB2' ' HE1' ' A' ' 30' ' ' PHE . 1.1 ttp -137.47 155.07 49.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.105 0.562 . . . . 0.0 110.21 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -146.16 147.21 18.02 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.75 129.83 42.85 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -128.1 141.71 51.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.265 1.026 . . . . 0.0 108.234 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -106.58 143.01 35.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -168.02 146.86 4.6 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.709 0.631 . . . . 0.0 110.255 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.37 -60.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 124.419 1.088 . . . . 0.0 110.789 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 92.5 Cg_endo -87.47 72.67 2.92 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -171.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.95 2.29 61.3 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.282 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.9 139.46 34.52 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.524 0.73 . . . . 0.0 109.526 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.06 175.66 6.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 109.458 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -60.91 105.71 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.736 0.303 . . . . 0.0 110.405 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.5 148.02 30.84 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.349 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.73 110.89 1.88 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.769 0.828 . . . . 0.0 111.323 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.57 -65.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -162.42 135.55 5.98 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.09 0.244 . . . . 0.0 111.402 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 82.3 t -121.46 150.37 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.697 1.199 . . . . 0.0 109.17 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD12 ' A' ' 71' ' ' ILE . 8.2 p -144.16 163.91 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.51 1.124 . . . . 0.0 108.755 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -85.22 164.99 17.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 170.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 36.7 p90 -52.6 -43.25 65.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.088 1.355 . . . . 0.0 113.539 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HG ' ' HD1' ' A' ' 54' ' ' TRP . 50.4 m -95.52 -6.11 41.26 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.42 0.688 . . . . 0.0 111.557 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 52' ' ' VAL . . . 86.14 20.5 55.05 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.404 -0.279 . . . . 0.0 112.404 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -57.75 -40.66 80.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.451 1.1 . . . . 0.0 111.749 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -132.52 138.18 47.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.888 0.875 . . . . 0.0 109.09 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 p -117.22 142.06 47.51 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.241 1.016 . . . . 0.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -136.24 125.89 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -137.74 142.72 40.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.6 131.59 46.74 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 163.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.62 -26.76 62.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 p -67.2 -42.27 84.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.834 0.854 . . . . 0.0 111.408 176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.92 -7.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.97 0.508 . . . . 0.0 111.064 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -76.18 115.87 16.32 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.69 -15.72 41.06 Favored Glycine 0 C--N 1.341 0.849 0 O-C-N 123.72 0.638 . . . . 0.0 112.59 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 18.3 ptp180 -116.41 -22.9 8.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.141 0.576 . . . . 0.0 109.993 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -112.12 143.95 42.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.18 0.992 . . . . 0.0 108.609 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -143.91 130.76 20.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.876 0.87 . . . . 0.0 108.881 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' A' ' 50' ' ' ALA . 3.7 mt -101.8 126.08 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -137.47 136.8 38.07 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -151.19 153.52 35.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.348 0.594 . . . . 0.0 112.142 -169.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.45 111.25 23.74 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -70.72 -30.22 66.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 112.091 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.59 -31.9 62.2 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.053 0.541 . . . . 0.0 111.813 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -96.55 -6.16 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.655 . . . . 0.0 111.198 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 61.54 31.09 18.94 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.139 0.976 . . . . 0.0 110.514 176.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 m -112.35 132.4 55.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 109.854 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 33.7 t -114.37 154.21 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.384 1.073 . . . . 0.0 110.223 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.81 145.45 48.37 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 125.189 1.396 . . . . 0.0 108.05 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.49 107.58 10.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -82.25 101.67 10.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.949 . . . . 0.0 109.581 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.76 145.18 25.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.25 0.62 . . . . 0.0 109.904 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -145.63 152.84 40.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 m 58.92 46.11 14.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.771 0.828 . . . . 0.0 112.121 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.49 126.56 29.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.593 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 155.87 75.07 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.28 -21.52 60.71 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.418 2.079 . . . . 0.0 113.547 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -77.19 -18.4 57.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.354 0.662 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.569 ' HB2' HG11 ' A' ' 121' ' ' VAL . 2.7 m-20 -67.07 -10.07 46.0 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.302 0.641 . . . . 0.0 111.396 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -56.21 100.98 0.05 OUTLIER 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.048 0.939 . . . . 0.0 109.81 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.06 162.74 4.62 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.22 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -85.81 118.33 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -86.9 115.72 24.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.724 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.82 131.69 48.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 35' ' ' MET . 38.5 t -83.94 106.87 15.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.18 112.29 25.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.87 168.98 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.788 0.835 . . . . 0.0 110.336 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.45 172.07 12.42 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -80.25 91.75 5.65 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -78.68 94.88 5.15 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.92 98.19 2.42 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.18 0.592 . . . . 0.0 109.846 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.3 178.88 15.93 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 81.9 p -79.16 4.09 15.82 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.484 1.114 . . . . 0.0 113.091 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.41 -57.42 3.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.257 0.623 . . . . 0.0 110.662 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 55.19 24.72 6.53 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.585 1.154 . . . . 0.0 113.112 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.37 162.74 28.69 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 119.446 -0.641 . . . . 0.0 111.533 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.94 80.84 0.27 Allowed Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.952 0.901 . . . . 0.0 110.994 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.97 146.79 78.71 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.835 2.357 . . . . 0.0 111.525 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -62.87 -38.46 90.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.8 0.44 . . . . 0.0 110.027 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.87 153.52 51.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.076 0.95 . . . . 0.0 109.16 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -153.19 152.14 30.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.11 -159.33 34.06 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 123.233 0.333 . . . . 0.0 113.853 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.01 -26.38 22.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.108 0.963 . . . . 0.0 111.068 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.43 157.92 32.39 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.789 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.3 t -131.04 108.08 9.52 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.401 1.08 . . . . 0.0 108.439 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -81.17 106.16 12.94 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -174.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -92.9 142.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.1 m -123.57 111.29 16.09 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.4 p -113.51 106.91 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.679 0.752 . . . . 0.0 109.935 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -78.92 145.63 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.594 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.5 p -63.59 151.4 41.69 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.002 0.521 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.83 86.56 0.09 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 59.78 -173.6 0.11 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.245 1.418 . . . . 0.0 111.372 -169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -90.59 59.67 4.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -109.1 0.17 19.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.686 1.194 . . . . 0.0 111.352 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -138.35 141.42 39.71 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.672 0.789 . . . . 0.0 109.334 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -155.58 45.49 0.47 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.933 0.493 . . . . 0.0 111.213 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 70.47 147.22 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.529 1.132 . . . . 0.0 111.176 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 122.943 0.497 . . . . 0.0 110.774 179.479 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -104.73 163.76 12.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.373 0.669 . . . . 0.0 109.627 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.781 HD11 ' HB1' ' A' ' 25' ' ' ALA . 45.8 tp -90.88 111.6 23.09 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 7.1 tp-100 -84.86 104.63 14.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.839 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.486 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.9 mt -95.15 108.76 20.88 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.599 0.759 . . . . 0.0 109.175 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.2 t -97.44 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -112.8 111.85 22.92 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -169.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -156.19 154.46 30.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.852 1.261 . . . . 0.0 109.256 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.02 -8.23 1.08 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.53 -0.305 . . . . 0.0 112.504 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.23 27.74 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.943 0.306 . . . . 0.0 112.584 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.16 -164.46 29.85 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.08 136.89 37.3 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.257 0.551 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p -151.8 145.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.225 1.41 . . . . 0.0 107.949 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.77 158.94 25.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.089 0.404 . . . . 0.0 110.592 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.53 125.92 27.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.231 0.612 . . . . 0.0 110.183 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 2.12 65.02 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.764 0.665 . . . . 0.0 112.151 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.31 -174.93 35.91 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.935 0.186 . . . . 0.0 113.32 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 p -123.75 147.41 47.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.382 1.073 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 tp -152.51 132.08 13.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.836 0.855 . . . . 0.0 108.762 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.85 127.45 55.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.354 0.662 . . . . 0.0 110.501 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 HG12 ' A' ' 119' ' ' VAL . 1.0 OUTLIER -93.03 156.51 16.84 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.788 0.835 . . . . 0.0 108.79 171.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -141.68 125.69 17.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 5' ' ' LEU . 47.9 t -117.17 104.41 11.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.321 0.649 . . . . 0.0 109.814 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.99 121.46 27.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.5 124.04 48.89 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.882 0.873 . . . . 0.0 109.502 -171.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 25.5 t -131.19 163.79 26.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.714 0.805 . . . . 0.0 111.012 -171.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 -102.98 1.64 Allowed Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.752 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.42 108.64 18.57 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 31' ' ' SER . 10.3 m -56.3 133.17 52.5 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -167.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.428 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 6.1 p90 -69.62 -19.52 63.63 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.064 0.945 . . . . 0.0 112.113 -176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 29' ' ' THR . 91.0 p -72.35 -5.54 37.0 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -88.13 -1.87 58.27 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.198 0.599 . . . . 0.0 110.436 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -136.79 173.86 11.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.84 0.856 . . . . 0.0 110.872 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.62 162.74 13.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 165.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.637 ' SD ' HG21 ' A' ' 80' ' ' VAL . 11.6 ptm -142.24 157.78 44.46 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 122.15 -0.344 . . . . 0.0 110.44 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -154.31 146.67 15.02 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.683 -0.235 . . . . 0.0 113.227 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -98.98 139.2 34.99 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.073 1.349 . . . . 0.0 109.951 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -129.15 170.22 13.81 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.13 1.372 . . . . 0.0 108.661 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -155.14 158.32 38.8 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.084 0.402 . . . . 0.0 111.833 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.12 153.9 12.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.002 0.921 . . . . 0.0 109.997 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.39 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 124.359 1.064 . . . . 0.0 111.286 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.42 67.35 8.48 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.021 1.814 . . . . 0.0 112.501 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.76 24.8 71.51 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.857 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -115.32 161.13 18.93 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.244 0.617 . . . . 0.0 112.123 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.33 175.35 7.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.637 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -66.1 103.57 0.99 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.72 153.5 17.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.923 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.52 110.64 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.792 0.837 . . . . 0.0 110.097 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.5 t -85.78 -59.41 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -171.47 147.42 2.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.031 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 36' ' ' GLY . 77.3 t -129.22 137.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.177 0.991 . . . . 0.0 108.535 174.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 59' ' ' THR . 7.0 p -124.61 160.65 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.833 0.853 . . . . 0.0 109.571 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.0 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 64.8 p-90 -57.13 -37.25 71.72 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.534 0.733 . . . . 0.0 112.741 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -76.72 -28.96 56.03 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.163 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.93 -8.22 70.34 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.278 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -59.51 -28.47 67.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.742 0.817 . . . . 0.0 112.432 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -108.61 122.55 47.34 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.547 0.739 . . . . 0.0 109.521 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 52' ' ' VAL . 38.6 p -127.15 133.64 50.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.498 1.119 . . . . 0.0 108.886 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -128.58 127.19 41.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -129.52 148.09 51.39 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.366 0.666 . . . . 0.0 110.698 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.69 137.51 42.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.69 -30.48 67.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.68 0.792 . . . . 0.0 112.992 -171.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.7 m -69.6 -41.58 75.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.214 0.606 . . . . 0.0 111.676 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.1 m -93.16 -9.44 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.338 0.655 . . . . 0.0 111.539 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -66.96 144.91 55.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.418 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.71 -24.9 7.96 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.447 0.467 . . . . 0.0 113.701 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.435 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 10.7 ptt180 -113.37 -20.72 11.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.223 0.609 . . . . 0.0 111.065 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m-30 -101.09 155.82 17.77 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.231 0.613 . . . . 0.0 110.24 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -149.07 136.6 20.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.112 . . . . 0.0 108.527 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.1 mp -101.05 121.6 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.6 m -124.3 136.84 54.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.71 131.73 21.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.574 0.702 . . . . 0.0 110.355 -174.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.5 109.15 20.69 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -68.5 -27.65 66.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.856 0.462 . . . . 0.0 110.077 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.59 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.834 0.853 . . . . 0.0 111.637 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -80.42 -16.03 55.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.355 . . . . 0.0 111.078 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 29.4 m-80 61.87 28.2 17.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.628 1.171 . . . . 0.0 110.872 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -120.83 135.11 55.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.959 0.503 . . . . 0.0 110.622 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.637 HG21 ' SD ' ' A' ' 35' ' ' MET . 19.4 t -108.81 155.59 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.788 1.235 . . . . 0.0 109.378 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -142.52 113.28 7.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.645 1.178 . . . . 0.0 108.961 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 98.86 11.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -84.83 104.92 15.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.803 0.841 . . . . 0.0 110.396 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.576 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.8 mtm -94.64 142.14 27.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.1 0.56 . . . . 0.0 109.612 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.16 162.44 34.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.563 1.145 . . . . 0.0 108.438 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 m 52.52 45.36 28.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.178 0.991 . . . . 0.0 112.153 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 84' ' ' MET . 81.2 mt -70.86 127.79 33.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.119 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -85.94 144.53 39.31 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.774 0.83 . . . . 0.0 108.94 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -44.15 -35.18 7.53 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 124.428 3.419 . . . . 0.0 115.142 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -73.52 -9.37 58.61 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.78 1.232 . . . . 0.0 113.407 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 -2.2 47.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.022 0.929 . . . . 0.0 112.65 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -58.99 105.81 0.35 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.367 0.667 . . . . 0.0 110.145 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.71 8.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.987 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.4 p -79.75 113.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.9 145.05 27.34 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 108.751 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.23 127.5 26.32 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -84.76 139.79 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -131.63 157.21 44.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.48 1.112 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -145.59 164.13 32.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 110.553 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.63 -154.73 21.6 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -88.94 117.4 27.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -59.4 -46.27 89.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.275 1.03 . . . . 0.0 112.318 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.92 153.05 20.47 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.89 49.76 0.43 Allowed Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.7 m 61.21 84.29 0.13 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.122 0.969 . . . . 0.0 109.808 -170.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 75.5 -58.54 0.56 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.798 1.639 . . . . 0.0 110.167 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -155.85 139.91 16.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.974 0.909 . . . . 0.0 109.488 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.88 -113.47 3.54 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.69 138.59 10.05 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 123.894 0.878 . . . . 0.0 109.685 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.54 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 32.9 Cg_exo -61.39 108.61 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.72 2.28 . . . . 0.0 110.982 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.56 -30.67 67.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.641 0.777 . . . . 0.0 111.864 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.8 m-85 -131.13 150.65 52.05 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.841 0.856 . . . . 0.0 109.847 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -124.22 139.24 54.11 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.07 0.948 . . . . 0.0 110.371 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -99.41 167.33 21.22 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.5 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -71.0 -48.39 53.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.803 0.441 . . . . 0.0 111.254 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.96 129.86 4.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.917 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.34 138.11 54.05 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.497 0.719 . . . . 0.0 110.669 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 54.0 tp60 -81.14 121.16 25.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 110.501 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 21' ' ' LEU . 2.9 m -94.93 137.56 22.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 92' ' ' THR . 31.8 m -123.69 103.59 8.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.81 104.75 16.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -59.06 134.5 57.05 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.8 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 m -74.0 95.59 2.53 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.399 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.21 142.45 58.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.358 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.47 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.194 0.998 . . . . 0.0 112.778 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -146.04 92.54 2.21 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -159.91 137.8 10.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.861 0.464 . . . . 0.0 109.942 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -78.33 97.83 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.785 . . . . 0.0 109.329 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -80.37 115.63 20.01 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.625 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -66.03 160.18 24.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.759 . . . . 0.0 110.972 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.9 p80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 123.908 0.883 . . . . 0.0 109.206 -176.148 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -143.3 168.56 19.49 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.51 0.671 . . . . 0.0 111.589 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.4 tp -89.57 111.69 22.69 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.121 176.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.28 107.9 10.02 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.818 0.847 . . . . 0.0 109.349 172.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -102.04 113.54 26.88 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.2 t -108.34 101.83 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.18 153.11 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.142 0.496 . . . . 0.0 110.678 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.4 p -154.32 170.28 21.68 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.72 18.95 30.82 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.31 86.87 0.32 Allowed Glycine 0 C--N 1.352 1.448 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.31 -168.29 12.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -120.5 147.88 44.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.3 p -151.06 147.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 108.065 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.1 mp0 -78.93 162.8 25.74 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.589 0.631 . . . . 0.0 110.887 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.788 ' HB3' ' HB3' ' A' ' 124' ' ' LEU . . . -63.9 138.38 58.45 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.084 0.554 . . . . 0.0 111.538 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -7.55 81.05 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 123.68 0.612 . . . . 0.0 112.507 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.41 -175.83 49.65 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 121.039 0.244 . . . . 0.0 113.332 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.4 p -125.19 159.45 31.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.408 1.083 . . . . 0.0 109.692 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.0 tp -152.45 122.16 6.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -96.6 112.56 24.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.491 0.716 . . . . 0.0 109.997 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -94.21 156.71 16.41 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.477 1.111 . . . . 0.0 109.699 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -133.45 152.92 51.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -149.98 109.83 4.08 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.51 121.0 26.63 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.25 129.59 53.58 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.695 0.798 . . . . 0.0 109.518 -175.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.7 t -142.63 154.43 44.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 109.61 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 -114.2 4.57 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 3' ' ' LEU . 1.6 mmp_? -61.94 134.36 56.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.063 0.545 . . . . 0.0 111.218 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.359 0.664 . . . . 0.0 110.393 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -64.06 -18.47 64.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.66 0.384 . . . . 0.0 110.265 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 52.0 p -66.79 -9.52 37.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.394 1.077 . . . . 0.0 112.484 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.9 t -98.02 -11.66 22.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 0.0 110.846 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.69 156.55 42.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.006 0.522 . . . . 0.0 111.442 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.96 143.86 26.05 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.419 ' SD ' HG21 ' A' ' 80' ' ' VAL . 10.1 ptm -128.88 170.02 13.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.193 0.597 . . . . 0.0 110.761 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.64 158.33 31.13 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.158 0.286 . . . . 0.0 113.051 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -104.62 136.48 44.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.735 0.814 . . . . 0.0 109.773 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -129.94 153.02 48.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.795 1.238 . . . . 0.0 108.178 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.39 157.98 45.53 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.397 0.544 . . . . 0.0 111.764 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.85 155.39 14.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.217 0.948 . . . . 0.0 110.126 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 175.22 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.806 1.242 . . . . 0.0 110.387 168.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.75 70.85 7.36 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.152 1.901 . . . . 0.0 112.941 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.2 66.62 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.62 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 60.6 mmtt -99.23 144.6 28.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.302 1.041 . . . . 0.0 110.981 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.52 173.21 8.46 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.966 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -66.61 103.76 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.75 152.65 20.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.287 0.635 . . . . 0.0 109.964 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.11 112.83 2.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.674 0.79 . . . . 0.0 109.653 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.6 -54.87 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.1 164.07 25.55 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.355 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.31 131.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.88 1.272 . . . . 0.0 108.283 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.86 151.53 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.336 0.655 . . . . 0.0 109.633 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 29.4 t-20 -82.09 147.48 29.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.583 0.753 . . . . 0.0 109.17 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 58.5 p-90 -54.84 -39.3 68.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.525 1.13 . . . . 0.0 113.102 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -80.72 -19.02 45.97 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.913 0.885 . . . . 0.0 110.699 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.97 61.73 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.122 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -74.04 -22.11 59.68 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.992 0.517 . . . . 0.0 110.804 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 28.8 mmt180 -133.76 137.79 45.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.194 0.997 . . . . 0.0 110.607 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -136.25 132.21 35.5 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.454 1.102 . . . . 0.0 108.582 168.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -126.32 138.46 53.59 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.98 148.59 52.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.795 0.438 . . . . 0.0 110.237 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 147.63 41.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.33 -43.52 53.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.274 1.03 . . . . 0.0 113.157 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 m -71.44 -29.69 65.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.67 0.788 . . . . 0.0 112.401 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.68 -7.35 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 111.366 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -69.7 132.26 45.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 0.0 110.427 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.67 8.06 74.12 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.705 0.628 . . . . 0.0 113.826 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 15.6 ptt180 -144.08 -26.76 0.53 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.057 0.543 . . . . 0.0 111.265 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-85 -96.27 152.56 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.8 m -150.24 134.3 17.0 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.682 1.193 . . . . 0.0 108.361 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -105.19 133.01 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -132.86 163.49 28.98 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.75 146.42 16.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.154 0.502 . . . . 0.0 110.656 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -105.1 121.23 43.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.473 0.709 . . . . 0.0 109.285 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.48 -35.51 75.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.253 0.621 . . . . 0.0 109.968 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.17 -23.82 66.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.637 0.775 . . . . 0.0 112.158 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.23 -20.0 13.64 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.389 0.676 . . . . 0.0 111.078 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 59.41 35.53 23.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.791 1.236 . . . . 0.0 110.757 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -124.27 132.17 53.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.43 0.692 . . . . 0.0 110.349 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG21 ' SD ' ' A' ' 35' ' ' MET . 50.3 t -99.43 130.48 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.524 1.13 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.47 114.56 26.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.676 0.79 . . . . 0.0 109.667 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.8 tm? -97.18 104.07 16.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -88.24 120.73 29.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.624 0.77 . . . . 0.0 110.493 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.464 ' HB3' HD21 ' A' ' 87' ' ' LEU . 62.9 mtt -105.49 147.74 27.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.291 1.036 . . . . 0.0 109.301 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -141.72 158.12 44.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.038 0.935 . . . . 0.0 108.514 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 m 55.35 41.57 31.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.047 0.939 . . . . 0.0 112.025 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -68.25 118.45 11.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 42.3 mtpt -84.2 154.36 63.33 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.314 172.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 10.8 Cg_endo -52.99 -19.7 11.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.022 2.481 . . . . 0.0 114.415 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 11.9 pt-20 -76.09 -12.33 60.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.14 0.976 . . . . 0.0 112.849 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.54 -5.34 56.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.314 0.646 . . . . 0.0 112.148 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 120' ' ' THR . 86.8 m -61.51 103.9 0.36 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.403 0.681 . . . . 0.0 110.686 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.02 160.39 12.0 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.982 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.6 p -85.22 111.94 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.264 0.554 . . . . 0.0 109.975 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -88.8 113.41 24.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.35 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.53 126.47 48.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.379 1.072 . . . . 0.0 108.746 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -84.66 136.31 33.8 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -132.16 161.52 33.13 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.936 0.895 . . . . 0.0 109.802 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -147.77 167.96 23.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.481 0.712 . . . . 0.0 110.032 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.39 13.98 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -67.63 112.25 4.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.009 0.923 . . . . 0.0 110.107 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -74.66 132.29 41.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.86 102.02 12.07 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.43 149.6 5.04 Favored Glycine 0 C--O 1.244 0.743 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.5 p -77.18 79.02 3.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 110.432 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -126.91 -66.1 0.92 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 57.18 -155.33 0.33 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.209 1.004 . . . . 0.0 111.603 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.73 -62.67 0.58 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.8 127.82 3.64 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.114 0.965 . . . . 0.0 108.467 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.71 145.41 95.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.675 2.25 . . . . 0.0 111.894 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -69.88 -47.85 61.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.286 0.565 . . . . 0.0 110.112 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 54.0 m-85 -112.66 146.38 38.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.4 p90 -150.33 168.79 23.06 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.298 0.639 . . . . 0.0 109.84 170.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.2 -168.23 18.8 Favored Glycine 0 C--O 1.239 0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.379 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -83.73 -39.27 20.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.15 0.98 . . . . 0.0 110.575 -174.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.25 132.67 7.84 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.551 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -107.84 111.69 23.96 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.916 0.886 . . . . 0.0 108.744 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 7.8 tm0? -79.24 110.26 14.34 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -96.15 140.35 17.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.555 ' HA ' HG23 ' A' ' 92' ' ' THR . 86.2 m -121.18 112.28 18.45 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.0 p -102.57 119.2 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.475 0.655 . . . . 0.0 109.294 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 5.8 m -65.24 139.0 58.59 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 111.034 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 24.0 t -76.0 79.89 2.86 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.659 0.784 . . . . 0.0 110.647 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 64.7 tp -79.84 97.98 6.89 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.38 131.48 48.4 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -82.18 101.02 10.19 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -74.43 104.48 5.18 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.043 0.937 . . . . 0.0 109.831 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -71.88 125.23 26.67 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -67.24 99.1 0.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -80.61 102.99 10.15 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.192 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.549 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 70.8 143.01 0.05 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.466 1.506 . . . . 0.0 111.773 -176.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 tp -89.91 112.5 23.88 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.81 116.9 29.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.984 0.914 . . . . 0.0 109.839 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.501 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.9 mt -118.51 123.05 44.18 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.832 0.853 . . . . 0.0 110.292 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 39.2 t -108.12 104.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.437 1.095 . . . . 0.0 109.421 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -76.29 152.58 36.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.797 0.439 . . . . 0.0 110.916 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -149.13 146.12 27.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.981 0.912 . . . . 0.0 110.276 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.13 20.71 8.15 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.259 0.35 . . . . 0.0 113.079 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.98 85.91 0.67 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.81 -164.29 10.97 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.15 144.25 45.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.084 0.554 . . . . 0.0 111.468 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 19' ' ' LEU . 7.5 p -152.02 152.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.834 1.254 . . . . 0.0 108.51 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -65.53 156.98 30.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.532 0.733 . . . . 0.0 112.412 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 139.77 57.13 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.095 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 -20.05 33.07 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.063 0.227 . . . . 0.0 112.816 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.4 -177.37 51.77 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-O 121.178 0.321 . . . . 0.0 113.467 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 p -115.13 160.7 19.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.073 0.949 . . . . 0.0 110.878 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HB2' HG11 ' A' ' 13' ' ' VAL . 40.8 tp -156.52 125.7 6.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.97 115.86 27.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.855 0.462 . . . . 0.0 109.979 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.5 mm? -94.6 156.38 16.46 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -144.78 144.72 31.31 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 35.5 t -124.98 113.72 18.19 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.924 0.889 . . . . 0.0 108.905 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -83.82 112.9 20.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.7 122.87 45.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.244 0.618 . . . . 0.0 109.401 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 m -62.79 126.08 26.11 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.02 74.44 0.01 OUTLIER Glycine 0 C--N 1.357 1.741 0 O-C-N 125.246 1.591 . . . . 0.0 115.691 -166.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -98.39 -174.79 2.92 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.867 1.267 . . . . 0.0 108.834 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -83.18 86.38 7.04 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.16 -26.35 65.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 35.4 p -66.03 -13.91 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.227 . . . . 0.0 113.055 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -82.19 -14.64 55.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.168 0.587 . . . . 0.0 111.954 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.14 140.94 44.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.064 0.545 . . . . 0.0 111.382 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 137.52 38.63 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 165.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.519 ' SD ' ' SG ' ' A' ' 97' ' ' CYS . 17.4 ttp -126.37 154.79 43.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.6 0.76 . . . . 0.0 109.644 -169.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.54 161.51 32.25 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 117.714 0.234 . . . . 0.0 113.101 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -97.79 139.47 33.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.825 0.85 . . . . 0.0 109.379 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.343 1.057 . . . . 0.0 109.162 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 95' ' ' TYR . 28.3 ptt180 -131.52 161.56 32.3 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.017 0.371 . . . . 0.0 111.775 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 94' ' ' VAL . 26.2 pt20 -171.91 146.74 2.07 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.357 171.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -178.11 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 123.891 0.876 . . . . 0.0 111.252 171.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 84.3 Cg_endo -80.35 70.27 7.59 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.155 1.903 . . . . 0.0 112.745 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.65 6.16 80.58 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.551 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.25 141.49 28.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.545 0.738 . . . . 0.0 110.633 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.38 176.95 7.61 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 162.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -60.41 104.76 0.36 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.961 0.504 . . . . 0.0 109.833 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.92 148.59 24.31 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.412 0.685 . . . . 0.0 109.634 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.53 121.16 14.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.522 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -104.88 -59.29 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.88 142.9 6.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.605 0.362 . . . . 0.0 110.434 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG11 ' HD2' ' A' ' 101' ' ' LYS . 61.0 t -123.99 130.44 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.107 0.963 . . . . 0.0 109.816 173.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -106.39 153.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.771 0.828 . . . . 0.0 109.507 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.49 151.71 37.96 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 49.5 p90 -59.69 -36.57 76.76 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.597 0.759 . . . . 0.0 112.165 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -84.46 -15.11 47.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.72 0.808 . . . . 0.0 111.18 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.7 79.99 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 116.416 -0.356 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -63.42 -49.41 73.84 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.679 0.792 . . . . 0.0 111.035 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -114.41 148.05 38.31 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.657 0.783 . . . . 0.0 110.115 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 52' ' ' VAL . 38.0 p -137.82 147.07 44.24 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.126 0.971 . . . . 0.0 109.133 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.98 129.89 38.8 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -122.32 145.96 47.76 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.84 148.59 36.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.46 -26.42 68.51 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 123.394 0.434 . . . . 0.0 111.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -67.17 -41.51 85.83 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.856 0.863 . . . . 0.0 111.186 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 m -112.65 13.46 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 111.65 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.93 105.94 0.75 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.366 1.066 . . . . 0.0 111.74 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.63 -26.04 18.13 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.768 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 16.6 ptp180 -84.54 -28.61 26.53 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 117.634 0.717 . . . . 0.0 110.43 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.411 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.7 m-30 -101.85 150.34 23.27 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.45 0.7 . . . . 0.0 109.44 172.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -147.63 132.74 18.28 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.04 0.936 . . . . 0.0 109.203 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 HD23 ' A' ' 82' ' ' LEU . 19.9 mt -101.88 138.63 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -135.77 156.14 49.27 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 154.55 34.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.323 0.582 . . . . 0.0 110.29 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -127.82 109.11 11.3 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -70.33 -30.92 68.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.704 0.802 . . . . 0.0 110.594 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.8 -38.31 54.2 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.117 0.567 . . . . 0.0 111.45 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.4 mmpt? -79.06 -17.89 54.42 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.31 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.8 m120 60.74 32.86 20.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.554 1.142 . . . . 0.0 109.832 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 m -133.63 133.09 41.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.435 0.694 . . . . 0.0 110.579 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 45.1 t -104.06 155.43 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.4 1.08 . . . . 0.0 109.425 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.54 137.97 44.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.32 1.048 . . . . 0.0 109.631 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.1 tm? -122.73 105.66 10.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.7 107.96 18.88 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.802 0.841 . . . . 0.0 110.007 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 87' ' ' LEU . 47.3 mtt -87.9 138.53 31.38 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.68 0.792 . . . . 0.0 109.402 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -139.73 133.2 30.15 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 m 58.36 72.93 0.5 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.717 0.807 . . . . 0.0 111.664 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' A' ' 84' ' ' MET . 49.8 mt -71.76 136.74 47.24 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.109 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 121' ' ' VAL . 53.7 mtpt -74.64 152.2 87.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.266 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.26 -25.16 79.45 Favored 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.297 1.998 . . . . 0.0 113.787 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.94 6.76 48.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.985 0.914 . . . . 0.0 112.931 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.39 -9.48 56.42 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 123.271 0.628 . . . . 0.0 112.315 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 121' ' ' VAL . 89.1 m -53.77 106.2 0.18 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.841 0.856 . . . . 0.0 111.149 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.84 158.55 20.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 110.017 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 40' ' ' GLN . 15.0 p -89.65 124.54 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' A' ' 39' ' ' ARG . 23.6 m-85 -98.25 122.45 41.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.029 0.932 . . . . 0.0 110.297 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.9 128.0 56.35 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' A' ' 35' ' ' MET . 46.8 t -83.78 103.06 12.76 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.52 131.63 52.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.656 0.782 . . . . 0.0 111.134 -175.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.99 167.61 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.574 0.75 . . . . 0.0 110.535 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.06 62.79 1.79 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.513 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.515 ' HD2' HG11 ' A' ' 51' ' ' VAL . 53.6 tttm -61.59 120.84 11.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 87.9 m95 66.66 104.83 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.797 1.31 . . . . 0.0 108.776 -160.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.21 164.31 11.2 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.071 0.549 . . . . 0.0 111.511 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.05 -40.97 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.167 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.3 t -71.65 -45.92 60.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.299 0.639 . . . . 0.0 110.722 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.52 156.7 48.47 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.624 0.769 . . . . 0.0 110.195 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -80.19 133.8 36.07 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.201 0.6 . . . . 0.0 110.274 173.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.56 163.99 13.27 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.18 95.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -92.5 142.96 2.4 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 121.886 1.724 . . . . 0.0 111.634 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.84 -50.53 23.5 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.028 0.918 . . . . 0.0 108.8 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -119.65 153.58 35.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -136.73 154.85 50.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.123 0.487 . . . . 0.0 111.405 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.28 161.45 41.2 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 164.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -82.87 11.25 6.28 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.37 138.69 1.69 Allowed Glycine 0 C--N 1.347 1.148 0 C-N-CA 123.224 0.44 . . . . 0.0 113.879 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 t -136.45 107.14 6.57 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -75.31 105.77 6.5 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.282 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.64 140.69 15.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 m -125.8 136.84 53.58 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.3 p -114.88 125.38 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.054 0.454 . . . . 0.0 110.143 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.0 t -83.42 111.71 19.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.1 p -77.82 138.18 38.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.818 0.847 . . . . 0.0 111.279 -174.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 71.65 -10.24 0.85 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.475 1.51 . . . . 0.0 113.493 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -68.8 100.18 1.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.32 0.509 . . . . 0.0 110.906 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -147.45 -48.45 0.17 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.371 1.069 . . . . 0.0 109.206 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 63.22 34.46 13.39 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 124.588 1.155 . . . . 0.0 109.363 -174.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -69.07 109.16 3.87 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.794 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -103.35 144.49 31.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.701 0.8 . . . . 0.0 108.956 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -82.48 116.87 22.12 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.806 0.442 . . . . 0.0 110.695 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 . . . . . 0 CA--C 1.551 1.007 0 C-N-CA 123.653 0.781 . . . . 0.0 109.134 174.882 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG3' ' HG2' ' A' ' 28' ' ' ARG . 45.0 tpp . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -133.3 154.0 51.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.022 0.929 . . . . 0.0 109.85 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 41.0 tp -86.18 111.05 20.02 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.47 128.09 34.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.905 0.882 . . . . 0.0 109.381 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.2 126.46 42.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.277 1.031 . . . . 0.0 108.737 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.27 104.1 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.636 0.775 . . . . 0.0 109.679 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.36 137.36 32.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.891 0.877 . . . . 0.0 109.558 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m -147.64 171.44 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.758 0.823 . . . . 0.0 110.335 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.36 13.13 66.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.037 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.37 145.73 18.61 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.43 -164.46 30.0 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.832 0.316 . . . . 0.0 112.549 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.09 144.11 31.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.129 0.572 . . . . 0.0 110.157 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.5 p -150.83 151.71 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.247 1.019 . . . . 0.0 108.526 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.06 155.61 23.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.676 0.391 . . . . 0.0 110.256 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . . . -72.98 129.57 38.4 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.39 66.12 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 123.772 0.701 . . . . 0.0 111.423 -167.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.87 -166.52 31.82 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.198 0.428 . . . . 0.0 113.698 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -147.58 160.83 42.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.272 1.029 . . . . 0.0 110.269 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -155.99 147.64 22.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.012 0.925 . . . . 0.0 108.547 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -128.11 118.68 23.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.281 0.492 . . . . 0.0 109.995 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 84' ' ' MET . 2.5 mm? -90.51 157.43 17.54 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.89 0.876 . . . . 0.0 109.857 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -142.15 123.77 15.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -122.74 118.74 28.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.981 0.512 . . . . 0.0 110.824 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.51 123.97 30.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.329 0.651 . . . . 0.0 110.09 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.81 143.43 38.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.1 0.96 . . . . 0.0 110.121 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -160.07 176.44 11.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.259 0.624 . . . . 0.0 110.419 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.85 -96.48 1.56 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 66.1 mtp180 -79.79 143.53 34.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.1 m -73.47 103.33 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -58.21 -25.9 62.19 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.01 0.924 . . . . 0.0 111.884 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 43.7 p -76.05 0.45 18.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.773 0.829 . . . . 0.0 112.502 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -87.88 -13.69 41.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.15 0.58 . . . . 0.0 110.143 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.53 170.42 10.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.386 0.674 . . . . 0.0 110.571 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 133.62 34.9 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.476 ' SD ' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -129.12 131.41 47.22 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.486 0.714 . . . . 0.0 109.35 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -152.23 159.98 28.66 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 114.223 0.449 . . . . 0.0 114.223 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -97.52 132.61 43.04 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.295 1.038 . . . . 0.0 110.384 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.59 129.94 45.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 108.387 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -114.53 156.67 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.502 0.321 . . . . 0.0 111.63 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.9 pp0? -167.23 149.27 5.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.83 0.706 . . . . 0.0 110.504 173.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -179.73 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.813 0.845 . . . . 0.0 111.32 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 88.3 Cg_endo -83.21 73.86 5.1 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.155 1.903 . . . . 0.0 112.481 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.03 74.46 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.181 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.6 mmpt? -115.7 145.5 42.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.542 0.737 . . . . 0.0 111.343 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.89 169.85 10.89 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 161.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -64.12 103.8 0.65 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.414 0.626 . . . . 0.0 110.14 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.49 150.38 20.37 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.573 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.01 108.59 1.85 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.946 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -90.11 -68.03 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.6 134.28 4.5 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.577 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG11 ' HE1' ' A' ' 102' ' ' TRP . 94.5 t -116.17 134.02 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 0.0 109.596 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 59' ' ' THR . 8.1 p -107.27 148.87 11.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 123.448 0.699 . . . . 0.0 110.595 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.1 149.97 35.67 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 168.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 61.8 p-90 -60.02 -34.94 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 0.0 112.925 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -86.86 -10.94 52.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 111.495 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.38 15.52 78.15 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.394 -171.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -59.62 -46.65 88.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.113 0.965 . . . . 0.0 111.11 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -133.57 129.25 36.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 52' ' ' VAL . 36.4 p -117.45 128.7 55.25 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.44 117.13 32.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.39 154.54 27.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 110.309 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.23 146.12 39.28 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.95 -25.91 67.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.905 0.482 . . . . 0.0 112.109 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -70.46 -41.95 72.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.751 0.821 . . . . 0.0 110.878 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 69' ' ' PHE . 8.1 m -94.63 -4.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.293 0.637 . . . . 0.0 111.992 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -67.36 119.4 12.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 0.0 111.094 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.64 17.88 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 123.525 0.583 . . . . 0.0 113.951 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -96.27 -13.5 23.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.364 0.666 . . . . 0.0 110.79 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 65' ' ' VAL . 97.3 m-85 -123.76 155.83 37.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.423 0.689 . . . . 0.0 109.261 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.3 m -148.77 138.1 21.76 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 108.289 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.617 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -102.81 144.5 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 m -136.48 155.87 49.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.71 157.23 36.26 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.65 119.37 13.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.83 -4.94 58.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.009 0.924 . . . . 0.0 112.269 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.99 -54.1 4.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -78.52 -14.23 59.45 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.873 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 60.94 34.47 19.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.627 1.171 . . . . 0.0 111.301 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.6 m -119.22 132.46 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.251 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.476 HG11 ' SD ' ' A' ' 35' ' ' MET . 51.6 t -104.33 119.39 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.142 0.977 . . . . 0.0 109.965 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.26 121.1 41.61 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.702 0.801 . . . . 0.0 110.281 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -105.64 110.54 22.9 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.84 102.81 13.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.902 0.881 . . . . 0.0 109.899 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.621 ' HB3' HD21 ' A' ' 87' ' ' LEU . 83.8 mtp -87.38 140.28 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 0.0 108.669 171.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.67 154.83 30.72 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 123.071 0.232 . . . . 0.0 110.733 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 m 61.07 38.65 16.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.447 1.099 . . . . 0.0 110.312 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.9 mt -68.11 129.16 39.09 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.188 -169.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -100.69 154.42 37.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.466 1.107 . . . . 0.0 108.077 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.847 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 12.1 Cg_endo -53.77 -24.42 30.52 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 123.446 2.764 . . . . 0.0 114.78 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.86 -13.85 59.57 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 112.68 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.5 -2.1 33.78 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.723 0.809 . . . . 0.0 112.208 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.561 HG23 ' HA ' ' A' ' 120' ' ' THR . 65.8 m -62.71 107.91 1.06 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.23 0.612 . . . . 0.0 109.805 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.18 160.01 9.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.572 0.545 . . . . 0.0 110.898 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 40' ' ' GLN . 14.4 p -85.68 115.64 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -94.28 116.25 28.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.106 0.962 . . . . 0.0 108.807 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.06 131.44 48.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.028 0.531 . . . . 0.0 109.72 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.4 t -82.16 102.07 10.85 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.48 162.08 14.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.306 1.042 . . . . 0.0 110.669 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.9 128.52 14.17 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.917 0.887 . . . . 0.0 108.951 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.12 158.92 31.21 Favored Glycine 0 C--O 1.241 0.553 0 O-C-N 123.768 0.668 . . . . 0.0 111.637 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -82.49 127.85 33.71 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.658 ' HE1' HG11 ' A' ' 51' ' ' VAL . 17.3 p-90 -147.47 137.64 23.1 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -83.38 -42.65 16.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.192 0.597 . . . . 0.0 110.888 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.69 -89.93 0.1 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 m -66.07 -45.34 81.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.443 0.697 . . . . 0.0 109.342 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -82.62 104.98 13.28 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -94.11 155.97 16.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.778 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.75 -114.83 4.01 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 132.41 7.77 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.76 110.66 0.86 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.01 1.807 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.6 -44.15 71.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.162 0.506 . . . . 0.0 109.839 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.42 150.47 31.1 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.342 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -158.32 151.96 23.47 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.691 1.196 . . . . 0.0 108.316 164.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.63 -163.26 26.43 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.49 -38.03 86.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.859 0.864 . . . . 0.0 110.123 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.34 130.88 7.17 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.909 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -99.93 108.26 20.45 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 109.416 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -79.34 102.86 8.89 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -91.62 137.11 22.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.561 ' HA ' HG23 ' A' ' 92' ' ' THR . 24.0 m -121.02 104.68 9.98 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 3.2 p -100.42 117.11 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.5 t -61.95 140.96 58.28 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.847 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 50.0 p -75.58 107.24 7.59 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.349 -175.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -67.66 148.89 50.75 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.521 ' H ' HD13 ' A' ' 124' ' ' LEU . 35.9 mt-10 -54.19 122.45 10.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.925 0.89 . . . . 0.0 112.551 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -95.8 89.51 5.31 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.404 0.682 . . . . 0.0 109.901 173.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -92.62 94.5 9.06 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 166.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -57.09 139.75 51.41 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.775 0.672 . . . . 0.0 111.246 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -68.84 91.64 0.46 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.594 0.758 . . . . 0.0 111.68 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -175.08 125.16 0.26 Allowed 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.369 1.068 . . . . 0.0 109.391 168.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.1 p80 . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 123.04 0.536 . . . . 0.0 109.916 175.432 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.717 0.294 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.92 172.73 15.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.397 0.679 . . . . 0.0 110.876 -171.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB1' ' A' ' 25' ' ' ALA . 52.9 tp -85.93 112.43 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.746 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 24.9 tt0 -102.83 105.65 16.09 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.599 0.76 . . . . 0.0 109.631 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HB3' ' SG ' ' A' ' 97' ' ' CYS . 79.1 mt -91.01 127.23 36.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.594 0.758 . . . . 0.0 109.346 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.11 102.86 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 109.042 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.58 123.19 29.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.1 0.56 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -117.9 130.8 56.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.558 1.143 . . . . 0.0 108.816 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.92 4.99 1.46 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-O 119.861 -0.411 . . . . 0.0 113.345 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.71 102.83 0.8 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.999 0.399 . . . . 0.0 112.17 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.84 -174.56 34.7 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.36 145.2 26.42 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.148 0.499 . . . . 0.0 111.812 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -146.85 154.85 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.47 1.108 . . . . 0.0 108.655 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -87.47 151.31 23.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.864 0.465 . . . . 0.0 111.233 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.91 110.35 5.59 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.431 0.692 . . . . 0.0 110.427 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.25 -4.11 40.8 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.202 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.99 -167.56 42.29 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.667 0.275 . . . . 0.0 112.955 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.7 m -124.92 157.86 34.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.733 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 tp -155.04 123.15 5.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.799 0.84 . . . . 0.0 108.833 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -93.66 119.68 32.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 1.9 mm? -103.84 153.89 20.23 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.83 123.31 8.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 51.9 t -104.99 127.52 52.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.344 0.658 . . . . 0.0 110.087 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.22 127.14 38.68 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.618 0.767 . . . . 0.0 109.601 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -104.83 128.77 53.13 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.591 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 4.1 m -120.2 151.08 39.64 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.717 0.807 . . . . 0.0 110.947 -169.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.38 -88.2 0.51 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 124.1 0.875 . . . . 0.0 112.832 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -74.25 146.49 43.21 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 0.0 110.528 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -65.18 110.1 2.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.621 0.768 . . . . 0.0 109.958 170.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 78' ' ' ASN . 2.4 p90 -61.45 -23.92 66.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.325 0.65 . . . . 0.0 110.701 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.3 p -72.03 -8.54 55.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 113.157 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 m -83.27 -2.67 56.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.847 0.459 . . . . 0.0 110.735 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -135.97 163.67 29.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.105 0.962 . . . . 0.0 109.967 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.13 127.18 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 97' ' ' CYS . 8.7 tmm? -119.97 135.91 54.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.693 0.397 . . . . 0.0 109.974 -170.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -133.07 166.22 23.76 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 123.157 0.408 . . . . 0.0 113.511 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -115.89 145.07 43.2 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 124.034 0.933 . . . . 0.0 108.991 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -136.15 146.22 46.67 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.741 1.216 . . . . 0.0 108.907 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -125.38 148.1 48.9 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.238 0.472 . . . . 0.0 110.506 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.84 155.02 4.5 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 123.584 0.754 . . . . 0.0 111.18 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 177.14 -61.07 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.802 1.241 . . . . 0.0 110.263 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.26 75.56 5.0 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 122.377 2.052 . . . . 0.0 112.603 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.16 24.18 70.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.594 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 28.4 mmmt -112.11 144.88 40.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.533 1.133 . . . . 0.0 110.374 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.87 160.93 14.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.906 0.882 . . . . 0.0 109.433 168.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -58.75 105.37 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.143 0.577 . . . . 0.0 111.236 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.78 150.93 19.85 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' HZ ' ' HB3' ' A' ' 60' ' ' TYR . 54.1 t80 -59.11 111.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.522 1.129 . . . . 0.0 109.112 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -100.06 -65.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.43 130.34 5.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.35 0.119 . . . . 0.0 110.905 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.688 HG22 ' HA3' ' A' ' 36' ' ' GLY . 67.0 t -117.83 138.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.009 0.923 . . . . 0.0 108.762 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG21 HH11 ' A' ' 73' ' ' ARG . 11.7 p -124.73 140.53 47.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.2 155.98 22.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -55.84 -40.62 73.12 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -167.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -92.42 -0.79 57.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.43 0.692 . . . . 0.0 110.88 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.25 7.57 67.97 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.173 -0.467 . . . . 0.0 114.074 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -66.57 -38.82 87.87 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.678 0.791 . . . . 0.0 110.237 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -115.19 138.05 51.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.545 0.738 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -131.67 144.6 51.14 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.601 1.16 . . . . 0.0 108.987 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.552 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 85.1 m-85 -128.82 137.37 51.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.317 1.047 . . . . 0.0 108.248 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -138.85 150.39 45.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.391 0.676 . . . . 0.0 109.823 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -82.08 138.61 34.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.02 -28.37 67.68 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.204 0.602 . . . . 0.0 111.639 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 t -65.69 -41.8 91.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.283 1.033 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 62' ' ' ALA . 22.6 m -103.06 -2.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.301 0.64 . . . . 0.0 111.735 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -64.85 117.71 7.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 0.0 111.355 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.29 20.11 Favored Glycine 0 C--N 1.345 1.034 0 O-C-N 123.82 0.7 . . . . 0.0 113.332 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 13.8 ptp180 -95.2 -23.34 17.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.141 0.496 . . . . 0.0 109.872 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 2.9 m-85 -107.03 153.52 22.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 92.4 m -145.31 130.68 18.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.927 0.891 . . . . 0.0 109.468 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.494 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 1.2 pp -104.13 128.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.054 0.542 . . . . 0.0 110.273 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -139.16 166.09 25.45 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.616 1.166 . . . . 0.0 108.635 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.627 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -159.77 161.46 34.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.111 0.481 . . . . 0.0 110.915 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.6 114.09 17.6 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -67.5 -35.23 78.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.517 0.727 . . . . 0.0 111.983 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.64 67.59 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.602 0.564 . . . . 0.0 111.364 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -83.16 -19.24 36.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.233 0.613 . . . . 0.0 111.779 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 2.6 m120 68.08 32.67 4.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.133 . . . . 0.0 110.692 -173.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.7 m -111.35 129.88 55.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.867 0.467 . . . . 0.0 110.073 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.78 144.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.752 0.821 . . . . 0.0 108.959 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 130.0 53.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.852 0.861 . . . . 0.0 109.803 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.9 tm? -115.33 106.68 14.29 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 16.1 mm100 -88.17 103.78 16.08 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.869 0.868 . . . . 0.0 109.682 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.8 mtt -87.28 133.89 33.62 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -141.1 145.3 35.61 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.3 m 56.23 47.03 20.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.164 0.986 . . . . 0.0 111.587 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.56 124.17 20.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.146 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.5 mtpt -70.22 155.07 94.03 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 -14.76 29.37 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 122.6 2.2 . . . . 0.0 113.605 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.93 -3.02 56.48 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.335 0.654 . . . . 0.0 112.621 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.66 5.06 8.14 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.5 m -64.8 100.63 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.87 152.09 11.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.241 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 4.1 p -80.35 123.11 36.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 170.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -94.72 139.11 31.69 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -137.93 121.36 17.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.193 0.997 . . . . 0.0 108.835 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.693 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 30.1 p -86.98 143.71 27.24 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -147.38 134.7 20.65 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.168 0.987 . . . . 0.0 109.729 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.98 161.03 15.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.377 0.671 . . . . 0.0 110.834 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 111' ' ' ASP . . . -160.99 133.08 3.07 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.814 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -71.8 115.67 11.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.708 0.403 . . . . 0.0 110.384 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 96.0 m95 68.12 103.48 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.041 1.736 . . . . 0.0 112.243 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -126.19 143.36 51.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.602 0.761 . . . . 0.0 110.234 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.38 52.79 0.57 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 t 66.66 15.74 10.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.234 1.413 . . . . 0.0 110.963 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -137.95 41.15 2.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.373 1.069 . . . . 0.0 109.334 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -51.78 115.71 1.79 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.904 0.882 . . . . 0.0 110.398 171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.0 -46.46 93.48 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.45 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.25 154.57 20.03 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 124.296 1.039 . . . . 0.0 109.155 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.2 96.07 0.22 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.003 1.802 . . . . 0.0 109.907 167.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB3' ' HA2' ' A' ' 100' ' ' GLY . 24.5 t0 -62.74 -37.34 86.19 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.669 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 92.5 m-85 -133.13 167.83 19.62 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.628 166.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 38.4 p90 -154.35 169.3 24.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.02 0.928 . . . . 0.0 109.178 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.19 -172.63 21.69 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.648 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -70.77 -45.12 65.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.333 0.653 . . . . 0.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.13 135.88 1.17 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.451 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.7 t -143.26 140.83 30.83 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.236 0.541 . . . . 0.0 110.314 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 55.8 tp60 -80.42 122.7 27.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.359 1.063 . . . . 0.0 111.408 -171.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.65 145.14 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.4 m -126.91 105.88 8.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.61 0.764 . . . . 0.0 109.339 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.7 p -90.73 117.92 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.402 0.62 . . . . 0.0 109.928 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.1 t -67.34 117.87 9.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.954 0.901 . . . . 0.0 109.802 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.7 m -71.74 96.14 1.58 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.468 0.707 . . . . 0.0 110.382 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.72 105.87 18.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.73 173.44 15.26 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.752 0.821 . . . . 0.0 110.03 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -157.35 -58.5 0.08 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -163.23 -38.81 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.25 0.62 . . . . 0.0 110.884 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 38.7 m80 64.54 -177.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.534 1.134 . . . . 0.0 111.246 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -142.32 120.93 12.54 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -108.94 115.28 29.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.017 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -55.84 107.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.937 0.895 . . . . 0.0 111.686 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 64.5 tp -81.31 110.91 17.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.58 127.66 37.12 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.604 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 73.8 mt -114.23 131.64 56.41 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 59.1 t -114.71 100.37 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.6 130.31 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 109.634 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -138.21 139.99 39.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.311 1.044 . . . . 0.0 109.049 -175.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.62 13.32 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 64.89 3.97 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.95 -164.99 13.35 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 123.569 0.604 . . . . 0.0 111.702 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.4 pp -104.06 142.4 34.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.121 0.569 . . . . 0.0 111.568 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -151.41 144.21 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.883 1.273 . . . . 0.0 108.004 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HB3' HD22 ' A' ' 124' ' ' LEU . 27.1 mp0 -69.59 154.57 41.8 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.745 0.418 . . . . 0.0 111.662 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 115.47 5.13 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.461 174.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.32 -14.34 28.02 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 123.885 0.755 . . . . 0.0 111.701 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.33 -163.78 26.75 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 121.307 0.393 . . . . 0.0 113.766 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -144.61 150.93 38.25 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.69 0.796 . . . . 0.0 110.023 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -155.72 124.65 6.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.165 0.586 . . . . 0.0 109.942 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -92.28 129.42 38.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.174 0.59 . . . . 0.0 110.427 175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mm? -96.18 157.32 15.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.101 0.96 . . . . 0.0 109.084 172.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -144.7 124.1 13.09 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.171 0.589 . . . . 0.0 109.564 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -114.53 115.43 27.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.519 0.728 . . . . 0.0 110.112 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.85 118.66 24.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.59 144.95 31.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.703 0.801 . . . . 0.0 109.759 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t -65.74 159.02 26.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.47 0.708 . . . . 0.0 109.895 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 55.16 4.79 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-O 121.302 0.39 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 1.6 mmp_? -98.8 -171.35 2.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.824 1.25 . . . . 0.0 110.781 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.4 p -81.29 41.76 0.63 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.892 0.877 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -69.13 -19.44 64.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.98 0.512 . . . . 0.0 111.817 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -77.39 -16.15 59.0 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 0.0 111.284 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.4 t -81.19 -12.84 59.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.998 0.519 . . . . 0.0 110.2 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.19 159.17 17.61 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 0.0 109.627 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.35 136.91 35.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 80' ' ' VAL . 2.6 ttp -101.41 155.25 18.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.76 149.93 21.5 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 117.93 0.332 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HE1' HG23 ' A' ' 71' ' ' ILE . 85.1 m95 -98.51 131.6 44.61 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.137 0.975 . . . . 0.0 109.564 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -131.37 166.6 20.91 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.686 1.194 . . . . 0.0 108.375 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -157.9 163.46 37.89 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 118.549 0.613 . . . . 0.0 111.408 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -169.91 162.88 9.46 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.072 0.949 . . . . 0.0 109.314 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.54 -58.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 C-N-CA 124.481 1.112 . . . . 0.0 110.891 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.23 69.0 8.13 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 122.692 2.262 . . . . 0.0 112.854 -170.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.81 67.33 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.657 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -107.72 146.64 31.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.535 0.734 . . . . 0.0 110.746 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.24 164.76 20.98 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.637 0.775 . . . . 0.0 108.926 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.13 104.91 0.42 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.214 0.53 . . . . 0.0 110.39 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.96 157.58 15.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.153 1.381 . . . . 0.0 110.727 -170.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.6 121.09 19.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.513 0.725 . . . . 0.0 110.344 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.74 -53.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.39 152.56 7.24 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.532 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -133.87 147.28 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.484 1.113 . . . . 0.0 108.782 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 71' ' ' ILE . 13.9 p -133.81 148.5 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 125.101 1.36 . . . . 0.0 108.948 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -77.71 161.63 27.59 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -56.92 -36.35 70.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -90.96 -8.37 49.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.075 0.55 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.83 21.16 58.24 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 112.289 -0.324 . . . . 0.0 112.289 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -60.59 -58.47 8.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.682 0.793 . . . . 0.0 111.283 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.09 138.39 53.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.225 0.61 . . . . 0.0 109.989 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -119.74 160.23 22.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 110.64 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -141.97 139.45 32.45 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 107.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.55 152.89 52.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.129 0.571 . . . . 0.0 110.106 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -69.83 133.58 47.55 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 166.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.03 -29.37 69.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -168.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.7 m -67.45 -31.13 71.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.651 0.78 . . . . 0.0 111.64 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.477 HG22 ' HB3' ' A' ' 62' ' ' ALA . 20.8 m -113.47 6.96 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.821 0.848 . . . . 0.0 111.661 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -75.1 118.17 17.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.035 0.534 . . . . 0.0 111.845 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.61 -26.12 25.62 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.828 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -94.82 -17.98 21.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.218 0.607 . . . . 0.0 110.117 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -104.7 145.83 29.8 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 m -148.74 138.13 21.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.891 0.876 . . . . 0.0 109.43 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.555 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.9 mp -101.11 131.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.8 m -122.43 154.78 37.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 133.38 8.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.046 0.385 . . . . 0.0 110.146 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.39 108.11 18.03 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.66 -29.02 68.21 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.93 0.892 . . . . 0.0 111.059 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.73 68.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.246 0.618 . . . . 0.0 111.162 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -14.96 59.43 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.626 0.37 . . . . 0.0 110.714 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 62.31 28.34 16.88 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 124.667 1.229 . . . . 0.0 110.132 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.3 m -125.99 132.51 52.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.093 0.557 . . . . 0.0 110.259 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 35' ' ' MET . 21.8 t -105.54 157.63 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.584 1.153 . . . . 0.0 109.137 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -137.84 145.36 42.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.818 1.247 . . . . 0.0 108.774 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 21' ' ' LEU . 2.9 tm? -134.37 108.61 8.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.07 104.98 16.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.336 0.654 . . . . 0.0 109.73 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.427 ' HB3' HD21 ' A' ' 87' ' ' LEU . 69.7 mtm -88.64 132.41 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -130.69 142.45 50.43 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t 57.73 70.98 0.61 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.67 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.8 mt -84.45 157.17 21.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.417 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -118.31 156.89 50.38 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.28 -21.74 67.98 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.49 2.127 . . . . 0.0 113.059 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.94 -11.43 59.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.274 1.029 . . . . 0.0 112.871 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -83.08 1.48 40.0 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.829 0.452 . . . . 0.0 112.149 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -64.59 108.33 1.65 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.765 0.826 . . . . 0.0 110.397 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.1 164.04 13.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.645 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 2.7 p -89.0 112.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -88.23 139.98 29.94 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -125.74 129.34 49.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.543 1.137 . . . . 0.0 108.753 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.44 121.98 28.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -113.71 161.84 17.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.836 0.854 . . . . 0.0 110.006 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.83 143.86 29.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.49 165.74 30.76 Favored Glycine 0 C--O 1.239 0.439 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -72.85 111.79 8.3 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.29 1.77 4.53 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.604 1.162 . . . . 0.0 113.301 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.2 85.86 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.456 . . . . 0.0 109.473 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 -116.4 4.77 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -168.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.5 m 60.92 17.38 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.641 1.177 . . . . 0.0 113.666 171.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.63 -34.78 72.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.534 0.734 . . . . 0.0 110.264 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -115.56 98.16 6.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.76 -142.64 7.39 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.569 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.1 143.37 22.34 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.675 0.79 . . . . 0.0 109.981 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.81 147.85 93.93 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.702 2.268 . . . . 0.0 111.469 170.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.72 -47.33 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.287 0.635 . . . . 0.0 110.149 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -128.04 165.26 20.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.967 0.907 . . . . 0.0 109.993 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 44.7 p90 -158.43 167.09 30.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.105 0.962 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.64 -161.26 29.99 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.991 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -85.43 -57.46 3.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.114 0.966 . . . . 0.0 109.209 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.39 144.72 17.7 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.416 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -143.43 149.49 37.7 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.343 0.657 . . . . 0.0 109.291 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 0.9 OUTLIER -91.36 118.11 30.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.376 0.67 . . . . 0.0 110.383 -169.097 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.28 126.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.447 0.641 . . . . 0.0 109.54 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 88.4 m -102.32 104.67 15.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.779 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.08 100.56 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.8 m -56.73 116.45 3.16 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.462 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.9 m -58.97 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 14' ' ' GLN . 26.3 tp -79.87 -3.58 48.57 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.19 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.35 81.23 0.21 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.742 1.217 . . . . 0.0 108.743 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -75.72 117.91 17.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.538 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -86.3 -57.89 2.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 111.247 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -86.77 80.98 8.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.268 0.627 . . . . 0.0 110.037 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -78.78 127.99 32.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.195 0.998 . . . . 0.0 111.624 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -81.94 149.8 28.02 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 0.0 109.943 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.9 t60 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 119.005 -0.521 . . . . 0.0 109.729 176.501 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.77 118.06 30.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 0.0 109.946 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.83 122.89 48.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.95 0.9 . . . . 0.0 108.627 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 92.5 t -117.52 103.31 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.149 0.98 . . . . 0.0 109.123 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.63 147.47 27.69 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.165 0.586 . . . . 0.0 109.77 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 p -162.47 178.57 8.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.362 1.065 . . . . 0.0 109.493 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.42 5.3 89.89 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 116.537 -0.301 . . . . 0.0 113.433 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.86 135.64 19.37 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.84 178.39 40.59 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -98.66 139.26 34.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.594 0.758 . . . . 0.0 111.006 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 11.3 p -151.12 151.35 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.328 1.051 . . . . 0.0 108.534 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 18.1 mp0 -70.12 159.54 33.72 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.258 0.623 . . . . 0.0 112.272 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 121.92 15.03 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.913 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.51 58.82 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.734 0.646 . . . . 0.0 112.172 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.39 -164.4 37.67 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.068 0.366 . . . . 0.0 112.984 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -148.72 155.67 41.32 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.214 0.606 . . . . 0.0 110.774 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -153.45 136.14 15.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.056 0.942 . . . . 0.0 109.339 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -99.24 132.99 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.277 0.561 . . . . 0.0 110.09 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 4.2 mm? -106.72 159.95 15.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.216 . . . . 0.0 109.79 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -137.75 156.04 48.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.956 0.902 . . . . 0.0 110.007 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 54.0 t -150.66 113.51 4.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 109.6 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.4 117.53 23.68 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.85 0.86 . . . . 0.0 109.051 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.3 124.58 49.79 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.263 0.625 . . . . 0.0 109.724 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.1 m -141.77 -178.08 5.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.935 1.294 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.19 -117.17 4.36 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.54 153.82 42.92 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.896 0.848 . . . . 0.0 110.746 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.3 p -68.9 107.29 3.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.909 0.483 . . . . 0.0 109.724 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ASN . 5.2 p90 -64.75 -14.62 59.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.255 0.622 . . . . 0.0 110.924 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.5 p -70.37 -3.55 18.02 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.162 0.985 . . . . 0.0 112.32 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -109.52 7.66 24.82 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.462 1.105 . . . . 0.0 110.08 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.07 156.19 49.08 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.123 0.969 . . . . 0.0 111.091 -173.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.8 133.16 50.97 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 17.7 ttp -118.23 142.11 47.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.286 0.634 . . . . 0.0 109.589 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -127.45 154.21 19.48 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.391 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -97.03 125.56 41.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.39 160.22 24.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.263 1.425 . . . . 0.0 107.64 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -139.89 162.14 35.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.86 0.755 . . . . 0.0 111.772 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -165.43 152.93 10.78 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.642 1.213 . . . . 0.0 110.52 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 173.27 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 125.245 1.418 . . . . 0.0 110.231 168.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 65.7 Cg_endo -87.58 80.51 1.3 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.938 1.758 . . . . 0.0 112.046 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.45 73.28 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.347 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -115.29 148.86 38.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.105 0.962 . . . . 0.0 112.03 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 178.19 5.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -61.46 102.63 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -99.86 147.32 25.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.038 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.87 114.49 3.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.229 0.612 . . . . 0.0 110.073 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG11 ' HE1' ' A' ' 95' ' ' TYR . 98.5 t -104.12 -55.78 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -158.54 152.49 23.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.547 0.739 . . . . 0.0 110.13 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 36' ' ' GLY . 42.9 t -137.71 141.86 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.32 1.048 . . . . 0.0 108.58 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.72 145.21 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.73 0.812 . . . . 0.0 109.272 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -81.08 156.34 25.85 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 166.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -52.16 -39.3 59.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.052 0.941 . . . . 0.0 112.523 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -68.49 -26.39 65.45 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.934 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.34 12.31 82.25 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.644 -166.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -65.24 -38.57 90.77 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.068 1.347 . . . . 0.0 110.902 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -128.38 128.08 43.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.492 0.717 . . . . 0.0 110.47 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -122.29 129.97 52.7 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 108.271 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -120.96 138.47 54.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.723 1.209 . . . . 0.0 107.973 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.01 138.82 44.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.195 0.598 . . . . 0.0 110.532 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 147.56 31.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.906 0.883 . . . . 0.0 109.635 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -59.02 -27.27 65.3 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.834 0.854 . . . . 0.0 112.745 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.2 m -64.56 -32.79 74.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.521 0.728 . . . . 0.0 112.019 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.78 5.16 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 124.388 1.075 . . . . 0.0 111.839 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.92 142.66 51.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 0.0 110.833 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.75 -22.51 9.05 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.424 0.453 . . . . 0.0 113.867 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -117.03 -17.43 10.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.535 0.734 . . . . 0.0 111.547 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.61 149.23 23.49 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -149.2 137.4 20.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.101 0.96 . . . . 0.0 108.952 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.405 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -102.03 151.39 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 175.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.0 m -146.02 159.6 43.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.972 1.309 . . . . 0.0 108.58 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.65 132.48 5.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.202 0.525 . . . . 0.0 111.238 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.68 107.43 19.09 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 30' ' ' PHE . 1.8 m-20 -69.63 -33.02 72.04 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 0.0 110.824 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.29 83.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.761 0.825 . . . . 0.0 111.104 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -97.72 -0.51 45.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.268 0.627 . . . . 0.0 112.105 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.9 OUTLIER 61.02 27.37 17.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.774 1.23 . . . . 0.0 113.46 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 m -119.36 131.81 55.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.56 0.344 . . . . 0.0 110.75 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 36.0 t -103.31 148.77 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.431 1.092 . . . . 0.0 108.923 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.11 152.07 51.43 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -132.19 108.28 9.16 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -83.61 102.76 12.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.062 0.945 . . . . 0.0 109.508 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 58.4 mtt -88.69 123.61 33.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -123.53 141.95 51.49 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.8 m 53.92 61.33 3.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.411 1.084 . . . . 0.0 111.791 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.38 117.18 11.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.365 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.415 ' O ' HG11 ' A' ' 121' ' ' VAL . 45.5 mtpt -75.05 149.38 85.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.405 1.082 . . . . 0.0 109.05 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 19.4 Cg_endo -56.54 -17.78 23.29 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.181 2.587 . . . . 0.0 114.681 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.51 -20.45 58.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.25 1.02 . . . . 0.0 113.051 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -77.14 -0.36 24.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 120' ' ' THR . 72.5 m -62.62 101.67 0.27 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.461 0.704 . . . . 0.0 110.1 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.54 160.99 15.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.036 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.69 116.52 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.349 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.483 ' HE1' HG11 ' A' ' 49' ' ' VAL . 15.7 m-85 -91.84 117.09 29.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.706 0.803 . . . . 0.0 111.092 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.64 130.07 47.91 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.038 0.935 . . . . 0.0 109.999 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.535 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.8 m -84.67 124.15 31.17 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.63 20.98 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.038 0.935 . . . . 0.0 109.695 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -119.34 167.93 11.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.858 0.863 . . . . 0.0 111.137 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.73 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.791 175.182 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.81 146.88 51.54 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.521 1.129 . . . . 0.0 109.121 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.02 156.92 42.96 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.034 0.934 . . . . 0.0 109.242 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.62 -163.34 26.14 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.219 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' A' ' 6' ' ' VAL . 41.7 mt-30 -81.59 -50.1 9.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.097 1.359 . . . . 0.0 110.689 -174.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.5 137.45 6.47 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.789 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 21' ' ' LEU . 10.0 t -114.59 115.82 27.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 109.564 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -73.49 111.83 8.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.745 0.818 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.5 145.12 16.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 52.2 m -127.88 139.2 52.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.2 p -119.78 113.14 39.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 31.1 t -58.38 113.19 1.85 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.595 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 37.8 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 124.534 1.134 . . . . 0.0 111.13 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -85.57 116.38 23.83 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -110.14 129.84 55.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.424 1.09 . . . . 0.0 108.296 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.529 ' HA ' HE21 ' A' ' 115' ' ' GLN . 34.6 t -121.9 98.25 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.85 139.64 30.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 122.89 0.476 . . . . 0.0 110.166 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -153.46 165.01 37.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.949 0.899 . . . . 0.0 109.957 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.34 -11.45 54.67 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.988 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.29 120.54 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.028 -0.318 . . . . 0.0 112.448 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.6 -169.42 22.9 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -79.63 135.49 36.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.498 0.319 . . . . 0.0 111.275 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.64 139.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.29 1.036 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.83 149.55 35.62 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.687 0.795 . . . . 0.0 112.025 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.27 7.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.218 0.607 . . . . 0.0 110.704 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.71 -10.37 25.65 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.033 0.825 . . . . 0.0 111.541 -175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.46 -170.82 44.5 Favored Glycine 0 C--N 1.346 1.124 0 C-N-CA 123.038 0.351 . . . . 0.0 113.862 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.4 p -121.52 162.1 21.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.252 1.021 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.96 126.9 8.29 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -98.4 118.33 34.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.163 0.585 . . . . 0.0 110.248 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -102.02 154.18 19.21 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.194 0.998 . . . . 0.0 109.018 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -145.67 146.84 31.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.595 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 53.6 t -138.37 123.43 19.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.22 114.77 22.57 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.26 24.51 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.408 0.683 . . . . 0.0 109.239 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 t -71.78 164.33 26.2 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.19 -11.25 51.36 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.384 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HE ' ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.9 127.45 26.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.326 1.051 . . . . 0.0 109.28 169.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.414 ' H ' ' HE ' ' A' ' 28' ' ' ARG . 6.8 p -60.77 89.04 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.12 -18.54 60.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.077 160.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 29.9 p -66.7 -14.43 62.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.069 1.347 . . . . 0.0 112.794 176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m -83.98 -4.24 58.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 0.0 111.225 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.32 168.91 17.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.591 0.757 . . . . 0.0 110.988 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 121.8 33.49 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttp -101.22 130.44 47.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 109.493 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -134.0 154.25 21.28 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.51 138.89 32.56 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.462 1.105 . . . . 0.0 109.187 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.77 170.25 14.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.159 1.384 . . . . 0.0 108.113 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -153.73 162.05 41.58 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.901 0.319 . . . . 0.0 111.802 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -168.02 151.86 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.529 1.143 . . . . 0.0 110.835 167.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 169.74 -59.11 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 125.283 1.433 . . . . 0.0 110.885 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.42 70.24 5.13 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.511 2.141 . . . . 0.0 112.609 -169.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.92 17.22 76.8 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.787 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -109.24 140.95 42.22 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 110.745 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.31 170.3 12.91 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.75 105.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.91 154.89 20.95 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 110.647 -171.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -66.6 110.38 3.17 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.674 171.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' HE1' ' A' ' 95' ' ' TYR . 95.2 t -88.81 -62.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.53 134.54 4.65 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.608 HG22 ' HA3' ' A' ' 36' ' ' GLY . 71.3 t -115.41 153.46 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.158 0.983 . . . . 0.0 108.595 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.9 151.39 31.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.6 152.99 44.61 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 52.9 p-90 -61.42 -36.05 79.25 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -82.72 -5.34 58.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.477 0.711 . . . . 0.0 111.659 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.55 79.87 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -58.51 -47.71 83.24 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.742 0.817 . . . . 0.0 111.234 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.1 mtt85 -130.71 141.23 50.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 p -110.99 130.2 55.66 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -114.93 116.33 28.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -114.27 142.21 46.58 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.83 47.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.35 -26.36 60.87 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.689 0.795 . . . . 0.0 111.978 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -69.6 -26.05 64.26 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.595 1.158 . . . . 0.0 112.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 33.5 m -127.96 7.64 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.03 0.932 . . . . 0.0 111.652 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.24 124.34 23.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 111.31 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -3.01 85.92 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.11 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -121.15 -10.9 8.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.487 0.643 . . . . 0.0 111.421 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -109.57 162.39 14.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.202 0.601 . . . . 0.0 109.873 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 86.4 m -151.59 130.57 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.267 1.027 . . . . 0.0 109.45 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.614 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -103.29 141.12 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 49.5 m -139.27 158.76 43.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.729 1.212 . . . . 0.0 108.248 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.18 131.12 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.029 0.443 . . . . 0.0 110.881 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.01 92.17 5.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.483 1.113 . . . . 0.0 108.27 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.46 -25.58 68.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.146 0.578 . . . . 0.0 111.413 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.8 98.1 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.87 0.868 . . . . 0.0 111.504 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.82 -10.25 37.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.637 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 58.21 45.27 17.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.117 0.967 . . . . 0.0 109.574 -170.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 m -115.34 148.39 39.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.283 1.033 . . . . 0.0 109.408 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 57.6 t -126.68 150.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 108.903 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 86.7 m-85 -133.53 146.23 50.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 0.0 108.975 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.3 tm? -133.87 107.19 7.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 35.4 tt0 -86.75 126.83 34.85 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.429 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.7 mtt -105.48 141.49 36.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.482 1.113 . . . . 0.0 108.824 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -141.61 147.33 37.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t 58.27 52.14 7.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.756 0.823 . . . . 0.0 111.28 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 84' ' ' MET . 77.8 mt -71.51 120.8 17.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.828 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.446 ' O ' HG11 ' A' ' 121' ' ' VAL . 39.2 mtmt -82.99 149.37 59.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.167 0.987 . . . . 0.0 108.985 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -55.98 -18.93 24.12 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 123.387 2.724 . . . . 0.0 114.791 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.49 -20.11 54.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.143 0.977 . . . . 0.0 112.609 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -71.18 -7.76 48.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.223 0.609 . . . . 0.0 112.544 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.5 m -56.58 101.82 0.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.961 0.904 . . . . 0.0 110.302 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.02 159.07 9.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.573 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.1 p -78.89 113.48 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.524 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.0 m-85 -87.98 112.51 22.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.237 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -104.57 122.73 46.21 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.493 1.117 . . . . 0.0 109.098 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.88 132.04 35.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.56 160.29 40.33 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.962 0.905 . . . . 0.0 109.295 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.43 160.65 39.35 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 CA-C-O 119.773 -0.459 . . . . 0.0 113.831 176.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 121.207 0.527 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -133.85 153.67 51.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.531 1.132 . . . . 0.0 109.302 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -149.64 148.88 29.83 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.126 0.971 . . . . 0.0 108.882 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.57 -155.7 32.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.935 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.529 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.8 mt-30 -97.69 -38.06 9.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.311 1.045 . . . . 0.0 110.587 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.91 136.81 9.2 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.172 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -117.58 114.31 23.23 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.07 0.948 . . . . 0.0 108.805 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 62.3 tp60 -71.9 108.84 5.37 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.32 145.29 7.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 25.2 m -132.6 109.67 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 88' ' ' LYS . 1.7 p -94.7 105.09 16.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.7 t -56.82 118.83 5.31 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.115 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.542 0.671 0 C-N-CA 124.168 0.987 . . . . 0.0 110.928 -176.13 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' TYR . 54.4 tp . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -72.38 104.35 3.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.126 0.57 . . . . 0.0 110.025 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.09 128.95 54.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 108.48 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.8 t -121.9 103.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.78 156.82 18.25 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.231 1.012 . . . . 0.0 110.412 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -159.44 171.81 19.04 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.882 0.873 . . . . 0.0 109.791 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.5 15.42 15.49 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.044 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.79 92.18 0.36 Allowed Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.933 0.301 . . . . 0.0 112.444 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.88 179.96 23.43 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.5 pp -107.36 147.86 29.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.084 0.554 . . . . 0.0 110.571 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.0 p -149.47 145.12 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.553 1.141 . . . . 0.0 108.707 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.2 mp0 -72.61 158.34 35.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.876 0.47 . . . . 0.0 112.026 -172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 114.33 3.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.923 0.889 . . . . 0.0 111.261 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.7 -10.0 25.73 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.486 0.565 . . . . 0.0 112.033 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.02 -163.82 39.33 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.026 0.346 . . . . 0.0 112.713 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.9 p -143.73 158.17 43.87 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.387 0.675 . . . . 0.0 109.981 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -149.59 119.66 7.21 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.9 ttt85 -96.6 116.12 28.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.722 0.809 . . . . 0.0 109.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.173 0.989 . . . . 0.0 110.216 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -132.7 145.22 50.87 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.637 0.775 . . . . 0.0 109.28 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.87 119.37 8.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.325 0.65 . . . . 0.0 110.45 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.73 129.74 34.75 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.029 0.532 . . . . 0.0 110.029 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.93 128.64 54.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.087 0.955 . . . . 0.0 110.156 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 49.9 m -142.76 159.4 42.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.097 0.959 . . . . 0.0 109.816 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.35 -117.96 5.9 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -77.26 163.84 26.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.581 0.752 . . . . 0.0 110.085 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -70.19 97.25 1.18 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.015 0.526 . . . . 0.0 111.1 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -68.43 -23.95 64.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.706 0.802 . . . . 0.0 110.798 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 60.6 p -72.5 -0.05 11.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.949 0.9 . . . . 0.0 112.276 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -99.46 -9.75 23.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.241 0.616 . . . . 0.0 111.116 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -123.48 169.42 11.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.428 0.633 . . . . 0.0 112.323 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.83 125.9 47.38 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.207 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 9.4 ptm -107.56 170.19 8.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 0.0 110.463 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.41 149.38 18.09 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 113.376 0.11 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -98.1 141.17 31.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.156 0.982 . . . . 0.0 109.995 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -138.28 133.24 32.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.654 1.181 . . . . 0.0 108.724 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -114.79 159.6 20.41 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.058 0.39 . . . . 0.0 111.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.527 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.6 pt20 -168.66 151.8 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.505 0.722 . . . . 0.0 110.712 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -179.59 -57.6 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 123.776 0.83 . . . . 0.0 111.114 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.73 64.99 7.39 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.342 2.028 . . . . 0.0 112.348 -171.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.43 22.32 76.37 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.78 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -103.34 149.1 25.08 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.931 0.892 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.38 178.48 5.95 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.472 1.109 . . . . 0.0 108.334 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.04 105.39 0.47 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 150.1 21.01 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HE2' HG23 ' A' ' 51' ' ' VAL . 58.2 t80 -63.08 112.58 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.757 0.823 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.18 -66.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.3 135.14 3.02 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' HE2' ' A' ' 48' ' ' PHE . 50.2 t -110.87 132.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.262 1.025 . . . . 0.0 109.208 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.92 151.17 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.688 0.795 . . . . 0.0 110.493 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 25.1 t-20 -75.69 156.65 34.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.982 0.913 . . . . 0.0 109.205 170.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 54.7 p-90 -58.78 -34.52 71.54 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.5 p -95.71 1.55 53.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 0.0 111.678 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.02 9.5 71.46 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 113.363 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -64.01 -35.31 80.3 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.33 1.052 . . . . 0.0 111.181 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 98.5 mtt180 -125.49 138.59 53.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.337 1.055 . . . . 0.0 109.229 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.8 p -140.29 131.92 27.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.621 0.768 . . . . 0.0 109.543 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.37 115.78 24.82 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 147.25 34.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.593 0.357 . . . . 0.0 110.241 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.18 146.59 43.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.22 -34.04 73.1 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.5 m -70.61 -28.16 64.64 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.034 0.534 . . . . 0.0 112.223 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 62' ' ' ALA . 12.1 m -109.77 1.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.193 0.597 . . . . 0.0 111.408 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -67.5 120.84 14.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.463 0.705 . . . . 0.0 111.824 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.25 -27.88 4.92 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.748 0.689 . . . . 0.0 113.959 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' NH2' HD23 ' A' ' 87' ' ' LEU . 1.6 ptm180 -89.05 -8.59 53.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.839 0.856 . . . . 0.0 110.901 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.21 151.97 27.64 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.5 m -140.19 119.41 12.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.163 0.985 . . . . 0.0 108.528 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.1 mp -103.54 127.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 m -133.83 157.78 45.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 108.206 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 150.75 18.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.127 0.489 . . . . 0.0 110.341 174.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 77' ' ' LYS . 17.8 m-20 -119.88 112.14 18.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -71.14 -26.95 63.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.072 0.549 . . . . 0.0 110.788 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.36 59.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.509 0.724 . . . . 0.0 111.02 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 72.5 mmtt -77.5 -25.01 49.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.616 0.366 . . . . 0.0 110.886 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 60.32 44.97 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.388 1.075 . . . . 0.0 110.039 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m -139.08 131.24 28.14 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.847 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 35' ' ' MET . 46.4 t -101.58 141.72 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.65 1.18 . . . . 0.0 109.593 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -125.09 126.33 45.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.186 0.994 . . . . 0.0 109.063 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.37 98.19 6.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -89.16 106.6 18.55 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.298 0.639 . . . . 0.0 110.207 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.4 mtm -88.07 139.39 30.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.322 0.649 . . . . 0.0 109.3 174.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 m 59.77 60.29 2.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.187 0.995 . . . . 0.0 111.123 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 84' ' ' MET . 99.3 mt -80.73 127.91 33.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.477 -173.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 2.3 mptp? -92.71 153.91 42.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.3 -25.7 4.97 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.875 3.05 . . . . 0.0 115.142 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.6 pt-20 -71.44 -23.27 61.81 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.743 1.217 . . . . 0.0 113.432 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 1.12 14.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.782 0.833 . . . . 0.0 113.196 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 120' ' ' THR . 54.9 m -62.99 103.13 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.291 0.636 . . . . 0.0 110.337 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.57 155.04 5.85 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.227 0.611 . . . . 0.0 111.452 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.3 p -78.95 112.29 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -87.68 113.47 23.38 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -102.71 128.8 49.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.24 129.38 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -138.53 163.52 31.77 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.264 1.025 . . . . 0.0 109.073 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -138.5 133.7 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.772 0.829 . . . . 0.0 108.774 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.466 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.484 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.508 0.67 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 34.2 m-85 -111.37 151.1 28.85 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.044 0.938 . . . . 0.0 109.14 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 42.4 p90 -166.08 167.42 16.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.869 0.868 . . . . 0.0 109.997 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.99 -147.85 10.13 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.206 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.23 -48.85 9.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.807 0.843 . . . . 0.0 110.383 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.8 151.57 25.33 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.817 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 t -122.64 111.42 16.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.336 1.054 . . . . 0.0 110.077 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 57.2 tp60 -72.47 113.87 9.98 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.474 0.71 . . . . 0.0 110.15 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.557 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.1 m -102.87 146.83 10.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.494 0.718 . . . . 0.0 109.366 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.52 ' HA ' HG23 ' A' ' 92' ' ' THR . 96.4 m -124.63 143.21 50.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.89 0.876 . . . . 0.0 109.001 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.7 p -129.86 125.62 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 109.791 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.458 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 7.9 m -80.03 122.48 26.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.468 1.107 . . . . 0.0 111.885 -170.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 123.763 0.825 . . . . 0.0 110.699 174.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -94.94 114.74 26.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.532 0.733 . . . . 0.0 109.328 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 96.0 mt -106.9 116.96 32.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.4 101.92 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -111.22 125.39 53.76 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.373 -166.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -165.75 -178.74 4.96 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.22 1.008 . . . . 0.0 110.239 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.5 -0.52 26.34 Favored Glycine 0 N--CA 1.476 1.355 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.33 151.51 29.84 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 122.88 0.276 . . . . 0.0 113.064 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.25 -168.94 31.08 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -91.31 145.54 24.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.226 0.536 . . . . 0.0 111.043 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.94 159.89 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.072 1.349 . . . . 0.0 108.13 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -87.26 166.2 15.09 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.957 0.503 . . . . 0.0 111.158 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.45 129.21 38.65 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.319 0.648 . . . . 0.0 109.959 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.46 81.75 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.741 0.651 . . . . 0.0 111.892 -170.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 -165.91 40.55 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 122.804 0.24 . . . . 0.0 112.941 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.8 p -148.18 159.03 44.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.861 0.864 . . . . 0.0 110.2 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -159.52 135.22 8.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.583 0.753 . . . . 0.0 109.496 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -109.38 126.51 53.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.841 0.457 . . . . 0.0 110.136 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -103.96 156.96 17.43 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.352 1.061 . . . . 0.0 109.332 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -144.57 154.64 43.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 111.006 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.6 t -150.68 134.2 16.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.453 0.701 . . . . 0.0 109.923 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 145.94 26.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.74 126.66 52.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -133.65 157.72 45.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.603 1.161 . . . . 0.0 109.2 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.96 1.08 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -95.16 164.38 12.89 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.574 0.749 . . . . 0.0 110.055 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 31' ' ' SER . 83.6 m -97.41 121.16 38.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.469 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 15.9 p90 -63.5 -16.45 60.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.558 0.743 . . . . 0.0 111.744 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 29' ' ' THR . 34.3 t -68.03 -15.17 63.48 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 0.0 112.613 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 p -93.05 9.68 34.75 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 122.024 -0.422 . . . . 0.0 110.661 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -134.25 167.56 20.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.379 1.071 . . . . 0.0 110.243 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.85 160.45 15.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 31.1 ttp -140.47 157.71 45.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.64 144.01 9.38 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -96.42 131.63 42.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.92 129.0 37.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.014 0.926 . . . . 0.0 108.557 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -109.05 162.35 14.32 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.727 0.299 . . . . 0.0 110.537 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -167.8 148.53 5.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.091 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 177.23 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.056 0.942 . . . . 0.0 111.352 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 68.5 Cg_endo -82.2 64.82 8.38 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 122.111 1.874 . . . . 0.0 112.523 -170.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.86 6.43 72.72 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.772 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -105.81 146.25 30.12 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.717 0.807 . . . . 0.0 110.142 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.8 178.04 6.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.861 0.864 . . . . 0.0 109.119 170.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -51.68 104.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.48 151.79 19.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.356 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -64.85 108.34 1.73 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -99.0 -49.08 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.49 150.3 6.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.23 138.56 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG23 HG22 ' A' ' 59' ' ' THR . 8.9 p -131.65 160.45 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.68 158.41 20.81 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -56.53 -38.16 71.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.532 0.733 . . . . 0.0 112.077 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -76.62 -23.48 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.625 0.77 . . . . 0.0 111.642 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.32 8.42 83.51 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.564 -165.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -58.42 -39.01 78.61 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.609 1.164 . . . . 0.0 111.049 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -119.52 130.87 55.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.286 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.472 HG22 HG23 ' A' ' 52' ' ' VAL . 46.5 p -122.36 133.21 54.65 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.906 0.883 . . . . 0.0 109.077 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.76 135.93 50.81 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -134.55 148.64 50.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.326 0.65 . . . . 0.0 109.973 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.99 128.32 33.71 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.66 -20.48 60.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.196 0.598 . . . . 0.0 112.436 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 p -64.94 -44.28 89.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.693 0.797 . . . . 0.0 111.129 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.33 -3.43 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.964 0.906 . . . . 0.0 111.782 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -66.81 134.71 52.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.298 0.639 . . . . 0.0 110.638 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.67 15.52 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.968 0.793 . . . . 0.0 113.387 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 19.0 ptt-85 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.01 0.405 . . . . 0.0 110.424 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 2.8 m-85 -105.94 151.04 25.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.729 0.812 . . . . 0.0 109.979 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 m -149.14 142.22 24.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.844 1.258 . . . . 0.0 108.211 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.4 mp -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -140.03 154.57 47.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.237 1.015 . . . . 0.0 108.334 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HG3' ' HE2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -159.72 131.29 6.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.69 98.9 10.26 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.109 0.963 . . . . 0.0 108.537 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.01 -25.5 67.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.98 0.912 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.34 72.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.415 1.086 . . . . 0.0 111.673 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -83.05 -11.23 58.22 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.148 0.579 . . . . 0.0 111.251 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.469 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 30.4 m-80 61.18 35.98 18.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 0.0 110.302 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 132.65 53.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.927 0.891 . . . . 0.0 110.257 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.1 t -99.99 153.11 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.112 1.365 . . . . 0.0 110.255 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -136.45 151.79 49.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.439 1.096 . . . . 0.0 109.829 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 1.8 tm? -132.2 115.16 15.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.84 102.31 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 109.725 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.56 ' HB3' HD21 ' A' ' 87' ' ' LEU . 67.1 mtt -95.16 136.8 35.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.422 0.689 . . . . 0.0 109.609 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 20.3 m120 -142.02 161.85 36.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.746 1.219 . . . . 0.0 108.001 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.3 m 54.12 31.41 13.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.297 1.039 . . . . 0.0 112.875 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 84' ' ' MET . 84.5 mt -61.04 130.07 44.55 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.872 0.869 . . . . 0.0 112.653 -169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD3' ' NH1' ' A' ' 68' ' ' ARG . 2.4 mptp? -98.52 152.3 37.85 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.102 0.961 . . . . 0.0 108.993 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -46.74 -27.38 5.46 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 124.202 3.268 . . . . 0.0 115.936 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -71.21 -16.66 62.52 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB2' HG11 ' A' ' 121' ' ' VAL . 40.3 m-20 -72.68 -11.94 60.83 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.845 0.458 . . . . 0.0 112.103 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 120' ' ' THR . 63.4 m -60.16 105.42 0.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.72 0.808 . . . . 0.0 110.796 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.7 165.88 4.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.883 0.873 . . . . 0.0 110.074 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.3 p -89.26 115.69 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -86.82 155.72 20.18 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.355 1.062 . . . . 0.0 109.439 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -145.81 115.98 7.45 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.75 0.657 . . . . 0.0 109.357 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 26.4 p -83.87 106.09 15.28 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.19 124.66 49.93 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.513 1.125 . . . . 0.0 110.911 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.22 151.24 38.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.716 0.807 . . . . 0.0 110.833 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.581 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -178.037 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.438 0.161 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.73 167.99 20.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.912 0.885 . . . . 0.0 109.911 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -157.4 168.69 26.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.901 0.881 . . . . 0.0 111.256 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -80.7 -172.23 45.28 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.547 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -66.98 -33.88 76.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.161 0.984 . . . . 0.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.52 108.79 2.5 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -100.95 121.84 42.45 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.39 0.676 . . . . 0.0 109.938 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.0 tm0? -90.94 127.71 36.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.9 m -113.43 140.73 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.47 ' HA ' HG23 ' A' ' 92' ' ' THR . 40.2 m -127.33 108.9 11.25 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.0 p -106.62 116.02 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 122.987 0.515 . . . . 0.0 109.63 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -73.57 148.28 43.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 110.614 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 123.916 0.886 . . . . 0.0 110.122 179.656 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -75.88 122.85 24.73 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.355 0.598 . . . . 0.0 110.818 -170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 70.6 mt -127.36 135.12 50.06 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.363 1.465 . . . . 0.0 108.475 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.38 100.42 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -97.29 135.02 39.81 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.386 0.674 . . . . 0.0 109.612 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -148.54 178.92 8.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.486 1.115 . . . . 0.0 109.49 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.38 -12.35 43.6 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.894 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.89 137.19 21.9 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.85 -169.55 36.91 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.94 137.64 37.72 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.971 0.386 . . . . 0.0 111.168 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.75 155.53 6.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 C-N-CA 124.946 1.298 . . . . 0.0 108.449 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.49 155.16 27.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.362 0.665 . . . . 0.0 109.948 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.46 111.05 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.241 0.616 . . . . 0.0 110.263 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.92 3.93 31.67 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.922 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.88 -165.98 39.53 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 122.97 0.319 . . . . 0.0 113.463 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 m -132.51 158.22 42.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.413 1.085 . . . . 0.0 110.051 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -152.26 151.12 30.54 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -119.96 113.05 19.96 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.151 0.58 . . . . 0.0 110.548 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -101.54 150.08 23.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.363 1.065 . . . . 0.0 108.782 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -153.08 140.48 19.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.363 0.665 . . . . 0.0 109.294 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.7 t -120.6 123.63 43.31 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.525 0.73 . . . . 0.0 110.258 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.47 115.52 22.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -106.8 163.15 13.17 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.377 1.071 . . . . 0.0 110.273 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -66.09 168.6 8.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.16 23.87 8.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.698 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -79.59 179.17 7.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 111.912 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -79.05 70.18 5.35 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.444 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 59.0 m-85 -66.22 -22.08 66.33 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.313 164.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -60.0 -29.81 68.71 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.999 1.32 . . . . 0.0 111.703 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 m -90.28 -15.04 32.03 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 0.0 111.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -108.58 175.5 5.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.853 0.861 . . . . 0.0 110.931 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.48 162.93 17.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 164.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.4 ttp -141.93 153.26 44.23 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.0 157.02 27.28 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -96.36 125.13 40.64 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.176 0.99 . . . . 0.0 108.355 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -123.61 170.08 10.81 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.319 1.448 . . . . 0.0 107.873 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -149.67 162.31 40.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.845 0.748 . . . . 0.0 112.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -170.1 151.5 3.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 124.385 1.053 . . . . 0.0 110.565 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.31 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 124.459 1.104 . . . . 0.0 111.518 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.57 64.87 8.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 C-N-CA 122.131 1.887 . . . . 0.0 112.481 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.16 14.6 66.4 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.894 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -104.92 160.02 15.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.462 0.705 . . . . 0.0 112.055 -172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.12 173.49 7.7 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.878 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -59.3 104.34 0.25 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.126 0.97 . . . . 0.0 109.655 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -106.67 150.49 26.19 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.651 0.78 . . . . 0.0 110.668 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.24 111.03 3.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.352 0.661 . . . . 0.0 110.835 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 HG11 ' A' ' 65' ' ' VAL . 70.1 t -94.15 -62.36 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.74 139.55 5.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 76.3 t -123.31 138.32 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.687 0.795 . . . . 0.0 110.436 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.65 157.13 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.283 1.033 . . . . 0.0 109.898 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 55' ' ' SER . 10.4 t30 -84.85 162.96 19.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 169.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.421 0.688 . . . . 0.0 112.479 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 63.6 p -81.69 -11.86 58.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.239 0.616 . . . . 0.0 111.537 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.91 83.11 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.509 0.505 . . . . 0.0 112.791 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -72.36 -23.99 61.21 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 110.969 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -122.89 134.85 54.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.117 0.967 . . . . 0.0 109.004 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.6 p -134.81 132.4 38.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.192 0.997 . . . . 0.0 109.156 173.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -124.22 134.35 53.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.135 1.374 . . . . 0.0 107.524 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.19 149.2 52.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.226 0.61 . . . . 0.0 110.224 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.63 146.11 42.71 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 166.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.76 -34.76 67.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -71.25 -41.88 69.54 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.327 0.651 . . . . 0.0 111.772 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 49' ' ' VAL . 16.1 m -90.17 -5.16 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 122.819 0.448 . . . . 0.0 111.47 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -70.83 120.22 16.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.917 0.887 . . . . 0.0 110.949 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.35 -8.64 77.19 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.449 0.468 . . . . 0.0 113.918 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 20.8 ptp180 -114.37 -26.64 7.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.423 0.689 . . . . 0.0 110.065 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-30 -98.46 150.45 21.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.829 0.851 . . . . 0.0 109.315 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -146.48 134.24 21.18 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.814 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG13 HD23 ' A' ' 82' ' ' LEU . 2.8 mp -102.81 136.72 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.6 m -135.42 160.37 38.66 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.757 1.223 . . . . 0.0 108.389 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.2 164.37 32.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.219 0.533 . . . . 0.0 111.437 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -129.76 106.64 8.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.929 1.291 . . . . 0.0 107.557 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.97 -31.1 71.82 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.318 1.047 . . . . 0.0 111.604 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.48 67.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.231 0.612 . . . . 0.0 110.743 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.71 -13.51 58.94 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.254 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.4 m120 59.05 31.86 21.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.26 1.024 . . . . 0.0 110.811 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.7 m -121.03 130.1 53.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.87 155.14 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.649 1.18 . . . . 0.0 108.519 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -137.66 141.73 41.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.559 1.144 . . . . 0.0 109.376 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.2 tm? -133.44 132.34 40.99 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -113.98 127.98 56.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.433 ' HB3' HD21 ' A' ' 87' ' ' LEU . 43.4 mtt -111.24 133.65 53.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.278 1.031 . . . . 0.0 110.042 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -133.91 149.54 51.3 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 60.05 54.16 4.28 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.036 0.935 . . . . 0.0 111.434 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 84' ' ' MET . 94.7 mt -75.1 115.96 15.3 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.995 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.48 146.11 95.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -61.39 -13.01 26.52 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 123.107 2.538 . . . . 0.0 113.92 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -88.21 -2.49 58.63 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.722 1.209 . . . . 0.0 112.211 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.483 ' HB3' HG11 ' A' ' 121' ' ' VAL . 14.3 t70 -74.56 -19.82 60.18 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.937 0.895 . . . . 0.0 110.967 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.501 HG23 ' HA ' ' A' ' 120' ' ' THR . 88.7 m -48.4 109.17 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.189 1.396 . . . . 0.0 112.32 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.35 153.79 3.06 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.857 0.723 . . . . 0.0 111.011 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 14.9 p -77.65 114.14 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.417 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.8 m-85 -85.6 111.11 19.75 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 121.476 0.655 . . . . 0.0 109.688 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.1 127.88 54.19 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.837 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.3 m -83.87 118.49 24.0 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.4 128.71 54.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.916 0.886 . . . . 0.0 109.007 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.69 169.86 11.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.684 0.794 . . . . 0.0 111.544 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.795 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.121 -176.073 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.027 0.441 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -135.71 160.06 39.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.837 0.855 . . . . 0.0 110.313 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -160.04 143.33 13.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.651 1.18 . . . . 0.0 108.573 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -90.35 -143.26 10.52 Favored Glycine 0 C--N 1.344 0.99 0 O-C-N 122.977 0.173 . . . . 0.0 112.81 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -84.84 -73.99 0.41 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.027 0.931 . . . . 0.0 110.286 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.48 165.11 11.17 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.201 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.407 HG21 HD12 ' A' ' 21' ' ' LEU . 5.4 t -143.56 108.38 4.91 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.893 0.877 . . . . 0.0 110.269 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 61.4 tp60 -68.97 111.27 4.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.105 0.562 . . . . 0.0 110.877 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -91.74 145.07 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 92' ' ' THR . 26.8 m -133.72 106.16 7.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.417 0.687 . . . . 0.0 109.492 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 91' ' ' ASP . 2.3 p -99.05 102.15 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.88 0.848 . . . . 0.0 108.774 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -57.18 141.86 44.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.958 1.703 . . . . 0.0 111.674 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.246 0.869 0 C-N-CA 124.022 0.929 . . . . 0.0 111.325 178.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 28' ' ' ARG . 62.1 tp . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.62 106.14 15.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.704 0.801 . . . . 0.0 108.973 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.532 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.4 mt -97.57 121.3 39.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.144 0.978 . . . . 0.0 108.846 173.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 60.1 t -114.51 101.19 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.536 0.734 . . . . 0.0 109.176 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -74.92 142.32 44.02 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.526 0.73 . . . . 0.0 109.751 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 p -157.17 166.04 34.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.487 1.115 . . . . 0.0 110.02 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.24 85.51 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.583 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -84.5 139.3 17.95 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.9 -163.95 28.88 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' THR . 3.9 pp -106.7 143.75 34.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.65 0.78 . . . . 0.0 111.623 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 14.5 p -151.57 156.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 108.266 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -73.07 167.38 21.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.719 0.408 . . . . 0.0 111.275 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.4 121.09 17.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.92 1.03 57.32 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.878 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.52 -172.67 49.27 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 123.058 0.361 . . . . 0.0 112.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -135.26 143.85 46.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.793 0.837 . . . . 0.0 109.664 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -140.97 124.21 16.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.041 0.937 . . . . 0.0 108.611 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -95.13 120.29 35.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.12 0.968 . . . . 0.0 109.737 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.1 mm? -99.31 157.68 16.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.563 0.745 . . . . 0.0 109.435 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.58 156.26 45.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.44 1.096 . . . . 0.0 108.644 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.558 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 52.5 t -150.4 117.61 6.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.768 0.427 . . . . 0.0 110.513 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.0 119.27 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.295 0.638 . . . . 0.0 109.662 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.48 124.69 49.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.255 1.022 . . . . 0.0 109.529 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -145.09 163.49 34.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.075 0.55 . . . . 0.0 111.127 -172.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.7 -90.5 1.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 112.362 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 27.8 tpt180 -79.59 154.47 28.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.228 0.611 . . . . 0.0 110.767 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 m -75.12 93.5 2.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.17 0.588 . . . . 0.0 110.091 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -61.36 -29.3 69.82 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.046 0.939 . . . . 0.0 111.43 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 57.3 p -77.16 0.37 21.96 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.747 0.819 . . . . 0.0 112.519 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -95.21 -14.59 23.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.173 0.589 . . . . 0.0 111.086 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.33 173.01 6.83 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.803 0.841 . . . . 0.0 110.891 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.34 160.81 18.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 163.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.9 ttp -137.87 136.52 37.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -139.38 140.85 11.2 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 122.969 0.319 . . . . 0.0 112.411 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -95.03 135.04 37.05 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.485 1.114 . . . . 0.0 108.96 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -127.81 149.97 50.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.054 1.342 . . . . 0.0 108.189 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -135.59 160.7 37.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.941 0.337 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.476 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.93 145.75 6.36 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.725 0.641 . . . . 0.0 110.67 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -177.03 -63.54 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.387 169.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 90.2 Cg_endo -78.86 75.96 4.77 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.249 1.966 . . . . 0.0 112.393 -171.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 15.58 68.13 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.168 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -105.15 143.25 33.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.281 1.032 . . . . 0.0 111.043 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.56 172.61 8.26 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 162.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -60.05 104.61 0.32 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.098 0.475 . . . . 0.0 110.118 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.57 152.34 18.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.629 1.172 . . . . 0.0 109.564 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -62.17 111.81 2.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.32 -54.08 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -166.29 136.82 3.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.499 0.499 . . . . 0.0 111.421 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' HA3' ' A' ' 36' ' ' GLY . 40.3 t -121.06 129.39 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.257 1.023 . . . . 0.0 109.58 173.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -116.03 158.26 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.284 1.034 . . . . 0.0 108.482 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.31 172.82 10.16 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 36.1 p-90 -62.33 -27.65 69.2 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.906 0.883 . . . . 0.0 113.255 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.3 m -86.06 -22.48 27.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.454 0.702 . . . . 0.0 112.543 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.43 10.98 83.84 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 123.08 0.237 . . . . 0.0 112.55 -172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -83.77 -23.66 31.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.842 1.257 . . . . 0.0 111.336 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -121.32 120.35 34.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.164 0.986 . . . . 0.0 108.574 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -127.93 130.75 48.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.652 0.781 . . . . 0.0 109.02 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.02 132.68 45.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 76.1 m-85 -128.56 150.84 50.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.378 0.671 . . . . 0.0 109.873 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.62 135.31 46.88 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.11 -30.87 38.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 112.0 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -62.88 -43.32 99.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.008 0.923 . . . . 0.0 112.153 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.57 1.71 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 26.3 ttpp -69.55 134.38 48.76 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.745 0.818 . . . . 0.0 110.845 -173.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.01 25.08 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.814 0.696 . . . . 0.0 113.718 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 29.4 ptt-85 -107.35 -20.74 13.18 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.235 0.518 . . . . 0.0 111.24 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-30 -97.61 157.69 15.9 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.161 0.585 . . . . 0.0 110.203 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.8 m -150.2 134.82 17.46 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.613 1.165 . . . . 0.0 109.122 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.482 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -102.56 142.04 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 169.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -142.02 160.38 40.33 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.999 1.32 . . . . 0.0 107.632 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 173.85 15.1 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -148.26 118.74 7.41 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.43 -24.67 59.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.814 0.846 . . . . 0.0 111.625 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.26 33.93 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.521 0.728 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.8 mmpt? -87.13 -14.59 40.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 0.0 111.401 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.93 27.72 16.85 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.559 1.162 . . . . 0.0 110.931 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -122.96 133.73 54.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.994 0.518 . . . . 0.0 110.549 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 91.5 t -104.39 154.08 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.591 1.556 . . . . 0.0 109.061 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.55 141.94 41.39 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.416 1.086 . . . . 0.0 109.072 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -131.59 99.56 4.84 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -85.65 117.08 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.372 0.669 . . . . 0.0 109.893 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.562 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.4 mtm -110.43 99.59 8.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.756 0.822 . . . . 0.0 109.872 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -99.0 154.06 18.38 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.655 0.782 . . . . 0.0 109.817 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t 56.62 42.24 27.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' MET . 18.1 mt -56.03 124.76 18.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.053 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' O ' HG11 ' A' ' 121' ' ' VAL . 80.6 tttt -90.69 142.7 28.07 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.724 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -34.55 -40.33 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 125.205 3.936 . . . . 0.0 116.182 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.24 -11.92 60.42 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.507 1.123 . . . . 0.0 113.736 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -80.64 -2.63 47.35 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.589 0.755 . . . . 0.0 112.515 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 90.0 m -63.47 106.19 0.89 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.319 0.648 . . . . 0.0 110.215 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.01 160.06 4.12 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 0.0 111.014 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 40' ' ' GLN . 7.6 p -83.04 114.54 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -87.5 113.77 23.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.926 0.891 . . . . 0.0 110.408 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.57 126.25 52.31 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.364 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.3 143.89 28.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -140.3 158.71 43.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.995 0.918 . . . . 0.0 109.915 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -134.94 141.83 46.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.988 0.515 . . . . 0.0 110.706 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.382 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.02 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 121.378 0.608 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 38.7 m-85 -118.76 155.74 30.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.249 1.019 . . . . 0.0 109.29 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 10.3 p90 -165.68 172.86 11.38 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.226 1.011 . . . . 0.0 109.753 170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.98 -149.69 16.24 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.338 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -84.84 -64.59 1.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.669 1.188 . . . . 0.0 109.109 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.68 142.19 6.28 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.453 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 10.2 t -122.52 117.89 26.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.895 0.878 . . . . 0.0 109.687 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 26.6 tp60 -78.2 106.47 10.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.12 0.568 . . . . 0.0 109.83 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.2 146.97 8.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.511 0.724 . . . . 0.0 109.276 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 47.1 m -131.93 133.99 45.16 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.458 0.703 . . . . 0.0 109.696 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.1 p -114.38 105.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -59.45 112.38 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.733 1.213 . . . . 0.0 110.754 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.242 0.66 0 C-N-CA 123.879 0.871 . . . . 0.0 110.621 -178.312 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 28' ' ' ARG . 43.9 tp . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 26.4 tp60 -80.23 123.38 27.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.438 0.695 . . . . 0.0 109.665 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.4 mt -111.55 111.28 22.18 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.7 t -98.55 100.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 6.8 tm-20 -82.56 131.02 35.22 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.9 m -138.88 128.32 24.41 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.317 1.047 . . . . 0.0 108.763 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.89 -155.13 26.22 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.55 151.01 5.29 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 122.914 0.293 . . . . 0.0 112.899 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.66 -173.61 43.28 Favored Glycine 0 C--O 1.241 0.593 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.08 134.35 41.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.543 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 HD12 ' A' ' 87' ' ' LEU . 13.5 p -152.56 156.67 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 108.913 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 43.3 mt-30 -81.26 161.23 24.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.368 0.667 . . . . 0.0 110.556 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 131.97 46.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.647 0.379 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.43 -15.08 62.7 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.743 0.652 . . . . 0.0 111.489 -170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.17 -171.08 40.23 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.027 0.346 . . . . 0.0 113.833 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.3 p -137.85 160.34 39.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 0.0 110.885 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.92 164.03 33.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -130.22 140.63 50.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 82' ' ' LEU . 1.7 mm? -119.64 157.81 27.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.606 1.563 . . . . 0.0 107.472 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 t -151.56 163.75 38.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.453 0.301 . . . . 0.0 110.256 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.6 t -152.86 122.62 6.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.06 0.544 . . . . 0.0 110.61 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 127.63 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.17 136.45 44.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.264 0.626 . . . . 0.0 109.49 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 9.5 t -71.94 -175.44 1.44 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.431 1.092 . . . . 0.0 112.674 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.58 -19.84 54.99 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HB2' HD13 ' A' ' 3' ' ' LEU . 45.7 mmm-85 -60.81 145.88 48.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.602 0.761 . . . . 0.0 111.346 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.3 p -70.63 91.16 0.79 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -60.18 -21.35 61.59 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.141 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 17.6 p -67.17 -0.2 3.19 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.44 1.496 . . . . 0.0 113.462 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 m -106.98 -3.3 20.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.253 0.621 . . . . 0.0 111.019 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.82 155.49 36.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.137 0.575 . . . . 0.0 111.021 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.87 125.84 35.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.538 ' HG2' HG21 ' A' ' 80' ' ' VAL . 3.0 tpt -99.17 116.92 32.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.413 1.085 . . . . 0.0 109.033 -172.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -132.85 142.19 13.67 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 114.072 0.389 . . . . 0.0 114.072 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -96.72 134.15 40.35 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.959 1.303 . . . . 0.0 109.319 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -124.5 164.73 19.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -143.13 154.12 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.161 0.437 . . . . 0.0 111.548 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.08 151.02 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.623 1.169 . . . . 0.0 109.025 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.36 -64.92 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 C-N-CA 124.017 0.927 . . . . 0.0 111.068 166.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 54.5 Cg_endo -84.43 69.63 6.07 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.008 1.805 . . . . 0.0 111.949 -172.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 5.61 63.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.341 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -92.37 139.97 30.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.142 0.977 . . . . 0.0 109.547 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.44 169.0 12.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.532 0.733 . . . . 0.0 109.495 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -63.11 103.84 0.51 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.91 155.47 22.6 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.904 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.9 109.52 1.28 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.718 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.83 -63.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.47 134.11 1.79 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.724 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HA3' ' A' ' 36' ' ' GLY . 69.9 t -118.31 129.97 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 109.344 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 59' ' ' THR . 11.7 p -105.94 146.27 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -77.26 148.91 35.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.4 p-90 -48.26 -33.65 9.04 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -83.57 -32.45 25.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.553 0.741 . . . . 0.0 111.483 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.6 -8.19 61.8 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.35 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.96 -41.46 78.36 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.794 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -107.7 130.87 54.89 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.383 0.673 . . . . 0.0 109.655 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.606 HG22 HG23 ' A' ' 52' ' ' VAL . 32.9 p -130.94 143.88 51.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.456 1.102 . . . . 0.0 109.002 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -131.45 144.5 51.22 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 109.682 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.89 145.51 42.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.523 0.729 . . . . 0.0 109.075 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.35 -29.61 66.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.536 0.734 . . . . 0.0 112.054 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 m -66.04 -31.27 72.06 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.253 1.021 . . . . 0.0 111.911 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.15 -2.56 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.955 0.902 . . . . 0.0 111.911 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -73.85 137.01 43.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.835 0.454 . . . . 0.0 110.825 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.95 -24.83 22.64 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.678 0.611 . . . . 0.0 113.015 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -113.04 -12.46 13.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.668 0.787 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 82' ' ' LEU . 3.1 m-85 -109.78 145.22 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.363 0.665 . . . . 0.0 109.725 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -144.35 129.82 18.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.045 0.938 . . . . 0.0 109.045 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.455 HG12 HD23 ' A' ' 82' ' ' LEU . 5.6 mt -101.65 120.48 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -124.92 138.3 54.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.57 0.748 . . . . 0.0 109.07 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.68 137.61 30.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.626 0.37 . . . . 0.0 110.031 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -105.79 101.6 11.1 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.584 0.754 . . . . 0.0 110.896 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.25 -44.54 79.17 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.282 1.033 . . . . 0.0 110.917 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -86.58 -10.92 52.93 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.401 0.68 . . . . 0.0 111.163 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.475 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 62.97 28.1 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.637 1.175 . . . . 0.0 110.362 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.6 m -121.94 132.15 54.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.666 0.786 . . . . 0.0 110.533 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 35' ' ' MET . 26.1 t -100.57 157.35 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -139.05 155.46 47.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.54 1.136 . . . . 0.0 109.247 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -130.42 122.14 27.22 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.62 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.347 1.059 . . . . 0.0 108.519 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 48.8 mtt -86.47 125.22 33.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.593 0.757 . . . . 0.0 109.056 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.63 153.59 47.11 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.1 m 54.88 46.48 24.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.825 0.85 . . . . 0.0 111.91 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD12 HG11 ' A' ' 13' ' ' VAL . 63.9 mt -66.33 128.97 38.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.556 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.08 157.84 53.54 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.521 1.129 . . . . 0.0 108.635 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.49 -16.49 35.97 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.677 2.252 . . . . 0.0 113.722 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.47 -26.3 68.66 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.339 1.056 . . . . 0.0 112.247 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.63 -12.51 60.02 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.7 m -61.43 99.34 0.1 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.327 0.512 . . . . 0.0 109.683 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.55 157.13 3.14 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.671 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 p -80.11 112.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -87.62 119.55 28.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.177 0.991 . . . . 0.0 109.719 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.404 HD22 ' HA3' ' A' ' 116' ' ' GLY . 18.6 m120 -101.81 126.18 48.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.185 0.994 . . . . 0.0 109.346 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 20.2 t -85.07 107.66 17.28 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.402 0.681 . . . . 0.0 109.628 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -108.21 158.31 17.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 110.997 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.67 123.51 15.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.162 0.985 . . . . 0.0 108.737 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.406 0 O-C-N 123.414 0.446 . . . . 0.0 112.003 -177.12 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.978 0.418 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -126.8 159.47 33.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 109.303 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 48.8 p90 -155.71 165.92 35.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.483 0.713 . . . . 0.0 110.211 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.7 -170.37 17.97 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.737 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.53 -56.63 11.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.778 0.831 . . . . 0.0 110.967 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.29 151.05 23.76 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.449 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 10.2 t -130.8 136.09 48.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.275 0.63 . . . . 0.0 111.213 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -75.14 108.48 7.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.56 139.85 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.524 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.1 m -126.07 105.34 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.59 109.06 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.192 0.597 . . . . 0.0 109.435 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 46.9 t -55.96 122.36 11.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.87 1.268 . . . . 0.0 111.07 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.0 t . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 123.918 0.887 . . . . 0.0 110.201 176.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 49.7 tp . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 27.5 tt0 -79.56 110.35 14.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.719 0.808 . . . . 0.0 109.578 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.512 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 44.0 mt -104.81 112.99 26.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.66 101.11 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.436 0.694 . . . . 0.0 109.572 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.41 149.3 26.77 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.773 0.32 . . . . 0.0 110.295 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.0 p -159.42 168.22 26.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.318 1.047 . . . . 0.0 109.553 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.46 -7.63 54.1 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 120.034 -0.315 . . . . 0.0 113.177 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 126.59 8.36 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.698 0.249 . . . . 0.0 112.808 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.71 -164.73 20.65 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.77 141.6 30.4 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.119 0.485 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.74 159.41 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.209 1.404 . . . . 0.0 107.968 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -88.11 165.12 15.35 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.889 0.476 . . . . 0.0 111.459 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.91 120.98 13.56 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.453 0.701 . . . . 0.0 109.425 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 5.03 75.8 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.926 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.67 -176.48 49.23 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.572 0.219 . . . . 0.0 113.145 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -134.46 158.04 44.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -158.01 143.13 16.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.295 0.638 . . . . 0.0 109.652 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -111.64 122.23 47.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -96.13 150.36 20.59 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -139.57 125.08 19.22 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.78 135.54 53.41 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.654 0.782 . . . . 0.0 109.107 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 118.93 37.51 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.307 0.643 . . . . 0.0 109.31 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 4' ' ' GLN . . . -104.56 135.94 45.04 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.162 0.585 . . . . 0.0 109.599 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.6 m -149.69 162.7 39.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.991 0.916 . . . . 0.0 110.07 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 -96.24 1.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.564 ' HB3' ' HE2' ' A' ' 33' ' ' TYR . 16.4 mmt85 -67.27 164.54 18.11 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.07 0.548 . . . . 0.0 111.869 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.3 p -71.63 83.98 0.86 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.874 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.487 ' HD1' HD21 ' A' ' 3' ' ' LEU . 78.2 t80 -57.73 -29.99 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.526 0.73 . . . . 0.0 111.37 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -71.18 0.68 7.27 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.392 1.077 . . . . 0.0 112.877 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.1 m -112.5 -9.25 13.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.998 0.919 . . . . 0.0 111.113 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HE2' ' HB3' ' A' ' 28' ' ' ARG . 47.0 m-85 -114.79 138.84 50.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.909 0.483 . . . . 0.0 110.75 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 157.62 26.34 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 167.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 13.9 ttp -141.37 147.54 38.2 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -141.82 150.83 22.31 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.23 0.332 . . . . 0.0 112.43 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -97.84 127.51 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.652 0.781 . . . . 0.0 109.155 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.52 132.77 49.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.031 . . . . 0.0 108.271 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 27.6 ptt180 -116.73 158.67 23.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.533 0.333 . . . . 0.0 110.771 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.539 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -170.06 153.81 4.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.686 0.794 . . . . 0.0 109.078 171.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.73 -54.34 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 118.516 -0.755 . . . . 0.0 111.528 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.43 68.22 8.07 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.039 1.826 . . . . 0.0 112.457 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.38 21.14 64.11 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.049 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -115.58 156.62 25.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.336 0.654 . . . . 0.0 111.564 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.57 170.43 16.66 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.546 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -61.64 103.89 0.37 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.55 146.54 24.38 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.671 0.788 . . . . 0.0 109.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -65.25 120.96 13.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.863 0.865 . . . . 0.0 110.23 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 95' ' ' TYR . 52.0 t -101.94 -54.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -168.31 154.81 7.39 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.112 -173.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 36' ' ' GLY . 70.5 t -140.37 147.5 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.704 1.202 . . . . 0.0 108.328 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -141.29 153.1 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.184 0.994 . . . . 0.0 108.985 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -76.66 161.15 28.78 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 167.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -55.17 -39.4 69.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.296 0.638 . . . . 0.0 110.696 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -74.31 -19.99 60.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.474 1.109 . . . . 0.0 111.584 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.03 78.21 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -167.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -58.91 -64.8 0.81 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.286 1.034 . . . . 0.0 110.851 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -112.84 129.56 56.4 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 52' ' ' VAL . 65.2 p -114.47 130.31 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -116.23 126.92 54.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -118.7 150.75 39.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.184 0.594 . . . . 0.0 109.923 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.62 130.71 35.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.89 -22.51 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -67.81 -40.98 83.77 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.626 0.77 . . . . 0.0 111.409 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 62' ' ' ALA . 32.2 m -106.86 3.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.934 0.894 . . . . 0.0 111.578 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.6 128.49 36.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.869 0.867 . . . . 0.0 111.288 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 -17.56 50.83 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 113.619 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -103.04 -19.12 14.68 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -102.34 157.88 16.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 110.216 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.2 m -149.27 133.12 17.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.105 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.507 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.6 mp -103.0 131.13 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -133.15 160.42 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 108.334 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 167.29 30.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.96 111.86 11.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.99 -16.19 60.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.588 0.755 . . . . 0.0 112.083 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.1 -50.64 11.64 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.0 -14.55 57.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.424 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER 61.7 28.64 17.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.004 1.321 . . . . 0.0 111.275 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 m -113.51 130.86 56.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.898 0.479 . . . . 0.0 110.516 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.31 151.55 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 109.787 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -135.5 112.94 10.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.397 1.079 . . . . 0.0 108.931 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.0 tm? -93.6 103.1 15.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 104.06 16.69 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.749 0.82 . . . . 0.0 109.329 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.451 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.7 mtt -90.41 139.4 30.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.85 1.26 . . . . 0.0 110.963 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.61 140.11 45.83 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 54.71 58.84 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 111.713 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 84' ' ' MET . 56.4 mt -64.17 124.78 22.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.819 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.9 mtpt -72.5 144.08 85.99 Favored Pre-proline 0 C--O 1.21 -0.984 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.668 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 51.3 Cg_exo -56.45 -21.52 37.94 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.868 2.379 . . . . 0.0 114.273 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.83 3.46 55.09 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.828 1.251 . . . . 0.0 112.79 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -79.79 -17.05 54.31 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.72 0.808 . . . . 0.0 111.35 -172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 120' ' ' THR . 94.2 m -53.57 108.73 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.701 1.2 . . . . 0.0 112.11 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.95 160.45 4.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.748 0.819 . . . . 0.0 111.295 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 13.8 p -81.04 114.49 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.041 0.448 . . . . 0.0 110.173 173.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HE2' HG11 ' A' ' 49' ' ' VAL . 19.8 m-85 -87.23 127.87 35.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.835 1.254 . . . . 0.0 110.374 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.67 142.94 51.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.696 0.798 . . . . 0.0 110.001 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.488 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.5 m -92.22 112.02 23.81 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.004 0.922 . . . . 0.0 109.159 173.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.97 112.71 25.94 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -108.12 169.84 8.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.547 0.739 . . . . 0.0 111.181 -174.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.313 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 51.0 m-85 -127.51 152.6 47.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.639 0.776 . . . . 0.0 110.01 -172.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -132.16 139.06 48.27 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.512 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.62 -169.03 44.58 Favored Glycine 0 C--O 1.244 0.741 0 O-C-N 123.117 0.261 . . . . 0.0 113.731 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.82 -54.78 9.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.435 0.694 . . . . 0.0 110.366 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 106.3 2.77 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.198 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -101.69 121.45 42.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.279 1.032 . . . . 0.0 109.848 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.7 tm0? -86.61 124.94 33.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.825 0.45 . . . . 0.0 110.059 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.99 141.31 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.523 0.729 . . . . 0.0 109.04 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.468 ' HA ' HG23 ' A' ' 92' ' ' THR . 57.5 m -129.16 106.84 9.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.281 0.632 . . . . 0.0 109.656 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.8 p -93.36 128.23 44.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.3 t -69.38 111.89 5.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.52 0.728 . . . . 0.0 109.217 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 34.9 p . . . . . 0 CA--C 1.542 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.655 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.4 tp . . . . . 0 C--O 1.241 0.629 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -72.28 102.69 3.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 87.9 mt -112.84 103.62 11.62 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 57.3 t -99.74 99.6 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 50.9 mt-10 -85.77 142.67 28.8 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.953 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -158.44 172.28 18.62 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.32 0.648 . . . . 0.0 110.16 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.52 6.77 70.12 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.051 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 119.68 4.97 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.26 -164.86 23.67 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.23 147.1 34.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.13 143.53 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.448 1.099 . . . . 0.0 108.345 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.93 153.37 42.24 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.53 0.732 . . . . 0.0 111.309 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 110.54 2.38 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.126 0.57 . . . . 0.0 110.231 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.05 10.49 59.72 Favored Glycine 0 N--CA 1.464 0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.599 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.29 -169.15 43.08 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.644 0.261 . . . . 0.0 112.998 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.5 p -123.11 148.68 45.42 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.732 0.813 . . . . 0.0 110.759 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 tp -152.66 123.64 7.48 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -99.41 111.16 23.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.64 157.65 20.28 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.043 0.937 . . . . 0.0 110.344 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -147.25 157.92 43.77 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.061 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 43.3 t -142.35 120.97 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.475 0.71 . . . . 0.0 109.799 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.79 109.69 18.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.42 38.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.49 0.716 . . . . 0.0 109.368 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -158.58 158.65 34.32 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.669 0.787 . . . . 0.0 109.853 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.72 -93.81 0.93 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HD3' ' H ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -91.64 154.02 19.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.417 0.687 . . . . 0.0 109.453 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.458 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 39.2 p -70.13 84.93 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.43 0.633 . . . . 0.0 110.892 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -63.24 -19.56 64.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.928 0.891 . . . . 0.0 111.212 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -49.22 -40.4 33.62 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.995 1.718 . . . . 0.0 113.141 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 -21.88 50.63 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.138 0.975 . . . . 0.0 112.199 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.93 148.68 22.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.01 156.63 33.88 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 165.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttp -141.58 141.09 33.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.13 0.572 . . . . 0.0 110.204 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 142.66 14.17 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -97.21 129.32 44.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 108.959 171.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -132.91 143.04 49.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.412 1.085 . . . . 0.0 109.359 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -125.64 155.85 40.14 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.256 0.48 . . . . 0.0 112.25 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.01 144.19 6.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.792 0.837 . . . . 0.0 110.992 171.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 167.87 -50.35 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 125.28 1.432 . . . . 0.0 111.939 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.28 61.96 8.34 Favored 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.558 2.172 . . . . 0.0 113.122 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.52 21.41 70.67 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.553 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -127.67 150.49 49.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.791 0.837 . . . . 0.0 110.728 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 173.47 9.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.82 0.848 . . . . 0.0 109.629 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -69.18 109.06 3.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.333 0.587 . . . . 0.0 111.056 -172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -112.14 157.76 20.44 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.342 -170.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -63.67 121.82 14.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.884 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 65' ' ' VAL . 61.7 t -106.59 -66.85 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -153.76 134.07 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.56 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -122.29 155.58 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.187 0.995 . . . . 0.0 108.589 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.23 150.27 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.04 170.14 14.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.829 0.452 . . . . 0.0 110.538 171.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -60.37 -43.23 96.77 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -88.63 -2.1 58.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.071 0.548 . . . . 0.0 111.874 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.88 85.12 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.122 0.264 . . . . 0.0 113.076 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.74 -39.44 94.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.2 1.0 . . . . 0.0 111.325 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -115.81 135.08 54.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.671 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 p -125.26 129.33 49.82 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.12 141.44 41.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.447 1.499 . . . . 0.0 108.286 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -141.43 146.09 36.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.292 0.637 . . . . 0.0 109.943 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.97 151.39 40.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 164.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.55 -33.74 47.0 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.12 0.968 . . . . 0.0 112.973 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -75.77 -41.89 51.8 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.098 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 9.3 m -92.08 -4.73 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.37 0.668 . . . . 0.0 111.244 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.01 129.14 38.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.587 0.755 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.73 -25.44 6.62 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.787 0.679 . . . . 0.0 113.906 176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 19.6 ptp180 -102.4 -24.58 13.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.531 0.733 . . . . 0.0 111.017 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.1 m-30 -97.84 161.29 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.5 m -148.41 135.74 20.4 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 108.736 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.9 mp -100.9 139.16 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -142.37 148.85 38.56 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.191 0.996 . . . . 0.0 109.127 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 136.73 19.95 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -117.29 117.69 30.23 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -85.24 -14.48 46.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.677 0.791 . . . . 0.0 111.928 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.38 -45.91 10.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.257 0.623 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.05 -20.13 56.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.947 0.899 . . . . 0.0 110.448 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.402 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER 62.2 39.45 12.66 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.574 1.171 . . . . 0.0 109.74 -175.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 m -129.51 131.43 46.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.917 0.487 . . . . 0.0 111.06 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 75.3 t -98.16 148.3 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 109.878 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -134.28 141.73 47.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 109.085 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -133.34 105.17 6.81 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -84.27 106.27 15.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.591 0.756 . . . . 0.0 109.068 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 53.3 mtt -102.11 128.7 48.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -128.1 144.39 51.11 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m 57.33 64.51 1.58 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.165 0.986 . . . . 0.0 112.014 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 91.4 mt -77.77 120.63 22.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.14 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG11 ' A' ' 121' ' ' VAL . 46.4 mtpt -74.23 152.32 88.13 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.073 -0.965 . . . . 0.0 108.643 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 98.7 Cg_exo -48.78 -26.97 10.39 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.205 2.603 . . . . 0.0 114.773 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.41 -22.72 60.15 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.089 0.956 . . . . 0.0 112.816 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.17 -6.63 14.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.577 0.751 . . . . 0.0 112.346 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.2 m -61.74 98.76 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.78 159.03 7.79 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.523 -170.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -86.35 114.4 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 171.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.465 ' HE2' HG11 ' A' ' 49' ' ' VAL . 49.9 m-85 -86.41 150.06 24.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.931 0.892 . . . . 0.0 108.706 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.65 121.58 12.79 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.7 p -85.09 102.53 13.32 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.39 142.89 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.633 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.64 121.54 44.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.072 0.463 . . . . 0.0 110.256 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.323 -177.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.6 t70 . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.035 0.445 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 57.3 m-85 -126.17 155.27 41.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.699 0.8 . . . . 0.0 109.573 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -136.11 147.94 48.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.633 0.773 . . . . 0.0 109.935 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.96 -170.23 45.13 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.521 -0.308 . . . . 0.0 113.46 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 15.5 mm100 -85.66 -38.65 18.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.213 0.605 . . . . 0.0 109.958 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.02 109.32 2.28 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.381 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 8.4 t -99.87 113.67 26.36 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.482 0.658 . . . . 0.0 109.563 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.615 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.1 tm0? -82.15 123.43 28.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -110.09 139.31 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.425 ' HA ' HG23 ' A' ' 92' ' ' THR . 27.6 m -117.66 104.84 11.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.5 p -88.85 101.22 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.0 t -65.71 113.08 4.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.965 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 18.3 p . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.525 0.73 . . . . 0.0 109.622 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 30' ' ' PHE . 46.0 tp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -86.29 104.03 15.44 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.657 0.783 . . . . 0.0 109.282 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.48 104.98 14.82 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.83 114.95 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -113.49 134.63 54.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.608 0.763 . . . . 0.0 109.422 -168.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -157.22 149.11 22.5 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.454 1.102 . . . . 0.0 109.998 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.13 -6.5 0.82 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.815 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.61 151.81 38.34 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.832 0.316 . . . . 0.0 113.617 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.72 -167.6 34.93 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -93.7 133.48 37.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.304 0.642 . . . . 0.0 110.384 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.57 143.32 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.1 0.96 . . . . 0.0 109.253 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.485 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -62.05 159.02 15.21 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.149 0.979 . . . . 0.0 112.784 -177.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.49 17.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.72 0.808 . . . . 0.0 110.396 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.46 -1.25 69.09 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.252 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.65 -163.41 29.29 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.19 0.424 . . . . 0.0 113.481 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -137.3 146.98 45.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.0 111.03 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.3 tp -154.5 121.41 5.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.45 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -96.23 129.58 43.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.562 1.145 . . . . 0.0 110.574 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -102.92 158.31 16.37 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.31 1.044 . . . . 0.0 108.712 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -151.15 124.17 8.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.656 0.383 . . . . 0.0 110.181 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 43.3 t -117.34 116.94 28.2 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.578 0.751 . . . . 0.0 110.245 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.03 119.7 25.26 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.05 139.76 40.93 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.39 1.076 . . . . 0.0 109.402 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.408 ' O ' HD12 ' A' ' 3' ' ' LEU . 12.6 t -153.72 173.26 16.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.895 0.478 . . . . 0.0 110.649 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 -106.26 3.39 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -84.49 168.22 15.66 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.282 0.541 . . . . 0.0 109.743 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -72.43 102.65 3.24 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.901 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 3' ' ' LEU . 16.7 p90 -64.85 -25.33 67.85 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.622 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 p -74.93 -0.1 17.52 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.955 1.302 . . . . 0.0 112.596 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -92.31 -7.69 47.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.21 0.604 . . . . 0.0 110.192 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -129.58 154.11 47.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 110.251 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.52 145.14 26.91 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 80' ' ' VAL . 15.2 ptm -120.24 159.04 25.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.802 0.441 . . . . 0.0 109.898 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.519 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.29 142.55 10.36 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.174 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -96.74 132.01 42.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.099 0.96 . . . . 0.0 109.193 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.94 164.82 19.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.374 1.07 . . . . 0.0 108.14 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 38.3 ptt180 -146.92 154.06 40.84 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.746 0.248 . . . . 0.0 111.263 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.417 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.16 145.79 7.25 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.069 0.856 . . . . 0.0 110.169 172.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 171.55 -52.66 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.23 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.38 50.6 3.06 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.749 2.299 . . . . 0.0 112.657 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.63 -8.92 53.42 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.019 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -94.7 132.35 39.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.77 0.828 . . . . 0.0 109.05 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.02 179.16 5.13 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.946 0.779 . . . . 0.0 110.817 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -54.1 105.4 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.46 0.704 . . . . 0.0 110.247 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -111.73 149.5 31.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.259 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.406 ' HE2' HG23 ' A' ' 51' ' ' VAL . 87.2 t80 -68.65 113.82 6.48 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.225 1.01 . . . . 0.0 109.626 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.04 -66.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -164.3 162.32 22.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.649 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG22 ' HA3' ' A' ' 36' ' ' GLY . 53.3 t -137.83 152.46 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.714 1.206 . . . . 0.0 107.77 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 59' ' ' THR . 13.3 p -131.46 143.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.047 0.939 . . . . 0.0 108.824 172.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.33 158.18 36.28 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -57.95 -35.63 71.4 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.519 0.728 . . . . 0.0 112.197 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.1 p -76.67 -29.89 56.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.422 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' NH1' ' A' ' 73' ' ' ARG . . . 83.67 3.42 89.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.524 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -62.69 -34.53 77.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.886 0.874 . . . . 0.0 111.041 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.83 130.9 49.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.734 0.814 . . . . 0.0 110.25 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 52' ' ' VAL . 30.5 p -115.44 129.24 56.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.571 1.148 . . . . 0.0 108.896 173.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -93.69 140.94 29.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.203 1.001 . . . . 0.0 108.887 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.39 151.67 50.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.157 0.583 . . . . 0.0 109.866 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.21 144.91 37.93 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 161.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.89 -28.75 64.48 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.855 0.462 . . . . 0.0 112.047 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.4 t -70.99 -44.35 66.14 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.753 0.421 . . . . 0.0 111.124 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -92.83 1.95 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.629 0.372 . . . . 0.0 111.58 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.74 108.82 1.06 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 111.734 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.88 -26.33 13.21 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.662 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 7.1 ptt180 -84.14 -33.47 24.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.294 0.547 . . . . 0.0 109.616 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 5.1 m-30 -97.41 158.74 15.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -145.47 130.69 18.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.206 1.002 . . . . 0.0 108.845 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -102.67 126.48 56.84 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 24.8 m -123.81 154.03 40.17 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.149 0.98 . . . . 0.0 108.654 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.435 ' NH1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -140.68 143.85 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -121.78 96.84 5.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.88 -25.38 65.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.514 0.726 . . . . 0.0 111.411 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.52 -52.59 30.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.516 0.727 . . . . 0.0 111.177 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.98 -4.66 59.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.279 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 60.8 30.95 20.0 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.813 1.245 . . . . 0.0 111.616 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -119.96 131.95 55.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.308 0.643 . . . . 0.0 110.827 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.572 HG21 ' SD ' ' A' ' 35' ' ' MET . 57.2 t -96.23 151.08 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 109.077 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 76.6 m-85 -132.62 146.16 51.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.872 0.869 . . . . 0.0 109.077 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -134.74 102.97 5.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.15 102.83 14.83 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.5 mtm -89.71 118.31 29.22 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.71 28.94 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.5 m 59.19 47.98 11.0 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.085 0.954 . . . . 0.0 110.827 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 84' ' ' MET . 78.3 mt -63.92 117.69 7.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.968 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' O ' HG11 ' A' ' 121' ' ' VAL . 48.4 mtpt -77.17 154.79 82.44 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.555 -0.735 . . . . 0.0 109.338 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.98 -25.38 21.94 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.25 2.633 . . . . 0.0 114.421 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.58 -18.72 60.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.867 0.867 . . . . 0.0 112.837 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.73 -8.35 47.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.77 0.828 . . . . 0.0 113.042 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.2 m -62.99 98.52 0.13 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.1 159.73 9.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.338 0.655 . . . . 0.0 111.116 -170.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.2 p -83.6 113.51 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -88.45 112.91 23.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.916 0.886 . . . . 0.0 109.238 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -103.6 129.46 50.87 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.439 1.096 . . . . 0.0 110.366 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.17 101.91 13.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.882 0.873 . . . . 0.0 109.578 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.35 28.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.517 0.727 . . . . 0.0 109.446 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.98 136.44 44.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.3 0.64 . . . . 0.0 109.448 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.852 0 O-C-N 123.641 0.588 . . . . 0.0 113.023 179.738 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.951 0.405 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -139.22 155.23 47.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 0.0 110.074 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -115.06 119.13 35.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.454 1.102 . . . . 0.0 108.416 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.85 151.22 38.86 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.51 -37.1 82.47 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.107 0.454 . . . . 0.0 110.8 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.74 171.79 24.14 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.177 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -127.65 135.18 49.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.971 0.385 . . . . 0.0 110.629 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 11.3 tm0? -80.35 107.79 13.44 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.4 m -91.21 146.38 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.8 m -123.15 114.11 19.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.343 0.657 . . . . 0.0 109.412 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 88' ' ' LYS . 3.7 p -98.56 120.98 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -72.47 111.97 8.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.187 0.995 . . . . 0.0 110.128 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.5 p . . . . . 0 C--O 1.242 0.693 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.935 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 61.2 tp . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -85.59 121.91 28.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.879 0.871 . . . . 0.0 109.35 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.584 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 74.7 mt -112.88 107.24 15.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.945 0.898 . . . . 0.0 108.733 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.24 104.42 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.9 156.74 18.73 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.019 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -159.5 172.35 18.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.296 1.038 . . . . 0.0 109.789 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.75 -4.91 69.22 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.285 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -79.43 129.71 9.35 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 117.094 0.447 . . . . 0.0 112.202 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.97 -164.07 29.12 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.3 pp -79.48 147.67 32.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 87' ' ' LEU . 3.9 p -151.64 151.85 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.483 1.113 . . . . 0.0 109.105 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.64 158.16 28.48 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.803 0.841 . . . . 0.0 110.653 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.12 111.16 4.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.543 0.737 . . . . 0.0 110.408 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.75 7.06 57.95 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.2 -163.74 36.34 Favored Glycine 0 C--N 1.352 1.451 0 C-N-CA 122.915 0.293 . . . . 0.0 113.058 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 p -137.13 151.57 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.697 0.799 . . . . 0.0 110.447 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -156.43 120.11 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.396 0.679 . . . . 0.0 109.437 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -92.07 119.59 31.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.419 0.687 . . . . 0.0 109.65 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.28 159.58 20.03 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.118 0.967 . . . . 0.0 109.076 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.9 t -142.41 163.01 34.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.382 0.673 . . . . 0.0 109.44 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.2 t -150.45 143.23 24.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.761 0.824 . . . . 0.0 109.865 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.11 53.72 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.87 122.56 46.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.699 0.8 . . . . 0.0 108.985 -175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.8 m -136.97 147.24 46.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.362 1.065 . . . . 0.0 109.739 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.5 -101.6 2.5 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -74.13 159.14 33.0 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.872 0.844 . . . . 0.0 112.787 -176.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.1 m -72.48 91.21 1.37 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.587 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.925 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 16.0 p -75.07 1.48 13.0 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.211 1.005 . . . . 0.0 112.493 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -98.98 -2.77 36.53 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.621 0.768 . . . . 0.0 110.179 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -131.23 174.38 10.1 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.681 0.792 . . . . 0.0 111.461 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 130.1 56.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.062 0.945 . . . . 0.0 108.459 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -114.64 154.41 28.44 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -156.95 154.25 25.37 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.677 -0.296 . . . . 0.0 113.632 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -97.35 143.08 28.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.791 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 98' ' ' ALA . 63.6 m-85 -138.2 138.52 38.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.722 1.209 . . . . 0.0 108.684 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -112.11 151.79 29.03 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.008 0.822 . . . . 0.0 111.323 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.08 152.05 4.16 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 110.433 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.45 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.155 0.982 . . . . 0.0 111.593 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.35 55.55 4.08 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 122.212 1.941 . . . . 0.0 112.968 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.26 40.95 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.973 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -115.61 162.43 17.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -98.49 166.7 11.23 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 0.0 108.821 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.98 102.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -101.55 153.75 19.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.488 0.715 . . . . 0.0 110.295 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.63 108.57 0.75 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.894 0.878 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.49 -64.31 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -157.81 133.15 8.88 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.435 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.494 HG22 ' HA3' ' A' ' 36' ' ' GLY . 79.6 t -126.46 123.85 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.262 1.025 . . . . 0.0 109.481 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.709 HG21 HH11 ' A' ' 73' ' ' ARG . 8.9 p -108.26 160.34 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.449 0.699 . . . . 0.0 109.439 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.97 162.78 13.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 168.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 29.1 p-90 -55.8 -43.84 77.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.293 1.037 . . . . 0.0 113.746 -174.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -83.8 -14.31 51.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.905 0.482 . . . . 0.0 110.913 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.54 10.22 82.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.179 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -67.29 -37.5 83.52 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.417 0.687 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -112.93 121.57 45.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.165 0.586 . . . . 0.0 109.888 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.484 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 p -118.04 131.89 56.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.807 1.243 . . . . 0.0 108.133 172.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -124.55 136.35 53.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.274 1.03 . . . . 0.0 108.231 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 70.5 m-85 -141.3 136.94 32.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.376 0.67 . . . . 0.0 109.58 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.91 142.11 53.01 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.47 -29.12 58.16 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.031 0.932 . . . . 0.0 112.721 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -28.78 70.16 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 112.543 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.14 -1.29 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 111.493 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 28.3 ttpp -73.06 126.9 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.497 0.719 . . . . 0.0 110.726 -172.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.67 -25.05 28.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.759 0.662 . . . . 0.0 112.809 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -103.42 -23.79 13.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.092 0.557 . . . . 0.0 110.813 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.45 154.25 19.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.903 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -146.07 135.24 22.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 109.089 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.496 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -101.48 128.73 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.8 m -125.17 141.23 52.23 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.709 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.11 149.82 34.75 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.137 0.426 . . . . 0.0 109.961 -177.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -129.44 108.67 10.45 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.721 1.208 . . . . 0.0 108.503 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -68.74 -38.91 80.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 111.061 -173.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.18 87.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.98 -13.19 56.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.933 0.493 . . . . 0.0 111.596 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 61.76 28.69 17.66 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.859 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.5 m -124.48 131.9 53.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.157 0.583 . . . . 0.0 110.677 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.68 160.1 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.531 1.132 . . . . 0.0 109.19 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -141.97 148.2 38.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.48 1.512 . . . . 0.0 108.86 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.86 100.83 5.03 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.54 102.29 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.783 0.833 . . . . 0.0 109.635 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 87' ' ' LEU . 58.5 mtm -88.44 132.43 34.47 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -133.13 153.52 51.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t 58.42 59.77 2.86 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.868 0.842 . . . . 0.0 110.711 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.6 mt -79.83 116.68 20.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.94 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 79.7 mttt -75.37 152.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.89 -25.73 22.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.0 2.467 . . . . 0.0 114.069 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 10.8 pt-20 -70.12 -23.25 63.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.042 0.937 . . . . 0.0 112.95 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.71 -3.69 19.87 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.392 0.677 . . . . 0.0 112.809 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.3 m -60.99 100.08 0.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.21 0.604 . . . . 0.0 109.719 170.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 161.04 5.55 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.677 0.791 . . . . 0.0 110.269 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.1 p -83.01 117.98 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.46 112.15 23.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -107.99 121.28 44.47 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.127 1.371 . . . . 0.0 109.365 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.7 p -88.52 143.0 27.24 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -142.7 132.94 24.66 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.354 1.062 . . . . 0.0 109.546 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.14 145.83 35.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.847 0.859 . . . . 0.0 110.964 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.686 177.424 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.744 0.307 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -140.61 155.33 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.832 1.253 . . . . 0.0 108.783 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 28.6 p90 -143.96 161.87 37.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.802 0.841 . . . . 0.0 109.667 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 5' ' ' LEU . . . -96.78 -150.08 26.38 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.386 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -90.88 -53.65 4.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.575 0.75 . . . . 0.0 110.21 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.76 120.31 4.49 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.77 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 t -105.86 121.53 44.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.883 0.873 . . . . 0.0 109.61 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 tm0? -87.39 125.28 34.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.928 0.491 . . . . 0.0 110.41 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 ' HE1' ' A' ' 84' ' ' MET . 5.9 m -111.56 145.4 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.653 0.781 . . . . 0.0 110.025 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 91.8 m -133.38 119.65 19.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.048 0.939 . . . . 0.0 108.908 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.3 p -104.89 116.4 48.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.0 m -63.91 113.86 3.72 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.57 1.148 . . . . 0.0 110.004 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.4 p . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 110.981 -176.333 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.3 tp . . . . . 0 C--O 1.235 0.309 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -105.14 131.2 52.94 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 84.6 mt -121.9 118.75 29.67 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.759 1.224 . . . . 0.0 108.455 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.43 103.0 14.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.67 127.74 46.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -155.09 141.27 18.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.341 1.057 . . . . 0.0 110.19 -169.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG21 ' A' ' 117' ' ' THR . . . 145.26 26.03 0.1 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -86.71 132.2 11.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.13 41.76 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.9 144.4 31.96 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.208 0.528 . . . . 0.0 110.56 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.48 153.64 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.531 . . . . 0.0 107.936 -174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.3 157.17 19.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.189 0.596 . . . . 0.0 110.953 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.75 111.79 5.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.463 0.705 . . . . 0.0 110.065 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.99 3.53 48.63 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.889 0.743 . . . . 0.0 111.504 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.76 -163.85 39.22 Favored Glycine 0 C--N 1.35 1.317 0 C-N-CA 122.792 0.234 . . . . 0.0 112.722 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.2 p -138.05 149.01 45.64 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.042 0.937 . . . . 0.0 109.921 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 tp -158.6 145.6 17.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -119.37 131.85 55.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.677 0.391 . . . . 0.0 110.881 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -92.29 159.62 15.52 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.074 0.95 . . . . 0.0 108.899 170.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -149.23 123.81 9.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.65 0.38 . . . . 0.0 110.081 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 51.7 t -127.38 106.55 9.28 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.145 0.578 . . . . 0.0 110.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.51 141.57 29.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.4 164.08 12.14 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.291 0.637 . . . . 0.0 109.861 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -66.65 166.92 11.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.384 0.674 . . . . 0.0 111.133 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.41 -13.48 50.28 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.63 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 136.62 57.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.575 1.15 . . . . 0.0 109.427 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 m -77.74 71.41 4.21 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 122.089 0.947 . . . . 0.0 111.966 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -79.84 -8.72 59.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.561 1.144 . . . . 0.0 110.574 164.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 t -57.04 -1.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 125.368 1.467 . . . . 0.0 113.812 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -91.04 -11.5 38.59 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.766 0.826 . . . . 0.0 112.088 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -107.64 167.06 10.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.366 0.666 . . . . 0.0 111.377 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.42 161.61 28.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 168.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.427 ' HE3' ' HB2' ' A' ' 35' ' ' MET . 4.4 ptm -143.0 169.84 16.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.355 0.662 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.4 146.74 11.46 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 121.787 -0.244 . . . . 0.0 113.689 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -97.64 141.1 31.08 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.238 1.415 . . . . 0.0 109.858 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -132.07 164.4 26.32 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.793 1.237 . . . . 0.0 108.884 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.1 156.25 47.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.033 0.379 . . . . 0.0 110.386 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.5 pt20 -166.38 136.01 3.17 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.976 0.797 . . . . 0.0 110.117 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 174.31 -62.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 124.469 1.107 . . . . 0.0 111.131 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.6 66.3 6.59 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.041 -168.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.29 62.57 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.96 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -98.91 133.64 42.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.761 0.824 . . . . 0.0 110.152 -173.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.15 174.13 8.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.952 0.901 . . . . 0.0 108.704 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -64.0 104.74 0.75 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.98 152.59 47.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 0.0 111.026 -169.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -58.12 110.61 0.97 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.433 1.493 . . . . 0.0 111.792 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.27 -55.86 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -169.07 132.47 1.34 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.745 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.8 141.21 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.571 1.148 . . . . 0.0 108.297 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 59' ' ' THR . 11.6 p -135.31 148.31 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.04 155.86 28.64 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -53.15 -39.07 63.27 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.098 1.359 . . . . 0.0 114.046 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.9 t -75.35 -27.13 59.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.268 0.627 . . . . 0.0 111.32 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.73 72.35 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.2 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -69.12 -55.14 11.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -106.1 124.52 49.71 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.751 . . . . 0.0 110.56 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.47 HG22 HG23 ' A' ' 52' ' ' VAL . 52.7 p -112.22 149.45 32.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.584 1.153 . . . . 0.0 109.657 174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -129.39 123.63 32.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -119.68 159.02 25.26 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.87 144.58 43.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 165.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.49 -34.25 64.42 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.042 0.937 . . . . 0.0 112.932 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -65.64 -35.66 81.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.385 0.674 . . . . 0.0 111.575 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.3 m -111.33 6.16 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 0.0 112.339 -172.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -68.67 111.55 4.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.941 0.496 . . . . 0.0 111.741 -171.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.87 15.01 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.868 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -83.17 -26.42 30.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.459 0.629 . . . . 0.0 109.565 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.16 153.4 18.94 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.6 m -146.98 136.76 23.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.034 0.934 . . . . 0.0 108.902 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.584 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -102.85 121.32 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -124.84 138.93 54.24 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -143.18 131.43 22.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.975 0.51 . . . . 0.0 110.068 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.0 95.36 6.12 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.48 -38.22 83.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 111.929 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.04 76.2 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.125 0.57 . . . . 0.0 111.446 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.45 -9.27 50.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.474 0.71 . . . . 0.0 112.042 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 18.4 m-80 58.64 27.33 15.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.683 1.193 . . . . 0.0 111.352 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.5 m -112.81 131.96 55.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.552 0.741 . . . . 0.0 109.283 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.423 HG21 ' SD ' ' A' ' 35' ' ' MET . 5.6 t -117.77 157.22 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.661 -174.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.59 127.85 19.81 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.824 1.25 . . . . 0.0 108.491 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.2 tm? -104.76 100.16 9.8 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.42 103.43 10.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 109.87 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 68.3 mtm -94.31 126.84 39.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.991 0.517 . . . . 0.0 109.775 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.35 148.01 51.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 m 57.55 58.8 3.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.394 1.078 . . . . 0.0 111.08 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 49.0 mt -73.61 117.5 15.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.502 -1.227 . . . . 0.0 112.221 -174.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -76.88 148.26 78.75 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.48 -24.06 20.9 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.0 2.466 . . . . 0.0 114.521 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -15.61 61.93 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.971 0.908 . . . . 0.0 113.255 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.38 -4.48 48.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.118 0.567 . . . . 0.0 112.261 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 120' ' ' THR . 85.2 m -61.58 103.98 0.38 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.773 0.829 . . . . 0.0 110.442 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -168.53 163.68 12.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.014 0.525 . . . . 0.0 110.993 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 8.3 p -81.07 121.61 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 168.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -86.01 143.49 28.1 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -135.48 112.3 10.17 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 41.6 t -83.13 140.6 32.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -143.61 162.84 34.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 109.366 -171.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.61 26.22 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.191 0.596 . . . . 0.0 110.745 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.454 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.579 -179.335 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -138.77 132.29 30.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.807 0.443 . . . . 0.0 110.513 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.509 ' HB2' ' ND2' ' A' ' 96' ' ' ASN . 4.4 p90 -122.87 161.48 24.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.91 0.884 . . . . 0.0 110.405 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -174.66 47.31 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 114.035 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -66.43 -44.68 82.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.215 1.006 . . . . 0.0 110.526 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 163.33 38.9 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.485 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 9' ' ' GLY . 7.5 t -143.82 138.93 29.03 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.848 0.459 . . . . 0.0 110.109 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.6 tm0? -91.15 121.65 33.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.05 0.54 . . . . 0.0 109.901 -173.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -107.21 144.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.103 0.961 . . . . 0.0 109.501 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.57 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.1 m -124.06 105.5 9.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.174 0.589 . . . . 0.0 109.891 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.0 101.32 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.266 1.031 . . . . 0.0 109.01 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.6 t -66.46 134.15 51.88 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.121 0.968 . . . . 0.0 111.36 -176.504 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -86.4 125.23 33.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -119.4 120.85 38.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.25 102.8 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.834 0.853 . . . . 0.0 109.316 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.67 138.03 33.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 110.348 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.4 m -149.8 165.79 31.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.892 0.877 . . . . 0.0 110.16 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.77 -1.19 32.03 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 112.867 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 145.64 32.03 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.06 -166.61 33.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.06 144.84 29.64 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.994 0.426 . . . . 0.0 111.227 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.23 161.27 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.662 1.185 . . . . 0.0 108.081 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.8 164.14 13.8 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.75 0.704 . . . . 0.0 110.494 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.48 143.17 50.11 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.471 0.708 . . . . 0.0 110.629 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 3.29 85.7 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -164.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.46 -169.6 46.15 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 114.174 0.43 . . . . 0.0 114.174 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 p -153.28 147.25 25.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.107 0.963 . . . . 0.0 110.03 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 tp -160.79 128.92 4.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.103 0.561 . . . . 0.0 109.803 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -93.77 117.3 29.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.276 0.63 . . . . 0.0 110.138 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.4 mm? -86.02 159.26 19.64 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.328 1.051 . . . . 0.0 109.245 168.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -136.57 165.7 25.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.555 0.742 . . . . 0.0 109.316 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.8 t -146.56 145.73 30.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.056 0.942 . . . . 0.0 109.255 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.66 114.72 20.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.44 154.55 20.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.049 0.54 . . . . 0.0 110.615 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 m -62.82 159.69 16.03 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.2 53.24 4.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.52 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -95.62 -167.59 1.63 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.043 1.337 . . . . 0.0 110.414 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 32' ' ' SER . 2.2 m -74.23 22.11 0.09 Allowed 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.4 0.68 . . . . 0.0 111.921 173.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.43 -29.83 69.24 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.306 1.043 . . . . 0.0 111.14 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 m -56.2 -26.29 50.32 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.881 0.872 . . . . 0.0 111.755 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB3' HG22 ' A' ' 29' ' ' THR . 23.3 t -113.1 -2.74 14.09 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.04 0.936 . . . . 0.0 112.018 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -83.46 127.19 33.51 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.741 0.7 . . . . 0.0 110.432 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.77 115.98 10.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.465 ' HE1' HG11 ' A' ' 80' ' ' VAL . 4.7 ptm -114.21 170.4 8.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 111.102 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.95 163.32 33.17 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -111.39 138.51 47.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.7 154.0 38.67 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.807 1.243 . . . . 0.0 108.349 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -126.03 158.75 34.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -174.39 160.07 3.16 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.274 0.984 . . . . 0.0 109.887 174.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 171.96 -58.08 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 124.472 1.109 . . . . 0.0 111.052 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.52 63.57 6.62 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 122.368 2.046 . . . . 0.0 112.821 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.61 -5.74 60.12 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.912 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 31.7 mmmt -92.95 148.04 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 109.58 -177.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.77 176.15 5.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.301 0.64 . . . . 0.0 110.359 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -61.13 106.64 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.155 0.582 . . . . 0.0 111.82 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.53 152.51 24.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.917 1.287 . . . . 0.0 110.138 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -57.19 113.98 1.96 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.7 0.8 . . . . 0.0 110.662 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 65' ' ' VAL . 71.8 t -98.36 -60.81 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.55 155.43 21.98 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.333 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.71 138.3 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.734 1.214 . . . . 0.0 107.957 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.565 HG23 HG22 ' A' ' 59' ' ' THR . 11.1 p -121.3 146.98 25.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.82 142.13 48.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -52.16 -41.4 62.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.291 1.036 . . . . 0.0 112.846 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -81.81 -9.27 59.66 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.46 0.704 . . . . 0.0 111.468 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.35 73.16 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 123.192 0.307 . . . . 0.0 112.561 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 31.2 tpt180 -67.38 -65.31 0.7 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.359 0.664 . . . . 0.0 110.679 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.481 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 36.6 mmt180 -113.76 127.41 56.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.279 0.631 . . . . 0.0 110.461 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.565 HG22 HG23 ' A' ' 52' ' ' VAL . 54.5 p -108.58 150.84 26.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.848 0.859 . . . . 0.0 108.746 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -133.71 130.22 37.85 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 70' ' ' THR . 98.3 m-85 -139.19 142.51 37.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.99 0.516 . . . . 0.0 109.982 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.92 142.38 47.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 162.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.51 -24.23 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.558 0.743 . . . . 0.0 111.91 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -61.0 -40.61 94.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.797 1.239 . . . . 0.0 112.199 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 49' ' ' VAL . 32.5 m -115.56 1.96 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.809 0.844 . . . . 0.0 111.67 -173.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.21 125.42 25.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.709 0.804 . . . . 0.0 111.676 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.66 -26.16 6.76 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.587 0.554 . . . . 0.0 114.462 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -93.92 -29.58 15.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.203 0.601 . . . . 0.0 110.138 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.33 146.59 25.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.401 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 91.1 m -149.95 130.36 13.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.26 1.024 . . . . 0.0 108.648 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.457 HG13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -102.05 133.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -124.98 152.06 44.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.888 1.275 . . . . 0.0 107.947 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 138.26 16.2 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.546 0.612 . . . . 0.0 111.711 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -93.48 108.43 20.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.3 -37.85 88.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 110.919 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.61 82.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.92 0.763 . . . . 0.0 111.743 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.1 mmpt? -94.68 -16.35 23.19 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.764 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 41.2 m-80 60.81 34.98 19.59 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.544 1.137 . . . . 0.0 110.804 -172.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 m -112.48 131.27 55.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.392 0.677 . . . . 0.0 109.845 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 35' ' ' MET . 6.3 t -113.22 161.32 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.07 0.948 . . . . 0.0 109.914 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -143.5 116.08 8.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.147 0.979 . . . . 0.0 108.874 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.457 HD23 HG13 ' A' ' 71' ' ' ILE . 2.6 tm? -101.21 96.69 7.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -82.8 129.77 35.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.968 0.907 . . . . 0.0 109.44 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.633 ' HB3' HD21 ' A' ' 87' ' ' LEU . 63.1 mtm -117.26 148.37 41.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.547 0.739 . . . . 0.0 109.992 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -146.25 160.16 42.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.351 1.06 . . . . 0.0 109.189 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m 54.56 48.02 21.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.564 1.145 . . . . 0.0 111.118 171.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD21 ' HB3' ' A' ' 84' ' ' MET . 97.0 mt -73.28 115.7 12.95 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.195 -171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -65.64 151.81 93.93 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.37 1.068 . . . . 0.0 109.056 166.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 20.0 Cg_endo -57.62 -22.79 53.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.268 2.645 . . . . 0.0 113.355 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 11.6 pt-20 -87.25 7.04 30.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.442 1.097 . . . . 0.0 112.285 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -87.5 2.04 51.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.665 0.386 . . . . 0.0 111.526 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.9 m -62.16 102.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 0.0 109.967 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.19 152.11 4.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.087 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.4 p -81.65 129.57 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.584 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.43 122.29 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.47 0.708 . . . . 0.0 109.854 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -103.76 132.47 49.99 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.773 0.829 . . . . 0.0 109.696 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.4 t -82.91 141.12 32.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' MET . . . -143.49 161.64 37.91 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.257 0.623 . . . . 0.0 109.716 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 146.42 36.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 0.0 108.991 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.687 0 O-C-N 123.18 0.3 . . . . 0.0 112.77 -178.625 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 121.268 0.556 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -130.99 149.0 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.356 1.062 . . . . 0.0 109.22 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -148.35 158.38 44.06 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.33 1.052 . . . . 0.0 108.492 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.89 -170.22 28.65 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.246 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.42 -39.29 20.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.245 1.018 . . . . 0.0 110.135 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.15 165.58 14.79 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.46 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 t -143.48 108.14 4.87 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 124.521 1.128 . . . . 0.0 109.455 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 58.6 tp60 -77.55 129.58 35.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.561 0.745 . . . . 0.0 111.258 -175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.37 144.94 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.571 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.9 m -127.75 105.97 8.81 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.52 106.64 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.733 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.3 t -61.55 132.21 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.005 1.322 . . . . 0.0 110.717 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 30.8 p . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 123.918 0.887 . . . . 0.0 112.495 -173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.742 HD11 ' HB1' ' A' ' 25' ' ' ALA . 57.6 tp . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -82.44 103.86 12.3 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.31 128.68 44.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.7 t -119.94 102.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.767 0.827 . . . . 0.0 108.931 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -90.92 149.66 21.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.264 0.625 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -154.39 170.07 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.118 0.967 . . . . 0.0 109.921 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.67 43.56 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.094 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.66 88.73 0.54 Allowed Glycine 0 C--N 1.345 1.078 0 C-N-CA 122.916 0.293 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.59 -172.76 13.26 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.184 0.421 . . . . 0.0 112.289 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.98 138.91 31.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.386 0.675 . . . . 0.0 110.684 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 6.4 p -152.2 153.17 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.675 1.19 . . . . 0.0 108.364 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -92.68 160.03 15.17 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.582 -0.699 . . . . 0.0 110.729 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.51 123.81 21.45 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.99 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.49 54.13 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.659 0.599 . . . . 0.0 112.124 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.16 50.33 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.817 0.363 . . . . 0.0 113.182 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.0 p -114.87 162.23 17.19 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.108 0.963 . . . . 0.0 110.398 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -160.55 125.57 3.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 109.927 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -95.2 125.32 39.76 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.09 159.19 16.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.049 1.34 . . . . 0.0 108.644 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -139.69 160.32 40.16 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.771 0.428 . . . . 0.0 110.157 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 52.9 t -150.77 133.04 15.43 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.394 1.078 . . . . 0.0 108.62 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.2 131.71 56.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.742 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -106.8 137.79 44.18 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.185 0.594 . . . . 0.0 110.681 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -144.44 169.16 18.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.26 -83.9 1.56 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -82.32 154.93 25.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.414 0.686 . . . . 0.0 109.796 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -77.5 96.58 4.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.548 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 54.0 t80 -63.75 -20.94 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.103 0.961 . . . . 0.0 111.311 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -64.53 -7.26 9.57 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.623 0.769 . . . . 0.0 112.779 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -109.44 4.84 22.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.525 0.73 . . . . 0.0 111.305 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.79 140.58 44.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 0.0 111.004 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.24 164.53 21.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.764 0.826 . . . . 0.0 109.693 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.548 ' HB2' ' HE1' ' A' ' 30' ' ' PHE . 1.1 ttp -137.47 155.07 49.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.105 0.562 . . . . 0.0 110.21 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -146.16 147.21 18.02 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.75 129.83 42.85 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -128.1 141.71 51.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.265 1.026 . . . . 0.0 108.234 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -106.58 143.01 35.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.02 146.86 4.6 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.709 0.631 . . . . 0.0 110.255 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.37 -60.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 124.419 1.088 . . . . 0.0 110.789 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 92.5 Cg_endo -87.47 72.67 2.92 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -171.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.95 2.29 61.3 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.282 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.9 139.46 34.52 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.524 0.73 . . . . 0.0 109.526 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.06 175.66 6.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 109.458 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -60.91 105.71 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.736 0.303 . . . . 0.0 110.405 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.5 148.02 30.84 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.349 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.73 110.89 1.88 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.769 0.828 . . . . 0.0 111.323 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.57 -65.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -162.42 135.55 5.98 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.09 0.244 . . . . 0.0 111.402 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 82.3 t -121.46 150.37 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.697 1.199 . . . . 0.0 109.17 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD12 ' A' ' 71' ' ' ILE . 8.2 p -144.16 163.91 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.51 1.124 . . . . 0.0 108.755 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -85.22 164.99 17.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 170.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 36.7 p90 -52.6 -43.25 65.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.088 1.355 . . . . 0.0 113.539 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HG ' ' HD1' ' A' ' 54' ' ' TRP . 50.4 m -95.52 -6.11 41.26 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.42 0.688 . . . . 0.0 111.557 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 52' ' ' VAL . . . 86.14 20.5 55.05 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.404 -0.279 . . . . 0.0 112.404 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -57.75 -40.66 80.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.451 1.1 . . . . 0.0 111.749 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -132.52 138.18 47.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.888 0.875 . . . . 0.0 109.09 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 p -117.22 142.06 47.51 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.241 1.016 . . . . 0.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -136.24 125.89 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -137.74 142.72 40.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.6 131.59 46.74 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 163.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.62 -26.76 62.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 p -67.2 -42.27 84.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.834 0.854 . . . . 0.0 111.408 176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.92 -7.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.97 0.508 . . . . 0.0 111.064 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -76.18 115.87 16.32 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.69 -15.72 41.06 Favored Glycine 0 C--N 1.341 0.849 0 O-C-N 123.72 0.638 . . . . 0.0 112.59 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 18.3 ptp180 -116.41 -22.9 8.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.141 0.576 . . . . 0.0 109.993 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -112.12 143.95 42.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.18 0.992 . . . . 0.0 108.609 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -143.91 130.76 20.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.876 0.87 . . . . 0.0 108.881 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' A' ' 50' ' ' ALA . 3.7 mt -101.8 126.08 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -137.47 136.8 38.07 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -151.19 153.52 35.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.348 0.594 . . . . 0.0 112.142 -169.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.45 111.25 23.74 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -70.72 -30.22 66.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 112.091 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.59 -31.9 62.2 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.053 0.541 . . . . 0.0 111.813 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -96.55 -6.16 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.655 . . . . 0.0 111.198 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 61.54 31.09 18.94 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.139 0.976 . . . . 0.0 110.514 176.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 m -112.35 132.4 55.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 109.854 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 33.7 t -114.37 154.21 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.384 1.073 . . . . 0.0 110.223 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.81 145.45 48.37 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 125.189 1.396 . . . . 0.0 108.05 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.49 107.58 10.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -82.25 101.67 10.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.949 . . . . 0.0 109.581 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.76 145.18 25.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.25 0.62 . . . . 0.0 109.904 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -145.63 152.84 40.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 m 58.92 46.11 14.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.771 0.828 . . . . 0.0 112.121 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.49 126.56 29.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.593 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 155.87 75.07 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.28 -21.52 60.71 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.418 2.079 . . . . 0.0 113.547 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -77.19 -18.4 57.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.354 0.662 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.569 ' HB2' HG11 ' A' ' 121' ' ' VAL . 2.7 m-20 -67.07 -10.07 46.0 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.302 0.641 . . . . 0.0 111.396 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -56.21 100.98 0.05 OUTLIER 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.048 0.939 . . . . 0.0 109.81 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.06 162.74 4.62 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.22 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -85.81 118.33 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -86.9 115.72 24.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.724 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.82 131.69 48.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 35' ' ' MET . 38.5 t -83.94 106.87 15.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.18 112.29 25.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.87 168.98 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.788 0.835 . . . . 0.0 110.336 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.497 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -176.601 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.001 0.429 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.87 153.52 51.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.076 0.95 . . . . 0.0 109.16 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -153.19 152.14 30.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.11 -159.33 34.06 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 123.233 0.333 . . . . 0.0 113.853 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.01 -26.38 22.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.108 0.963 . . . . 0.0 111.068 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.43 157.92 32.39 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.789 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.3 t -131.04 108.08 9.52 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.401 1.08 . . . . 0.0 108.439 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 10.1 tm0? -81.17 106.16 12.94 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -92.9 142.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.1 m -123.57 111.29 16.09 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.4 p -113.51 106.91 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.679 0.752 . . . . 0.0 109.935 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -78.92 145.63 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.594 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.5 p . . . . . 0 N--CA 1.474 0.747 0 C-N-CA 123.002 0.521 . . . . 0.0 111.071 177.537 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.781 HD11 ' HB1' ' A' ' 25' ' ' ALA . 45.8 tp . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 54.1 tp60 -84.86 104.63 14.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.839 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.486 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.9 mt -95.15 108.76 20.88 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.599 0.759 . . . . 0.0 109.175 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.4 HG22 HE21 ' A' ' 4' ' ' GLN . 64.2 t -97.44 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -112.8 111.85 22.92 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -169.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -156.19 154.46 30.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.852 1.261 . . . . 0.0 109.256 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.02 -8.23 1.08 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.53 -0.305 . . . . 0.0 112.504 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.23 27.74 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.943 0.306 . . . . 0.0 112.584 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.16 -164.46 29.85 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.08 136.89 37.3 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.257 0.551 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p -151.8 145.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.225 1.41 . . . . 0.0 107.949 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.77 158.94 25.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.089 0.404 . . . . 0.0 110.592 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.53 125.92 27.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.231 0.612 . . . . 0.0 110.183 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 2.12 65.02 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.764 0.665 . . . . 0.0 112.151 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.31 -174.93 35.91 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.935 0.186 . . . . 0.0 113.32 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 p -123.75 147.41 47.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.382 1.073 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 tp -152.51 132.08 13.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.836 0.855 . . . . 0.0 108.762 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.85 127.45 55.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.354 0.662 . . . . 0.0 110.501 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 HG12 ' A' ' 119' ' ' VAL . 1.0 OUTLIER -93.03 156.51 16.84 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.788 0.835 . . . . 0.0 108.79 171.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -141.68 125.69 17.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 5' ' ' LEU . 47.9 t -117.17 104.41 11.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.321 0.649 . . . . 0.0 109.814 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.99 121.46 27.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.5 124.04 48.89 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.882 0.873 . . . . 0.0 109.502 -171.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 25.5 t -131.19 163.79 26.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.714 0.805 . . . . 0.0 111.012 -171.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 -102.98 1.64 Allowed Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.752 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.42 108.64 18.57 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 31' ' ' SER . 10.3 m -56.3 133.17 52.5 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -167.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.428 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 6.1 p90 -69.62 -19.52 63.63 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.064 0.945 . . . . 0.0 112.113 -176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 29' ' ' THR . 91.0 p -72.35 -5.54 37.0 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -88.13 -1.87 58.27 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.198 0.599 . . . . 0.0 110.436 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -136.79 173.86 11.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.84 0.856 . . . . 0.0 110.872 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.62 162.74 13.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 165.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.637 ' SD ' HG21 ' A' ' 80' ' ' VAL . 11.6 ptm -142.24 157.78 44.46 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 122.15 -0.344 . . . . 0.0 110.44 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -154.31 146.67 15.02 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.683 -0.235 . . . . 0.0 113.227 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -98.98 139.2 34.99 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.073 1.349 . . . . 0.0 109.951 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -129.15 170.22 13.81 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.13 1.372 . . . . 0.0 108.661 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -155.14 158.32 38.8 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.084 0.402 . . . . 0.0 111.833 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.12 153.9 12.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.002 0.921 . . . . 0.0 109.997 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.39 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 124.359 1.064 . . . . 0.0 111.286 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.42 67.35 8.48 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.021 1.814 . . . . 0.0 112.501 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.76 24.8 71.51 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.857 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -115.32 161.13 18.93 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.244 0.617 . . . . 0.0 112.123 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.33 175.35 7.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.637 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -66.1 103.57 0.99 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.72 153.5 17.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.923 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.52 110.64 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.792 0.837 . . . . 0.0 110.097 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.5 t -85.78 -59.41 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -171.47 147.42 2.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.031 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 36' ' ' GLY . 77.3 t -129.22 137.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.177 0.991 . . . . 0.0 108.535 174.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 59' ' ' THR . 7.0 p -124.61 160.65 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.833 0.853 . . . . 0.0 109.571 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.0 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 64.8 p-90 -57.13 -37.25 71.72 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.534 0.733 . . . . 0.0 112.741 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -76.72 -28.96 56.03 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.163 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.93 -8.22 70.34 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.278 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -59.51 -28.47 67.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.742 0.817 . . . . 0.0 112.432 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -108.61 122.55 47.34 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.547 0.739 . . . . 0.0 109.521 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 52' ' ' VAL . 38.6 p -127.15 133.64 50.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.498 1.119 . . . . 0.0 108.886 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -128.58 127.19 41.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -129.52 148.09 51.39 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.366 0.666 . . . . 0.0 110.698 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.69 137.51 42.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.69 -30.48 67.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.68 0.792 . . . . 0.0 112.992 -171.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.7 m -69.6 -41.58 75.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.214 0.606 . . . . 0.0 111.676 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.1 m -93.16 -9.44 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.338 0.655 . . . . 0.0 111.539 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -66.96 144.91 55.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.418 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.71 -24.9 7.96 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.447 0.467 . . . . 0.0 113.701 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.435 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 10.7 ptt180 -113.37 -20.72 11.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.223 0.609 . . . . 0.0 111.065 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m-30 -101.09 155.82 17.77 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.231 0.613 . . . . 0.0 110.24 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -149.07 136.6 20.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.112 . . . . 0.0 108.527 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.1 mp -101.05 121.6 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.6 m -124.3 136.84 54.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.71 131.73 21.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.574 0.702 . . . . 0.0 110.355 -174.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.5 109.15 20.69 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -68.5 -27.65 66.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.856 0.462 . . . . 0.0 110.077 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.59 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.834 0.853 . . . . 0.0 111.637 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -80.42 -16.03 55.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.355 . . . . 0.0 111.078 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.428 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 29.4 m-80 61.87 28.2 17.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.628 1.171 . . . . 0.0 110.872 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -120.83 135.11 55.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.959 0.503 . . . . 0.0 110.622 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.637 HG21 ' SD ' ' A' ' 35' ' ' MET . 19.4 t -108.81 155.59 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.788 1.235 . . . . 0.0 109.378 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -142.52 113.28 7.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.645 1.178 . . . . 0.0 108.961 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 98.86 11.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -84.83 104.92 15.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.803 0.841 . . . . 0.0 110.396 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.576 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.8 mtm -94.64 142.14 27.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.1 0.56 . . . . 0.0 109.612 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.16 162.44 34.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.563 1.145 . . . . 0.0 108.438 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 m 52.52 45.36 28.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.178 0.991 . . . . 0.0 112.153 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 84' ' ' MET . 81.2 mt -70.86 127.79 33.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.119 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -85.94 144.53 39.31 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.774 0.83 . . . . 0.0 108.94 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -44.15 -35.18 7.53 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 124.428 3.419 . . . . 0.0 115.142 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -73.52 -9.37 58.61 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.78 1.232 . . . . 0.0 113.407 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 -2.2 47.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.022 0.929 . . . . 0.0 112.65 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -58.99 105.81 0.35 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.367 0.667 . . . . 0.0 110.145 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.71 8.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.987 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.4 p -79.75 113.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.9 145.05 27.34 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 108.751 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.23 127.5 26.32 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -84.76 139.79 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -131.63 157.21 44.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.48 1.112 . . . . 0.0 108.398 175.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -145.59 164.13 32.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 110.553 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.651 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.033 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.8 m-85 -131.13 150.65 52.05 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.841 0.856 . . . . 0.0 109.847 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -124.22 139.24 54.11 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.07 0.948 . . . . 0.0 110.371 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -99.41 167.33 21.22 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.5 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -71.0 -48.39 53.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.803 0.441 . . . . 0.0 111.254 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.96 129.86 4.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.917 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.34 138.11 54.05 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.497 0.719 . . . . 0.0 110.669 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 54.0 tp60 -81.14 121.16 25.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 110.501 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 21' ' ' LEU . 2.9 m -94.93 137.56 22.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 92' ' ' THR . 31.8 m -123.69 103.59 8.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.81 104.75 16.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -59.06 134.5 57.05 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.8 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.241 0.623 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.399 175.092 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.4 tp . . . . . 0 C--O 1.239 0.51 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.28 107.9 10.02 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.818 0.847 . . . . 0.0 109.349 172.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -102.04 113.54 26.88 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.41 HG22 ' NE2' ' A' ' 115' ' ' GLN . 28.2 t -108.34 101.83 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.18 153.11 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.142 0.496 . . . . 0.0 110.678 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.4 p -154.32 170.28 21.68 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.72 18.95 30.82 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.31 86.87 0.32 Allowed Glycine 0 C--N 1.352 1.448 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.31 -168.29 12.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -120.5 147.88 44.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.3 p -151.06 147.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 108.065 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.1 mp0 -78.93 162.8 25.74 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.589 0.631 . . . . 0.0 110.887 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 87' ' ' LEU . . . -63.9 138.38 58.45 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.084 0.554 . . . . 0.0 111.538 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -7.55 81.05 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 123.68 0.612 . . . . 0.0 112.507 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.41 -175.83 49.65 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 121.039 0.244 . . . . 0.0 113.332 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.4 p -125.19 159.45 31.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.408 1.083 . . . . 0.0 109.692 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.0 tp -152.45 122.16 6.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -96.6 112.56 24.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.491 0.716 . . . . 0.0 109.997 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -94.21 156.71 16.41 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.477 1.111 . . . . 0.0 109.699 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -133.45 152.92 51.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -149.98 109.83 4.08 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.51 121.0 26.63 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.25 129.59 53.58 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.695 0.798 . . . . 0.0 109.518 -175.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.7 t -142.63 154.43 44.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 109.61 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 -114.2 4.57 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 3' ' ' LEU . 1.6 mmp_? -61.94 134.36 56.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.063 0.545 . . . . 0.0 111.218 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.359 0.664 . . . . 0.0 110.393 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -64.06 -18.47 64.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.66 0.384 . . . . 0.0 110.265 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 52.0 p -66.79 -9.52 37.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.394 1.077 . . . . 0.0 112.484 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.9 t -98.02 -11.66 22.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 0.0 110.846 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.69 156.55 42.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.006 0.522 . . . . 0.0 111.442 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.96 143.86 26.05 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.419 ' SD ' HG21 ' A' ' 80' ' ' VAL . 10.1 ptm -128.88 170.02 13.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.193 0.597 . . . . 0.0 110.761 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.64 158.33 31.13 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.158 0.286 . . . . 0.0 113.051 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -104.62 136.48 44.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.735 0.814 . . . . 0.0 109.773 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -129.94 153.02 48.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.795 1.238 . . . . 0.0 108.178 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.39 157.98 45.53 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.397 0.544 . . . . 0.0 111.764 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.446 ' NE2' ' HG3' ' A' ' 46' ' ' ARG . 3.9 pt20 -164.85 155.39 14.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.217 0.948 . . . . 0.0 110.126 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 175.22 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.806 1.242 . . . . 0.0 110.387 168.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.75 70.85 7.36 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.152 1.901 . . . . 0.0 112.941 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.2 66.62 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.62 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 60.6 mmtt -99.23 144.6 28.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.302 1.041 . . . . 0.0 110.981 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.52 173.21 8.46 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.966 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG3' ' NE2' ' A' ' 40' ' ' GLN . 1.9 mtm180 -66.61 103.76 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.75 152.65 20.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.287 0.635 . . . . 0.0 109.964 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.11 112.83 2.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.674 0.79 . . . . 0.0 109.653 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.6 -54.87 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.1 164.07 25.55 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.355 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.31 131.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.88 1.272 . . . . 0.0 108.283 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.86 151.53 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.336 0.655 . . . . 0.0 109.633 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 29.4 t-20 -82.09 147.48 29.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.583 0.753 . . . . 0.0 109.17 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 58.5 p-90 -54.84 -39.3 68.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.525 1.13 . . . . 0.0 113.102 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -80.72 -19.02 45.97 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.913 0.885 . . . . 0.0 110.699 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.97 61.73 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.122 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -74.04 -22.11 59.68 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.992 0.517 . . . . 0.0 110.804 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 28.8 mmt180 -133.76 137.79 45.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.194 0.997 . . . . 0.0 110.607 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -136.25 132.21 35.5 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.454 1.102 . . . . 0.0 108.582 168.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -126.32 138.46 53.59 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.98 148.59 52.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.795 0.438 . . . . 0.0 110.237 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 147.63 41.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.33 -43.52 53.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.274 1.03 . . . . 0.0 113.157 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 m -71.44 -29.69 65.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.67 0.788 . . . . 0.0 112.401 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.68 -7.35 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 111.366 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -69.7 132.26 45.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 0.0 110.427 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.67 8.06 74.12 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.705 0.628 . . . . 0.0 113.826 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 15.6 ptt180 -144.08 -26.76 0.53 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.057 0.543 . . . . 0.0 111.265 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-85 -96.27 152.56 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.8 m -150.24 134.3 17.0 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.682 1.193 . . . . 0.0 108.361 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -105.19 133.01 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -132.86 163.49 28.98 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.75 146.42 16.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.154 0.502 . . . . 0.0 110.656 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -105.1 121.23 43.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.473 0.709 . . . . 0.0 109.285 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.48 -35.51 75.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.253 0.621 . . . . 0.0 109.968 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.17 -23.82 66.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.637 0.775 . . . . 0.0 112.158 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.23 -20.0 13.64 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.389 0.676 . . . . 0.0 111.078 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 59.41 35.53 23.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.791 1.236 . . . . 0.0 110.757 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -124.27 132.17 53.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.43 0.692 . . . . 0.0 110.349 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG21 ' SD ' ' A' ' 35' ' ' MET . 50.3 t -99.43 130.48 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.524 1.13 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.47 114.56 26.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.676 0.79 . . . . 0.0 109.667 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.8 tm? -97.18 104.07 16.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.532 ' H ' HE21 ' A' ' 83' ' ' GLN . 0.0 OUTLIER -88.24 120.73 29.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.624 0.77 . . . . 0.0 110.493 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.464 ' HB3' HD21 ' A' ' 87' ' ' LEU . 62.9 mtt -105.49 147.74 27.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.291 1.036 . . . . 0.0 109.301 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -141.72 158.12 44.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.038 0.935 . . . . 0.0 108.514 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 m 55.35 41.57 31.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.047 0.939 . . . . 0.0 112.025 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -68.25 118.45 11.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 42.3 mtpt -84.2 154.36 63.33 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.314 172.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 10.8 Cg_endo -52.99 -19.7 11.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.022 2.481 . . . . 0.0 114.415 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 11.9 pt-20 -76.09 -12.33 60.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.14 0.976 . . . . 0.0 112.849 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.54 -5.34 56.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.314 0.646 . . . . 0.0 112.148 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 120' ' ' THR . 86.8 m -61.51 103.9 0.36 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.403 0.681 . . . . 0.0 110.686 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.02 160.39 12.0 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.982 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.6 p -85.22 111.94 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.264 0.554 . . . . 0.0 109.975 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -88.8 113.41 24.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.35 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.53 126.47 48.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.379 1.072 . . . . 0.0 108.746 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -84.66 136.31 33.8 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -132.16 161.52 33.13 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.936 0.895 . . . . 0.0 109.802 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -147.77 167.96 23.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.481 0.712 . . . . 0.0 110.032 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.782 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.332 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 121.286 0.565 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 54.0 m-85 -112.66 146.38 38.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.4 p90 -150.33 168.79 23.06 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.298 0.639 . . . . 0.0 109.84 170.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.2 -168.23 18.8 Favored Glycine 0 C--O 1.239 0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.379 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.41 ' NE2' HG22 ' A' ' 6' ' ' VAL . 74.5 mt-30 -83.73 -39.27 20.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.15 0.98 . . . . 0.0 110.575 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.25 132.67 7.84 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.551 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -107.84 111.69 23.96 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.916 0.886 . . . . 0.0 108.744 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 7.8 tm0? -79.24 110.26 14.34 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -96.15 140.35 17.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.555 ' HA ' HG23 ' A' ' 92' ' ' THR . 86.2 m -121.18 112.28 18.45 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.0 p -102.57 119.2 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.475 0.655 . . . . 0.0 109.294 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 5.8 m -65.24 139.0 58.59 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 111.034 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 24.0 t . . . . . 0 C--O 1.238 0.477 0 C-N-CA 123.659 0.784 . . . . 0.0 110.647 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 tp . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.81 116.9 29.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.984 0.914 . . . . 0.0 109.839 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.501 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.9 mt -118.51 123.05 44.18 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.832 0.853 . . . . 0.0 110.292 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 39.2 t -108.12 104.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.437 1.095 . . . . 0.0 109.421 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -76.29 152.58 36.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.797 0.439 . . . . 0.0 110.916 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -149.13 146.12 27.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.981 0.912 . . . . 0.0 110.276 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.13 20.71 8.15 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.259 0.35 . . . . 0.0 113.079 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.98 85.91 0.67 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.81 -164.29 10.97 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.15 144.25 45.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.084 0.554 . . . . 0.0 111.468 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 19' ' ' LEU . 7.5 p -152.02 152.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.834 1.254 . . . . 0.0 108.51 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.53 156.98 30.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.532 0.733 . . . . 0.0 112.412 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 139.77 57.13 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.095 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 -20.05 33.07 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.063 0.227 . . . . 0.0 112.816 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.4 -177.37 51.77 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-O 121.178 0.321 . . . . 0.0 113.467 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 p -115.13 160.7 19.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.073 0.949 . . . . 0.0 110.878 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HB2' HG11 ' A' ' 13' ' ' VAL . 40.8 tp -156.52 125.7 6.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.97 115.86 27.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.855 0.462 . . . . 0.0 109.979 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.5 mm? -94.6 156.38 16.46 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -144.78 144.72 31.31 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 35.5 t -124.98 113.72 18.19 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.924 0.889 . . . . 0.0 108.905 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -83.82 112.9 20.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.7 122.87 45.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.244 0.618 . . . . 0.0 109.401 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 m -62.79 126.08 26.11 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.02 74.44 0.01 OUTLIER Glycine 0 C--N 1.357 1.741 0 O-C-N 125.246 1.591 . . . . 0.0 115.691 -166.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -98.39 -174.79 2.92 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.867 1.267 . . . . 0.0 108.834 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -83.18 86.38 7.04 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.16 -26.35 65.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 35.4 p -66.03 -13.91 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.227 . . . . 0.0 113.055 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -82.19 -14.64 55.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.168 0.587 . . . . 0.0 111.954 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.14 140.94 44.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.064 0.545 . . . . 0.0 111.382 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 137.52 38.63 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 165.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.519 ' SD ' ' SG ' ' A' ' 97' ' ' CYS . 17.4 ttp -126.37 154.79 43.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.6 0.76 . . . . 0.0 109.644 -169.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.54 161.51 32.25 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 117.714 0.234 . . . . 0.0 113.101 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -97.79 139.47 33.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.825 0.85 . . . . 0.0 109.379 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.343 1.057 . . . . 0.0 109.162 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 95' ' ' TYR . 28.3 ptt180 -131.52 161.56 32.3 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.017 0.371 . . . . 0.0 111.775 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -171.91 146.74 2.07 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.357 171.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -178.11 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 123.891 0.876 . . . . 0.0 111.252 171.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 84.3 Cg_endo -80.35 70.27 7.59 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.155 1.903 . . . . 0.0 112.745 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.65 6.16 80.58 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.551 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.25 141.49 28.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.545 0.738 . . . . 0.0 110.633 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.38 176.95 7.61 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 162.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -60.41 104.76 0.36 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.961 0.504 . . . . 0.0 109.833 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.92 148.59 24.31 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.412 0.685 . . . . 0.0 109.634 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.53 121.16 14.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.522 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -104.88 -59.29 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.88 142.9 6.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.605 0.362 . . . . 0.0 110.434 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.0 t -123.99 130.44 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.107 0.963 . . . . 0.0 109.816 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -106.39 153.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.771 0.828 . . . . 0.0 109.507 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.49 151.71 37.96 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 49.5 p90 -59.69 -36.57 76.76 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.597 0.759 . . . . 0.0 112.165 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -84.46 -15.11 47.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.72 0.808 . . . . 0.0 111.18 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.7 79.99 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 116.416 -0.356 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -63.42 -49.41 73.84 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.679 0.792 . . . . 0.0 111.035 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -114.41 148.05 38.31 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.657 0.783 . . . . 0.0 110.115 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 52' ' ' VAL . 38.0 p -137.82 147.07 44.24 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.126 0.971 . . . . 0.0 109.133 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.98 129.89 38.8 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -122.32 145.96 47.76 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.84 148.59 36.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.46 -26.42 68.51 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 123.394 0.434 . . . . 0.0 111.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -67.17 -41.51 85.83 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.856 0.863 . . . . 0.0 111.186 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 m -112.65 13.46 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 111.65 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.93 105.94 0.75 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.366 1.066 . . . . 0.0 111.74 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.63 -26.04 18.13 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.768 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 16.6 ptp180 -84.54 -28.61 26.53 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 117.634 0.717 . . . . 0.0 110.43 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.411 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.7 m-30 -101.85 150.34 23.27 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.45 0.7 . . . . 0.0 109.44 172.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -147.63 132.74 18.28 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.04 0.936 . . . . 0.0 109.203 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 HD23 ' A' ' 82' ' ' LEU . 19.9 mt -101.88 138.63 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -135.77 156.14 49.27 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 154.55 34.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.323 0.582 . . . . 0.0 110.29 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -127.82 109.11 11.3 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -70.33 -30.92 68.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.704 0.802 . . . . 0.0 110.594 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.8 -38.31 54.2 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.117 0.567 . . . . 0.0 111.45 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.4 mmpt? -79.06 -17.89 54.42 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.31 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 60.74 32.86 20.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.554 1.142 . . . . 0.0 109.832 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 m -133.63 133.09 41.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.435 0.694 . . . . 0.0 110.579 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 45.1 t -104.06 155.43 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.4 1.08 . . . . 0.0 109.425 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.54 137.97 44.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.32 1.048 . . . . 0.0 109.631 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.1 tm? -122.73 105.66 10.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.7 107.96 18.88 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.802 0.841 . . . . 0.0 110.007 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 87' ' ' LEU . 47.3 mtt -87.9 138.53 31.38 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.68 0.792 . . . . 0.0 109.402 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -139.73 133.2 30.15 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 m 58.36 72.93 0.5 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.717 0.807 . . . . 0.0 111.664 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' A' ' 84' ' ' MET . 49.8 mt -71.76 136.74 47.24 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.109 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 121' ' ' VAL . 53.7 mtpt -74.64 152.2 87.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.266 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.26 -25.16 79.45 Favored 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.297 1.998 . . . . 0.0 113.787 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.94 6.76 48.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.985 0.914 . . . . 0.0 112.931 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.39 -9.48 56.42 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 123.271 0.628 . . . . 0.0 112.315 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 121' ' ' VAL . 89.1 m -53.77 106.2 0.18 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.841 0.856 . . . . 0.0 111.149 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.84 158.55 20.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 110.017 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 40' ' ' GLN . 15.0 p -89.65 124.54 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' A' ' 39' ' ' ARG . 23.6 m-85 -98.25 122.45 41.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.029 0.932 . . . . 0.0 110.297 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.9 128.0 56.35 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' A' ' 35' ' ' MET . 46.8 t -83.78 103.06 12.76 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.52 131.63 52.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.656 0.782 . . . . 0.0 111.134 -175.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.99 167.61 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.574 0.75 . . . . 0.0 110.535 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.831 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.513 -178.738 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 122.028 0.918 . . . . 0.0 108.8 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -119.65 153.58 35.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -136.73 154.85 50.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.123 0.487 . . . . 0.0 111.405 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.28 161.45 41.2 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 164.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.87 11.25 6.28 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.37 138.69 1.69 Allowed Glycine 0 C--N 1.347 1.148 0 C-N-CA 123.224 0.44 . . . . 0.0 113.879 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 t -136.45 107.14 6.57 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -75.31 105.77 6.5 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.282 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.64 140.69 15.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 m -125.8 136.84 53.58 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.3 p -114.88 125.38 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.054 0.454 . . . . 0.0 110.143 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.0 t -83.42 111.71 19.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.1 p . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 123.818 0.847 . . . . 0.0 111.279 -174.68 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 41.0 tp . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.47 128.09 34.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.905 0.882 . . . . 0.0 109.381 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.2 126.46 42.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.277 1.031 . . . . 0.0 108.737 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.27 104.1 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.636 0.775 . . . . 0.0 109.679 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.36 137.36 32.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.891 0.877 . . . . 0.0 109.558 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m -147.64 171.44 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.758 0.823 . . . . 0.0 110.335 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.36 13.13 66.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.037 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.37 145.73 18.61 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.43 -164.46 30.0 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.832 0.316 . . . . 0.0 112.549 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.09 144.11 31.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.129 0.572 . . . . 0.0 110.157 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.5 p -150.83 151.71 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.247 1.019 . . . . 0.0 108.526 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.06 155.61 23.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.676 0.391 . . . . 0.0 110.256 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 129.57 38.4 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.39 66.12 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 123.772 0.701 . . . . 0.0 111.423 -167.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.87 -166.52 31.82 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.198 0.428 . . . . 0.0 113.698 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -147.58 160.83 42.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.272 1.029 . . . . 0.0 110.269 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -155.99 147.64 22.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.012 0.925 . . . . 0.0 108.547 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -128.11 118.68 23.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.281 0.492 . . . . 0.0 109.995 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 84' ' ' MET . 2.5 mm? -90.51 157.43 17.54 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.89 0.876 . . . . 0.0 109.857 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -142.15 123.77 15.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -122.74 118.74 28.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.981 0.512 . . . . 0.0 110.824 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.51 123.97 30.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.329 0.651 . . . . 0.0 110.09 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.81 143.43 38.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.1 0.96 . . . . 0.0 110.121 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -160.07 176.44 11.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.259 0.624 . . . . 0.0 110.419 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.85 -96.48 1.56 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 66.1 mtp180 -79.79 143.53 34.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.1 m -73.47 103.33 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -58.21 -25.9 62.19 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.01 0.924 . . . . 0.0 111.884 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 43.7 p -76.05 0.45 18.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.773 0.829 . . . . 0.0 112.502 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -87.88 -13.69 41.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.15 0.58 . . . . 0.0 110.143 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.53 170.42 10.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.386 0.674 . . . . 0.0 110.571 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 133.62 34.9 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.476 ' SD ' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -129.12 131.41 47.22 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.486 0.714 . . . . 0.0 109.35 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -152.23 159.98 28.66 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 114.223 0.449 . . . . 0.0 114.223 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -97.52 132.61 43.04 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.295 1.038 . . . . 0.0 110.384 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.59 129.94 45.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 108.387 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -114.53 156.67 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.502 0.321 . . . . 0.0 111.63 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -167.23 149.27 5.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.83 0.706 . . . . 0.0 110.504 173.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -179.73 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.813 0.845 . . . . 0.0 111.32 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 88.3 Cg_endo -83.21 73.86 5.1 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.155 1.903 . . . . 0.0 112.481 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.03 74.46 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.181 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.6 mmpt? -115.7 145.5 42.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.542 0.737 . . . . 0.0 111.343 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.89 169.85 10.89 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 161.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -64.12 103.8 0.65 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.414 0.626 . . . . 0.0 110.14 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.49 150.38 20.37 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.573 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.01 108.59 1.85 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.946 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -90.11 -68.03 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.6 134.28 4.5 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.577 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.526 HG22 ' HA3' ' A' ' 36' ' ' GLY . 94.5 t -116.17 134.02 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 0.0 109.596 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 59' ' ' THR . 8.1 p -107.27 148.87 11.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 123.448 0.699 . . . . 0.0 110.595 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.1 149.97 35.67 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 168.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 61.8 p-90 -60.02 -34.94 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 0.0 112.925 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -86.86 -10.94 52.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 111.495 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.38 15.52 78.15 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.394 -171.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -59.62 -46.65 88.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.113 0.965 . . . . 0.0 111.11 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -133.57 129.25 36.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 52' ' ' VAL . 36.4 p -117.45 128.7 55.25 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.44 117.13 32.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.39 154.54 27.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 110.309 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.23 146.12 39.28 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.95 -25.91 67.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.905 0.482 . . . . 0.0 112.109 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -70.46 -41.95 72.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.751 0.821 . . . . 0.0 110.878 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 69' ' ' PHE . 8.1 m -94.63 -4.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.293 0.637 . . . . 0.0 111.992 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -67.36 119.4 12.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 0.0 111.094 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.64 17.88 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 123.525 0.583 . . . . 0.0 113.951 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -96.27 -13.5 23.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.364 0.666 . . . . 0.0 110.79 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 65' ' ' VAL . 97.3 m-85 -123.76 155.83 37.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.423 0.689 . . . . 0.0 109.261 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.3 m -148.77 138.1 21.76 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 108.289 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.617 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -102.81 144.5 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 m -136.48 155.87 49.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.71 157.23 36.26 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.65 119.37 13.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.83 -4.94 58.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.009 0.924 . . . . 0.0 112.269 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.99 -54.1 4.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -78.52 -14.23 59.45 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.873 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.94 34.47 19.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.627 1.171 . . . . 0.0 111.301 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.6 m -119.22 132.46 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.251 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.476 HG11 ' SD ' ' A' ' 35' ' ' MET . 51.6 t -104.33 119.39 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.142 0.977 . . . . 0.0 109.965 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.26 121.1 41.61 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.702 0.801 . . . . 0.0 110.281 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -105.64 110.54 22.9 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.84 102.81 13.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.902 0.881 . . . . 0.0 109.899 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.621 ' HB3' HD21 ' A' ' 87' ' ' LEU . 83.8 mtp -87.38 140.28 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 0.0 108.669 171.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.67 154.83 30.72 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 123.071 0.232 . . . . 0.0 110.733 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 m 61.07 38.65 16.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.447 1.099 . . . . 0.0 110.312 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.9 mt -68.11 129.16 39.09 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.188 -169.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -100.69 154.42 37.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.466 1.107 . . . . 0.0 108.077 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.847 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 12.1 Cg_endo -53.77 -24.42 30.52 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 123.446 2.764 . . . . 0.0 114.78 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.86 -13.85 59.57 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 112.68 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.5 -2.1 33.78 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.723 0.809 . . . . 0.0 112.208 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.561 HG23 ' HA ' ' A' ' 120' ' ' THR . 65.8 m -62.71 107.91 1.06 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.23 0.612 . . . . 0.0 109.805 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.18 160.01 9.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.572 0.545 . . . . 0.0 110.898 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 40' ' ' GLN . 14.4 p -85.68 115.64 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -94.28 116.25 28.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.106 0.962 . . . . 0.0 108.807 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.06 131.44 48.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.028 0.531 . . . . 0.0 109.72 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.4 t -82.16 102.07 10.85 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.48 162.08 14.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.306 1.042 . . . . 0.0 110.669 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.9 128.52 14.17 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.917 0.887 . . . . 0.0 108.951 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.553 0 O-C-N 123.768 0.668 . . . . 0.0 111.637 -178.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.162 0.506 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.42 150.47 31.1 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.342 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -158.32 151.96 23.47 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.691 1.196 . . . . 0.0 108.316 164.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.63 -163.26 26.43 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.49 -38.03 86.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.859 0.864 . . . . 0.0 110.123 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.34 130.88 7.17 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.909 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -99.93 108.26 20.45 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 109.416 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -79.34 102.86 8.89 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -91.62 137.11 22.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.561 ' HA ' HG23 ' A' ' 92' ' ' THR . 24.0 m -121.02 104.68 9.98 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 3.2 p -100.42 117.11 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.5 t -61.95 140.96 58.28 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.847 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 50.0 p . . . . . 0 C--O 1.239 0.524 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.349 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB1' ' A' ' 25' ' ' ALA . 52.9 tp . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 24.9 tt0 -102.83 105.65 16.09 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.599 0.76 . . . . 0.0 109.631 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HB3' ' SG ' ' A' ' 97' ' ' CYS . 79.1 mt -91.01 127.23 36.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.594 0.758 . . . . 0.0 109.346 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.11 102.86 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 109.042 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.58 123.19 29.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.1 0.56 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -117.9 130.8 56.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.558 1.143 . . . . 0.0 108.816 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.92 4.99 1.46 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-O 119.861 -0.411 . . . . 0.0 113.345 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.71 102.83 0.8 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.999 0.399 . . . . 0.0 112.17 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.84 -174.56 34.7 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.36 145.2 26.42 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.148 0.499 . . . . 0.0 111.812 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -146.85 154.85 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.47 1.108 . . . . 0.0 108.655 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -87.47 151.31 23.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.864 0.465 . . . . 0.0 111.233 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.91 110.35 5.59 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.431 0.692 . . . . 0.0 110.427 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.25 -4.11 40.8 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.202 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.99 -167.56 42.29 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.667 0.275 . . . . 0.0 112.955 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.7 m -124.92 157.86 34.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.733 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 tp -155.04 123.15 5.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.799 0.84 . . . . 0.0 108.833 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -93.66 119.68 32.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 1.9 mm? -103.84 153.89 20.23 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.83 123.31 8.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 51.9 t -104.99 127.52 52.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.344 0.658 . . . . 0.0 110.087 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.22 127.14 38.68 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.618 0.767 . . . . 0.0 109.601 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -104.83 128.77 53.13 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.591 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 4.1 m -120.2 151.08 39.64 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.717 0.807 . . . . 0.0 110.947 -169.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.38 -88.2 0.51 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 124.1 0.875 . . . . 0.0 112.832 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -74.25 146.49 43.21 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 0.0 110.528 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -65.18 110.1 2.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.621 0.768 . . . . 0.0 109.958 170.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 78' ' ' ASN . 2.4 p90 -61.45 -23.92 66.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.325 0.65 . . . . 0.0 110.701 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.3 p -72.03 -8.54 55.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 113.157 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 m -83.27 -2.67 56.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.847 0.459 . . . . 0.0 110.735 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -135.97 163.67 29.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.105 0.962 . . . . 0.0 109.967 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.13 127.18 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 97' ' ' CYS . 8.7 tmm? -119.97 135.91 54.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.693 0.397 . . . . 0.0 109.974 -170.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -133.07 166.22 23.76 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 123.157 0.408 . . . . 0.0 113.511 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -115.89 145.07 43.2 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 124.034 0.933 . . . . 0.0 108.991 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -136.15 146.22 46.67 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.741 1.216 . . . . 0.0 108.907 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -125.38 148.1 48.9 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.238 0.472 . . . . 0.0 110.506 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.84 155.02 4.5 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 123.584 0.754 . . . . 0.0 111.18 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 177.14 -61.07 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.802 1.241 . . . . 0.0 110.263 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.26 75.56 5.0 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 122.377 2.052 . . . . 0.0 112.603 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.16 24.18 70.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.594 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 28.4 mmmt -112.11 144.88 40.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.533 1.133 . . . . 0.0 110.374 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.87 160.93 14.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.906 0.882 . . . . 0.0 109.433 168.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -58.75 105.37 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.143 0.577 . . . . 0.0 111.236 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.78 150.93 19.85 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' HZ ' ' HB3' ' A' ' 60' ' ' TYR . 54.1 t80 -59.11 111.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.522 1.129 . . . . 0.0 109.112 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -100.06 -65.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.43 130.34 5.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.35 0.119 . . . . 0.0 110.905 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.688 HG22 ' HA3' ' A' ' 36' ' ' GLY . 67.0 t -117.83 138.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.009 0.923 . . . . 0.0 108.762 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.627 HG21 HH11 ' A' ' 73' ' ' ARG . 11.7 p -124.73 140.53 47.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.2 155.98 22.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -55.84 -40.62 73.12 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -167.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -92.42 -0.79 57.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.43 0.692 . . . . 0.0 110.88 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.25 7.57 67.97 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.173 -0.467 . . . . 0.0 114.074 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -66.57 -38.82 87.87 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.678 0.791 . . . . 0.0 110.237 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -115.19 138.05 51.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.545 0.738 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -131.67 144.6 51.14 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.601 1.16 . . . . 0.0 108.987 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.552 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 85.1 m-85 -128.82 137.37 51.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.317 1.047 . . . . 0.0 108.248 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -138.85 150.39 45.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.391 0.676 . . . . 0.0 109.823 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -82.08 138.61 34.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.02 -28.37 67.68 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.204 0.602 . . . . 0.0 111.639 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 t -65.69 -41.8 91.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.283 1.033 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 62' ' ' ALA . 22.6 m -103.06 -2.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.301 0.64 . . . . 0.0 111.735 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -64.85 117.71 7.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 0.0 111.355 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.29 20.11 Favored Glycine 0 C--N 1.345 1.034 0 O-C-N 123.82 0.7 . . . . 0.0 113.332 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 13.8 ptp180 -95.2 -23.34 17.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.141 0.496 . . . . 0.0 109.872 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 2.9 m-85 -107.03 153.52 22.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 92.4 m -145.31 130.68 18.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.927 0.891 . . . . 0.0 109.468 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.494 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 1.2 pp -104.13 128.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.054 0.542 . . . . 0.0 110.273 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -139.16 166.09 25.45 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.616 1.166 . . . . 0.0 108.635 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.627 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -159.77 161.46 34.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.111 0.481 . . . . 0.0 110.915 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.6 114.09 17.6 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -67.5 -35.23 78.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.517 0.727 . . . . 0.0 111.983 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.64 67.59 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.602 0.564 . . . . 0.0 111.364 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -83.16 -19.24 36.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.233 0.613 . . . . 0.0 111.779 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 68.08 32.67 4.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.133 . . . . 0.0 110.692 -173.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.7 m -111.35 129.88 55.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.867 0.467 . . . . 0.0 110.073 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.78 144.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.752 0.821 . . . . 0.0 108.959 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 130.0 53.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.852 0.861 . . . . 0.0 109.803 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.9 tm? -115.33 106.68 14.29 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 16.1 mm100 -88.17 103.78 16.08 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.869 0.868 . . . . 0.0 109.682 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.8 mtt -87.28 133.89 33.62 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -141.1 145.3 35.61 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.3 m 56.23 47.03 20.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.164 0.986 . . . . 0.0 111.587 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.56 124.17 20.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.146 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.5 mtpt -70.22 155.07 94.03 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 -14.76 29.37 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 122.6 2.2 . . . . 0.0 113.605 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.93 -3.02 56.48 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.335 0.654 . . . . 0.0 112.621 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.66 5.06 8.14 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.5 m -64.8 100.63 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.87 152.09 11.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.241 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 4.1 p -80.35 123.11 36.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 170.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -94.72 139.11 31.69 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -137.93 121.36 17.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.193 0.997 . . . . 0.0 108.835 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.693 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 30.1 p -86.98 143.71 27.24 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -147.38 134.7 20.65 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.168 0.987 . . . . 0.0 109.729 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.98 161.03 15.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.377 0.671 . . . . 0.0 110.834 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 111' ' ' ASP . . . . . . . . 0 C--N 1.343 0.932 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.814 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB3' ' HA2' ' A' ' 100' ' ' GLY . 24.5 t0 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.741 0.781 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 92.5 m-85 -133.13 167.83 19.62 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.628 166.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 38.4 p90 -154.35 169.3 24.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.02 0.928 . . . . 0.0 109.178 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.19 -172.63 21.69 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.648 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.77 -45.12 65.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.333 0.653 . . . . 0.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.13 135.88 1.17 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.451 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.7 t -143.26 140.83 30.83 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.236 0.541 . . . . 0.0 110.314 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 55.8 tp60 -80.42 122.7 27.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.359 1.063 . . . . 0.0 111.408 -171.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.65 145.14 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.4 m -126.91 105.88 8.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.61 0.764 . . . . 0.0 109.339 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.7 p -90.73 117.92 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.402 0.62 . . . . 0.0 109.928 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.1 t -67.34 117.87 9.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.954 0.901 . . . . 0.0 109.802 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.468 0.707 . . . . 0.0 110.382 -178.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 64.5 tp . . . . . 0 C--O 1.236 0.394 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.58 127.66 37.12 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.604 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 73.8 mt -114.23 131.64 56.41 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.443 ' HA ' HE21 ' A' ' 115' ' ' GLN . 59.1 t -114.71 100.37 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.6 130.31 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 109.634 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -138.21 139.99 39.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.311 1.044 . . . . 0.0 109.049 -175.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.62 13.32 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 64.89 3.97 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.95 -164.99 13.35 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 123.569 0.604 . . . . 0.0 111.702 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.4 pp -104.06 142.4 34.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.121 0.569 . . . . 0.0 111.568 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -151.41 144.21 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.883 1.273 . . . . 0.0 108.004 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -69.59 154.57 41.8 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.745 0.418 . . . . 0.0 111.662 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 115.47 5.13 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.461 174.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.32 -14.34 28.02 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 123.885 0.755 . . . . 0.0 111.701 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.33 -163.78 26.75 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 121.307 0.393 . . . . 0.0 113.766 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -144.61 150.93 38.25 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.69 0.796 . . . . 0.0 110.023 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -155.72 124.65 6.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.165 0.586 . . . . 0.0 109.942 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -92.28 129.42 38.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.174 0.59 . . . . 0.0 110.427 175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mm? -96.18 157.32 15.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.101 0.96 . . . . 0.0 109.084 172.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -144.7 124.1 13.09 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.171 0.589 . . . . 0.0 109.564 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -114.53 115.43 27.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.519 0.728 . . . . 0.0 110.112 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.85 118.66 24.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.59 144.95 31.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.703 0.801 . . . . 0.0 109.759 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t -65.74 159.02 26.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.47 0.708 . . . . 0.0 109.895 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 55.16 4.79 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-O 121.302 0.39 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 1.6 mmp_? -98.8 -171.35 2.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.824 1.25 . . . . 0.0 110.781 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.4 p -81.29 41.76 0.63 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.892 0.877 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -69.13 -19.44 64.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.98 0.512 . . . . 0.0 111.817 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -77.39 -16.15 59.0 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 0.0 111.284 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.4 t -81.19 -12.84 59.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.998 0.519 . . . . 0.0 110.2 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.19 159.17 17.61 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 0.0 109.627 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.35 136.91 35.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 80' ' ' VAL . 2.6 ttp -101.41 155.25 18.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.76 149.93 21.5 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 117.93 0.332 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HE1' HG23 ' A' ' 71' ' ' ILE . 85.1 m95 -98.51 131.6 44.61 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.137 0.975 . . . . 0.0 109.564 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -131.37 166.6 20.91 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.686 1.194 . . . . 0.0 108.375 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -157.9 163.46 37.89 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 118.549 0.613 . . . . 0.0 111.408 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.91 162.88 9.46 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.072 0.949 . . . . 0.0 109.314 172.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.54 -58.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 C-N-CA 124.481 1.112 . . . . 0.0 110.891 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.23 69.0 8.13 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 122.692 2.262 . . . . 0.0 112.854 -170.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.81 67.33 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.657 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -107.72 146.64 31.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.535 0.734 . . . . 0.0 110.746 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.24 164.76 20.98 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.637 0.775 . . . . 0.0 108.926 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.13 104.91 0.42 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.214 0.53 . . . . 0.0 110.39 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.96 157.58 15.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.153 1.381 . . . . 0.0 110.727 -170.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.6 121.09 19.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.513 0.725 . . . . 0.0 110.344 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.74 -53.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.39 152.56 7.24 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.532 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -133.87 147.28 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.484 1.113 . . . . 0.0 108.782 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 71' ' ' ILE . 13.9 p -133.81 148.5 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 125.101 1.36 . . . . 0.0 108.948 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -77.71 161.63 27.59 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -56.92 -36.35 70.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -90.96 -8.37 49.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.075 0.55 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.83 21.16 58.24 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 112.289 -0.324 . . . . 0.0 112.289 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -60.59 -58.47 8.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.682 0.793 . . . . 0.0 111.283 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.09 138.39 53.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.225 0.61 . . . . 0.0 109.989 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -119.74 160.23 22.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 110.64 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -141.97 139.45 32.45 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 107.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.55 152.89 52.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.129 0.571 . . . . 0.0 110.106 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -69.83 133.58 47.55 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 166.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.03 -29.37 69.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -168.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.7 m -67.45 -31.13 71.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.651 0.78 . . . . 0.0 111.64 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.477 HG22 ' HB3' ' A' ' 62' ' ' ALA . 20.8 m -113.47 6.96 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.821 0.848 . . . . 0.0 111.661 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -75.1 118.17 17.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.035 0.534 . . . . 0.0 111.845 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.61 -26.12 25.62 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.828 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -94.82 -17.98 21.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.218 0.607 . . . . 0.0 110.117 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -104.7 145.83 29.8 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 m -148.74 138.13 21.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.891 0.876 . . . . 0.0 109.43 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.555 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.9 mp -101.11 131.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.8 m -122.43 154.78 37.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 133.38 8.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.046 0.385 . . . . 0.0 110.146 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.39 108.11 18.03 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.66 -29.02 68.21 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.93 0.892 . . . . 0.0 111.059 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.73 68.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.246 0.618 . . . . 0.0 111.162 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -14.96 59.43 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.626 0.37 . . . . 0.0 110.714 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 62.31 28.34 16.88 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 124.667 1.229 . . . . 0.0 110.132 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.3 m -125.99 132.51 52.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.093 0.557 . . . . 0.0 110.259 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 35' ' ' MET . 21.8 t -105.54 157.63 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.584 1.153 . . . . 0.0 109.137 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -137.84 145.36 42.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.818 1.247 . . . . 0.0 108.774 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 21' ' ' LEU . 2.9 tm? -134.37 108.61 8.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.07 104.98 16.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.336 0.654 . . . . 0.0 109.73 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.427 ' HB3' HD21 ' A' ' 87' ' ' LEU . 69.7 mtm -88.64 132.41 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -130.69 142.45 50.43 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t 57.73 70.98 0.61 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.67 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.8 mt -84.45 157.17 21.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.417 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -118.31 156.89 50.38 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.28 -21.74 67.98 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.49 2.127 . . . . 0.0 113.059 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.94 -11.43 59.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.274 1.029 . . . . 0.0 112.871 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -83.08 1.48 40.0 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.829 0.452 . . . . 0.0 112.149 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -64.59 108.33 1.65 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.765 0.826 . . . . 0.0 110.397 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.1 164.04 13.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.645 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 2.7 p -89.0 112.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -88.23 139.98 29.94 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -125.74 129.34 49.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.543 1.137 . . . . 0.0 108.753 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.44 121.98 28.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -113.71 161.84 17.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.836 0.854 . . . . 0.0 110.006 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.83 143.86 29.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.439 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.631 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.292 0.568 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -128.04 165.26 20.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.967 0.907 . . . . 0.0 109.993 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 44.7 p90 -158.43 167.09 30.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.105 0.962 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.64 -161.26 29.99 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.991 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 6' ' ' VAL . 47.4 mt-30 -85.43 -57.46 3.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.114 0.966 . . . . 0.0 109.209 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.39 144.72 17.7 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.416 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -143.43 149.49 37.7 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.343 0.657 . . . . 0.0 109.291 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 17.5 tm0? -91.36 118.11 30.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.376 0.67 . . . . 0.0 110.383 -169.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.28 126.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.447 0.641 . . . . 0.0 109.54 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 88.4 m -102.32 104.67 15.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.779 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.08 100.56 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.8 m -56.73 116.45 3.16 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.462 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.541 0.6 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 177.695 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.737 0.303 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -108.93 168.72 9.16 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.825 0.85 . . . . 0.0 110.201 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 tp -97.72 111.67 23.86 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -91.77 118.06 30.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 0.0 109.946 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -113.83 122.89 48.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.95 0.9 . . . . 0.0 108.627 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 92.5 t -117.52 103.31 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.149 0.98 . . . . 0.0 109.123 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.63 147.47 27.69 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.165 0.586 . . . . 0.0 109.77 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 p -162.47 178.57 8.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.362 1.065 . . . . 0.0 109.493 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 80.42 5.3 89.89 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 116.537 -0.301 . . . . 0.0 113.433 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.86 135.64 19.37 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -165.84 178.39 40.59 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -98.66 139.26 34.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.594 0.758 . . . . 0.0 111.006 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 11.3 p -151.12 151.35 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.328 1.051 . . . . 0.0 108.534 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 18.1 mp0 -70.12 159.54 33.72 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.258 0.623 . . . . 0.0 112.272 -177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 121.92 15.03 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.913 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.75 -6.51 58.82 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 123.734 0.646 . . . . 0.0 112.172 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.39 -164.4 37.67 Favored Glycine 0 C--N 1.349 1.264 0 C-N-CA 123.068 0.366 . . . . 0.0 112.984 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.0 p -148.72 155.67 41.32 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.214 0.606 . . . . 0.0 110.774 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -153.45 136.14 15.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.056 0.942 . . . . 0.0 109.339 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -99.24 132.99 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.277 0.561 . . . . 0.0 110.09 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 4.2 mm? -106.72 159.95 15.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.741 1.216 . . . . 0.0 109.79 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.1 t -137.75 156.04 48.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.956 0.902 . . . . 0.0 110.007 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 54.0 t -150.66 113.51 4.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.002 0.921 . . . . 0.0 109.6 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.4 117.53 23.68 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.85 0.86 . . . . 0.0 109.051 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.3 124.58 49.79 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.263 0.625 . . . . 0.0 109.724 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 71.1 m -141.77 -178.08 5.5 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.935 1.294 . . . . 0.0 109.492 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.19 -117.17 4.36 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.54 153.82 42.92 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.896 0.848 . . . . 0.0 110.746 174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.3 p -68.9 107.29 3.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.909 0.483 . . . . 0.0 109.724 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 75' ' ' ASN . 5.2 p90 -64.75 -14.62 59.49 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.255 0.622 . . . . 0.0 110.924 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.5 p -70.37 -3.55 18.02 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.162 0.985 . . . . 0.0 112.32 172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.0 t -109.52 7.66 24.82 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.462 1.105 . . . . 0.0 110.08 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -136.07 156.19 49.08 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.123 0.969 . . . . 0.0 111.091 -173.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.8 133.16 50.97 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 165.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.535 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 17.7 ttp -118.23 142.11 47.81 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.286 0.634 . . . . 0.0 109.589 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -127.45 154.21 19.48 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.391 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.7 m95 -97.03 125.56 41.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.39 160.22 24.53 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.263 1.425 . . . . 0.0 107.64 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -139.89 162.14 35.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.86 0.755 . . . . 0.0 111.772 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -165.43 152.93 10.78 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.642 1.213 . . . . 0.0 110.52 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 173.27 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 125.245 1.418 . . . . 0.0 110.231 168.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 65.7 Cg_endo -87.58 80.51 1.3 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.938 1.758 . . . . 0.0 112.046 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.0 26.45 73.28 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.347 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -115.29 148.86 38.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.105 0.962 . . . . 0.0 112.03 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 178.19 5.22 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 161.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -61.46 102.63 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -99.86 147.32 25.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.038 -178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.87 114.49 3.08 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.229 0.612 . . . . 0.0 110.073 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG11 ' HE1' ' A' ' 95' ' ' TYR . 98.5 t -104.12 -55.78 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -158.54 152.49 23.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.547 0.739 . . . . 0.0 110.13 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 36' ' ' GLY . 42.9 t -137.71 141.86 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.32 1.048 . . . . 0.0 108.58 173.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.72 145.21 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 123.73 0.812 . . . . 0.0 109.272 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -81.08 156.34 25.85 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 166.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -52.16 -39.3 59.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.052 0.941 . . . . 0.0 112.523 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -68.49 -26.39 65.45 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.93 0.892 . . . . 0.0 111.934 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.34 12.31 82.25 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.644 -166.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -65.24 -38.57 90.77 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.068 1.347 . . . . 0.0 110.902 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -128.38 128.08 43.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.492 0.717 . . . . 0.0 110.47 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -122.29 129.97 52.7 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.007 1.323 . . . . 0.0 108.271 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -120.96 138.47 54.12 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.723 1.209 . . . . 0.0 107.973 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.01 138.82 44.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.195 0.598 . . . . 0.0 110.532 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 147.56 31.68 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.906 0.883 . . . . 0.0 109.635 173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -59.02 -27.27 65.3 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.834 0.854 . . . . 0.0 112.745 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.2 m -64.56 -32.79 74.59 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.521 0.728 . . . . 0.0 112.019 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.78 5.16 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 124.388 1.075 . . . . 0.0 111.839 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -70.92 142.66 51.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.39 0.676 . . . . 0.0 110.833 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.75 -22.51 9.05 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.424 0.453 . . . . 0.0 113.867 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -117.03 -17.43 10.34 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.535 0.734 . . . . 0.0 111.547 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.61 149.23 23.49 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -149.2 137.4 20.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.101 0.96 . . . . 0.0 108.952 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.405 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -102.03 151.39 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 175.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.0 m -146.02 159.6 43.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.972 1.309 . . . . 0.0 108.58 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.65 132.48 5.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.202 0.525 . . . . 0.0 111.238 175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.68 107.43 19.09 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 30' ' ' PHE . 1.8 m-20 -69.63 -33.02 72.04 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.378 0.671 . . . . 0.0 110.824 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.29 83.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.761 0.825 . . . . 0.0 111.104 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -97.72 -0.51 45.29 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.268 0.627 . . . . 0.0 112.105 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.9 OUTLIER 61.02 27.37 17.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.774 1.23 . . . . 0.0 113.46 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 m -119.36 131.81 55.76 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.56 0.344 . . . . 0.0 110.75 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 36.0 t -103.31 148.77 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.431 1.092 . . . . 0.0 108.923 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -132.11 152.07 51.43 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.533 1.133 . . . . 0.0 109.353 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -132.19 108.28 9.16 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -83.61 102.76 12.41 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.062 0.945 . . . . 0.0 109.508 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 58.4 mtt -88.69 123.61 33.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -123.53 141.95 51.49 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.8 m 53.92 61.33 3.12 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.411 1.084 . . . . 0.0 111.791 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.8 mt -70.38 117.18 11.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.365 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.415 ' O ' HG11 ' A' ' 121' ' ' VAL . 45.5 mtpt -75.05 149.38 85.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.405 1.082 . . . . 0.0 109.05 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 19.4 Cg_endo -56.54 -17.78 23.29 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.181 2.587 . . . . 0.0 114.681 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.51 -20.45 58.72 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.25 1.02 . . . . 0.0 113.051 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -77.14 -0.36 24.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 120' ' ' THR . 72.5 m -62.62 101.67 0.27 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.461 0.704 . . . . 0.0 110.1 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -166.54 160.99 15.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.036 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -88.69 116.52 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.349 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.483 ' HE1' HG11 ' A' ' 49' ' ' VAL . 15.7 m-85 -91.84 117.09 29.46 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.706 0.803 . . . . 0.0 111.092 -177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -101.64 130.07 47.91 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.038 0.935 . . . . 0.0 109.999 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.535 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.8 m -84.67 124.15 31.17 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.58 120.63 20.98 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.038 0.935 . . . . 0.0 109.695 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 35' ' ' MET . . . -119.34 167.93 11.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.858 0.863 . . . . 0.0 111.137 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.94 -146.63 16.73 Favored Glycine 0 C--O 1.244 0.73 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.791 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.52 114.37 20.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.933 0.893 . . . . 0.0 109.81 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -89.65 133.42 34.65 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 168.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -120.98 -70.36 0.79 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.451 0.7 . . . . 0.0 110.36 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.92 -36.22 0.42 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.0 t -57.03 126.94 29.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.799 0.84 . . . . 0.0 110.576 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -82.15 2.52 31.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.157 0.583 . . . . 0.0 112.185 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -67.7 101.04 0.98 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.6 79.71 1.08 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.183 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.84 97.15 33.38 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.067 0.947 . . . . 0.0 108.593 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 159.56 28.54 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.151 2.567 . . . . 0.0 112.571 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.44 -41.96 37.83 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.601 0.761 . . . . 0.0 109.561 174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.81 146.88 51.54 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.521 1.129 . . . . 0.0 109.121 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -149.02 156.92 42.96 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.034 0.934 . . . . 0.0 109.242 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.62 -163.34 26.14 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.219 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.454 HE21 ' HA ' ' A' ' 6' ' ' VAL . 41.7 mt-30 -81.59 -50.1 9.75 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.097 1.359 . . . . 0.0 110.689 -174.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.5 137.45 6.47 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.789 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 21' ' ' LEU . 10.0 t -114.59 115.82 27.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.123 0.969 . . . . 0.0 109.564 176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -73.49 111.83 8.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.745 0.818 . . . . 0.0 110.054 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.5 145.12 16.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 52.2 m -127.88 139.2 52.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.2 p -119.78 113.14 39.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 31.1 t -58.38 113.19 1.85 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.595 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 37.8 m -74.37 -174.46 2.02 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.534 1.134 . . . . 0.0 111.13 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.3 tp 69.47 97.27 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.575 1.15 . . . . 0.0 109.756 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.43 -27.24 65.87 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.764 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.6 t60 78.04 -32.25 0.17 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.45 1.5 . . . . 0.0 113.644 167.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -68.41 97.11 0.72 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.758 0.79 . . . . 0.0 111.163 -172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -78.99 -35.41 42.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.8 t60 67.81 -78.33 0.04 OUTLIER 'General case' 0 C--N 1.363 1.157 0 O-C-N 125.02 1.45 . . . . 0.0 109.908 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -151.03 164.52 36.23 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.191 1.397 . . . . 0.0 108.043 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--O 1.25 1.096 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.688 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -153.99 173.55 15.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.001 0.52 . . . . 0.0 110.555 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.0 tp -76.36 111.36 11.72 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -85.57 116.38 23.83 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.9 mt -110.14 129.84 55.64 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.424 1.09 . . . . 0.0 108.296 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.529 ' HA ' HE21 ' A' ' 115' ' ' GLN . 34.6 t -121.9 98.25 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.85 139.64 30.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 122.89 0.476 . . . . 0.0 110.166 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.0 p -153.46 165.01 37.16 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.949 0.899 . . . . 0.0 109.957 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.34 -11.45 54.67 Favored Glycine 0 N--CA 1.474 1.201 0 CA-C-N 116.378 -0.373 . . . . 0.0 112.988 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.29 120.54 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.028 -0.318 . . . . 0.0 112.448 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.6 -169.42 22.9 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -79.63 135.49 36.58 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.498 0.319 . . . . 0.0 111.275 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.64 139.97 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.29 1.036 . . . . 0.0 109.448 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.83 149.55 35.62 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.687 0.795 . . . . 0.0 112.025 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.48 116.27 7.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.218 0.607 . . . . 0.0 110.704 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.71 -10.37 25.65 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.033 0.825 . . . . 0.0 111.541 -175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.46 -170.82 44.5 Favored Glycine 0 C--N 1.346 1.124 0 C-N-CA 123.038 0.351 . . . . 0.0 113.862 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.4 p -121.52 162.1 21.16 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.252 1.021 . . . . 0.0 110.223 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.96 126.9 8.29 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -98.4 118.33 34.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.163 0.585 . . . . 0.0 110.248 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -102.02 154.18 19.21 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.194 0.998 . . . . 0.0 109.018 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -145.67 146.84 31.46 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.595 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 53.6 t -138.37 123.43 19.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.22 114.77 22.57 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.15 150.26 24.51 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.408 0.683 . . . . 0.0 109.239 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 t -71.78 164.33 26.2 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.19 -11.25 51.36 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.384 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HE ' ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.9 127.45 26.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.326 1.051 . . . . 0.0 109.28 169.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.414 ' H ' ' HE ' ' A' ' 28' ' ' ARG . 6.8 p -60.77 89.04 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -74.12 -18.54 60.79 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.077 160.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 29.9 p -66.7 -14.43 62.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.069 1.347 . . . . 0.0 112.794 176.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.5 m -83.98 -4.24 58.58 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 0.0 111.225 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -132.32 168.91 17.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.591 0.757 . . . . 0.0 110.988 -173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 121.8 33.49 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 164.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.8 ttp -101.22 130.44 47.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.553 0.741 . . . . 0.0 109.493 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -134.0 154.25 21.28 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -95.51 138.89 32.56 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.462 1.105 . . . . 0.0 109.187 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -130.77 170.25 14.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.159 1.384 . . . . 0.0 108.113 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -153.73 162.05 41.58 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.901 0.319 . . . . 0.0 111.802 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -168.02 151.86 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 124.529 1.143 . . . . 0.0 110.835 167.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 169.74 -59.11 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 125.283 1.433 . . . . 0.0 110.885 171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.42 70.24 5.13 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.511 2.141 . . . . 0.0 112.609 -169.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.92 17.22 76.8 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.787 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -109.24 140.95 42.22 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.818 0.847 . . . . 0.0 110.745 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.31 170.3 12.91 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.75 105.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.91 154.89 20.95 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 110.647 -171.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -66.6 110.38 3.17 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.674 171.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG11 ' HE1' ' A' ' 95' ' ' TYR . 95.2 t -88.81 -62.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.53 134.54 4.65 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.702 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.608 HG22 ' HA3' ' A' ' 36' ' ' GLY . 71.3 t -115.41 153.46 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.158 0.983 . . . . 0.0 108.595 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.9 151.39 31.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -68.6 152.99 44.61 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 166.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 52.9 p-90 -61.42 -36.05 79.25 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -82.72 -5.34 58.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.477 0.711 . . . . 0.0 111.659 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.84 19.55 79.87 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -58.51 -47.71 83.24 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.742 0.817 . . . . 0.0 111.234 -175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 30.1 mtt85 -130.71 141.23 50.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.9 p -110.99 130.2 55.66 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -114.93 116.33 28.34 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -114.27 142.21 46.58 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.83 47.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.35 -26.36 60.87 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.689 0.795 . . . . 0.0 111.978 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 m -69.6 -26.05 64.26 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.595 1.158 . . . . 0.0 112.563 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 33.5 m -127.96 7.64 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.03 0.932 . . . . 0.0 111.652 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.24 124.34 23.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 111.31 -171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -3.01 85.92 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.11 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -121.15 -10.9 8.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.487 0.643 . . . . 0.0 111.421 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -109.57 162.39 14.44 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.202 0.601 . . . . 0.0 109.873 171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 83' ' ' GLN . 86.4 m -151.59 130.57 12.57 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.267 1.027 . . . . 0.0 109.45 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.614 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.7 mp -103.29 141.12 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 49.5 m -139.27 158.76 43.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.729 1.212 . . . . 0.0 108.248 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.18 131.12 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.029 0.443 . . . . 0.0 110.881 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.01 92.17 5.37 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.483 1.113 . . . . 0.0 108.27 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.46 -25.58 68.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.146 0.578 . . . . 0.0 111.413 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.8 98.1 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.87 0.868 . . . . 0.0 111.504 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -92.82 -10.25 37.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.637 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 58.21 45.27 17.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.117 0.967 . . . . 0.0 109.574 -170.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.3 m -115.34 148.39 39.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.283 1.033 . . . . 0.0 109.408 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 57.6 t -126.68 150.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.101 0.96 . . . . 0.0 108.903 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 86.7 m-85 -133.53 146.23 50.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 0.0 108.975 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.3 tm? -133.87 107.19 7.7 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' HB3' ' HB ' ' A' ' 70' ' ' THR . 35.4 tt0 -86.75 126.83 34.85 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.429 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.7 mtt -105.48 141.49 36.88 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.482 1.113 . . . . 0.0 108.824 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -141.61 147.33 37.43 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.4 t 58.27 52.14 7.71 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.756 0.823 . . . . 0.0 111.28 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 84' ' ' MET . 77.8 mt -71.51 120.8 17.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.828 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' O ' HG11 ' A' ' 121' ' ' VAL . 39.2 mtmt -82.99 149.37 59.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.167 0.987 . . . . 0.0 108.985 173.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -55.98 -18.93 24.12 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 123.387 2.724 . . . . 0.0 114.791 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.49 -20.11 54.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.143 0.977 . . . . 0.0 112.609 -177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -71.18 -7.76 48.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.223 0.609 . . . . 0.0 112.544 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.5 m -56.58 101.82 0.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.961 0.904 . . . . 0.0 110.302 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.02 159.07 9.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.573 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.1 p -78.89 113.48 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.524 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.0 m-85 -87.98 112.51 22.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.237 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -104.57 122.73 46.21 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.493 1.117 . . . . 0.0 109.098 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.88 132.04 35.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -140.56 160.29 40.33 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.962 0.905 . . . . 0.0 109.295 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.43 160.65 39.35 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.494 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . 110.57 10.72 21.06 Favored Glycine 0 N--CA 1.466 0.659 0 CA-C-O 119.773 -0.459 . . . . 0.0 113.831 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' HD3' HG21 ' A' ' 51' ' ' VAL . 87.8 tttt -86.6 149.5 24.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -111.52 169.33 8.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.827 0.851 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -69.7 101.33 1.65 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.643 0.777 . . . . 0.0 110.241 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.16 -99.06 1.53 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.7 t 60.21 -165.46 0.21 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.465 1.106 . . . . 0.0 111.136 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -114.54 113.53 24.53 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -63.53 134.92 56.4 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.798 0.439 . . . . 0.0 111.081 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.57 -44.0 0.04 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -172.2 147.68 1.87 Allowed Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.076 0.95 . . . . 0.0 110.66 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.55 157.35 32.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.307 2.005 . . . . 0.0 111.176 167.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.494 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 20.1 t70 -77.0 -32.75 57.42 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.103 0.561 . . . . 0.0 110.185 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -133.85 153.67 51.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.531 1.132 . . . . 0.0 109.302 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -149.64 148.88 29.83 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.126 0.971 . . . . 0.0 108.882 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.57 -155.7 32.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.935 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.529 HE21 ' HA ' ' A' ' 6' ' ' VAL . 48.8 mt-30 -97.69 -38.06 9.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.311 1.045 . . . . 0.0 110.587 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.91 136.81 9.2 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.172 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -117.58 114.31 23.23 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.07 0.948 . . . . 0.0 108.805 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 62.3 tp60 -71.9 108.84 5.37 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -91.32 145.29 7.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 25.2 m -132.6 109.67 9.9 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 88' ' ' LYS . 1.7 p -94.7 105.09 16.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.7 t -56.82 118.83 5.31 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.115 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 m -68.47 125.31 26.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.168 0.987 . . . . 0.0 110.928 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 23.3 tp -96.15 25.46 4.86 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.859 0.864 . . . . 0.0 109.849 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 63.85 -178.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.553 1.141 . . . . 0.0 111.81 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -103.9 -53.61 2.72 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 168.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 51.31 66.51 1.16 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.473 1.509 . . . . 0.0 112.321 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -177.0 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.7 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 65.4 -179.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.829 0.851 . . . . 0.0 110.289 -163.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 63.38 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.787 0.835 . . . . 0.0 109.755 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 125.634 1.574 . . . . 0.0 108.862 -159.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 pm0 -76.0 152.04 37.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.841 0.856 . . . . 0.0 111.766 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' TYR . 54.4 tp -85.46 111.6 20.12 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 173.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -72.38 104.35 3.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.126 0.57 . . . . 0.0 110.025 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.09 128.95 54.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 108.48 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.8 t -121.9 103.92 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.78 156.82 18.25 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.231 1.012 . . . . 0.0 110.412 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 78.9 p -159.44 171.81 19.04 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.882 0.873 . . . . 0.0 109.791 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.5 15.42 15.49 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.044 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.79 92.18 0.36 Allowed Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.933 0.301 . . . . 0.0 112.444 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.88 179.96 23.43 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.5 pp -107.36 147.86 29.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.084 0.554 . . . . 0.0 110.571 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.0 p -149.47 145.12 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.553 1.141 . . . . 0.0 108.707 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.2 mp0 -72.61 158.34 35.84 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.876 0.47 . . . . 0.0 112.026 -172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.06 114.33 3.64 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.923 0.889 . . . . 0.0 111.261 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.7 -10.0 25.73 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.486 0.565 . . . . 0.0 112.033 -175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.02 -163.82 39.33 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.026 0.346 . . . . 0.0 112.713 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.9 p -143.73 158.17 43.87 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.387 0.675 . . . . 0.0 109.981 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -149.59 119.66 7.21 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.9 ttt85 -96.6 116.12 28.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.722 0.809 . . . . 0.0 109.85 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.46 156.55 18.12 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.173 0.989 . . . . 0.0 110.216 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -132.7 145.22 50.87 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.637 0.775 . . . . 0.0 109.28 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.9 t -146.87 119.37 8.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.325 0.65 . . . . 0.0 110.45 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.73 129.74 34.75 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.029 0.532 . . . . 0.0 110.029 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.93 128.64 54.49 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.087 0.955 . . . . 0.0 110.156 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.412 ' O ' HD12 ' A' ' 3' ' ' LEU . 49.9 m -142.76 159.4 42.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.097 0.959 . . . . 0.0 109.816 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.35 -117.96 5.9 Favored Glycine 0 C--N 1.342 0.887 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -77.26 163.84 26.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.581 0.752 . . . . 0.0 110.085 -175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -70.19 97.25 1.18 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.015 0.526 . . . . 0.0 111.1 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -68.43 -23.95 64.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.706 0.802 . . . . 0.0 110.798 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.561 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 60.6 p -72.5 -0.05 11.68 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.949 0.9 . . . . 0.0 112.276 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -99.46 -9.75 23.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.241 0.616 . . . . 0.0 111.116 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -123.48 169.42 11.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.428 0.633 . . . . 0.0 112.323 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.645 ' H ' ' HB2' ' A' ' 101' ' ' LYS . . . -100.83 125.9 47.38 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.207 166.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 9.4 ptm -107.56 170.19 8.12 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.386 0.674 . . . . 0.0 110.463 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.41 149.38 18.09 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 113.376 0.11 . . . . 0.0 113.376 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -98.1 141.17 31.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.156 0.982 . . . . 0.0 109.995 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -138.28 133.24 32.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.654 1.181 . . . . 0.0 108.724 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -114.79 159.6 20.41 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.058 0.39 . . . . 0.0 111.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.527 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.6 pt20 -168.66 151.8 5.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.505 0.722 . . . . 0.0 110.712 176.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -179.59 -57.6 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 123.776 0.83 . . . . 0.0 111.114 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.73 64.99 7.39 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.342 2.028 . . . . 0.0 112.348 -171.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.43 22.32 76.37 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.78 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm -103.34 149.1 25.08 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.931 0.892 . . . . 0.0 111.031 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.38 178.48 5.95 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.472 1.109 . . . . 0.0 108.334 164.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.04 105.39 0.47 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 150.1 21.01 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HE2' HG23 ' A' ' 51' ' ' VAL . 58.2 t80 -63.08 112.58 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.757 0.823 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.18 -66.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 170.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.3 135.14 3.02 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.413 HG23 ' HE2' ' A' ' 48' ' ' PHE . 50.2 t -110.87 132.44 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.262 1.025 . . . . 0.0 109.208 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.92 151.17 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.688 0.795 . . . . 0.0 110.493 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 25.1 t-20 -75.69 156.65 34.54 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.982 0.913 . . . . 0.0 109.205 170.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 54.7 p-90 -58.78 -34.52 71.54 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -177.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.5 p -95.71 1.55 53.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 0.0 111.678 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.02 9.5 71.46 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 113.363 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -64.01 -35.31 80.3 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.33 1.052 . . . . 0.0 111.181 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 98.5 mtt180 -125.49 138.59 53.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.337 1.055 . . . . 0.0 109.229 -176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.8 p -140.29 131.92 27.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.621 0.768 . . . . 0.0 109.543 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -119.37 115.78 24.82 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 147.25 34.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.593 0.357 . . . . 0.0 110.241 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.18 146.59 43.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -60.22 -34.04 73.1 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.5 m -70.61 -28.16 64.64 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.034 0.534 . . . . 0.0 112.223 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 62' ' ' ALA . 12.1 m -109.77 1.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.193 0.597 . . . . 0.0 111.408 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -67.5 120.84 14.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.463 0.705 . . . . 0.0 111.824 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.25 -27.88 4.92 Favored Glycine 0 C--N 1.346 1.133 0 C-N-CA 123.748 0.689 . . . . 0.0 113.959 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' NH2' HD23 ' A' ' 87' ' ' LEU . 1.6 ptm180 -89.05 -8.59 53.66 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.839 0.856 . . . . 0.0 110.901 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -111.21 151.97 27.64 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 171.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.5 m -140.19 119.41 12.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.163 0.985 . . . . 0.0 108.528 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 71' ' ' ILE . 1.1 mp -103.54 127.55 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 m -133.83 157.78 45.04 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.312 1.045 . . . . 0.0 108.206 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.38 150.75 18.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.127 0.489 . . . . 0.0 110.341 174.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 77' ' ' LYS . 17.8 m-20 -119.88 112.14 18.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -71.14 -26.95 63.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.072 0.549 . . . . 0.0 110.788 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.36 59.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.509 0.724 . . . . 0.0 111.02 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 72.5 mmtt -77.5 -25.01 49.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.616 0.366 . . . . 0.0 110.886 173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 60.32 44.97 11.77 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.388 1.075 . . . . 0.0 110.039 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 m -139.08 131.24 28.14 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.847 -176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 35' ' ' MET . 46.4 t -101.58 141.72 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.65 1.18 . . . . 0.0 109.593 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -125.09 126.33 45.17 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.186 0.994 . . . . 0.0 109.063 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.37 98.19 6.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -89.16 106.6 18.55 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.298 0.639 . . . . 0.0 110.207 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' HD21 ' A' ' 87' ' ' LEU . 56.4 mtm -88.07 139.39 30.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.322 0.649 . . . . 0.0 109.3 174.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -134.07 146.74 50.59 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.0 m 59.77 60.29 2.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.187 0.995 . . . . 0.0 111.123 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 84' ' ' MET . 99.3 mt -80.73 127.91 33.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.477 -173.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 2.3 mptp? -92.71 153.91 42.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -47.3 -25.7 4.97 Favored 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.875 3.05 . . . . 0.0 115.142 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 12.6 pt-20 -71.44 -23.27 61.81 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 124.743 1.217 . . . . 0.0 113.432 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.46 1.12 14.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.782 0.833 . . . . 0.0 113.196 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 120' ' ' THR . 54.9 m -62.99 103.13 0.42 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.291 0.636 . . . . 0.0 110.337 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.57 155.04 5.85 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.227 0.611 . . . . 0.0 111.452 -173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.3 p -78.95 112.29 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 173.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -87.68 113.47 23.38 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -102.71 128.8 49.28 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.24 129.38 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -138.53 163.52 31.77 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.264 1.025 . . . . 0.0 109.073 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' MET . . . -138.5 133.7 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.772 0.829 . . . . 0.0 108.774 173.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 110' ' ' PRO . . . -176.46 83.44 0.07 OUTLIER Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -175.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.645 ' HB2' ' H ' ' A' ' 34' ' ' ALA . 60.3 tttm -77.61 129.03 35.09 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.362 0.665 . . . . 0.0 109.999 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -70.74 82.64 0.62 Allowed 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 166.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.87 -47.76 8.75 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.109 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.83 175.64 16.0 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.293 172.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 m -76.26 154.87 34.83 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.989 0.516 . . . . 0.0 110.57 175.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 71.31 16.18 6.18 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.892 1.277 . . . . 0.0 111.981 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -110.45 36.01 3.24 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.888 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.98 63.77 4.39 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.142 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -170.1 142.24 1.85 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.477 1.111 . . . . 0.0 108.866 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.651 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 71.1 Cg_endo -74.14 108.74 2.73 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.988 1.792 . . . . 0.0 110.839 174.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.81 -32.46 74.0 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.508 0.67 . . . . 0.0 110.831 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 34.2 m-85 -111.37 151.1 28.85 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.044 0.938 . . . . 0.0 109.14 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 42.4 p90 -166.08 167.42 16.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.869 0.868 . . . . 0.0 109.997 173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.99 -147.85 10.13 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.206 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -84.23 -48.85 9.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.807 0.843 . . . . 0.0 110.383 -176.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.8 151.57 25.33 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.817 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.9 t -122.64 111.42 16.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.336 1.054 . . . . 0.0 110.077 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 57.2 tp60 -72.47 113.87 9.98 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.474 0.71 . . . . 0.0 110.15 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.557 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.1 m -102.87 146.83 10.18 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.494 0.718 . . . . 0.0 109.366 175.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.52 ' HA ' HG23 ' A' ' 92' ' ' THR . 96.4 m -124.63 143.21 50.85 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.89 0.876 . . . . 0.0 109.001 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.7 p -129.86 125.62 61.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.357 0.663 . . . . 0.0 109.791 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.458 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 7.9 m -80.03 122.48 26.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.468 1.107 . . . . 0.0 111.885 -170.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.6 p -78.17 143.73 36.97 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.763 0.825 . . . . 0.0 110.699 174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 59.8 tp -84.09 -76.24 0.31 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.793 0.437 . . . . 0.0 111.098 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.74 85.75 7.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.29 0.636 . . . . 0.0 110.405 -174.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -76.98 -29.59 55.59 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.533 172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -142.21 143.3 32.85 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.948 1.299 . . . . 0.0 108.563 169.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -159.16 156.38 28.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.301 0.641 . . . . 0.0 110.329 172.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -159.13 128.52 5.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.639 0.775 . . . . 0.0 109.154 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -75.05 104.65 5.72 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 61.2 m80 . . . . . 0 CA--C 1.553 1.092 0 C-N-CA 125.052 1.341 . . . . 0.0 110.307 -177.268 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -99.65 163.7 12.38 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.4 tp -86.65 110.96 20.2 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.264 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -94.94 114.74 26.61 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.532 0.733 . . . . 0.0 109.328 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.681 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 96.0 mt -106.9 116.96 32.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.4 101.92 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -111.22 125.39 53.76 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.373 -166.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -165.75 -178.74 4.96 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.22 1.008 . . . . 0.0 110.239 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.5 -0.52 26.34 Favored Glycine 0 N--CA 1.476 1.355 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.33 151.51 29.84 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 122.88 0.276 . . . . 0.0 113.064 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.25 -168.94 31.08 Favored Glycine 0 C--O 1.243 0.716 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -91.31 145.54 24.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.226 0.536 . . . . 0.0 111.043 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.94 159.89 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.072 1.349 . . . . 0.0 108.13 -175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -87.26 166.2 15.09 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.957 0.503 . . . . 0.0 111.158 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' H ' HD13 ' A' ' 124' ' ' LEU . . . -70.45 129.21 38.65 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.319 0.648 . . . . 0.0 109.959 173.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.46 81.75 Favored Glycine 0 C--N 1.34 0.765 0 O-C-N 123.741 0.651 . . . . 0.0 111.892 -170.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.72 -165.91 40.55 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 122.804 0.24 . . . . 0.0 112.941 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.8 p -148.18 159.03 44.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.861 0.864 . . . . 0.0 110.2 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.3 tp -159.52 135.22 8.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.583 0.753 . . . . 0.0 109.496 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -109.38 126.51 53.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.841 0.457 . . . . 0.0 110.136 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -103.96 156.96 17.43 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.352 1.061 . . . . 0.0 109.332 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.2 m -144.57 154.64 43.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 111.006 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.681 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.6 t -150.68 134.2 16.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.453 0.701 . . . . 0.0 109.923 176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 145.94 26.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.74 126.66 52.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -133.65 157.72 45.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.603 1.161 . . . . 0.0 109.2 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.99 -82.96 1.08 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -95.16 164.38 12.89 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.574 0.749 . . . . 0.0 110.055 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 31' ' ' SER . 83.6 m -97.41 121.16 38.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 15.9 p90 -63.5 -16.45 60.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.558 0.743 . . . . 0.0 111.744 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 29' ' ' THR . 34.3 t -68.03 -15.17 63.48 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 0.0 112.613 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.8 p -93.05 9.68 34.75 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 122.024 -0.422 . . . . 0.0 110.661 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -134.25 167.56 20.48 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.379 1.071 . . . . 0.0 110.243 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.85 160.45 15.3 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 31.1 ttp -140.47 157.71 45.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.64 144.01 9.38 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -96.42 131.63 42.79 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -132.92 129.0 37.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.014 0.926 . . . . 0.0 108.557 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -109.05 162.35 14.32 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 120.727 0.299 . . . . 0.0 110.537 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -167.8 148.53 5.21 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.091 176.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 177.23 -58.52 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 124.056 0.942 . . . . 0.0 111.352 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 68.5 Cg_endo -82.2 64.82 8.38 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 122.111 1.874 . . . . 0.0 112.523 -170.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.86 6.43 72.72 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.772 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -105.81 146.25 30.12 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.717 0.807 . . . . 0.0 110.142 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.8 178.04 6.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.861 0.864 . . . . 0.0 109.119 170.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -51.68 104.57 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.48 151.79 19.65 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.356 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -64.85 108.34 1.73 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -99.0 -49.08 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.49 150.3 6.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.15 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.3 t -134.23 138.56 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG23 HG22 ' A' ' 59' ' ' THR . 8.9 p -131.65 160.45 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -84.68 158.41 20.81 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -56.53 -38.16 71.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.532 0.733 . . . . 0.0 112.077 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.4 m -76.62 -23.48 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.625 0.77 . . . . 0.0 111.642 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.32 8.42 83.51 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.564 -165.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -58.42 -39.01 78.61 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.609 1.164 . . . . 0.0 111.049 -175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -119.52 130.87 55.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.286 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.472 HG22 HG23 ' A' ' 52' ' ' VAL . 46.5 p -122.36 133.21 54.65 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.906 0.883 . . . . 0.0 109.077 175.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.76 135.93 50.81 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -134.55 148.64 50.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.326 0.65 . . . . 0.0 109.973 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.99 128.32 33.71 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.66 -20.48 60.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.196 0.598 . . . . 0.0 112.436 -173.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.8 p -64.94 -44.28 89.96 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.693 0.797 . . . . 0.0 111.129 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.0 m -104.33 -3.43 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.964 0.906 . . . . 0.0 111.782 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -66.81 134.71 52.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.298 0.639 . . . . 0.0 110.638 -176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.9 -26.67 15.52 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.968 0.793 . . . . 0.0 113.387 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 19.0 ptt-85 -103.43 -18.62 14.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.01 0.405 . . . . 0.0 110.424 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 2.8 m-85 -105.94 151.04 25.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.729 0.812 . . . . 0.0 109.979 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.8 m -149.14 142.22 24.91 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.844 1.258 . . . . 0.0 108.211 170.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.545 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.4 mp -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.8 m -140.03 154.57 47.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.237 1.015 . . . . 0.0 108.334 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HG3' ' HE2' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -159.72 131.29 6.13 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.69 98.9 10.26 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.109 0.963 . . . . 0.0 108.537 171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.01 -25.5 67.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.98 0.912 . . . . 0.0 110.301 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.34 72.15 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.415 1.086 . . . . 0.0 111.673 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -83.05 -11.23 58.22 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.148 0.579 . . . . 0.0 111.251 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.469 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 30.4 m-80 61.18 35.98 18.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.116 0.966 . . . . 0.0 110.302 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -124.09 132.65 53.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.927 0.891 . . . . 0.0 110.257 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.1 t -99.99 153.11 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.112 1.365 . . . . 0.0 110.255 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -136.45 151.79 49.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.439 1.096 . . . . 0.0 109.829 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 1.8 tm? -132.2 115.16 15.35 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.84 102.31 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.185 0.994 . . . . 0.0 109.725 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.56 ' HB3' HD21 ' A' ' 87' ' ' LEU . 67.1 mtt -95.16 136.8 35.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.422 0.689 . . . . 0.0 109.609 173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 20.3 m120 -142.02 161.85 36.96 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.746 1.219 . . . . 0.0 108.001 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.3 m 54.12 31.41 13.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.297 1.039 . . . . 0.0 112.875 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 84' ' ' MET . 84.5 mt -61.04 130.07 44.55 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.872 0.869 . . . . 0.0 112.653 -169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD3' ' NH1' ' A' ' 68' ' ' ARG . 2.4 mptp? -98.52 152.3 37.85 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.102 0.961 . . . . 0.0 108.993 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -46.74 -27.38 5.46 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 124.202 3.268 . . . . 0.0 115.936 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -71.21 -16.66 62.52 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB2' HG11 ' A' ' 121' ' ' VAL . 40.3 m-20 -72.68 -11.94 60.83 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.845 0.458 . . . . 0.0 112.103 178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 120' ' ' THR . 63.4 m -60.16 105.42 0.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.72 0.808 . . . . 0.0 110.796 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.7 165.88 4.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.883 0.873 . . . . 0.0 110.074 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.3 p -89.26 115.69 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -86.82 155.72 20.18 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.355 1.062 . . . . 0.0 109.439 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -145.81 115.98 7.45 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.75 0.657 . . . . 0.0 109.357 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 26.4 p -83.87 106.09 15.28 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.19 124.66 49.93 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.513 1.125 . . . . 0.0 110.911 -175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.22 151.24 38.02 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.716 0.807 . . . . 0.0 110.833 -177.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.12 -157.57 27.75 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -85.54 123.91 31.5 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -93.73 51.89 1.62 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.47 1.129 . . . . 0.0 108.748 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -114.37 156.29 24.73 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.674 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -179.75 107.87 0.23 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.561 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.0 m -69.03 -39.91 78.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.41 0.684 . . . . 0.0 109.703 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -140.37 92.14 2.5 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 62.32 176.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.806 1.242 . . . . 0.0 112.324 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.95 166.52 33.52 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.208 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.4 128.61 5.9 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.58 141.54 86.53 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.551 2.167 . . . . 0.0 112.2 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.2 -44.67 94.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.935 0.894 . . . . 0.0 111.265 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -139.73 167.99 20.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.912 0.885 . . . . 0.0 109.911 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -157.4 168.69 26.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.901 0.881 . . . . 0.0 111.256 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -80.7 -172.23 45.28 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.547 -174.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -66.98 -33.88 76.53 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.161 0.984 . . . . 0.0 111.111 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.52 108.79 2.5 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -100.95 121.84 42.45 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.39 0.676 . . . . 0.0 109.938 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.0 tm0? -90.94 127.71 36.5 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.9 m -113.43 140.73 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.47 ' HA ' HG23 ' A' ' 92' ' ' THR . 40.2 m -127.33 108.9 11.25 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.0 p -106.62 116.02 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 122.987 0.515 . . . . 0.0 109.63 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -73.57 148.28 43.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.742 1.217 . . . . 0.0 110.614 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.8 p -86.21 109.84 19.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.916 0.886 . . . . 0.0 110.122 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.501 HD13 ' H ' ' A' ' 15' ' ' ALA . 9.8 mp -114.67 98.91 7.14 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.951 0.901 . . . . 0.0 108.778 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.25 87.58 0.98 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.155 0.979 . . . . 0.0 109.697 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -77.87 113.95 16.25 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -68.88 142.2 54.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.506 0.322 . . . . 0.0 110.441 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -163.04 153.17 15.99 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.629 0.772 . . . . 0.0 109.695 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -70.95 83.44 0.67 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.384 0.673 . . . . 0.0 110.176 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -86.1 142.34 28.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.842 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 73.4 m80 . . . . . 0 C--O 1.248 1.012 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 175.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.87 175.58 5.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.63 0.772 . . . . 0.0 109.454 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 tp -121.67 111.95 17.83 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -75.88 122.85 24.73 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.355 0.598 . . . . 0.0 110.818 -170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 70.6 mt -127.36 135.12 50.06 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 125.363 1.465 . . . . 0.0 108.475 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.38 100.42 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -97.29 135.02 39.81 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.386 0.674 . . . . 0.0 109.612 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -148.54 178.92 8.21 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.486 1.115 . . . . 0.0 109.49 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.38 -12.35 43.6 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.894 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.89 137.19 21.9 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 112.403 -0.279 . . . . 0.0 112.403 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.85 -169.55 36.91 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.94 137.64 37.72 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 116.971 0.386 . . . . 0.0 111.168 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.75 155.53 6.87 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 C-N-CA 124.946 1.298 . . . . 0.0 108.449 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.49 155.16 27.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.362 0.665 . . . . 0.0 109.948 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 124' ' ' LEU . . . -69.46 111.05 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.241 0.616 . . . . 0.0 110.263 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.92 3.93 31.67 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.922 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.88 -165.98 39.53 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 122.97 0.319 . . . . 0.0 113.463 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 m -132.51 158.22 42.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.413 1.085 . . . . 0.0 110.051 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.9 tp -152.26 151.12 30.54 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -119.96 113.05 19.96 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.151 0.58 . . . . 0.0 110.548 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.9 mm? -101.54 150.08 23.44 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.363 1.065 . . . . 0.0 108.782 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -153.08 140.48 19.66 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.363 0.665 . . . . 0.0 109.294 176.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.7 t -120.6 123.63 43.31 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.525 0.73 . . . . 0.0 110.258 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.47 115.52 22.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 30' ' ' PHE . . . -106.8 163.15 13.17 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.377 1.071 . . . . 0.0 110.273 -172.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -66.09 168.6 8.13 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.338 0.655 . . . . 0.0 112.389 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.16 23.87 8.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.698 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mmm-85 -79.59 179.17 7.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 111.912 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -79.05 70.18 5.35 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.444 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 25' ' ' ALA . 59.0 m-85 -66.22 -22.08 66.33 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.313 164.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -60.0 -29.81 68.71 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.999 1.32 . . . . 0.0 111.703 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 m -90.28 -15.04 32.03 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 0.0 111.441 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -108.58 175.5 5.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.853 0.861 . . . . 0.0 110.931 -176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.48 162.93 17.17 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 164.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.4 ttp -141.93 153.26 44.23 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.0 157.02 27.28 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -96.36 125.13 40.64 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.176 0.99 . . . . 0.0 108.355 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -123.61 170.08 10.81 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.319 1.448 . . . . 0.0 107.873 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -149.67 162.31 40.47 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.845 0.748 . . . . 0.0 112.195 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -170.1 151.5 3.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 124.385 1.053 . . . . 0.0 110.565 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.31 -52.41 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 124.459 1.104 . . . . 0.0 111.518 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.57 64.87 8.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 C-N-CA 122.131 1.887 . . . . 0.0 112.481 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.16 14.6 66.4 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.894 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -104.92 160.02 15.35 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.462 0.705 . . . . 0.0 112.055 -172.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.12 173.49 7.7 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.878 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -59.3 104.34 0.25 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.126 0.97 . . . . 0.0 109.655 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -106.67 150.49 26.19 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.651 0.78 . . . . 0.0 110.668 -173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -66.24 111.03 3.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.352 0.661 . . . . 0.0 110.835 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG13 HG11 ' A' ' 65' ' ' VAL . 70.1 t -94.15 -62.36 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.74 139.55 5.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.724 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 76.3 t -123.31 138.32 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.687 0.795 . . . . 0.0 110.436 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.65 157.13 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 124.283 1.033 . . . . 0.0 109.898 176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 55' ' ' SER . 10.4 t30 -84.85 162.96 19.32 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 169.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.421 0.688 . . . . 0.0 112.479 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 63.6 p -81.69 -11.86 58.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.239 0.616 . . . . 0.0 111.537 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.91 83.11 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.509 0.505 . . . . 0.0 112.791 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -72.36 -23.99 61.21 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.622 0.769 . . . . 0.0 110.969 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -122.89 134.85 54.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.117 0.967 . . . . 0.0 109.004 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.6 p -134.81 132.4 38.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.192 0.997 . . . . 0.0 109.156 173.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -124.22 134.35 53.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.135 1.374 . . . . 0.0 107.524 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.19 149.2 52.44 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.226 0.61 . . . . 0.0 110.224 -177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.63 146.11 42.71 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 166.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.76 -34.76 67.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -168.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.9 m -71.25 -41.88 69.54 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.327 0.651 . . . . 0.0 111.772 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 49' ' ' VAL . 16.1 m -90.17 -5.16 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 122.819 0.448 . . . . 0.0 111.47 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -70.83 120.22 16.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.917 0.887 . . . . 0.0 110.949 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.35 -8.64 77.19 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.449 0.468 . . . . 0.0 113.918 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.43 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 20.8 ptp180 -114.37 -26.64 7.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.423 0.689 . . . . 0.0 110.065 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 3.1 m-30 -98.46 150.45 21.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.829 0.851 . . . . 0.0 109.315 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -146.48 134.24 21.18 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.814 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.581 HG13 HD23 ' A' ' 82' ' ' LEU . 2.8 mp -102.81 136.72 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.6 m -135.42 160.37 38.66 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.757 1.223 . . . . 0.0 108.389 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.2 164.37 32.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.219 0.533 . . . . 0.0 111.437 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -129.76 106.64 8.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.929 1.291 . . . . 0.0 107.557 175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.97 -31.1 71.82 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.318 1.047 . . . . 0.0 111.604 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.41 -44.48 67.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.231 0.612 . . . . 0.0 110.743 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -80.71 -13.51 58.94 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.254 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.4 m120 59.05 31.86 21.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.26 1.024 . . . . 0.0 110.811 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.7 m -121.03 130.1 53.65 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.87 155.14 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.649 1.18 . . . . 0.0 108.519 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -137.66 141.73 41.14 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.559 1.144 . . . . 0.0 109.376 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.2 tm? -133.44 132.34 40.99 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -113.98 127.98 56.19 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.433 ' HB3' HD21 ' A' ' 87' ' ' LEU . 43.4 mtt -111.24 133.65 53.42 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.278 1.031 . . . . 0.0 110.042 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -133.91 149.54 51.3 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 60.05 54.16 4.28 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.036 0.935 . . . . 0.0 111.434 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 84' ' ' MET . 94.7 mt -75.1 115.96 15.3 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.995 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.48 146.11 95.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -61.39 -13.01 26.52 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 123.107 2.538 . . . . 0.0 113.92 -175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -88.21 -2.49 58.63 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.722 1.209 . . . . 0.0 112.211 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.483 ' HB3' HG11 ' A' ' 121' ' ' VAL . 14.3 t70 -74.56 -19.82 60.18 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.937 0.895 . . . . 0.0 110.967 -177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.501 HG23 ' HA ' ' A' ' 120' ' ' THR . 88.7 m -48.4 109.17 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.189 1.396 . . . . 0.0 112.32 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.35 153.79 3.06 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.857 0.723 . . . . 0.0 111.011 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 14.9 p -77.65 114.14 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.417 ' HE1' HG11 ' A' ' 49' ' ' VAL . 14.8 m-85 -85.6 111.11 19.75 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 121.476 0.655 . . . . 0.0 109.688 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.1 127.88 54.19 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.837 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.3 m -83.87 118.49 24.0 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' HB1' ' HG3' ' A' ' 110' ' ' PRO . . . -107.4 128.71 54.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.916 0.886 . . . . 0.0 109.007 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.69 169.86 11.07 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.684 0.794 . . . . 0.0 111.544 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.11 -174.06 15.22 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.121 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -72.23 110.56 6.76 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 117.19 0.495 . . . . 0.0 109.753 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -81.43 70.07 8.21 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.732 0.777 . . . . 0.0 109.561 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.2 t70 178.16 150.0 0.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.026 1.33 . . . . 0.0 108.68 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.86 -50.27 3.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 123.233 0.333 . . . . 0.0 112.462 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.1 m -80.61 87.05 5.79 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.055 0.542 . . . . 0.0 110.03 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -79.78 102.15 8.88 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 66.16 -163.12 0.24 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.475 1.11 . . . . 0.0 110.823 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.77 -86.74 1.41 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.82 154.64 7.66 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.898 0.879 . . . . 0.0 109.939 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' HG3' ' HB1' ' A' ' 98' ' ' ALA . 73.0 Cg_endo -72.93 176.54 8.88 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.607 2.204 . . . . 0.0 111.105 167.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.77 -43.33 75.99 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.027 0.441 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -135.71 160.06 39.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.837 0.855 . . . . 0.0 110.313 -174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 41.3 p90 -160.04 143.33 13.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.651 1.18 . . . . 0.0 108.573 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 5' ' ' LEU . . . -90.35 -143.26 10.52 Favored Glycine 0 C--N 1.344 0.99 0 O-C-N 122.977 0.173 . . . . 0.0 112.81 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -84.84 -73.99 0.41 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.027 0.931 . . . . 0.0 110.286 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 132.48 165.11 11.17 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.201 -175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.407 HG21 HD12 ' A' ' 21' ' ' LEU . 5.4 t -143.56 108.38 4.91 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.893 0.877 . . . . 0.0 110.269 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 61.4 tp60 -68.97 111.27 4.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.105 0.562 . . . . 0.0 110.877 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -91.74 145.07 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 92' ' ' THR . 26.8 m -133.72 106.16 7.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.417 0.687 . . . . 0.0 109.492 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 91' ' ' ASP . 2.3 p -99.05 102.15 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.88 0.848 . . . . 0.0 108.774 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.8 m -57.18 141.86 44.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.958 1.703 . . . . 0.0 111.674 177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t -65.52 149.51 49.93 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.022 0.929 . . . . 0.0 111.325 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 47.9 tp -160.73 -43.5 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.329 0.652 . . . . 0.0 109.754 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -77.39 83.29 3.83 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.479 0.712 . . . . 0.0 110.865 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -90.27 -20.84 22.49 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.164 0.586 . . . . 0.0 110.308 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -107.31 101.28 10.67 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -74.25 93.18 2.32 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -154.26 112.92 3.62 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.253 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -113.79 153.54 28.9 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.365 1.066 . . . . 0.0 109.375 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 69.2 t60 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.275 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 7.7 tt0 65.57 174.32 0.22 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.804 1.242 . . . . 0.0 111.599 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 28' ' ' ARG . 62.1 tp -87.19 110.27 20.04 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -84.62 106.14 15.96 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.704 0.801 . . . . 0.0 108.973 174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.532 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.4 mt -97.57 121.3 39.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.144 0.978 . . . . 0.0 108.846 173.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 60.1 t -114.51 101.19 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.536 0.734 . . . . 0.0 109.176 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -74.92 142.32 44.02 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.526 0.73 . . . . 0.0 109.751 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.1 p -157.17 166.04 34.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.487 1.115 . . . . 0.0 110.02 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.39 11.24 85.51 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.583 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' ' OG1' ' A' ' 117' ' ' THR . . . -84.5 139.3 17.95 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.9 -163.95 28.88 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' THR . 3.9 pp -106.7 143.75 34.36 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.65 0.78 . . . . 0.0 111.623 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 14.5 p -151.57 156.01 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 108.266 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -73.07 167.38 21.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.719 0.408 . . . . 0.0 111.275 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . . . -70.4 121.09 17.06 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 0.0 109.935 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.92 1.03 57.32 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.878 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.52 -172.67 49.27 Favored Glycine 0 C--N 1.351 1.374 0 C-N-CA 123.058 0.361 . . . . 0.0 112.712 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -135.26 143.85 46.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.793 0.837 . . . . 0.0 109.664 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -140.97 124.21 16.54 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.041 0.937 . . . . 0.0 108.611 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -95.13 120.29 35.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.12 0.968 . . . . 0.0 109.737 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.1 mm? -99.31 157.68 16.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.563 0.745 . . . . 0.0 109.435 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.58 156.26 45.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.44 1.096 . . . . 0.0 108.644 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.558 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 52.5 t -150.4 117.61 6.0 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.768 0.427 . . . . 0.0 110.513 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -85.0 119.27 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.295 0.638 . . . . 0.0 109.662 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.48 124.69 49.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.255 1.022 . . . . 0.0 109.529 -175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.4 t -145.09 163.49 34.12 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.075 0.55 . . . . 0.0 111.127 -172.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.7 -90.5 1.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 112.362 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . 27.8 tpt180 -79.59 154.47 28.71 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.228 0.611 . . . . 0.0 110.767 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.4 m -75.12 93.5 2.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.17 0.588 . . . . 0.0 110.091 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -61.36 -29.3 69.82 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.046 0.939 . . . . 0.0 111.43 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 57.3 p -77.16 0.37 21.96 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.747 0.819 . . . . 0.0 112.519 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -95.21 -14.59 23.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.173 0.589 . . . . 0.0 111.086 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -116.33 173.01 6.83 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.803 0.841 . . . . 0.0 110.891 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.34 160.81 18.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 163.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.9 ttp -137.87 136.52 37.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -139.38 140.85 11.2 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 122.969 0.319 . . . . 0.0 112.411 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -95.03 135.04 37.05 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 124.485 1.114 . . . . 0.0 108.96 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -127.81 149.97 50.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.054 1.342 . . . . 0.0 108.189 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -135.59 160.7 37.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.941 0.337 . . . . 0.0 110.333 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.476 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.93 145.75 6.36 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.725 0.641 . . . . 0.0 110.67 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -177.03 -63.54 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.387 169.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 90.2 Cg_endo -78.86 75.96 4.77 Favored 'Trans proline' 0 C--N 1.401 3.315 0 C-N-CA 122.249 1.966 . . . . 0.0 112.393 -171.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 15.58 68.13 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.168 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -105.15 143.25 33.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.281 1.032 . . . . 0.0 111.043 -172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.56 172.61 8.26 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 162.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -60.05 104.61 0.32 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.098 0.475 . . . . 0.0 110.118 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.57 152.34 18.52 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.629 1.172 . . . . 0.0 109.564 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -62.17 111.81 2.12 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 171.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -100.32 -54.08 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -166.29 136.82 3.41 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.499 0.499 . . . . 0.0 111.421 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG22 ' HA3' ' A' ' 36' ' ' GLY . 40.3 t -121.06 129.39 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.257 1.023 . . . . 0.0 109.58 173.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -116.03 158.26 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.284 1.034 . . . . 0.0 108.482 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.31 172.82 10.16 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 169.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 36.1 p-90 -62.33 -27.65 69.2 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.906 0.883 . . . . 0.0 113.255 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.3 m -86.06 -22.48 27.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.454 0.702 . . . . 0.0 112.543 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.43 10.98 83.84 Favored Glycine 0 CA--C 1.538 1.48 0 O-C-N 123.08 0.237 . . . . 0.0 112.55 -172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -83.77 -23.66 31.41 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.842 1.257 . . . . 0.0 111.336 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -121.32 120.35 34.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.164 0.986 . . . . 0.0 108.574 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.3 p -127.93 130.75 48.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.652 0.781 . . . . 0.0 109.02 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.02 132.68 45.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 76.1 m-85 -128.56 150.84 50.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.378 0.671 . . . . 0.0 109.873 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.62 135.31 46.88 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -53.11 -30.87 38.99 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.717 0.807 . . . . 0.0 112.0 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 t -62.88 -43.32 99.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.008 0.923 . . . . 0.0 112.153 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.57 1.71 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 26.3 ttpp -69.55 134.38 48.76 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.745 0.818 . . . . 0.0 110.845 -173.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.83 -26.01 25.08 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.814 0.696 . . . . 0.0 113.718 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.439 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 29.4 ptt-85 -107.35 -20.74 13.18 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.235 0.518 . . . . 0.0 111.24 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.439 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-30 -97.61 157.69 15.9 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.161 0.585 . . . . 0.0 110.203 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.8 m -150.2 134.82 17.46 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.613 1.165 . . . . 0.0 109.122 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.482 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -102.56 142.04 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 169.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -142.02 160.38 40.33 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.999 1.32 . . . . 0.0 107.632 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.25 173.85 15.1 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -148.26 118.74 7.41 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.43 -24.67 59.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.814 0.846 . . . . 0.0 111.625 -173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -80.13 -37.26 33.93 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.521 0.728 . . . . 0.0 110.983 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 10.8 mmpt? -87.13 -14.59 40.86 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.41 0.684 . . . . 0.0 111.401 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.8 m120 61.93 27.72 16.85 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.559 1.162 . . . . 0.0 110.931 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.2 m -122.96 133.73 54.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.994 0.518 . . . . 0.0 110.549 -171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 91.5 t -104.39 154.08 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.591 1.556 . . . . 0.0 109.061 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -137.55 141.94 41.39 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.416 1.086 . . . . 0.0 109.072 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tm? -131.59 99.56 4.84 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -85.65 117.08 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.372 0.669 . . . . 0.0 109.893 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.562 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.4 mtm -110.43 99.59 8.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.756 0.822 . . . . 0.0 109.872 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -99.0 154.06 18.38 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.655 0.782 . . . . 0.0 109.817 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t 56.62 42.24 27.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.51 1.124 . . . . 0.0 110.93 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' MET . 18.1 mt -56.03 124.76 18.85 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.053 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' O ' HG11 ' A' ' 121' ' ' VAL . 80.6 tttt -90.69 142.7 28.07 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.724 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -34.55 -40.33 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 125.205 3.936 . . . . 0.0 116.182 175.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.24 -11.92 60.42 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.507 1.123 . . . . 0.0 113.736 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -80.64 -2.63 47.35 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.589 0.755 . . . . 0.0 112.515 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 90.0 m -63.47 106.19 0.89 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.319 0.648 . . . . 0.0 110.215 173.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.01 160.06 4.12 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.449 0.7 . . . . 0.0 111.014 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 40' ' ' GLN . 7.6 p -83.04 114.54 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -87.5 113.77 23.5 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.926 0.891 . . . . 0.0 110.408 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -107.57 126.25 52.31 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.364 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -85.3 143.89 28.41 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -140.3 158.71 43.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.995 0.918 . . . . 0.0 109.915 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -134.94 141.83 46.38 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.988 0.515 . . . . 0.0 110.706 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.67 165.62 22.25 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -94.96 125.99 40.0 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.021 0.911 . . . . 0.0 110.084 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.544 ' HA ' ' HA3' ' A' ' 108' ' ' GLY . 24.3 m-90 -103.2 22.81 13.41 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.246 1.018 . . . . 0.0 109.892 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -83.05 141.39 32.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.447 1.099 . . . . 0.0 110.332 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.85 -73.7 2.52 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.3 t -75.69 147.43 39.42 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.525 0.73 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -75.16 -21.97 58.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.649 0.78 . . . . 0.0 110.308 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.45 79.64 1.41 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.145 0.978 . . . . 0.0 108.577 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 102' ' ' TRP . . . -76.95 142.46 27.59 Favored Glycine 0 C--N 1.344 0.993 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.055 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.17 113.78 43.82 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.585 0.754 . . . . 0.0 111.2 -174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.87 86.15 1.65 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.623 2.215 . . . . 0.0 108.688 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.8 -25.02 64.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.008 0.923 . . . . 0.0 111.438 -173.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 38.7 m-85 -118.76 155.74 30.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.249 1.019 . . . . 0.0 109.29 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 10.3 p90 -165.68 172.86 11.38 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.226 1.011 . . . . 0.0 109.753 170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.98 -149.69 16.24 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.338 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -84.84 -64.59 1.13 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.669 1.188 . . . . 0.0 109.109 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 121.68 142.19 6.28 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.453 ' OG1' ' HA3' ' A' ' 10' ' ' GLY . 10.2 t -122.52 117.89 26.99 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.895 0.878 . . . . 0.0 109.687 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 26.6 tp60 -78.2 106.47 10.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.12 0.568 . . . . 0.0 109.83 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.9 m -101.2 146.97 8.68 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 C-N-CA 123.511 0.724 . . . . 0.0 109.276 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 47.1 m -131.93 133.99 45.16 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.458 0.703 . . . . 0.0 109.696 177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.1 p -114.38 105.42 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.8 t -59.45 112.38 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.733 1.213 . . . . 0.0 110.754 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.2 p -80.73 110.32 16.12 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.879 0.871 . . . . 0.0 110.621 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 15' ' ' ALA . 1.1 pp -87.19 47.42 1.5 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.147 0.979 . . . . 0.0 109.907 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -72.6 145.38 47.38 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.596 -1.183 . . . . 0.0 111.397 -173.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -142.79 134.42 26.58 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.242 1.017 . . . . 0.0 108.896 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.56 149.35 48.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.955 0.502 . . . . 0.0 110.706 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -71.54 96.76 1.57 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 122.889 0.475 . . . . 0.0 109.987 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 82.2 t60 75.29 139.17 0.06 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.041 1.336 . . . . 0.0 113.158 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -68.51 104.84 2.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.994 0.918 . . . . 0.0 109.778 172.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 124.817 1.247 . . . . 0.0 110.371 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' ' HD3' ' A' ' 28' ' ' ARG . 58.0 tpp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -154.03 139.69 17.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.65 0.78 . . . . 0.0 109.863 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 28' ' ' ARG . 43.9 tp -88.59 112.27 22.86 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 26.4 tp60 -80.23 123.38 27.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.438 0.695 . . . . 0.0 109.665 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 95.4 mt -111.55 111.28 22.18 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.7 t -98.55 100.51 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 6.8 tm-20 -82.56 131.02 35.22 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.9 m -138.88 128.32 24.41 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.317 1.047 . . . . 0.0 108.763 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.89 -155.13 26.22 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.55 151.01 5.29 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 122.914 0.293 . . . . 0.0 112.899 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.66 -173.61 43.28 Favored Glycine 0 C--O 1.241 0.593 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.08 134.35 41.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.543 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 HD12 ' A' ' 87' ' ' LEU . 13.5 p -152.56 156.67 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.712 0.805 . . . . 0.0 108.913 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 122' ' ' SER . 43.3 mt-30 -81.26 161.23 24.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.368 0.667 . . . . 0.0 110.556 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 131.97 46.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.647 0.379 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.43 -15.08 62.7 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.743 0.652 . . . . 0.0 111.489 -170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.17 -171.08 40.23 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.027 0.346 . . . . 0.0 113.833 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 18.3 p -137.85 160.34 39.53 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 0.0 110.885 -173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.1 tp -159.92 164.03 33.78 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -130.22 140.63 50.7 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.246 0.546 . . . . 0.0 111.121 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.606 HD23 HD12 ' A' ' 82' ' ' LEU . 1.7 mm? -119.64 157.81 27.71 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.606 1.563 . . . . 0.0 107.472 171.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 t -151.56 163.75 38.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.453 0.301 . . . . 0.0 110.256 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.6 t -152.86 122.62 6.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.06 0.544 . . . . 0.0 110.61 177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.61 127.63 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.17 136.45 44.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.264 0.626 . . . . 0.0 109.49 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 9.5 t -71.94 -175.44 1.44 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.431 1.092 . . . . 0.0 112.674 -173.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.58 -19.84 54.99 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 45.7 mmm-85 -60.81 145.88 48.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.602 0.761 . . . . 0.0 111.346 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 64.3 p -70.63 91.16 0.79 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 0.0 110.133 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -60.18 -21.35 61.59 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.141 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 17.6 p -67.17 -0.2 3.19 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.44 1.496 . . . . 0.0 113.462 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.8 m -106.98 -3.3 20.26 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.253 0.621 . . . . 0.0 111.019 173.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.82 155.49 36.48 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.137 0.575 . . . . 0.0 111.021 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.87 125.84 35.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.538 ' HG2' HG21 ' A' ' 80' ' ' VAL . 3.0 tpt -99.17 116.92 32.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.413 1.085 . . . . 0.0 109.033 -172.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.641 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -132.85 142.19 13.67 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 114.072 0.389 . . . . 0.0 114.072 -173.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -96.72 134.15 40.35 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.959 1.303 . . . . 0.0 109.319 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -124.5 164.73 19.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.908 1.283 . . . . 0.0 108.354 173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -143.13 154.12 43.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.161 0.437 . . . . 0.0 111.548 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -166.08 151.02 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.623 1.169 . . . . 0.0 109.025 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.36 -64.92 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 C-N-CA 124.017 0.927 . . . . 0.0 111.068 166.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 54.5 Cg_endo -84.43 69.63 6.07 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.008 1.805 . . . . 0.0 111.949 -172.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.31 5.61 63.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.341 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -92.37 139.97 30.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.142 0.977 . . . . 0.0 109.547 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -87.44 169.0 12.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.532 0.733 . . . . 0.0 109.495 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -63.11 103.84 0.51 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.91 155.47 22.6 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.904 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.9 109.52 1.28 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.718 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -87.83 -63.62 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.47 134.11 1.79 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.724 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG22 ' HA3' ' A' ' 36' ' ' GLY . 69.9 t -118.31 129.97 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.662 0.785 . . . . 0.0 109.344 174.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 59' ' ' THR . 11.7 p -105.94 146.27 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -77.26 148.91 35.51 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.4 p-90 -48.26 -33.65 9.04 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -169.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.1 t -83.57 -32.45 25.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.553 0.741 . . . . 0.0 111.483 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.6 -8.19 61.8 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.35 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.96 -41.46 78.36 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.794 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -107.7 130.87 54.89 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.383 0.673 . . . . 0.0 109.655 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.606 HG22 HG23 ' A' ' 52' ' ' VAL . 32.9 p -130.94 143.88 51.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.456 1.102 . . . . 0.0 109.002 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -131.45 144.5 51.22 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.312 0.645 . . . . 0.0 109.682 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.89 145.51 42.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.523 0.729 . . . . 0.0 109.075 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -58.35 -29.61 66.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.536 0.734 . . . . 0.0 112.054 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 m -66.04 -31.27 72.06 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.253 1.021 . . . . 0.0 111.911 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.15 -2.56 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.955 0.902 . . . . 0.0 111.911 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -73.85 137.01 43.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.835 0.454 . . . . 0.0 110.825 -174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.95 -24.83 22.64 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.678 0.611 . . . . 0.0 113.015 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.7 ptt85 -113.04 -12.46 13.2 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.668 0.787 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 82' ' ' LEU . 3.1 m-85 -109.78 145.22 37.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.363 0.665 . . . . 0.0 109.725 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -144.35 129.82 18.96 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.045 0.938 . . . . 0.0 109.045 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.455 HG12 HD23 ' A' ' 82' ' ' LEU . 5.6 mt -101.65 120.48 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -124.92 138.3 54.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.57 0.748 . . . . 0.0 109.07 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.68 137.61 30.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.626 0.37 . . . . 0.0 110.031 -175.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -105.79 101.6 11.1 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.16 -21.69 65.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.584 0.754 . . . . 0.0 110.896 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.25 -44.54 79.17 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.282 1.033 . . . . 0.0 110.917 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -86.58 -10.92 52.93 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.401 0.68 . . . . 0.0 111.163 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.475 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 62.97 28.1 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.637 1.175 . . . . 0.0 110.362 -177.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.6 m -121.94 132.15 54.39 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.666 0.786 . . . . 0.0 110.533 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 35' ' ' MET . 26.1 t -100.57 157.35 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.714 1.206 . . . . 0.0 109.236 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -139.05 155.46 47.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.54 1.136 . . . . 0.0 109.247 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.606 HD12 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -130.42 122.14 27.22 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 170.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -98.62 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.347 1.059 . . . . 0.0 108.519 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 48.8 mtt -86.47 125.22 33.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.593 0.757 . . . . 0.0 109.056 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.63 153.59 47.11 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.1 m 54.88 46.48 24.36 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.825 0.85 . . . . 0.0 111.91 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD12 HG11 ' A' ' 13' ' ' VAL . 63.9 mt -66.33 128.97 38.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.556 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.08 157.84 53.54 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 124.521 1.129 . . . . 0.0 108.635 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.49 -16.49 35.97 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.677 2.252 . . . . 0.0 113.722 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.47 -26.3 68.66 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.339 1.056 . . . . 0.0 112.247 177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.63 -12.51 60.02 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.7 m -61.43 99.34 0.1 Allowed 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.327 0.512 . . . . 0.0 109.683 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.55 157.13 3.14 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.671 -171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 117' ' ' THR . 5.1 p -80.11 112.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 171.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -87.62 119.55 28.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.177 0.991 . . . . 0.0 109.719 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.404 HD22 ' HA3' ' A' ' 116' ' ' GLY . 18.6 m120 -101.81 126.18 48.63 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.185 0.994 . . . . 0.0 109.346 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 20.2 t -85.07 107.66 17.28 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.402 0.681 . . . . 0.0 109.628 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -108.21 158.31 17.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.635 0.774 . . . . 0.0 110.997 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.67 123.51 15.28 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.162 0.985 . . . . 0.0 108.737 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.08 178.54 37.87 Favored Glycine 0 C--N 1.333 0.406 0 O-C-N 123.414 0.446 . . . . 0.0 112.003 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -81.78 95.27 7.22 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 67.54 -78.05 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.903 1.281 . . . . 0.0 110.332 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -178.53 -52.6 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.924 1.69 . . . . 0.0 107.754 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.42 -145.08 8.58 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.54 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.7 m -148.78 -75.26 0.17 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.156 0.583 . . . . 0.0 110.132 172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -89.63 -33.9 16.49 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.438 0.695 . . . . 0.0 109.13 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -122.5 139.91 53.35 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.43 1.092 . . . . 0.0 108.182 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.85 130.81 10.38 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.42 104.48 1.67 Allowed Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.327 0.651 . . . . 0.0 110.177 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.08 128.0 20.69 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.858 2.372 . . . . 0.0 111.756 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.77 -46.84 88.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.928 0.891 . . . . 0.0 111.254 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -126.8 159.47 33.73 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 109.303 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 48.8 p90 -155.71 165.92 35.07 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.483 0.713 . . . . 0.0 110.211 176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -112.7 -170.37 17.97 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.737 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -65.53 -56.63 11.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.778 0.831 . . . . 0.0 110.967 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.29 151.05 23.76 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.449 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 10.2 t -130.8 136.09 48.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.275 0.63 . . . . 0.0 111.213 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -75.14 108.48 7.92 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.56 139.85 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.524 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.1 m -126.07 105.34 8.81 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.59 109.06 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.192 0.597 . . . . 0.0 109.435 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 46.9 t -55.96 122.36 11.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.87 1.268 . . . . 0.0 111.07 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.0 t -63.5 93.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.918 0.887 . . . . 0.0 110.201 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -116.14 100.94 8.29 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -168.79 133.61 1.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.256 1.023 . . . . 0.0 108.579 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -62.96 127.3 30.61 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.567 0.542 . . . . 0.0 110.779 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -165.56 146.07 6.9 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.721 0.809 . . . . 0.0 109.732 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -153.11 131.69 12.24 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.604 0.762 . . . . 0.0 109.105 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -99.38 151.36 21.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -157.35 179.42 9.27 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.574 0.75 . . . . 0.0 109.523 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 35.9 m170 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 170.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -139.28 174.08 10.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.814 0.846 . . . . 0.0 111.161 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 49.7 tp -96.31 110.62 22.91 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 25' ' ' ALA . 27.5 tt0 -79.56 110.35 14.8 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.719 0.808 . . . . 0.0 109.578 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.512 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 44.0 mt -104.81 112.99 26.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.66 101.11 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.436 0.694 . . . . 0.0 109.572 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.41 149.3 26.77 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.773 0.32 . . . . 0.0 110.295 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.0 p -159.42 168.22 26.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.318 1.047 . . . . 0.0 109.553 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.46 -7.63 54.1 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-O 120.034 -0.315 . . . . 0.0 113.177 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.14 126.59 8.36 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.698 0.249 . . . . 0.0 112.808 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.71 -164.73 20.65 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.77 141.6 30.4 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.119 0.485 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -151.74 159.41 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.209 1.404 . . . . 0.0 107.968 -177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -88.11 165.12 15.35 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.889 0.476 . . . . 0.0 111.459 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.91 120.98 13.56 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.453 0.701 . . . . 0.0 109.425 172.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 5.03 75.8 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.926 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.67 -176.48 49.23 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.572 0.219 . . . . 0.0 113.145 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.0 p -134.46 158.04 44.93 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -158.01 143.13 16.67 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.295 0.638 . . . . 0.0 109.652 -173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -111.64 122.23 47.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.8 mm? -96.13 150.36 20.59 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.5 t -139.57 125.08 19.22 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.78 135.54 53.41 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.654 0.782 . . . . 0.0 109.107 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.73 118.93 37.51 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.307 0.643 . . . . 0.0 109.31 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 4' ' ' GLN . . . -104.56 135.94 45.04 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.162 0.585 . . . . 0.0 109.599 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 65.6 m -149.69 162.7 39.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.991 0.916 . . . . 0.0 110.07 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 -96.24 1.89 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.564 ' HB3' ' HE2' ' A' ' 33' ' ' TYR . 16.4 mmt85 -67.27 164.54 18.11 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.07 0.548 . . . . 0.0 111.869 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.3 p -71.63 83.98 0.86 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.874 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.487 ' HD1' HD21 ' A' ' 3' ' ' LEU . 78.2 t80 -57.73 -29.99 65.2 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.526 0.73 . . . . 0.0 111.37 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -71.18 0.68 7.27 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.392 1.077 . . . . 0.0 112.877 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.1 m -112.5 -9.25 13.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.998 0.919 . . . . 0.0 111.113 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.564 ' HE2' ' HB3' ' A' ' 28' ' ' ARG . 47.0 m-85 -114.79 138.84 50.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.909 0.483 . . . . 0.0 110.75 -175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.31 157.62 26.34 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 167.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.488 ' SD ' ' HB3' ' A' ' 97' ' ' CYS . 13.9 ttp -141.37 147.54 38.2 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -141.82 150.83 22.31 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.23 0.332 . . . . 0.0 112.43 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -97.84 127.51 43.83 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.652 0.781 . . . . 0.0 109.155 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.52 132.77 49.89 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.276 1.031 . . . . 0.0 108.271 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 27.6 ptt180 -116.73 158.67 23.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.533 0.333 . . . . 0.0 110.771 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.539 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -170.06 153.81 4.81 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.686 0.794 . . . . 0.0 109.078 171.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.73 -54.34 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 118.516 -0.755 . . . . 0.0 111.528 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.43 68.22 8.07 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.039 1.826 . . . . 0.0 112.457 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.38 21.14 64.11 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.049 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -115.58 156.62 25.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.336 0.654 . . . . 0.0 111.564 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.57 170.43 16.66 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.546 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -61.64 103.89 0.37 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.55 146.54 24.38 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.671 0.788 . . . . 0.0 109.562 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -65.25 120.96 13.7 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.863 0.865 . . . . 0.0 110.23 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.577 HG11 ' HE2' ' A' ' 95' ' ' TYR . 52.0 t -101.94 -54.35 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -168.31 154.81 7.39 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.112 -173.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 ' HA3' ' A' ' 36' ' ' GLY . 70.5 t -140.37 147.5 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.704 1.202 . . . . 0.0 108.328 170.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -141.29 153.1 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.184 0.994 . . . . 0.0 108.985 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -76.66 161.15 28.78 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 167.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -55.17 -39.4 69.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.296 0.638 . . . . 0.0 110.696 172.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -74.31 -19.99 60.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.474 1.109 . . . . 0.0 111.584 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.87 19.03 78.21 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -167.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -58.91 -64.8 0.81 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.286 1.034 . . . . 0.0 110.851 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -112.84 129.56 56.4 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 52' ' ' VAL . 65.2 p -114.47 130.31 56.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -116.23 126.92 54.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -118.7 150.75 39.21 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.184 0.594 . . . . 0.0 109.923 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -79.62 130.71 35.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.89 -22.51 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -67.81 -40.98 83.77 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.626 0.77 . . . . 0.0 111.409 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 62' ' ' ALA . 32.2 m -106.86 3.72 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.934 0.894 . . . . 0.0 111.578 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -68.6 128.49 36.8 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.869 0.867 . . . . 0.0 111.288 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 -17.56 50.83 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.361 -0.381 . . . . 0.0 113.619 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -103.04 -19.12 14.68 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -102.34 157.88 16.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.372 0.669 . . . . 0.0 110.216 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.2 m -149.27 133.12 17.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.588 1.155 . . . . 0.0 108.105 173.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.507 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.6 mp -103.0 131.13 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -133.15 160.42 37.29 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.323 1.049 . . . . 0.0 108.334 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 167.29 30.57 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -132.96 111.86 11.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.99 -16.19 60.63 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.588 0.755 . . . . 0.0 112.083 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.1 -50.64 11.64 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.0 -14.55 57.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.424 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER 61.7 28.64 17.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.004 1.321 . . . . 0.0 111.275 -177.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 m -113.51 130.86 56.25 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.898 0.479 . . . . 0.0 110.516 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.31 151.55 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.852 1.261 . . . . 0.0 109.787 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -135.5 112.94 10.66 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.397 1.079 . . . . 0.0 108.931 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.0 tm? -93.6 103.1 15.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.73 104.06 16.69 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.749 0.82 . . . . 0.0 109.329 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.451 ' HB3' HD21 ' A' ' 87' ' ' LEU . 44.7 mtt -90.41 139.4 30.71 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.85 1.26 . . . . 0.0 110.963 178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.61 140.11 45.83 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m 54.71 58.84 4.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 111.713 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 84' ' ' MET . 56.4 mt -64.17 124.78 22.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.819 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.9 mtpt -72.5 144.08 85.99 Favored Pre-proline 0 C--O 1.21 -0.984 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.668 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 51.3 Cg_exo -56.45 -21.52 37.94 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.868 2.379 . . . . 0.0 114.273 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.83 3.46 55.09 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.828 1.251 . . . . 0.0 112.79 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -79.79 -17.05 54.31 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.72 0.808 . . . . 0.0 111.35 -172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 120' ' ' THR . 94.2 m -53.57 108.73 0.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.701 1.2 . . . . 0.0 112.11 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.95 160.45 4.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.748 0.819 . . . . 0.0 111.295 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 13.8 p -81.04 114.49 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.041 0.448 . . . . 0.0 110.173 173.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HE2' HG11 ' A' ' 49' ' ' VAL . 19.8 m-85 -87.23 127.87 35.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.835 1.254 . . . . 0.0 110.374 177.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.67 142.94 51.02 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.696 0.798 . . . . 0.0 110.001 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.488 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 71.5 m -92.22 112.02 23.81 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.004 0.922 . . . . 0.0 109.159 173.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.97 112.71 25.94 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -108.12 169.84 8.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.547 0.739 . . . . 0.0 111.181 -174.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.91 -149.66 17.77 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -96.1 117.78 31.39 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -98.95 -3.92 33.94 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.774 0.83 . . . . 0.0 109.703 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -103.87 171.88 7.11 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.878 0.871 . . . . 0.0 110.783 -169.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.49 -80.47 1.82 Allowed Glycine 0 C--N 1.349 1.288 0 C-N-CA 123.586 0.612 . . . . 0.0 112.091 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.3 t -152.53 29.35 0.54 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.292 1.037 . . . . 0.0 108.67 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -122.29 29.03 7.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 0.0 110.733 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -70.88 101.55 2.17 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.546 0.738 . . . . 0.0 109.543 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.04 -16.69 32.74 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.415 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.05 101.73 23.45 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.074 0.949 . . . . 0.0 109.951 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -84.87 162.06 11.98 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.3 2.0 . . . . 0.0 111.656 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.65 -34.38 17.28 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 169.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 51.0 m-85 -127.51 152.6 47.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.639 0.776 . . . . 0.0 110.01 -172.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -132.16 139.06 48.27 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.512 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.62 -169.03 44.58 Favored Glycine 0 C--O 1.244 0.741 0 O-C-N 123.117 0.261 . . . . 0.0 113.731 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -71.82 -54.78 9.08 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.435 0.694 . . . . 0.0 110.366 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 106.3 2.77 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.198 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.0 t -101.69 121.45 42.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.279 1.032 . . . . 0.0 109.848 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 15.7 tm0? -86.61 124.94 33.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.825 0.45 . . . . 0.0 110.059 -175.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.99 141.31 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.523 0.729 . . . . 0.0 109.04 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.468 ' HA ' HG23 ' A' ' 92' ' ' THR . 57.5 m -129.16 106.84 9.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.281 0.632 . . . . 0.0 109.656 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.8 p -93.36 128.23 44.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.3 t -69.38 111.89 5.56 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.52 0.728 . . . . 0.0 109.217 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 34.9 p -76.78 81.27 3.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.325 0.65 . . . . 0.0 110.655 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 42.1 tp -81.74 72.91 8.8 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.415 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -139.37 161.71 36.8 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.246 1.018 . . . . 0.0 109.748 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -79.57 -23.49 42.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.155 0.582 . . . . 0.0 110.581 171.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.0 m80 61.23 28.55 18.11 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.655 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -89.62 49.63 1.77 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.727 0.811 . . . . 0.0 110.645 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -77.93 -42.96 31.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -156.9 -76.35 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.477 1.111 . . . . 0.0 108.636 173.051 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 mtm . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -144.38 64.74 1.3 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.556 1.17 . . . . 0.0 110.199 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.4 tp -128.67 112.91 14.74 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 113.709 -1.587 . . . . 0.0 107.175 171.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -72.28 102.69 3.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HB2' ' HA2' ' A' ' 114' ' ' GLY . 87.9 mt -112.84 103.62 11.62 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 57.3 t -99.74 99.6 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -175.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 117' ' ' THR . 50.9 mt-10 -85.77 142.67 28.8 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.953 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 t -158.44 172.28 18.62 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.32 0.648 . . . . 0.0 110.16 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.52 6.77 70.12 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.051 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 119.68 4.97 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.26 -164.86 23.67 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.6 pp -78.23 147.1 34.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.13 143.53 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.448 1.099 . . . . 0.0 108.345 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.93 153.37 42.24 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.53 0.732 . . . . 0.0 111.309 -177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 110.54 2.38 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.126 0.57 . . . . 0.0 110.231 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.05 10.49 59.72 Favored Glycine 0 N--CA 1.464 0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.599 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.29 -169.15 43.08 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.644 0.261 . . . . 0.0 112.998 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.5 p -123.11 148.68 45.42 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.732 0.813 . . . . 0.0 110.759 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 tp -152.66 123.64 7.48 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -99.41 111.16 23.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.083 0.468 . . . . 0.0 110.382 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.64 157.65 20.28 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.043 0.937 . . . . 0.0 110.344 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.9 t -147.25 157.92 43.77 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.061 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 43.3 t -142.35 120.97 12.55 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.475 0.71 . . . . 0.0 109.799 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -84.79 109.69 18.26 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.42 38.09 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.49 0.716 . . . . 0.0 109.368 -173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -158.58 158.65 34.32 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.669 0.787 . . . . 0.0 109.853 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.72 -93.81 0.93 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HD3' ' H ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -91.64 154.02 19.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.417 0.687 . . . . 0.0 109.453 -177.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.458 ' H ' ' HD3' ' A' ' 28' ' ' ARG . 39.2 p -70.13 84.93 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.43 0.633 . . . . 0.0 110.892 175.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -63.24 -19.56 64.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.928 0.891 . . . . 0.0 111.212 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -49.22 -40.4 33.62 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.995 1.718 . . . . 0.0 113.141 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m -77.88 -21.88 50.63 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.138 0.975 . . . . 0.0 112.199 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -96.93 148.68 22.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.37 0.668 . . . . 0.0 110.797 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . . . -76.01 156.63 33.88 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttp -141.58 141.09 33.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.13 0.572 . . . . 0.0 110.204 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 142.66 14.17 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -97.21 129.32 44.57 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 108.959 171.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -132.91 143.04 49.23 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.412 1.085 . . . . 0.0 109.359 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -125.64 155.85 40.14 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 118.256 0.48 . . . . 0.0 112.25 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.01 144.19 6.74 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.792 0.837 . . . . 0.0 110.992 171.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 167.87 -50.35 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 C-N-CA 125.28 1.432 . . . . 0.0 111.939 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.28 61.96 8.34 Favored 'Trans proline' 0 C--N 1.4 3.268 0 C-N-CA 122.558 2.172 . . . . 0.0 113.122 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.52 21.41 70.67 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.553 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -127.67 150.49 49.73 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.791 0.837 . . . . 0.0 110.728 -173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 173.47 9.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.82 0.848 . . . . 0.0 109.629 175.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -69.18 109.06 3.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.333 0.587 . . . . 0.0 111.056 -172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -112.14 157.76 20.44 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.342 -170.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -63.67 121.82 14.87 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.884 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HG11 ' A' ' 65' ' ' VAL . 61.7 t -106.59 -66.85 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -153.76 134.07 13.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.56 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.8 t -122.29 155.58 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.187 0.995 . . . . 0.0 108.589 177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.23 150.27 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.04 170.14 14.21 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.829 0.452 . . . . 0.0 110.538 171.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -60.37 -43.23 96.77 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -170.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.1 m -88.63 -2.1 58.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.071 0.548 . . . . 0.0 111.874 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.22 11.88 85.12 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.122 0.264 . . . . 0.0 113.076 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -62.74 -39.44 94.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.2 1.0 . . . . 0.0 111.325 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -115.81 135.08 54.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.671 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 p -125.26 129.33 49.82 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.12 141.44 41.31 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.447 1.499 . . . . 0.0 108.286 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -141.43 146.09 36.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.292 0.637 . . . . 0.0 109.943 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.97 151.39 40.33 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 164.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.55 -33.74 47.0 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.12 0.968 . . . . 0.0 112.973 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -75.77 -41.89 51.8 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.098 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.478 HG11 HG13 ' A' ' 49' ' ' VAL . 9.3 m -92.08 -4.73 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.37 0.668 . . . . 0.0 111.244 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.01 129.14 38.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.587 0.755 . . . . 0.0 110.734 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.73 -25.44 6.62 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.787 0.679 . . . . 0.0 113.906 176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.413 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 19.6 ptp180 -102.4 -24.58 13.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.531 0.733 . . . . 0.0 111.017 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.413 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.1 m-30 -97.84 161.29 13.82 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.5 m -148.41 135.74 20.4 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.601 1.16 . . . . 0.0 108.736 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.513 HD11 ' HB1' ' A' ' 50' ' ' ALA . 1.9 mp -100.9 139.16 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -142.37 148.85 38.56 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.191 0.996 . . . . 0.0 109.127 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 136.73 19.95 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -117.29 117.69 30.23 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -85.24 -14.48 46.6 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.677 0.791 . . . . 0.0 111.928 -171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -86.38 -45.91 10.76 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.257 0.623 . . . . 0.0 110.254 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.05 -20.13 56.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.947 0.899 . . . . 0.0 110.448 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.402 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER 62.2 39.45 12.66 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.574 1.171 . . . . 0.0 109.74 -175.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 m -129.51 131.43 46.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.917 0.487 . . . . 0.0 111.06 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 75.3 t -98.16 148.3 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.297 1.439 . . . . 0.0 109.878 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -134.28 141.73 47.06 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.039 0.936 . . . . 0.0 109.085 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -133.34 105.17 6.81 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -84.27 106.27 15.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.591 0.756 . . . . 0.0 109.068 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 53.3 mtt -102.11 128.7 48.47 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -128.1 144.39 51.11 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m 57.33 64.51 1.58 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.165 0.986 . . . . 0.0 112.014 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 91.4 mt -77.77 120.63 22.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.14 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' HG11 ' A' ' 121' ' ' VAL . 46.4 mtpt -74.23 152.32 88.13 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-O 118.073 -0.965 . . . . 0.0 108.643 175.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.553 ' HB3' ' HB3' ' A' ' 123' ' ' SER . 98.7 Cg_exo -48.78 -26.97 10.39 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.205 2.603 . . . . 0.0 114.773 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.41 -22.72 60.15 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.089 0.956 . . . . 0.0 112.816 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.17 -6.63 14.08 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.577 0.751 . . . . 0.0 112.346 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.2 m -61.74 98.76 0.1 Allowed 'General case' 0 C--N 1.364 1.225 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.78 159.03 7.79 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.523 -170.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -86.35 114.4 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 171.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.465 ' HE2' HG11 ' A' ' 49' ' ' VAL . 49.9 m-85 -86.41 150.06 24.57 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.931 0.892 . . . . 0.0 108.706 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.65 121.58 12.79 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 29.7 p -85.09 102.53 13.32 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.39 142.89 35.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.633 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.64 121.54 44.54 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.072 0.463 . . . . 0.0 110.256 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.94 142.32 5.07 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.323 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . 2.9 tmmm? -82.21 102.22 10.98 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 36.5 m0 59.68 83.87 0.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.053 1.341 . . . . 0.0 111.052 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -78.83 143.35 36.09 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.759 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.81 -12.36 47.21 Favored Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.505 0.574 . . . . 0.0 112.948 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.1 m 66.89 8.26 5.93 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.014 1.326 . . . . 0.0 112.802 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -178.46 -58.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -82.0 84.97 6.8 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.05 152.2 26.59 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -166.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.26 155.06 70.45 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 123.851 0.86 . . . . 0.0 109.365 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.27 141.82 40.04 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.498 2.132 . . . . 0.0 111.072 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.55 -24.93 61.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.967 0.507 . . . . 0.0 110.735 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 57.3 m-85 -126.17 155.27 41.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.699 0.8 . . . . 0.0 109.573 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -136.11 147.94 48.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.633 0.773 . . . . 0.0 109.935 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -88.96 -170.23 45.13 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 116.521 -0.308 . . . . 0.0 113.46 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 5' ' ' LEU . 15.5 mm100 -85.66 -38.65 18.13 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.213 0.605 . . . . 0.0 109.958 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.02 109.32 2.28 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.381 -174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 7' ' ' GLU . 8.4 t -99.87 113.67 26.36 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.482 0.658 . . . . 0.0 109.563 174.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.615 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.1 tm0? -82.15 123.43 28.98 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 m -110.09 139.31 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.425 ' HA ' HG23 ' A' ' 92' ' ' THR . 27.6 m -117.66 104.84 11.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.5 p -88.85 101.22 11.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 172.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.0 t -65.71 113.08 4.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.965 -174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 18.3 p -70.06 94.98 0.92 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.525 0.73 . . . . 0.0 109.622 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.41 67.73 5.23 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.961 0.904 . . . . 0.0 108.816 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -70.82 -73.09 0.18 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.726 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -140.28 -69.13 0.4 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.518 0.727 . . . . 0.0 109.17 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.3 m80 59.74 88.07 0.08 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.027 1.331 . . . . 0.0 111.325 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -142.3 -179.41 6.25 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.026 0.93 . . . . 0.0 109.973 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 63.71 30.6 14.71 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 123.867 0.867 . . . . 0.0 109.902 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -59.58 -31.11 69.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.982 0.913 . . . . 0.0 110.698 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 C--O 1.249 1.039 0 C-N-CA 123.877 0.871 . . . . 0.0 108.804 167.646 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -86.67 177.73 7.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.073 0.549 . . . . 0.0 110.516 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 30' ' ' PHE . 46.0 tp -112.72 111.76 22.78 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -86.29 104.03 15.44 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.657 0.783 . . . . 0.0 109.282 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.48 104.98 14.82 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.83 114.95 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -113.49 134.63 54.57 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.608 0.763 . . . . 0.0 109.422 -168.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.1 m -157.22 149.11 22.5 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.454 1.102 . . . . 0.0 109.998 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.13 -6.5 0.82 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-O 119.775 -0.458 . . . . 0.0 112.815 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.61 151.81 38.34 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.832 0.316 . . . . 0.0 113.617 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.72 -167.6 34.93 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 pp -93.7 133.48 37.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.304 0.642 . . . . 0.0 110.384 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.57 143.32 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.1 0.96 . . . . 0.0 109.253 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.485 ' H ' ' NE2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -62.05 159.02 15.21 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.149 0.979 . . . . 0.0 112.784 -177.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.18 122.49 17.21 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.72 0.808 . . . . 0.0 110.396 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.46 -1.25 69.09 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.252 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.65 -163.41 29.29 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.19 0.424 . . . . 0.0 113.481 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -137.3 146.98 45.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.0 111.03 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.3 tp -154.5 121.41 5.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.655 0.782 . . . . 0.0 109.45 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -96.23 129.58 43.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.562 1.145 . . . . 0.0 110.574 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -102.92 158.31 16.37 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.31 1.044 . . . . 0.0 108.712 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -151.15 124.17 8.7 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.656 0.383 . . . . 0.0 110.181 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 43.3 t -117.34 116.94 28.2 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.578 0.751 . . . . 0.0 110.245 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.03 119.7 25.26 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.05 139.76 40.93 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.39 1.076 . . . . 0.0 109.402 -177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.408 ' O ' HD12 ' A' ' 3' ' ' LEU . 12.6 t -153.72 173.26 16.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.895 0.478 . . . . 0.0 110.649 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.59 -106.26 3.39 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -84.49 168.22 15.66 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.282 0.541 . . . . 0.0 109.743 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.8 p -72.43 102.65 3.24 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.901 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.443 ' HB3' HD11 ' A' ' 3' ' ' LEU . 16.7 p90 -64.85 -25.33 67.85 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.622 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 p -74.93 -0.1 17.52 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.955 1.302 . . . . 0.0 112.596 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.9 t -92.31 -7.69 47.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.21 0.604 . . . . 0.0 110.192 170.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -129.58 154.11 47.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.343 1.057 . . . . 0.0 110.251 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 102' ' ' TRP . . . -86.52 145.14 26.91 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.572 ' SD ' HG21 ' A' ' 80' ' ' VAL . 15.2 ptm -120.24 159.04 25.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.802 0.441 . . . . 0.0 109.898 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.519 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -147.29 142.55 10.36 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.174 -176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -96.74 132.01 42.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.099 0.96 . . . . 0.0 109.193 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.94 164.82 19.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.374 1.07 . . . . 0.0 108.14 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 38.3 ptt180 -146.92 154.06 40.84 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.746 0.248 . . . . 0.0 111.263 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.417 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -165.16 145.79 7.25 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.069 0.856 . . . . 0.0 110.169 172.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 171.55 -52.66 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.23 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.38 50.6 3.06 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 122.749 2.299 . . . . 0.0 112.657 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.63 -8.92 53.42 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.019 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -94.7 132.35 39.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.77 0.828 . . . . 0.0 109.05 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.02 179.16 5.13 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.946 0.779 . . . . 0.0 110.817 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -54.1 105.4 0.14 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.46 0.704 . . . . 0.0 110.247 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -111.73 149.5 31.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.259 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.406 ' HE2' HG23 ' A' ' 51' ' ' VAL . 87.2 t80 -68.65 113.82 6.48 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.225 1.01 . . . . 0.0 109.626 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -89.04 -66.4 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -164.3 162.32 22.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.649 -174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG22 ' HA3' ' A' ' 36' ' ' GLY . 53.3 t -137.83 152.46 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.714 1.206 . . . . 0.0 107.77 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG23 HG22 ' A' ' 59' ' ' THR . 13.3 p -131.46 143.37 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.047 0.939 . . . . 0.0 108.824 172.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.33 158.18 36.28 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -57.95 -35.63 71.4 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.519 0.728 . . . . 0.0 112.197 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.1 p -76.67 -29.89 56.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.422 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' NH1' ' A' ' 73' ' ' ARG . . . 83.67 3.42 89.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 113.524 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -62.69 -34.53 77.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.886 0.874 . . . . 0.0 111.041 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.83 130.9 49.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.734 0.814 . . . . 0.0 110.25 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.502 HG22 HG23 ' A' ' 52' ' ' VAL . 30.5 p -115.44 129.24 56.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.571 1.148 . . . . 0.0 108.896 173.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -93.69 140.94 29.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.203 1.001 . . . . 0.0 108.887 174.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -130.39 151.67 50.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.157 0.583 . . . . 0.0 109.866 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.21 144.91 37.93 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 161.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -57.89 -28.75 64.48 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.855 0.462 . . . . 0.0 112.047 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.4 t -70.99 -44.35 66.14 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.753 0.421 . . . . 0.0 111.124 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -92.83 1.95 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.629 0.372 . . . . 0.0 111.58 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.74 108.82 1.06 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.369 1.068 . . . . 0.0 111.734 -176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.88 -26.33 13.21 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.662 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 7.1 ptt180 -84.14 -33.47 24.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.294 0.547 . . . . 0.0 109.616 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.426 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 5.1 m-30 -97.41 158.74 15.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -145.47 130.69 18.5 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.206 1.002 . . . . 0.0 108.845 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.481 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -102.67 126.48 56.84 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 24.8 m -123.81 154.03 40.17 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.149 0.98 . . . . 0.0 108.654 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' NH1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -140.68 143.85 35.33 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -121.78 96.84 5.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -67.88 -25.38 65.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.514 0.726 . . . . 0.0 111.411 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.52 -52.59 30.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.516 0.727 . . . . 0.0 111.177 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -86.98 -4.66 59.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.279 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 60.8 30.95 20.0 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.813 1.245 . . . . 0.0 111.616 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -119.96 131.95 55.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.308 0.643 . . . . 0.0 110.827 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.572 HG21 ' SD ' ' A' ' 35' ' ' MET . 57.2 t -96.23 151.08 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.986 1.314 . . . . 0.0 109.077 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 72' ' ' SER . 76.6 m-85 -132.62 146.16 51.66 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.872 0.869 . . . . 0.0 109.077 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -134.74 102.97 5.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -87.15 102.83 14.83 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.611 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.5 mtm -89.71 118.31 29.22 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.81 156.71 28.94 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.5 m 59.19 47.98 11.0 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.085 0.954 . . . . 0.0 110.827 174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 84' ' ' MET . 78.3 mt -63.92 117.69 7.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.968 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' O ' HG11 ' A' ' 121' ' ' VAL . 48.4 mtpt -77.17 154.79 82.44 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.555 -0.735 . . . . 0.0 109.338 176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -51.98 -25.38 21.94 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.25 2.633 . . . . 0.0 114.421 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.58 -18.72 60.53 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.867 0.867 . . . . 0.0 112.837 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.73 -8.35 47.16 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.77 0.828 . . . . 0.0 113.042 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.2 m -62.99 98.52 0.13 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -169.1 159.73 9.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.338 0.655 . . . . 0.0 111.116 -170.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.2 p -83.6 113.51 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -88.45 112.91 23.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.916 0.886 . . . . 0.0 109.238 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -103.6 129.46 50.87 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.439 1.096 . . . . 0.0 110.366 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.17 101.91 13.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.882 0.873 . . . . 0.0 109.578 174.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.35 28.53 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.517 0.727 . . . . 0.0 109.446 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.98 136.44 44.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.3 0.64 . . . . 0.0 109.448 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.695 ' HA3' ' H ' ' A' ' 111' ' ' ASP . . . 132.13 -28.34 3.5 Favored Glycine 0 C--N 1.341 0.852 0 O-C-N 123.641 0.588 . . . . 0.0 113.023 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -74.66 93.49 2.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.203 0.525 . . . . 0.0 109.708 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.637 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . 22.1 t90 -98.91 2.41 46.54 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.182 0.993 . . . . 0.0 110.239 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.56 139.34 34.98 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.654 0.782 . . . . 0.0 110.158 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.87 45.72 1.11 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.0 p -143.64 -68.47 0.33 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.349 0.66 . . . . 0.0 110.294 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.38 -57.91 8.77 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.802 0.841 . . . . 0.0 110.125 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -167.69 -72.53 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.881 0.872 . . . . 0.0 109.186 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.59 82.5 0.09 OUTLIER Glycine 0 C--N 1.351 1.367 0 O-C-N 123.544 0.528 . . . . 0.0 112.069 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.8 133.08 82.52 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.271 0.628 . . . . 0.0 111.548 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.31 116.37 3.85 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.171 1.914 . . . . 0.0 110.314 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.695 ' H ' ' HA3' ' A' ' 100' ' ' GLY . 29.5 t70 -62.72 -46.21 89.13 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.702 1.201 . . . . 0.0 110.564 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -139.22 155.23 47.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 0.0 110.074 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -115.06 119.13 35.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.454 1.102 . . . . 0.0 108.416 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.85 151.22 38.86 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.51 -37.1 82.47 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.107 0.454 . . . . 0.0 110.8 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.74 171.79 24.14 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.177 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -127.65 135.18 49.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.971 0.385 . . . . 0.0 110.629 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 11.3 tm0? -80.35 107.79 13.44 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG11 ' HE1' ' A' ' 84' ' ' MET . 4.4 m -91.21 146.38 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.8 m -123.15 114.11 19.87 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.343 0.657 . . . . 0.0 109.412 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 88' ' ' LYS . 3.7 p -98.56 120.98 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 43.0 t -72.47 111.97 8.12 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.187 0.995 . . . . 0.0 110.128 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.5 p -73.42 118.37 16.3 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 63.0 tp -69.76 78.31 0.45 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.117 0.967 . . . . 0.0 109.988 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -179.88 -38.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.012 1.325 . . . . 0.0 109.187 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -115.18 52.25 0.88 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.121 0.968 . . . . 0.0 109.688 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -78.1 79.71 4.54 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -93.49 116.46 28.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.282 1.033 . . . . 0.0 110.778 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -91.07 81.67 5.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.581 0.705 . . . . 0.0 109.944 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.77 147.45 50.01 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.213 1.005 . . . . 0.0 108.81 174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 124.13 0.972 . . . . 0.0 109.501 -177.58 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.533 0.206 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -110.11 160.18 16.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.303 0.641 . . . . 0.0 110.458 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 61.2 tp -115.35 110.63 19.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -85.59 121.91 28.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.879 0.871 . . . . 0.0 109.35 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.584 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 74.7 mt -112.88 107.24 15.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.945 0.898 . . . . 0.0 108.733 177.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.24 104.42 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.9 156.74 18.73 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.019 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -159.5 172.35 18.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.296 1.038 . . . . 0.0 109.789 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.75 -4.91 69.22 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-O 119.904 -0.387 . . . . 0.0 113.285 176.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -79.43 129.71 9.35 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 117.094 0.447 . . . . 0.0 112.202 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.97 -164.07 29.12 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.3 pp -79.48 147.67 32.16 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.146 0.498 . . . . 0.0 111.374 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 87' ' ' LEU . 3.9 p -151.64 151.85 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.483 1.113 . . . . 0.0 109.105 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.64 158.16 28.48 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.803 0.841 . . . . 0.0 110.653 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.12 111.16 4.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.543 0.737 . . . . 0.0 110.408 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.75 7.06 57.95 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.2 -163.74 36.34 Favored Glycine 0 C--N 1.352 1.451 0 C-N-CA 122.915 0.293 . . . . 0.0 113.058 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 p -137.13 151.57 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.697 0.799 . . . . 0.0 110.447 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -156.43 120.11 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.396 0.679 . . . . 0.0 109.437 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -92.07 119.59 31.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.419 0.687 . . . . 0.0 109.65 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -85.28 159.58 20.03 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.118 0.967 . . . . 0.0 109.076 170.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.9 t -142.41 163.01 34.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.382 0.673 . . . . 0.0 109.44 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 44.2 t -150.45 143.23 24.64 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.761 0.824 . . . . 0.0 109.865 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.14 126.11 53.72 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.87 122.56 46.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.699 0.8 . . . . 0.0 108.985 -175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.8 m -136.97 147.24 46.21 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.362 1.065 . . . . 0.0 109.739 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.5 -101.6 2.5 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -74.13 159.14 33.0 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.872 0.844 . . . . 0.0 112.787 -176.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 63.1 m -72.48 91.21 1.37 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.587 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -63.13 -23.45 67.44 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.677 0.791 . . . . 0.0 110.925 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 16.0 p -75.07 1.48 13.0 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.211 1.005 . . . . 0.0 112.493 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -98.98 -2.77 36.53 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.621 0.768 . . . . 0.0 110.179 169.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -131.23 174.38 10.1 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.681 0.792 . . . . 0.0 111.461 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 130.1 56.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.062 0.945 . . . . 0.0 108.459 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -114.64 154.41 28.44 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -156.95 154.25 25.37 Favored Glycine 0 C--N 1.341 0.86 0 C-N-CA 121.677 -0.296 . . . . 0.0 113.632 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 60.0 m95 -97.35 143.08 28.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.228 1.011 . . . . 0.0 109.791 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 98' ' ' ALA . 63.6 m-85 -138.2 138.52 38.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.722 1.209 . . . . 0.0 108.684 -175.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -112.11 151.79 29.03 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.008 0.822 . . . . 0.0 111.323 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.08 152.05 4.16 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.999 0.92 . . . . 0.0 110.433 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 177.45 -53.73 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.155 0.982 . . . . 0.0 111.593 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -85.35 55.55 4.08 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 122.212 1.941 . . . . 0.0 112.968 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.26 40.95 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.973 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -115.61 162.43 17.24 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -98.49 166.7 11.23 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 0.0 108.821 170.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.98 102.78 0.3 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -101.55 153.75 19.45 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.488 0.715 . . . . 0.0 110.295 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.63 108.57 0.75 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.894 0.878 . . . . 0.0 110.628 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.49 -64.31 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -157.81 133.15 8.88 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.435 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.494 HG22 ' HA3' ' A' ' 36' ' ' GLY . 79.6 t -126.46 123.85 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.262 1.025 . . . . 0.0 109.481 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.709 HG21 HH11 ' A' ' 73' ' ' ARG . 8.9 p -108.26 160.34 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.449 0.699 . . . . 0.0 109.439 175.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.97 162.78 13.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 168.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 29.1 p-90 -55.8 -43.84 77.25 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.293 1.037 . . . . 0.0 113.746 -174.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 t -83.8 -14.31 51.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.905 0.482 . . . . 0.0 110.913 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.54 10.22 82.09 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.179 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -67.29 -37.5 83.52 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.417 0.687 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.0 mmt85 -112.93 121.57 45.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.165 0.586 . . . . 0.0 109.888 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.484 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 p -118.04 131.89 56.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.807 1.243 . . . . 0.0 108.133 172.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -124.55 136.35 53.9 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.274 1.03 . . . . 0.0 108.231 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 70.5 m-85 -141.3 136.94 32.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.376 0.67 . . . . 0.0 109.58 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.91 142.11 53.01 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.47 -29.12 58.16 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.031 0.932 . . . . 0.0 112.721 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -28.78 70.16 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 125.234 1.414 . . . . 0.0 112.543 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.14 -1.29 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.535 1.134 . . . . 0.0 111.493 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HG3' ' HB2' ' A' ' 61' ' ' TYR . 28.3 ttpp -73.06 126.9 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.497 0.719 . . . . 0.0 110.726 -172.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.67 -25.05 28.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.759 0.662 . . . . 0.0 112.809 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -103.42 -23.79 13.52 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.092 0.557 . . . . 0.0 110.813 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -103.45 154.25 19.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.903 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.7 m -146.07 135.24 22.78 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 109.089 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.496 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -101.48 128.73 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.8 m -125.17 141.23 52.23 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.709 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -146.11 149.82 34.75 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.137 0.426 . . . . 0.0 109.961 -177.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -129.44 108.67 10.45 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.721 1.208 . . . . 0.0 108.503 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -68.74 -38.91 80.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.297 1.039 . . . . 0.0 111.061 -173.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.18 87.13 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.98 -13.19 56.45 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.933 0.493 . . . . 0.0 111.596 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 61.76 28.69 17.66 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.859 -175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.5 m -124.48 131.9 53.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.157 0.583 . . . . 0.0 110.677 -173.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.68 160.1 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.531 1.132 . . . . 0.0 109.19 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -141.97 148.2 38.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.48 1.512 . . . . 0.0 108.86 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.86 100.83 5.03 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.54 102.29 9.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.783 0.833 . . . . 0.0 109.635 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.602 ' HB3' HD21 ' A' ' 87' ' ' LEU . 58.5 mtm -88.44 132.43 34.47 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -133.13 153.52 51.45 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.7 t 58.42 59.77 2.86 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.868 0.842 . . . . 0.0 110.711 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.6 mt -79.83 116.68 20.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.94 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 79.7 mttt -75.37 152.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -51.89 -25.73 22.42 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.0 2.467 . . . . 0.0 114.069 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 10.8 pt-20 -70.12 -23.25 63.0 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.042 0.937 . . . . 0.0 112.95 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.71 -3.69 19.87 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.392 0.677 . . . . 0.0 112.809 -175.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 120' ' ' THR . 49.3 m -60.99 100.08 0.11 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.21 0.604 . . . . 0.0 109.719 170.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 161.04 5.55 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.677 0.791 . . . . 0.0 110.269 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.1 p -83.01 117.98 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 172.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.46 112.15 23.22 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -107.99 121.28 44.47 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.127 1.371 . . . . 0.0 109.365 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 28.7 p -88.52 143.0 27.24 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -142.7 132.94 24.66 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.354 1.062 . . . . 0.0 109.546 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -109.14 145.83 35.08 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.847 0.859 . . . . 0.0 110.964 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.48 -179.34 42.06 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.686 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -89.42 95.95 10.5 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.407 0.622 . . . . 0.0 109.681 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -79.12 78.77 5.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -168.56 115.88 0.67 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.484 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.09 32.96 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.3 p -137.76 -72.72 0.42 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.553 0.741 . . . . 0.0 109.514 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -72.63 -28.84 62.99 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.569 0.699 . . . . 0.0 109.661 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -87.72 145.54 26.09 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.176 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.4 -161.14 16.1 Favored Glycine 0 C--O 1.241 0.57 0 CA-C-O 119.465 -0.63 . . . . 0.0 111.693 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 69.46 146.2 0.11 Allowed Pre-proline 0 N--CA 1.485 1.311 0 C-N-CA 125.347 1.459 . . . . 0.0 111.534 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.27 138.2 38.79 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 121.85 1.7 . . . . 0.0 110.529 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.42 -32.27 73.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.389 0.676 . . . . 0.0 110.521 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -140.61 155.33 46.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.832 1.253 . . . . 0.0 108.783 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 28.6 p90 -143.96 161.87 37.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.802 0.841 . . . . 0.0 109.667 171.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 5' ' ' LEU . . . -96.78 -150.08 26.38 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.386 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -90.88 -53.65 4.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.575 0.75 . . . . 0.0 110.21 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.76 120.31 4.49 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.77 -171.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 t -105.86 121.53 44.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.883 0.873 . . . . 0.0 109.61 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.9 tm0? -87.39 125.28 34.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.928 0.491 . . . . 0.0 110.41 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG11 ' HE1' ' A' ' 84' ' ' MET . 5.9 m -111.56 145.4 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.653 0.781 . . . . 0.0 110.025 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.536 ' HA ' HG23 ' A' ' 92' ' ' THR . 91.8 m -133.38 119.65 19.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.048 0.939 . . . . 0.0 108.908 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.412 HG11 ' O ' ' A' ' 88' ' ' LYS . 2.3 p -104.89 116.4 48.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.0 m -63.91 113.86 3.72 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.57 1.148 . . . . 0.0 110.004 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 62.4 p -73.71 88.2 1.73 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 110.981 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.2 tp -79.1 77.67 5.57 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -122.36 4.76 9.68 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.863 -171.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -126.54 146.89 49.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -72.91 -66.97 0.6 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.716 0.806 . . . . 0.0 111.635 -171.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -113.22 27.66 9.42 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.555 0.693 . . . . 0.0 110.92 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -82.03 108.8 15.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.67 -0.643 . . . . 0.0 110.109 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -62.92 122.34 15.75 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.625 0.77 . . . . 0.0 109.965 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 . . . . . 0 CA--C 1.552 1.041 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.87 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 110.644 -0.132 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HG3' ' CE1' ' A' ' 112' ' ' TYR . 54.5 tt0 68.48 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.481 1.512 . . . . 0.0 112.066 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.3 tp -84.96 128.49 34.65 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 122.737 0.415 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -105.14 131.2 52.94 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 166.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.53 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 84.6 mt -121.9 118.75 29.67 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.759 1.224 . . . . 0.0 108.455 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.6 t -99.43 103.0 14.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.67 127.74 46.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.7 m -155.09 141.27 18.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.341 1.057 . . . . 0.0 110.19 -169.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.443 ' N ' HG21 ' A' ' 117' ' ' THR . . . 145.26 26.03 0.1 Allowed Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 119' ' ' VAL . . . -86.71 132.2 11.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.13 41.76 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.9 144.4 31.96 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.208 0.528 . . . . 0.0 110.56 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 p -150.48 153.64 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.526 1.531 . . . . 0.0 107.936 -174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' HD22 ' A' ' 124' ' ' LEU . 1.7 mp0 -87.3 157.17 19.35 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.189 0.596 . . . . 0.0 110.953 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.75 111.79 5.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.463 0.705 . . . . 0.0 110.065 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.99 3.53 48.63 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 123.889 0.743 . . . . 0.0 111.504 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.76 -163.85 39.22 Favored Glycine 0 C--N 1.35 1.317 0 C-N-CA 122.792 0.234 . . . . 0.0 112.722 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.2 p -138.05 149.01 45.64 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.042 0.937 . . . . 0.0 109.921 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 tp -158.6 145.6 17.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -119.37 131.85 55.75 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.677 0.391 . . . . 0.0 110.881 -174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.6 mm? -92.29 159.62 15.52 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.074 0.95 . . . . 0.0 108.899 170.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -149.23 123.81 9.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.65 0.38 . . . . 0.0 110.081 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 51.7 t -127.38 106.55 9.28 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.145 0.578 . . . . 0.0 110.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.51 141.57 29.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.4 164.08 12.14 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.291 0.637 . . . . 0.0 109.861 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -66.65 166.92 11.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.384 0.674 . . . . 0.0 111.133 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.41 -13.48 50.28 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.63 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.29 136.62 57.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.575 1.15 . . . . 0.0 109.427 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.2 m -77.74 71.41 4.21 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 122.089 0.947 . . . . 0.0 111.966 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -79.84 -8.72 59.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.561 1.144 . . . . 0.0 110.574 164.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 t -57.04 -1.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 125.368 1.467 . . . . 0.0 113.812 170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -91.04 -11.5 38.59 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.766 0.826 . . . . 0.0 112.088 174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -107.64 167.06 10.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.366 0.666 . . . . 0.0 111.377 -174.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.42 161.61 28.53 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 168.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HE3' ' HB2' ' A' ' 35' ' ' MET . 4.4 ptm -143.0 169.84 16.81 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.355 0.662 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.4 146.74 11.46 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 121.787 -0.244 . . . . 0.0 113.689 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -97.64 141.1 31.08 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.238 1.415 . . . . 0.0 109.858 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -132.07 164.4 26.32 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.793 1.237 . . . . 0.0 108.884 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -139.1 156.25 47.3 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.033 0.379 . . . . 0.0 110.386 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 94' ' ' VAL . 4.5 pt20 -166.38 136.01 3.17 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.976 0.797 . . . . 0.0 110.117 173.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 93' ' ' ALA . . . 174.31 -62.27 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 124.469 1.107 . . . . 0.0 111.131 171.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.6 66.3 6.59 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.041 -168.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.35 -2.29 62.57 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.96 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -98.91 133.64 42.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.761 0.824 . . . . 0.0 110.152 -173.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -89.15 174.13 8.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.952 0.901 . . . . 0.0 108.704 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -64.0 104.74 0.75 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.98 152.59 47.01 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.035 0.934 . . . . 0.0 111.026 -169.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -58.12 110.61 0.97 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.433 1.493 . . . . 0.0 111.792 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -89.27 -55.86 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.584 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -169.07 132.47 1.34 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.745 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.8 141.21 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 124.571 1.148 . . . . 0.0 108.297 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 HG22 ' A' ' 59' ' ' THR . 11.6 p -135.31 148.31 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -79.04 155.86 28.64 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -53.15 -39.07 63.27 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.098 1.359 . . . . 0.0 114.046 -172.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.9 t -75.35 -27.13 59.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.268 0.627 . . . . 0.0 111.32 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.73 72.35 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.2 -175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -69.12 -55.14 11.6 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -106.1 124.52 49.71 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.751 . . . . 0.0 110.56 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.47 HG22 HG23 ' A' ' 52' ' ' VAL . 52.7 p -112.22 149.45 32.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.584 1.153 . . . . 0.0 109.657 174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -129.39 123.63 32.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -119.68 159.02 25.26 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.87 144.58 43.31 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 165.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.49 -34.25 64.42 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.042 0.937 . . . . 0.0 112.932 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -65.64 -35.66 81.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.385 0.674 . . . . 0.0 111.575 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.3 m -111.33 6.16 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.457 0.703 . . . . 0.0 112.339 -172.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -68.67 111.55 4.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.941 0.496 . . . . 0.0 111.741 -171.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.09 -27.87 15.01 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.868 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.7 ptt85 -83.17 -26.42 30.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.459 0.629 . . . . 0.0 109.565 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.16 153.4 18.94 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.6 m -146.98 136.76 23.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.034 0.934 . . . . 0.0 108.902 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.584 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -102.85 121.32 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -124.84 138.93 54.24 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HB3' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -143.18 131.43 22.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.975 0.51 . . . . 0.0 110.068 -175.097 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.0 95.36 6.12 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.48 -38.22 83.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.176 0.99 . . . . 0.0 111.929 -173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.02 -35.04 76.2 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.125 0.57 . . . . 0.0 111.446 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -89.45 -9.27 50.76 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.474 0.71 . . . . 0.0 112.042 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 18.4 m-80 58.64 27.33 15.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.683 1.193 . . . . 0.0 111.352 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.5 m -112.81 131.96 55.47 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.552 0.741 . . . . 0.0 109.283 -175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.423 HG21 ' SD ' ' A' ' 35' ' ' MET . 5.6 t -117.77 157.22 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.016 0.926 . . . . 0.0 109.661 -174.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.59 127.85 19.81 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.824 1.25 . . . . 0.0 108.491 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.2 tm? -104.76 100.16 9.8 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.42 103.43 10.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 109.87 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.578 ' HB3' HD21 ' A' ' 87' ' ' LEU . 68.3 mtm -94.31 126.84 39.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.991 0.517 . . . . 0.0 109.775 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.35 148.01 51.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.3 m 57.55 58.8 3.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.394 1.078 . . . . 0.0 111.08 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 84' ' ' MET . 49.0 mt -73.61 117.5 15.45 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.502 -1.227 . . . . 0.0 112.221 -174.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -76.88 148.26 78.75 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.48 -24.06 20.9 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.0 2.466 . . . . 0.0 114.521 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.23 -15.61 61.93 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.971 0.908 . . . . 0.0 113.255 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -78.38 -4.48 48.42 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.118 0.567 . . . . 0.0 112.261 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' HA ' ' A' ' 120' ' ' THR . 85.2 m -61.58 103.98 0.38 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.773 0.829 . . . . 0.0 110.442 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . . . -168.53 163.68 12.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.014 0.525 . . . . 0.0 110.993 -175.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 8.3 p -81.07 121.61 34.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 168.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -86.01 143.49 28.1 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -135.48 112.3 10.17 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.424 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 41.6 t -83.13 140.6 32.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -143.61 162.84 34.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 109.366 -171.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.36 145.61 26.22 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.191 0.596 . . . . 0.0 110.745 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.09 164.21 27.26 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.579 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -93.55 110.57 22.15 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 67.28 88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.797 1.239 . . . . 0.0 109.902 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -150.54 -179.45 7.24 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.866 0.866 . . . . 0.0 111.05 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.53 19.58 61.74 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.18 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 21.3 t -95.42 61.07 2.31 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.808 0.843 . . . . 0.0 109.806 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 63.7 -78.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.702 1.601 . . . . 0.0 111.859 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -88.4 -15.5 35.35 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.77 0.828 . . . . 0.0 109.918 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.04 82.75 0.23 Allowed Glycine 0 C--N 1.359 1.84 0 O-C-N 123.679 0.612 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.39 81.23 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.076 0.95 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -59.59 154.8 45.96 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.345 2.696 . . . . 0.0 113.887 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -53.47 -46.79 70.08 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 124.319 1.012 . . . . 0.0 112.153 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.409 ' CE1' ' HG3' ' A' ' 2' ' ' GLN . 65.2 m-85 -138.77 132.29 30.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.807 0.443 . . . . 0.0 110.513 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.509 ' HB2' ' ND2' ' A' ' 96' ' ' ASN . 4.4 p90 -122.87 161.48 24.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.91 0.884 . . . . 0.0 110.405 175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -174.66 47.31 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.396 -0.82 . . . . 0.0 114.035 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -66.43 -44.68 82.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.215 1.006 . . . . 0.0 110.526 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 163.33 38.9 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.485 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 9' ' ' GLY . 7.5 t -143.82 138.93 29.03 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.848 0.459 . . . . 0.0 110.109 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 12.6 tm0? -91.15 121.65 33.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.05 0.54 . . . . 0.0 109.901 -173.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG12 ' HA2' ' A' ' 10' ' ' GLY . 18.8 m -107.21 144.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.103 0.961 . . . . 0.0 109.501 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.57 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.1 m -124.06 105.5 9.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.174 0.589 . . . . 0.0 109.891 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.2 p -88.0 101.32 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.266 1.031 . . . . 0.0 109.01 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.6 t -66.46 134.15 51.88 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.803 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.6 m -70.77 86.75 0.68 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.121 0.968 . . . . 0.0 111.36 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD22 ' HG3' ' A' ' 14' ' ' GLN . 10.9 mp -119.04 62.06 0.8 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.294 1.037 . . . . 0.0 110.106 177.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.22 132.91 37.76 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -138.69 80.41 1.79 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -152.94 -51.5 0.1 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.465 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 55.31 46.34 23.74 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.871 1.268 . . . . 0.0 112.255 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -148.12 122.2 9.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -94.35 143.21 26.59 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 CA--C 1.553 1.074 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.449 176.56 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -140.79 132.41 27.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.869 0.868 . . . . 0.0 108.855 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.16 111.34 22.85 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -86.4 125.23 33.53 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -119.4 120.85 38.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.25 102.8 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.834 0.853 . . . . 0.0 109.316 -177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -95.67 138.03 33.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.315 0.646 . . . . 0.0 110.348 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.4 m -149.8 165.79 31.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.892 0.877 . . . . 0.0 110.16 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.77 -1.19 32.03 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 112.867 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 145.64 32.03 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 112.595 -0.202 . . . . 0.0 112.595 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.06 -166.61 33.12 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 pp -83.06 144.84 29.64 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.994 0.426 . . . . 0.0 111.227 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -152.23 161.27 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.662 1.185 . . . . 0.0 108.081 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.8 164.14 13.8 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.75 0.704 . . . . 0.0 110.494 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . . . -71.48 143.17 50.11 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.471 0.708 . . . . 0.0 110.629 177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 3.29 85.7 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -164.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.46 -169.6 46.15 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 114.174 0.43 . . . . 0.0 114.174 -172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 p -153.28 147.25 25.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.107 0.963 . . . . 0.0 110.03 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 tp -160.79 128.92 4.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.103 0.561 . . . . 0.0 109.803 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -93.77 117.3 29.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.276 0.63 . . . . 0.0 110.138 175.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 2.4 mm? -86.02 159.26 19.64 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.328 1.051 . . . . 0.0 109.245 168.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.9 t -136.57 165.7 25.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.555 0.742 . . . . 0.0 109.316 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.8 t -146.56 145.73 30.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.056 0.942 . . . . 0.0 109.255 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.66 114.72 20.97 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 78' ' ' ASN . . . -105.44 154.55 20.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.049 0.54 . . . . 0.0 110.615 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 m -62.82 159.69 16.03 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.778 0.831 . . . . 0.0 110.942 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.2 53.24 4.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.52 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -95.62 -167.59 1.63 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.043 1.337 . . . . 0.0 110.414 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 32' ' ' SER . 2.2 m -74.23 22.11 0.09 Allowed 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.4 0.68 . . . . 0.0 111.921 173.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.43 -29.83 69.24 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.306 1.043 . . . . 0.0 111.14 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.1 m -56.2 -26.29 50.32 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.881 0.872 . . . . 0.0 111.755 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB3' HG22 ' A' ' 29' ' ' THR . 23.3 t -113.1 -2.74 14.09 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.04 0.936 . . . . 0.0 112.018 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -83.46 127.19 33.51 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.741 0.7 . . . . 0.0 110.432 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.77 115.98 10.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.465 ' HE1' HG11 ' A' ' 80' ' ' VAL . 4.7 ptm -114.21 170.4 8.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.172 0.589 . . . . 0.0 111.102 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.95 163.32 33.17 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 112.639 -0.185 . . . . 0.0 112.639 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -111.39 138.51 47.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -122.7 154.0 38.67 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.807 1.243 . . . . 0.0 108.349 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -126.03 158.75 34.54 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -174.39 160.07 3.16 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.274 0.984 . . . . 0.0 109.887 174.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 171.96 -58.08 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.718 0 C-N-CA 124.472 1.109 . . . . 0.0 111.052 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.52 63.57 6.62 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 122.368 2.046 . . . . 0.0 112.821 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.61 -5.74 60.12 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.912 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 31.7 mmmt -92.95 148.04 22.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 109.58 -177.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.77 176.15 5.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.301 0.64 . . . . 0.0 110.359 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -61.13 106.64 0.63 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.155 0.582 . . . . 0.0 111.82 -172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.53 152.51 24.14 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.917 1.287 . . . . 0.0 110.138 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -57.19 113.98 1.96 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.7 0.8 . . . . 0.0 110.662 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 65' ' ' VAL . 71.8 t -98.36 -60.81 2.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.55 155.43 21.98 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.333 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.71 138.3 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.734 1.214 . . . . 0.0 107.957 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.565 HG23 HG22 ' A' ' 59' ' ' THR . 11.1 p -121.3 146.98 25.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.82 142.13 48.02 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -52.16 -41.4 62.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.291 1.036 . . . . 0.0 112.846 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 t -81.81 -9.27 59.66 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.46 0.704 . . . . 0.0 111.468 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.35 73.16 Favored Glycine 0 C--N 1.343 0.952 0 O-C-N 123.192 0.307 . . . . 0.0 112.561 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.481 ' HG3' ' HG2' ' A' ' 58' ' ' ARG . 31.2 tpt180 -67.38 -65.31 0.7 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.359 0.664 . . . . 0.0 110.679 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.481 ' HG2' ' HG3' ' A' ' 57' ' ' ARG . 36.6 mmt180 -113.76 127.41 56.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.279 0.631 . . . . 0.0 110.461 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.565 HG22 HG23 ' A' ' 52' ' ' VAL . 54.5 p -108.58 150.84 26.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.848 0.859 . . . . 0.0 108.746 175.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -133.71 130.22 37.85 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 70' ' ' THR . 98.3 m-85 -139.19 142.51 37.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.99 0.516 . . . . 0.0 109.982 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.92 142.38 47.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 162.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -57.51 -24.23 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.558 0.743 . . . . 0.0 111.91 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -61.0 -40.61 94.19 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.797 1.239 . . . . 0.0 112.199 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.504 HG11 HG13 ' A' ' 49' ' ' VAL . 32.5 m -115.56 1.96 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.809 0.844 . . . . 0.0 111.67 -173.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -66.21 125.42 25.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.709 0.804 . . . . 0.0 111.676 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.66 -26.16 6.76 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.587 0.554 . . . . 0.0 114.462 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -93.92 -29.58 15.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.203 0.601 . . . . 0.0 110.138 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.33 146.59 25.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.401 ' HA ' ' OH ' ' A' ' 61' ' ' TYR . 91.1 m -149.95 130.36 13.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.26 1.024 . . . . 0.0 108.648 178.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.457 HG13 HD23 ' A' ' 82' ' ' LEU . 2.9 mp -102.05 133.49 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -124.98 152.06 44.69 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.888 1.275 . . . . 0.0 107.947 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.47 138.26 16.2 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.546 0.612 . . . . 0.0 111.711 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -93.48 108.43 20.11 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.3 -37.85 88.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.124 0.569 . . . . 0.0 110.919 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.61 82.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.92 0.763 . . . . 0.0 111.743 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.1 mmpt? -94.68 -16.35 23.19 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.764 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 41.2 m-80 60.81 34.98 19.59 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.544 1.137 . . . . 0.0 110.804 -172.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 31.3 m -112.48 131.27 55.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.392 0.677 . . . . 0.0 109.845 -176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 35' ' ' MET . 6.3 t -113.22 161.32 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.07 0.948 . . . . 0.0 109.914 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -143.5 116.08 8.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.147 0.979 . . . . 0.0 108.874 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.457 HD23 HG13 ' A' ' 71' ' ' ILE . 2.6 tm? -101.21 96.69 7.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -82.8 129.77 35.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.968 0.907 . . . . 0.0 109.44 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.633 ' HB3' HD21 ' A' ' 87' ' ' LEU . 63.1 mtm -117.26 148.37 41.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.547 0.739 . . . . 0.0 109.992 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -146.25 160.16 42.36 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.351 1.06 . . . . 0.0 109.189 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.6 m 54.56 48.02 21.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.564 1.145 . . . . 0.0 111.118 171.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD21 ' HB3' ' A' ' 84' ' ' MET . 97.0 mt -73.28 115.7 12.95 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.195 -171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -65.64 151.81 93.93 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.37 1.068 . . . . 0.0 109.056 166.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 20.0 Cg_endo -57.62 -22.79 53.76 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.268 2.645 . . . . 0.0 113.355 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' HB3' ' A' ' 88' ' ' LYS . 11.6 pt-20 -87.25 7.04 30.24 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.442 1.097 . . . . 0.0 112.285 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -87.5 2.04 51.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.665 0.386 . . . . 0.0 111.526 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.9 m -62.16 102.78 0.32 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 0.0 109.967 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.19 152.11 4.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.087 -172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 12.4 p -81.65 129.57 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.584 171.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.43 122.29 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.47 0.708 . . . . 0.0 109.854 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -103.76 132.47 49.99 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.773 0.829 . . . . 0.0 109.696 176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.4 t -82.91 141.12 32.43 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 170.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' MET . . . -143.49 161.64 37.91 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.257 0.623 . . . . 0.0 109.716 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.72 146.42 36.01 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 0.0 108.991 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.78 153.78 24.99 Favored Glycine 0 C--N 1.338 0.687 0 O-C-N 123.18 0.3 . . . . 0.0 112.77 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -91.38 107.29 19.1 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -88.46 51.12 2.1 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.85 -31.0 40.47 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 167.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -110.85 155.75 15.93 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.066 173.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.8 p -84.49 88.13 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.716 0.806 . . . . 0.0 110.605 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -92.39 103.02 15.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.388 0.675 . . . . 0.0 110.405 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -83.57 1.32 42.65 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -174.61 161.03 30.62 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 64.53 92.59 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 124.924 1.29 . . . . 0.0 111.457 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.38 179.77 5.21 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.922 2.415 . . . . 0.0 112.277 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.18 -42.9 59.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.52 0.728 . . . . 0.0 110.239 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -130.99 149.0 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.356 1.062 . . . . 0.0 109.22 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -148.35 158.38 44.06 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.33 1.052 . . . . 0.0 108.492 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.89 -170.22 28.65 Favored Glycine 0 C--O 1.239 0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.246 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -83.42 -39.29 20.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.245 1.018 . . . . 0.0 110.135 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 115.15 165.58 14.79 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.46 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 t -143.48 108.14 4.87 Favored 'General case' 0 CA--C 1.559 1.327 0 C-N-CA 124.521 1.128 . . . . 0.0 109.455 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 58.6 tp60 -77.55 129.58 35.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.561 0.745 . . . . 0.0 111.258 -175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 m -115.37 144.94 21.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.571 ' HA ' HG23 ' A' ' 92' ' ' THR . 60.9 m -127.75 105.97 8.81 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.52 106.64 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.733 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.3 t -61.55 132.21 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.005 1.322 . . . . 0.0 110.717 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 30.8 p -70.76 135.86 48.49 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.918 0.887 . . . . 0.0 112.495 -173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 22.7 tp -66.77 -18.23 65.27 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.948 0.899 . . . . 0.0 109.75 173.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -57.28 -44.5 84.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.081 0.952 . . . . 0.0 110.739 172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -111.96 99.82 8.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.892 -172.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -88.49 -22.04 23.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.277 0.631 . . . . 0.0 111.192 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -75.92 94.01 3.31 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -123.47 96.33 4.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 109.626 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -83.11 137.51 34.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.758 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 170.254 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 67.6 132.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.137 1.375 . . . . 0.0 112.055 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.742 HD11 ' HB1' ' A' ' 25' ' ' ALA . 57.6 tp -108.85 112.57 24.9 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -82.44 103.86 12.3 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.3 mt -98.31 128.68 44.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.151 0.98 . . . . 0.0 109.215 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.7 t -119.94 102.08 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.767 0.827 . . . . 0.0 108.931 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -90.92 149.66 21.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.264 0.625 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -154.39 170.07 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.118 0.967 . . . . 0.0 109.921 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.31 -0.67 43.56 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 113.094 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.66 88.73 0.54 Allowed Glycine 0 C--N 1.345 1.078 0 C-N-CA 122.916 0.293 . . . . 0.0 112.594 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.59 -172.76 13.26 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.184 0.421 . . . . 0.0 112.289 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.98 138.91 31.04 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.386 0.675 . . . . 0.0 110.684 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 6.4 p -152.2 153.17 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.675 1.19 . . . . 0.0 108.364 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -92.68 160.03 15.17 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.582 -0.699 . . . . 0.0 110.729 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.51 123.81 21.45 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.99 -176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.49 54.13 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.659 0.599 . . . . 0.0 112.124 -174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.16 50.33 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.817 0.363 . . . . 0.0 113.182 -178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 76.0 p -114.87 162.23 17.19 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.108 0.963 . . . . 0.0 110.398 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.2 tp -160.55 125.57 3.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 109.927 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -95.2 125.32 39.76 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.122 0.487 . . . . 0.0 109.898 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -106.09 159.19 16.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.049 1.34 . . . . 0.0 108.644 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -139.69 160.32 40.16 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.771 0.428 . . . . 0.0 110.157 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 52.9 t -150.77 133.04 15.43 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 124.394 1.078 . . . . 0.0 108.62 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.2 131.71 56.84 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.742 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -106.8 137.79 44.18 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.185 0.594 . . . . 0.0 110.681 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.9 m -144.44 169.16 18.47 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 109.976 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.26 -83.9 1.56 Allowed Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -82.32 154.93 25.05 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.414 0.686 . . . . 0.0 109.796 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.7 m -77.5 96.58 4.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.548 ' HE1' ' HB2' ' A' ' 35' ' ' MET . 54.0 t80 -63.75 -20.94 66.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.103 0.961 . . . . 0.0 111.311 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.6 m -64.53 -7.26 9.57 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.623 0.769 . . . . 0.0 112.779 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -109.44 4.84 22.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.525 0.73 . . . . 0.0 111.305 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.79 140.58 44.39 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.643 0.777 . . . . 0.0 111.004 -171.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.24 164.53 21.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.764 0.826 . . . . 0.0 109.693 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.548 ' HB2' ' HE1' ' A' ' 30' ' ' PHE . 1.1 ttp -137.47 155.07 49.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.105 0.562 . . . . 0.0 110.21 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -146.16 147.21 18.02 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.75 129.83 42.85 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -128.1 141.71 51.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.265 1.026 . . . . 0.0 108.234 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -106.58 143.01 35.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.02 146.86 4.6 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.709 0.631 . . . . 0.0 110.255 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . 175.37 -60.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 124.419 1.088 . . . . 0.0 110.789 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 92.5 Cg_endo -87.47 72.67 2.92 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.285 1.99 . . . . 0.0 112.198 -171.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.95 2.29 61.3 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.282 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -98.9 139.46 34.52 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.524 0.73 . . . . 0.0 109.526 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.06 175.66 6.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 109.458 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -60.91 105.71 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 120.736 0.303 . . . . 0.0 110.405 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -108.5 148.02 30.84 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.349 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.73 110.89 1.88 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.769 0.828 . . . . 0.0 111.323 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.57 -65.43 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -162.42 135.55 5.98 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.09 0.244 . . . . 0.0 111.402 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 36' ' ' GLY . 82.3 t -121.46 150.37 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 124.697 1.199 . . . . 0.0 109.17 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HB ' HD12 ' A' ' 71' ' ' ILE . 8.2 p -144.16 163.91 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.51 1.124 . . . . 0.0 108.755 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -85.22 164.99 17.74 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.573 0.349 . . . . 0.0 110.742 170.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.41 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 36.7 p90 -52.6 -43.25 65.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.088 1.355 . . . . 0.0 113.539 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HG ' ' HD1' ' A' ' 54' ' ' TRP . 50.4 m -95.52 -6.11 41.26 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.42 0.688 . . . . 0.0 111.557 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 52' ' ' VAL . . . 86.14 20.5 55.05 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 112.404 -0.279 . . . . 0.0 112.404 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 -57.75 -40.66 80.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.451 1.1 . . . . 0.0 111.749 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -132.52 138.18 47.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.888 0.875 . . . . 0.0 109.09 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 p -117.22 142.06 47.51 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.241 1.016 . . . . 0.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -136.24 125.89 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -137.74 142.72 40.97 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.6 131.59 46.74 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 163.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -57.62 -26.76 62.04 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 p -67.2 -42.27 84.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.834 0.854 . . . . 0.0 111.408 176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.92 -7.92 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 122.97 0.508 . . . . 0.0 111.064 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -76.18 115.87 16.32 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.69 -15.72 41.06 Favored Glycine 0 C--N 1.341 0.849 0 O-C-N 123.72 0.638 . . . . 0.0 112.59 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' HG3' ' CD2' ' A' ' 69' ' ' PHE . 18.3 ptp180 -116.41 -22.9 8.55 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.141 0.576 . . . . 0.0 109.993 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' CD2' ' HG3' ' A' ' 68' ' ' ARG . 3.5 m-30 -112.12 143.95 42.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.18 0.992 . . . . 0.0 108.609 174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.2 m -143.91 130.76 20.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.876 0.87 . . . . 0.0 108.881 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' A' ' 50' ' ' ALA . 3.7 mt -101.8 126.08 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -137.47 136.8 38.07 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HB3' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -151.19 153.52 35.09 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.348 0.594 . . . . 0.0 112.142 -169.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -106.45 111.25 23.74 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -70.72 -30.22 66.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.342 0.657 . . . . 0.0 112.091 -173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.59 -31.9 62.2 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.053 0.541 . . . . 0.0 111.813 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -96.55 -6.16 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.655 . . . . 0.0 111.198 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 61.54 31.09 18.94 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.139 0.976 . . . . 0.0 110.514 176.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.2 m -112.35 132.4 55.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.963 0.905 . . . . 0.0 109.854 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 33.7 t -114.37 154.21 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.384 1.073 . . . . 0.0 110.223 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.81 145.45 48.37 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 125.189 1.396 . . . . 0.0 108.05 173.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.49 107.58 10.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -82.25 101.67 10.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.071 0.949 . . . . 0.0 109.581 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.76 145.18 25.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.25 0.62 . . . . 0.0 109.904 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -145.63 152.84 40.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.9 m 58.92 46.11 14.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.771 0.828 . . . . 0.0 112.121 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.49 126.56 29.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.593 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.91 155.87 75.07 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.28 -21.52 60.71 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.418 2.079 . . . . 0.0 113.547 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -77.19 -18.4 57.79 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.354 0.662 . . . . 0.0 111.908 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.569 ' HB2' HG11 ' A' ' 121' ' ' VAL . 2.7 m-20 -67.07 -10.07 46.0 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.302 0.641 . . . . 0.0 111.396 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.9 m -56.21 100.98 0.05 OUTLIER 'General case' 0 C--N 1.362 1.135 0 C-N-CA 124.048 0.939 . . . . 0.0 109.81 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.06 162.74 4.62 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.22 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.7 p -85.81 118.33 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -86.9 115.72 24.49 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.724 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.82 131.69 48.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 35' ' ' MET . 38.5 t -83.94 106.87 15.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.18 112.29 25.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.757 0.823 . . . . 0.0 108.796 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.87 168.98 8.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.788 0.835 . . . . 0.0 110.336 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.45 172.07 12.42 Favored Glycine 0 CA--C 1.506 -0.497 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -80.25 91.75 5.65 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -78.68 94.88 5.15 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -151.92 98.19 2.42 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.18 0.592 . . . . 0.0 109.846 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 134.3 178.88 15.93 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.563 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 81.9 p -79.16 4.09 15.82 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.484 1.114 . . . . 0.0 113.091 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -75.41 -57.42 3.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.257 0.623 . . . . 0.0 110.662 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 55.19 24.72 6.53 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.585 1.154 . . . . 0.0 113.112 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.37 162.74 28.69 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-O 119.446 -0.641 . . . . 0.0 111.533 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.94 80.84 0.27 Allowed Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.952 0.901 . . . . 0.0 110.994 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.97 146.79 78.71 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.835 2.357 . . . . 0.0 111.525 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -62.87 -38.46 90.94 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.8 0.44 . . . . 0.0 110.027 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.87 153.52 51.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.076 0.95 . . . . 0.0 109.16 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -153.19 152.14 30.9 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.11 -159.33 34.06 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 123.233 0.333 . . . . 0.0 113.853 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -88.01 -26.38 22.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.108 0.963 . . . . 0.0 111.068 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.43 157.92 32.39 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.789 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.3 t -131.04 108.08 9.52 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.401 1.08 . . . . 0.0 108.439 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 10.1 tm0? -81.17 106.16 12.94 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -92.9 142.21 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.1 m -123.57 111.29 16.09 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 91' ' ' ASP . 2.4 p -113.51 106.91 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.679 0.752 . . . . 0.0 109.935 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -78.92 145.63 33.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.594 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.5 p -63.59 151.4 41.69 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.002 0.521 . . . . 0.0 111.071 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.83 86.56 0.09 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 59.78 -173.6 0.11 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.245 1.418 . . . . 0.0 111.372 -169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -90.59 59.67 4.32 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -109.1 0.17 19.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.686 1.194 . . . . 0.0 111.352 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -138.35 141.42 39.71 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.672 0.789 . . . . 0.0 109.334 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -155.58 45.49 0.47 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.933 0.493 . . . . 0.0 111.213 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 70.47 147.22 0.07 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.529 1.132 . . . . 0.0 111.176 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 122.943 0.497 . . . . 0.0 110.774 179.479 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -104.73 163.76 12.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.373 0.669 . . . . 0.0 109.627 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.781 HD11 ' HB1' ' A' ' 25' ' ' ALA . 45.8 tp -90.88 111.6 23.09 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 26' ' ' SER . 54.1 tp60 -84.86 104.63 14.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.839 174.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.486 HD22 ' SG ' ' A' ' 23' ' ' CYS . 95.9 mt -95.15 108.76 20.88 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.599 0.759 . . . . 0.0 109.175 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.4 HG22 HE21 ' A' ' 4' ' ' GLN . 64.2 t -97.44 100.52 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HB3' ' H ' ' A' ' 116' ' ' GLY . 0.5 OUTLIER -112.8 111.85 22.92 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -169.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -156.19 154.46 30.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.852 1.261 . . . . 0.0 109.256 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.02 -8.23 1.08 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.53 -0.305 . . . . 0.0 112.504 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.39 145.23 27.74 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.943 0.306 . . . . 0.0 112.584 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.16 -164.46 29.85 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.08 136.89 37.3 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.257 0.551 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p -151.8 145.57 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.225 1.41 . . . . 0.0 107.949 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.77 158.94 25.31 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.089 0.404 . . . . 0.0 110.592 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.53 125.92 27.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.231 0.612 . . . . 0.0 110.183 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.86 2.12 65.02 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.764 0.665 . . . . 0.0 112.151 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.31 -174.93 35.91 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.935 0.186 . . . . 0.0 113.32 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.3 p -123.75 147.41 47.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.382 1.073 . . . . 0.0 110.707 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.4 tp -152.51 132.08 13.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.836 0.855 . . . . 0.0 108.762 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.85 127.45 55.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.354 0.662 . . . . 0.0 110.501 -176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 HD11 HG12 ' A' ' 119' ' ' VAL . 1.0 OUTLIER -93.03 156.51 16.84 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.788 0.835 . . . . 0.0 108.79 171.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -141.68 125.69 17.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 5' ' ' LEU . 47.9 t -117.17 104.41 11.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.321 0.649 . . . . 0.0 109.814 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.99 121.46 27.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.5 124.04 48.89 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.882 0.873 . . . . 0.0 109.502 -171.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 4' ' ' GLN . 25.5 t -131.19 163.79 26.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.714 0.805 . . . . 0.0 111.012 -171.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.21 -102.98 1.64 Allowed Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.752 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.42 108.64 18.57 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 31' ' ' SER . 10.3 m -56.3 133.17 52.5 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -167.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.428 ' HE1' ' HA ' ' A' ' 78' ' ' ASN . 6.1 p90 -69.62 -19.52 63.63 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.064 0.945 . . . . 0.0 112.113 -176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 29' ' ' THR . 91.0 p -72.35 -5.54 37.0 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -173.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 t -88.13 -1.87 58.27 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.198 0.599 . . . . 0.0 110.436 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -136.79 173.86 11.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.84 0.856 . . . . 0.0 110.872 -171.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.62 162.74 13.15 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 165.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.637 ' SD ' HG21 ' A' ' 80' ' ' VAL . 11.6 ptm -142.24 157.78 44.46 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 122.15 -0.344 . . . . 0.0 110.44 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -154.31 146.67 15.02 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.683 -0.235 . . . . 0.0 113.227 -178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -98.98 139.2 34.99 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 125.073 1.349 . . . . 0.0 109.951 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -129.15 170.22 13.81 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.13 1.372 . . . . 0.0 108.661 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -155.14 158.32 38.8 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.084 0.402 . . . . 0.0 111.833 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -165.12 153.9 12.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.002 0.921 . . . . 0.0 109.997 174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.39 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 124.359 1.064 . . . . 0.0 111.286 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.42 67.35 8.48 Favored 'Trans proline' 0 C--N 1.398 3.133 0 C-N-CA 122.021 1.814 . . . . 0.0 112.501 -173.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.76 24.8 71.51 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.857 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -115.32 161.13 18.93 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.244 0.617 . . . . 0.0 112.123 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.33 175.35 7.14 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.637 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -66.1 103.57 0.99 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.72 153.5 17.7 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.923 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -62.52 110.64 1.75 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.792 0.837 . . . . 0.0 110.097 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.5 t -85.78 -59.41 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -171.47 147.42 2.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.031 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 36' ' ' GLY . 77.3 t -129.22 137.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.177 0.991 . . . . 0.0 108.535 174.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 59' ' ' THR . 7.0 p -124.61 160.65 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.833 0.853 . . . . 0.0 109.571 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.0 154.87 21.14 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 166.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.437 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 64.8 p-90 -57.13 -37.25 71.72 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.534 0.733 . . . . 0.0 112.741 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -76.72 -28.96 56.03 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.163 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.93 -8.22 70.34 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.278 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 ppt_? -59.51 -28.47 67.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.742 0.817 . . . . 0.0 112.432 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -108.61 122.55 47.34 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.547 0.739 . . . . 0.0 109.521 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 52' ' ' VAL . 38.6 p -127.15 133.64 50.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.498 1.119 . . . . 0.0 108.886 176.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -128.58 127.19 41.81 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -129.52 148.09 51.39 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.366 0.666 . . . . 0.0 110.698 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -74.69 137.51 42.19 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 166.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.69 -30.48 67.43 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.68 0.792 . . . . 0.0 112.992 -171.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.7 m -69.6 -41.58 75.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.214 0.606 . . . . 0.0 111.676 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 62' ' ' ALA . 17.1 m -93.16 -9.44 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.338 0.655 . . . . 0.0 111.539 -177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -66.96 144.91 55.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.601 0.76 . . . . 0.0 110.418 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.71 -24.9 7.96 Favored Glycine 0 C--N 1.342 0.88 0 O-C-N 123.447 0.467 . . . . 0.0 113.701 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.435 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 10.7 ptt180 -113.37 -20.72 11.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.223 0.609 . . . . 0.0 111.065 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.435 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.4 m-30 -101.09 155.82 17.77 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.231 0.613 . . . . 0.0 110.24 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.1 m -149.07 136.6 20.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.481 1.112 . . . . 0.0 108.527 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.1 mp -101.05 121.6 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 167.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.6 m -124.3 136.84 54.42 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.71 131.73 21.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.574 0.702 . . . . 0.0 110.355 -174.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -102.5 109.15 20.69 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -68.5 -27.65 66.31 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.856 0.462 . . . . 0.0 110.077 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.59 65.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.834 0.853 . . . . 0.0 111.637 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -80.42 -16.03 55.41 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.355 . . . . 0.0 111.078 174.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.428 ' HA ' ' HE1' ' A' ' 30' ' ' PHE . 29.4 m-80 61.87 28.2 17.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.628 1.171 . . . . 0.0 110.872 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.0 m -120.83 135.11 55.25 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.959 0.503 . . . . 0.0 110.622 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.637 HG21 ' SD ' ' A' ' 35' ' ' MET . 19.4 t -108.81 155.59 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.788 1.235 . . . . 0.0 109.378 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -142.52 113.28 7.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.645 1.178 . . . . 0.0 108.961 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.7 98.86 11.68 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -84.83 104.92 15.21 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.803 0.841 . . . . 0.0 110.396 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.576 ' HB3' HD21 ' A' ' 87' ' ' LEU . 57.8 mtm -94.64 142.14 27.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.1 0.56 . . . . 0.0 109.612 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.16 162.44 34.24 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.563 1.145 . . . . 0.0 108.438 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.4 m 52.52 45.36 28.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.178 0.991 . . . . 0.0 112.153 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 84' ' ' MET . 81.2 mt -70.86 127.79 33.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.119 -173.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -85.94 144.53 39.31 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.774 0.83 . . . . 0.0 108.94 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -44.15 -35.18 7.53 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 124.428 3.419 . . . . 0.0 115.142 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -73.52 -9.37 58.61 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.78 1.232 . . . . 0.0 113.407 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.05 -2.2 47.15 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.022 0.929 . . . . 0.0 112.65 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -58.99 105.81 0.35 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.367 0.667 . . . . 0.0 110.145 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -165.77 149.71 8.09 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.987 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.4 p -79.75 113.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -85.9 145.05 27.34 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.861 0.864 . . . . 0.0 108.751 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.23 127.5 26.32 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 38.4 t -84.76 139.79 31.71 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' HB3' ' A' ' 110' ' ' PRO . . . -131.63 157.21 44.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.48 1.112 . . . . 0.0 108.398 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -145.59 164.13 32.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 110.553 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 134.63 -154.73 21.6 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -88.94 117.4 27.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -59.4 -46.27 89.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.275 1.03 . . . . 0.0 112.318 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.92 153.05 20.47 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.89 49.76 0.43 Allowed Glycine 0 C--N 1.333 0.385 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.7 m 61.21 84.29 0.13 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.122 0.969 . . . . 0.0 109.808 -170.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 75.5 -58.54 0.56 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.798 1.639 . . . . 0.0 110.167 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -155.85 139.91 16.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.974 0.909 . . . . 0.0 109.488 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.88 -113.47 3.54 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.69 138.59 10.05 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 123.894 0.878 . . . . 0.0 109.685 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.54 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 32.9 Cg_exo -61.39 108.61 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.72 2.28 . . . . 0.0 110.982 174.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.56 -30.67 67.32 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.641 0.777 . . . . 0.0 111.864 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 64.8 m-85 -131.13 150.65 52.05 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.841 0.856 . . . . 0.0 109.847 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -124.22 139.24 54.11 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.07 0.948 . . . . 0.0 110.371 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -99.41 167.33 21.22 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.5 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -71.0 -48.39 53.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.803 0.441 . . . . 0.0 111.254 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 7' ' ' GLU . . . 89.96 129.86 4.03 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.917 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.34 138.11 54.05 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.497 0.719 . . . . 0.0 110.669 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 54.0 tp60 -81.14 121.16 25.77 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 110.501 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG12 HD11 ' A' ' 21' ' ' LEU . 2.9 m -94.93 137.56 22.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 92' ' ' THR . 31.8 m -123.69 103.59 8.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.81 104.75 16.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 t -59.06 134.5 57.05 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.8 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 m -74.0 95.59 2.53 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.399 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.21 142.45 58.38 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.358 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -53.47 90.05 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.194 0.998 . . . . 0.0 112.778 -167.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -146.04 92.54 2.21 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -159.91 137.8 10.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.861 0.464 . . . . 0.0 109.942 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -78.33 97.83 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.661 0.785 . . . . 0.0 109.329 175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -80.37 115.63 20.01 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.625 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -66.03 160.18 24.3 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.599 0.759 . . . . 0.0 110.972 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.9 p80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 123.908 0.883 . . . . 0.0 109.206 -176.148 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.774 0.321 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -143.3 168.56 19.49 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.51 0.671 . . . . 0.0 111.589 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.615 HD11 ' HB1' ' A' ' 25' ' ' ALA . 40.4 tp -89.57 111.69 22.69 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.121 176.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -77.28 107.9 10.02 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.818 0.847 . . . . 0.0 109.349 172.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -102.04 113.54 26.88 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.41 HG22 ' NE2' ' A' ' 115' ' ' GLN . 28.2 t -108.34 101.83 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -80.18 153.11 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.142 0.496 . . . . 0.0 110.678 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.4 p -154.32 170.28 21.68 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.305 1.042 . . . . 0.0 109.635 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.72 18.95 30.82 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.31 86.87 0.32 Allowed Glycine 0 C--N 1.352 1.448 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.31 -168.29 12.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' THR . 2.2 pp -120.5 147.88 44.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.429 0.692 . . . . 0.0 112.321 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.3 p -151.06 147.36 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 108.065 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 122' ' ' SER . 2.1 mp0 -78.93 162.8 25.74 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.589 0.631 . . . . 0.0 110.887 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.788 ' HB3' ' HB3' ' A' ' 124' ' ' LEU . . . -63.9 138.38 58.45 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.084 0.554 . . . . 0.0 111.538 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.1 -7.55 81.05 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 123.68 0.612 . . . . 0.0 112.507 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.41 -175.83 49.65 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-O 121.039 0.244 . . . . 0.0 113.332 -178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.4 p -125.19 159.45 31.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.408 1.083 . . . . 0.0 109.692 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.0 tp -152.45 122.16 6.93 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -96.6 112.56 24.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.491 0.716 . . . . 0.0 109.997 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.0 mm? -94.21 156.71 16.41 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.477 1.111 . . . . 0.0 109.699 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.2 t -133.45 152.92 51.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -149.98 109.83 4.08 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.51 121.0 26.63 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.615 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -105.25 129.59 53.58 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.695 0.798 . . . . 0.0 109.518 -175.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.7 t -142.63 154.43 44.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 109.61 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.59 -114.2 4.57 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 3' ' ' LEU . 1.6 mmp_? -61.94 134.36 56.56 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.063 0.545 . . . . 0.0 111.218 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -63.95 104.96 0.77 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.359 0.664 . . . . 0.0 110.393 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -64.06 -18.47 64.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.66 0.384 . . . . 0.0 110.265 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 52.0 p -66.79 -9.52 37.96 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.394 1.077 . . . . 0.0 112.484 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.9 t -98.02 -11.66 22.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 0.0 110.846 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.69 156.55 42.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.006 0.522 . . . . 0.0 111.442 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.96 143.86 26.05 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.419 ' SD ' HG21 ' A' ' 80' ' ' VAL . 10.1 ptm -128.88 170.02 13.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.193 0.597 . . . . 0.0 110.761 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.64 158.33 31.13 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.158 0.286 . . . . 0.0 113.051 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -104.62 136.48 44.09 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.735 0.814 . . . . 0.0 109.773 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -129.94 153.02 48.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.795 1.238 . . . . 0.0 108.178 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.39 157.98 45.53 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.397 0.544 . . . . 0.0 111.764 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' NE2' ' HG3' ' A' ' 46' ' ' ARG . 3.9 pt20 -164.85 155.39 14.22 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.217 0.948 . . . . 0.0 110.126 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 175.22 -60.49 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.806 1.242 . . . . 0.0 110.387 168.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.75 70.85 7.36 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.152 1.901 . . . . 0.0 112.941 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 22.2 66.62 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.62 -173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 60.6 mmtt -99.23 144.6 28.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.302 1.041 . . . . 0.0 110.981 -174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.52 173.21 8.46 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.966 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HG3' ' NE2' ' A' ' 40' ' ' GLN . 1.9 mtm180 -66.61 103.76 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.75 152.65 20.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.287 0.635 . . . . 0.0 109.964 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.11 112.83 2.53 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.674 0.79 . . . . 0.0 109.653 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -92.6 -54.87 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.1 164.07 25.55 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.355 -175.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 t -141.31 131.71 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.88 1.272 . . . . 0.0 108.283 170.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -122.86 151.53 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.336 0.655 . . . . 0.0 109.633 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 58' ' ' ARG . 29.4 t-20 -82.09 147.48 29.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.583 0.753 . . . . 0.0 109.17 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.456 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 58.5 p-90 -54.84 -39.3 68.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.525 1.13 . . . . 0.0 113.102 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.8 t -80.72 -19.02 45.97 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.913 0.885 . . . . 0.0 110.699 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.97 61.73 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.122 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -74.04 -22.11 59.68 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.992 0.517 . . . . 0.0 110.804 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 53' ' ' ASN . 28.8 mmt180 -133.76 137.79 45.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.194 0.997 . . . . 0.0 110.607 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.0 p -136.25 132.21 35.5 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.454 1.102 . . . . 0.0 108.582 168.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -126.32 138.46 53.59 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -131.98 148.59 52.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.795 0.438 . . . . 0.0 110.237 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 147.63 41.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 168.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -50.33 -43.52 53.93 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.274 1.03 . . . . 0.0 113.157 -174.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 m -71.44 -29.69 65.16 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.67 0.788 . . . . 0.0 112.401 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.68 -7.35 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 111.366 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -69.7 132.26 45.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 0.0 110.427 -177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.67 8.06 74.12 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.705 0.628 . . . . 0.0 113.826 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' HG3' ' HD1' ' A' ' 69' ' ' PHE . 15.6 ptt180 -144.08 -26.76 0.53 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.057 0.543 . . . . 0.0 111.265 176.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HD1' ' HG3' ' A' ' 68' ' ' ARG . 3.3 m-85 -96.27 152.56 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.8 m -150.24 134.3 17.0 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.682 1.193 . . . . 0.0 108.361 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -105.19 133.01 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -132.86 163.49 28.98 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.75 146.42 16.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.154 0.502 . . . . 0.0 110.656 173.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -105.1 121.23 43.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.473 0.709 . . . . 0.0 109.285 170.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.48 -35.51 75.64 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.253 0.621 . . . . 0.0 109.968 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.17 -23.82 66.53 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.637 0.775 . . . . 0.0 112.158 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.23 -20.0 13.64 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.389 0.676 . . . . 0.0 111.078 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 59.41 35.53 23.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.791 1.236 . . . . 0.0 110.757 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -124.27 132.17 53.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.43 0.692 . . . . 0.0 110.349 -174.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG21 ' SD ' ' A' ' 35' ' ' MET . 50.3 t -99.43 130.48 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.524 1.13 . . . . 0.0 109.998 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -113.47 114.56 26.72 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.676 0.79 . . . . 0.0 109.667 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.8 tm? -97.18 104.07 16.06 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.532 ' H ' HE21 ' A' ' 83' ' ' GLN . 0.0 OUTLIER -88.24 120.73 29.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.624 0.77 . . . . 0.0 110.493 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.464 ' HB3' HD21 ' A' ' 87' ' ' LEU . 62.9 mtt -105.49 147.74 27.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.291 1.036 . . . . 0.0 109.301 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -141.72 158.12 44.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.038 0.935 . . . . 0.0 108.514 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.1 m 55.35 41.57 31.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.047 0.939 . . . . 0.0 112.025 171.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 84' ' ' MET . 76.1 mt -68.25 118.45 11.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 42.3 mtpt -84.2 154.36 63.33 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.919 -1.038 . . . . 0.0 108.314 172.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 10.8 Cg_endo -52.99 -19.7 11.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.022 2.481 . . . . 0.0 114.415 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 88' ' ' LYS . 11.9 pt-20 -76.09 -12.33 60.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.14 0.976 . . . . 0.0 112.849 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.54 -5.34 56.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.314 0.646 . . . . 0.0 112.148 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 120' ' ' THR . 86.8 m -61.51 103.9 0.36 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.403 0.681 . . . . 0.0 110.686 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.02 160.39 12.0 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.982 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 7.6 p -85.22 111.94 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.264 0.554 . . . . 0.0 109.975 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -88.8 113.41 24.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.35 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.53 126.47 48.34 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.379 1.072 . . . . 0.0 108.746 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.6 t -84.66 136.31 33.8 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -132.16 161.52 33.13 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.936 0.895 . . . . 0.0 109.802 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -147.77 167.96 23.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.481 0.712 . . . . 0.0 110.032 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.77 39.39 13.98 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -174.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -67.63 112.25 4.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.009 0.923 . . . . 0.0 110.107 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -74.66 132.29 41.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.86 102.02 12.07 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.43 149.6 5.04 Favored Glycine 0 C--O 1.244 0.743 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.5 p -77.18 79.02 3.71 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.425 0.631 . . . . 0.0 110.432 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -126.91 -66.1 0.92 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 57.18 -155.33 0.33 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.209 1.004 . . . . 0.0 111.603 174.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.73 -62.67 0.58 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.8 127.82 3.64 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.114 0.965 . . . . 0.0 108.467 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.71 145.41 95.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.675 2.25 . . . . 0.0 111.894 175.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -69.88 -47.85 61.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.286 0.565 . . . . 0.0 110.112 -177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 54.0 m-85 -112.66 146.38 38.77 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.4 p90 -150.33 168.79 23.06 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.298 0.639 . . . . 0.0 109.84 170.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -111.2 -168.23 18.8 Favored Glycine 0 C--O 1.239 0.447 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.379 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.41 ' NE2' HG22 ' A' ' 6' ' ' VAL . 74.5 mt-30 -83.73 -39.27 20.31 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.15 0.98 . . . . 0.0 110.575 -174.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.25 132.67 7.84 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.551 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.5 t -107.84 111.69 23.96 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.916 0.886 . . . . 0.0 108.744 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 7.8 tm0? -79.24 110.26 14.34 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -96.15 140.35 17.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.555 ' HA ' HG23 ' A' ' 92' ' ' THR . 86.2 m -121.18 112.28 18.45 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 2.0 p -102.57 119.2 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.475 0.655 . . . . 0.0 109.294 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 5.8 m -65.24 139.0 58.59 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.186 1.394 . . . . 0.0 111.034 -175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.401 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 24.0 t -76.0 79.89 2.86 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.659 0.784 . . . . 0.0 110.647 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 64.7 tp -79.84 97.98 6.89 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.38 131.48 48.4 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -82.18 101.02 10.19 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -74.43 104.48 5.18 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.043 0.937 . . . . 0.0 109.831 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -71.88 125.23 26.67 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -67.24 99.1 0.66 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -80.61 102.99 10.15 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.192 -177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 171.549 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 70.8 143.01 0.05 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.466 1.506 . . . . 0.0 111.773 -176.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 tp -89.91 112.5 23.88 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -92.81 116.9 29.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.984 0.914 . . . . 0.0 109.839 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.501 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 91.9 mt -118.51 123.05 44.18 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.832 0.853 . . . . 0.0 110.292 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 39.2 t -108.12 104.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.437 1.095 . . . . 0.0 109.421 -174.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -76.29 152.58 36.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.797 0.439 . . . . 0.0 110.916 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -149.13 146.12 27.52 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.981 0.912 . . . . 0.0 110.276 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.13 20.71 8.15 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.259 0.35 . . . . 0.0 113.079 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.98 85.91 0.67 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.81 -164.29 10.97 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.15 144.25 45.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.084 0.554 . . . . 0.0 111.468 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 19' ' ' LEU . 7.5 p -152.02 152.23 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.834 1.254 . . . . 0.0 108.51 175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.53 156.98 30.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.532 0.733 . . . . 0.0 112.412 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 139.77 57.13 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.095 172.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.52 -20.05 33.07 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 123.063 0.227 . . . . 0.0 112.816 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.4 -177.37 51.77 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-O 121.178 0.321 . . . . 0.0 113.467 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 p -115.13 160.7 19.36 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.073 0.949 . . . . 0.0 110.878 -177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' HB2' HG11 ' A' ' 13' ' ' VAL . 40.8 tp -156.52 125.7 6.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.97 115.86 27.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.855 0.462 . . . . 0.0 109.979 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 3.5 mm? -94.6 156.38 16.46 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.1 t -144.78 144.72 31.31 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 35.5 t -124.98 113.72 18.19 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.924 0.889 . . . . 0.0 108.905 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . . . -83.82 112.9 20.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.7 122.87 45.96 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.244 0.618 . . . . 0.0 109.401 -171.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 m -62.79 126.08 26.11 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.02 74.44 0.01 OUTLIER Glycine 0 C--N 1.357 1.741 0 O-C-N 125.246 1.591 . . . . 0.0 115.691 -166.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -98.39 -174.79 2.92 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.867 1.267 . . . . 0.0 108.834 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.6 p -83.18 86.38 7.04 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.16 -26.35 65.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 35.4 p -66.03 -13.91 60.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.227 . . . . 0.0 113.055 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.1 m -82.19 -14.64 55.29 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.168 0.587 . . . . 0.0 111.954 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.14 140.94 44.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.064 0.545 . . . . 0.0 111.382 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.59 137.52 38.63 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 165.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.519 ' SD ' ' SG ' ' A' ' 97' ' ' CYS . 17.4 ttp -126.37 154.79 43.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.6 0.76 . . . . 0.0 109.644 -169.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.54 161.51 32.25 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 117.714 0.234 . . . . 0.0 113.101 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -97.79 139.47 33.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.825 0.85 . . . . 0.0 109.379 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.343 1.057 . . . . 0.0 109.162 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HD3' ' OH ' ' A' ' 95' ' ' TYR . 28.3 ptt180 -131.52 161.56 32.3 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.017 0.371 . . . . 0.0 111.775 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 94' ' ' VAL . 5.0 pt20 -171.91 146.74 2.07 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.357 171.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -178.11 -61.24 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 123.891 0.876 . . . . 0.0 111.252 171.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 84.3 Cg_endo -80.35 70.27 7.59 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.155 1.903 . . . . 0.0 112.745 -171.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.65 6.16 80.58 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.356 -0.838 . . . . 0.0 113.551 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.25 141.49 28.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.545 0.738 . . . . 0.0 110.633 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.38 176.95 7.61 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 162.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -60.41 104.76 0.36 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.961 0.504 . . . . 0.0 109.833 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.92 148.59 24.31 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.412 0.685 . . . . 0.0 109.634 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.53 121.16 14.28 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.522 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -104.88 -59.29 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -164.88 142.9 6.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.605 0.362 . . . . 0.0 110.434 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG11 ' HD2' ' A' ' 101' ' ' LYS . 61.0 t -123.99 130.44 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.107 0.963 . . . . 0.0 109.816 173.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 59' ' ' THR . 10.6 p -106.39 153.93 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.771 0.828 . . . . 0.0 109.507 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -75.49 151.71 37.96 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 49.5 p90 -59.69 -36.57 76.76 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.597 0.759 . . . . 0.0 112.165 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -84.46 -15.11 47.25 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.72 0.808 . . . . 0.0 111.18 174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.38 13.7 79.99 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 116.416 -0.356 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -63.42 -49.41 73.84 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.679 0.792 . . . . 0.0 111.035 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -114.41 148.05 38.31 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.657 0.783 . . . . 0.0 110.115 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 52' ' ' VAL . 38.0 p -137.82 147.07 44.24 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.126 0.971 . . . . 0.0 109.133 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -132.98 129.89 38.8 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -122.32 145.96 47.76 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.84 148.59 36.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.46 -26.42 68.51 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 123.394 0.434 . . . . 0.0 111.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -67.17 -41.51 85.83 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.856 0.863 . . . . 0.0 111.186 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.2 m -112.65 13.46 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.398 0.679 . . . . 0.0 111.65 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -62.93 105.94 0.75 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.366 1.066 . . . . 0.0 111.74 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.63 -26.04 18.13 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.768 176.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.411 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 16.6 ptp180 -84.54 -28.61 26.53 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 117.634 0.717 . . . . 0.0 110.43 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.411 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 3.7 m-30 -101.85 150.34 23.27 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.45 0.7 . . . . 0.0 109.44 172.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.3 m -147.63 132.74 18.28 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.04 0.936 . . . . 0.0 109.203 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.459 HG12 HD23 ' A' ' 82' ' ' LEU . 19.9 mt -101.88 138.63 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -135.77 156.14 49.27 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 154.55 34.22 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.323 0.582 . . . . 0.0 110.29 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -127.82 109.11 11.3 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -70.33 -30.92 68.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.704 0.802 . . . . 0.0 110.594 -177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.8 -38.31 54.2 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.117 0.567 . . . . 0.0 111.45 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 11.4 mmpt? -79.06 -17.89 54.42 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.31 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 60.74 32.86 20.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.554 1.142 . . . . 0.0 109.832 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 m -133.63 133.09 41.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.435 0.694 . . . . 0.0 110.579 -172.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 23' ' ' CYS . 45.1 t -104.06 155.43 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.4 1.08 . . . . 0.0 109.425 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -134.54 137.97 44.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.32 1.048 . . . . 0.0 109.631 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 3.1 tm? -122.73 105.66 10.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.7 107.96 18.88 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.802 0.841 . . . . 0.0 110.007 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.528 ' SD ' HD21 ' A' ' 87' ' ' LEU . 47.3 mtt -87.9 138.53 31.38 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.68 0.792 . . . . 0.0 109.402 174.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -139.73 133.2 30.15 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.8 m 58.36 72.93 0.5 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.717 0.807 . . . . 0.0 111.664 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 ' SD ' ' A' ' 84' ' ' MET . 49.8 mt -71.76 136.74 47.24 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.109 174.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' O ' HG11 ' A' ' 121' ' ' VAL . 53.7 mtpt -74.64 152.2 87.23 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.266 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.26 -25.16 79.45 Favored 'Trans proline' 0 CA--C 1.56 1.778 0 C-N-CA 122.297 1.998 . . . . 0.0 113.787 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.94 6.76 48.11 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.985 0.914 . . . . 0.0 112.931 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.39 -9.48 56.42 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 123.271 0.628 . . . . 0.0 112.315 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.402 ' OG1' HG12 ' A' ' 121' ' ' VAL . 89.1 m -53.77 106.2 0.18 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.841 0.856 . . . . 0.0 111.149 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -163.84 158.55 20.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.792 0.837 . . . . 0.0 110.017 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 40' ' ' GLN . 15.0 p -89.65 124.54 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.403 ' OH ' ' HD3' ' A' ' 39' ' ' ARG . 23.6 m-85 -98.25 122.45 41.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.029 0.932 . . . . 0.0 110.297 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.9 128.0 56.35 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SD ' ' A' ' 35' ' ' MET . 46.8 t -83.78 103.06 12.76 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.52 131.63 52.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.656 0.782 . . . . 0.0 111.134 -175.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -107.99 167.61 9.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.574 0.75 . . . . 0.0 110.535 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.06 62.79 1.79 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.513 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.515 ' HD2' HG11 ' A' ' 51' ' ' VAL . 53.6 tttm -61.59 120.84 11.35 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 87.9 m95 66.66 104.83 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.797 1.31 . . . . 0.0 108.776 -160.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.21 164.31 11.2 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.071 0.549 . . . . 0.0 111.511 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -178.05 -40.97 0.06 OUTLIER Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.167 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.3 t -71.65 -45.92 60.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.299 0.639 . . . . 0.0 110.722 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -135.52 156.7 48.47 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.624 0.769 . . . . 0.0 110.195 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -80.19 133.8 36.07 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.201 0.6 . . . . 0.0 110.274 173.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.56 163.99 13.27 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.09 -47.18 95.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 171.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -92.5 142.96 2.4 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 121.886 1.724 . . . . 0.0 111.634 161.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -72.84 -50.53 23.5 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 122.028 0.918 . . . . 0.0 108.8 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -119.65 153.58 35.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -136.73 154.85 50.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.123 0.487 . . . . 0.0 111.405 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 5' ' ' LEU . . . -82.28 161.45 41.2 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 164.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.87 11.25 6.28 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.37 138.69 1.69 Allowed Glycine 0 C--N 1.347 1.148 0 C-N-CA 123.224 0.44 . . . . 0.0 113.879 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.2 t -136.45 107.14 6.57 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -75.31 105.77 6.5 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.282 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 m -91.64 140.69 15.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 m -125.8 136.84 53.58 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.3 p -114.88 125.38 72.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.054 0.454 . . . . 0.0 110.143 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.0 t -83.42 111.71 19.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.1 p -77.82 138.18 38.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.818 0.847 . . . . 0.0 111.279 -174.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 71.65 -10.24 0.85 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.475 1.51 . . . . 0.0 113.493 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -68.8 100.18 1.13 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.32 0.509 . . . . 0.0 110.906 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -147.45 -48.45 0.17 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.371 1.069 . . . . 0.0 109.206 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 63.22 34.46 13.39 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 124.588 1.155 . . . . 0.0 109.363 -174.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -69.07 109.16 3.87 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.794 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -103.35 144.49 31.3 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.701 0.8 . . . . 0.0 108.956 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -82.48 116.87 22.12 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.806 0.442 . . . . 0.0 110.695 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 . . . . . 0 CA--C 1.551 1.007 0 C-N-CA 123.653 0.781 . . . . 0.0 109.134 174.882 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HG3' ' HG2' ' A' ' 28' ' ' ARG . 45.0 tpp . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -133.3 154.0 51.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.022 0.929 . . . . 0.0 109.85 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 41.0 tp -86.18 111.05 20.02 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.47 128.09 34.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.905 0.882 . . . . 0.0 109.381 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.2 126.46 42.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.277 1.031 . . . . 0.0 108.737 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.27 104.1 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.636 0.775 . . . . 0.0 109.679 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.36 137.36 32.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.891 0.877 . . . . 0.0 109.558 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 m -147.64 171.44 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.758 0.823 . . . . 0.0 110.335 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.36 13.13 66.23 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.037 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.37 145.73 18.61 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -175.43 -164.46 30.0 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.832 0.316 . . . . 0.0 112.549 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 pp -81.09 144.11 31.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.129 0.572 . . . . 0.0 110.157 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 7.5 p -150.83 151.71 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.247 1.019 . . . . 0.0 108.526 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -83.06 155.61 23.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.676 0.391 . . . . 0.0 110.256 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . . . -72.98 129.57 38.4 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.39 66.12 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 123.772 0.701 . . . . 0.0 111.423 -167.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.87 -166.52 31.82 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.198 0.428 . . . . 0.0 113.698 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 p -147.58 160.83 42.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.272 1.029 . . . . 0.0 110.269 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.5 tp -155.99 147.64 22.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.012 0.925 . . . . 0.0 108.547 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -128.11 118.68 23.86 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.281 0.492 . . . . 0.0 109.995 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 84' ' ' MET . 2.5 mm? -90.51 157.43 17.54 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.89 0.876 . . . . 0.0 109.857 177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -142.15 123.77 15.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -122.74 118.74 28.75 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.981 0.512 . . . . 0.0 110.824 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.51 123.97 30.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.329 0.651 . . . . 0.0 110.09 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.81 143.43 38.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.1 0.96 . . . . 0.0 110.121 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -160.07 176.44 11.8 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.259 0.624 . . . . 0.0 110.419 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.85 -96.48 1.56 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . 66.1 mtp180 -79.79 143.53 34.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.1 m -73.47 103.33 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -58.21 -25.9 62.19 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.01 0.924 . . . . 0.0 111.884 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 54' ' ' TRP . 43.7 p -76.05 0.45 18.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.773 0.829 . . . . 0.0 112.502 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -87.88 -13.69 41.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.15 0.58 . . . . 0.0 110.143 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -124.53 170.42 10.92 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.386 0.674 . . . . 0.0 110.571 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 133.62 34.9 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.476 ' SD ' HG11 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -129.12 131.41 47.22 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.486 0.714 . . . . 0.0 109.35 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -152.23 159.98 28.66 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 114.223 0.449 . . . . 0.0 114.223 -176.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -97.52 132.61 43.04 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.295 1.038 . . . . 0.0 110.384 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -129.59 129.94 45.04 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.814 1.246 . . . . 0.0 108.387 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -114.53 156.67 24.18 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 122.502 0.321 . . . . 0.0 111.63 -174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' O ' HG12 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -167.23 149.27 5.95 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.83 0.706 . . . . 0.0 110.504 173.1 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 42' ' ' PRO . . . -179.73 -59.68 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.813 0.845 . . . . 0.0 111.32 169.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 41' ' ' ALA . 88.3 Cg_endo -83.21 73.86 5.1 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.155 1.903 . . . . 0.0 112.481 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.03 74.46 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.181 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.6 mmpt? -115.7 145.5 42.7 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.542 0.737 . . . . 0.0 111.343 -173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.89 169.85 10.89 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 161.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -64.12 103.8 0.65 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.414 0.626 . . . . 0.0 110.14 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.49 150.38 20.37 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.573 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.01 108.59 1.85 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.946 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.6 t -90.11 -68.03 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -163.6 134.28 4.5 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.577 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG11 ' HE1' ' A' ' 102' ' ' TRP . 94.5 t -116.17 134.02 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 0.0 109.596 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 59' ' ' THR . 8.1 p -107.27 148.87 11.16 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 C-N-CA 123.448 0.699 . . . . 0.0 110.595 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.1 149.97 35.67 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 168.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 61.8 p-90 -60.02 -34.94 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 0.0 112.925 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.3 p -86.86 -10.94 52.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 111.495 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.38 15.52 78.15 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.394 -171.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -59.62 -46.65 88.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.113 0.965 . . . . 0.0 111.11 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 -133.57 129.25 36.75 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 52' ' ' VAL . 36.4 p -117.45 128.7 55.25 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.44 117.13 32.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.39 154.54 27.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 110.309 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.23 146.12 39.28 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 161.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.95 -25.91 67.14 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.905 0.482 . . . . 0.0 112.109 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 t -70.46 -41.95 72.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.751 0.821 . . . . 0.0 110.878 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 69' ' ' PHE . 8.1 m -94.63 -4.61 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.293 0.637 . . . . 0.0 111.992 -173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -67.36 119.4 12.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 0.0 111.094 -175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.0 -26.64 17.88 Favored Glycine 0 C--N 1.347 1.14 0 C-N-CA 123.525 0.583 . . . . 0.0 113.951 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -96.27 -13.5 23.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.364 0.666 . . . . 0.0 110.79 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.508 ' CD1' ' HB ' ' A' ' 65' ' ' VAL . 97.3 m-85 -123.76 155.83 37.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.423 0.689 . . . . 0.0 109.261 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.3 m -148.77 138.1 21.76 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 108.289 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.617 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -102.81 144.5 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 m -136.48 155.87 49.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 173.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.71 157.23 36.26 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.65 119.37 13.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.83 -4.94 58.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.009 0.924 . . . . 0.0 112.269 -172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.99 -54.1 4.69 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -78.52 -14.23 59.45 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.873 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 60.94 34.47 19.45 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.627 1.171 . . . . 0.0 111.301 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.6 m -119.22 132.46 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.251 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.476 HG11 ' SD ' ' A' ' 35' ' ' MET . 51.6 t -104.33 119.39 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.142 0.977 . . . . 0.0 109.965 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.26 121.1 41.61 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.702 0.801 . . . . 0.0 110.281 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -105.64 110.54 22.9 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -84.84 102.81 13.37 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.902 0.881 . . . . 0.0 109.899 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.621 ' HB3' HD21 ' A' ' 87' ' ' LEU . 83.8 mtp -87.38 140.28 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 0.0 108.669 171.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -156.67 154.83 30.72 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 123.071 0.232 . . . . 0.0 110.733 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.0 m 61.07 38.65 16.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.447 1.099 . . . . 0.0 110.312 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.9 mt -68.11 129.16 39.09 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.188 -169.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -100.69 154.42 37.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.466 1.107 . . . . 0.0 108.077 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.847 ' HB3' ' HA ' ' A' ' 123' ' ' SER . 12.1 Cg_endo -53.77 -24.42 30.52 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 123.446 2.764 . . . . 0.0 114.78 -174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -78.86 -13.85 59.57 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 112.68 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.5 -2.1 33.78 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.723 0.809 . . . . 0.0 112.208 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.561 HG23 ' HA ' ' A' ' 120' ' ' THR . 65.8 m -62.71 107.91 1.06 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.23 0.612 . . . . 0.0 109.805 174.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.18 160.01 9.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.572 0.545 . . . . 0.0 110.898 -172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 40' ' ' GLN . 14.4 p -85.68 115.64 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -94.28 116.25 28.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.106 0.962 . . . . 0.0 108.807 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.06 131.44 48.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.028 0.531 . . . . 0.0 109.72 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.4 t -82.16 102.07 10.85 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.48 162.08 14.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.306 1.042 . . . . 0.0 110.669 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.9 128.52 14.17 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.917 0.887 . . . . 0.0 108.951 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.12 158.92 31.21 Favored Glycine 0 C--O 1.241 0.553 0 O-C-N 123.768 0.668 . . . . 0.0 111.637 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -82.49 127.85 33.71 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.658 ' HE1' HG11 ' A' ' 51' ' ' VAL . 17.3 p-90 -147.47 137.64 23.1 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -83.38 -42.65 16.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.192 0.597 . . . . 0.0 110.888 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.69 -89.93 0.1 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 m -66.07 -45.34 81.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.443 0.697 . . . . 0.0 109.342 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -82.62 104.98 13.28 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -94.11 155.97 16.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.778 171.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.75 -114.83 4.01 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 174.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.77 132.41 7.77 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.76 110.66 0.86 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.01 1.807 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.6 -44.15 71.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.162 0.506 . . . . 0.0 109.839 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -112.42 150.47 31.1 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.342 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -158.32 151.96 23.47 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.691 1.196 . . . . 0.0 108.316 164.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.63 -163.26 26.43 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.956 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.49 -38.03 86.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.859 0.864 . . . . 0.0 110.123 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.34 130.88 7.17 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.909 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.3 t -99.93 108.26 20.45 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.698 0.799 . . . . 0.0 109.416 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -79.34 102.86 8.89 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.528 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.9 m -91.62 137.11 22.64 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.561 ' HA ' HG23 ' A' ' 92' ' ' THR . 24.0 m -121.02 104.68 9.98 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 3.2 p -100.42 117.11 45.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.5 t -61.95 140.96 58.28 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.847 ' HA ' ' HB3' ' A' ' 89' ' ' PRO . 50.0 p -75.58 107.24 7.59 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.349 -175.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -67.66 148.89 50.75 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.521 ' H ' HD13 ' A' ' 124' ' ' LEU . 35.9 mt-10 -54.19 122.45 10.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.925 0.89 . . . . 0.0 112.551 -175.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -95.8 89.51 5.31 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.404 0.682 . . . . 0.0 109.901 173.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -92.62 94.5 9.06 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 166.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -57.09 139.75 51.41 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.775 0.672 . . . . 0.0 111.246 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -68.84 91.64 0.46 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.594 0.758 . . . . 0.0 111.68 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -175.08 125.16 0.26 Allowed 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.369 1.068 . . . . 0.0 109.391 168.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.1 p80 . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 123.04 0.536 . . . . 0.0 109.916 175.432 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 120.717 0.294 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -151.92 172.73 15.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.397 0.679 . . . . 0.0 110.876 -171.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB1' ' A' ' 25' ' ' ALA . 52.9 tp -85.93 112.43 21.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.746 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 24.9 tt0 -102.83 105.65 16.09 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.599 0.76 . . . . 0.0 109.631 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HB3' ' SG ' ' A' ' 97' ' ' CYS . 79.1 mt -91.01 127.23 36.35 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.594 0.758 . . . . 0.0 109.346 177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.11 102.86 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.912 0.885 . . . . 0.0 109.042 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.58 123.19 29.52 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.1 0.56 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -117.9 130.8 56.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.558 1.143 . . . . 0.0 108.816 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.92 4.99 1.46 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-O 119.861 -0.411 . . . . 0.0 113.345 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.71 102.83 0.8 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.999 0.399 . . . . 0.0 112.17 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.84 -174.56 34.7 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.36 145.2 26.42 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.148 0.499 . . . . 0.0 111.812 -176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -146.85 154.85 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.47 1.108 . . . . 0.0 108.655 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -87.47 151.31 23.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.864 0.465 . . . . 0.0 111.233 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.91 110.35 5.59 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.431 0.692 . . . . 0.0 110.427 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.25 -4.11 40.8 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.202 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.99 -167.56 42.29 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.667 0.275 . . . . 0.0 112.955 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.7 m -124.92 157.86 34.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.855 0.862 . . . . 0.0 110.733 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.3 tp -155.04 123.15 5.86 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.799 0.84 . . . . 0.0 108.833 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -93.66 119.68 32.97 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 82' ' ' LEU . 1.9 mm? -103.84 153.89 20.23 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.83 123.31 8.45 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 51.9 t -104.99 127.52 52.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.344 0.658 . . . . 0.0 110.087 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.22 127.14 38.68 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.618 0.767 . . . . 0.0 109.601 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -104.83 128.77 53.13 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.591 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 4.1 m -120.2 151.08 39.64 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.717 0.807 . . . . 0.0 110.947 -169.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.38 -88.2 0.51 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 124.1 0.875 . . . . 0.0 112.832 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -74.25 146.49 43.21 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 0.0 110.528 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.0 p -65.18 110.1 2.43 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.621 0.768 . . . . 0.0 109.958 170.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 78' ' ' ASN . 2.4 p90 -61.45 -23.92 66.19 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.325 0.65 . . . . 0.0 110.701 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.3 p -72.03 -8.54 55.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 113.157 -175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 m -83.27 -2.67 56.21 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.847 0.459 . . . . 0.0 110.735 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -135.97 163.67 29.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.105 0.962 . . . . 0.0 109.967 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.13 127.18 46.42 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.693 ' SD ' ' HB2' ' A' ' 97' ' ' CYS . 8.7 tmm? -119.97 135.91 54.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.693 0.397 . . . . 0.0 109.974 -170.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.688 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -133.07 166.22 23.76 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 123.157 0.408 . . . . 0.0 113.511 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -115.89 145.07 43.2 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 124.034 0.933 . . . . 0.0 108.991 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -136.15 146.22 46.67 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.741 1.216 . . . . 0.0 108.907 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -125.38 148.1 48.9 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 118.238 0.472 . . . . 0.0 110.506 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.84 155.02 4.5 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 123.584 0.754 . . . . 0.0 111.18 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 44' ' ' LYS . . . 177.14 -61.07 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.802 1.241 . . . . 0.0 110.263 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.26 75.56 5.0 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 122.377 2.052 . . . . 0.0 112.603 -170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.16 24.18 70.26 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.594 -174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 28.4 mmmt -112.11 144.88 40.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.533 1.133 . . . . 0.0 110.374 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -103.87 160.93 14.39 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.906 0.882 . . . . 0.0 109.433 168.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -58.75 105.37 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.143 0.577 . . . . 0.0 111.236 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.78 150.93 19.85 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' HZ ' ' HB3' ' A' ' 60' ' ' TYR . 54.1 t80 -59.11 111.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.522 1.129 . . . . 0.0 109.112 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -100.06 -65.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.43 130.34 5.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.35 0.119 . . . . 0.0 110.905 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.688 HG22 ' HA3' ' A' ' 36' ' ' GLY . 67.0 t -117.83 138.19 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.009 0.923 . . . . 0.0 108.762 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.627 HG21 HH11 ' A' ' 73' ' ' ARG . 11.7 p -124.73 140.53 47.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.2 155.98 22.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -55.84 -40.62 73.12 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -167.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.2 t -92.42 -0.79 57.33 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.43 0.692 . . . . 0.0 110.88 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.25 7.57 67.97 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-N 116.173 -0.467 . . . . 0.0 114.074 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -66.57 -38.82 87.87 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.678 0.791 . . . . 0.0 110.237 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -115.19 138.05 51.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.545 0.738 . . . . 0.0 109.478 174.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.0 p -131.67 144.6 51.14 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.601 1.16 . . . . 0.0 108.987 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.552 ' HB3' ' HZ ' ' A' ' 48' ' ' PHE . 85.1 m-85 -128.82 137.37 51.46 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.317 1.047 . . . . 0.0 108.248 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -138.85 150.39 45.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.391 0.676 . . . . 0.0 109.823 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.508 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -82.08 138.61 34.77 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.02 -28.37 67.68 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.204 0.602 . . . . 0.0 111.639 -174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 t -65.69 -41.8 91.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.283 1.033 . . . . 0.0 111.59 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 62' ' ' ALA . 22.6 m -103.06 -2.49 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.301 0.64 . . . . 0.0 111.735 -175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -64.85 117.71 7.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.538 0.735 . . . . 0.0 111.355 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.29 20.11 Favored Glycine 0 C--N 1.345 1.034 0 O-C-N 123.82 0.7 . . . . 0.0 113.332 177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG3' ' HD2' ' A' ' 69' ' ' PHE . 13.8 ptp180 -95.2 -23.34 17.31 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.141 0.496 . . . . 0.0 109.872 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD2' ' HG3' ' A' ' 68' ' ' ARG . 2.9 m-85 -107.03 153.52 22.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 170.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 83' ' ' GLN . 92.4 m -145.31 130.68 18.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.927 0.891 . . . . 0.0 109.468 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.494 ' HB ' ' HB ' ' A' ' 52' ' ' VAL . 1.2 pp -104.13 128.32 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.054 0.542 . . . . 0.0 110.273 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -139.16 166.09 25.45 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.616 1.166 . . . . 0.0 108.635 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.627 HH11 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -159.77 161.46 34.67 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.111 0.481 . . . . 0.0 110.915 177.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.6 114.09 17.6 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -67.5 -35.23 78.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.517 0.727 . . . . 0.0 111.983 -173.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.64 67.59 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.602 0.564 . . . . 0.0 111.364 -175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -83.16 -19.24 36.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.233 0.613 . . . . 0.0 111.779 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.508 ' HB3' ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 68.08 32.67 4.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.133 . . . . 0.0 110.692 -173.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.7 m -111.35 129.88 55.86 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.867 0.467 . . . . 0.0 110.073 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.78 144.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.752 0.821 . . . . 0.0 108.959 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 130.0 53.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.852 0.861 . . . . 0.0 109.803 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 2.9 tm? -115.33 106.68 14.29 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 16.1 mm100 -88.17 103.78 16.08 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.869 0.868 . . . . 0.0 109.682 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 61.8 mtt -87.28 133.89 33.62 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -141.1 145.3 35.61 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 46.3 m 56.23 47.03 20.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.164 0.986 . . . . 0.0 111.587 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -63.56 124.17 20.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.146 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' O ' HG11 ' A' ' 121' ' ' VAL . 44.5 mtpt -70.22 155.07 94.03 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 -14.76 29.37 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 122.6 2.2 . . . . 0.0 113.605 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.93 -3.02 56.48 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.335 0.654 . . . . 0.0 112.621 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.66 5.06 8.14 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 120' ' ' THR . 92.5 m -64.8 100.63 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 169.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.87 152.09 11.14 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.241 -171.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 4.1 p -80.35 123.11 36.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 170.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -94.72 139.11 31.69 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -137.93 121.36 17.15 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.193 0.997 . . . . 0.0 108.835 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.693 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 30.1 p -86.98 143.71 27.24 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -147.38 134.7 20.65 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.168 0.987 . . . . 0.0 109.729 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . . . -106.98 161.03 15.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.377 0.671 . . . . 0.0 110.834 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 111' ' ' ASP . . . -160.99 133.08 3.07 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.814 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -71.8 115.67 11.28 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 122.708 0.403 . . . . 0.0 110.384 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 96.0 m95 68.12 103.48 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.041 1.736 . . . . 0.0 112.243 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -126.19 143.36 51.17 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.602 0.761 . . . . 0.0 110.234 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.38 52.79 0.57 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 t 66.66 15.74 10.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.234 1.413 . . . . 0.0 110.963 -174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -137.95 41.15 2.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.373 1.069 . . . . 0.0 109.334 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -51.78 115.71 1.79 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.904 0.882 . . . . 0.0 110.398 171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.0 -46.46 93.48 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.45 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.25 154.57 20.03 Favored Pre-proline 0 C--O 1.244 0.78 0 C-N-CA 124.296 1.039 . . . . 0.0 109.155 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.2 96.07 0.22 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.003 1.802 . . . . 0.0 109.907 167.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB3' ' HA2' ' A' ' 100' ' ' GLY . 24.5 t0 -62.74 -37.34 86.19 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.669 177.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 99' ' ' ALA . 92.5 m-85 -133.13 167.83 19.62 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.628 166.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 38.4 p90 -154.35 169.3 24.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.02 0.928 . . . . 0.0 109.178 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -108.19 -172.63 21.69 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.648 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.77 -45.12 65.32 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.333 0.653 . . . . 0.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.13 135.88 1.17 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.451 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.7 t -143.26 140.83 30.83 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.236 0.541 . . . . 0.0 110.314 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 55.8 tp60 -80.42 122.7 27.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.359 1.063 . . . . 0.0 111.408 -171.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 m -98.65 145.14 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.497 ' HA ' HG23 ' A' ' 92' ' ' THR . 39.4 m -126.91 105.88 8.93 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.61 0.764 . . . . 0.0 109.339 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 88' ' ' LYS . 7.7 p -90.73 117.92 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.402 0.62 . . . . 0.0 109.928 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.1 t -67.34 117.87 9.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.954 0.901 . . . . 0.0 109.802 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.7 m -71.74 96.14 1.58 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.468 0.707 . . . . 0.0 110.382 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.72 105.87 18.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.73 173.44 15.26 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.752 0.821 . . . . 0.0 110.03 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -157.35 -58.5 0.08 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -163.23 -38.81 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.25 0.62 . . . . 0.0 110.884 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 38.7 m80 64.54 -177.22 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.534 1.134 . . . . 0.0 111.246 -170.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -142.32 120.93 12.54 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -108.94 115.28 29.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.017 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -55.84 107.77 0.38 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.937 0.895 . . . . 0.0 111.686 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 28' ' ' ARG . 64.5 tp -81.31 110.91 17.21 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.58 127.66 37.12 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.604 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 73.8 mt -114.23 131.64 56.41 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.443 ' HA ' HE21 ' A' ' 115' ' ' GLN . 59.1 t -114.71 100.37 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -82.6 130.31 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 109.634 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -138.21 139.99 39.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.311 1.044 . . . . 0.0 109.049 -175.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.62 13.32 5.2 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.55 64.89 3.97 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.95 -164.99 13.35 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 123.569 0.604 . . . . 0.0 111.702 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 120' ' ' THR . 4.4 pp -104.06 142.4 34.53 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.121 0.569 . . . . 0.0 111.568 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 p -151.41 144.21 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.883 1.273 . . . . 0.0 108.004 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HB3' HD22 ' A' ' 124' ' ' LEU . 27.1 mp0 -69.59 154.57 41.8 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.745 0.418 . . . . 0.0 111.662 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.38 115.47 5.13 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.461 174.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.32 -14.34 28.02 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 123.885 0.755 . . . . 0.0 111.701 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.33 -163.78 26.75 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 121.307 0.393 . . . . 0.0 113.766 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.5 p -144.61 150.93 38.25 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.69 0.796 . . . . 0.0 110.023 -177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -155.72 124.65 6.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.165 0.586 . . . . 0.0 109.942 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -92.28 129.42 38.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.174 0.59 . . . . 0.0 110.427 175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 82' ' ' LEU . 1.6 mm? -96.18 157.32 15.95 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.101 0.96 . . . . 0.0 109.084 172.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -144.7 124.1 13.09 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.171 0.589 . . . . 0.0 109.564 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 5' ' ' LEU . 53.5 t -114.53 115.43 27.2 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.519 0.728 . . . . 0.0 110.112 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.85 118.66 24.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.59 144.95 31.63 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.703 0.801 . . . . 0.0 109.759 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t -65.74 159.02 26.05 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.47 0.708 . . . . 0.0 109.895 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 55.16 4.79 Favored Glycine 0 N--CA 1.473 1.106 0 CA-C-O 121.302 0.39 . . . . 0.0 112.638 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 1.6 mmp_? -98.8 -171.35 2.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.824 1.25 . . . . 0.0 110.781 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.4 p -81.29 41.76 0.63 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.892 0.877 . . . . 0.0 112.217 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -69.13 -19.44 64.03 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.98 0.512 . . . . 0.0 111.817 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -77.39 -16.15 59.0 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 0.0 111.284 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.4 t -81.19 -12.84 59.07 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.998 0.519 . . . . 0.0 110.2 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.19 159.17 17.61 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 0.0 109.627 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.35 136.91 35.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.494 ' SD ' HG11 ' A' ' 80' ' ' VAL . 2.6 ttp -101.41 155.25 18.17 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.76 149.93 21.5 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 117.93 0.332 . . . . 0.0 112.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HE1' HG23 ' A' ' 71' ' ' ILE . 85.1 m95 -98.51 131.6 44.61 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.137 0.975 . . . . 0.0 109.564 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -131.37 166.6 20.91 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.686 1.194 . . . . 0.0 108.375 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -157.9 163.46 37.89 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 118.549 0.613 . . . . 0.0 111.408 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.91 162.88 9.46 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.072 0.949 . . . . 0.0 109.314 172.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.54 -58.1 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 C-N-CA 124.481 1.112 . . . . 0.0 110.891 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.23 69.0 8.13 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 122.692 2.262 . . . . 0.0 112.854 -170.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.08 18.81 67.33 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.657 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -107.72 146.64 31.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.535 0.734 . . . . 0.0 110.746 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.24 164.76 20.98 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.637 0.775 . . . . 0.0 108.926 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.13 104.91 0.42 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 121.214 0.53 . . . . 0.0 110.39 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -95.96 157.58 15.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.153 1.381 . . . . 0.0 110.727 -170.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -72.6 121.09 19.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.513 0.725 . . . . 0.0 110.344 172.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.74 -53.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -167.39 152.56 7.24 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.532 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -133.87 147.28 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.484 1.113 . . . . 0.0 108.782 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 71' ' ' ILE . 13.9 p -133.81 148.5 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 125.101 1.36 . . . . 0.0 108.948 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -77.71 161.63 27.59 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -56.92 -36.35 70.1 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -90.96 -8.37 49.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.075 0.55 . . . . 0.0 111.336 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.83 21.16 58.24 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 112.289 -0.324 . . . . 0.0 112.289 -173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -60.59 -58.47 8.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.682 0.793 . . . . 0.0 111.283 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -127.09 138.39 53.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.225 0.61 . . . . 0.0 109.989 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -119.74 160.23 22.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 110.64 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -141.97 139.45 32.45 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 107.692 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -134.55 152.89 52.09 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.129 0.571 . . . . 0.0 110.106 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.477 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -69.83 133.58 47.55 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 166.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -61.03 -29.37 69.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -168.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.7 m -67.45 -31.13 71.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.651 0.78 . . . . 0.0 111.64 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.477 HG22 ' HB3' ' A' ' 62' ' ' ALA . 20.8 m -113.47 6.96 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.821 0.848 . . . . 0.0 111.661 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -75.1 118.17 17.75 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.035 0.534 . . . . 0.0 111.845 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.61 -26.12 25.62 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.828 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -94.82 -17.98 21.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.218 0.607 . . . . 0.0 110.117 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -104.7 145.83 29.8 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.9 m -148.74 138.13 21.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.891 0.876 . . . . 0.0 109.43 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.555 HD11 ' HB1' ' A' ' 50' ' ' ALA . 2.9 mp -101.11 131.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.8 m -122.43 154.78 37.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.91 133.38 8.94 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.046 0.385 . . . . 0.0 110.146 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.39 108.11 18.03 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.66 -29.02 68.21 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.93 0.892 . . . . 0.0 111.059 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.73 68.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.246 0.618 . . . . 0.0 111.162 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -14.96 59.43 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.626 0.37 . . . . 0.0 110.714 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 62.31 28.34 16.88 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 124.667 1.229 . . . . 0.0 110.132 -176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 19.3 m -125.99 132.51 52.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.093 0.557 . . . . 0.0 110.259 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.494 HG11 ' SD ' ' A' ' 35' ' ' MET . 21.8 t -105.54 157.63 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.584 1.153 . . . . 0.0 109.137 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -137.84 145.36 42.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.818 1.247 . . . . 0.0 108.774 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 21' ' ' LEU . 2.9 tm? -134.37 108.61 8.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -87.07 104.98 16.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.336 0.654 . . . . 0.0 109.73 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.427 ' HB3' HD21 ' A' ' 87' ' ' LEU . 69.7 mtm -88.64 132.41 34.57 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -130.69 142.45 50.43 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t 57.73 70.98 0.61 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.05 0.94 . . . . 0.0 110.67 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 84' ' ' MET . 90.8 mt -84.45 157.17 21.45 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.417 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -118.31 156.89 50.38 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -60.28 -21.74 67.98 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.49 2.127 . . . . 0.0 113.059 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.94 -11.43 59.81 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.274 1.029 . . . . 0.0 112.871 -176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -83.08 1.48 40.0 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.829 0.452 . . . . 0.0 112.149 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 120' ' ' THR . 89.5 m -64.59 108.33 1.65 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.765 0.826 . . . . 0.0 110.397 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -168.1 164.04 13.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.418 0.687 . . . . 0.0 110.875 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.645 ' HA ' ' HA ' ' A' ' 118' ' ' GLN . 2.7 p -89.0 112.58 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 172.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -88.23 139.98 29.94 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -125.74 129.34 49.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.543 1.137 . . . . 0.0 108.753 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.44 121.98 28.93 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' TRP . . . -113.71 161.84 17.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.836 0.854 . . . . 0.0 110.006 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.83 143.86 29.9 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.832 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.49 165.74 30.76 Favored Glycine 0 C--O 1.239 0.439 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -72.85 111.79 8.3 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.29 1.77 4.53 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.604 1.162 . . . . 0.0 113.301 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.2 85.86 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.341 1.456 . . . . 0.0 109.473 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.08 -116.4 4.77 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -168.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.5 m 60.92 17.38 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.641 1.177 . . . . 0.0 113.666 171.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -70.63 -34.78 72.45 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.534 0.734 . . . . 0.0 110.264 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -115.56 98.16 6.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.76 -142.64 7.39 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.569 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.1 143.37 22.34 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.675 0.79 . . . . 0.0 109.981 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.81 147.85 93.93 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.702 2.268 . . . . 0.0 111.469 170.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.72 -47.33 72.67 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.287 0.635 . . . . 0.0 110.149 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -128.04 165.26 20.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.967 0.907 . . . . 0.0 109.993 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 44.7 p90 -158.43 167.09 30.61 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.105 0.962 . . . . 0.0 109.041 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.64 -161.26 29.99 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.991 -174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 6' ' ' VAL . 47.4 mt-30 -85.43 -57.46 3.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.114 0.966 . . . . 0.0 109.209 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.39 144.72 17.7 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.416 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -143.43 149.49 37.7 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.343 0.657 . . . . 0.0 109.291 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 94' ' ' VAL . 17.5 tm0? -91.36 118.11 30.24 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.376 0.67 . . . . 0.0 110.383 -169.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.28 126.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.447 0.641 . . . . 0.0 109.54 172.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' LEU . 88.4 m -102.32 104.67 15.2 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.779 176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.08 100.56 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 170.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.8 m -56.73 116.45 3.16 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.462 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.9 m -58.97 93.28 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.502 1.121 . . . . 0.0 110.205 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 14' ' ' GLN . 26.3 tp -79.87 -3.58 48.57 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.19 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 64.35 81.23 0.21 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 124.742 1.217 . . . . 0.0 108.743 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -75.72 117.91 17.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.538 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.7 m80 -86.3 -57.89 2.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.698 0.799 . . . . 0.0 111.247 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -86.77 80.98 8.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.268 0.627 . . . . 0.0 110.037 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -78.78 127.99 32.8 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.195 0.998 . . . . 0.0 111.624 -172.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -81.94 149.8 28.02 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.511 0.724 . . . . 0.0 109.943 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.9 t60 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 119.005 -0.521 . . . . 0.0 109.729 176.501 . . . . . . . . 0 0 . 1 stop_ save_